CHEMBL_IND_41739
type: DrugIndication
chembl id: CHEMBL_IND_41739
has molecule: CHEMBL22
highest development phase: 4
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_50158
type: DrugIndication
chembl id: CHEMBL_IND_50158
has molecule: CHEMBL6995
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_49683
type: DrugIndication
chembl id: CHEMBL_IND_49683
has molecule: CHEMBL35
highest development phase: 2
has mesh: D014860
has mesh heading: WARTS
has EFO: HP_0200043
has EFO name: VERRUCAE

CHEMBL_IND_27204
type: DrugIndication
chembl id: CHEMBL_IND_27204
has molecule: CHEMBL35
highest development phase: 1
has mesh: D004417
has mesh heading: DYSPNEA
has EFO: HP_0002094
has EFO name: DYSPNEA

CHEMBL_IND_45310
type: DrugIndication
chembl id: CHEMBL_IND_45310
has molecule: CHEMBL35
highest development phase: 2
has mesh: D001988
has mesh heading: BRONCHIOLITIS
has EFO: HP_0011950
has EFO name: BRONCHIOLITIS

CHEMBL_IND_52496
type: DrugIndication
chembl id: CHEMBL_IND_52496
has molecule: CHEMBL35
highest development phase: 3
has mesh: D007674
has mesh heading: KIDNEY DISEASES
has EFO: EFO_0003086
has EFO name: KIDNEY DISEASE

CHEMBL_IND_45092
type: DrugIndication
chembl id: CHEMBL_IND_45092
has molecule: CHEMBL35
highest development phase: 3
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_23218
type: DrugIndication
chembl id: CHEMBL_IND_23218
has molecule: CHEMBL35
highest development phase: 3
has mesh: D011655
has mesh heading: PULMONARY EMBOLISM
has EFO: EFO_0003827
has EFO name: PULMONARY EMBOLISM

CHEMBL_IND_23217
type: DrugIndication
chembl id: CHEMBL_IND_23217
has molecule: CHEMBL35
highest development phase: 3
has mesh: D008171
has mesh heading: LUNG DISEASES
has EFO: EFO_0003818
has EFO name: LUNG DISEASE

CHEMBL_IND_23216
type: DrugIndication
chembl id: CHEMBL_IND_23216
has molecule: CHEMBL35
highest development phase: 4
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0000373
has EFO name: CONGESTIVE HEART FAILURE

CHEMBL_IND_42655
type: DrugIndication
chembl id: CHEMBL_IND_42655
has molecule: CHEMBL35
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_24463
type: DrugIndication
chembl id: CHEMBL_IND_24463
has molecule: CHEMBL35
highest development phase: 4
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0003144
has EFO name: HEART FAILURE

CHEMBL_IND_51779
type: DrugIndication
chembl id: CHEMBL_IND_51779
has molecule: CHEMBL35
highest development phase: 2
has mesh: D058186
has mesh heading: ACUTE KIDNEY INJURY
has EFO: HP_0001919
has EFO name: ACUTE KIDNEY INJURY

CHEMBL_IND_51943
type: DrugIndication
chembl id: CHEMBL_IND_51943
has molecule: CHEMBL35
highest development phase: 2
has mesh: D001997
has mesh heading: BRONCHOPULMONARY DYSPLASIA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: BRONCHOPULMONARY DYSPLASIA

CHEMBL_IND_22684
type: DrugIndication
chembl id: CHEMBL_IND_22684
has molecule: CHEMBL405
highest development phase: 2
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_24137
type: DrugIndication
chembl id: CHEMBL_IND_24137
has molecule: CHEMBL405
highest development phase: 4
has mesh: D001289
has mesh heading: ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY
has EFO: EFO_0003888
has EFO name: ATTENTION DEFICIT HYPERACTIVITY DISORDER

CHEMBL_IND_23197
type: DrugIndication
chembl id: CHEMBL_IND_23197
has molecule: CHEMBL407
highest development phase: 1
has mesh: D007319
has mesh heading: SLEEP INITIATION AND MAINTENANCE DISORDERS
has EFO: EFO_0004698
has EFO name: INSOMNIA

CHEMBL_IND_25325
type: DrugIndication
chembl id: CHEMBL_IND_25325
has molecule: CHEMBL407
highest development phase: 2
has mesh: D009771
has mesh heading: OBSESSIVE-COMPULSIVE DISORDER
has EFO: EFO_0004242
has EFO name: OBSESSIVE-COMPULSIVE DISORDER

CHEMBL_IND_27251
type: DrugIndication
chembl id: CHEMBL_IND_27251
has molecule: CHEMBL6622
highest development phase: 1
has mesh: D020388
has mesh heading: MUSCULAR DYSTROPHY, DUCHENNE
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: DUCHENNE MUSCULAR DYSTROPHY

CHEMBL_IND_28223
type: DrugIndication
chembl id: CHEMBL_IND_28223
has molecule: CHEMBL6622
highest development phase: 0
has mesh: D054058
has mesh heading: ACUTE CORONARY SYNDROME
has EFO: EFO_0005672
has EFO name: ACUTE CORONARY SYNDROME

CHEMBL_IND_52185
type: DrugIndication
chembl id: CHEMBL_IND_52185
has molecule: CHEMBL6622
highest development phase: 3
has mesh: D017719
has mesh heading: DIABETIC FOOT
has EFO: EFO_1001459
has EFO name: DIABETIC FOOT

CHEMBL_IND_45527
type: DrugIndication
chembl id: CHEMBL_IND_45527
has molecule: CHEMBL6622
highest development phase: 2
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0000373
has EFO name: CONGESTIVE HEART FAILURE

CHEMBL_IND_42659
type: DrugIndication
chembl id: CHEMBL_IND_42659
has molecule: CHEMBL6622
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_25854
type: DrugIndication
chembl id: CHEMBL_IND_25854
has molecule: CHEMBL14
highest development phase: 4
has mesh: D005901
has mesh heading: GLAUCOMA
has EFO: EFO_0000516
has EFO name: GLAUCOMA

CHEMBL_IND_26419
type: DrugIndication
chembl id: CHEMBL_IND_26419
has molecule: CHEMBL409
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_42196
type: DrugIndication
chembl id: CHEMBL_IND_42196
has molecule: CHEMBL409
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_40073
type: DrugIndication
chembl id: CHEMBL_IND_40073
has molecule: CHEMBL409
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0003869
has EFO name: BREAST NEOPLASM

CHEMBL_IND_22774
type: DrugIndication
chembl id: CHEMBL_IND_22774
has molecule: CHEMBL409
highest development phase: 3
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_25112
type: DrugIndication
chembl id: CHEMBL_IND_25112
has molecule: CHEMBL409
highest development phase: 3
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_25111
type: DrugIndication
chembl id: CHEMBL_IND_25111
has molecule: CHEMBL409
highest development phase: 3
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000196
has EFO name: METASTATIC PROSTATE CANCER

CHEMBL_IND_52648
type: DrugIndication
chembl id: CHEMBL_IND_52648
has molecule: CHEMBL16
highest development phase: 2
has mesh: D009902
has mesh heading: OPTIC NEURITIS
has EFO: EFO_0007405
has EFO name: OPTIC NEURITIS

CHEMBL_IND_43436
type: DrugIndication
chembl id: CHEMBL_IND_43436
has molecule: CHEMBL16
highest development phase: 2
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_23700
type: DrugIndication
chembl id: CHEMBL_IND_23700
has molecule: CHEMBL16
highest development phase: 4
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_27389
type: DrugIndication
chembl id: CHEMBL_IND_27389
has molecule: CHEMBL16
highest development phase: 4
has mesh: D012640
has mesh heading: SEIZURES
has EFO: HP_0001250
has EFO name: SEIZURES

CHEMBL_IND_49552
type: DrugIndication
chembl id: CHEMBL_IND_49552
has molecule: CHEMBL20
highest development phase: 1
has mesh: D009103
has mesh heading: MULTIPLE SCLEROSIS
has EFO: EFO_0003885
has EFO name: MULTIPLE SCLEROSIS

CHEMBL_IND_26988
type: DrugIndication
chembl id: CHEMBL_IND_26988
has molecule: CHEMBL20
highest development phase: 2
has mesh: D016481
has mesh heading: HELICOBACTER INFECTIONS
has EFO: HP_0005202
has EFO name: HELICOBACTER PYLORI INFECTION

CHEMBL_IND_45782
type: DrugIndication
chembl id: CHEMBL_IND_45782
has molecule: CHEMBL20
highest development phase: 2
has mesh: D006976
has mesh heading: HYPERTENSION, PULMONARY
has EFO: EFO_0001361
has EFO name: PULMONARY HYPERTENSION

CHEMBL_IND_41590
type: DrugIndication
chembl id: CHEMBL_IND_41590
has molecule: CHEMBL20
highest development phase: 4
has mesh: D015812
has mesh heading: GLAUCOMA, ANGLE-CLOSURE

CHEMBL_IND_41573
type: DrugIndication
chembl id: CHEMBL_IND_41573
has molecule: CHEMBL20
highest development phase: 4
has mesh: D004487
has mesh heading: EDEMA

CHEMBL_IND_41884
type: DrugIndication
chembl id: CHEMBL_IND_41884
has molecule: CHEMBL20
highest development phase: 4
has mesh: D000532
has mesh heading: ALTITUDE SICKNESS
has EFO: EFO_1000782
has EFO name: ALTITUDE SICKNESS

CHEMBL_IND_27999
type: DrugIndication
chembl id: CHEMBL_IND_27999
has molecule: CHEMBL20
highest development phase: 1
has mesh: D050030
has mesh heading: ANDERSEN SYNDROME
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CARDIODYSRHYTHMIC POTASSIUM-SENSITIVE PERIODIC PARALYSIS

CHEMBL_IND_47178
type: DrugIndication
chembl id: CHEMBL_IND_47178
has molecule: CHEMBL20
highest development phase: 3
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_22627
type: DrugIndication
chembl id: CHEMBL_IND_22627
has molecule: CHEMBL20
highest development phase: 2
has mesh: D007674
has mesh heading: KIDNEY DISEASES
has EFO: EFO_0003086
has EFO name: KIDNEY DISEASE

CHEMBL_IND_22625
type: DrugIndication
chembl id: CHEMBL_IND_22625
has molecule: CHEMBL20
highest development phase: 4
has mesh: D005901
has mesh heading: GLAUCOMA
has EFO: EFO_0000516
has EFO name: GLAUCOMA

CHEMBL_IND_22623
type: DrugIndication
chembl id: CHEMBL_IND_22623
has molecule: CHEMBL20
highest development phase: 4
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_25930
type: DrugIndication
chembl id: CHEMBL_IND_25930
has molecule: CHEMBL411
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_26954
type: DrugIndication
chembl id: CHEMBL_IND_26954
has molecule: CHEMBL433
highest development phase: 3
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_52565
type: DrugIndication
chembl id: CHEMBL_IND_52565
has molecule: CHEMBL433
highest development phase: 0
has mesh: D015451
has mesh heading: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
has EFO: EFO_0000095
has EFO name: CHRONIC LYMPHOCYTIC LEUKEMIA

CHEMBL_IND_25706
type: DrugIndication
chembl id: CHEMBL_IND_25706
has molecule: CHEMBL433
highest development phase: 3
has mesh: D000437
has mesh heading: ALCOHOLISM
has EFO: EFO_0003829
has EFO name: ALCOHOL DEPENDENCE

CHEMBL_IND_52341
type: DrugIndication
chembl id: CHEMBL_IND_52341
has molecule: CHEMBL433
highest development phase: 3
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_28425
type: DrugIndication
chembl id: CHEMBL_IND_28425
has molecule: CHEMBL433
highest development phase: 1
has mesh: D012640
has mesh heading: SEIZURES
has EFO: HP_0001250
has EFO name: SEIZURES

CHEMBL_IND_27498
type: DrugIndication
chembl id: CHEMBL_IND_27498
has molecule: CHEMBL433
highest development phase: 2
has mesh: D012415
has mesh heading: RUBINSTEIN-TAYBI SYNDROME
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: RUBINSTEIN-TAYBI SYNDROME

CHEMBL_IND_27494
type: DrugIndication
chembl id: CHEMBL_IND_27494
has molecule: CHEMBL433
highest development phase: 3
has mesh: D011595
has mesh heading: PSYCHOMOTOR AGITATION
has EFO: HP_0000713
has EFO name: AGITATION

CHEMBL_IND_24018
type: DrugIndication
chembl id: CHEMBL_IND_24018
has molecule: CHEMBL433
highest development phase: 1
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_24623
type: DrugIndication
chembl id: CHEMBL_IND_24623
has molecule: CHEMBL450
highest development phase: 4
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_27095
type: DrugIndication
chembl id: CHEMBL_IND_27095
has molecule: CHEMBL451
highest development phase: 4
has mesh: D001007
has mesh heading: ANXIETY
has EFO: EFO_0005230
has EFO name: ANXIETY

CHEMBL_IND_53997
type: DrugIndication
chembl id: CHEMBL_IND_53997
has molecule: CHEMBL1201558
highest development phase: 2
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_27244
type: DrugIndication
chembl id: CHEMBL_IND_27244
has molecule: CHEMBL1201558
highest development phase: 2
has mesh: D019698
has mesh heading: HEPATITIS C, CHRONIC
has EFO: EFO_0004220
has EFO name: CHRONIC HEPATITIS C INFECTION

CHEMBL_IND_45603
type: DrugIndication
chembl id: CHEMBL_IND_45603
has molecule: CHEMBL1201558
highest development phase: 1
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_25398
type: DrugIndication
chembl id: CHEMBL_IND_25398
has molecule: CHEMBL1201558
highest development phase: 1
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: EFO_0001075
has EFO name: OVARIAN CARCINOMA

CHEMBL_IND_27748
type: DrugIndication
chembl id: CHEMBL_IND_27748
has molecule: CHEMBL1201558
highest development phase: 3
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_27747
type: DrugIndication
chembl id: CHEMBL_IND_27747
has molecule: CHEMBL1201558
highest development phase: 3
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000389
has EFO name: CUTANEOUS MELANOMA

CHEMBL_IND_23355
type: DrugIndication
chembl id: CHEMBL_IND_23355
has molecule: CHEMBL1201558
highest development phase: 3
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_23354
type: DrugIndication
chembl id: CHEMBL_IND_23354
has molecule: CHEMBL1201558
highest development phase: 1
has mesh: D006526
has mesh heading: HEPATITIS C
has EFO: EFO_0003047
has EFO name: HEPATITIS C INFECTION

CHEMBL_IND_23353
type: DrugIndication
chembl id: CHEMBL_IND_23353
has molecule: CHEMBL1201558
highest development phase: 3
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_45049
type: DrugIndication
chembl id: CHEMBL_IND_45049
has molecule: CHEMBL1201516
highest development phase: 2
has mesh: D011472
has mesh heading: PROSTATITIS
has EFO: EFO_0003830
has EFO name: PROSTATITIS

CHEMBL_IND_42785
type: DrugIndication
chembl id: CHEMBL_IND_42785
has molecule: CHEMBL1201516
highest development phase: 4
has mesh: D014648
has mesh heading: VARICOSE VEINS
has EFO: HP_0002619
has EFO name: VARICOSE VEIN

CHEMBL_IND_42515
type: DrugIndication
chembl id: CHEMBL_IND_42515
has molecule: CHEMBL443
highest development phase: 4
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_46629
type: DrugIndication
chembl id: CHEMBL_IND_46629
has molecule: CHEMBL7301
highest development phase: 2
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_46541
type: DrugIndication
chembl id: CHEMBL_IND_46541
has molecule: CHEMBL7301
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_47891
type: DrugIndication
chembl id: CHEMBL_IND_47891
has molecule: CHEMBL7301
highest development phase: 3
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000292
has EFO name: BLADDER CARCINOMA

CHEMBL_IND_45736
type: DrugIndication
chembl id: CHEMBL_IND_45736
has molecule: CHEMBL7301
highest development phase: 3
has mesh: D002583
has mesh heading: UTERINE CERVICAL NEOPLASMS
has EFO: EFO_0001061
has EFO name: CERVICAL CARCINOMA

CHEMBL_IND_45348
type: DrugIndication
chembl id: CHEMBL_IND_45348
has molecule: CHEMBL7301
highest development phase: 1
has mesh: D003550
has mesh heading: CYSTIC FIBROSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CYSTIC FIBROSIS

CHEMBL_IND_43149
type: DrugIndication
chembl id: CHEMBL_IND_43149
has molecule: CHEMBL7301
highest development phase: 2
has mesh: D016411
has mesh heading: LYMPHOMA, T-CELL, PERIPHERAL
has EFO: EFO_0000211
has EFO name: UNSPECIFIED PERIPHERAL T-CELL LYMPHOMA

CHEMBL_IND_54354
type: DrugIndication
chembl id: CHEMBL_IND_54354
has molecule: CHEMBL7301
highest development phase: 2
has mesh: D018316
has mesh heading: GLIOSARCOMA
has EFO: EFO_1001465
has EFO name: GLIOSARCOMA

CHEMBL_IND_44865
type: DrugIndication
chembl id: CHEMBL_IND_44865
has molecule: CHEMBL7301
highest development phase: 2
has mesh: D008268
has mesh heading: MACULAR DEGENERATION
has EFO: EFO_0001365
has EFO name: AGE-RELATED MACULAR DEGENERATION

CHEMBL_IND_47303
type: DrugIndication
chembl id: CHEMBL_IND_47303
has molecule: CHEMBL7301
highest development phase: 2
has mesh: D009447
has mesh heading: NEUROBLASTOMA
has EFO: EFO_0000621
has EFO name: NEUROBLASTOMA

CHEMBL_IND_44482
type: DrugIndication
chembl id: CHEMBL_IND_44482
has molecule: CHEMBL7301
highest development phase: 3
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_47114
type: DrugIndication
chembl id: CHEMBL_IND_47114
has molecule: CHEMBL45
highest development phase: 3
has mesh: D001471
has mesh heading: BARRETT ESOPHAGUS
has EFO: EFO_0000280
has EFO name: BARRETT'S ESOPHAGUS

CHEMBL_IND_47034
type: DrugIndication
chembl id: CHEMBL_IND_47034
has molecule: CHEMBL45
highest development phase: 2
has mesh: D006470
has mesh heading: HEMORRHAGE
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: HEMORRHAGE

CHEMBL_IND_43584
type: DrugIndication
chembl id: CHEMBL_IND_43584
has molecule: CHEMBL45
highest development phase: 2
has mesh: D003093
has mesh heading: COLITIS, ULCERATIVE
has EFO: EFO_0000729
has EFO name: ULCERATIVE COLITIS

CHEMBL_IND_44259
type: DrugIndication
chembl id: CHEMBL_IND_44259
has molecule: CHEMBL45
highest development phase: 2
has mesh: D005221
has mesh heading: FATIGUE
has EFO: HP_0012378
has EFO name: FATIGUE

CHEMBL_IND_46670
type: DrugIndication
chembl id: CHEMBL_IND_46670
has molecule: CHEMBL45
highest development phase: 1
has mesh: D018805
has mesh heading: SEPSIS
has EFO: EFO_0001420
has EFO name: SEPSIS

CHEMBL_IND_49490
type: DrugIndication
chembl id: CHEMBL_IND_49490
has molecule: CHEMBL45
highest development phase: 3
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_43990
type: DrugIndication
chembl id: CHEMBL_IND_43990
has molecule: CHEMBL45
highest development phase: 3
has mesh: D001289
has mesh heading: ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY
has EFO: EFO_0003888
has EFO name: ATTENTION DEFICIT HYPERACTIVITY DISORDER

CHEMBL_IND_54099
type: DrugIndication
chembl id: CHEMBL_IND_54099
has molecule: CHEMBL45
highest development phase: 3
has mesh: D001007
has mesh heading: ANXIETY
has EFO: EFO_0005230
has EFO name: ANXIETY

CHEMBL_IND_49393
type: DrugIndication
chembl id: CHEMBL_IND_49393
has molecule: CHEMBL45
highest development phase: 3
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_45308
type: DrugIndication
chembl id: CHEMBL_IND_45308
has molecule: CHEMBL45
highest development phase: 2
has mesh: D053206
has mesh heading: NOCTURNAL ENURESIS
has EFO: HP_0010677
has EFO name: ENURESIS NOCTURNA

CHEMBL_IND_45130
type: DrugIndication
chembl id: CHEMBL_IND_45130
has molecule: CHEMBL45
highest development phase: 2
has mesh: D020529
has mesh heading: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
has EFO: EFO_0003929
has EFO name: RELAPSING-REMITTING MULTIPLE SCLEROSIS

CHEMBL_IND_54731
type: DrugIndication
chembl id: CHEMBL_IND_54731
has molecule: CHEMBL45
highest development phase: 2
has mesh: D047928
has mesh heading: PREMATURE BIRTH
has EFO: EFO_0003917
has EFO name: PREMATURE BIRTH

CHEMBL_IND_48442
type: DrugIndication
chembl id: CHEMBL_IND_48442
has molecule: CHEMBL45
highest development phase: 2
has mesh: D060825
has mesh heading: MILD COGNITIVE IMPAIRMENT
has EFO: HP_0100543
has EFO name: COGNITIVE IMPAIRMENT

CHEMBL_IND_45686
type: DrugIndication
chembl id: CHEMBL_IND_45686
has molecule: CHEMBL45
highest development phase: 1
has mesh: D012871
has mesh heading: SKIN DISEASES
has EFO: EFO_0000701
has EFO name: SKIN DISEASE

CHEMBL_IND_48247
type: DrugIndication
chembl id: CHEMBL_IND_48247
has molecule: CHEMBL45
highest development phase: 3
has mesh: D008881
has mesh heading: MIGRAINE DISORDERS
has EFO: EFO_0003821
has EFO name: MIGRAINE DISORDER

CHEMBL_IND_44744
type: DrugIndication
chembl id: CHEMBL_IND_44744
has molecule: CHEMBL45
highest development phase: 2
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_45437
type: DrugIndication
chembl id: CHEMBL_IND_45437
has molecule: CHEMBL45
highest development phase: 2
has mesh: D001281
has mesh heading: ATRIAL FIBRILLATION
has EFO: EFO_0000275
has EFO name: ATRIAL FIBRILLATION

CHEMBL_IND_46014
type: DrugIndication
chembl id: CHEMBL_IND_46014
has molecule: CHEMBL45
highest development phase: 3
has mesh: D005764
has mesh heading: GASTROESOPHAGEAL REFLUX
has EFO: EFO_0003948
has EFO name: GASTROESOPHAGEAL REFLUX DISEASE

CHEMBL_IND_46430
type: DrugIndication
chembl id: CHEMBL_IND_46430
has molecule: CHEMBL45
highest development phase: 0
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_43376
type: DrugIndication
chembl id: CHEMBL_IND_43376
has molecule: CHEMBL45
highest development phase: 3
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_46357
type: DrugIndication
chembl id: CHEMBL_IND_46357
has molecule: CHEMBL45
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_43206
type: DrugIndication
chembl id: CHEMBL_IND_43206
has molecule: CHEMBL45
highest development phase: 2
has mesh: D003876
has mesh heading: DERMATITIS, ATOPIC
has EFO: EFO_0000274
has EFO name: ATOPIC ECZEMA

CHEMBL_IND_43143
type: DrugIndication
chembl id: CHEMBL_IND_43143
has molecule: CHEMBL45
highest development phase: 2
has mesh: D024821
has mesh heading: METABOLIC SYNDROME X
has EFO: EFO_0000195
has EFO name: METABOLIC SYNDROME

CHEMBL_IND_40106
type: DrugIndication
chembl id: CHEMBL_IND_40106
has molecule: CHEMBL45
highest development phase: 1
has mesh: D013375
has mesh heading: SUBSTANCE WITHDRAWAL SYNDROME
has EFO: EFO_0005800
has EFO name: SUBSTANCE WITHDRAWAL SYNDROME

CHEMBL_IND_54579
type: DrugIndication
chembl id: CHEMBL_IND_54579
has molecule: CHEMBL45
highest development phase: 1
has mesh: D002545
has mesh heading: BRAIN ISCHEMIA
has EFO: HP_0002637
has EFO name: CEREBRAL ISCHEMIA

CHEMBL_IND_47609
type: DrugIndication
chembl id: CHEMBL_IND_47609
has molecule: CHEMBL45
highest development phase: 2
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_47576
type: DrugIndication
chembl id: CHEMBL_IND_47576
has molecule: CHEMBL45
highest development phase: 2
has mesh: D001321
has mesh heading: AUTISTIC DISORDER
has EFO: EFO_0003758
has EFO name: AUTISM

CHEMBL_IND_44126
type: DrugIndication
chembl id: CHEMBL_IND_44126
has molecule: CHEMBL45
highest development phase: 3
has mesh: D007319
has mesh heading: SLEEP INITIATION AND MAINTENANCE DISORDERS
has EFO: EFO_0004698
has EFO name: INSOMNIA

CHEMBL_IND_44654
type: DrugIndication
chembl id: CHEMBL_IND_44654
has molecule: CHEMBL45
highest development phase: 3
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_44653
type: DrugIndication
chembl id: CHEMBL_IND_44653
has molecule: CHEMBL45
highest development phase: 2
has mesh: D009203
has mesh heading: MYOCARDIAL INFARCTION
has EFO: EFO_0000612
has EFO name: MYOCARDIAL INFARCTION

CHEMBL_IND_44580
type: DrugIndication
chembl id: CHEMBL_IND_44580
has molecule: CHEMBL45
highest development phase: 2
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_44479
type: DrugIndication
chembl id: CHEMBL_IND_44479
has molecule: CHEMBL45
highest development phase: 3
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_39796
type: DrugIndication
chembl id: CHEMBL_IND_39796
has molecule: CHEMBL45
highest development phase: 1
has mesh: D013471
has mesh heading: SUNBURN
has EFO: EFO_0003958
has EFO name: SUNBURN

CHEMBL_IND_40331
type: DrugIndication
chembl id: CHEMBL_IND_40331
has molecule: CHEMBL45
highest development phase: 2
has mesh: D001014
has mesh heading: AORTIC ANEURYSM
has EFO: EFO_0001666
has EFO name: AORTIC ANEURYSM

CHEMBL_IND_52573
type: DrugIndication
chembl id: CHEMBL_IND_52573
has molecule: CHEMBL456
highest development phase: 1
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000292
has EFO name: BLADDER CARCINOMA

CHEMBL_IND_25982
type: DrugIndication
chembl id: CHEMBL_IND_25982
has molecule: CHEMBL456
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_42194
type: DrugIndication
chembl id: CHEMBL_IND_42194
has molecule: CHEMBL52
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_47483
type: DrugIndication
chembl id: CHEMBL_IND_47483
has molecule: CHEMBL52
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_27150
type: DrugIndication
chembl id: CHEMBL_IND_27150
has molecule: CHEMBL465
highest development phase: 4
has mesh: D009325
has mesh heading: NAUSEA
has EFO: HP_0002018
has EFO name: NAUSEA

CHEMBL_IND_27149
type: DrugIndication
chembl id: CHEMBL_IND_27149
has molecule: CHEMBL465
highest development phase: 1
has mesh: D019966
has mesh heading: SUBSTANCE-RELATED DISORDERS
has EFO: EFO_0003890
has EFO name: DRUG DEPENDENCE

CHEMBL_IND_26542
type: DrugIndication
chembl id: CHEMBL_IND_26542
has molecule: CHEMBL465
highest development phase: 3
has mesh: D000856
has mesh heading: ANOREXIA NERVOSA
has EFO: EFO_0004215
has EFO name: ANOREXIA NERVOSA

CHEMBL_IND_52445
type: DrugIndication
chembl id: CHEMBL_IND_52445
has molecule: CHEMBL465
highest development phase: 2
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_27668
type: DrugIndication
chembl id: CHEMBL_IND_27668
has molecule: CHEMBL465
highest development phase: 1
has mesh: D000437
has mesh heading: ALCOHOLISM
has EFO: EFO_0003829
has EFO name: ALCOHOL DEPENDENCE

CHEMBL_IND_25271
type: DrugIndication
chembl id: CHEMBL_IND_25271
has molecule: CHEMBL465
highest development phase: 2
has mesh: D020181
has mesh heading: SLEEP APNEA, OBSTRUCTIVE
has EFO: EFO_0003918
has EFO name: OBSTRUCTIVE SLEEP APNEA

CHEMBL_IND_25270
type: DrugIndication
chembl id: CHEMBL_IND_25270
has molecule: CHEMBL465
highest development phase: 4
has mesh: D009325
has mesh heading: NAUSEA
has EFO: EFO_0006911
has EFO name: CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING

CHEMBL_IND_24383
type: DrugIndication
chembl id: CHEMBL_IND_24383
has molecule: CHEMBL465
highest development phase: 1
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_24382
type: DrugIndication
chembl id: CHEMBL_IND_24382
has molecule: CHEMBL465
highest development phase: 2
has mesh: D002189
has mesh heading: MARIJUANA ABUSE
has EFO: EFO_0004218
has EFO name: MARIJUANA DEPENDENCE

CHEMBL_IND_24381
type: DrugIndication
chembl id: CHEMBL_IND_24381
has molecule: CHEMBL465
highest development phase: 2
has mesh: D043183
has mesh heading: IRRITABLE BOWEL SYNDROME
has EFO: EFO_0000555
has EFO name: IRRITABLE BOWEL SYNDROME

CHEMBL_IND_27533
type: DrugIndication
chembl id: CHEMBL_IND_27533
has molecule: CHEMBL488
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_49261
type: DrugIndication
chembl id: CHEMBL_IND_49261
has molecule: CHEMBL57
highest development phase: 3
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_45378
type: DrugIndication
chembl id: CHEMBL_IND_45378
has molecule: CHEMBL57
highest development phase: 4
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000180
has EFO name: HIV-1 INFECTION

CHEMBL_IND_42710
type: DrugIndication
chembl id: CHEMBL_IND_42710
has molecule: CHEMBL57
highest development phase: 4
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_54100
type: DrugIndication
chembl id: CHEMBL_IND_54100
has molecule: CHEMBL8659
highest development phase: 2
has mesh: D000236
has mesh heading: ADENOMA
has EFO: EFO_0005406
has EFO name: COLORECTAL ADENOMA

CHEMBL_IND_47931
type: DrugIndication
chembl id: CHEMBL_IND_47931
has molecule: CHEMBL8659
highest development phase: 1
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_50461
type: DrugIndication
chembl id: CHEMBL_IND_50461
has molecule: CHEMBL55
highest development phase: 1
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_50651
type: DrugIndication
chembl id: CHEMBL_IND_50651
has molecule: CHEMBL55
highest development phase: 2
has mesh: D014352
has mesh heading: TRYPANOSOMIASIS
has EFO: DOID:10113
has EFO name: TRYPANOSOMIASIS

CHEMBL_IND_55255
type: DrugIndication
chembl id: CHEMBL_IND_55255
has molecule: CHEMBL55
highest development phase: 1
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_50267
type: DrugIndication
chembl id: CHEMBL_IND_50267
has molecule: CHEMBL55
highest development phase: 3
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_50346
type: DrugIndication
chembl id: CHEMBL_IND_50346
has molecule: CHEMBL55
highest development phase: 1
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_53234
type: DrugIndication
chembl id: CHEMBL_IND_53234
has molecule: CHEMBL55
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000389
has EFO name: CUTANEOUS MELANOMA

CHEMBL_IND_27954
type: DrugIndication
chembl id: CHEMBL_IND_27954
has molecule: CHEMBL479
highest development phase: 1
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_23955
type: DrugIndication
chembl id: CHEMBL_IND_23955
has molecule: CHEMBL479
highest development phase: 4
has mesh: D011618
has mesh heading: PSYCHOTIC DISORDERS
has EFO: EFO_0005407
has EFO name: PSYCHOSIS

CHEMBL_IND_47068
type: DrugIndication
chembl id: CHEMBL_IND_47068
has molecule: CHEMBL483
highest development phase: 3
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000180
has EFO name: HIV-1 INFECTION

CHEMBL_IND_43611
type: DrugIndication
chembl id: CHEMBL_IND_43611
has molecule: CHEMBL483
highest development phase: 3
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_45166
type: DrugIndication
chembl id: CHEMBL_IND_45166
has molecule: CHEMBL483
highest development phase: 3
has mesh: D019694
has mesh heading: HEPATITIS B, CHRONIC
has EFO: EFO_0004239
has EFO name: CHRONIC HEPATITIS B INFECTION

CHEMBL_IND_44038
type: DrugIndication
chembl id: CHEMBL_IND_44038
has molecule: CHEMBL483
highest development phase: 3
has mesh: D019694
has mesh heading: HEPATITIS B, CHRONIC
has EFO: EFO_0004197
has EFO name: HEPATITIS B INFECTION

CHEMBL_IND_49661
type: DrugIndication
chembl id: CHEMBL_IND_49661
has molecule: CHEMBL473
highest development phase: 1
has mesh: D008133
has mesh heading: LONG QT SYNDROME
has EFO: HP_0001657
has EFO name: PROLONGED QT INTERVAL

CHEMBL_IND_25941
type: DrugIndication
chembl id: CHEMBL_IND_25941
has molecule: CHEMBL473
highest development phase: 4
has mesh: D001145
has mesh heading: ARRHYTHMIAS, CARDIAC
has EFO: EFO_0004269
has EFO name: CARDIAC ARRHYTHMIA

CHEMBL_IND_43600
type: DrugIndication
chembl id: CHEMBL_IND_43600
has molecule: CHEMBL476
highest development phase: 4
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_48699
type: DrugIndication
chembl id: CHEMBL_IND_48699
has molecule: CHEMBL476
highest development phase: 2
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_29232
type: DrugIndication
chembl id: CHEMBL_IND_29232
has molecule: CHEMBL476
highest development phase: 4
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0002617
has EFO name: METASTATIC MELANOMA

CHEMBL_IND_46383
type: DrugIndication
chembl id: CHEMBL_IND_46383
has molecule: CHEMBL476
highest development phase: 3
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_44548
type: DrugIndication
chembl id: CHEMBL_IND_44548
has molecule: CHEMBL476
highest development phase: 4
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000389
has EFO name: CUTANEOUS MELANOMA

CHEMBL_IND_49564
type: DrugIndication
chembl id: CHEMBL_IND_49564
has molecule: CHEMBL480
highest development phase: 2
has mesh: D047928
has mesh heading: PREMATURE BIRTH
has EFO: EFO_0003917
has EFO name: PREMATURE BIRTH

CHEMBL_IND_26657
type: DrugIndication
chembl id: CHEMBL_IND_26657
has molecule: CHEMBL480
highest development phase: 3
has mesh: D004381
has mesh heading: DUODENAL ULCER
has EFO: EFO_0004607
has EFO name: DUODENAL ULCER

CHEMBL_IND_25412
type: DrugIndication
chembl id: CHEMBL_IND_25412
has molecule: CHEMBL480
highest development phase: 4
has mesh: D010437
has mesh heading: PEPTIC ULCER
has EFO: HP_0004398
has EFO name: PEPTIC ULCER

CHEMBL_IND_52042
type: DrugIndication
chembl id: CHEMBL_IND_52042
has molecule: CHEMBL480
highest development phase: 3
has mesh: D004942
has mesh heading: ESOPHAGITIS, PEPTIC
has EFO: EFO_1001095
has EFO name: PEPTIC ESOPHAGITIS

CHEMBL_IND_23389
type: DrugIndication
chembl id: CHEMBL_IND_23389
has molecule: CHEMBL480
highest development phase: 4
has mesh: D005764
has mesh heading: GASTROESOPHAGEAL REFLUX
has EFO: EFO_0003948
has EFO name: GASTROESOPHAGEAL REFLUX DISEASE

CHEMBL_IND_42385
type: DrugIndication
chembl id: CHEMBL_IND_42385
has molecule: CHEMBL61
highest development phase: 4
has mesh: D014777
has mesh heading: VIRUS DISEASES
has EFO: EFO_0000763
has EFO name: VIRAL DISEASE

CHEMBL_IND_53200
type: DrugIndication
chembl id: CHEMBL_IND_53200
has molecule: CHEMBL10316
highest development phase: 0
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_54795
type: DrugIndication
chembl id: CHEMBL_IND_54795
has molecule: CHEMBL9960
highest development phase: 1
has mesh: D007249
has mesh heading: INFLAMMATION
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: INFLAMMATION

CHEMBL_IND_53507
type: DrugIndication
chembl id: CHEMBL_IND_53507
has molecule: CHEMBL9960
highest development phase: 1
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_52755
type: DrugIndication
chembl id: CHEMBL_IND_52755
has molecule: CHEMBL9967
highest development phase: 4
has mesh: D010437
has mesh heading: PEPTIC ULCER
has EFO: HP_0004398
has EFO name: PEPTIC ULCER

CHEMBL_IND_52800
type: DrugIndication
chembl id: CHEMBL_IND_52800
has molecule: CHEMBL9967
highest development phase: 4
has mesh: D005764
has mesh heading: GASTROESOPHAGEAL REFLUX
has EFO: EFO_0003948
has EFO name: GASTROESOPHAGEAL REFLUX DISEASE

CHEMBL_IND_42317
type: DrugIndication
chembl id: CHEMBL_IND_42317
has molecule: CHEMBL74
highest development phase: 4
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_48394
type: DrugIndication
chembl id: CHEMBL_IND_48394
has molecule: CHEMBL74
highest development phase: 1
has mesh: D012393
has mesh heading: ROSACEA
has EFO: EFO_1000760
has EFO name: ROSACEA

CHEMBL_IND_47030
type: DrugIndication
chembl id: CHEMBL_IND_47030
has molecule: CHEMBL499
highest development phase: 2
has mesh: D012883
has mesh heading: SKIN ULCER
has EFO: HP_0200042
has EFO name: SKIN ULCER

CHEMBL_IND_46994
type: DrugIndication
chembl id: CHEMBL_IND_46994
has molecule: CHEMBL499
highest development phase: 4
has mesh: D009798
has mesh heading: OCULAR HYPERTENSION
has EFO: EFO_1001069
has EFO name: OCULAR HYPERTENSION

CHEMBL_IND_26316
type: DrugIndication
chembl id: CHEMBL_IND_26316
has molecule: CHEMBL499
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_28492
type: DrugIndication
chembl id: CHEMBL_IND_28492
has molecule: CHEMBL499
highest development phase: 2
has mesh: D006391
has mesh heading: HEMANGIOMA
has EFO: EFO_1000635
has EFO name: HEMANGIOMA

CHEMBL_IND_24948
type: DrugIndication
chembl id: CHEMBL_IND_24948
has molecule: CHEMBL499
highest development phase: 2
has mesh: D005902
has mesh heading: GLAUCOMA, OPEN-ANGLE
has EFO: EFO_0004190
has EFO name: OPEN-ANGLE GLAUCOMA

CHEMBL_IND_24946
type: DrugIndication
chembl id: CHEMBL_IND_24946
has molecule: CHEMBL499
highest development phase: 4
has mesh: D005901
has mesh heading: GLAUCOMA
has EFO: EFO_0000516
has EFO name: GLAUCOMA

CHEMBL_IND_43977
type: DrugIndication
chembl id: CHEMBL_IND_43977
has molecule: CHEMBL494
highest development phase: 2
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_28594
type: DrugIndication
chembl id: CHEMBL_IND_28594
has molecule: CHEMBL494
highest development phase: 4
has mesh: D013927
has mesh heading: THROMBOSIS
has EFO: HP_0004419
has EFO name: RECURRENT THROMBOPHLEBITIS

CHEMBL_IND_44825
type: DrugIndication
chembl id: CHEMBL_IND_44825
has molecule: CHEMBL494
highest development phase: 2
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_26041
type: DrugIndication
chembl id: CHEMBL_IND_26041
has molecule: CHEMBL494
highest development phase: 2
has mesh: D012595
has mesh heading: SCLERODERMA, SYSTEMIC
has EFO: EFO_0000717
has EFO name: SYSTEMIC SCLERODERMA

CHEMBL_IND_44097
type: DrugIndication
chembl id: CHEMBL_IND_44097
has molecule: CHEMBL494
highest development phase: 2
has mesh: D016757
has mesh heading: DEATH, SUDDEN, CARDIAC
has EFO: EFO_0004278
has EFO name: SUDDEN CARDIAC ARREST

CHEMBL_IND_23306
type: DrugIndication
chembl id: CHEMBL_IND_23306
has molecule: CHEMBL494
highest development phase: 3
has mesh: D006976
has mesh heading: HYPERTENSION, PULMONARY
has EFO: EFO_0001361
has EFO name: PULMONARY HYPERTENSION

CHEMBL_IND_24516
type: DrugIndication
chembl id: CHEMBL_IND_24516
has molecule: CHEMBL494
highest development phase: 2
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_29026
type: DrugIndication
chembl id: CHEMBL_IND_29026
has molecule: CHEMBL501
highest development phase: 4
has mesh: D009290
has mesh heading: NARCOLEPSY
has EFO: EFO_0000614
has EFO name: NARCOLEPSY

CHEMBL_IND_22682
type: DrugIndication
chembl id: CHEMBL_IND_22682
has molecule: CHEMBL501
highest development phase: 4
has mesh: D001289
has mesh heading: ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY
has EFO: EFO_0003888
has EFO name: ATTENTION DEFICIT HYPERACTIVITY DISORDER

CHEMBL_IND_45763
type: DrugIndication
chembl id: CHEMBL_IND_45763
has molecule: CHEMBL11298
highest development phase: 2
has mesh: D013313
has mesh heading: STRESS DISORDERS, POST-TRAUMATIC
has EFO: EFO_0001358
has EFO name: POST-TRAUMATIC STRESS DISORDER

CHEMBL_IND_53602
type: DrugIndication
chembl id: CHEMBL_IND_53602
has molecule: CHEMBL11298
highest development phase: 1
has mesh: D065626
has mesh heading: NON-ALCOHOLIC FATTY LIVER DISEASE
has EFO: EFO_0003095
has EFO name: NON-ALCOHOLIC FATTY LIVER DISEASE

CHEMBL_IND_43187
type: DrugIndication
chembl id: CHEMBL_IND_43187
has molecule: CHEMBL11298
highest development phase: 1
has mesh: D000690
has mesh heading: AMYOTROPHIC LATERAL SCLEROSIS
has EFO: EFO_0000253
has EFO name: AMYOTROPHIC LATERAL SCLEROSIS

CHEMBL_IND_47521
type: DrugIndication
chembl id: CHEMBL_IND_47521
has molecule: CHEMBL11298
highest development phase: 2
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_43634
type: DrugIndication
chembl id: CHEMBL_IND_43634
has molecule: CHEMBL11359
highest development phase: 3
has mesh: D002583
has mesh heading: UTERINE CERVICAL NEOPLASMS
has EFO: EFO_0001061
has EFO name: CERVICAL CARCINOMA

CHEMBL_IND_43601
type: DrugIndication
chembl id: CHEMBL_IND_43601
has molecule: CHEMBL11359
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_43566
type: DrugIndication
chembl id: CHEMBL_IND_43566
has molecule: CHEMBL11359
highest development phase: 3
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000707
has EFO name: SQUAMOUS CELL CARCINOMA

CHEMBL_IND_43842
type: DrugIndication
chembl id: CHEMBL_IND_43842
has molecule: CHEMBL11359
highest development phase: 3
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_43725
type: DrugIndication
chembl id: CHEMBL_IND_43725
has molecule: CHEMBL11359
highest development phase: 3
has mesh: D002583
has mesh heading: UTERINE CERVICAL NEOPLASMS
has EFO: EFO_0001416
has EFO name: CERVICAL ADENOCARCINOMA

CHEMBL_IND_48823
type: DrugIndication
chembl id: CHEMBL_IND_48823
has molecule: CHEMBL11359
highest development phase: 1
has mesh: D013964
has mesh heading: THYROID NEOPLASMS
has EFO: EFO_0002892
has EFO name: THYROID CARCINOMA

CHEMBL_IND_46714
type: DrugIndication
chembl id: CHEMBL_IND_46714
has molecule: CHEMBL11359
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0002617
has EFO name: METASTATIC MELANOMA

CHEMBL_IND_48073
type: DrugIndication
chembl id: CHEMBL_IND_48073
has molecule: CHEMBL11359
highest development phase: 3
has mesh: D055752
has mesh heading: SMALL CELL LUNG CARCINOMA
has EFO: EFO_0000702
has EFO name: SMALL CELL LUNG CARCINOMA

CHEMBL_IND_48038
type: DrugIndication
chembl id: CHEMBL_IND_48038
has molecule: CHEMBL11359
highest development phase: 2
has mesh: D012516
has mesh heading: OSTEOSARCOMA
has EFO: EFO_0000637
has EFO name: OSTEOSARCOMA

CHEMBL_IND_45301
type: DrugIndication
chembl id: CHEMBL_IND_45301
has molecule: CHEMBL11359
highest development phase: 3
has mesh: D010996
has mesh heading: PLEURAL EFFUSION
has EFO: HP_0002202
has EFO name: PLEURAL EFFUSION

CHEMBL_IND_48698
type: DrugIndication
chembl id: CHEMBL_IND_48698
has molecule: CHEMBL11359
highest development phase: 2
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_52330
type: DrugIndication
chembl id: CHEMBL_IND_52330
has molecule: CHEMBL11359
highest development phase: 2
has mesh: D061325
has mesh heading: HEREDITARY BREAST AND OVARIAN CANCER SYNDROME
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: HEREDITARY BREAST AND OVARIAN CANCER SYNDROME

CHEMBL_IND_41394
type: DrugIndication
chembl id: CHEMBL_IND_41394
has molecule: CHEMBL11359
highest development phase: 2
has mesh: D020031
has mesh heading: EPSTEIN-BARR VIRUS INFECTION
has EFO: EFO_0000769
has EFO name: EPSTEIN-BARR VIRUS INFECTION

CHEMBL_IND_45377
type: DrugIndication
chembl id: CHEMBL_IND_45377
has molecule: CHEMBL11359
highest development phase: 2
has mesh: D013274
has mesh heading: STOMACH NEOPLASMS
has EFO: EFO_0000178
has EFO name: GASTRIC CARCINOMA

CHEMBL_IND_45997
type: DrugIndication
chembl id: CHEMBL_IND_45997
has molecule: CHEMBL11359
highest development phase: 2
has mesh: D013274
has mesh heading: STOMACH NEOPLASMS
has EFO: EFO_0003897
has EFO name: STOMACH NEOPLASM

CHEMBL_IND_47843
type: DrugIndication
chembl id: CHEMBL_IND_47843
has molecule: CHEMBL11359
highest development phase: 3
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_43481
type: DrugIndication
chembl id: CHEMBL_IND_43481
has molecule: CHEMBL11359
highest development phase: 3
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_43287
type: DrugIndication
chembl id: CHEMBL_IND_43287
has molecule: CHEMBL11359
highest development phase: 3
has mesh: D002277
has mesh heading: CARCINOMA
has EFO: EFO_0000313
has EFO name: CARCINOMA

CHEMBL_IND_43118
type: DrugIndication
chembl id: CHEMBL_IND_43118
has molecule: CHEMBL11359
highest development phase: 3
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000181
has EFO name: HEAD AND NECK SQUAMOUS CELL CARCINOMA

CHEMBL_IND_45483
type: DrugIndication
chembl id: CHEMBL_IND_45483
has molecule: CHEMBL11359
highest development phase: 3
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_45455
type: DrugIndication
chembl id: CHEMBL_IND_45455
has molecule: CHEMBL11359
highest development phase: 3
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000294
has EFO name: BLADDER TUMOR

CHEMBL_IND_44443
type: DrugIndication
chembl id: CHEMBL_IND_44443
has molecule: CHEMBL11359
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_44436
type: DrugIndication
chembl id: CHEMBL_IND_44436
has molecule: CHEMBL11359
highest development phase: 3
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000292
has EFO name: BLADDER CARCINOMA

CHEMBL_IND_51815
type: DrugIndication
chembl id: CHEMBL_IND_51815
has molecule: CHEMBL11359
highest development phase: 2
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_47536
type: DrugIndication
chembl id: CHEMBL_IND_47536
has molecule: CHEMBL11359
highest development phase: 2
has mesh: D004938
has mesh heading: ESOPHAGEAL NEOPLASMS
has EFO: EFO_0002916
has EFO name: ESOPHAGEAL CARCINOMA

CHEMBL_IND_44099
type: DrugIndication
chembl id: CHEMBL_IND_44099
has molecule: CHEMBL11359
highest development phase: 3
has mesh: D006258
has mesh heading: HEAD AND NECK NEOPLASMS
has EFO: EFO_0004284
has EFO name: UPPER AERODIGESTIVE TRACT NEOPLASM

CHEMBL_IND_44072
type: DrugIndication
chembl id: CHEMBL_IND_44072
has molecule: CHEMBL11359
highest development phase: 3
has mesh: D009303
has mesh heading: NASOPHARYNGEAL NEOPLASMS
has EFO: EFO_0004252
has EFO name: NASOPHARYNGEAL NEOPLASM

CHEMBL_IND_44053
type: DrugIndication
chembl id: CHEMBL_IND_44053
has molecule: CHEMBL11359
highest development phase: 2
has mesh: D016889
has mesh heading: ENDOMETRIAL NEOPLASMS
has EFO: EFO_0004230
has EFO name: ENDOMETRIAL NEOPLASM

CHEMBL_IND_51690
type: DrugIndication
chembl id: CHEMBL_IND_51690
has molecule: CHEMBL11359
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0003869
has EFO name: BREAST NEOPLASM

CHEMBL_IND_42848
type: DrugIndication
chembl id: CHEMBL_IND_42848
has molecule: CHEMBL91
highest development phase: 4
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_45723
type: DrugIndication
chembl id: CHEMBL_IND_45723
has molecule: CHEMBL91
highest development phase: 3
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_54527
type: DrugIndication
chembl id: CHEMBL_IND_54527
has molecule: CHEMBL12208
highest development phase: 1
has mesh: D015209
has mesh heading: CHOLANGITIS, SCLEROSING
has EFO: EFO_0004268
has EFO name: SCLEROSING CHOLANGITIS

CHEMBL_IND_52801
type: DrugIndication
chembl id: CHEMBL_IND_52801
has molecule: CHEMBL12318
highest development phase: 4
has mesh: D001847
has mesh heading: BONE DISEASES
has EFO: EFO_0004260
has EFO name: BONE DISEASE

CHEMBL_IND_49123
type: DrugIndication
chembl id: CHEMBL_IND_49123
has molecule: CHEMBL515
highest development phase: 3
has mesh: D018442
has mesh heading: LYMPHOMA, B-CELL, MARGINAL ZONE
has EFO: EFO_0000191
has EFO name: MALT LYMPHOMA

CHEMBL_IND_43105
type: DrugIndication
chembl id: CHEMBL_IND_43105
has molecule: CHEMBL515
highest development phase: 3
has mesh: D015451
has mesh heading: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
has EFO: EFO_0000095
has EFO name: CHRONIC LYMPHOCYTIC LEUKEMIA

CHEMBL_IND_41677
type: DrugIndication
chembl id: CHEMBL_IND_41677
has molecule: CHEMBL515
highest development phase: 4
has mesh: D054198
has mesh heading: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
has EFO: EFO_0000220
has EFO name: ACUTE LYMPHOBLASTIC LEUKEMIA

CHEMBL_IND_53294
type: DrugIndication
chembl id: CHEMBL_IND_53294
has molecule: CHEMBL506
highest development phase: 1
has mesh: D009765
has mesh heading: OBESITY
has EFO: EFO_0001073
has EFO name: OBESITY

CHEMBL_IND_52826
type: DrugIndication
chembl id: CHEMBL_IND_52826
has molecule: CHEMBL506
highest development phase: 4
has mesh: D008288
has mesh heading: MALARIA
has EFO: EFO_0001068
has EFO name: MALARIA

CHEMBL_IND_53903
type: DrugIndication
chembl id: CHEMBL_IND_53903
has molecule: CHEMBL506
highest development phase: 1
has mesh: D016780
has mesh heading: MALARIA, VIVAX
has EFO: EFO_0007445
has EFO name: PLASMODIUM VIVAX MALARIA

CHEMBL_IND_53096
type: DrugIndication
chembl id: CHEMBL_IND_53096
has molecule: CHEMBL506
highest development phase: 3
has mesh: D016778
has mesh heading: MALARIA, FALCIPARUM
has EFO: EFO_0007444
has EFO name: PLASMODIUM FALCIPARUM MALARIA

CHEMBL_IND_42023
type: DrugIndication
chembl id: CHEMBL_IND_42023
has molecule: CHEMBL12948
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_45564
type: DrugIndication
chembl id: CHEMBL_IND_45564
has molecule: CHEMBL12948
highest development phase: 3
has mesh: D005909
has mesh heading: GLIOBLASTOMA
has EFO: EFO_0000519
has EFO name: GLIOBLASTOMA MULTIFORME

CHEMBL_IND_26971
type: DrugIndication
chembl id: CHEMBL_IND_26971
has molecule: CHEMBL98
highest development phase: 1
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_25730
type: DrugIndication
chembl id: CHEMBL_IND_25730
has molecule: CHEMBL98
highest development phase: 2
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_25729
type: DrugIndication
chembl id: CHEMBL_IND_25729
has molecule: CHEMBL98
highest development phase: 2
has mesh: D009447
has mesh heading: NEUROBLASTOMA
has EFO: EFO_0000621
has EFO name: NEUROBLASTOMA

CHEMBL_IND_25728
type: DrugIndication
chembl id: CHEMBL_IND_25728
has molecule: CHEMBL98
highest development phase: 2
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_49452
type: DrugIndication
chembl id: CHEMBL_IND_49452
has molecule: CHEMBL98
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_45255
type: DrugIndication
chembl id: CHEMBL_IND_45255
has molecule: CHEMBL98
highest development phase: 2
has mesh: D018567
has mesh heading: BREAST NEOPLASMS, MALE
has EFO: EFO_0006861
has EFO name: MALE BREAST CARCINOMA

CHEMBL_IND_48693
type: DrugIndication
chembl id: CHEMBL_IND_48693
has molecule: CHEMBL98
highest development phase: 2
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0000681
has EFO name: RENAL CELL CARCINOMA

CHEMBL_IND_52425
type: DrugIndication
chembl id: CHEMBL_IND_52425
has molecule: CHEMBL98
highest development phase: 2
has mesh: D018316
has mesh heading: GLIOSARCOMA
has EFO: EFO_1001465
has EFO name: GLIOSARCOMA

CHEMBL_IND_28432
type: DrugIndication
chembl id: CHEMBL_IND_28432
has molecule: CHEMBL98
highest development phase: 2
has mesh: D009190
has mesh heading: MYELODYSPLASTIC SYNDROMES
has EFO: EFO_0000198
has EFO name: MYELODYSPLASTIC SYNDROME

CHEMBL_IND_52629
type: DrugIndication
chembl id: CHEMBL_IND_52629
has molecule: CHEMBL98
highest development phase: 1
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: EFO_0003893
has EFO name: OVARIAN NEOPLASM

CHEMBL_IND_26346
type: DrugIndication
chembl id: CHEMBL_IND_26346
has molecule: CHEMBL98
highest development phase: 1
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_26345
type: DrugIndication
chembl id: CHEMBL_IND_26345
has molecule: CHEMBL98
highest development phase: 4
has mesh: D016410
has mesh heading: LYMPHOMA, T-CELL, CUTANEOUS
has EFO: EFO_0002913
has EFO name: CUTANEOUS T-CELL LYMPHOMA

CHEMBL_IND_26344
type: DrugIndication
chembl id: CHEMBL_IND_26344
has molecule: CHEMBL98
highest development phase: 2
has mesh: D001927
has mesh heading: BRAIN DISEASES
has EFO: EFO_0005774
has EFO name: BRAIN DISEASE

CHEMBL_IND_49692
type: DrugIndication
chembl id: CHEMBL_IND_49692
has molecule: CHEMBL98
highest development phase: 2
has mesh: D000755
has mesh heading: ANEMIA, SICKLE CELL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SICKLE CELL ANEMIA

CHEMBL_IND_27988
type: DrugIndication
chembl id: CHEMBL_IND_27988
has molecule: CHEMBL98
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_27987
type: DrugIndication
chembl id: CHEMBL_IND_27987
has molecule: CHEMBL98
highest development phase: 2
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000180
has EFO name: HIV-1 INFECTION

CHEMBL_IND_51900
type: DrugIndication
chembl id: CHEMBL_IND_51900
has molecule: CHEMBL98
highest development phase: 2
has mesh: D009182
has mesh heading: MYCOSIS FUNGOIDES
has EFO: EFO_1001051
has EFO name: MYCOSIS FUNGOIDES

CHEMBL_IND_25011
type: DrugIndication
chembl id: CHEMBL_IND_25011
has molecule: CHEMBL98
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_24059
type: DrugIndication
chembl id: CHEMBL_IND_24059
has molecule: CHEMBL98
highest development phase: 2
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_24058
type: DrugIndication
chembl id: CHEMBL_IND_24058
has molecule: CHEMBL98
highest development phase: 1
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_24057
type: DrugIndication
chembl id: CHEMBL_IND_24057
has molecule: CHEMBL98
highest development phase: 2
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_51811
type: DrugIndication
chembl id: CHEMBL_IND_51811
has molecule: CHEMBL98
highest development phase: 1
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_50611
type: DrugIndication
chembl id: CHEMBL_IND_50611
has molecule: CHEMBL13209
highest development phase: 3
has mesh: D007319
has mesh heading: SLEEP INITIATION AND MAINTENANCE DISORDERS
has EFO: EFO_0004698
has EFO name: INSOMNIA

CHEMBL_IND_25570
type: DrugIndication
chembl id: CHEMBL_IND_25570
has molecule: CHEMBL101
highest development phase: 4
has mesh: D012216
has mesh heading: RHEUMATIC DISEASES
has EFO: EFO_0005755
has EFO name: RHEUMATIC DISEASE

CHEMBL_IND_28342
type: DrugIndication
chembl id: CHEMBL_IND_28342
has molecule: CHEMBL101
highest development phase: 4
has mesh: D018771
has mesh heading: ARTHRALGIA
has EFO: HP_0002829
has EFO name: ARTHRALGIA

CHEMBL_IND_27387
type: DrugIndication
chembl id: CHEMBL_IND_27387
has molecule: CHEMBL101
highest development phase: 4
has mesh: D063806
has mesh heading: MYALGIA
has EFO: HP_0003326
has EFO name: MYALGIA

CHEMBL_IND_49411
type: DrugIndication
chembl id: CHEMBL_IND_49411
has molecule: CHEMBL96
highest development phase: 1
has mesh: D003922
has mesh heading: DIABETES MELLITUS, TYPE 1
has EFO: EFO_0001359
has EFO name: TYPE I DIABETES MELLITUS

CHEMBL_IND_42169
type: DrugIndication
chembl id: CHEMBL_IND_42169
has molecule: CHEMBL96
highest development phase: 4
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_42514
type: DrugIndication
chembl id: CHEMBL_IND_42514
has molecule: CHEMBL104
highest development phase: 4
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_52022
type: DrugIndication
chembl id: CHEMBL_IND_52022
has molecule: CHEMBL104
highest development phase: 1
has mesh: D014008
has mesh heading: TINEA PEDIS
has EFO: EFO_0007512
has EFO name: TINEA PEDIS

CHEMBL_IND_47391
type: DrugIndication
chembl id: CHEMBL_IND_47391
has molecule: CHEMBL104
highest development phase: 3
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_51730
type: DrugIndication
chembl id: CHEMBL_IND_51730
has molecule: CHEMBL104
highest development phase: 3
has mesh: D002181
has mesh heading: CANDIDIASIS, VULVOVAGINAL
has EFO: EFO_0007543
has EFO name: VULVOVAGINAL CANDIDIASIS

CHEMBL_IND_50197
type: DrugIndication
chembl id: CHEMBL_IND_50197
has molecule: CHEMBL14370
highest development phase: 4
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_49248
type: DrugIndication
chembl id: CHEMBL_IND_49248
has molecule: CHEMBL103
highest development phase: 3
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_47837
type: DrugIndication
chembl id: CHEMBL_IND_47837
has molecule: CHEMBL103
highest development phase: 2
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000180
has EFO name: HIV-1 INFECTION

CHEMBL_IND_26242
type: DrugIndication
chembl id: CHEMBL_IND_26242
has molecule: CHEMBL103
highest development phase: 2
has mesh: D014029
has mesh heading: TOBACCO USE DISORDER
has EFO: EFO_0003768
has EFO name: NICOTINE DEPENDENCE

CHEMBL_IND_26241
type: DrugIndication
chembl id: CHEMBL_IND_26241
has molecule: CHEMBL103
highest development phase: 2
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_28461
type: DrugIndication
chembl id: CHEMBL_IND_28461
has molecule: CHEMBL103
highest development phase: 3
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_23742
type: DrugIndication
chembl id: CHEMBL_IND_23742
has molecule: CHEMBL103
highest development phase: 3
has mesh: D047928
has mesh heading: PREMATURE BIRTH
has EFO: EFO_0003917
has EFO name: PREMATURE BIRTH

CHEMBL_IND_23741
type: DrugIndication
chembl id: CHEMBL_IND_23741
has molecule: CHEMBL103
highest development phase: 3
has mesh: D007246
has mesh heading: INFERTILITY
has EFO: EFO_0000545
has EFO name: INFERTILITY

CHEMBL_IND_51833
type: DrugIndication
chembl id: CHEMBL_IND_51833
has molecule: CHEMBL103
highest development phase: 3
has mesh: D011247
has mesh heading: PREGNANCY
has EFO: EFO_0002950
has EFO name: PREGNANCY

CHEMBL_IND_27897
type: DrugIndication
chembl id: CHEMBL_IND_27897
has molecule: CHEMBL103
highest development phase: 2
has mesh: D011225
has mesh heading: PRE-ECLAMPSIA
has EFO: EFO_0000668
has EFO name: PREECLAMPSIA

CHEMBL_IND_27401
type: DrugIndication
chembl id: CHEMBL_IND_27401
has molecule: CHEMBL103
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_24821
type: DrugIndication
chembl id: CHEMBL_IND_24821
has molecule: CHEMBL103
highest development phase: 4
has mesh: D000568
has mesh heading: AMENORRHEA
has EFO: HP_0000869
has EFO name: SECONDARY AMENORRHEA

CHEMBL_IND_24820
type: DrugIndication
chembl id: CHEMBL_IND_24820
has molecule: CHEMBL103
highest development phase: 3
has mesh: D008593
has mesh heading: MENOPAUSE
has EFO: EFO_0003922
has EFO name: MENOPAUSE

CHEMBL_IND_40347
type: DrugIndication
chembl id: CHEMBL_IND_40347
has molecule: CHEMBL103
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0003869
has EFO name: BREAST NEOPLASM

CHEMBL_IND_52980
type: DrugIndication
chembl id: CHEMBL_IND_52980
has molecule: CHEMBL553
highest development phase: 2
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_53020
type: DrugIndication
chembl id: CHEMBL_IND_53020
has molecule: CHEMBL553
highest development phase: 3
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_53013
type: DrugIndication
chembl id: CHEMBL_IND_53013
has molecule: CHEMBL553
highest development phase: 2
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_53976
type: DrugIndication
chembl id: CHEMBL_IND_53976
has molecule: CHEMBL553
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_53968
type: DrugIndication
chembl id: CHEMBL_IND_53968
has molecule: CHEMBL553
highest development phase: 2
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000292
has EFO name: BLADDER CARCINOMA

CHEMBL_IND_54074
type: DrugIndication
chembl id: CHEMBL_IND_54074
has molecule: CHEMBL553
highest development phase: 3
has mesh: D009062
has mesh heading: MOUTH NEOPLASMS
has EFO: EFO_0003868
has EFO name: MOUTH NEOPLASM

CHEMBL_IND_53246
type: DrugIndication
chembl id: CHEMBL_IND_53246
has molecule: CHEMBL553
highest development phase: 2
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_54695
type: DrugIndication
chembl id: CHEMBL_IND_54695
has molecule: CHEMBL553
highest development phase: 2
has mesh: D011087
has mesh heading: POLYCYTHEMIA VERA
has EFO: EFO_0002429
has EFO name: POLYCYTHEMIA VERA

CHEMBL_IND_52845
type: DrugIndication
chembl id: CHEMBL_IND_52845
has molecule: CHEMBL553
highest development phase: 2
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000181
has EFO name: HEAD AND NECK SQUAMOUS CELL CARCINOMA

CHEMBL_IND_53561
type: DrugIndication
chembl id: CHEMBL_IND_53561
has molecule: CHEMBL553
highest development phase: 2
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000707
has EFO name: SQUAMOUS CELL CARCINOMA

CHEMBL_IND_53546
type: DrugIndication
chembl id: CHEMBL_IND_53546
has molecule: CHEMBL553
highest development phase: 2
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_53870
type: DrugIndication
chembl id: CHEMBL_IND_53870
has molecule: CHEMBL553
highest development phase: 2
has mesh: D012878
has mesh heading: SKIN NEOPLASMS
has EFO: EFO_0004198
has EFO name: SKIN NEOPLASM

CHEMBL_IND_53725
type: DrugIndication
chembl id: CHEMBL_IND_53725
has molecule: CHEMBL553
highest development phase: 2
has mesh: D009190
has mesh heading: MYELODYSPLASTIC SYNDROMES
has EFO: EFO_0000198
has EFO name: MYELODYSPLASTIC SYNDROME

CHEMBL_IND_53662
type: DrugIndication
chembl id: CHEMBL_IND_53662
has molecule: CHEMBL553
highest development phase: 2
has mesh: D004806
has mesh heading: EPENDYMOMA
has EFO: EFO_1000028
has EFO name: EPENDYMOMA

CHEMBL_IND_52726
type: DrugIndication
chembl id: CHEMBL_IND_52726
has molecule: CHEMBL553
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_54299
type: DrugIndication
chembl id: CHEMBL_IND_54299
has molecule: CHEMBL553
highest development phase: 1
has mesh: D019698
has mesh heading: HEPATITIS C, CHRONIC
has EFO: EFO_0004220
has EFO name: CHRONIC HEPATITIS C INFECTION

CHEMBL_IND_53498
type: DrugIndication
chembl id: CHEMBL_IND_53498
has molecule: CHEMBL553
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_54843
type: DrugIndication
chembl id: CHEMBL_IND_54843
has molecule: CHEMBL553
highest development phase: 2
has mesh: D002277
has mesh heading: CARCINOMA
has EFO: EFO_0000313
has EFO name: CARCINOMA

CHEMBL_IND_27083
type: DrugIndication
chembl id: CHEMBL_IND_27083
has molecule: CHEMBL108
highest development phase: 4
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_41570
type: DrugIndication
chembl id: CHEMBL_IND_41570
has molecule: CHEMBL108
highest development phase: 4
has mesh: D020435
has mesh heading: GLOSSOPHARYNGEAL NERVE DISEASES

CHEMBL_IND_41894
type: DrugIndication
chembl id: CHEMBL_IND_41894
has molecule: CHEMBL108
highest development phase: 4
has mesh: D014277
has mesh heading: TRIGEMINAL NEURALGIA
has EFO: EFO_1001219
has EFO name: TRIGEMINAL NEURALGIA

CHEMBL_IND_22855
type: DrugIndication
chembl id: CHEMBL_IND_22855
has molecule: CHEMBL108
highest development phase: 4
has mesh: D004828
has mesh heading: EPILEPSIES, PARTIAL
has EFO: EFO_0004263
has EFO name: PARTIAL EPILEPSY

CHEMBL_IND_22854
type: DrugIndication
chembl id: CHEMBL_IND_22854
has molecule: CHEMBL108
highest development phase: 4
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_53982
type: DrugIndication
chembl id: CHEMBL_IND_53982
has molecule: CHEMBL554
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_53969
type: DrugIndication
chembl id: CHEMBL_IND_53969
has molecule: CHEMBL554
highest development phase: 0
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000292
has EFO name: BLADDER CARCINOMA

CHEMBL_IND_54251
type: DrugIndication
chembl id: CHEMBL_IND_54251
has molecule: CHEMBL554
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_54078
type: DrugIndication
chembl id: CHEMBL_IND_54078
has molecule: CHEMBL554
highest development phase: 1
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_54709
type: DrugIndication
chembl id: CHEMBL_IND_54709
has molecule: CHEMBL554
highest development phase: 2
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_52869
type: DrugIndication
chembl id: CHEMBL_IND_52869
has molecule: CHEMBL554
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_52843
type: DrugIndication
chembl id: CHEMBL_IND_52843
has molecule: CHEMBL554
highest development phase: 2
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000181
has EFO name: HEAD AND NECK SQUAMOUS CELL CARCINOMA

CHEMBL_IND_53351
type: DrugIndication
chembl id: CHEMBL_IND_53351
has molecule: CHEMBL554
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0003869
has EFO name: BREAST NEOPLASM

CHEMBL_IND_53327
type: DrugIndication
chembl id: CHEMBL_IND_53327
has molecule: CHEMBL554
highest development phase: 2
has mesh: D004938
has mesh heading: ESOPHAGEAL NEOPLASMS
has EFO: EFO_0002916
has EFO name: ESOPHAGEAL CARCINOMA

CHEMBL_IND_52785
type: DrugIndication
chembl id: CHEMBL_IND_52785
has molecule: CHEMBL554
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_53191
type: DrugIndication
chembl id: CHEMBL_IND_53191
has molecule: CHEMBL554
highest development phase: 2
has mesh: D013274
has mesh heading: STOMACH NEOPLASMS
has EFO: EFO_0000178
has EFO name: GASTRIC CARCINOMA

CHEMBL_IND_54468
type: DrugIndication
chembl id: CHEMBL_IND_54468
has molecule: CHEMBL554
highest development phase: 2
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000707
has EFO name: SQUAMOUS CELL CARCINOMA

CHEMBL_IND_41942
type: DrugIndication
chembl id: CHEMBL_IND_41942
has molecule: CHEMBL539
highest development phase: 4
has mesh: D007249
has mesh heading: INFLAMMATION
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: INFLAMMATION

CHEMBL_IND_52089
type: DrugIndication
chembl id: CHEMBL_IND_52089
has molecule: CHEMBL539
highest development phase: 2
has mesh: D001471
has mesh heading: BARRETT ESOPHAGUS
has EFO: EFO_0000280
has EFO name: BARRETT'S ESOPHAGUS

CHEMBL_IND_42686
type: DrugIndication
chembl id: CHEMBL_IND_42686
has molecule: CHEMBL539
highest development phase: 4
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_28343
type: DrugIndication
chembl id: CHEMBL_IND_28343
has molecule: CHEMBL550
highest development phase: 1
has mesh: D014549
has mesh heading: URINARY INCONTINENCE
has EFO: HP_0000020
has EFO name: URINARY INCONTINENCE

CHEMBL_IND_26218
type: DrugIndication
chembl id: CHEMBL_IND_26218
has molecule: CHEMBL550
highest development phase: 4
has mesh: D005901
has mesh heading: GLAUCOMA
has EFO: EFO_0000516
has EFO name: GLAUCOMA

CHEMBL_IND_49631
type: DrugIndication
chembl id: CHEMBL_IND_49631
has molecule: CHEMBL112
highest development phase: 2
has mesh: D001927
has mesh heading: BRAIN DISEASES
has EFO: EFO_0005774
has EFO name: BRAIN DISEASE

CHEMBL_IND_44280
type: DrugIndication
chembl id: CHEMBL_IND_44280
has molecule: CHEMBL112
highest development phase: 2
has mesh: D006470
has mesh heading: HEMORRHAGE
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: HEMORRHAGE

CHEMBL_IND_25749
type: DrugIndication
chembl id: CHEMBL_IND_25749
has molecule: CHEMBL112
highest development phase: 2
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_47973
type: DrugIndication
chembl id: CHEMBL_IND_47973
has molecule: CHEMBL112
highest development phase: 0
has mesh: D005901
has mesh heading: GLAUCOMA
has EFO: EFO_0000516
has EFO name: GLAUCOMA

CHEMBL_IND_48435
type: DrugIndication
chembl id: CHEMBL_IND_48435
has molecule: CHEMBL112
highest development phase: 2
has mesh: D014069
has mesh heading: TONSILLITIS
has EFO: HP_0011110
has EFO name: TONSILLITIS

CHEMBL_IND_52422
type: DrugIndication
chembl id: CHEMBL_IND_52422
has molecule: CHEMBL112
highest development phase: 2
has mesh: D056844
has mesh heading: RENAL COLIC
has EFO: EFO_1001412
has EFO name: RENAL COLIC

CHEMBL_IND_52295
type: DrugIndication
chembl id: CHEMBL_IND_52295
has molecule: CHEMBL112
highest development phase: 3
has mesh: D015207
has mesh heading: OSTEOARTHRITIS, HIP
has EFO: EFO_1000786
has EFO name: OSTEOARTHRITIS, HIP

CHEMBL_IND_41940
type: DrugIndication
chembl id: CHEMBL_IND_41940
has molecule: CHEMBL112
highest development phase: 4
has mesh: D004412
has mesh heading: DYSMENORRHEA
has EFO: HP_0100607
has EFO name: DYSMENORRHEA

CHEMBL_IND_41357
type: DrugIndication
chembl id: CHEMBL_IND_41357
has molecule: CHEMBL112
highest development phase: 3
has mesh: D015746
has mesh heading: ABDOMINAL PAIN
has EFO: HP_0002027
has EFO name: ABDOMINAL PAIN

CHEMBL_IND_52237
type: DrugIndication
chembl id: CHEMBL_IND_52237
has molecule: CHEMBL112
highest development phase: 2
has mesh: D003922
has mesh heading: DIABETES MELLITUS, TYPE 1
has EFO: EFO_0001359
has EFO name: TYPE I DIABETES MELLITUS

CHEMBL_IND_26361
type: DrugIndication
chembl id: CHEMBL_IND_26361
has molecule: CHEMBL112
highest development phase: 4
has mesh: D007251
has mesh heading: INFLUENZA, HUMAN
has EFO: EFO_0001669
has EFO name: INFLUENZA INFECTION

CHEMBL_IND_42254
type: DrugIndication
chembl id: CHEMBL_IND_42254
has molecule: CHEMBL112
highest development phase: 4
has mesh: D003139
has mesh heading: COMMON COLD
has EFO: EFO_0007214
has EFO name: COMMON COLD

CHEMBL_IND_46148
type: DrugIndication
chembl id: CHEMBL_IND_46148
has molecule: CHEMBL112
highest development phase: 3
has mesh: D016920
has mesh heading: MENINGITIS, BACTERIAL
has EFO: EFO_1000831
has EFO name: BACTERIAL MENINGITIS

CHEMBL_IND_28469
type: DrugIndication
chembl id: CHEMBL_IND_28469
has molecule: CHEMBL112
highest development phase: 2
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_27517
type: DrugIndication
chembl id: CHEMBL_IND_27517
has molecule: CHEMBL112
highest development phase: 2
has mesh: D018805
has mesh heading: SEPSIS
has EFO: EFO_0001420
has EFO name: SEPSIS

CHEMBL_IND_27516
type: DrugIndication
chembl id: CHEMBL_IND_27516
has molecule: CHEMBL112
highest development phase: 2
has mesh: D001883
has mesh heading: BORDERLINE PERSONALITY DISORDER
has EFO: EFO_0005429
has EFO name: BORDERLINE PERSONALITY DISORDER SYMPTOM

CHEMBL_IND_47460
type: DrugIndication
chembl id: CHEMBL_IND_47460
has molecule: CHEMBL112
highest development phase: 2
has mesh: D002583
has mesh heading: UTERINE CERVICAL NEOPLASMS
has EFO: EFO_0001416
has EFO name: CERVICAL ADENOCARCINOMA

CHEMBL_IND_41676
type: DrugIndication
chembl id: CHEMBL_IND_41676
has molecule: CHEMBL112
highest development phase: 4
has mesh: D010612
has mesh heading: PHARYNGITIS

CHEMBL_IND_41608
type: DrugIndication
chembl id: CHEMBL_IND_41608
has molecule: CHEMBL112
highest development phase: 4
has mesh: D014098
has mesh heading: TOOTHACHE

CHEMBL_IND_22622
type: DrugIndication
chembl id: CHEMBL_IND_22622
has molecule: CHEMBL112
highest development phase: 4
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_22621
type: DrugIndication
chembl id: CHEMBL_IND_22621
has molecule: CHEMBL112
highest development phase: 3
has mesh: D020370
has mesh heading: OSTEOARTHRITIS, KNEE
has EFO: EFO_0004616
has EFO name: OSTEOARTHRITIS, KNEE

CHEMBL_IND_22620
type: DrugIndication
chembl id: CHEMBL_IND_22620
has molecule: CHEMBL112
highest development phase: 3
has mesh: D010003
has mesh heading: OSTEOARTHRITIS
has EFO: EFO_0002506
has EFO name: OSTEOARTHRITIS

CHEMBL_IND_22619
type: DrugIndication
chembl id: CHEMBL_IND_22619
has molecule: CHEMBL112
highest development phase: 4
has mesh: D008881
has mesh heading: MIGRAINE DISORDERS
has EFO: EFO_0003821
has EFO name: MIGRAINE DISORDER

CHEMBL_IND_22617
type: DrugIndication
chembl id: CHEMBL_IND_22617
has molecule: CHEMBL112
highest development phase: 4
has mesh: D005334
has mesh heading: FEVER
has EFO: HP_0001945
has EFO name: FEVER

CHEMBL_IND_51749
type: DrugIndication
chembl id: CHEMBL_IND_51749
has molecule: CHEMBL112
highest development phase: 2
has mesh: D011671
has mesh heading: PULPITIS
has EFO: EFO_1001139
has EFO name: PULPITIS

CHEMBL_IND_25030
type: DrugIndication
chembl id: CHEMBL_IND_25030
has molecule: CHEMBL112
highest development phase: 2
has mesh: D004374
has mesh heading: DUCTUS ARTERIOSUS, PATENT
has EFO: HP_0001643
has EFO name: PATENT DUCTUS ARTERIOSUS

CHEMBL_IND_25029
type: DrugIndication
chembl id: CHEMBL_IND_25029
has molecule: CHEMBL112
highest development phase: 2
has mesh: D002972
has mesh heading: CLEFT PALATE
has EFO: HP_0000175
has EFO name: CLEFT PALATE

CHEMBL_IND_25028
type: DrugIndication
chembl id: CHEMBL_IND_25028
has molecule: CHEMBL112
highest development phase: 4
has mesh: D001168
has mesh heading: ARTHRITIS
has EFO: EFO_0005856
has EFO name: ARTHRITIS

CHEMBL_IND_24097
type: DrugIndication
chembl id: CHEMBL_IND_24097
has molecule: CHEMBL112
highest development phase: 2
has mesh: D004066
has mesh heading: DIGESTIVE SYSTEM DISEASES
has EFO: EFO_0000405
has EFO name: DIGESTIVE SYSTEM DISEASE

CHEMBL_IND_27624
type: DrugIndication
chembl id: CHEMBL_IND_27624
has molecule: CHEMBL107
highest development phase: 2
has mesh: D010003
has mesh heading: OSTEOARTHRITIS
has EFO: EFO_0002506
has EFO name: OSTEOARTHRITIS

CHEMBL_IND_27623
type: DrugIndication
chembl id: CHEMBL_IND_27623
has molecule: CHEMBL107
highest development phase: 2
has mesh: D003928
has mesh heading: DIABETIC NEPHROPATHIES
has EFO: EFO_0000401
has EFO name: DIABETIC NEPHROPATHY

CHEMBL_IND_27109
type: DrugIndication
chembl id: CHEMBL_IND_27109
has molecule: CHEMBL107
highest development phase: 2
has mesh: D014652
has mesh heading: VASCULAR DISEASES
has EFO: EFO_0004264
has EFO name: VASCULAR DISEASE

CHEMBL_IND_27108
type: DrugIndication
chembl id: CHEMBL_IND_27108
has molecule: CHEMBL107
highest development phase: 4
has mesh: D010505
has mesh heading: FAMILIAL MEDITERRANEAN FEVER
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: FAMILIAL MEDITERRANEAN FEVER

CHEMBL_IND_28068
type: DrugIndication
chembl id: CHEMBL_IND_28068
has molecule: CHEMBL107
highest development phase: 2
has mesh: D019698
has mesh heading: HEPATITIS C, CHRONIC
has EFO: EFO_0004220
has EFO name: CHRONIC HEPATITIS C INFECTION

CHEMBL_IND_52236
type: DrugIndication
chembl id: CHEMBL_IND_52236
has molecule: CHEMBL107
highest development phase: 1
has mesh: D009765
has mesh heading: OBESITY
has EFO: EFO_0001073
has EFO name: OBESITY

CHEMBL_IND_25881
type: DrugIndication
chembl id: CHEMBL_IND_25881
has molecule: CHEMBL107
highest development phase: 4
has mesh: D006073
has mesh heading: GOUT
has EFO: EFO_0004274
has EFO name: GOUT

CHEMBL_IND_43335
type: DrugIndication
chembl id: CHEMBL_IND_43335
has molecule: CHEMBL107
highest development phase: 2
has mesh: D003324
has mesh heading: CORONARY ARTERY DISEASE
has EFO: EFO_0000378
has EFO name: CORONARY ARTERY DISEASE

CHEMBL_IND_26474
type: DrugIndication
chembl id: CHEMBL_IND_26474
has molecule: CHEMBL107
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_26473
type: DrugIndication
chembl id: CHEMBL_IND_26473
has molecule: CHEMBL107
highest development phase: 2
has mesh: D001528
has mesh heading: BEHCET SYNDROME
has EFO: EFO_0003780
has EFO name: BEHCET'S SYNDROME

CHEMBL_IND_46336
type: DrugIndication
chembl id: CHEMBL_IND_46336
has molecule: CHEMBL107
highest development phase: 3
has mesh: D001281
has mesh heading: ATRIAL FIBRILLATION
has EFO: EFO_0000275
has EFO name: ATRIAL FIBRILLATION

CHEMBL_IND_44356
type: DrugIndication
chembl id: CHEMBL_IND_44356
has molecule: CHEMBL107
highest development phase: 2
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_51872
type: DrugIndication
chembl id: CHEMBL_IND_51872
has molecule: CHEMBL107
highest development phase: 3
has mesh: D010493
has mesh heading: PERICARDITIS
has EFO: EFO_0007427
has EFO name: PERICARDITIS

CHEMBL_IND_22941
type: DrugIndication
chembl id: CHEMBL_IND_22941
has molecule: CHEMBL107
highest development phase: 2
has mesh: D013281
has mesh heading: STOMATITIS, APHTHOUS
has EFO: EFO_0003938
has EFO name: APHTHOUS ULCER

CHEMBL_IND_25191
type: DrugIndication
chembl id: CHEMBL_IND_25191
has molecule: CHEMBL107
highest development phase: 2
has mesh: D054058
has mesh heading: ACUTE CORONARY SYNDROME
has EFO: EFO_0005672
has EFO name: ACUTE CORONARY SYNDROME

CHEMBL_IND_49570
type: DrugIndication
chembl id: CHEMBL_IND_49570
has molecule: CHEMBL109
highest development phase: 2
has mesh: D000505
has mesh heading: ALOPECIA
has EFO: EFO_0004191
has EFO name: ANDROGENETIC ALOPECIA

CHEMBL_IND_26960
type: DrugIndication
chembl id: CHEMBL_IND_26960
has molecule: CHEMBL109
highest development phase: 2
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_46801
type: DrugIndication
chembl id: CHEMBL_IND_46801
has molecule: CHEMBL109
highest development phase: 2
has mesh: D013964
has mesh heading: THYROID NEOPLASMS
has EFO: EFO_0003841
has EFO name: THYROID NEOPLASM

CHEMBL_IND_52460
type: DrugIndication
chembl id: CHEMBL_IND_52460
has molecule: CHEMBL109
highest development phase: 1
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_25712
type: DrugIndication
chembl id: CHEMBL_IND_25712
has molecule: CHEMBL109
highest development phase: 1
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_25710
type: DrugIndication
chembl id: CHEMBL_IND_25710
has molecule: CHEMBL109
highest development phase: 2
has mesh: D012174
has mesh heading: RETINITIS PIGMENTOSA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: RETINITIS PIGMENTOSA

CHEMBL_IND_25708
type: DrugIndication
chembl id: CHEMBL_IND_25708
has molecule: CHEMBL109
highest development phase: 2
has mesh: D013494
has mesh heading: SUPRANUCLEAR PALSY, PROGRESSIVE
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: PROGRESSIVE SUPRANUCLEAR PALSY

CHEMBL_IND_44766
type: DrugIndication
chembl id: CHEMBL_IND_44766
has molecule: CHEMBL109
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_46346
type: DrugIndication
chembl id: CHEMBL_IND_46346
has molecule: CHEMBL109
highest development phase: 0
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000292
has EFO name: BLADDER CARCINOMA

CHEMBL_IND_49006
type: DrugIndication
chembl id: CHEMBL_IND_49006
has molecule: CHEMBL109
highest development phase: 2
has mesh: D009437
has mesh heading: NEURALGIA
has EFO: EFO_0005762
has EFO name: NEUROPATHIC PAIN

CHEMBL_IND_47172
type: DrugIndication
chembl id: CHEMBL_IND_47172
has molecule: CHEMBL109
highest development phase: 1
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_44353
type: DrugIndication
chembl id: CHEMBL_IND_44353
has molecule: CHEMBL109
highest development phase: 0
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000181
has EFO name: HEAD AND NECK SQUAMOUS CELL CARCINOMA

CHEMBL_IND_27497
type: DrugIndication
chembl id: CHEMBL_IND_27497
has molecule: CHEMBL109
highest development phase: 1
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_27495
type: DrugIndication
chembl id: CHEMBL_IND_27495
has molecule: CHEMBL109
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_52128
type: DrugIndication
chembl id: CHEMBL_IND_52128
has molecule: CHEMBL109
highest development phase: 1
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_27980
type: DrugIndication
chembl id: CHEMBL_IND_27980
has molecule: CHEMBL109
highest development phase: 2
has mesh: D009134
has mesh heading: MUSCULAR ATROPHY, SPINAL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: PROXIMAL SPINAL MUSCULAR ATROPHY TYPE 3

CHEMBL_IND_27978
type: DrugIndication
chembl id: CHEMBL_IND_27978
has molecule: CHEMBL109
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_42769
type: DrugIndication
chembl id: CHEMBL_IND_42769
has molecule: CHEMBL109
highest development phase: 4
has mesh: D017029
has mesh heading: EPILEPSY, COMPLEX PARTIAL
has EFO: EFO_1000877
has EFO name: COMPLEX PARTIAL EPILEPSY

CHEMBL_IND_24993
type: DrugIndication
chembl id: CHEMBL_IND_24993
has molecule: CHEMBL109
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_24989
type: DrugIndication
chembl id: CHEMBL_IND_24989
has molecule: CHEMBL109
highest development phase: 4
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_24985
type: DrugIndication
chembl id: CHEMBL_IND_24985
has molecule: CHEMBL109
highest development phase: 0
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_51603
type: DrugIndication
chembl id: CHEMBL_IND_51603
has molecule: CHEMBL109
highest development phase: 4
has mesh: D004832
has mesh heading: EPILEPSY, ABSENCE
has EFO: HP_0002121
has EFO name: ABSENCE SEIZURES

CHEMBL_IND_24021
type: DrugIndication
chembl id: CHEMBL_IND_24021
has molecule: CHEMBL109
highest development phase: 2
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_24019
type: DrugIndication
chembl id: CHEMBL_IND_24019
has molecule: CHEMBL109
highest development phase: 4
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_42287
type: DrugIndication
chembl id: CHEMBL_IND_42287
has molecule: CHEMBL16073
highest development phase: 4
has mesh: D005334
has mesh heading: FEVER
has EFO: HP_0001945
has EFO name: FEVER

CHEMBL_IND_41797
type: DrugIndication
chembl id: CHEMBL_IND_41797
has molecule: CHEMBL16073
highest development phase: 4
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_45443
type: DrugIndication
chembl id: CHEMBL_IND_45443
has molecule: CHEMBL560
highest development phase: 2
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_42721
type: DrugIndication
chembl id: CHEMBL_IND_42721
has molecule: CHEMBL560
highest development phase: 4
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_27643
type: DrugIndication
chembl id: CHEMBL_IND_27643
has molecule: CHEMBL559
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_43397
type: DrugIndication
chembl id: CHEMBL_IND_43397
has molecule: CHEMBL23261
highest development phase: 3
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_43947
type: DrugIndication
chembl id: CHEMBL_IND_43947
has molecule: CHEMBL23393
highest development phase: 1
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_54761
type: DrugIndication
chembl id: CHEMBL_IND_54761
has molecule: CHEMBL23393
highest development phase: 1
has mesh: D014008
has mesh heading: TINEA PEDIS
has EFO: EFO_0007512
has EFO name: TINEA PEDIS

CHEMBL_IND_45688
type: DrugIndication
chembl id: CHEMBL_IND_45688
has molecule: CHEMBL23393
highest development phase: 1
has mesh: D012871
has mesh heading: SKIN DISEASES
has EFO: EFO_0000701
has EFO name: SKIN DISEASE

CHEMBL_IND_27178
type: DrugIndication
chembl id: CHEMBL_IND_27178
has molecule: CHEMBL622
highest development phase: 1
has mesh: D007863
has mesh heading: LECITHIN ACYLTRANSFERASE DEFICIENCY
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: FISH-EYE DISEASE

CHEMBL_IND_42538
type: DrugIndication
chembl id: CHEMBL_IND_42538
has molecule: CHEMBL622
highest development phase: 4
has mesh: D001172
has mesh heading: ARTHRITIS, RHEUMATOID
has EFO: EFO_0000685
has EFO name: RHEUMATOID ARTHRITIS

CHEMBL_IND_42045
type: DrugIndication
chembl id: CHEMBL_IND_42045
has molecule: CHEMBL622
highest development phase: 4
has mesh: D010003
has mesh heading: OSTEOARTHRITIS
has EFO: EFO_0002506
has EFO name: OSTEOARTHRITIS

CHEMBL_IND_23151
type: DrugIndication
chembl id: CHEMBL_IND_23151
has molecule: CHEMBL622
highest development phase: 4
has mesh: D012216
has mesh heading: RHEUMATIC DISEASES
has EFO: EFO_0005755
has EFO name: RHEUMATIC DISEASE

CHEMBL_IND_24422
type: DrugIndication
chembl id: CHEMBL_IND_24422
has molecule: CHEMBL622
highest development phase: 4
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_27130
type: DrugIndication
chembl id: CHEMBL_IND_27130
has molecule: CHEMBL139
highest development phase: 4
has mesh: D018771
has mesh heading: ARTHRALGIA
has EFO: HP_0002829
has EFO name: ARTHRALGIA

CHEMBL_IND_28111
type: DrugIndication
chembl id: CHEMBL_IND_28111
has molecule: CHEMBL139
highest development phase: 2
has mesh: D011655
has mesh heading: PULMONARY EMBOLISM
has EFO: EFO_0003827
has EFO name: PULMONARY EMBOLISM

CHEMBL_IND_28110
type: DrugIndication
chembl id: CHEMBL_IND_28110
has molecule: CHEMBL139
highest development phase: 4
has mesh: D063806
has mesh heading: MYALGIA
has EFO: HP_0003326
has EFO name: MYALGIA

CHEMBL_IND_28108
type: DrugIndication
chembl id: CHEMBL_IND_28108
has molecule: CHEMBL139
highest development phase: 1
has mesh: D003930
has mesh heading: DIABETIC RETINOPATHY
has EFO: EFO_0003770
has EFO name: DIABETIC RETINOPATHY

CHEMBL_IND_48627
type: DrugIndication
chembl id: CHEMBL_IND_48627
has molecule: CHEMBL139
highest development phase: 3
has mesh: D007246
has mesh heading: INFERTILITY
has EFO: EFO_0000545
has EFO name: INFERTILITY

CHEMBL_IND_52655
type: DrugIndication
chembl id: CHEMBL_IND_52655
has molecule: CHEMBL139
highest development phase: 3
has mesh: D015207
has mesh heading: OSTEOARTHRITIS, HIP
has EFO: EFO_1000786
has EFO name: OSTEOARTHRITIS, HIP

CHEMBL_IND_42247
type: DrugIndication
chembl id: CHEMBL_IND_42247
has molecule: CHEMBL139
highest development phase: 4
has mesh: D012216
has mesh heading: RHEUMATIC DISEASES
has EFO: EFO_0005755
has EFO name: RHEUMATIC DISEASE

CHEMBL_IND_23034
type: DrugIndication
chembl id: CHEMBL_IND_23034
has molecule: CHEMBL139
highest development phase: 3
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_23032
type: DrugIndication
chembl id: CHEMBL_IND_23032
has molecule: CHEMBL139
highest development phase: 3
has mesh: D020370
has mesh heading: OSTEOARTHRITIS, KNEE
has EFO: EFO_0004616
has EFO name: OSTEOARTHRITIS, KNEE

CHEMBL_IND_23031
type: DrugIndication
chembl id: CHEMBL_IND_23031
has molecule: CHEMBL139
highest development phase: 4
has mesh: D010003
has mesh heading: OSTEOARTHRITIS
has EFO: EFO_0002506
has EFO name: OSTEOARTHRITIS

CHEMBL_IND_23025
type: DrugIndication
chembl id: CHEMBL_IND_23025
has molecule: CHEMBL139
highest development phase: 4
has mesh: D005128
has mesh heading: EYE DISEASES
has EFO: EFO_0005752
has EFO name: EYE INFLAMMATION

CHEMBL_IND_24349
type: DrugIndication
chembl id: CHEMBL_IND_24349
has molecule: CHEMBL139
highest development phase: 1
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_24347
type: DrugIndication
chembl id: CHEMBL_IND_24347
has molecule: CHEMBL139
highest development phase: 4
has mesh: D001172
has mesh heading: ARTHRITIS, RHEUMATOID
has EFO: EFO_0000685
has EFO name: RHEUMATOID ARTHRITIS

CHEMBL_IND_24341
type: DrugIndication
chembl id: CHEMBL_IND_24341
has molecule: CHEMBL139
highest development phase: 2
has mesh: D002280
has mesh heading: CARCINOMA, BASAL CELL
has EFO: EFO_0004193
has EFO name: BASAL CELL CARCINOMA

CHEMBL_IND_24339
type: DrugIndication
chembl id: CHEMBL_IND_24339
has molecule: CHEMBL139
highest development phase: 4
has mesh: D013167
has mesh heading: SPONDYLITIS, ANKYLOSING
has EFO: EFO_0003898
has EFO name: ANKYLOSING SPONDYLITIS

CHEMBL_IND_50189
type: DrugIndication
chembl id: CHEMBL_IND_50189
has molecule: CHEMBL23588
highest development phase: 4
has mesh: D012216
has mesh heading: RHEUMATIC DISEASES
has EFO: EFO_0005755
has EFO name: RHEUMATIC DISEASE

CHEMBL_IND_50931
type: DrugIndication
chembl id: CHEMBL_IND_50931
has molecule: CHEMBL19236
highest development phase: 3
has mesh: D006331
has mesh heading: HEART DISEASES
has EFO: EFO_0003777
has EFO name: HEART DISEASE

CHEMBL_IND_50076
type: DrugIndication
chembl id: CHEMBL_IND_50076
has molecule: CHEMBL19236
highest development phase: 4
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_43570
type: DrugIndication
chembl id: CHEMBL_IND_43570
has molecule: CHEMBL689
highest development phase: 2
has mesh: D020521
has mesh heading: STROKE
has EFO: EFO_0000712
has EFO name: STROKE

CHEMBL_IND_46724
type: DrugIndication
chembl id: CHEMBL_IND_46724
has molecule: CHEMBL689
highest development phase: 3
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0002890
has EFO name: RENAL CARCINOMA

CHEMBL_IND_47932
type: DrugIndication
chembl id: CHEMBL_IND_47932
has molecule: CHEMBL689
highest development phase: 1
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_45300
type: DrugIndication
chembl id: CHEMBL_IND_45300
has molecule: CHEMBL689
highest development phase: 3
has mesh: D001987
has mesh heading: BRONCHIECTASIS
has EFO: HP_0002110
has EFO name: BRONCHIECTASIS

CHEMBL_IND_47724
type: DrugIndication
chembl id: CHEMBL_IND_47724
has molecule: CHEMBL689
highest development phase: 2
has mesh: D007022
has mesh heading: HYPOTENSION
has EFO: EFO_0005251
has EFO name: HYPOTENSION

CHEMBL_IND_43431
type: DrugIndication
chembl id: CHEMBL_IND_43431
has molecule: CHEMBL689
highest development phase: 3
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_48887
type: DrugIndication
chembl id: CHEMBL_IND_48887
has molecule: CHEMBL689
highest development phase: 1
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_44308
type: DrugIndication
chembl id: CHEMBL_IND_44308
has molecule: CHEMBL689
highest development phase: 3
has mesh: D003550
has mesh heading: CYSTIC FIBROSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CYSTIC FIBROSIS

CHEMBL_IND_51722
type: DrugIndication
chembl id: CHEMBL_IND_51722
has molecule: CHEMBL689
highest development phase: 1
has mesh: D016697
has mesh heading: HERPES ZOSTER OTICUS
has EFO: EFO_0007281
has EFO name: GENICULATE HERPES ZOSTER

CHEMBL_IND_47047
type: DrugIndication
chembl id: CHEMBL_IND_47047
has molecule: CHEMBL126
highest development phase: 2
has mesh: D003550
has mesh heading: CYSTIC FIBROSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CYSTIC FIBROSIS

CHEMBL_IND_43560
type: DrugIndication
chembl id: CHEMBL_IND_43560
has molecule: CHEMBL126
highest development phase: 3
has mesh: D012871
has mesh heading: SKIN DISEASES
has EFO: EFO_0000701
has EFO name: SKIN DISEASE

CHEMBL_IND_43879
type: DrugIndication
chembl id: CHEMBL_IND_43879
has molecule: CHEMBL126
highest development phase: 4
has mesh: D011014
has mesh heading: PNEUMONIA
has EFO: EFO_0003106
has EFO name: PNEUMONIA

CHEMBL_IND_43405
type: DrugIndication
chembl id: CHEMBL_IND_43405
has molecule: CHEMBL126
highest development phase: 3
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_44288
type: DrugIndication
chembl id: CHEMBL_IND_44288
has molecule: CHEMBL126
highest development phase: 2
has mesh: D014376
has mesh heading: TUBERCULOSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: TUBERCULOSIS

CHEMBL_IND_51731
type: DrugIndication
chembl id: CHEMBL_IND_51731
has molecule: CHEMBL126
highest development phase: 2
has mesh: D014397
has mesh heading: TUBERCULOSIS, PULMONARY
has EFO: EFO_1000049
has EFO name: PULMONARY TUBERCULOSIS

CHEMBL_IND_42508
type: DrugIndication
chembl id: CHEMBL_IND_42508
has molecule: CHEMBL23838
highest development phase: 4
has mesh: D005901
has mesh heading: GLAUCOMA
has EFO: EFO_0000516
has EFO name: GLAUCOMA

CHEMBL_IND_53376
type: DrugIndication
chembl id: CHEMBL_IND_53376
has molecule: CHEMBL716
highest development phase: 2
has mesh: D007319
has mesh heading: SLEEP INITIATION AND MAINTENANCE DISORDERS
has EFO: EFO_0004698
has EFO name: INSOMNIA

CHEMBL_IND_52962
type: DrugIndication
chembl id: CHEMBL_IND_52962
has molecule: CHEMBL716
highest development phase: 4
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_54102
type: DrugIndication
chembl id: CHEMBL_IND_54102
has molecule: CHEMBL716
highest development phase: 3
has mesh: D001883
has mesh heading: BORDERLINE PERSONALITY DISORDER
has EFO: EFO_0005429
has EFO name: BORDERLINE PERSONALITY DISORDER SYMPTOM

CHEMBL_IND_52866
type: DrugIndication
chembl id: CHEMBL_IND_52866
has molecule: CHEMBL716
highest development phase: 4
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_53631
type: DrugIndication
chembl id: CHEMBL_IND_53631
has molecule: CHEMBL716
highest development phase: 3
has mesh: D019964
has mesh heading: MOOD DISORDERS
has EFO: EFO_0004247
has EFO name: MOOD DISORDER

CHEMBL_IND_53905
type: DrugIndication
chembl id: CHEMBL_IND_53905
has molecule: CHEMBL716
highest development phase: 2
has mesh: D019052
has mesh heading: DEPRESSION, POSTPARTUM
has EFO: EFO_0007453
has EFO name: POSTPARTUM DEPRESSION

CHEMBL_IND_53848
type: DrugIndication
chembl id: CHEMBL_IND_53848
has molecule: CHEMBL716
highest development phase: 2
has mesh: D000437
has mesh heading: ALCOHOLISM
has EFO: EFO_0003829
has EFO name: ALCOHOL DEPENDENCE

CHEMBL_IND_52790
type: DrugIndication
chembl id: CHEMBL_IND_52790
has molecule: CHEMBL716
highest development phase: 4
has mesh: D011618
has mesh heading: PSYCHOTIC DISORDERS
has EFO: EFO_0005407
has EFO name: PSYCHOSIS

CHEMBL_IND_54319
type: DrugIndication
chembl id: CHEMBL_IND_54319
has molecule: CHEMBL716
highest development phase: 3
has mesh: D001007
has mesh heading: ANXIETY
has EFO: EFO_0005230
has EFO name: ANXIETY

CHEMBL_IND_53063
type: DrugIndication
chembl id: CHEMBL_IND_53063
has molecule: CHEMBL716
highest development phase: 2
has mesh: D002189
has mesh heading: MARIJUANA ABUSE
has EFO: EFO_0004218
has EFO name: MARIJUANA DEPENDENCE

CHEMBL_IND_54536
type: DrugIndication
chembl id: CHEMBL_IND_54536
has molecule: CHEMBL716
highest development phase: 0
has mesh: D019969
has mesh heading: AMPHETAMINE-RELATED DISORDERS
has EFO: EFO_0004701
has EFO name: METAMPHETAMINE DEPENDENCE

CHEMBL_IND_54819
type: DrugIndication
chembl id: CHEMBL_IND_54819
has molecule: CHEMBL716
highest development phase: 3
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_46633
type: DrugIndication
chembl id: CHEMBL_IND_46633
has molecule: CHEMBL24828
highest development phase: 2
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_26964
type: DrugIndication
chembl id: CHEMBL_IND_26964
has molecule: CHEMBL24828
highest development phase: 4
has mesh: D013964
has mesh heading: THYROID NEOPLASMS
has EFO: EFO_0003841
has EFO name: THYROID NEOPLASM

CHEMBL_IND_47899
type: DrugIndication
chembl id: CHEMBL_IND_47899
has molecule: CHEMBL24828
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_25718
type: DrugIndication
chembl id: CHEMBL_IND_25718
has molecule: CHEMBL24828
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_25717
type: DrugIndication
chembl id: CHEMBL_IND_25717
has molecule: CHEMBL24828
highest development phase: 1
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: EFO_0001075
has EFO name: OVARIAN CARCINOMA

CHEMBL_IND_25716
type: DrugIndication
chembl id: CHEMBL_IND_25716
has molecule: CHEMBL24828
highest development phase: 3
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_43318
type: DrugIndication
chembl id: CHEMBL_IND_43318
has molecule: CHEMBL24828
highest development phase: 2
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0000349
has EFO name: CLEAR CELL RENAL CARCINOMA

CHEMBL_IND_26337
type: DrugIndication
chembl id: CHEMBL_IND_26337
has molecule: CHEMBL24828
highest development phase: 2
has mesh: D046152
has mesh heading: GASTROINTESTINAL STROMAL TUMORS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: GASTROINTESTINAL STROMAL TUMOR

CHEMBL_IND_46367
type: DrugIndication
chembl id: CHEMBL_IND_46367
has molecule: CHEMBL24828
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_42193
type: DrugIndication
chembl id: CHEMBL_IND_42193
has molecule: CHEMBL24828
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_27982
type: DrugIndication
chembl id: CHEMBL_IND_27982
has molecule: CHEMBL24828
highest development phase: 2
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_44685
type: DrugIndication
chembl id: CHEMBL_IND_44685
has molecule: CHEMBL24828
highest development phase: 1
has mesh: D009447
has mesh heading: NEUROBLASTOMA
has EFO: EFO_0000621
has EFO name: NEUROBLASTOMA

CHEMBL_IND_24999
type: DrugIndication
chembl id: CHEMBL_IND_24999
has molecule: CHEMBL24828
highest development phase: 4
has mesh: D013964
has mesh heading: THYROID NEOPLASMS
has EFO: EFO_0002892
has EFO name: THYROID CARCINOMA

CHEMBL_IND_24998
type: DrugIndication
chembl id: CHEMBL_IND_24998
has molecule: CHEMBL24828
highest development phase: 2
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_24997
type: DrugIndication
chembl id: CHEMBL_IND_24997
has molecule: CHEMBL24828
highest development phase: 1
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_24030
type: DrugIndication
chembl id: CHEMBL_IND_24030
has molecule: CHEMBL24828
highest development phase: 2
has mesh: D008654
has mesh heading: MESOTHELIOMA
has EFO: EFO_0000588
has EFO name: MESOTHELIOMA

CHEMBL_IND_47020
type: DrugIndication
chembl id: CHEMBL_IND_47020
has molecule: CHEMBL940
highest development phase: 2
has mesh: D000022
has mesh heading: ABORTION, SPONTANEOUS
has EFO: HP_0005268
has EFO name: SPONTANEOUS ABORTION

CHEMBL_IND_46687
type: DrugIndication
chembl id: CHEMBL_IND_46687
has molecule: CHEMBL940
highest development phase: 3
has mesh: D008103
has mesh heading: LIVER CIRRHOSIS
has EFO: EFO_0001422
has EFO name: CIRRHOSIS OF LIVER

CHEMBL_IND_26604
type: DrugIndication
chembl id: CHEMBL_IND_26604
has molecule: CHEMBL940
highest development phase: 1
has mesh: D047928
has mesh heading: PREMATURE BIRTH
has EFO: EFO_0003917
has EFO name: PREMATURE BIRTH

CHEMBL_IND_26603
type: DrugIndication
chembl id: CHEMBL_IND_26603
has molecule: CHEMBL940
highest development phase: 1
has mesh: D009437
has mesh heading: NEURALGIA
has EFO: EFO_0005762
has EFO name: NEUROPATHIC PAIN

CHEMBL_IND_26602
type: DrugIndication
chembl id: CHEMBL_IND_26602
has molecule: CHEMBL940
highest development phase: 3
has mesh: D002349
has mesh heading: CARPAL TUNNEL SYNDROME
has EFO: EFO_0004143
has EFO name: CARPAL TUNNEL SYNDROME

CHEMBL_IND_26601
type: DrugIndication
chembl id: CHEMBL_IND_26601
has molecule: CHEMBL940
highest development phase: 2
has mesh: D000437
has mesh heading: ALCOHOLISM
has EFO: EFO_0003829
has EFO name: ALCOHOL DEPENDENCE

CHEMBL_IND_46781
type: DrugIndication
chembl id: CHEMBL_IND_46781
has molecule: CHEMBL940
highest development phase: 2
has mesh: D014029
has mesh heading: TOBACCO USE DISORDER
has EFO: EFO_0003768
has EFO name: NICOTINE DEPENDENCE

CHEMBL_IND_28191
type: DrugIndication
chembl id: CHEMBL_IND_28191
has molecule: CHEMBL940
highest development phase: 3
has mesh: D004828
has mesh heading: EPILEPSIES, PARTIAL
has EFO: EFO_0004263
has EFO name: PARTIAL EPILEPSY

CHEMBL_IND_28190
type: DrugIndication
chembl id: CHEMBL_IND_28190
has molecule: CHEMBL940
highest development phase: 2
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_48416
type: DrugIndication
chembl id: CHEMBL_IND_48416
has molecule: CHEMBL940
highest development phase: 3
has mesh: D014839
has mesh heading: VOMITING
has EFO: HP_0002013
has EFO name: VOMITING

CHEMBL_IND_26014
type: DrugIndication
chembl id: CHEMBL_IND_26014
has molecule: CHEMBL940
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_26013
type: DrugIndication
chembl id: CHEMBL_IND_26013
has molecule: CHEMBL940
highest development phase: 4
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_47734
type: DrugIndication
chembl id: CHEMBL_IND_47734
has molecule: CHEMBL940
highest development phase: 2
has mesh: D009293
has mesh heading: OPIOID-RELATED DISORDERS
has EFO: EFO_0005611
has EFO name: OPIOID DEPENDENCE

CHEMBL_IND_52028
type: DrugIndication
chembl id: CHEMBL_IND_52028
has molecule: CHEMBL940
highest development phase: 3
has mesh: D003929
has mesh heading: DIABETIC NEUROPATHIES
has EFO: EFO_1000783
has EFO name: DIABETIC NEUROPATHY

CHEMBL_IND_48994
type: DrugIndication
chembl id: CHEMBL_IND_48994
has molecule: CHEMBL940
highest development phase: 1
has mesh: D011618
has mesh heading: PSYCHOTIC DISORDERS
has EFO: EFO_0005407
has EFO name: PSYCHOSIS

CHEMBL_IND_47644
type: DrugIndication
chembl id: CHEMBL_IND_47644
has molecule: CHEMBL940
highest development phase: 1
has mesh: D019966
has mesh heading: SUBSTANCE-RELATED DISORDERS
has EFO: EFO_0003890
has EFO name: DRUG DEPENDENCE

CHEMBL_IND_27718
type: DrugIndication
chembl id: CHEMBL_IND_27718
has molecule: CHEMBL940
highest development phase: 3
has mesh: D007405
has mesh heading: INTERVERTEBRAL DISC DISPLACEMENT
has EFO: EFO_0004994
has EFO name: LUMBAR DISC DEGENERATION

CHEMBL_IND_27717
type: DrugIndication
chembl id: CHEMBL_IND_27717
has molecule: CHEMBL940
highest development phase: 3
has mesh: D005356
has mesh heading: FIBROMYALGIA
has EFO: EFO_0005687
has EFO name: FIBROMYALGIA

CHEMBL_IND_23220
type: DrugIndication
chembl id: CHEMBL_IND_23220
has molecule: CHEMBL940
highest development phase: 3
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_23219
type: DrugIndication
chembl id: CHEMBL_IND_23219
has molecule: CHEMBL940
highest development phase: 3
has mesh: D007319
has mesh heading: SLEEP INITIATION AND MAINTENANCE DISORDERS
has EFO: EFO_0004698
has EFO name: INSOMNIA

CHEMBL_IND_25341
type: DrugIndication
chembl id: CHEMBL_IND_25341
has molecule: CHEMBL940
highest development phase: 2
has mesh: D014012
has mesh heading: TINNITUS
has EFO: HP_0000360
has EFO name: TINNITUS

CHEMBL_IND_25340
type: DrugIndication
chembl id: CHEMBL_IND_25340
has molecule: CHEMBL940
highest development phase: 2
has mesh: D000755
has mesh heading: ANEMIA, SICKLE CELL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SICKLE CELL ANEMIA

CHEMBL_IND_25339
type: DrugIndication
chembl id: CHEMBL_IND_25339
has molecule: CHEMBL940
highest development phase: 3
has mesh: D012600
has mesh heading: SCOLIOSIS
has EFO: EFO_0004273
has EFO name: SCOLIOSIS

CHEMBL_IND_24464
type: DrugIndication
chembl id: CHEMBL_IND_24464
has molecule: CHEMBL940
highest development phase: 1
has mesh: D011537
has mesh heading: PRURITUS
has EFO: HP_0000989
has EFO name: PRURITUS

CHEMBL_IND_43943
type: DrugIndication
chembl id: CHEMBL_IND_43943
has molecule: CHEMBL658
highest development phase: 3
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_44619
type: DrugIndication
chembl id: CHEMBL_IND_44619
has molecule: CHEMBL658
highest development phase: 2
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_24418
type: DrugIndication
chembl id: CHEMBL_IND_24418
has molecule: CHEMBL1201468
highest development phase: 2
has mesh: D008593
has mesh heading: MENOPAUSE
has EFO: EFO_0003922
has EFO name: MENOPAUSE

CHEMBL_IND_44094
type: DrugIndication
chembl id: CHEMBL_IND_44094
has molecule: CHEMBL685
highest development phase: 3
has mesh: D000740
has mesh heading: ANEMIA
has EFO: EFO_0004272
has EFO name: ANEMIA

CHEMBL_IND_44498
type: DrugIndication
chembl id: CHEMBL_IND_44498
has molecule: CHEMBL685
highest development phase: 1
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_26844
type: DrugIndication
chembl id: CHEMBL_IND_26844
has molecule: CHEMBL728
highest development phase: 2
has mesh: D020250
has mesh heading: POSTOPERATIVE NAUSEA AND VOMITING
has EFO: HP_0002017
has EFO name: NAUSEA AND VOMITING

CHEMBL_IND_28351
type: DrugIndication
chembl id: CHEMBL_IND_28351
has molecule: CHEMBL728
highest development phase: 4
has mesh: D011618
has mesh heading: PSYCHOTIC DISORDERS
has EFO: EFO_0005407
has EFO name: PSYCHOSIS

CHEMBL_IND_48886
type: DrugIndication
chembl id: CHEMBL_IND_48886
has molecule: CHEMBL728
highest development phase: 3
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_24818
type: DrugIndication
chembl id: CHEMBL_IND_24818
has molecule: CHEMBL728
highest development phase: 3
has mesh: D008881
has mesh heading: MIGRAINE DISORDERS
has EFO: EFO_0003821
has EFO name: MIGRAINE DISORDER

CHEMBL_IND_51936
type: DrugIndication
chembl id: CHEMBL_IND_51936
has molecule: CHEMBL751
highest development phase: 1
has mesh: D007249
has mesh heading: INFLAMMATION
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: INFLAMMATION

CHEMBL_IND_24218
type: DrugIndication
chembl id: CHEMBL_IND_24218
has molecule: CHEMBL751
highest development phase: 2
has mesh: D002386
has mesh heading: CATARACT
has EFO: EFO_0001059
has EFO name: CATARACT

CHEMBL_IND_42486
type: DrugIndication
chembl id: CHEMBL_IND_42486
has molecule: CHEMBL628
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_26814
type: DrugIndication
chembl id: CHEMBL_IND_26814
has molecule: CHEMBL628
highest development phase: 2
has mesh: D016773
has mesh heading: LEISHMANIASIS, CUTANEOUS
has EFO: EFO_0005046
has EFO name: CUTANEOUS LEISHMANIASIS

CHEMBL_IND_52194
type: DrugIndication
chembl id: CHEMBL_IND_52194
has molecule: CHEMBL628
highest development phase: 2
has mesh: D058186
has mesh heading: ACUTE KIDNEY INJURY
has EFO: HP_0001919
has EFO name: ACUTE KIDNEY INJURY

CHEMBL_IND_52181
type: DrugIndication
chembl id: CHEMBL_IND_52181
has molecule: CHEMBL628
highest development phase: 3
has mesh: D006519
has mesh heading: HEPATITIS, ALCOHOLIC
has EFO: EFO_1001345
has EFO name: HEPATITIS, ALCOHOLIC

CHEMBL_IND_25567
type: DrugIndication
chembl id: CHEMBL_IND_25567
has molecule: CHEMBL628
highest development phase: 1
has mesh: D020388
has mesh heading: MUSCULAR DYSTROPHY, DUCHENNE
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: DUCHENNE MUSCULAR DYSTROPHY

CHEMBL_IND_25566
type: DrugIndication
chembl id: CHEMBL_IND_25566
has molecule: CHEMBL628
highest development phase: 2
has mesh: D001656
has mesh heading: BILIARY ATRESIA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: BILIARY ATRESIA

CHEMBL_IND_28338
type: DrugIndication
chembl id: CHEMBL_IND_28338
has molecule: CHEMBL628
highest development phase: 2
has mesh: D004374
has mesh heading: DUCTUS ARTERIOSUS, PATENT
has EFO: HP_0001643
has EFO name: PATENT DUCTUS ARTERIOSUS

CHEMBL_IND_28337
type: DrugIndication
chembl id: CHEMBL_IND_28337
has molecule: CHEMBL628
highest development phase: 2
has mesh: D020345
has mesh heading: ENTEROCOLITIS, NECROTIZING
has EFO: EFO_0003928
has EFO name: NECROTIZING ENTEROCOLITIS

CHEMBL_IND_28336
type: DrugIndication
chembl id: CHEMBL_IND_28336
has molecule: CHEMBL628
highest development phase: 3
has mesh: D004715
has mesh heading: ENDOMETRIOSIS
has EFO: EFO_0001065
has EFO name: ENDOMETRIOSIS

CHEMBL_IND_52693
type: DrugIndication
chembl id: CHEMBL_IND_52693
has molecule: CHEMBL628
highest development phase: 2
has mesh: D005234
has mesh heading: FATTY LIVER
has EFO: HP_0001397
has EFO name: HEPATIC STEATOSIS

CHEMBL_IND_24778
type: DrugIndication
chembl id: CHEMBL_IND_24778
has molecule: CHEMBL628
highest development phase: 2
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_45264
type: DrugIndication
chembl id: CHEMBL_IND_45264
has molecule: CHEMBL642
highest development phase: 3
has mesh: D006391
has mesh heading: HEMANGIOMA
has EFO: EFO_1000635
has EFO name: HEMANGIOMA

CHEMBL_IND_42157
type: DrugIndication
chembl id: CHEMBL_IND_42157
has molecule: CHEMBL642
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_44286
type: DrugIndication
chembl id: CHEMBL_IND_44286
has molecule: CHEMBL137
highest development phase: 2
has mesh: D014376
has mesh heading: TUBERCULOSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: TUBERCULOSIS

CHEMBL_IND_44231
type: DrugIndication
chembl id: CHEMBL_IND_44231
has molecule: CHEMBL137
highest development phase: 2
has mesh: D003967
has mesh heading: DIARRHEA
has EFO: HP_0002014
has EFO name: DIARRHEA

CHEMBL_IND_42513
type: DrugIndication
chembl id: CHEMBL_IND_42513
has molecule: CHEMBL137
highest development phase: 4
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_48338
type: DrugIndication
chembl id: CHEMBL_IND_48338
has molecule: CHEMBL137
highest development phase: 1
has mesh: D015209
has mesh heading: CHOLANGITIS, SCLEROSING
has EFO: EFO_0004268
has EFO name: SCLEROSING CHOLANGITIS

CHEMBL_IND_44691
type: DrugIndication
chembl id: CHEMBL_IND_44691
has molecule: CHEMBL137
highest development phase: 2
has mesh: D010518
has mesh heading: PERIODONTITIS
has EFO: EFO_0000649
has EFO name: PERIODONTITIS

CHEMBL_IND_43346
type: DrugIndication
chembl id: CHEMBL_IND_43346
has molecule: CHEMBL137
highest development phase: 3
has mesh: D003424
has mesh heading: CROHN DISEASE
has EFO: EFO_0000384
has EFO name: CROHN'S DISEASE

CHEMBL_IND_46145
type: DrugIndication
chembl id: CHEMBL_IND_46145
has molecule: CHEMBL137
highest development phase: 3
has mesh: D012393
has mesh heading: ROSACEA
has EFO: EFO_1000760
has EFO name: ROSACEA

CHEMBL_IND_41812
type: DrugIndication
chembl id: CHEMBL_IND_41812
has molecule: CHEMBL137
highest development phase: 4
has mesh: D016585
has mesh heading: VAGINOSIS, BACTERIAL
has EFO: EFO_0003932
has EFO name: BACTERIAL VAGINOSIS

CHEMBL_IND_41706
type: DrugIndication
chembl id: CHEMBL_IND_41706
has molecule: CHEMBL24072
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_42478
type: DrugIndication
chembl id: CHEMBL_IND_42478
has molecule: CHEMBL141
highest development phase: 4
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000180
has EFO name: HIV-1 INFECTION

CHEMBL_IND_42389
type: DrugIndication
chembl id: CHEMBL_IND_42389
has molecule: CHEMBL141
highest development phase: 4
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_42360
type: DrugIndication
chembl id: CHEMBL_IND_42360
has molecule: CHEMBL141
highest development phase: 4
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_45385
type: DrugIndication
chembl id: CHEMBL_IND_45385
has molecule: CHEMBL141
highest development phase: 3
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_46028
type: DrugIndication
chembl id: CHEMBL_IND_46028
has molecule: CHEMBL141
highest development phase: 4
has mesh: D019694
has mesh heading: HEPATITIS B, CHRONIC
has EFO: EFO_0004197
has EFO name: HEPATITIS B INFECTION

CHEMBL_IND_41818
type: DrugIndication
chembl id: CHEMBL_IND_41818
has molecule: CHEMBL141
highest development phase: 4
has mesh: D019694
has mesh heading: HEPATITIS B, CHRONIC
has EFO: EFO_0004239
has EFO name: CHRONIC HEPATITIS B INFECTION

CHEMBL_IND_41625
type: DrugIndication
chembl id: CHEMBL_IND_41625
has molecule: CHEMBL141
highest development phase: 4
has mesh: D006509
has mesh heading: HEPATITIS B

CHEMBL_IND_42801
type: DrugIndication
chembl id: CHEMBL_IND_42801
has molecule: CHEMBL141
highest development phase: 4
has mesh: D007249
has mesh heading: INFLAMMATION
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: INFLAMMATION

CHEMBL_IND_26378
type: DrugIndication
chembl id: CHEMBL_IND_26378
has molecule: CHEMBL661
highest development phase: 2
has mesh: D013313
has mesh heading: STRESS DISORDERS, POST-TRAUMATIC
has EFO: EFO_0001358
has EFO name: POST-TRAUMATIC STRESS DISORDER

CHEMBL_IND_22664
type: DrugIndication
chembl id: CHEMBL_IND_22664
has molecule: CHEMBL661
highest development phase: 4
has mesh: D016584
has mesh heading: PANIC DISORDER
has EFO: EFO_0004262
has EFO name: PANIC DISORDER

CHEMBL_IND_41860
type: DrugIndication
chembl id: CHEMBL_IND_41860
has molecule: CHEMBL661
highest development phase: 4
has mesh: D001008
has mesh heading: ANXIETY DISORDERS
has EFO: EFO_0006788
has EFO name: ANXIETY DISORDER

CHEMBL_IND_24127
type: DrugIndication
chembl id: CHEMBL_IND_24127
has molecule: CHEMBL661
highest development phase: 4
has mesh: D001007
has mesh heading: ANXIETY
has EFO: EFO_0005230
has EFO name: ANXIETY

CHEMBL_IND_52818
type: DrugIndication
chembl id: CHEMBL_IND_52818
has molecule: CHEMBL594
highest development phase: 4
has mesh: D005132
has mesh heading: EYE MANIFESTATIONS
has EFO: EFO_0005751
has EFO name: EYE ALLERGY

CHEMBL_IND_45233
type: DrugIndication
chembl id: CHEMBL_IND_45233
has molecule: CHEMBL19449
highest development phase: 2
has mesh: D009293
has mesh heading: OPIOID-RELATED DISORDERS
has EFO: EFO_0005611
has EFO name: OPIOID DEPENDENCE

CHEMBL_IND_41924
type: DrugIndication
chembl id: CHEMBL_IND_41924
has molecule: CHEMBL19449
highest development phase: 4
has mesh: D008173
has mesh heading: LUNG DISEASES, OBSTRUCTIVE
has EFO: HP_0006536
has EFO name: OBSTRUCTIVE LUNG DISEASE

CHEMBL_IND_45949
type: DrugIndication
chembl id: CHEMBL_IND_45949
has molecule: CHEMBL19449
highest development phase: 2
has mesh: D020528
has mesh heading: MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE
has EFO: EFO_0003840
has EFO name: CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS

CHEMBL_IND_48877
type: DrugIndication
chembl id: CHEMBL_IND_48877
has molecule: CHEMBL19449
highest development phase: 1
has mesh: D000437
has mesh heading: ALCOHOLISM
has EFO: EFO_0003829
has EFO name: ALCOHOL DEPENDENCE

CHEMBL_IND_43184
type: DrugIndication
chembl id: CHEMBL_IND_43184
has molecule: CHEMBL19449
highest development phase: 2
has mesh: D000690
has mesh heading: AMYOTROPHIC LATERAL SCLEROSIS
has EFO: EFO_0000253
has EFO name: AMYOTROPHIC LATERAL SCLEROSIS

CHEMBL_IND_53076
type: DrugIndication
chembl id: CHEMBL_IND_53076
has molecule: CHEMBL19449
highest development phase: 1
has mesh: D019969
has mesh heading: AMPHETAMINE-RELATED DISORDERS
has EFO: EFO_0004701
has EFO name: METAMPHETAMINE DEPENDENCE

CHEMBL_IND_45072
type: DrugIndication
chembl id: CHEMBL_IND_45072
has molecule: CHEMBL19449
highest development phase: 1
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_47589
type: DrugIndication
chembl id: CHEMBL_IND_47589
has molecule: CHEMBL19449
highest development phase: 1
has mesh: D008881
has mesh heading: MIGRAINE DISORDERS
has EFO: EFO_0003821
has EFO name: MIGRAINE DISORDER

CHEMBL_IND_52809
type: DrugIndication
chembl id: CHEMBL_IND_52809
has molecule: CHEMBL647
highest development phase: 4
has mesh: D005901
has mesh heading: GLAUCOMA
has EFO: EFO_0000516
has EFO name: GLAUCOMA

CHEMBL_IND_50577
type: DrugIndication
chembl id: CHEMBL_IND_50577
has molecule: CHEMBL659
highest development phase: 2
has mesh: D014029
has mesh heading: TOBACCO USE DISORDER
has EFO: EFO_0003768
has EFO name: NICOTINE DEPENDENCE

CHEMBL_IND_50536
type: DrugIndication
chembl id: CHEMBL_IND_50536
has molecule: CHEMBL659
highest development phase: 1
has mesh: D009765
has mesh heading: OBESITY
has EFO: EFO_0001073
has EFO name: OBESITY

CHEMBL_IND_50112
type: DrugIndication
chembl id: CHEMBL_IND_50112
has molecule: CHEMBL659
highest development phase: 4
has mesh: D003704
has mesh heading: DEMENTIA
has EFO: EFO_0003862
has EFO name: DEMENTIA

CHEMBL_IND_50729
type: DrugIndication
chembl id: CHEMBL_IND_50729
has molecule: CHEMBL659
highest development phase: 1
has mesh: D008569
has mesh heading: MEMORY DISORDERS
has EFO: EFO_0001072
has EFO name: MEMORY IMPAIRMENT

CHEMBL_IND_50662
type: DrugIndication
chembl id: CHEMBL_IND_50662
has molecule: CHEMBL659
highest development phase: 3
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_50885
type: DrugIndication
chembl id: CHEMBL_IND_50885
has molecule: CHEMBL659
highest development phase: 2
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_53808
type: DrugIndication
chembl id: CHEMBL_IND_53808
has molecule: CHEMBL659
highest development phase: 1
has mesh: D013345
has mesh heading: SUBARACHNOID HEMORRHAGE
has EFO: EFO_0000713
has EFO name: SUBARACHNOID HEMORRHAGE

CHEMBL_IND_50450
type: DrugIndication
chembl id: CHEMBL_IND_50450
has molecule: CHEMBL659
highest development phase: 1
has mesh: D007863
has mesh heading: LECITHIN ACYLTRANSFERASE DEFICIENCY
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: FISH-EYE DISEASE

CHEMBL_IND_54989
type: DrugIndication
chembl id: CHEMBL_IND_54989
has molecule: CHEMBL659
highest development phase: 2
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_27467
type: DrugIndication
chembl id: CHEMBL_IND_27467
has molecule: CHEMBL698
highest development phase: 4
has mesh: D011537
has mesh heading: PRURITUS
has EFO: HP_0000989
has EFO name: PRURITUS

CHEMBL_IND_24940
type: DrugIndication
chembl id: CHEMBL_IND_24940
has molecule: CHEMBL698
highest development phase: 2
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_24939
type: DrugIndication
chembl id: CHEMBL_IND_24939
has molecule: CHEMBL698
highest development phase: 3
has mesh: D002386
has mesh heading: CATARACT
has EFO: EFO_0001059
has EFO name: CATARACT

CHEMBL_IND_51456
type: DrugIndication
chembl id: CHEMBL_IND_51456
has molecule: CHEMBL698
highest development phase: 4
has mesh: D000698
has mesh heading: ANALGESIA
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_50146
type: DrugIndication
chembl id: CHEMBL_IND_50146
has molecule: CHEMBL28218
highest development phase: 4
has mesh: D011618
has mesh heading: PSYCHOTIC DISORDERS
has EFO: EFO_0005407
has EFO name: PSYCHOSIS

CHEMBL_IND_50672
type: DrugIndication
chembl id: CHEMBL_IND_50672
has molecule: CHEMBL27759
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_52890
type: DrugIndication
chembl id: CHEMBL_IND_52890
has molecule: CHEMBL27759
highest development phase: 1
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_50209
type: DrugIndication
chembl id: CHEMBL_IND_50209
has molecule: CHEMBL27759
highest development phase: 2
has mesh: D006689
has mesh heading: HODGKIN DISEASE
has EFO: EFO_0000183
has EFO name: HODGKINS LYMPHOMA

CHEMBL_IND_49654
type: DrugIndication
chembl id: CHEMBL_IND_49654
has molecule: CHEMBL27769
highest development phase: 2
has mesh: D007006
has mesh heading: HYPOGONADISM
has EFO: HP_0000135
has EFO name: HYPOGONADISM

CHEMBL_IND_26862
type: DrugIndication
chembl id: CHEMBL_IND_26862
has molecule: CHEMBL744
highest development phase: 2
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_46892
type: DrugIndication
chembl id: CHEMBL_IND_46892
has molecule: CHEMBL744
highest development phase: 2
has mesh: D009771
has mesh heading: OBSESSIVE-COMPULSIVE DISORDER
has EFO: EFO_0004242
has EFO name: OBSESSIVE-COMPULSIVE DISORDER

CHEMBL_IND_25612
type: DrugIndication
chembl id: CHEMBL_IND_25612
has molecule: CHEMBL744
highest development phase: 2
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_25611
type: DrugIndication
chembl id: CHEMBL_IND_25611
has molecule: CHEMBL744
highest development phase: 2
has mesh: D002659
has mesh heading: CHILD DEVELOPMENT DISORDERS, PERVASIVE
has EFO: EFO_0003756
has EFO name: AUTISM SPECTRUM DISORDER

CHEMBL_IND_28364
type: DrugIndication
chembl id: CHEMBL_IND_28364
has molecule: CHEMBL744
highest development phase: 2
has mesh: D009134
has mesh heading: MUSCULAR ATROPHY, SPINAL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: PROXIMAL SPINAL MUSCULAR ATROPHY

CHEMBL_IND_28363
type: DrugIndication
chembl id: CHEMBL_IND_28363
has molecule: CHEMBL744
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000389
has EFO name: CUTANEOUS MELANOMA

CHEMBL_IND_28362
type: DrugIndication
chembl id: CHEMBL_IND_28362
has molecule: CHEMBL744
highest development phase: 2
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_46366
type: DrugIndication
chembl id: CHEMBL_IND_46366
has molecule: CHEMBL744
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_46317
type: DrugIndication
chembl id: CHEMBL_IND_46317
has molecule: CHEMBL744
highest development phase: 2
has mesh: D000690
has mesh heading: AMYOTROPHIC LATERAL SCLEROSIS
has EFO: EFO_0000253
has EFO name: AMYOTROPHIC LATERAL SCLEROSIS

CHEMBL_IND_23796
type: DrugIndication
chembl id: CHEMBL_IND_23796
has molecule: CHEMBL744
highest development phase: 1
has mesh: D013313
has mesh heading: STRESS DISORDERS, POST-TRAUMATIC
has EFO: EFO_0001358
has EFO name: POST-TRAUMATIC STRESS DISORDER

CHEMBL_IND_23795
type: DrugIndication
chembl id: CHEMBL_IND_23795
has molecule: CHEMBL744
highest development phase: 2
has mesh: D020528
has mesh heading: MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE
has EFO: EFO_0003840
has EFO name: CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS

CHEMBL_IND_24848
type: DrugIndication
chembl id: CHEMBL_IND_24848
has molecule: CHEMBL744
highest development phase: 2
has mesh: D001259
has mesh heading: ATAXIA
has EFO: HP_0001251
has EFO name: ATAXIA

CHEMBL_IND_42843
type: DrugIndication
chembl id: CHEMBL_IND_42843
has molecule: CHEMBL718
highest development phase: 4
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_48671
type: DrugIndication
chembl id: CHEMBL_IND_48671
has molecule: CHEMBL671
highest development phase: 2
has mesh: D012516
has mesh heading: OSTEOSARCOMA
has EFO: EFO_0000637
has EFO name: OSTEOSARCOMA

CHEMBL_IND_43352
type: DrugIndication
chembl id: CHEMBL_IND_43352
has molecule: CHEMBL25202
highest development phase: 2
has mesh: D003424
has mesh heading: CROHN DISEASE
has EFO: EFO_0000384
has EFO name: CROHN'S DISEASE

CHEMBL_IND_44391
type: DrugIndication
chembl id: CHEMBL_IND_44391
has molecule: CHEMBL25202
highest development phase: 2
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_26214
type: DrugIndication
chembl id: CHEMBL_IND_26214
has molecule: CHEMBL16694
highest development phase: 1
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_28560
type: DrugIndication
chembl id: CHEMBL_IND_28560
has molecule: CHEMBL16694
highest development phase: 4
has mesh: D013927
has mesh heading: THROMBOSIS
has EFO: HP_0004419
has EFO name: RECURRENT THROMBOPHLEBITIS

CHEMBL_IND_26712
type: DrugIndication
chembl id: CHEMBL_IND_26712
has molecule: CHEMBL650
highest development phase: 4
has mesh: D000152
has mesh heading: ACNE VULGARIS
has EFO: EFO_0003894
has EFO name: ACNE

CHEMBL_IND_28266
type: DrugIndication
chembl id: CHEMBL_IND_28266
has molecule: CHEMBL650
highest development phase: 2
has mesh: D013167
has mesh heading: SPONDYLITIS, ANKYLOSING
has EFO: EFO_0003898
has EFO name: ANKYLOSING SPONDYLITIS

CHEMBL_IND_28265
type: DrugIndication
chembl id: CHEMBL_IND_28265
has molecule: CHEMBL650
highest development phase: 2
has mesh: D006086
has mesh heading: GRAFT VS HOST DISEASE
has EFO: EFO_0004599
has EFO name: ACUTE GRAFT VS. HOST DISEASE

CHEMBL_IND_52505
type: DrugIndication
chembl id: CHEMBL_IND_52505
has molecule: CHEMBL650
highest development phase: 1
has mesh: D050197
has mesh heading: ATHEROSCLEROSIS
has EFO: EFO_0003914
has EFO name: ATHEROSCLEROSIS

CHEMBL_IND_52484
type: DrugIndication
chembl id: CHEMBL_IND_52484
has molecule: CHEMBL650
highest development phase: 3
has mesh: D019337
has mesh heading: HEMATOLOGIC NEOPLASMS
has EFO: EFO_0001642
has EFO name: LYMPHOID NEOPLASM

CHEMBL_IND_52315
type: DrugIndication
chembl id: CHEMBL_IND_52315
has molecule: CHEMBL650
highest development phase: 2
has mesh: D049970
has mesh heading: GRAVES OPHTHALMOPATHY
has EFO: EFO_1001466
has EFO name: GRAVES OPHTHALMOPATHY

CHEMBL_IND_52306
type: DrugIndication
chembl id: CHEMBL_IND_52306
has molecule: CHEMBL650
highest development phase: 2
has mesh: D006519
has mesh heading: HEPATITIS, ALCOHOLIC
has EFO: EFO_1001345
has EFO name: HEPATITIS, ALCOHOLIC

CHEMBL_IND_25463
type: DrugIndication
chembl id: CHEMBL_IND_25463
has molecule: CHEMBL650
highest development phase: 2
has mesh: D008575
has mesh heading: MENIERE DISEASE
has EFO: EFO_0006862
has EFO name: MENIERE DISEASE

CHEMBL_IND_48188
type: DrugIndication
chembl id: CHEMBL_IND_48188
has molecule: CHEMBL650
highest development phase: 3
has mesh: D008180
has mesh heading: LUPUS ERYTHEMATOSUS, SYSTEMIC
has EFO: EFO_0002690
has EFO name: SYSTEMIC LUPUS ERYTHEMATOSUS

CHEMBL_IND_45319
type: DrugIndication
chembl id: CHEMBL_IND_45319
has molecule: CHEMBL650
highest development phase: 1
has mesh: D060825
has mesh heading: MILD COGNITIVE IMPAIRMENT
has EFO: HP_0100543
has EFO name: COGNITIVE IMPAIRMENT

CHEMBL_IND_52286
type: DrugIndication
chembl id: CHEMBL_IND_52286
has molecule: CHEMBL650
highest development phase: 2
has mesh: D012852
has mesh heading: SINUSITIS
has EFO: EFO_0007486
has EFO name: SINUSITIS

CHEMBL_IND_52645
type: DrugIndication
chembl id: CHEMBL_IND_52645
has molecule: CHEMBL650
highest development phase: 2
has mesh: D016553
has mesh heading: PURPURA, THROMBOCYTOPENIC, IDIOPATHIC
has EFO: EFO_0007160
has EFO name: AUTOIMMUNE THROMBOCYTOPENIC PURPURA

CHEMBL_IND_52636
type: DrugIndication
chembl id: CHEMBL_IND_52636
has molecule: CHEMBL650
highest development phase: 1
has mesh: D009471
has mesh heading: NEUROMYELITIS OPTICA
has EFO: EFO_0004256
has EFO name: NEUROMYELITIS OPTICA

CHEMBL_IND_52616
type: DrugIndication
chembl id: CHEMBL_IND_52616
has molecule: CHEMBL650
highest development phase: 3
has mesh: D007674
has mesh heading: KIDNEY DISEASES
has EFO: EFO_0003086
has EFO name: KIDNEY DISEASE

CHEMBL_IND_52031
type: DrugIndication
chembl id: CHEMBL_IND_52031
has molecule: CHEMBL650
highest development phase: 3
has mesh: D018917
has mesh heading: OPTIC NEUROPATHY, ISCHEMIC
has EFO: EFO_1000809
has EFO name: ANTERIOR ISCHEMIC OPTIC NEUROPATHY

CHEMBL_IND_46256
type: DrugIndication
chembl id: CHEMBL_IND_46256
has molecule: CHEMBL650
highest development phase: 0
has mesh: D005621
has mesh heading: FRIEDREICH ATAXIA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: FRIEDREICH ATAXIA

CHEMBL_IND_51985
type: DrugIndication
chembl id: CHEMBL_IND_51985
has molecule: CHEMBL650
highest development phase: 3
has mesh: D014552
has mesh heading: URINARY TRACT INFECTIONS
has EFO: EFO_0003103
has EFO name: URINARY TRACT INFECTION

CHEMBL_IND_26130
type: DrugIndication
chembl id: CHEMBL_IND_26130
has molecule: CHEMBL650
highest development phase: 4
has mesh: D009103
has mesh heading: MULTIPLE SCLEROSIS
has EFO: EFO_0003885
has EFO name: MULTIPLE SCLEROSIS

CHEMBL_IND_52106
type: DrugIndication
chembl id: CHEMBL_IND_52106
has molecule: CHEMBL650
highest development phase: 2
has mesh: D025242
has mesh heading: SPONDYLARTHROPATHIES
has EFO: EFO_0000706
has EFO name: SPONDYLOARTHROPATHY

CHEMBL_IND_51855
type: DrugIndication
chembl id: CHEMBL_IND_51855
has molecule: CHEMBL650
highest development phase: 2
has mesh: D002349
has mesh heading: CARPAL TUNNEL SYNDROME
has EFO: EFO_0004143
has EFO name: CARPAL TUNNEL SYNDROME

CHEMBL_IND_47601
type: DrugIndication
chembl id: CHEMBL_IND_47601
has molecule: CHEMBL650
highest development phase: 3
has mesh: D020528
has mesh heading: MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE
has EFO: EFO_0003840
has EFO name: CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS

CHEMBL_IND_27815
type: DrugIndication
chembl id: CHEMBL_IND_27815
has molecule: CHEMBL650
highest development phase: 1
has mesh: D016471
has mesh heading: OVARIAN HYPERSTIMULATION SYNDROME
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: OVARIAN HYPERSTIMULATION SYNDROME

CHEMBL_IND_51667
type: DrugIndication
chembl id: CHEMBL_IND_51667
has molecule: CHEMBL650
highest development phase: 2
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_24636
type: DrugIndication
chembl id: CHEMBL_IND_24636
has molecule: CHEMBL650
highest development phase: 3
has mesh: D010003
has mesh heading: OSTEOARTHRITIS
has EFO: EFO_0002506
has EFO name: OSTEOARTHRITIS

CHEMBL_IND_51808
type: DrugIndication
chembl id: CHEMBL_IND_51808
has molecule: CHEMBL650
highest development phase: 3
has mesh: D012140
has mesh heading: RESPIRATORY TRACT DISEASES
has EFO: EFO_0000684
has EFO name: RESPIRATORY SYSTEM DISEASE

CHEMBL_IND_23501
type: DrugIndication
chembl id: CHEMBL_IND_23501
has molecule: CHEMBL650
highest development phase: 3
has mesh: D020529
has mesh heading: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
has EFO: EFO_0003929
has EFO name: RELAPSING-REMITTING MULTIPLE SCLEROSIS

CHEMBL_IND_23500
type: DrugIndication
chembl id: CHEMBL_IND_23500
has molecule: CHEMBL650
highest development phase: 4
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_43080
type: DrugIndication
chembl id: CHEMBL_IND_43080
has molecule: CHEMBL644
highest development phase: 4
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_25811
type: DrugIndication
chembl id: CHEMBL_IND_25811
has molecule: CHEMBL701
highest development phase: 1
has mesh: D001321
has mesh heading: AUTISTIC DISORDER
has EFO: EFO_0003758
has EFO name: AUTISM

CHEMBL_IND_25810
type: DrugIndication
chembl id: CHEMBL_IND_25810
has molecule: CHEMBL701
highest development phase: 3
has mesh: D000437
has mesh heading: ALCOHOLISM
has EFO: EFO_0003829
has EFO name: ALCOHOL DEPENDENCE

CHEMBL_IND_41660
type: DrugIndication
chembl id: CHEMBL_IND_41660
has molecule: CHEMBL701
highest development phase: 4
has mesh: D013118
has mesh heading: SPINAL CORD DISEASES

CHEMBL_IND_41659
type: DrugIndication
chembl id: CHEMBL_IND_41659
has molecule: CHEMBL701
highest development phase: 4
has mesh: D009119
has mesh heading: MUSCLE CONTRACTION

CHEMBL_IND_41631
type: DrugIndication
chembl id: CHEMBL_IND_41631
has molecule: CHEMBL701
highest development phase: 4
has mesh: D009127
has mesh heading: MUSCLE RIGIDITY

CHEMBL_IND_25094
type: DrugIndication
chembl id: CHEMBL_IND_25094
has molecule: CHEMBL701
highest development phase: 3
has mesh: D013375
has mesh heading: SUBSTANCE WITHDRAWAL SYNDROME
has EFO: EFO_0004777
has EFO name: ALCOHOL WITHDRAWAL

CHEMBL_IND_24186
type: DrugIndication
chembl id: CHEMBL_IND_24186
has molecule: CHEMBL701
highest development phase: 4
has mesh: D009128
has mesh heading: MUSCLE SPASTICITY
has EFO: HP_0001257
has EFO name: SPASTICITY

CHEMBL_IND_24185
type: DrugIndication
chembl id: CHEMBL_IND_24185
has molecule: CHEMBL701
highest development phase: 2
has mesh: D014029
has mesh heading: TOBACCO USE DISORDER
has EFO: EFO_0003768
has EFO name: NICOTINE DEPENDENCE

CHEMBL_IND_24184
type: DrugIndication
chembl id: CHEMBL_IND_24184
has molecule: CHEMBL701
highest development phase: 2
has mesh: D002189
has mesh heading: MARIJUANA ABUSE
has EFO: EFO_0004218
has EFO name: MARIJUANA DEPENDENCE

CHEMBL_IND_24183
type: DrugIndication
chembl id: CHEMBL_IND_24183
has molecule: CHEMBL701
highest development phase: 2
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_24182
type: DrugIndication
chembl id: CHEMBL_IND_24182
has molecule: CHEMBL701
highest development phase: 2
has mesh: D008103
has mesh heading: LIVER CIRRHOSIS
has EFO: EFO_0001422
has EFO name: CIRRHOSIS OF LIVER

CHEMBL_IND_22749
type: DrugIndication
chembl id: CHEMBL_IND_22749
has molecule: CHEMBL701
highest development phase: 4
has mesh: D009103
has mesh heading: MULTIPLE SCLEROSIS
has EFO: EFO_0003885
has EFO name: MULTIPLE SCLEROSIS

CHEMBL_IND_43009
type: DrugIndication
chembl id: CHEMBL_IND_43009
has molecule: CHEMBL635
highest development phase: 4
has mesh: D009404
has mesh heading: NEPHROTIC SYNDROME
has EFO: EFO_0004255
has EFO name: NEPHROTIC SYNDROME

CHEMBL_IND_26841
type: DrugIndication
chembl id: CHEMBL_IND_26841
has molecule: CHEMBL635
highest development phase: 3
has mesh: D010523
has mesh heading: PERIPHERAL NERVOUS SYSTEM DISEASES
has EFO: EFO_0004149
has EFO name: NEUROPATHY

CHEMBL_IND_43772
type: DrugIndication
chembl id: CHEMBL_IND_43772
has molecule: CHEMBL635
highest development phase: 2
has mesh: D055728
has mesh heading: PRIMARY MYELOFIBROSIS
has EFO: EFO_0002430
has EFO name: PRIMARY MYELOFIBROSIS

CHEMBL_IND_26839
type: DrugIndication
chembl id: CHEMBL_IND_26839
has molecule: CHEMBL635
highest development phase: 2
has mesh: D009190
has mesh heading: MYELODYSPLASTIC SYNDROMES
has EFO: EFO_0000198
has EFO name: MYELODYSPLASTIC SYNDROME

CHEMBL_IND_26838
type: DrugIndication
chembl id: CHEMBL_IND_26838
has molecule: CHEMBL635
highest development phase: 3
has mesh: D020388
has mesh heading: MUSCULAR DYSTROPHY, DUCHENNE
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: DUCHENNE MUSCULAR DYSTROPHY

CHEMBL_IND_26837
type: DrugIndication
chembl id: CHEMBL_IND_26837
has molecule: CHEMBL635
highest development phase: 4
has mesh: D006255
has mesh heading: RHINITIS, ALLERGIC, SEASONAL
has EFO: EFO_0005854
has EFO name: ALLERGIC RHINITIS

CHEMBL_IND_42605
type: DrugIndication
chembl id: CHEMBL_IND_42605
has molecule: CHEMBL635
highest development phase: 4
has mesh: D013968
has mesh heading: THYROIDITIS, SUBACUTE
has EFO: EFO_1001194
has EFO name: SUBACUTE THYROIDITIS

CHEMBL_IND_42603
type: DrugIndication
chembl id: CHEMBL_IND_42603
has molecule: CHEMBL635
highest development phase: 4
has mesh: D009182
has mesh heading: MYCOSIS FUNGOIDES
has EFO: EFO_1001051
has EFO name: MYCOSIS FUNGOIDES

CHEMBL_IND_42597
type: DrugIndication
chembl id: CHEMBL_IND_42597
has molecule: CHEMBL635
highest development phase: 4
has mesh: D016553
has mesh heading: PURPURA, THROMBOCYTOPENIC, IDIOPATHIC
has EFO: EFO_0007160
has EFO name: AUTOIMMUNE THROMBOCYTOPENIC PURPURA

CHEMBL_IND_42925
type: DrugIndication
chembl id: CHEMBL_IND_42925
has molecule: CHEMBL635
highest development phase: 4
has mesh: D013921
has mesh heading: THROMBOCYTOPENIA
has EFO: HP_0001873
has EFO name: THROMBOCYTOPENIA

CHEMBL_IND_42912
type: DrugIndication
chembl id: CHEMBL_IND_42912
has molecule: CHEMBL635
highest development phase: 4
has mesh: D014235
has mesh heading: TRICHINELLOSIS
has EFO: EFO_0007520
has EFO name: TRICHINOSIS

CHEMBL_IND_42910
type: DrugIndication
chembl id: CHEMBL_IND_42910
has molecule: CHEMBL635
highest development phase: 4
has mesh: D011657
has mesh heading: PULMONARY EOSINOPHILIA
has EFO: EFO_0007257
has EFO name: EOSINOPHILIC PNEUMONIA

CHEMBL_IND_42909
type: DrugIndication
chembl id: CHEMBL_IND_42909
has molecule: CHEMBL635
highest development phase: 4
has mesh: D001607
has mesh heading: BERYLLIOSIS
has EFO: EFO_0007168
has EFO name: BERYLLIOSIS

CHEMBL_IND_42906
type: DrugIndication
chembl id: CHEMBL_IND_42906
has molecule: CHEMBL635
highest development phase: 4
has mesh: D001168
has mesh heading: ARTHRITIS
has EFO: EFO_0005856
has EFO name: ARTHRITIS

CHEMBL_IND_42891
type: DrugIndication
chembl id: CHEMBL_IND_42891
has molecule: CHEMBL635
highest development phase: 4
has mesh: D010392
has mesh heading: PEMPHIGUS
has EFO: EFO_0004719
has EFO name: PEMPHIGUS VULGARIS

CHEMBL_IND_42890
type: DrugIndication
chembl id: CHEMBL_IND_42890
has molecule: CHEMBL635
highest development phase: 4
has mesh: D013262
has mesh heading: STEVENS-JOHNSON SYNDROME
has EFO: EFO_0004276
has EFO name: STEVENS-JOHNSON SYNDROME

CHEMBL_IND_42876
type: DrugIndication
chembl id: CHEMBL_IND_42876
has molecule: CHEMBL635
highest development phase: 4
has mesh: D015535
has mesh heading: ARTHRITIS, PSORIATIC
has EFO: EFO_0003778
has EFO name: PSORIATIC ARTHRITIS

CHEMBL_IND_42850
type: DrugIndication
chembl id: CHEMBL_IND_42850
has molecule: CHEMBL635
highest development phase: 4
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_52051
type: DrugIndication
chembl id: CHEMBL_IND_52051
has molecule: CHEMBL635
highest development phase: 2
has mesh: D006519
has mesh heading: HEPATITIS, ALCOHOLIC
has EFO: EFO_1001345
has EFO name: HEPATITIS, ALCOHOLIC

CHEMBL_IND_42550
type: DrugIndication
chembl id: CHEMBL_IND_42550
has molecule: CHEMBL635
highest development phase: 4
has mesh: D001171
has mesh heading: ARTHRITIS, JUVENILE
has EFO: EFO_0002609
has EFO name: CHRONIC CHILDHOOD ARTHRITIS

CHEMBL_IND_42341
type: DrugIndication
chembl id: CHEMBL_IND_42341
has molecule: CHEMBL635
highest development phase: 4
has mesh: D003882
has mesh heading: DERMATOMYOSITIS
has EFO: EFO_0000398
has EFO name: DERMATOMYOSITIS

CHEMBL_IND_49386
type: DrugIndication
chembl id: CHEMBL_IND_49386
has molecule: CHEMBL635
highest development phase: 3
has mesh: D003638
has mesh heading: DEAFNESS
has EFO: EFO_0001063
has EFO name: DEAFNESS

CHEMBL_IND_52180
type: DrugIndication
chembl id: CHEMBL_IND_52180
has molecule: CHEMBL635
highest development phase: 3
has mesh: D014605
has mesh heading: UVEITIS
has EFO: EFO_1001231
has EFO name: UVEITIS

CHEMBL_IND_41955
type: DrugIndication
chembl id: CHEMBL_IND_41955
has molecule: CHEMBL635
highest development phase: 4
has mesh: D003876
has mesh heading: DERMATITIS, ATOPIC
has EFO: EFO_0000274
has EFO name: ATOPIC ECZEMA

CHEMBL_IND_48408
type: DrugIndication
chembl id: CHEMBL_IND_48408
has molecule: CHEMBL635
highest development phase: 2
has mesh: D000309
has mesh heading: ADRENAL INSUFFICIENCY
has EFO: HP_0000846
has EFO name: ADRENAL INSUFFICIENCY

CHEMBL_IND_45648
type: DrugIndication
chembl id: CHEMBL_IND_45648
has molecule: CHEMBL635
highest development phase: 3
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_52311
type: DrugIndication
chembl id: CHEMBL_IND_52311
has molecule: CHEMBL635
highest development phase: 3
has mesh: D012221
has mesh heading: RHINITIS, ALLERGIC, PERENNIAL
has EFO: EFO_1001417
has EFO name: RHINITIS, ALLERGIC, PERENNIAL

CHEMBL_IND_44822
type: DrugIndication
chembl id: CHEMBL_IND_44822
has molecule: CHEMBL635
highest development phase: 2
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_52291
type: DrugIndication
chembl id: CHEMBL_IND_52291
has molecule: CHEMBL635
highest development phase: 2
has mesh: D008010
has mesh heading: LICHEN PLANUS
has EFO: EFO_1000726
has EFO name: LICHEN PLANUS

CHEMBL_IND_42144
type: DrugIndication
chembl id: CHEMBL_IND_42144
has molecule: CHEMBL635
highest development phase: 4
has mesh: D012507
has mesh heading: SARCOIDOSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SARCOIDOSIS

CHEMBL_IND_42108
type: DrugIndication
chembl id: CHEMBL_IND_42108
has molecule: CHEMBL635
highest development phase: 4
has mesh: D013717
has mesh heading: TENOSYNOVITIS
has EFO: EFO_1001435
has EFO name: TENOSYNOVITIS

CHEMBL_IND_42074
type: DrugIndication
chembl id: CHEMBL_IND_42074
has molecule: CHEMBL635
highest development phase: 4
has mesh: D003877
has mesh heading: DERMATITIS, CONTACT
has EFO: EFO_0005319
has EFO name: CONTACT DERMATITIS

CHEMBL_IND_42060
type: DrugIndication
chembl id: CHEMBL_IND_42060
has molecule: CHEMBL635
highest development phase: 4
has mesh: D013167
has mesh heading: SPONDYLITIS, ANKYLOSING
has EFO: EFO_0003898
has EFO name: ANKYLOSING SPONDYLITIS

CHEMBL_IND_47750
type: DrugIndication
chembl id: CHEMBL_IND_47750
has molecule: CHEMBL635
highest development phase: 2
has mesh: D006391
has mesh heading: HEMANGIOMA
has EFO: EFO_1000635
has EFO name: HEMANGIOMA

CHEMBL_IND_42269
type: DrugIndication
chembl id: CHEMBL_IND_42269
has molecule: CHEMBL635
highest development phase: 4
has mesh: D002062
has mesh heading: BURSITIS
has EFO: EFO_1000941
has EFO name: FROZEN SHOULDER

CHEMBL_IND_42260
type: DrugIndication
chembl id: CHEMBL_IND_42260
has molecule: CHEMBL635
highest development phase: 4
has mesh: D014390
has mesh heading: TUBERCULOSIS, MENINGEAL
has EFO: EFO_1000039
has EFO name: MENINGEAL TUBERCULOSIS

CHEMBL_IND_48996
type: DrugIndication
chembl id: CHEMBL_IND_48996
has molecule: CHEMBL635
highest development phase: 2
has mesh: D014581
has mesh heading: URTICARIA
has EFO: EFO_0005531
has EFO name: URTICARIA

CHEMBL_IND_26235
type: DrugIndication
chembl id: CHEMBL_IND_26235
has molecule: CHEMBL635
highest development phase: 4
has mesh: D008180
has mesh heading: LUPUS ERYTHEMATOSUS, SYSTEMIC
has EFO: EFO_0002690
has EFO name: SYSTEMIC LUPUS ERYTHEMATOSUS

CHEMBL_IND_26234
type: DrugIndication
chembl id: CHEMBL_IND_26234
has molecule: CHEMBL635
highest development phase: 3
has mesh: D009157
has mesh heading: MYASTHENIA GRAVIS
has EFO: EFO_0004991
has EFO name: MYASTHENIA GRAVIS

CHEMBL_IND_42204
type: DrugIndication
chembl id: CHEMBL_IND_42204
has molecule: CHEMBL635
highest development phase: 4
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_43045
type: DrugIndication
chembl id: CHEMBL_IND_43045
has molecule: CHEMBL635
highest development phase: 4
has mesh: D000741
has mesh heading: ANEMIA, APLASTIC
has EFO: HP_0001915
has EFO name: APLASTIC ANEMIA

CHEMBL_IND_43036
type: DrugIndication
chembl id: CHEMBL_IND_43036
has molecule: CHEMBL635
highest development phase: 4
has mesh: D009879
has mesh heading: OPHTHALMIA, SYMPATHETIC
has EFO: EFO_1001205
has EFO name: SYMPATHETIC OPHTHALMIA

CHEMBL_IND_43035
type: DrugIndication
chembl id: CHEMBL_IND_43035
has molecule: CHEMBL635
highest development phase: 4
has mesh: D007500
has mesh heading: IRITIS
has EFO: EFO_1000997
has EFO name: IRITIS

CHEMBL_IND_43029
type: DrugIndication
chembl id: CHEMBL_IND_43029
has molecule: CHEMBL635
highest development phase: 4
has mesh: D004892
has mesh heading: ERYTHEMA MULTIFORME
has EFO: EFO_1000694
has EFO name: ERYTHEMA MULTIFORME

CHEMBL_IND_43028
type: DrugIndication
chembl id: CHEMBL_IND_43028
has molecule: CHEMBL635
highest development phase: 4
has mesh: D006563
has mesh heading: HERPES ZOSTER OPHTHALMICUS
has EFO: EFO_0007403
has EFO name: OPHTHALMIC HERPES ZOSTER

CHEMBL_IND_43026
type: DrugIndication
chembl id: CHEMBL_IND_43026
has molecule: CHEMBL635
highest development phase: 4
has mesh: D003233
has mesh heading: CONJUNCTIVITIS, ALLERGIC
has EFO: EFO_0007141
has EFO name: ALLERGIC CONJUNCTIVITIS

CHEMBL_IND_51861
type: DrugIndication
chembl id: CHEMBL_IND_51861
has molecule: CHEMBL635
highest development phase: 3
has mesh: D006086
has mesh heading: GRAFT VS HOST DISEASE
has EFO: EFO_0004599
has EFO name: ACUTE GRAFT VS. HOST DISEASE

CHEMBL_IND_23732
type: DrugIndication
chembl id: CHEMBL_IND_23732
has molecule: CHEMBL635
highest development phase: 3
has mesh: D014890
has mesh heading: GRANULOMATOSIS WITH POLYANGIITIS
has EFO: EFO_0005297
has EFO name: WEGENER'S GRANULOMATOSIS

CHEMBL_IND_23731
type: DrugIndication
chembl id: CHEMBL_IND_23731
has molecule: CHEMBL635
highest development phase: 2
has mesh: D012585
has mesh heading: SCIATICA
has EFO: HP_0011868
has EFO name: SCIATICA

CHEMBL_IND_23730
type: DrugIndication
chembl id: CHEMBL_IND_23730
has molecule: CHEMBL635
highest development phase: 4
has mesh: D001172
has mesh heading: ARTHRITIS, RHEUMATOID
has EFO: EFO_0000685
has EFO name: RHEUMATOID ARTHRITIS

CHEMBL_IND_23729
type: DrugIndication
chembl id: CHEMBL_IND_23729
has molecule: CHEMBL635
highest development phase: 3
has mesh: D017565
has mesh heading: SARCOIDOSIS, PULMONARY
has EFO: DOID:13406
has EFO name: PULMONARY SARCOIDOSIS

CHEMBL_IND_23728
type: DrugIndication
chembl id: CHEMBL_IND_23728
has molecule: CHEMBL635
highest development phase: 3
has mesh: D009298
has mesh heading: NASAL POLYPS
has EFO: EFO_1000391
has EFO name: NASAL CAVITY POLYP

CHEMBL_IND_23727
type: DrugIndication
chembl id: CHEMBL_IND_23727
has molecule: CHEMBL635
highest development phase: 2
has mesh: D006467
has mesh heading: HEMOPHILIA A
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: HEMOPHILIA A

CHEMBL_IND_23726
type: DrugIndication
chembl id: CHEMBL_IND_23726
has molecule: CHEMBL635
highest development phase: 4
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_41840
type: DrugIndication
chembl id: CHEMBL_IND_41840
has molecule: CHEMBL635
highest development phase: 4
has mesh: D000743
has mesh heading: ANEMIA, HEMOLYTIC
has EFO: EFO_0005558
has EFO name: HEMOLYTIC ANEMIA

CHEMBL_IND_27893
type: DrugIndication
chembl id: CHEMBL_IND_27893
has molecule: CHEMBL635
highest development phase: 2
has mesh: D006526
has mesh heading: HEPATITIS C
has EFO: EFO_0003047
has EFO name: HEPATITIS C INFECTION

CHEMBL_IND_41823
type: DrugIndication
chembl id: CHEMBL_IND_41823
has molecule: CHEMBL635
highest development phase: 4
has mesh: D015210
has mesh heading: ARTHRITIS, GOUTY
has EFO: EFO_0004274
has EFO name: GOUT

CHEMBL_IND_41813
type: DrugIndication
chembl id: CHEMBL_IND_41813
has molecule: CHEMBL635
highest development phase: 4
has mesh: D006255
has mesh heading: RHINITIS, ALLERGIC, SEASONAL
has EFO: EFO_0003956
has EFO name: SEASONAL ALLERGIC RHINITIS

CHEMBL_IND_41781
type: DrugIndication
chembl id: CHEMBL_IND_41781
has molecule: CHEMBL635
highest development phase: 4
has mesh: D017285
has mesh heading: POLYMYOSITIS
has EFO: EFO_0003063
has EFO name: POLYMYOSITIS

CHEMBL_IND_41763
type: DrugIndication
chembl id: CHEMBL_IND_41763
has molecule: CHEMBL635
highest development phase: 4
has mesh: D003093
has mesh heading: COLITIS, ULCERATIVE
has EFO: EFO_0000729
has EFO name: ULCERATIVE COLITIS

CHEMBL_IND_41708
type: DrugIndication
chembl id: CHEMBL_IND_41708
has molecule: CHEMBL635
highest development phase: 4
has mesh: D003424
has mesh heading: CROHN DISEASE
has EFO: EFO_0000384
has EFO name: CROHN'S DISEASE

CHEMBL_IND_41673
type: DrugIndication
chembl id: CHEMBL_IND_41673
has molecule: CHEMBL635
highest development phase: 4
has mesh: D012713
has mesh heading: SERUM SICKNESS

CHEMBL_IND_41670
type: DrugIndication
chembl id: CHEMBL_IND_41670
has molecule: CHEMBL635
highest development phase: 4
has mesh: D013716
has mesh heading: TENNIS ELBOW

CHEMBL_IND_41668
type: DrugIndication
chembl id: CHEMBL_IND_41668
has molecule: CHEMBL635
highest development phase: 4
has mesh: D015863
has mesh heading: IRIDOCYCLITIS

CHEMBL_IND_41661
type: DrugIndication
chembl id: CHEMBL_IND_41661
has molecule: CHEMBL635
highest development phase: 4
has mesh: D007634
has mesh heading: KERATITIS

CHEMBL_IND_41649
type: DrugIndication
chembl id: CHEMBL_IND_41649
has molecule: CHEMBL635
highest development phase: 4
has mesh: D013585
has mesh heading: SYNOVITIS

CHEMBL_IND_41613
type: DrugIndication
chembl id: CHEMBL_IND_41613
has molecule: CHEMBL635
highest development phase: 4
has mesh: D002825
has mesh heading: CHORIORETINITIS

CHEMBL_IND_41606
type: DrugIndication
chembl id: CHEMBL_IND_41606
has molecule: CHEMBL635
highest development phase: 4
has mesh: D003873
has mesh heading: DERMATITIS, EXFOLIATIVE

CHEMBL_IND_41601
type: DrugIndication
chembl id: CHEMBL_IND_41601
has molecule: CHEMBL635
highest development phase: 4
has mesh: D002833
has mesh heading: CHOROIDITIS

CHEMBL_IND_40406
type: DrugIndication
chembl id: CHEMBL_IND_40406
has molecule: CHEMBL635
highest development phase: 3
has mesh: D012852
has mesh heading: SINUSITIS
has EFO: EFO_0007486
has EFO name: SINUSITIS

CHEMBL_IND_42808
type: DrugIndication
chembl id: CHEMBL_IND_42808
has molecule: CHEMBL635
highest development phase: 4
has mesh: D000312
has mesh heading: ADRENAL HYPERPLASIA, CONGENITAL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY

CHEMBL_IND_42798
type: DrugIndication
chembl id: CHEMBL_IND_42798
has molecule: CHEMBL635
highest development phase: 4
has mesh: D009205
has mesh heading: MYOCARDITIS
has EFO: HP_0012819
has EFO name: MYOCARDITIS

CHEMBL_IND_24807
type: DrugIndication
chembl id: CHEMBL_IND_24807
has molecule: CHEMBL635
highest development phase: 3
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_24806
type: DrugIndication
chembl id: CHEMBL_IND_24806
has molecule: CHEMBL635
highest development phase: 4
has mesh: D011014
has mesh heading: PNEUMONIA
has EFO: EFO_0003106
has EFO name: PNEUMONIA

CHEMBL_IND_24805
type: DrugIndication
chembl id: CHEMBL_IND_24805
has molecule: CHEMBL635
highest development phase: 2
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_24804
type: DrugIndication
chembl id: CHEMBL_IND_24804
has molecule: CHEMBL635
highest development phase: 3
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0003144
has EFO name: HEART FAILURE

CHEMBL_IND_24803
type: DrugIndication
chembl id: CHEMBL_IND_24803
has molecule: CHEMBL635
highest development phase: 3
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_42771
type: DrugIndication
chembl id: CHEMBL_IND_42771
has molecule: CHEMBL635
highest development phase: 4
has mesh: D015866
has mesh heading: UVEITIS, POSTERIOR
has EFO: EFO_1001119
has EFO name: POSTERIOR UVEITIS

CHEMBL_IND_42767
type: DrugIndication
chembl id: CHEMBL_IND_42767
has molecule: CHEMBL635
highest development phase: 4
has mesh: D012628
has mesh heading: DERMATITIS, SEBORRHEIC
has EFO: EFO_1000764
has EFO name: SEBORRHEIC DERMATITIS

CHEMBL_IND_42766
type: DrugIndication
chembl id: CHEMBL_IND_42766
has molecule: CHEMBL635
highest development phase: 4
has mesh: D003874
has mesh heading: DERMATITIS HERPETIFORMIS
has EFO: EFO_1000684
has EFO name: DERMATITIS HERPETIFORMIS

CHEMBL_IND_42763
type: DrugIndication
chembl id: CHEMBL_IND_42763
has molecule: CHEMBL635
highest development phase: 4
has mesh: D014397
has mesh heading: TUBERCULOSIS, PULMONARY
has EFO: EFO_1000049
has EFO name: PULMONARY TUBERCULOSIS

CHEMBL_IND_42758
type: DrugIndication
chembl id: CHEMBL_IND_42758
has molecule: CHEMBL635
highest development phase: 4
has mesh: D009902
has mesh heading: OPTIC NEURITIS
has EFO: EFO_0007405
has EFO name: OPTIC NEURITIS

CHEMBL_IND_42712
type: DrugIndication
chembl id: CHEMBL_IND_42712
has molecule: CHEMBL635
highest development phase: 4
has mesh: D010003
has mesh heading: OSTEOARTHRITIS
has EFO: EFO_0002506
has EFO name: OSTEOARTHRITIS

CHEMBL_IND_42690
type: DrugIndication
chembl id: CHEMBL_IND_42690
has molecule: CHEMBL635
highest development phase: 4
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_42642
type: DrugIndication
chembl id: CHEMBL_IND_42642
has molecule: CHEMBL635
highest development phase: 4
has mesh: D000224
has mesh heading: ADDISON DISEASE
has EFO: HP_0008207
has EFO name: PRIMARY ADRENAL INSUFFICIENCY

CHEMBL_IND_51524
type: DrugIndication
chembl id: CHEMBL_IND_51524
has molecule: CHEMBL635
highest development phase: 4
has mesh: D006934
has mesh heading: HYPERCALCEMIA
has EFO: HP_0003072
has EFO name: HYPERCALCEMIA

CHEMBL_IND_47097
type: DrugIndication
chembl id: CHEMBL_IND_47097
has molecule: CHEMBL22587
highest development phase: 1
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_49580
type: DrugIndication
chembl id: CHEMBL_IND_49580
has molecule: CHEMBL22587
highest development phase: 1
has mesh: D019698
has mesh heading: HEPATITIS C, CHRONIC
has EFO: EFO_0004220
has EFO name: CHRONIC HEPATITIS C INFECTION

CHEMBL_IND_44257
type: DrugIndication
chembl id: CHEMBL_IND_44257
has molecule: CHEMBL22587
highest development phase: 4
has mesh: D014009
has mesh heading: ONYCHOMYCOSIS
has EFO: HP_0012203
has EFO name: ONYCHOMYCOSIS

CHEMBL_IND_49479
type: DrugIndication
chembl id: CHEMBL_IND_49479
has molecule: CHEMBL22587
highest development phase: 0
has mesh: D004938
has mesh heading: ESOPHAGEAL NEOPLASMS
has EFO: EFO_0002916
has EFO name: ESOPHAGEAL CARCINOMA

CHEMBL_IND_45238
type: DrugIndication
chembl id: CHEMBL_IND_45238
has molecule: CHEMBL22587
highest development phase: 1
has mesh: D009437
has mesh heading: NEURALGIA
has EFO: EFO_0005762
has EFO name: NEUROPATHIC PAIN

CHEMBL_IND_45150
type: DrugIndication
chembl id: CHEMBL_IND_45150
has molecule: CHEMBL22587
highest development phase: 0
has mesh: D002280
has mesh heading: CARCINOMA, BASAL CELL
has EFO: EFO_0004193
has EFO name: BASAL CELL CARCINOMA

CHEMBL_IND_48434
type: DrugIndication
chembl id: CHEMBL_IND_48434
has molecule: CHEMBL22587
highest development phase: 1
has mesh: D020246
has mesh heading: VENOUS THROMBOSIS
has EFO: HP_0004936
has EFO name: VENOUS THROMBOSIS

CHEMBL_IND_44702
type: DrugIndication
chembl id: CHEMBL_IND_44702
has molecule: CHEMBL22587
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_47758
type: DrugIndication
chembl id: CHEMBL_IND_47758
has molecule: CHEMBL22587
highest development phase: 1
has mesh: D053158
has mesh heading: NOCTURIA
has EFO: HP_0000017
has EFO name: NOCTURIA

CHEMBL_IND_47151
type: DrugIndication
chembl id: CHEMBL_IND_47151
has molecule: CHEMBL22587
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_52098
type: DrugIndication
chembl id: CHEMBL_IND_52098
has molecule: CHEMBL22587
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_40130
type: DrugIndication
chembl id: CHEMBL_IND_40130
has molecule: CHEMBL22587
highest development phase: 2
has mesh: D012852
has mesh heading: SINUSITIS
has EFO: EFO_0007486
has EFO name: SINUSITIS

CHEMBL_IND_47545
type: DrugIndication
chembl id: CHEMBL_IND_47545
has molecule: CHEMBL22587
highest development phase: 2
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_44900
type: DrugIndication
chembl id: CHEMBL_IND_44900
has molecule: CHEMBL22587
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_44609
type: DrugIndication
chembl id: CHEMBL_IND_44609
has molecule: CHEMBL22587
highest development phase: 3
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_24780
type: DrugIndication
chembl id: CHEMBL_IND_24780
has molecule: CHEMBL567
highest development phase: 4
has mesh: D011618
has mesh heading: PSYCHOTIC DISORDERS
has EFO: EFO_0005407
has EFO name: PSYCHOSIS

CHEMBL_IND_45590
type: DrugIndication
chembl id: CHEMBL_IND_45590
has molecule: CHEMBL719
highest development phase: 1
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_43410
type: DrugIndication
chembl id: CHEMBL_IND_43410
has molecule: CHEMBL719
highest development phase: 3
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_52026
type: DrugIndication
chembl id: CHEMBL_IND_52026
has molecule: CHEMBL719
highest development phase: 1
has mesh: D007169
has mesh heading: IMPETIGO
has EFO: EFO_1000714
has EFO name: IMPETIGO

CHEMBL_IND_46141
type: DrugIndication
chembl id: CHEMBL_IND_46141
has molecule: CHEMBL719
highest development phase: 2
has mesh: D006391
has mesh heading: HEMANGIOMA
has EFO: EFO_1000635
has EFO name: HEMANGIOMA

CHEMBL_IND_42778
type: DrugIndication
chembl id: CHEMBL_IND_42778
has molecule: CHEMBL719
highest development phase: 4
has mesh: D015508
has mesh heading: NASAL OBSTRUCTION
has EFO: HP_0001742
has EFO name: NASAL OBSTRUCTION

CHEMBL_IND_25582
type: DrugIndication
chembl id: CHEMBL_IND_25582
has molecule: CHEMBL690
highest development phase: 2
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000180
has EFO name: HIV-1 INFECTION

CHEMBL_IND_28598
type: DrugIndication
chembl id: CHEMBL_IND_28598
has molecule: CHEMBL711
highest development phase: 4
has mesh: D013927
has mesh heading: THROMBOSIS
has EFO: HP_0004419
has EFO name: RECURRENT THROMBOPHLEBITIS

CHEMBL_IND_51517
type: DrugIndication
chembl id: CHEMBL_IND_51517
has molecule: CHEMBL604
highest development phase: 4
has mesh: D018798
has mesh heading: ANEMIA, IRON-DEFICIENCY
has EFO: HP_0001891
has EFO name: IRON DEFICIENCY ANEMIA

CHEMBL_IND_52043
type: DrugIndication
chembl id: CHEMBL_IND_52043
has molecule: CHEMBL1201863
highest development phase: 3
has mesh: D004942
has mesh heading: ESOPHAGITIS, PEPTIC
has EFO: EFO_1001095
has EFO name: PEPTIC ESOPHAGITIS

CHEMBL_IND_51426
type: DrugIndication
chembl id: CHEMBL_IND_51426
has molecule: CHEMBL1201863
highest development phase: 4
has mesh: D006356
has mesh heading: HEARTBURN

CHEMBL_IND_25221
type: DrugIndication
chembl id: CHEMBL_IND_25221
has molecule: CHEMBL1201863
highest development phase: 4
has mesh: D010437
has mesh heading: PEPTIC ULCER
has EFO: HP_0004398
has EFO name: PEPTIC ULCER

CHEMBL_IND_24321
type: DrugIndication
chembl id: CHEMBL_IND_24321
has molecule: CHEMBL1201863
highest development phase: 4
has mesh: D005764
has mesh heading: GASTROESOPHAGEAL REFLUX
has EFO: EFO_0003948
has EFO name: GASTROESOPHAGEAL REFLUX DISEASE

CHEMBL_IND_51547
type: DrugIndication
chembl id: CHEMBL_IND_51547
has molecule: CHEMBL1201863
highest development phase: 4
has mesh: D004941
has mesh heading: ESOPHAGITIS
has EFO: HP_0100633
has EFO name: ESOPHAGITIS

CHEMBL_IND_27275
type: DrugIndication
chembl id: CHEMBL_IND_27275
has molecule: CHEMBL1201866
highest development phase: 2
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_26677
type: DrugIndication
chembl id: CHEMBL_IND_26677
has molecule: CHEMBL1201866
highest development phase: 3
has mesh: D009765
has mesh heading: OBESITY
has EFO: EFO_0001073
has EFO name: OBESITY

CHEMBL_IND_25429
type: DrugIndication
chembl id: CHEMBL_IND_25429
has molecule: CHEMBL1201866
highest development phase: 4
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: MODY

CHEMBL_IND_25428
type: DrugIndication
chembl id: CHEMBL_IND_25428
has molecule: CHEMBL1201866
highest development phase: 3
has mesh: D006943
has mesh heading: HYPERGLYCEMIA
has EFO: HP_0003074
has EFO name: HYPERGLYCEMIA

CHEMBL_IND_45086
type: DrugIndication
chembl id: CHEMBL_IND_45086
has molecule: CHEMBL1201866
highest development phase: 1
has mesh: D012891
has mesh heading: SLEEP APNEA SYNDROMES
has EFO: EFO_0003877
has EFO name: SLEEP APNEA

CHEMBL_IND_52120
type: DrugIndication
chembl id: CHEMBL_IND_52120
has molecule: CHEMBL1201866
highest development phase: 2
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_27776
type: DrugIndication
chembl id: CHEMBL_IND_27776
has molecule: CHEMBL1201866
highest development phase: 3
has mesh: D003928
has mesh heading: DIABETIC NEPHROPATHIES
has EFO: EFO_0000401
has EFO name: DIABETIC NEPHROPATHY

CHEMBL_IND_23424
type: DrugIndication
chembl id: CHEMBL_IND_23424
has molecule: CHEMBL1201866
highest development phase: 4
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_23423
type: DrugIndication
chembl id: CHEMBL_IND_23423
has molecule: CHEMBL1201866
highest development phase: 3
has mesh: D003922
has mesh heading: DIABETES MELLITUS, TYPE 1
has EFO: EFO_0001359
has EFO name: TYPE I DIABETES MELLITUS

CHEMBL_IND_23422
type: DrugIndication
chembl id: CHEMBL_IND_23422
has molecule: CHEMBL1201866
highest development phase: 2
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_23421
type: DrugIndication
chembl id: CHEMBL_IND_23421
has molecule: CHEMBL1201866
highest development phase: 2
has mesh: D018149
has mesh heading: GLUCOSE INTOLERANCE
has EFO: EFO_0002546
has EFO name: ABNORMAL GLUCOSE TOLERANCE

CHEMBL_IND_24594
type: DrugIndication
chembl id: CHEMBL_IND_24594
has molecule: CHEMBL1201866
highest development phase: 2
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0003144
has EFO name: HEART FAILURE

CHEMBL_IND_48444
type: DrugIndication
chembl id: CHEMBL_IND_48444
has molecule: CHEMBL803
highest development phase: 3
has mesh: D015614
has mesh heading: HISTIOCYTOSIS
has EFO: HP_0100727
has EFO name: HISTIOCYTOSIS

CHEMBL_IND_25889
type: DrugIndication
chembl id: CHEMBL_IND_25889
has molecule: CHEMBL803
highest development phase: 2
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_25888
type: DrugIndication
chembl id: CHEMBL_IND_25888
has molecule: CHEMBL803
highest development phase: 3
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_26480
type: DrugIndication
chembl id: CHEMBL_IND_26480
has molecule: CHEMBL803
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_41751
type: DrugIndication
chembl id: CHEMBL_IND_41751
has molecule: CHEMBL803
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_22962
type: DrugIndication
chembl id: CHEMBL_IND_22962
has molecule: CHEMBL803
highest development phase: 3
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_22961
type: DrugIndication
chembl id: CHEMBL_IND_22961
has molecule: CHEMBL803
highest development phase: 3
has mesh: D054198
has mesh heading: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
has EFO: EFO_0000220
has EFO name: ACUTE LYMPHOBLASTIC LEUKEMIA

CHEMBL_IND_51641
type: DrugIndication
chembl id: CHEMBL_IND_51641
has molecule: CHEMBL803
highest development phase: 3
has mesh: D015473
has mesh heading: LEUKEMIA, PROMYELOCYTIC, ACUTE
has EFO: EFO_0000224
has EFO name: ACUTE PROMYELOCYTIC LEUKEMIA

CHEMBL_IND_24298
type: DrugIndication
chembl id: CHEMBL_IND_24298
has molecule: CHEMBL803
highest development phase: 2
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_24297
type: DrugIndication
chembl id: CHEMBL_IND_24297
has molecule: CHEMBL803
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_26146
type: DrugIndication
chembl id: CHEMBL_IND_26146
has molecule: CHEMBL802
highest development phase: 4
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_23514
type: DrugIndication
chembl id: CHEMBL_IND_23514
has molecule: CHEMBL802
highest development phase: 3
has mesh: D000505
has mesh heading: ALOPECIA
has EFO: EFO_0004191
has EFO name: ANDROGENETIC ALOPECIA

CHEMBL_IND_23513
type: DrugIndication
chembl id: CHEMBL_IND_23513
has molecule: CHEMBL802
highest development phase: 3
has mesh: D000505
has mesh heading: ALOPECIA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: ALOPECIA

CHEMBL_IND_26910
type: DrugIndication
chembl id: CHEMBL_IND_26910
has molecule: CHEMBL786
highest development phase: 2
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000292
has EFO name: BLADDER CARCINOMA

CHEMBL_IND_45796
type: DrugIndication
chembl id: CHEMBL_IND_45796
has molecule: CHEMBL786
highest development phase: 2
has mesh: D002583
has mesh heading: UTERINE CERVICAL NEOPLASMS
has EFO: EFO_0001416
has EFO name: CERVICAL ADENOCARCINOMA

CHEMBL_IND_52437
type: DrugIndication
chembl id: CHEMBL_IND_52437
has molecule: CHEMBL786
highest development phase: 2
has mesh: D061325
has mesh heading: HEREDITARY BREAST AND OVARIAN CANCER SYNDROME
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: HEREDITARY BREAST AND OVARIAN CANCER SYNDROME

CHEMBL_IND_25673
type: DrugIndication
chembl id: CHEMBL_IND_25673
has molecule: CHEMBL786
highest development phase: 1
has mesh: D019698
has mesh heading: HEPATITIS C, CHRONIC
has EFO: EFO_0004220
has EFO name: CHRONIC HEPATITIS C INFECTION

CHEMBL_IND_25672
type: DrugIndication
chembl id: CHEMBL_IND_25672
has molecule: CHEMBL786
highest development phase: 2
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_52691
type: DrugIndication
chembl id: CHEMBL_IND_52691
has molecule: CHEMBL786
highest development phase: 1
has mesh: D020388
has mesh heading: MUSCULAR DYSTROPHY, DUCHENNE
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: DUCHENNE MUSCULAR DYSTROPHY

CHEMBL_IND_26301
type: DrugIndication
chembl id: CHEMBL_IND_26301
has molecule: CHEMBL786
highest development phase: 3
has mesh: D002277
has mesh heading: CARCINOMA
has EFO: EFO_0000313
has EFO name: CARCINOMA

CHEMBL_IND_26300
type: DrugIndication
chembl id: CHEMBL_IND_26300
has molecule: CHEMBL786
highest development phase: 3
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_47147
type: DrugIndication
chembl id: CHEMBL_IND_47147
has molecule: CHEMBL786
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_52078
type: DrugIndication
chembl id: CHEMBL_IND_52078
has molecule: CHEMBL786
highest development phase: 2
has mesh: D006470
has mesh heading: HEMORRHAGE
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: HEMORRHAGE

CHEMBL_IND_23922
type: DrugIndication
chembl id: CHEMBL_IND_23922
has molecule: CHEMBL786
highest development phase: 3
has mesh: D018567
has mesh heading: BREAST NEOPLASMS, MALE
has EFO: EFO_0006861
has EFO name: MALE BREAST CARCINOMA

CHEMBL_IND_23921
type: DrugIndication
chembl id: CHEMBL_IND_23921
has molecule: CHEMBL786
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_40071
type: DrugIndication
chembl id: CHEMBL_IND_40071
has molecule: CHEMBL786
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0003869
has EFO name: BREAST NEOPLASM

CHEMBL_IND_47476
type: DrugIndication
chembl id: CHEMBL_IND_47476
has molecule: CHEMBL786
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_47423
type: DrugIndication
chembl id: CHEMBL_IND_47423
has molecule: CHEMBL786
highest development phase: 2
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: EFO_0001075
has EFO name: OVARIAN CARCINOMA

CHEMBL_IND_51688
type: DrugIndication
chembl id: CHEMBL_IND_51688
has molecule: CHEMBL786
highest development phase: 2
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_24926
type: DrugIndication
chembl id: CHEMBL_IND_24926
has molecule: CHEMBL786
highest development phase: 2
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000294
has EFO name: BLADDER TUMOR

CHEMBL_IND_24925
type: DrugIndication
chembl id: CHEMBL_IND_24925
has molecule: CHEMBL786
highest development phase: 2
has mesh: D000690
has mesh heading: AMYOTROPHIC LATERAL SCLEROSIS
has EFO: EFO_0000253
has EFO name: AMYOTROPHIC LATERAL SCLEROSIS

CHEMBL_IND_49985
type: DrugIndication
chembl id: CHEMBL_IND_49985
has molecule: CHEMBL813
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_55158
type: DrugIndication
chembl id: CHEMBL_IND_55158
has molecule: CHEMBL813
highest development phase: 3
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_42325
type: DrugIndication
chembl id: CHEMBL_IND_42325
has molecule: CHEMBL38380
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_47872
type: DrugIndication
chembl id: CHEMBL_IND_47872
has molecule: CHEMBL38380
highest development phase: 2
has mesh: D000690
has mesh heading: AMYOTROPHIC LATERAL SCLEROSIS
has EFO: EFO_0000253
has EFO name: AMYOTROPHIC LATERAL SCLEROSIS

CHEMBL_IND_40802
type: DrugIndication
chembl id: CHEMBL_IND_40802
has molecule: CHEMBL38380
highest development phase: 2
has mesh: D016893
has mesh heading: CAROTID STENOSIS
has EFO: EFO_0002615
has EFO name: INTERNAL CAROTID ARTERY STENOSIS

CHEMBL_IND_43011
type: DrugIndication
chembl id: CHEMBL_IND_43011
has molecule: CHEMBL741
highest development phase: 4
has mesh: D004828
has mesh heading: EPILEPSIES, PARTIAL
has EFO: EFO_0004263
has EFO name: PARTIAL EPILEPSY

CHEMBL_IND_42927
type: DrugIndication
chembl id: CHEMBL_IND_42927
has molecule: CHEMBL741
highest development phase: 4
has mesh: D004830
has mesh heading: EPILEPSY, TONIC-CLONIC
has EFO: HP_0002069
has EFO name: GENERALIZED TONIC-CLONIC SEIZURES

CHEMBL_IND_26655
type: DrugIndication
chembl id: CHEMBL_IND_26655
has molecule: CHEMBL741
highest development phase: 2
has mesh: D009456
has mesh heading: NEUROFIBROMATOSIS 1
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: NEUROFIBROMATOSIS TYPE 1

CHEMBL_IND_28229
type: DrugIndication
chembl id: CHEMBL_IND_28229
has molecule: CHEMBL741
highest development phase: 2
has mesh: D020529
has mesh heading: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
has EFO: EFO_0003929
has EFO name: RELAPSING-REMITTING MULTIPLE SCLEROSIS

CHEMBL_IND_41906
type: DrugIndication
chembl id: CHEMBL_IND_41906
has molecule: CHEMBL741
highest development phase: 4
has mesh: D012640
has mesh heading: SEIZURES
has EFO: HP_0001250
has EFO name: SEIZURES

CHEMBL_IND_45991
type: DrugIndication
chembl id: CHEMBL_IND_45991
has molecule: CHEMBL741
highest development phase: 2
has mesh: D019966
has mesh heading: SUBSTANCE-RELATED DISORDERS
has EFO: EFO_0003890
has EFO name: DRUG DEPENDENCE

CHEMBL_IND_23387
type: DrugIndication
chembl id: CHEMBL_IND_23387
has molecule: CHEMBL741
highest development phase: 1
has mesh: D007863
has mesh heading: LECITHIN ACYLTRANSFERASE DEFICIENCY
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: FISH-EYE DISEASE

CHEMBL_IND_23386
type: DrugIndication
chembl id: CHEMBL_IND_23386
has molecule: CHEMBL741
highest development phase: 4
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_23385
type: DrugIndication
chembl id: CHEMBL_IND_23385
has molecule: CHEMBL741
highest development phase: 4
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_42805
type: DrugIndication
chembl id: CHEMBL_IND_42805
has molecule: CHEMBL741
highest development phase: 4
has mesh: D065768
has mesh heading: LENNOX GASTAUT SYNDROME
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: LENNOX-GASTAUT SYNDROME

CHEMBL_IND_24572
type: DrugIndication
chembl id: CHEMBL_IND_24572
has molecule: CHEMBL741
highest development phase: 3
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_24571
type: DrugIndication
chembl id: CHEMBL_IND_24571
has molecule: CHEMBL741
highest development phase: 3
has mesh: D019964
has mesh heading: MOOD DISORDERS
has EFO: EFO_0004247
has EFO name: MOOD DISORDER

CHEMBL_IND_24570
type: DrugIndication
chembl id: CHEMBL_IND_24570
has molecule: CHEMBL741
highest development phase: 1
has mesh: D001523
has mesh heading: MENTAL DISORDERS
has EFO: EFO_0000677
has EFO name: MENTAL OR BEHAVIOURAL DISORDER

CHEMBL_IND_43594
type: DrugIndication
chembl id: CHEMBL_IND_43594
has molecule: CHEMBL810
highest development phase: 3
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_49470
type: DrugIndication
chembl id: CHEMBL_IND_49470
has molecule: CHEMBL810
highest development phase: 3
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0002617
has EFO name: METASTATIC MELANOMA

CHEMBL_IND_43921
type: DrugIndication
chembl id: CHEMBL_IND_43921
has molecule: CHEMBL810
highest development phase: 3
has mesh: D001932
has mesh heading: BRAIN NEOPLASMS
has EFO: EFO_0003833
has EFO name: BRAIN NEOPLASM

CHEMBL_IND_48030
type: DrugIndication
chembl id: CHEMBL_IND_48030
has molecule: CHEMBL810
highest development phase: 2
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_47879
type: DrugIndication
chembl id: CHEMBL_IND_47879
has molecule: CHEMBL810
highest development phase: 2
has mesh: D001254
has mesh heading: ASTROCYTOMA
has EFO: EFO_0000272
has EFO name: ASTROCYTOMA

CHEMBL_IND_48538
type: DrugIndication
chembl id: CHEMBL_IND_48538
has molecule: CHEMBL810
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_45636
type: DrugIndication
chembl id: CHEMBL_IND_45636
has molecule: CHEMBL810
highest development phase: 2
has mesh: D009447
has mesh heading: NEUROBLASTOMA
has EFO: EFO_0000621
has EFO name: NEUROBLASTOMA

CHEMBL_IND_52338
type: DrugIndication
chembl id: CHEMBL_IND_52338
has molecule: CHEMBL810
highest development phase: 2
has mesh: D012175
has mesh heading: RETINOBLASTOMA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: RETINOBLASTOMA

CHEMBL_IND_44817
type: DrugIndication
chembl id: CHEMBL_IND_44817
has molecule: CHEMBL810
highest development phase: 2
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_44750
type: DrugIndication
chembl id: CHEMBL_IND_44750
has molecule: CHEMBL810
highest development phase: 2
has mesh: D055752
has mesh heading: SMALL CELL LUNG CARCINOMA
has EFO: EFO_0000702
has EFO name: SMALL CELL LUNG CARCINOMA

CHEMBL_IND_47812
type: DrugIndication
chembl id: CHEMBL_IND_47812
has molecule: CHEMBL810
highest development phase: 2
has mesh: D046152
has mesh heading: GASTROINTESTINAL STROMAL TUMORS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: GASTROINTESTINAL STROMAL TUMOR

CHEMBL_IND_49131
type: DrugIndication
chembl id: CHEMBL_IND_49131
has molecule: CHEMBL810
highest development phase: 2
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_46492
type: DrugIndication
chembl id: CHEMBL_IND_46492
has molecule: CHEMBL810
highest development phase: 2
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_43444
type: DrugIndication
chembl id: CHEMBL_IND_43444
has molecule: CHEMBL810
highest development phase: 2
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_43383
type: DrugIndication
chembl id: CHEMBL_IND_43383
has molecule: CHEMBL810
highest development phase: 4
has mesh: D005909
has mesh heading: GLIOBLASTOMA
has EFO: EFO_0000519
has EFO name: GLIOBLASTOMA MULTIFORME

CHEMBL_IND_52016
type: DrugIndication
chembl id: CHEMBL_IND_52016
has molecule: CHEMBL810
highest development phase: 2
has mesh: D001927
has mesh heading: BRAIN DISEASES
has EFO: EFO_0005774
has EFO name: BRAIN DISEASE

CHEMBL_IND_43297
type: DrugIndication
chembl id: CHEMBL_IND_43297
has molecule: CHEMBL810
highest development phase: 3
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_46369
type: DrugIndication
chembl id: CHEMBL_IND_46369
has molecule: CHEMBL810
highest development phase: 2
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_48997
type: DrugIndication
chembl id: CHEMBL_IND_48997
has molecule: CHEMBL810
highest development phase: 3
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0005543
has EFO name: GLIOMA

CHEMBL_IND_46262
type: DrugIndication
chembl id: CHEMBL_IND_46262
has molecule: CHEMBL810
highest development phase: 1
has mesh: D012512
has mesh heading: SARCOMA, EWING
has EFO: EFO_0000174
has EFO name: EWING SARCOMA

CHEMBL_IND_44974
type: DrugIndication
chembl id: CHEMBL_IND_44974
has molecule: CHEMBL810
highest development phase: 3
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_47538
type: DrugIndication
chembl id: CHEMBL_IND_47538
has molecule: CHEMBL810
highest development phase: 2
has mesh: D008527
has mesh heading: MEDULLOBLASTOMA
has EFO: EFO_0002939
has EFO name: MEDULLOBLASTOMA

CHEMBL_IND_47342
type: DrugIndication
chembl id: CHEMBL_IND_47342
has molecule: CHEMBL810
highest development phase: 2
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_44546
type: DrugIndication
chembl id: CHEMBL_IND_44546
has molecule: CHEMBL810
highest development phase: 3
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000389
has EFO name: CUTANEOUS MELANOMA

CHEMBL_IND_51766
type: DrugIndication
chembl id: CHEMBL_IND_51766
has molecule: CHEMBL810
highest development phase: 3
has mesh: D018316
has mesh heading: GLIOSARCOMA
has EFO: EFO_1001465
has EFO name: GLIOSARCOMA

CHEMBL_IND_51737
type: DrugIndication
chembl id: CHEMBL_IND_51737
has molecule: CHEMBL810
highest development phase: 1
has mesh: D012004
has mesh heading: RECTAL NEOPLASMS
has EFO: EFO_1000657
has EFO name: RECTUM CANCER

CHEMBL_IND_44777
type: DrugIndication
chembl id: CHEMBL_IND_44777
has molecule: CHEMBL38700
highest development phase: 2
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_42610
type: DrugIndication
chembl id: CHEMBL_IND_42610
has molecule: CHEMBL746
highest development phase: 4
has mesh: D015508
has mesh heading: NASAL OBSTRUCTION
has EFO: HP_0001742
has EFO name: NASAL OBSTRUCTION

CHEMBL_IND_42584
type: DrugIndication
chembl id: CHEMBL_IND_42584
has molecule: CHEMBL746
highest development phase: 4
has mesh: D005132
has mesh heading: EYE MANIFESTATIONS
has EFO: EFO_0005751
has EFO name: EYE ALLERGY

CHEMBL_IND_47875
type: DrugIndication
chembl id: CHEMBL_IND_47875
has molecule: CHEMBL746
highest development phase: 1
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_42501
type: DrugIndication
chembl id: CHEMBL_IND_42501
has molecule: CHEMBL783
highest development phase: 4
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_23560
type: DrugIndication
chembl id: CHEMBL_IND_23560
has molecule: CHEMBL783
highest development phase: 4
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_26733
type: DrugIndication
chembl id: CHEMBL_IND_26733
has molecule: CHEMBL606
highest development phase: 3
has mesh: D007889
has mesh heading: LEIOMYOMA
has EFO: EFO_0000731
has EFO name: UTERINE FIBROID

CHEMBL_IND_28278
type: DrugIndication
chembl id: CHEMBL_IND_28278
has molecule: CHEMBL606
highest development phase: 4
has mesh: D005764
has mesh heading: GASTROESOPHAGEAL REFLUX
has EFO: EFO_0003948
has EFO name: GASTROESOPHAGEAL REFLUX DISEASE

CHEMBL_IND_48680
type: DrugIndication
chembl id: CHEMBL_IND_48680
has molecule: CHEMBL606
highest development phase: 3
has mesh: D011225
has mesh heading: PRE-ECLAMPSIA
has EFO: EFO_0000668
has EFO name: PREECLAMPSIA

CHEMBL_IND_48312
type: DrugIndication
chembl id: CHEMBL_IND_48312
has molecule: CHEMBL606
highest development phase: 3
has mesh: D008595
has mesh heading: MENORRHAGIA
has EFO: EFO_0003945
has EFO name: MENORRHAGIA

CHEMBL_IND_45953
type: DrugIndication
chembl id: CHEMBL_IND_45953
has molecule: CHEMBL606
highest development phase: 3
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_27319
type: DrugIndication
chembl id: CHEMBL_IND_27319
has molecule: CHEMBL606
highest development phase: 4
has mesh: D010437
has mesh heading: PEPTIC ULCER
has EFO: HP_0004398
has EFO name: PEPTIC ULCER

CHEMBL_IND_51679
type: DrugIndication
chembl id: CHEMBL_IND_51679
has molecule: CHEMBL606
highest development phase: 3
has mesh: D011247
has mesh heading: PREGNANCY
has EFO: EFO_0002950
has EFO name: PREGNANCY

CHEMBL_IND_24660
type: DrugIndication
chembl id: CHEMBL_IND_24660
has molecule: CHEMBL606
highest development phase: 0
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_24659
type: DrugIndication
chembl id: CHEMBL_IND_24659
has molecule: CHEMBL606
highest development phase: 2
has mesh: D003586
has mesh heading: CYTOMEGALOVIRUS INFECTIONS
has EFO: EFO_0001062
has EFO name: CYTOMEGALOVIRUS INFECTION

CHEMBL_IND_23518
type: DrugIndication
chembl id: CHEMBL_IND_23518
has molecule: CHEMBL606
highest development phase: 3
has mesh: D000022
has mesh heading: ABORTION, SPONTANEOUS
has EFO: HP_0005268
has EFO name: SPONTANEOUS ABORTION

CHEMBL_IND_23517
type: DrugIndication
chembl id: CHEMBL_IND_23517
has molecule: CHEMBL606
highest development phase: 3
has mesh: D006470
has mesh heading: HEMORRHAGE
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: HEMORRHAGE

CHEMBL_IND_28405
type: DrugIndication
chembl id: CHEMBL_IND_28405
has molecule: CHEMBL782
highest development phase: 4
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_53906
type: DrugIndication
chembl id: CHEMBL_IND_53906
has molecule: CHEMBL808
highest development phase: 2
has mesh: D014008
has mesh heading: TINEA PEDIS
has EFO: EFO_0007512
has EFO name: TINEA PEDIS

CHEMBL_IND_26848
type: DrugIndication
chembl id: CHEMBL_IND_26848
has molecule: CHEMBL812
highest development phase: 2
has mesh: D007022
has mesh heading: HYPOTENSION
has EFO: EFO_0005251
has EFO name: HYPOTENSION

CHEMBL_IND_47728
type: DrugIndication
chembl id: CHEMBL_IND_47728
has molecule: CHEMBL812
highest development phase: 2
has mesh: D007024
has mesh heading: HYPOTENSION, ORTHOSTATIC
has EFO: EFO_0005252
has EFO name: ORTHOSTATIC HYPOTENSION

CHEMBL_IND_49698
type: DrugIndication
chembl id: CHEMBL_IND_49698
has molecule: CHEMBL812
highest development phase: 0
has mesh: D006009
has mesh heading: GLYCOGEN STORAGE DISEASE TYPE II
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY

CHEMBL_IND_27904
type: DrugIndication
chembl id: CHEMBL_IND_27904
has molecule: CHEMBL812
highest development phase: 2
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_27903
type: DrugIndication
chembl id: CHEMBL_IND_27903
has molecule: CHEMBL812
highest development phase: 2
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0003144
has EFO name: HEART FAILURE

CHEMBL_IND_42676
type: DrugIndication
chembl id: CHEMBL_IND_42676
has molecule: CHEMBL20835
highest development phase: 4
has mesh: D005901
has mesh heading: GLAUCOMA
has EFO: EFO_0000516
has EFO name: GLAUCOMA

CHEMBL_IND_42723
type: DrugIndication
chembl id: CHEMBL_IND_42723
has molecule: CHEMBL33986
highest development phase: 4
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_43757
type: DrugIndication
chembl id: CHEMBL_IND_43757
has molecule: CHEMBL848
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_42968
type: DrugIndication
chembl id: CHEMBL_IND_42968
has molecule: CHEMBL848
highest development phase: 4
has mesh: D007154
has mesh heading: IMMUNE SYSTEM DISEASES
has EFO: EFO_0000540
has EFO name: IMMUNE SYSTEM DISEASE

CHEMBL_IND_49510
type: DrugIndication
chembl id: CHEMBL_IND_49510
has molecule: CHEMBL848
highest development phase: 2
has mesh: D001321
has mesh heading: AUTISTIC DISORDER
has EFO: EFO_0003758
has EFO name: AUTISM

CHEMBL_IND_52046
type: DrugIndication
chembl id: CHEMBL_IND_52046
has molecule: CHEMBL848
highest development phase: 2
has mesh: D012019
has mesh heading: REFLEX SYMPATHETIC DYSTROPHY
has EFO: EFO_1001147
has EFO name: REFLEX SYMPATHETIC DYSTROPHY

CHEMBL_IND_43713
type: DrugIndication
chembl id: CHEMBL_IND_43713
has molecule: CHEMBL848
highest development phase: 3
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_46716
type: DrugIndication
chembl id: CHEMBL_IND_46716
has molecule: CHEMBL848
highest development phase: 1
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_48001
type: DrugIndication
chembl id: CHEMBL_IND_48001
has molecule: CHEMBL848
highest development phase: 1
has mesh: D012514
has mesh heading: SARCOMA, KAPOSI
has EFO: EFO_0000558
has EFO name: KAPOSI'S SARCOMA

CHEMBL_IND_47893
type: DrugIndication
chembl id: CHEMBL_IND_47893
has molecule: CHEMBL848
highest development phase: 2
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000292
has EFO name: BLADDER CARCINOMA

CHEMBL_IND_45884
type: DrugIndication
chembl id: CHEMBL_IND_45884
has molecule: CHEMBL848
highest development phase: 1
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_45838
type: DrugIndication
chembl id: CHEMBL_IND_45838
has molecule: CHEMBL848
highest development phase: 2
has mesh: D055728
has mesh heading: PRIMARY MYELOFIBROSIS
has EFO: EFO_0002430
has EFO name: PRIMARY MYELOFIBROSIS

CHEMBL_IND_45756
type: DrugIndication
chembl id: CHEMBL_IND_45756
has molecule: CHEMBL848
highest development phase: 1
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: EFO_0001075
has EFO name: OVARIAN CARCINOMA

CHEMBL_IND_48550
type: DrugIndication
chembl id: CHEMBL_IND_48550
has molecule: CHEMBL848
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_48474
type: DrugIndication
chembl id: CHEMBL_IND_48474
has molecule: CHEMBL848
highest development phase: 1
has mesh: D008224
has mesh heading: LYMPHOMA, FOLLICULAR
has EFO: EFO_0000096
has EFO name: NEOPLASM OF MATURE B-CELLS

CHEMBL_IND_52334
type: DrugIndication
chembl id: CHEMBL_IND_52334
has molecule: CHEMBL848
highest development phase: 2
has mesh: D000686
has mesh heading: AMYLOIDOSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: PRIMARY SYSTEMIC AMYLOIDOSIS

CHEMBL_IND_48268
type: DrugIndication
chembl id: CHEMBL_IND_48268
has molecule: CHEMBL848
highest development phase: 2
has mesh: D013964
has mesh heading: THYROID NEOPLASMS
has EFO: EFO_0003841
has EFO name: THYROID NEOPLASM

CHEMBL_IND_44782
type: DrugIndication
chembl id: CHEMBL_IND_44782
has molecule: CHEMBL848
highest development phase: 2
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_44772
type: DrugIndication
chembl id: CHEMBL_IND_44772
has molecule: CHEMBL848
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_45403
type: DrugIndication
chembl id: CHEMBL_IND_45403
has molecule: CHEMBL848
highest development phase: 2
has mesh: D015456
has mesh heading: LEUKEMIA, BIPHENOTYPIC, ACUTE
has EFO: EFO_0000209
has EFO name: T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

CHEMBL_IND_45364
type: DrugIndication
chembl id: CHEMBL_IND_45364
has molecule: CHEMBL848
highest development phase: 2
has mesh: D028226
has mesh heading: AMYLOIDOSIS, FAMILIAL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: AL AMYLOIDOSIS

CHEMBL_IND_40965
type: DrugIndication
chembl id: CHEMBL_IND_40965
has molecule: CHEMBL848
highest development phase: 1
has mesh: D002100
has mesh heading: CACHEXIA
has EFO: HP_0004326
has EFO name: CACHEXIA

CHEMBL_IND_40944
type: DrugIndication
chembl id: CHEMBL_IND_40944
has molecule: CHEMBL848
highest development phase: 3
has mesh: D020522
has mesh heading: LYMPHOMA, MANTLE-CELL
has EFO: EFO_1001469
has EFO name: MANTLE CELL LYMPHOMA

CHEMBL_IND_47835
type: DrugIndication
chembl id: CHEMBL_IND_47835
has molecule: CHEMBL848
highest development phase: 2
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000180
has EFO name: HIV-1 INFECTION

CHEMBL_IND_49126
type: DrugIndication
chembl id: CHEMBL_IND_49126
has molecule: CHEMBL848
highest development phase: 2
has mesh: D016411
has mesh heading: LYMPHOMA, T-CELL, PERIPHERAL
has EFO: EFO_0000211
has EFO name: UNSPECIFIED PERIPHERAL T-CELL LYMPHOMA

CHEMBL_IND_46438
type: DrugIndication
chembl id: CHEMBL_IND_46438
has molecule: CHEMBL848
highest development phase: 3
has mesh: D016403
has mesh heading: LYMPHOMA, LARGE B-CELL, DIFFUSE
has EFO: EFO_0000403
has EFO name: DIFFUSE LARGE B-CELL LYMPHOMA

CHEMBL_IND_43449
type: DrugIndication
chembl id: CHEMBL_IND_43449
has molecule: CHEMBL848
highest development phase: 3
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_43443
type: DrugIndication
chembl id: CHEMBL_IND_43443
has molecule: CHEMBL848
highest development phase: 2
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_43226
type: DrugIndication
chembl id: CHEMBL_IND_43226
has molecule: CHEMBL848
highest development phase: 2
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000294
has EFO name: BLADDER TUMOR

CHEMBL_IND_43156
type: DrugIndication
chembl id: CHEMBL_IND_43156
has molecule: CHEMBL848
highest development phase: 2
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_43146
type: DrugIndication
chembl id: CHEMBL_IND_43146
has molecule: CHEMBL848
highest development phase: 3
has mesh: D009190
has mesh heading: MYELODYSPLASTIC SYNDROMES
has EFO: EFO_0000198
has EFO name: MYELODYSPLASTIC SYNDROME

CHEMBL_IND_43139
type: DrugIndication
chembl id: CHEMBL_IND_43139
has molecule: CHEMBL848
highest development phase: 2
has mesh: D018442
has mesh heading: LYMPHOMA, B-CELL, MARGINAL ZONE
has EFO: EFO_0000191
has EFO name: MALT LYMPHOMA

CHEMBL_IND_43137
type: DrugIndication
chembl id: CHEMBL_IND_43137
has molecule: CHEMBL848
highest development phase: 2
has mesh: D006689
has mesh heading: HODGKIN DISEASE
has EFO: EFO_0000183
has EFO name: HODGKINS LYMPHOMA

CHEMBL_IND_43124
type: DrugIndication
chembl id: CHEMBL_IND_43124
has molecule: CHEMBL848
highest development phase: 2
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_43101
type: DrugIndication
chembl id: CHEMBL_IND_43101
has molecule: CHEMBL848
highest development phase: 3
has mesh: D015451
has mesh heading: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
has EFO: EFO_0000095
has EFO name: CHRONIC LYMPHOCYTIC LEUKEMIA

CHEMBL_IND_46126
type: DrugIndication
chembl id: CHEMBL_IND_46126
has molecule: CHEMBL848
highest development phase: 2
has mesh: D008228
has mesh heading: LYMPHOMA, NON-HODGKIN
has EFO: EFO_0005952
has EFO name: NON-HODGKINS LYMPHOMA

CHEMBL_IND_44945
type: DrugIndication
chembl id: CHEMBL_IND_44945
has molecule: CHEMBL848
highest development phase: 1
has mesh: D008258
has mesh heading: WALDENSTROM MACROGLOBULINEMIA
has EFO: EFO_0002616
has EFO name: MACROGLOBULINEMIA

CHEMBL_IND_44112
type: DrugIndication
chembl id: CHEMBL_IND_44112
has molecule: CHEMBL848
highest development phase: 2
has mesh: D006086
has mesh heading: GRAFT VS HOST DISEASE
has EFO: EFO_0004599
has EFO name: ACUTE GRAFT VS. HOST DISEASE

CHEMBL_IND_44090
type: DrugIndication
chembl id: CHEMBL_IND_44090
has molecule: CHEMBL848
highest development phase: 3
has mesh: D000740
has mesh heading: ANEMIA
has EFO: EFO_0004272
has EFO name: ANEMIA

CHEMBL_IND_44659
type: DrugIndication
chembl id: CHEMBL_IND_44659
has molecule: CHEMBL848
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_44514
type: DrugIndication
chembl id: CHEMBL_IND_44514
has molecule: CHEMBL848
highest development phase: 2
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_49619
type: DrugIndication
chembl id: CHEMBL_IND_49619
has molecule: CHEMBL796
highest development phase: 1
has mesh: D011183
has mesh heading: POSTOPERATIVE COMPLICATIONS
has EFO: EFO_0005323
has EFO name: POST-OPERATIVE SIGN OR SYMPTOM

CHEMBL_IND_47865
type: DrugIndication
chembl id: CHEMBL_IND_47865
has molecule: CHEMBL796
highest development phase: 3
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_52488
type: DrugIndication
chembl id: CHEMBL_IND_52488
has molecule: CHEMBL796
highest development phase: 1
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_25460
type: DrugIndication
chembl id: CHEMBL_IND_25460
has molecule: CHEMBL796
highest development phase: 2
has mesh: D001068
has mesh heading: EATING DISORDERS
has EFO: EFO_0005203
has EFO name: EATING DISORDER

CHEMBL_IND_25459
type: DrugIndication
chembl id: CHEMBL_IND_25459
has molecule: CHEMBL796
highest development phase: 3
has mesh: D003704
has mesh heading: DEMENTIA
has EFO: EFO_0003862
has EFO name: DEMENTIA

CHEMBL_IND_25458
type: DrugIndication
chembl id: CHEMBL_IND_25458
has molecule: CHEMBL796
highest development phase: 3
has mesh: D001932
has mesh heading: BRAIN NEOPLASMS
has EFO: EFO_0003833
has EFO name: BRAIN NEOPLASM

CHEMBL_IND_47790
type: DrugIndication
chembl id: CHEMBL_IND_47790
has molecule: CHEMBL796
highest development phase: 1
has mesh: D005221
has mesh heading: FATIGUE
has EFO: HP_0012378
has EFO name: FATIGUE

CHEMBL_IND_26128
type: DrugIndication
chembl id: CHEMBL_IND_26128
has molecule: CHEMBL796
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_26127
type: DrugIndication
chembl id: CHEMBL_IND_26127
has molecule: CHEMBL796
highest development phase: 0
has mesh: D013313
has mesh heading: STRESS DISORDERS, POST-TRAUMATIC
has EFO: EFO_0001358
has EFO name: POST-TRAUMATIC STRESS DISORDER

CHEMBL_IND_26126
type: DrugIndication
chembl id: CHEMBL_IND_26126
has molecule: CHEMBL796
highest development phase: 2
has mesh: D009103
has mesh heading: MULTIPLE SCLEROSIS
has EFO: EFO_0003885
has EFO name: MULTIPLE SCLEROSIS

CHEMBL_IND_28459
type: DrugIndication
chembl id: CHEMBL_IND_28459
has molecule: CHEMBL796
highest development phase: 2
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_52134
type: DrugIndication
chembl id: CHEMBL_IND_52134
has molecule: CHEMBL796
highest development phase: 2
has mesh: D014029
has mesh heading: TOBACCO USE DISORDER
has EFO: EFO_0003768
has EFO name: NICOTINE DEPENDENCE

CHEMBL_IND_47494
type: DrugIndication
chembl id: CHEMBL_IND_47494
has molecule: CHEMBL796
highest development phase: 0
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_27813
type: DrugIndication
chembl id: CHEMBL_IND_27813
has molecule: CHEMBL796
highest development phase: 3
has mesh: D000755
has mesh heading: ANEMIA, SICKLE CELL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SICKLE CELL ANEMIA

CHEMBL_IND_24630
type: DrugIndication
chembl id: CHEMBL_IND_24630
has molecule: CHEMBL796
highest development phase: 3
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_24628
type: DrugIndication
chembl id: CHEMBL_IND_24628
has molecule: CHEMBL796
highest development phase: 2
has mesh: D019969
has mesh heading: AMPHETAMINE-RELATED DISORDERS
has EFO: EFO_0004701
has EFO name: METAMPHETAMINE DEPENDENCE

CHEMBL_IND_23497
type: DrugIndication
chembl id: CHEMBL_IND_23497
has molecule: CHEMBL796
highest development phase: 2
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_23496
type: DrugIndication
chembl id: CHEMBL_IND_23496
has molecule: CHEMBL796
highest development phase: 3
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_23494
type: DrugIndication
chembl id: CHEMBL_IND_23494
has molecule: CHEMBL796
highest development phase: 4
has mesh: D001289
has mesh heading: ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY
has EFO: EFO_0003888
has EFO name: ATTENTION DEFICIT HYPERACTIVITY DISORDER

CHEMBL_IND_41945
type: DrugIndication
chembl id: CHEMBL_IND_41945
has molecule: CHEMBL614
highest development phase: 4
has mesh: D014376
has mesh heading: TUBERCULOSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: TUBERCULOSIS

CHEMBL_IND_42762
type: DrugIndication
chembl id: CHEMBL_IND_42762
has molecule: CHEMBL614
highest development phase: 4
has mesh: D014397
has mesh heading: TUBERCULOSIS, PULMONARY
has EFO: EFO_1000049
has EFO name: PULMONARY TUBERCULOSIS

CHEMBL_IND_42978
type: DrugIndication
chembl id: CHEMBL_IND_42978
has molecule: CHEMBL46286
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_43441
type: DrugIndication
chembl id: CHEMBL_IND_43441
has molecule: CHEMBL46286
highest development phase: 3
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_46396
type: DrugIndication
chembl id: CHEMBL_IND_46396
has molecule: CHEMBL46286
highest development phase: 2
has mesh: D015464
has mesh heading: LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE
has EFO: EFO_0000339
has EFO name: CHRONIC MYELOGENOUS LEUKEMIA

CHEMBL_IND_46386
type: DrugIndication
chembl id: CHEMBL_IND_46386
has molecule: CHEMBL46286
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_46295
type: DrugIndication
chembl id: CHEMBL_IND_46295
has molecule: CHEMBL46286
highest development phase: 2
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_26581
type: DrugIndication
chembl id: CHEMBL_IND_26581
has molecule: CHEMBL902
highest development phase: 2
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_52321
type: DrugIndication
chembl id: CHEMBL_IND_52321
has molecule: CHEMBL902
highest development phase: 3
has mesh: D006471
has mesh heading: GASTROINTESTINAL HEMORRHAGE
has EFO: HP_0002239
has EFO name: GASTROINTESTINAL HEMORRHAGE

CHEMBL_IND_52231
type: DrugIndication
chembl id: CHEMBL_IND_52231
has molecule: CHEMBL902
highest development phase: 1
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_23176
type: DrugIndication
chembl id: CHEMBL_IND_23176
has molecule: CHEMBL902
highest development phase: 4
has mesh: D010437
has mesh heading: PEPTIC ULCER
has EFO: HP_0004398
has EFO name: PEPTIC ULCER

CHEMBL_IND_23175
type: DrugIndication
chembl id: CHEMBL_IND_23175
has molecule: CHEMBL902
highest development phase: 2
has mesh: D009069
has mesh heading: MOVEMENT DISORDERS
has EFO: EFO_0004280
has EFO name: MOVEMENT DISORDER

CHEMBL_IND_25314
type: DrugIndication
chembl id: CHEMBL_IND_25314
has molecule: CHEMBL902
highest development phase: 4
has mesh: D005764
has mesh heading: GASTROESOPHAGEAL REFLUX
has EFO: EFO_0003948
has EFO name: GASTROESOPHAGEAL REFLUX DISEASE

CHEMBL_IND_42988
type: DrugIndication
chembl id: CHEMBL_IND_42988
has molecule: CHEMBL29609
highest development phase: 4
has mesh: D014777
has mesh heading: VIRUS DISEASES
has EFO: EFO_0000763
has EFO name: VIRAL DISEASE

CHEMBL_IND_48146
type: DrugIndication
chembl id: CHEMBL_IND_48146
has molecule: CHEMBL29609
highest development phase: 2
has mesh: D018805
has mesh heading: SEPSIS
has EFO: EFO_0001420
has EFO name: SEPSIS

CHEMBL_IND_52789
type: DrugIndication
chembl id: CHEMBL_IND_52789
has molecule: CHEMBL871
highest development phase: 4
has mesh: D001847
has mesh heading: BONE DISEASES
has EFO: EFO_0004260
has EFO name: BONE DISEASE

CHEMBL_IND_27196
type: DrugIndication
chembl id: CHEMBL_IND_27196
has molecule: CHEMBL917
highest development phase: 2
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_49218
type: DrugIndication
chembl id: CHEMBL_IND_49218
has molecule: CHEMBL917
highest development phase: 2
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_46191
type: DrugIndication
chembl id: CHEMBL_IND_46191
has molecule: CHEMBL49429
highest development phase: 3
has mesh: D007010
has mesh heading: HYPONATREMIA
has EFO: HP_0002902
has EFO name: HYPONATREMIA

CHEMBL_IND_44525
type: DrugIndication
chembl id: CHEMBL_IND_44525
has molecule: CHEMBL49429
highest development phase: 2
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0000373
has EFO name: CONGESTIVE HEART FAILURE

CHEMBL_IND_49608
type: DrugIndication
chembl id: CHEMBL_IND_49608
has molecule: CHEMBL771
highest development phase: 3
has mesh: D016540
has mesh heading: SMOKING CESSATION
has EFO: EFO_0004319
has EFO name: SMOKING CESSATION

CHEMBL_IND_46643
type: DrugIndication
chembl id: CHEMBL_IND_46643
has molecule: CHEMBL771
highest development phase: 2
has mesh: D013313
has mesh heading: STRESS DISORDERS, POST-TRAUMATIC
has EFO: EFO_0001358
has EFO name: POST-TRAUMATIC STRESS DISORDER

CHEMBL_IND_46572
type: DrugIndication
chembl id: CHEMBL_IND_46572
has molecule: CHEMBL771
highest development phase: 3
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_49554
type: DrugIndication
chembl id: CHEMBL_IND_49554
has molecule: CHEMBL771
highest development phase: 2
has mesh: D019966
has mesh heading: SUBSTANCE-RELATED DISORDERS
has EFO: EFO_0003890
has EFO name: DRUG DEPENDENCE

CHEMBL_IND_46811
type: DrugIndication
chembl id: CHEMBL_IND_46811
has molecule: CHEMBL771
highest development phase: 2
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_48079
type: DrugIndication
chembl id: CHEMBL_IND_48079
has molecule: CHEMBL771
highest development phase: 2
has mesh: D020521
has mesh heading: STROKE
has EFO: EFO_0000712
has EFO name: STROKE

CHEMBL_IND_48351
type: DrugIndication
chembl id: CHEMBL_IND_48351
has molecule: CHEMBL771
highest development phase: 2
has mesh: D000428
has mesh heading: ALCOHOL DRINKING
has EFO: EFO_0004329
has EFO name: ALCOHOL DRINKING

CHEMBL_IND_48236
type: DrugIndication
chembl id: CHEMBL_IND_48236
has molecule: CHEMBL771
highest development phase: 1
has mesh: D014029
has mesh heading: TOBACCO USE DISORDER
has EFO: EFO_0003768
has EFO name: NICOTINE DEPENDENCE

CHEMBL_IND_47690
type: DrugIndication
chembl id: CHEMBL_IND_47690
has molecule: CHEMBL771
highest development phase: 3
has mesh: D016584
has mesh heading: PANIC DISORDER
has EFO: EFO_0004262
has EFO name: PANIC DISORDER

CHEMBL_IND_43316
type: DrugIndication
chembl id: CHEMBL_IND_43316
has molecule: CHEMBL771
highest development phase: 0
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_49762
type: DrugIndication
chembl id: CHEMBL_IND_49762
has molecule: CHEMBL771
highest development phase: 2
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_45087
type: DrugIndication
chembl id: CHEMBL_IND_45087
has molecule: CHEMBL771
highest development phase: 1
has mesh: D012891
has mesh heading: SLEEP APNEA SYNDROMES
has EFO: EFO_0003877
has EFO name: SLEEP APNEA

CHEMBL_IND_45028
type: DrugIndication
chembl id: CHEMBL_IND_45028
has molecule: CHEMBL771
highest development phase: 3
has mesh: D001321
has mesh heading: AUTISTIC DISORDER
has EFO: EFO_0003758
has EFO name: AUTISM

CHEMBL_IND_44940
type: DrugIndication
chembl id: CHEMBL_IND_44940
has molecule: CHEMBL771
highest development phase: 2
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_44069
type: DrugIndication
chembl id: CHEMBL_IND_44069
has molecule: CHEMBL771
highest development phase: 3
has mesh: D009771
has mesh heading: OBSESSIVE-COMPULSIVE DISORDER
has EFO: EFO_0004242
has EFO name: OBSESSIVE-COMPULSIVE DISORDER

CHEMBL_IND_44617
type: DrugIndication
chembl id: CHEMBL_IND_44617
has molecule: CHEMBL771
highest development phase: 2
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_42150
type: DrugIndication
chembl id: CHEMBL_IND_42150
has molecule: CHEMBL51149
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_50875
type: DrugIndication
chembl id: CHEMBL_IND_50875
has molecule: CHEMBL889
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_55170
type: DrugIndication
chembl id: CHEMBL_IND_55170
has molecule: CHEMBL889
highest development phase: 1
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_54930
type: DrugIndication
chembl id: CHEMBL_IND_54930
has molecule: CHEMBL889
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_54921
type: DrugIndication
chembl id: CHEMBL_IND_54921
has molecule: CHEMBL889
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_42237
type: DrugIndication
chembl id: CHEMBL_IND_42237
has molecule: CHEMBL47050
highest development phase: 4
has mesh: D011618
has mesh heading: PSYCHOTIC DISORDERS
has EFO: EFO_0005407
has EFO name: PSYCHOSIS

CHEMBL_IND_27610
type: DrugIndication
chembl id: CHEMBL_IND_27610
has molecule: CHEMBL908
highest development phase: 4
has mesh: D011618
has mesh heading: PSYCHOTIC DISORDERS
has EFO: EFO_0005407
has EFO name: PSYCHOSIS

CHEMBL_IND_50164
type: DrugIndication
chembl id: CHEMBL_IND_50164
has molecule: CHEMBL48582
highest development phase: 4
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_50550
type: DrugIndication
chembl id: CHEMBL_IND_50550
has molecule: CHEMBL42336
highest development phase: 3
has mesh: D008107
has mesh heading: LIVER DISEASES
has EFO: EFO_0001421
has EFO name: LIVER DISEASE

CHEMBL_IND_50655
type: DrugIndication
chembl id: CHEMBL_IND_50655
has molecule: CHEMBL42336
highest development phase: 1
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_55223
type: DrugIndication
chembl id: CHEMBL_IND_55223
has molecule: CHEMBL42336
highest development phase: 1
has mesh: D015746
has mesh heading: ABDOMINAL PAIN
has EFO: HP_0002027
has EFO name: ABDOMINAL PAIN

CHEMBL_IND_53716
type: DrugIndication
chembl id: CHEMBL_IND_53716
has molecule: CHEMBL42336
highest development phase: 2
has mesh: D017565
has mesh heading: SARCOIDOSIS, PULMONARY
has EFO: DOID:13406
has EFO name: PULMONARY SARCOIDOSIS

CHEMBL_IND_54484
type: DrugIndication
chembl id: CHEMBL_IND_54484
has molecule: CHEMBL42336
highest development phase: 1
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_50237
type: DrugIndication
chembl id: CHEMBL_IND_50237
has molecule: CHEMBL49642
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_55068
type: DrugIndication
chembl id: CHEMBL_IND_55068
has molecule: CHEMBL49642
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_54923
type: DrugIndication
chembl id: CHEMBL_IND_54923
has molecule: CHEMBL49642
highest development phase: 1
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_48703
type: DrugIndication
chembl id: CHEMBL_IND_48703
has molecule: CHEMBL843
highest development phase: 2
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_25625
type: DrugIndication
chembl id: CHEMBL_IND_25625
has molecule: CHEMBL843
highest development phase: 2
has mesh: D007972
has mesh heading: LEUKOPLAKIA, ORAL
has EFO: HP_0002745
has EFO name: ORAL LEUKOPLAKIA

CHEMBL_IND_23834
type: DrugIndication
chembl id: CHEMBL_IND_23834
has molecule: CHEMBL843
highest development phase: 4
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_23833
type: DrugIndication
chembl id: CHEMBL_IND_23833
has molecule: CHEMBL843
highest development phase: 1
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_24867
type: DrugIndication
chembl id: CHEMBL_IND_24867
has molecule: CHEMBL843
highest development phase: 2
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_44499
type: DrugIndication
chembl id: CHEMBL_IND_44499
has molecule: CHEMBL43068
highest development phase: 1
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_28114
type: DrugIndication
chembl id: CHEMBL_IND_28114
has molecule: CHEMBL898
highest development phase: 4
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_27648
type: DrugIndication
chembl id: CHEMBL_IND_27648
has molecule: CHEMBL898
highest development phase: 4
has mesh: D005334
has mesh heading: FEVER
has EFO: HP_0001945
has EFO name: FEVER

CHEMBL_IND_29111
type: DrugIndication
chembl id: CHEMBL_IND_29111
has molecule: CHEMBL44354
highest development phase: 4
has mesh: D059413
has mesh heading: INTRAABDOMINAL INFECTIONS

CHEMBL_IND_29241
type: DrugIndication
chembl id: CHEMBL_IND_29241
has molecule: CHEMBL44354
highest development phase: 4
has mesh: D014552
has mesh heading: URINARY TRACT INFECTIONS
has EFO: EFO_0003103
has EFO name: URINARY TRACT INFECTION

CHEMBL_IND_52130
type: DrugIndication
chembl id: CHEMBL_IND_52130
has molecule: CHEMBL44354
highest development phase: 3
has mesh: D011014
has mesh heading: PNEUMONIA
has EFO: EFO_0003106
has EFO name: PNEUMONIA

CHEMBL_IND_51601
type: DrugIndication
chembl id: CHEMBL_IND_51601
has molecule: CHEMBL44354
highest development phase: 4
has mesh: D011704
has mesh heading: PYELONEPHRITIS
has EFO: EFO_1001141
has EFO name: PYELONEPHRITIS

CHEMBL_IND_45676
type: DrugIndication
chembl id: CHEMBL_IND_45676
has molecule: CHEMBL42161
highest development phase: 2
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_54569
type: DrugIndication
chembl id: CHEMBL_IND_54569
has molecule: CHEMBL42161
highest development phase: 2
has mesh: D018316
has mesh heading: GLIOSARCOMA
has EFO: EFO_1001465
has EFO name: GLIOSARCOMA

CHEMBL_IND_49653
type: DrugIndication
chembl id: CHEMBL_IND_49653
has molecule: CHEMBL52440
highest development phase: 3
has mesh: D011507
has mesh heading: PROTEINURIA
has EFO: HP_0000093
has EFO name: PROTEINURIA

CHEMBL_IND_49622
type: DrugIndication
chembl id: CHEMBL_IND_49622
has molecule: CHEMBL52440
highest development phase: 3
has mesh: D009293
has mesh heading: OPIOID-RELATED DISORDERS
has EFO: EFO_0005611
has EFO name: OPIOID DEPENDENCE

CHEMBL_IND_40565
type: DrugIndication
chembl id: CHEMBL_IND_40565
has molecule: CHEMBL52440
highest development phase: 2
has mesh: D015518
has mesh heading: RETT SYNDROME
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: RETT SYNDROME

CHEMBL_IND_48383
type: DrugIndication
chembl id: CHEMBL_IND_48383
has molecule: CHEMBL52440
highest development phase: 2
has mesh: D009437
has mesh heading: NEURALGIA
has EFO: EFO_0005762
has EFO name: NEUROPATHIC PAIN

CHEMBL_IND_45680
type: DrugIndication
chembl id: CHEMBL_IND_45680
has molecule: CHEMBL52440
highest development phase: 2
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_42140
type: DrugIndication
chembl id: CHEMBL_IND_42140
has molecule: CHEMBL52440
highest development phase: 4
has mesh: D003371
has mesh heading: COUGH
has EFO: HP_0012735
has EFO name: COUGH

CHEMBL_IND_46214
type: DrugIndication
chembl id: CHEMBL_IND_46214
has molecule: CHEMBL52440
highest development phase: 1
has mesh: D060825
has mesh heading: MILD COGNITIVE IMPAIRMENT
has EFO: HP_0100543
has EFO name: COGNITIVE IMPAIRMENT

CHEMBL_IND_47559
type: DrugIndication
chembl id: CHEMBL_IND_47559
has molecule: CHEMBL52440
highest development phase: 2
has mesh: D010523
has mesh heading: PERIPHERAL NERVOUS SYSTEM DISEASES
has EFO: EFO_0003100
has EFO name: PERIPHERAL NEUROPATHY

CHEMBL_IND_41537
type: DrugIndication
chembl id: CHEMBL_IND_41537
has molecule: CHEMBL926
highest development phase: 3
has mesh: D013771
has mesh heading: TETRALOGY OF FALLOT
has EFO: HP_0001636
has EFO name: TETRALOGY OF FALLOT

CHEMBL_IND_47744
type: DrugIndication
chembl id: CHEMBL_IND_47744
has molecule: CHEMBL926
highest development phase: 2
has mesh: D012772
has mesh heading: SHOCK, SEPTIC
has EFO: EFO_0006834
has EFO name: SEPTIC SHOCK

CHEMBL_IND_42822
type: DrugIndication
chembl id: CHEMBL_IND_42822
has molecule: CHEMBL926
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_42500
type: DrugIndication
chembl id: CHEMBL_IND_42500
has molecule: CHEMBL31601
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_44757
type: DrugIndication
chembl id: CHEMBL_IND_44757
has molecule: CHEMBL29404
highest development phase: 2
has mesh: D020521
has mesh heading: STROKE
has EFO: EFO_0000712
has EFO name: STROKE

CHEMBL_IND_43890
type: DrugIndication
chembl id: CHEMBL_IND_43890
has molecule: CHEMBL878
highest development phase: 2
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0003144
has EFO name: HEART FAILURE

CHEMBL_IND_24640
type: DrugIndication
chembl id: CHEMBL_IND_24640
has molecule: CHEMBL878
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_41925
type: DrugIndication
chembl id: CHEMBL_IND_41925
has molecule: CHEMBL32800
highest development phase: 4
has mesh: D008173
has mesh heading: LUNG DISEASES, OBSTRUCTIVE
has EFO: HP_0006536
has EFO name: OBSTRUCTIVE LUNG DISEASE

CHEMBL_IND_43191
type: DrugIndication
chembl id: CHEMBL_IND_43191
has molecule: CHEMBL32800
highest development phase: 3
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_42436
type: DrugIndication
chembl id: CHEMBL_IND_42436
has molecule: CHEMBL880
highest development phase: 4
has mesh: D006562
has mesh heading: HERPES ZOSTER
has EFO: EFO_0006510
has EFO name: HERPES ZOSTER

CHEMBL_IND_48391
type: DrugIndication
chembl id: CHEMBL_IND_48391
has molecule: CHEMBL880
highest development phase: 3
has mesh: D008575
has mesh heading: MENIERE DISEASE
has EFO: EFO_0006862
has EFO name: MENIERE DISEASE

CHEMBL_IND_41867
type: DrugIndication
chembl id: CHEMBL_IND_41867
has molecule: CHEMBL880
highest development phase: 4
has mesh: D006558
has mesh heading: HERPES GENITALIS
has EFO: EFO_0007282
has EFO name: GENITAL HERPES

CHEMBL_IND_42276
type: DrugIndication
chembl id: CHEMBL_IND_42276
has molecule: CHEMBL880
highest development phase: 4
has mesh: D006560
has mesh heading: HERPES LABIALIS
has EFO: EFO_1001347
has EFO name: HERPES LABIALIS

CHEMBL_IND_42708
type: DrugIndication
chembl id: CHEMBL_IND_42708
has molecule: CHEMBL880
highest development phase: 4
has mesh: D014777
has mesh heading: VIRUS DISEASES
has EFO: EFO_0000763
has EFO name: VIRAL DISEASE

CHEMBL_IND_47112
type: DrugIndication
chembl id: CHEMBL_IND_47112
has molecule: CHEMBL865
highest development phase: 2
has mesh: D010195
has mesh heading: PANCREATITIS
has EFO: EFO_0000278
has EFO name: PANCREATITIS

CHEMBL_IND_25703
type: DrugIndication
chembl id: CHEMBL_IND_25703
has molecule: CHEMBL865
highest development phase: 3
has mesh: D010003
has mesh heading: OSTEOARTHRITIS
has EFO: EFO_0002506
has EFO name: OSTEOARTHRITIS

CHEMBL_IND_41853
type: DrugIndication
chembl id: CHEMBL_IND_41853
has molecule: CHEMBL865
highest development phase: 4
has mesh: D012216
has mesh heading: RHEUMATIC DISEASES
has EFO: EFO_0005755
has EFO name: RHEUMATIC DISEASE

CHEMBL_IND_24013
type: DrugIndication
chembl id: CHEMBL_IND_24013
has molecule: CHEMBL865
highest development phase: 3
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_26231
type: DrugIndication
chembl id: CHEMBL_IND_26231
has molecule: CHEMBL969
highest development phase: 4
has mesh: D001007
has mesh heading: ANXIETY
has EFO: EFO_0005230
has EFO name: ANXIETY

CHEMBL_IND_42318
type: DrugIndication
chembl id: CHEMBL_IND_42318
has molecule: CHEMBL852
highest development phase: 4
has mesh: D002277
has mesh heading: CARCINOMA
has EFO: EFO_0000313
has EFO name: CARCINOMA

CHEMBL_IND_49363
type: DrugIndication
chembl id: CHEMBL_IND_49363
has molecule: CHEMBL852
highest development phase: 3
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_48551
type: DrugIndication
chembl id: CHEMBL_IND_48551
has molecule: CHEMBL852
highest development phase: 2
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_46426
type: DrugIndication
chembl id: CHEMBL_IND_46426
has molecule: CHEMBL852
highest development phase: 3
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000389
has EFO name: CUTANEOUS MELANOMA

CHEMBL_IND_42207
type: DrugIndication
chembl id: CHEMBL_IND_42207
has molecule: CHEMBL852
highest development phase: 4
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_47294
type: DrugIndication
chembl id: CHEMBL_IND_47294
has molecule: CHEMBL852
highest development phase: 2
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_51945
type: DrugIndication
chembl id: CHEMBL_IND_51945
has molecule: CHEMBL852
highest development phase: 2
has mesh: D012175
has mesh heading: RETINOBLASTOMA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: RETINOBLASTOMA

CHEMBL_IND_45552
type: DrugIndication
chembl id: CHEMBL_IND_45552
has molecule: CHEMBL58547
highest development phase: 2
has mesh: D004066
has mesh heading: DIGESTIVE SYSTEM DISEASES
has EFO: EFO_0000405
has EFO name: DIGESTIVE SYSTEM DISEASE

CHEMBL_IND_44519
type: DrugIndication
chembl id: CHEMBL_IND_44519
has molecule: CHEMBL64130
highest development phase: 3
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_44483
type: DrugIndication
chembl id: CHEMBL_IND_44483
has molecule: CHEMBL64130
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_50044
type: DrugIndication
chembl id: CHEMBL_IND_50044
has molecule: CHEMBL64195
highest development phase: 4
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_26913
type: DrugIndication
chembl id: CHEMBL_IND_26913
has molecule: CHEMBL967
highest development phase: 4
has mesh: D007319
has mesh heading: SLEEP INITIATION AND MAINTENANCE DISORDERS
has EFO: EFO_0004698
has EFO name: INSOMNIA

CHEMBL_IND_26295
type: DrugIndication
chembl id: CHEMBL_IND_26295
has molecule: CHEMBL832
highest development phase: 4
has mesh: D006073
has mesh heading: GOUT
has EFO: EFO_0004274
has EFO name: GOUT

CHEMBL_IND_24294
type: DrugIndication
chembl id: CHEMBL_IND_24294
has molecule: CHEMBL61593
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_42615
type: DrugIndication
chembl id: CHEMBL_IND_42615
has molecule: CHEMBL857
highest development phase: 4
has mesh: D018798
has mesh heading: ANEMIA, IRON-DEFICIENCY
has EFO: HP_0001891
has EFO name: IRON DEFICIENCY ANEMIA

CHEMBL_IND_42545
type: DrugIndication
chembl id: CHEMBL_IND_42545
has molecule: CHEMBL857
highest development phase: 4
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_45983
type: DrugIndication
chembl id: CHEMBL_IND_45983
has molecule: CHEMBL857
highest development phase: 3
has mesh: D009103
has mesh heading: MULTIPLE SCLEROSIS
has EFO: EFO_0003885
has EFO name: MULTIPLE SCLEROSIS

CHEMBL_IND_51612
type: DrugIndication
chembl id: CHEMBL_IND_51612
has molecule: CHEMBL857
highest development phase: 4
has mesh: D000740
has mesh heading: ANEMIA
has EFO: EFO_0004272
has EFO name: ANEMIA

CHEMBL_IND_47013
type: DrugIndication
chembl id: CHEMBL_IND_47013
has molecule: CHEMBL60889
highest development phase: 3
has mesh: D003248
has mesh heading: CONSTIPATION
has EFO: HP_0002019
has EFO name: CONSTIPATION

CHEMBL_IND_46481
type: DrugIndication
chembl id: CHEMBL_IND_46481
has molecule: CHEMBL60889
highest development phase: 3
has mesh: D043183
has mesh heading: IRRITABLE BOWEL SYNDROME
has EFO: EFO_0000555
has EFO name: IRRITABLE BOWEL SYNDROME

CHEMBL_IND_49626
type: DrugIndication
chembl id: CHEMBL_IND_49626
has molecule: CHEMBL59356
highest development phase: 2
has mesh: D054058
has mesh heading: ACUTE CORONARY SYNDROME
has EFO: EFO_0005672
has EFO name: ACUTE CORONARY SYNDROME

CHEMBL_IND_47958
type: DrugIndication
chembl id: CHEMBL_IND_47958
has molecule: CHEMBL59356
highest development phase: 2
has mesh: D003324
has mesh heading: CORONARY ARTERY DISEASE
has EFO: EFO_0000378
has EFO name: CORONARY ARTERY DISEASE

CHEMBL_IND_47656
type: DrugIndication
chembl id: CHEMBL_IND_47656
has molecule: CHEMBL59356
highest development phase: 2
has mesh: D050197
has mesh heading: ATHEROSCLEROSIS
has EFO: EFO_0003914
has EFO name: ATHEROSCLEROSIS

CHEMBL_IND_50122
type: DrugIndication
chembl id: CHEMBL_IND_50122
has molecule: CHEMBL56564
highest development phase: 4
has mesh: D009325
has mesh heading: NAUSEA
has EFO: HP_0002018
has EFO name: NAUSEA

CHEMBL_IND_53345
type: DrugIndication
chembl id: CHEMBL_IND_53345
has molecule: CHEMBL56564
highest development phase: 2
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_53965
type: DrugIndication
chembl id: CHEMBL_IND_53965
has molecule: CHEMBL1016
highest development phase: 3
has mesh: D001024
has mesh heading: AORTIC VALVE STENOSIS
has EFO: EFO_0000266
has EFO name: AORTIC STENOSIS

CHEMBL_IND_48852
type: DrugIndication
chembl id: CHEMBL_IND_48852
has molecule: CHEMBL1016
highest development phase: 3
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0003144
has EFO name: HEART FAILURE

CHEMBL_IND_54060
type: DrugIndication
chembl id: CHEMBL_IND_54060
has molecule: CHEMBL1016
highest development phase: 2
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_49423
type: DrugIndication
chembl id: CHEMBL_IND_49423
has molecule: CHEMBL1016
highest development phase: 3
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_54272
type: DrugIndication
chembl id: CHEMBL_IND_54272
has molecule: CHEMBL1016
highest development phase: 2
has mesh: D006526
has mesh heading: HEPATITIS C
has EFO: EFO_0003047
has EFO name: HEPATITIS C INFECTION

CHEMBL_IND_48763
type: DrugIndication
chembl id: CHEMBL_IND_48763
has molecule: CHEMBL1016
highest development phase: 3
has mesh: D003922
has mesh heading: DIABETES MELLITUS, TYPE 1
has EFO: EFO_0001359
has EFO name: TYPE I DIABETES MELLITUS

CHEMBL_IND_52902
type: DrugIndication
chembl id: CHEMBL_IND_52902
has molecule: CHEMBL1016
highest development phase: 3
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0000373
has EFO name: CONGESTIVE HEART FAILURE

CHEMBL_IND_43391
type: DrugIndication
chembl id: CHEMBL_IND_43391
has molecule: CHEMBL1016
highest development phase: 3
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_54581
type: DrugIndication
chembl id: CHEMBL_IND_54581
has molecule: CHEMBL1016
highest development phase: 2
has mesh: D060825
has mesh heading: MILD COGNITIVE IMPAIRMENT
has EFO: HP_0100543
has EFO name: COGNITIVE IMPAIRMENT

CHEMBL_IND_54563
type: DrugIndication
chembl id: CHEMBL_IND_54563
has molecule: CHEMBL1016
highest development phase: 1
has mesh: D006519
has mesh heading: HEPATITIS, ALCOHOLIC
has EFO: EFO_1001345
has EFO name: HEPATITIS, ALCOHOLIC

CHEMBL_IND_54537
type: DrugIndication
chembl id: CHEMBL_IND_54537
has molecule: CHEMBL1016
highest development phase: 1
has mesh: D019969
has mesh heading: AMPHETAMINE-RELATED DISORDERS
has EFO: EFO_0004701
has EFO name: METAMPHETAMINE DEPENDENCE

CHEMBL_IND_54405
type: DrugIndication
chembl id: CHEMBL_IND_54405
has molecule: CHEMBL1016
highest development phase: 0
has mesh: D001471
has mesh heading: BARRETT ESOPHAGUS
has EFO: EFO_0000280
has EFO name: BARRETT'S ESOPHAGUS

CHEMBL_IND_42651
type: DrugIndication
chembl id: CHEMBL_IND_42651
has molecule: CHEMBL1016
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_45956
type: DrugIndication
chembl id: CHEMBL_IND_45956
has molecule: CHEMBL75124
highest development phase: 3
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_54267
type: DrugIndication
chembl id: CHEMBL_IND_54267
has molecule: CHEMBL75133
highest development phase: 1
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_26730
type: DrugIndication
chembl id: CHEMBL_IND_26730
has molecule: CHEMBL1029
highest development phase: 2
has mesh: D003550
has mesh heading: CYSTIC FIBROSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CYSTIC FIBROSIS

CHEMBL_IND_26144
type: DrugIndication
chembl id: CHEMBL_IND_26144
has molecule: CHEMBL1029
highest development phase: 3
has mesh: D005776
has mesh heading: GAUCHER DISEASE
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: GAUCHER DISEASE

CHEMBL_IND_24654
type: DrugIndication
chembl id: CHEMBL_IND_24654
has molecule: CHEMBL1029
highest development phase: 3
has mesh: D052556
has mesh heading: NIEMANN-PICK DISEASE, TYPE C
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: NIEMANN-PICK DISEASE TYPE C

CHEMBL_IND_50222
type: DrugIndication
chembl id: CHEMBL_IND_50222
has molecule: CHEMBL73822
highest development phase: 3
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000292
has EFO name: BLADDER CARCINOMA

CHEMBL_IND_43019
type: DrugIndication
chembl id: CHEMBL_IND_43019
has molecule: CHEMBL53904
highest development phase: 4
has mesh: D011618
has mesh heading: PSYCHOTIC DISORDERS
has EFO: EFO_0005407
has EFO name: PSYCHOSIS

CHEMBL_IND_52581
type: DrugIndication
chembl id: CHEMBL_IND_52581
has molecule: CHEMBL928
highest development phase: 1
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_46040
type: DrugIndication
chembl id: CHEMBL_IND_46040
has molecule: CHEMBL995
highest development phase: 2
has mesh: D057765
has mesh heading: EOSINOPHILIC ESOPHAGITIS
has EFO: EFO_0004232
has EFO name: EOSINOPHILIC ESOPHAGITIS

CHEMBL_IND_23439
type: DrugIndication
chembl id: CHEMBL_IND_23439
has molecule: CHEMBL995
highest development phase: 3
has mesh: D008382
has mesh heading: MARFAN SYNDROME
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: MARFAN SYNDROME

CHEMBL_IND_23437
type: DrugIndication
chembl id: CHEMBL_IND_23437
has molecule: CHEMBL995
highest development phase: 4
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_24599
type: DrugIndication
chembl id: CHEMBL_IND_24599
has molecule: CHEMBL995
highest development phase: 3
has mesh: D011507
has mesh heading: PROTEINURIA
has EFO: HP_0000093
has EFO name: PROTEINURIA

CHEMBL_IND_27249
type: DrugIndication
chembl id: CHEMBL_IND_27249
has molecule: CHEMBL1025
highest development phase: 4
has mesh: D005901
has mesh heading: GLAUCOMA
has EFO: EFO_0000516
has EFO name: GLAUCOMA

CHEMBL_IND_46211
type: DrugIndication
chembl id: CHEMBL_IND_46211
has molecule: CHEMBL1021
highest development phase: 2
has mesh: D008269
has mesh heading: MACULAR EDEMA
has EFO: HP_0040049
has EFO name: MACULAR EDEMA

CHEMBL_IND_27337
type: DrugIndication
chembl id: CHEMBL_IND_27337
has molecule: CHEMBL1021
highest development phase: 4
has mesh: D005128
has mesh heading: EYE DISEASES
has EFO: EFO_0005752
has EFO name: EYE INFLAMMATION

CHEMBL_IND_24698
type: DrugIndication
chembl id: CHEMBL_IND_24698
has molecule: CHEMBL1021
highest development phase: 4
has mesh: D002386
has mesh heading: CATARACT
has EFO: EFO_0001059
has EFO name: CATARACT

CHEMBL_IND_23563
type: DrugIndication
chembl id: CHEMBL_IND_23563
has molecule: CHEMBL1021
highest development phase: 2
has mesh: D003930
has mesh heading: DIABETIC RETINOPATHY
has EFO: EFO_0003770
has EFO name: DIABETIC RETINOPATHY

CHEMBL_IND_43851
type: DrugIndication
chembl id: CHEMBL_IND_43851
has molecule: CHEMBL925
highest development phase: 2
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_42043
type: DrugIndication
chembl id: CHEMBL_IND_42043
has molecule: CHEMBL925
highest development phase: 4
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_52121
type: DrugIndication
chembl id: CHEMBL_IND_52121
has molecule: CHEMBL925
highest development phase: 1
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_44013
type: DrugIndication
chembl id: CHEMBL_IND_44013
has molecule: CHEMBL924
highest development phase: 1
has mesh: D008593
has mesh heading: MENOPAUSE
has EFO: EFO_0003922
has EFO name: MENOPAUSE

CHEMBL_IND_26979
type: DrugIndication
chembl id: CHEMBL_IND_26979
has molecule: CHEMBL924
highest development phase: 2
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0002890
has EFO name: RENAL CARCINOMA

CHEMBL_IND_26978
type: DrugIndication
chembl id: CHEMBL_IND_26978
has molecule: CHEMBL924
highest development phase: 3
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_26977
type: DrugIndication
chembl id: CHEMBL_IND_26977
has molecule: CHEMBL924
highest development phase: 3
has mesh: D001851
has mesh heading: BONE DISEASES, METABOLIC
has EFO: HP_0000938
has EFO name: OSTEOPENIA

CHEMBL_IND_26976
type: DrugIndication
chembl id: CHEMBL_IND_26976
has molecule: CHEMBL924
highest development phase: 2
has mesh: D009303
has mesh heading: NASOPHARYNGEAL NEOPLASMS
has EFO: EFO_0004252
has EFO name: NASOPHARYNGEAL NEOPLASM

CHEMBL_IND_26975
type: DrugIndication
chembl id: CHEMBL_IND_26975
has molecule: CHEMBL924
highest development phase: 3
has mesh: D012512
has mesh heading: SARCOMA, EWING
has EFO: EFO_0000174
has EFO name: EWING SARCOMA

CHEMBL_IND_25738
type: DrugIndication
chembl id: CHEMBL_IND_25738
has molecule: CHEMBL924
highest development phase: 4
has mesh: D015663
has mesh heading: OSTEOPOROSIS, POSTMENOPAUSAL
has EFO: EFO_0003854
has EFO name: POSTMENOPAUSAL OSTEOPOROSIS

CHEMBL_IND_25737
type: DrugIndication
chembl id: CHEMBL_IND_25737
has molecule: CHEMBL924
highest development phase: 3
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_25736
type: DrugIndication
chembl id: CHEMBL_IND_25736
has molecule: CHEMBL924
highest development phase: 2
has mesh: D008654
has mesh heading: MESOTHELIOMA
has EFO: EFO_0000588
has EFO name: MESOTHELIOMA

CHEMBL_IND_52538
type: DrugIndication
chembl id: CHEMBL_IND_52538
has molecule: CHEMBL924
highest development phase: 2
has mesh: D012019
has mesh heading: REFLEX SYMPATHETIC DYSTROPHY
has EFO: EFO_1001147
has EFO name: REFLEX SYMPATHETIC DYSTROPHY

CHEMBL_IND_45650
type: DrugIndication
chembl id: CHEMBL_IND_45650
has molecule: CHEMBL924
highest development phase: 3
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_48171
type: DrugIndication
chembl id: CHEMBL_IND_48171
has molecule: CHEMBL924
highest development phase: 2
has mesh: D055728
has mesh heading: PRIMARY MYELOFIBROSIS
has EFO: EFO_0002430
has EFO name: PRIMARY MYELOFIBROSIS

CHEMBL_IND_40790
type: DrugIndication
chembl id: CHEMBL_IND_40790
has molecule: CHEMBL924
highest development phase: 2
has mesh: D017086
has mesh heading: BETA-THALASSEMIA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: BETA-THALASSEMIA

CHEMBL_IND_28455
type: DrugIndication
chembl id: CHEMBL_IND_28455
has molecule: CHEMBL924
highest development phase: 3
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_47153
type: DrugIndication
chembl id: CHEMBL_IND_47153
has molecule: CHEMBL924
highest development phase: 2
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_27512
type: DrugIndication
chembl id: CHEMBL_IND_27512
has molecule: CHEMBL924
highest development phase: 1
has mesh: D000755
has mesh heading: ANEMIA, SICKLE CELL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SICKLE CELL ANEMIA

CHEMBL_IND_40072
type: DrugIndication
chembl id: CHEMBL_IND_40072
has molecule: CHEMBL924
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0003869
has EFO name: BREAST NEOPLASM

CHEMBL_IND_27993
type: DrugIndication
chembl id: CHEMBL_IND_27993
has molecule: CHEMBL924
highest development phase: 3
has mesh: D001172
has mesh heading: ARTHRITIS, RHEUMATOID
has EFO: EFO_0000685
has EFO name: RHEUMATOID ARTHRITIS

CHEMBL_IND_47399
type: DrugIndication
chembl id: CHEMBL_IND_47399
has molecule: CHEMBL924
highest development phase: 2
has mesh: D002583
has mesh heading: UTERINE CERVICAL NEOPLASMS
has EFO: EFO_0001061
has EFO name: CERVICAL CARCINOMA

CHEMBL_IND_25024
type: DrugIndication
chembl id: CHEMBL_IND_25024
has molecule: CHEMBL924
highest development phase: 2
has mesh: D010020
has mesh heading: OSTEONECROSIS
has EFO: EFO_0004259
has EFO name: OSTEONECROSIS

CHEMBL_IND_25023
type: DrugIndication
chembl id: CHEMBL_IND_25023
has molecule: CHEMBL924
highest development phase: 3
has mesh: D010013
has mesh heading: OSTEOGENESIS IMPERFECTA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: OSTEOGENESIS IMPERFECTA

CHEMBL_IND_51593
type: DrugIndication
chembl id: CHEMBL_IND_51593
has molecule: CHEMBL924
highest development phase: 4
has mesh: D001847
has mesh heading: BONE DISEASES
has EFO: EFO_0004260
has EFO name: BONE DISEASE

CHEMBL_IND_24086
type: DrugIndication
chembl id: CHEMBL_IND_24086
has molecule: CHEMBL924
highest development phase: 3
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_24085
type: DrugIndication
chembl id: CHEMBL_IND_24085
has molecule: CHEMBL924
highest development phase: 2
has mesh: D012516
has mesh heading: OSTEOSARCOMA
has EFO: EFO_0000637
has EFO name: OSTEOSARCOMA

CHEMBL_IND_24084
type: DrugIndication
chembl id: CHEMBL_IND_24084
has molecule: CHEMBL924
highest development phase: 4
has mesh: D010024
has mesh heading: OSTEOPOROSIS
has EFO: EFO_0003882
has EFO name: OSTEOPOROSIS

CHEMBL_IND_24081
type: DrugIndication
chembl id: CHEMBL_IND_24081
has molecule: CHEMBL924
highest development phase: 4
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_24080
type: DrugIndication
chembl id: CHEMBL_IND_24080
has molecule: CHEMBL924
highest development phase: 2
has mesh: D002583
has mesh heading: UTERINE CERVICAL NEOPLASMS
has EFO: EFO_0001416
has EFO name: CERVICAL ADENOCARCINOMA

CHEMBL_IND_24079
type: DrugIndication
chembl id: CHEMBL_IND_24079
has molecule: CHEMBL924
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_24078
type: DrugIndication
chembl id: CHEMBL_IND_24078
has molecule: CHEMBL924
highest development phase: 1
has mesh: D000230
has mesh heading: ADENOCARCINOMA
has EFO: EFO_0000228
has EFO name: ADENOCARCINOMA

CHEMBL_IND_50847
type: DrugIndication
chembl id: CHEMBL_IND_50847
has molecule: CHEMBL71595
highest development phase: 1
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_50045
type: DrugIndication
chembl id: CHEMBL_IND_50045
has molecule: CHEMBL71595
highest development phase: 4
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_26669
type: DrugIndication
chembl id: CHEMBL_IND_26669
has molecule: CHEMBL1009
highest development phase: 3
has mesh: D012148
has mesh heading: RESTLESS LEGS SYNDROME
has EFO: EFO_0004270
has EFO name: RESTLESS LEGS SYNDROME

CHEMBL_IND_26668
type: DrugIndication
chembl id: CHEMBL_IND_26668
has molecule: CHEMBL1009
highest development phase: 2
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_27769
type: DrugIndication
chembl id: CHEMBL_IND_27769
has molecule: CHEMBL1009
highest development phase: 3
has mesh: D020521
has mesh heading: STROKE
has EFO: EFO_0000712
has EFO name: STROKE

CHEMBL_IND_23406
type: DrugIndication
chembl id: CHEMBL_IND_23406
has molecule: CHEMBL1009
highest development phase: 4
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_42573
type: DrugIndication
chembl id: CHEMBL_IND_42573
has molecule: CHEMBL87045
highest development phase: 4
has mesh: D001145
has mesh heading: ARRHYTHMIAS, CARDIAC
has EFO: EFO_0004269
has EFO name: CARDIAC ARRHYTHMIA

CHEMBL_IND_44117
type: DrugIndication
chembl id: CHEMBL_IND_44117
has molecule: CHEMBL79686
highest development phase: 2
has mesh: D004381
has mesh heading: DUODENAL ULCER
has EFO: EFO_0004607
has EFO name: DUODENAL ULCER

CHEMBL_IND_44134
type: DrugIndication
chembl id: CHEMBL_IND_44134
has molecule: CHEMBL84158
highest development phase: 3
has mesh: D005879
has mesh heading: TOURETTE SYNDROME
has EFO: EFO_0004895
has EFO name: TOURETTE SYNDROME

CHEMBL_IND_50051
type: DrugIndication
chembl id: CHEMBL_IND_50051
has molecule: CHEMBL1065
highest development phase: 4
has mesh: D008881
has mesh heading: MIGRAINE DISORDERS
has EFO: EFO_0003821
has EFO name: MIGRAINE DISORDER

CHEMBL_IND_46616
type: DrugIndication
chembl id: CHEMBL_IND_46616
has molecule: CHEMBL991
highest development phase: 3
has mesh: D000163
has mesh heading: ACQUIRED IMMUNODEFICIENCY SYNDROME
has EFO: EFO_0000765
has EFO name: AIDS

CHEMBL_IND_24679
type: DrugIndication
chembl id: CHEMBL_IND_24679
has molecule: CHEMBL1070
highest development phase: 4
has mesh: D012216
has mesh heading: RHEUMATIC DISEASES
has EFO: EFO_0005755
has EFO name: RHEUMATIC DISEASE

CHEMBL_IND_23234
type: DrugIndication
chembl id: CHEMBL_IND_23234
has molecule: CHEMBL1073
highest development phase: 4
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_23233
type: DrugIndication
chembl id: CHEMBL_IND_23233
has molecule: CHEMBL1073
highest development phase: 3
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_53572
type: DrugIndication
chembl id: CHEMBL_IND_53572
has molecule: CHEMBL87563
highest development phase: 3
has mesh: D008107
has mesh heading: LIVER DISEASES
has EFO: EFO_0001421
has EFO name: LIVER DISEASE

CHEMBL_IND_42238
type: DrugIndication
chembl id: CHEMBL_IND_42238
has molecule: CHEMBL87385
highest development phase: 4
has mesh: D011618
has mesh heading: PSYCHOTIC DISORDERS
has EFO: EFO_0005407
has EFO name: PSYCHOSIS

CHEMBL_IND_46995
type: DrugIndication
chembl id: CHEMBL_IND_46995
has molecule: CHEMBL1051
highest development phase: 4
has mesh: D009798
has mesh heading: OCULAR HYPERTENSION
has EFO: EFO_1001069
has EFO name: OCULAR HYPERTENSION

CHEMBL_IND_23391
type: DrugIndication
chembl id: CHEMBL_IND_23391
has molecule: CHEMBL1051
highest development phase: 4
has mesh: D005901
has mesh heading: GLAUCOMA
has EFO: EFO_0000516
has EFO name: GLAUCOMA

CHEMBL_IND_49529
type: DrugIndication
chembl id: CHEMBL_IND_49529
has molecule: CHEMBL69308
highest development phase: 3
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_48697
type: DrugIndication
chembl id: CHEMBL_IND_48697
has molecule: CHEMBL69308
highest development phase: 3
has mesh: D001172
has mesh heading: ARTHRITIS, RHEUMATOID
has EFO: EFO_0000685
has EFO name: RHEUMATOID ARTHRITIS

CHEMBL_IND_52309
type: DrugIndication
chembl id: CHEMBL_IND_52309
has molecule: CHEMBL998
highest development phase: 2
has mesh: D012221
has mesh heading: RHINITIS, ALLERGIC, PERENNIAL
has EFO: EFO_1001417
has EFO name: RHINITIS, ALLERGIC, PERENNIAL

CHEMBL_IND_25431
type: DrugIndication
chembl id: CHEMBL_IND_25431
has molecule: CHEMBL998
highest development phase: 4
has mesh: D006967
has mesh heading: HYPERSENSITIVITY
has EFO: EFO_0003785
has EFO name: ALLERGY

CHEMBL_IND_27779
type: DrugIndication
chembl id: CHEMBL_IND_27779
has molecule: CHEMBL998
highest development phase: 2
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_24598
type: DrugIndication
chembl id: CHEMBL_IND_24598
has molecule: CHEMBL998
highest development phase: 3
has mesh: D006255
has mesh heading: RHINITIS, ALLERGIC, SEASONAL
has EFO: EFO_0003956
has EFO name: SEASONAL ALLERGIC RHINITIS

CHEMBL_IND_27859
type: DrugIndication
chembl id: CHEMBL_IND_27859
has molecule: CHEMBL1071
highest development phase: 4
has mesh: D012216
has mesh heading: RHEUMATIC DISEASES
has EFO: EFO_0005755
has EFO name: RHEUMATIC DISEASE

CHEMBL_IND_43442
type: DrugIndication
chembl id: CHEMBL_IND_43442
has molecule: CHEMBL77517
highest development phase: 2
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_42612
type: DrugIndication
chembl id: CHEMBL_IND_42612
has molecule: CHEMBL986
highest development phase: 4
has mesh: D015508
has mesh heading: NASAL OBSTRUCTION
has EFO: HP_0001742
has EFO name: NASAL OBSTRUCTION

CHEMBL_IND_52475
type: DrugIndication
chembl id: CHEMBL_IND_52475
has molecule: CHEMBL986
highest development phase: 3
has mesh: D008288
has mesh heading: MALARIA
has EFO: EFO_0001068
has EFO name: MALARIA

CHEMBL_IND_47774
type: DrugIndication
chembl id: CHEMBL_IND_47774
has molecule: CHEMBL986
highest development phase: 3
has mesh: D003967
has mesh heading: DIARRHEA
has EFO: HP_0002014
has EFO name: DIARRHEA

CHEMBL_IND_41807
type: DrugIndication
chembl id: CHEMBL_IND_41807
has molecule: CHEMBL986
highest development phase: 4
has mesh: D000152
has mesh heading: ACNE VULGARIS
has EFO: EFO_0003894
has EFO name: ACNE

CHEMBL_IND_51706
type: DrugIndication
chembl id: CHEMBL_IND_51706
has molecule: CHEMBL986
highest development phase: 3
has mesh: D000740
has mesh heading: ANEMIA
has EFO: EFO_0004272
has EFO name: ANEMIA

CHEMBL_IND_41820
type: DrugIndication
chembl id: CHEMBL_IND_41820
has molecule: CHEMBL1075
highest development phase: 4
has mesh: D001145
has mesh heading: ARRHYTHMIAS, CARDIAC
has EFO: EFO_0004269
has EFO name: CARDIAC ARRHYTHMIA

CHEMBL_IND_43378
type: DrugIndication
chembl id: CHEMBL_IND_43378
has molecule: CHEMBL1067
highest development phase: 1
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_43216
type: DrugIndication
chembl id: CHEMBL_IND_43216
has molecule: CHEMBL1067
highest development phase: 3
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_47210
type: DrugIndication
chembl id: CHEMBL_IND_47210
has molecule: CHEMBL83626
highest development phase: 2
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_27173
type: DrugIndication
chembl id: CHEMBL_IND_27173
has molecule: CHEMBL87992
highest development phase: 2
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_26563
type: DrugIndication
chembl id: CHEMBL_IND_26563
has molecule: CHEMBL87992
highest development phase: 2
has mesh: D008881
has mesh heading: MIGRAINE DISORDERS
has EFO: EFO_0003821
has EFO name: MIGRAINE DISORDER

CHEMBL_IND_25973
type: DrugIndication
chembl id: CHEMBL_IND_25973
has molecule: CHEMBL87992
highest development phase: 2
has mesh: D005356
has mesh heading: FIBROMYALGIA
has EFO: EFO_0005687
has EFO name: FIBROMYALGIA

CHEMBL_IND_51446
type: DrugIndication
chembl id: CHEMBL_IND_51446
has molecule: CHEMBL87992
highest development phase: 4
has mesh: D012640
has mesh heading: SEIZURES
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_51743
type: DrugIndication
chembl id: CHEMBL_IND_51743
has molecule: CHEMBL87992
highest development phase: 3
has mesh: D003929
has mesh heading: DIABETIC NEUROPATHIES
has EFO: EFO_1000783
has EFO name: DIABETIC NEUROPATHY

CHEMBL_IND_23126
type: DrugIndication
chembl id: CHEMBL_IND_23126
has molecule: CHEMBL87992
highest development phase: 3
has mesh: D004828
has mesh heading: EPILEPSIES, PARTIAL
has EFO: EFO_0004263
has EFO name: PARTIAL EPILEPSY

CHEMBL_IND_23125
type: DrugIndication
chembl id: CHEMBL_IND_23125
has molecule: CHEMBL87992
highest development phase: 4
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_40182
type: DrugIndication
chembl id: CHEMBL_IND_40182
has molecule: CHEMBL87992
highest development phase: 3
has mesh: D017029
has mesh heading: EPILEPSY, COMPLEX PARTIAL
has EFO: EFO_1000877
has EFO name: COMPLEX PARTIAL EPILEPSY

CHEMBL_IND_44210
type: DrugIndication
chembl id: CHEMBL_IND_44210
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D007006
has mesh heading: HYPOGONADISM
has EFO: HP_0000135
has EFO name: HYPOGONADISM

CHEMBL_IND_27099
type: DrugIndication
chembl id: CHEMBL_IND_27099
has molecule: CHEMBL1042
highest development phase: 2
has mesh: D009765
has mesh heading: OBESITY
has EFO: EFO_0001073
has EFO name: OBESITY

CHEMBL_IND_27098
type: DrugIndication
chembl id: CHEMBL_IND_27098
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D015451
has mesh heading: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
has EFO: EFO_0000095
has EFO name: CHRONIC LYMPHOCYTIC LEUKEMIA

CHEMBL_IND_46543
type: DrugIndication
chembl id: CHEMBL_IND_46543
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_49516
type: DrugIndication
chembl id: CHEMBL_IND_49516
has molecule: CHEMBL1042
highest development phase: 2
has mesh: D006967
has mesh heading: HYPERSENSITIVITY
has EFO: EFO_0003785
has EFO name: ALLERGY

CHEMBL_IND_43962
type: DrugIndication
chembl id: CHEMBL_IND_43962
has molecule: CHEMBL1042
highest development phase: 4
has mesh: D010024
has mesh heading: OSTEOPOROSIS
has EFO: EFO_0003882
has EFO name: OSTEOPOROSIS

CHEMBL_IND_25867
type: DrugIndication
chembl id: CHEMBL_IND_25867
has molecule: CHEMBL1042
highest development phase: 2
has mesh: D003424
has mesh heading: CROHN DISEASE
has EFO: EFO_0000384
has EFO name: CROHN'S DISEASE

CHEMBL_IND_25865
type: DrugIndication
chembl id: CHEMBL_IND_25865
has molecule: CHEMBL1042
highest development phase: 2
has mesh: D018149
has mesh heading: GLUCOSE INTOLERANCE
has EFO: EFO_0002546
has EFO name: ABNORMAL GLUCOSE TOLERANCE

CHEMBL_IND_26459
type: DrugIndication
chembl id: CHEMBL_IND_26459
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D000236
has mesh heading: ADENOMA
has EFO: EFO_0005406
has EFO name: COLORECTAL ADENOMA

CHEMBL_IND_48843
type: DrugIndication
chembl id: CHEMBL_IND_48843
has molecule: CHEMBL1042
highest development phase: 2
has mesh: D065626
has mesh heading: NON-ALCOHOLIC FATTY LIVER DISEASE
has EFO: EFO_0003095
has EFO name: NON-ALCOHOLIC FATTY LIVER DISEASE

CHEMBL_IND_28058
type: DrugIndication
chembl id: CHEMBL_IND_28058
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D014376
has mesh heading: TUBERCULOSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: TUBERCULOSIS

CHEMBL_IND_28057
type: DrugIndication
chembl id: CHEMBL_IND_28057
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D060825
has mesh heading: MILD COGNITIVE IMPAIRMENT
has EFO: HP_0100543
has EFO name: COGNITIVE IMPAIRMENT

CHEMBL_IND_52144
type: DrugIndication
chembl id: CHEMBL_IND_52144
has molecule: CHEMBL1042
highest development phase: 0
has mesh: D047928
has mesh heading: PREMATURE BIRTH
has EFO: EFO_0003917
has EFO name: PREMATURE BIRTH

CHEMBL_IND_48631
type: DrugIndication
chembl id: CHEMBL_IND_48631
has molecule: CHEMBL1042
highest development phase: 1
has mesh: D043183
has mesh heading: IRRITABLE BOWEL SYNDROME
has EFO: EFO_0000555
has EFO name: IRRITABLE BOWEL SYNDROME

CHEMBL_IND_45727
type: DrugIndication
chembl id: CHEMBL_IND_45727
has molecule: CHEMBL1042
highest development phase: 2
has mesh: D000163
has mesh heading: ACQUIRED IMMUNODEFICIENCY SYNDROME
has EFO: EFO_0000765
has EFO name: AIDS

CHEMBL_IND_52576
type: DrugIndication
chembl id: CHEMBL_IND_52576
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_52556
type: DrugIndication
chembl id: CHEMBL_IND_52556
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D012141
has mesh heading: RESPIRATORY TRACT INFECTIONS
has EFO: HP_0011947
has EFO name: RESPIRATORY TRACT INFECTION

CHEMBL_IND_52473
type: DrugIndication
chembl id: CHEMBL_IND_52473
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_52399
type: DrugIndication
chembl id: CHEMBL_IND_52399
has molecule: CHEMBL1042
highest development phase: 2
has mesh: D009902
has mesh heading: OPTIC NEURITIS
has EFO: EFO_0007405
has EFO name: OPTIC NEURITIS

CHEMBL_IND_52633
type: DrugIndication
chembl id: CHEMBL_IND_52633
has molecule: CHEMBL1042
highest development phase: 2
has mesh: D050723
has mesh heading: FRACTURES, BONE
has EFO: EFO_0003931
has EFO name: BONE FRACTURE

CHEMBL_IND_52592
type: DrugIndication
chembl id: CHEMBL_IND_52592
has molecule: CHEMBL1042
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_25868
type: DrugIndication
chembl id: CHEMBL_IND_25868
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D007251
has mesh heading: INFLUENZA, HUMAN
has EFO: EFO_0001669
has EFO name: INFLUENZA INFECTION

CHEMBL_IND_49150
type: DrugIndication
chembl id: CHEMBL_IND_49150
has molecule: CHEMBL1042
highest development phase: 2
has mesh: D003876
has mesh heading: DERMATITIS, ATOPIC
has EFO: EFO_0000274
has EFO name: ATOPIC ECZEMA

CHEMBL_IND_43360
type: DrugIndication
chembl id: CHEMBL_IND_43360
has molecule: CHEMBL1042
highest development phase: 2
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_26461
type: DrugIndication
chembl id: CHEMBL_IND_26461
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_49015
type: DrugIndication
chembl id: CHEMBL_IND_49015
has molecule: CHEMBL1042
highest development phase: 2
has mesh: D003233
has mesh heading: CONJUNCTIVITIS, ALLERGIC
has EFO: EFO_0007141
has EFO name: ALLERGIC CONJUNCTIVITIS

CHEMBL_IND_46281
type: DrugIndication
chembl id: CHEMBL_IND_46281
has molecule: CHEMBL1042
highest development phase: 2
has mesh: D024821
has mesh heading: METABOLIC SYNDROME X
has EFO: EFO_0000195
has EFO name: METABOLIC SYNDROME

CHEMBL_IND_51989
type: DrugIndication
chembl id: CHEMBL_IND_51989
has molecule: CHEMBL1042
highest development phase: 1
has mesh: D006949
has mesh heading: HYPERLIPIDEMIAS
has EFO: EFO_0003774
has EFO name: HYPERLIPIDEMIA

CHEMBL_IND_46029
type: DrugIndication
chembl id: CHEMBL_IND_46029
has molecule: CHEMBL1042
highest development phase: 1
has mesh: D012878
has mesh heading: SKIN NEOPLASMS
has EFO: EFO_0004198
has EFO name: SKIN NEOPLASM

CHEMBL_IND_44404
type: DrugIndication
chembl id: CHEMBL_IND_44404
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_27611
type: DrugIndication
chembl id: CHEMBL_IND_27611
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_52080
type: DrugIndication
chembl id: CHEMBL_IND_52080
has molecule: CHEMBL1042
highest development phase: 2
has mesh: D061325
has mesh heading: HEREDITARY BREAST AND OVARIAN CANCER SYNDROME
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: HEREDITARY BREAST AND OVARIAN CANCER SYNDROME

CHEMBL_IND_51841
type: DrugIndication
chembl id: CHEMBL_IND_51841
has molecule: CHEMBL1042
highest development phase: 2
has mesh: D001321
has mesh heading: AUTISTIC DISORDER
has EFO: EFO_0003758
has EFO name: AUTISM

CHEMBL_IND_51829
type: DrugIndication
chembl id: CHEMBL_IND_51829
has molecule: CHEMBL1042
highest development phase: 2
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_47435
type: DrugIndication
chembl id: CHEMBL_IND_47435
has molecule: CHEMBL1042
highest development phase: 1
has mesh: D003922
has mesh heading: DIABETES MELLITUS, TYPE 1
has EFO: EFO_0001359
has EFO name: TYPE I DIABETES MELLITUS

CHEMBL_IND_44509
type: DrugIndication
chembl id: CHEMBL_IND_44509
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_51924
type: DrugIndication
chembl id: CHEMBL_IND_51924
has molecule: CHEMBL1042
highest development phase: 2
has mesh: D000375
has mesh heading: AGING
has EFO: GO:0007568
has EFO name: AGING

CHEMBL_IND_22903
type: DrugIndication
chembl id: CHEMBL_IND_22903
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_22902
type: DrugIndication
chembl id: CHEMBL_IND_22902
has molecule: CHEMBL1042
highest development phase: 1
has mesh: D013978
has mesh heading: TIBIAL FRACTURES
has EFO: EFO_0003944
has EFO name: TIBIA FRACTURE

CHEMBL_IND_22901
type: DrugIndication
chembl id: CHEMBL_IND_22901
has molecule: CHEMBL1042
highest development phase: 2
has mesh: D008180
has mesh heading: LUPUS ERYTHEMATOSUS, SYSTEMIC
has EFO: EFO_0002690
has EFO name: SYSTEMIC LUPUS ERYTHEMATOSUS

CHEMBL_IND_22900
type: DrugIndication
chembl id: CHEMBL_IND_22900
has molecule: CHEMBL1042
highest development phase: 1
has mesh: D000755
has mesh heading: ANEMIA, SICKLE CELL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SICKLE CELL ANEMIA

CHEMBL_IND_22898
type: DrugIndication
chembl id: CHEMBL_IND_22898
has molecule: CHEMBL1042
highest development phase: 2
has mesh: D009456
has mesh heading: NEUROFIBROMATOSIS 1
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: NEUROFIBROMATOSIS TYPE 1

CHEMBL_IND_22897
type: DrugIndication
chembl id: CHEMBL_IND_22897
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D006526
has mesh heading: HEPATITIS C
has EFO: EFO_0003047
has EFO name: HEPATITIS C INFECTION

CHEMBL_IND_22896
type: DrugIndication
chembl id: CHEMBL_IND_22896
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0003144
has EFO name: HEART FAILURE

CHEMBL_IND_22894
type: DrugIndication
chembl id: CHEMBL_IND_22894
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_51689
type: DrugIndication
chembl id: CHEMBL_IND_51689
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D015663
has mesh heading: OSTEOPOROSIS, POSTMENOPAUSAL
has EFO: EFO_0003854
has EFO name: POSTMENOPAUSAL OSTEOPOROSIS

CHEMBL_IND_25174
type: DrugIndication
chembl id: CHEMBL_IND_25174
has molecule: CHEMBL1042
highest development phase: 4
has mesh: D014808
has mesh heading: VITAMIN D DEFICIENCY
has EFO: EFO_0003762
has EFO name: VITAMIN D DEFICIENCY

CHEMBL_IND_25173
type: DrugIndication
chembl id: CHEMBL_IND_25173
has molecule: CHEMBL1042
highest development phase: 2
has mesh: D009103
has mesh heading: MULTIPLE SCLEROSIS
has EFO: EFO_0003885
has EFO name: MULTIPLE SCLEROSIS

CHEMBL_IND_25171
type: DrugIndication
chembl id: CHEMBL_IND_25171
has molecule: CHEMBL1042
highest development phase: 2
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_51681
type: DrugIndication
chembl id: CHEMBL_IND_51681
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D011247
has mesh heading: PREGNANCY
has EFO: EFO_0002950
has EFO name: PREGNANCY

CHEMBL_IND_24266
type: DrugIndication
chembl id: CHEMBL_IND_24266
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D020529
has mesh heading: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
has EFO: EFO_0003929
has EFO name: RELAPSING-REMITTING MULTIPLE SCLEROSIS

CHEMBL_IND_24265
type: DrugIndication
chembl id: CHEMBL_IND_24265
has molecule: CHEMBL1042
highest development phase: 1
has mesh: D011014
has mesh heading: PNEUMONIA
has EFO: EFO_0003106
has EFO name: PNEUMONIA

CHEMBL_IND_24263
type: DrugIndication
chembl id: CHEMBL_IND_24263
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_24262
type: DrugIndication
chembl id: CHEMBL_IND_24262
has molecule: CHEMBL1042
highest development phase: 3
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_39756
type: DrugIndication
chembl id: CHEMBL_IND_39756
has molecule: CHEMBL81697
highest development phase: 4
has mesh: D013927
has mesh heading: THROMBOSIS
has EFO: HP_0004419
has EFO name: RECURRENT THROMBOPHLEBITIS

CHEMBL_IND_43755
type: DrugIndication
chembl id: CHEMBL_IND_43755
has molecule: CHEMBL276711
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_48084
type: DrugIndication
chembl id: CHEMBL_IND_48084
has molecule: CHEMBL276711
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_47941
type: DrugIndication
chembl id: CHEMBL_IND_47941
has molecule: CHEMBL276711
highest development phase: 2
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_44725
type: DrugIndication
chembl id: CHEMBL_IND_44725
has molecule: CHEMBL276711
highest development phase: 2
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0000681
has EFO name: RENAL CELL CARCINOMA

CHEMBL_IND_46503
type: DrugIndication
chembl id: CHEMBL_IND_46503
has molecule: CHEMBL276711
highest development phase: 2
has mesh: D008654
has mesh heading: MESOTHELIOMA
has EFO: EFO_0000588
has EFO name: MESOTHELIOMA

CHEMBL_IND_49239
type: DrugIndication
chembl id: CHEMBL_IND_49239
has molecule: CHEMBL91829
highest development phase: 1
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_43901
type: DrugIndication
chembl id: CHEMBL_IND_43901
has molecule: CHEMBL91829
highest development phase: 3
has mesh: D003930
has mesh heading: DIABETIC RETINOPATHY
has EFO: EFO_0003770
has EFO name: DIABETIC RETINOPATHY

CHEMBL_IND_49417
type: DrugIndication
chembl id: CHEMBL_IND_49417
has molecule: CHEMBL91829
highest development phase: 3
has mesh: D003922
has mesh heading: DIABETES MELLITUS, TYPE 1
has EFO: EFO_0001359
has EFO name: TYPE I DIABETES MELLITUS

CHEMBL_IND_54712
type: DrugIndication
chembl id: CHEMBL_IND_54712
has molecule: CHEMBL91829
highest development phase: 1
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0003144
has EFO name: HEART FAILURE

CHEMBL_IND_25769
type: DrugIndication
chembl id: CHEMBL_IND_25769
has molecule: CHEMBL1046
highest development phase: 2
has mesh: D003398
has mesh heading: CRANIOSYNOSTOSES
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CRANIOSYNOSTOSIS

CHEMBL_IND_45265
type: DrugIndication
chembl id: CHEMBL_IND_45265
has molecule: CHEMBL1046
highest development phase: 0
has mesh: D012393
has mesh heading: ROSACEA
has EFO: EFO_1000760
has EFO name: ROSACEA

CHEMBL_IND_52513
type: DrugIndication
chembl id: CHEMBL_IND_52513
has molecule: CHEMBL1046
highest development phase: 1
has mesh: D002543
has mesh heading: CEREBRAL HEMORRHAGE
has EFO: EFO_0005669
has EFO name: INTRACEREBRAL HEMORRHAGE

CHEMBL_IND_26382
type: DrugIndication
chembl id: CHEMBL_IND_26382
has molecule: CHEMBL1046
highest development phase: 4
has mesh: D006470
has mesh heading: HEMORRHAGE
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: HEMORRHAGE

CHEMBL_IND_52076
type: DrugIndication
chembl id: CHEMBL_IND_52076
has molecule: CHEMBL1046
highest development phase: 2
has mesh: D007249
has mesh heading: INFLAMMATION
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: INFLAMMATION

CHEMBL_IND_28011
type: DrugIndication
chembl id: CHEMBL_IND_28011
has molecule: CHEMBL1046
highest development phase: 0
has mesh: D001018
has mesh heading: AORTIC DISEASES
has EFO: EFO_0005775
has EFO name: AORTIC DISEASE

CHEMBL_IND_25768
type: DrugIndication
chembl id: CHEMBL_IND_25768
has molecule: CHEMBL1111
highest development phase: 3
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_48397
type: DrugIndication
chembl id: CHEMBL_IND_48397
has molecule: CHEMBL1111
highest development phase: 1
has mesh: D000532
has mesh heading: ALTITUDE SICKNESS
has EFO: EFO_1000782
has EFO name: ALTITUDE SICKNESS

CHEMBL_IND_26380
type: DrugIndication
chembl id: CHEMBL_IND_26380
has molecule: CHEMBL1111
highest development phase: 2
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_43071
type: DrugIndication
chembl id: CHEMBL_IND_43071
has molecule: CHEMBL1111
highest development phase: 4
has mesh: D065627
has mesh heading: FAMILIAL PRIMARY PULMONARY HYPERTENSION
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: IDIOPATHIC AND/OR FAMILIAL PULMONARY ARTERIAL HYPERTENSION

CHEMBL_IND_49691
type: DrugIndication
chembl id: CHEMBL_IND_49691
has molecule: CHEMBL1111
highest development phase: 1
has mesh: D000755
has mesh heading: ANEMIA, SICKLE CELL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SICKLE CELL ANEMIA

CHEMBL_IND_22671
type: DrugIndication
chembl id: CHEMBL_IND_22671
has molecule: CHEMBL1111
highest development phase: 3
has mesh: D006976
has mesh heading: HYPERTENSION, PULMONARY
has EFO: EFO_0001361
has EFO name: PULMONARY HYPERTENSION

CHEMBL_IND_25053
type: DrugIndication
chembl id: CHEMBL_IND_25053
has molecule: CHEMBL1111
highest development phase: 3
has mesh: D014652
has mesh heading: VASCULAR DISEASES
has EFO: EFO_0004264
has EFO name: VASCULAR DISEASE

CHEMBL_IND_25052
type: DrugIndication
chembl id: CHEMBL_IND_25052
has molecule: CHEMBL1111
highest development phase: 3
has mesh: D054990
has mesh heading: IDIOPATHIC PULMONARY FIBROSIS
has EFO: EFO_0000768
has EFO name: IDIOPATHIC PULMONARY FIBROSIS

CHEMBL_IND_43537
type: DrugIndication
chembl id: CHEMBL_IND_43537
has molecule: CHEMBL101253
highest development phase: 2
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_49491
type: DrugIndication
chembl id: CHEMBL_IND_49491
has molecule: CHEMBL101253
highest development phase: 2
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_48018
type: DrugIndication
chembl id: CHEMBL_IND_48018
has molecule: CHEMBL101253
highest development phase: 2
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_48773
type: DrugIndication
chembl id: CHEMBL_IND_48773
has molecule: CHEMBL101253
highest development phase: 1
has mesh: D008268
has mesh heading: MACULAR DEGENERATION
has EFO: EFO_0001365
has EFO name: AGE-RELATED MACULAR DEGENERATION

CHEMBL_IND_44765
type: DrugIndication
chembl id: CHEMBL_IND_44765
has molecule: CHEMBL101253
highest development phase: 1
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_53772
type: DrugIndication
chembl id: CHEMBL_IND_53772
has molecule: CHEMBL101253
highest development phase: 2
has mesh: D008654
has mesh heading: MESOTHELIOMA
has EFO: EFO_0000588
has EFO name: MESOTHELIOMA

CHEMBL_IND_44901
type: DrugIndication
chembl id: CHEMBL_IND_44901
has molecule: CHEMBL101253
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_44872
type: DrugIndication
chembl id: CHEMBL_IND_44872
has molecule: CHEMBL101253
highest development phase: 2
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_44563
type: DrugIndication
chembl id: CHEMBL_IND_44563
has molecule: CHEMBL101253
highest development phase: 2
has mesh: D016403
has mesh heading: LYMPHOMA, LARGE B-CELL, DIFFUSE
has EFO: EFO_0000403
has EFO name: DIFFUSE LARGE B-CELL LYMPHOMA

CHEMBL_IND_47046
type: DrugIndication
chembl id: CHEMBL_IND_47046
has molecule: CHEMBL96783
highest development phase: 1
has mesh: D003550
has mesh heading: CYSTIC FIBROSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CYSTIC FIBROSIS

CHEMBL_IND_53039
type: DrugIndication
chembl id: CHEMBL_IND_53039
has molecule: CHEMBL96783
highest development phase: 3
has mesh: D003731
has mesh heading: DENTAL CARIES
has EFO: EFO_0003819
has EFO name: DENTAL CARIES

CHEMBL_IND_44558
type: DrugIndication
chembl id: CHEMBL_IND_44558
has molecule: CHEMBL96783
highest development phase: 2
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_41698
type: DrugIndication
chembl id: CHEMBL_IND_41698
has molecule: CHEMBL87697
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_53540
type: DrugIndication
chembl id: CHEMBL_IND_53540
has molecule: CHEMBL274654
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_53721
type: DrugIndication
chembl id: CHEMBL_IND_53721
has molecule: CHEMBL274654
highest development phase: 3
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_55346
type: DrugIndication
chembl id: CHEMBL_IND_55346
has molecule: CHEMBL99946
highest development phase: 3
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_28330
type: DrugIndication
chembl id: CHEMBL_IND_28330
has molecule: CHEMBL1100
highest development phase: 4
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_43096
type: DrugIndication
chembl id: CHEMBL_IND_43096
has molecule: CHEMBL107360
highest development phase: 4
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_50488
type: DrugIndication
chembl id: CHEMBL_IND_50488
has molecule: CHEMBL109480
highest development phase: 2
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_50851
type: DrugIndication
chembl id: CHEMBL_IND_50851
has molecule: CHEMBL109480
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_54973
type: DrugIndication
chembl id: CHEMBL_IND_54973
has molecule: CHEMBL109480
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_54956
type: DrugIndication
chembl id: CHEMBL_IND_54956
has molecule: CHEMBL109480
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_42431
type: DrugIndication
chembl id: CHEMBL_IND_42431
has molecule: CHEMBL94081
highest development phase: 4
has mesh: D012216
has mesh heading: RHEUMATIC DISEASES
has EFO: EFO_0005755
has EFO name: RHEUMATIC DISEASE

CHEMBL_IND_28164
type: DrugIndication
chembl id: CHEMBL_IND_28164
has molecule: CHEMBL1095
highest development phase: 4
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_42197
type: DrugIndication
chembl id: CHEMBL_IND_42197
has molecule: CHEMBL108358
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_52501
type: DrugIndication
chembl id: CHEMBL_IND_52501
has molecule: CHEMBL1141
highest development phase: 2
has mesh: D003731
has mesh heading: DENTAL CARIES
has EFO: EFO_0003819
has EFO name: DENTAL CARIES

CHEMBL_IND_52374
type: DrugIndication
chembl id: CHEMBL_IND_52374
has molecule: CHEMBL1141
highest development phase: 3
has mesh: D011247
has mesh heading: PREGNANCY
has EFO: EFO_0002950
has EFO name: PREGNANCY

CHEMBL_IND_51441
type: DrugIndication
chembl id: CHEMBL_IND_51441
has molecule: CHEMBL108545
highest development phase: 4
has mesh: D009120
has mesh heading: MUSCLE CRAMP

CHEMBL_IND_51616
type: DrugIndication
chembl id: CHEMBL_IND_51616
has molecule: CHEMBL108545
highest development phase: 4
has mesh: D052256
has mesh heading: TENDINOPATHY
has EFO: EFO_1001434
has EFO name: TENDINOPATHY

CHEMBL_IND_51578
type: DrugIndication
chembl id: CHEMBL_IND_51578
has molecule: CHEMBL108545
highest development phase: 4
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_51513
type: DrugIndication
chembl id: CHEMBL_IND_51513
has molecule: CHEMBL108545
highest development phase: 4
has mesh: D002062
has mesh heading: BURSITIS
has EFO: EFO_1000941
has EFO name: FROZEN SHOULDER

CHEMBL_IND_51509
type: DrugIndication
chembl id: CHEMBL_IND_51509
has molecule: CHEMBL108545
highest development phase: 4
has mesh: D001168
has mesh heading: ARTHRITIS
has EFO: EFO_0005856
has EFO name: ARTHRITIS

CHEMBL_IND_51484
type: DrugIndication
chembl id: CHEMBL_IND_51484
has molecule: CHEMBL108545
highest development phase: 4
has mesh: D063806
has mesh heading: MYALGIA
has EFO: HP_0003326
has EFO name: MYALGIA

CHEMBL_IND_51455
type: DrugIndication
chembl id: CHEMBL_IND_51455
has molecule: CHEMBL108545
highest development phase: 4
has mesh: D001416
has mesh heading: BACK PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_53824
type: DrugIndication
chembl id: CHEMBL_IND_53824
has molecule: CHEMBL113178
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_50174
type: DrugIndication
chembl id: CHEMBL_IND_50174
has molecule: CHEMBL93645
highest development phase: 4
has mesh: D018771
has mesh heading: ARTHRALGIA
has EFO: HP_0002829
has EFO name: ARTHRALGIA

CHEMBL_IND_50152
type: DrugIndication
chembl id: CHEMBL_IND_50152
has molecule: CHEMBL93645
highest development phase: 4
has mesh: D063806
has mesh heading: MYALGIA
has EFO: HP_0003326
has EFO name: MYALGIA

CHEMBL_IND_50148
type: DrugIndication
chembl id: CHEMBL_IND_50148
has molecule: CHEMBL93645
highest development phase: 4
has mesh: D012216
has mesh heading: RHEUMATIC DISEASES
has EFO: EFO_0005755
has EFO name: RHEUMATIC DISEASE

CHEMBL_IND_49274
type: DrugIndication
chembl id: CHEMBL_IND_49274
has molecule: CHEMBL1139
highest development phase: 1
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_49428
type: DrugIndication
chembl id: CHEMBL_IND_49428
has molecule: CHEMBL1139
highest development phase: 3
has mesh: D006976
has mesh heading: HYPERTENSION, PULMONARY
has EFO: EFO_0001361
has EFO name: PULMONARY HYPERTENSION

CHEMBL_IND_49351
type: DrugIndication
chembl id: CHEMBL_IND_49351
has molecule: CHEMBL1139
highest development phase: 2
has mesh: D013345
has mesh heading: SUBARACHNOID HEMORRHAGE
has EFO: EFO_0000713
has EFO name: SUBARACHNOID HEMORRHAGE

CHEMBL_IND_53334
type: DrugIndication
chembl id: CHEMBL_IND_53334
has molecule: CHEMBL1139
highest development phase: 3
has mesh: D007674
has mesh heading: KIDNEY DISEASES
has EFO: EFO_0003086
has EFO name: KIDNEY DISEASE

CHEMBL_IND_39709
type: DrugIndication
chembl id: CHEMBL_IND_39709
has molecule: CHEMBL1139
highest development phase: 4
has mesh: D013927
has mesh heading: THROMBOSIS
has EFO: HP_0004419
has EFO name: RECURRENT THROMBOPHLEBITIS

CHEMBL_IND_49208
type: DrugIndication
chembl id: CHEMBL_IND_49208
has molecule: CHEMBL124660
highest development phase: 2
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0000349
has EFO name: CLEAR CELL RENAL CARCINOMA

CHEMBL_IND_53687
type: DrugIndication
chembl id: CHEMBL_IND_53687
has molecule: CHEMBL124660
highest development phase: 1
has mesh: D018316
has mesh heading: GLIOSARCOMA
has EFO: EFO_1001465
has EFO name: GLIOSARCOMA

CHEMBL_IND_53175
type: DrugIndication
chembl id: CHEMBL_IND_53175
has molecule: CHEMBL110458
highest development phase: 3
has mesh: D000795
has mesh heading: FABRY DISEASE
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: FABRY DISEASE

CHEMBL_IND_53415
type: DrugIndication
chembl id: CHEMBL_IND_53415
has molecule: CHEMBL119709
highest development phase: 3
has mesh: D007638
has mesh heading: KERATOCONJUNCTIVITIS SICCA
has EFO: EFO_1001001
has EFO name: KERATOCONJUNCTIVITIS SICCA

CHEMBL_IND_48053
type: DrugIndication
chembl id: CHEMBL_IND_48053
has molecule: CHEMBL119709
highest development phase: 2
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_44727
type: DrugIndication
chembl id: CHEMBL_IND_44727
has molecule: CHEMBL119709
highest development phase: 2
has mesh: D001172
has mesh heading: ARTHRITIS, RHEUMATOID
has EFO: EFO_0000685
has EFO name: RHEUMATOID ARTHRITIS

CHEMBL_IND_44119
type: DrugIndication
chembl id: CHEMBL_IND_44119
has molecule: CHEMBL119709
highest development phase: 2
has mesh: D020370
has mesh heading: OSTEOARTHRITIS, KNEE
has EFO: EFO_0004616
has EFO name: OSTEOARTHRITIS, KNEE

CHEMBL_IND_22629
type: DrugIndication
chembl id: CHEMBL_IND_22629
has molecule: CHEMBL1131
highest development phase: 4
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_50113
type: DrugIndication
chembl id: CHEMBL_IND_50113
has molecule: CHEMBL113461
highest development phase: 4
has mesh: D001145
has mesh heading: ARRHYTHMIAS, CARDIAC
has EFO: EFO_0004269
has EFO name: CARDIAC ARRHYTHMIA

CHEMBL_IND_41767
type: DrugIndication
chembl id: CHEMBL_IND_41767
has molecule: CHEMBL120563
highest development phase: 4
has mesh: D004478
has mesh heading: ECTOPARASITIC INFESTATIONS
has EFO: EFO_0001067
has EFO name: PARASITIC INFECTION

CHEMBL_IND_42126
type: DrugIndication
chembl id: CHEMBL_IND_42126
has molecule: CHEMBL102358
highest development phase: 4
has mesh: D063806
has mesh heading: MYALGIA
has EFO: HP_0003326
has EFO name: MYALGIA

CHEMBL_IND_43051
type: DrugIndication
chembl id: CHEMBL_IND_43051
has molecule: CHEMBL102358
highest development phase: 4
has mesh: D018771
has mesh heading: ARTHRALGIA
has EFO: HP_0002829
has EFO name: ARTHRALGIA

CHEMBL_IND_50078
type: DrugIndication
chembl id: CHEMBL_IND_50078
has molecule: CHEMBL132530
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_41984
type: DrugIndication
chembl id: CHEMBL_IND_41984
has molecule: CHEMBL132767
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_26310
type: DrugIndication
chembl id: CHEMBL_IND_26310
has molecule: CHEMBL117785
highest development phase: 2
has mesh: D005879
has mesh heading: TOURETTE SYNDROME
has EFO: EFO_0004895
has EFO name: TOURETTE SYNDROME

CHEMBL_IND_27951
type: DrugIndication
chembl id: CHEMBL_IND_27951
has molecule: CHEMBL117785
highest development phase: 3
has mesh: D009069
has mesh heading: MOVEMENT DISORDERS
has EFO: EFO_0004280
has EFO name: MOVEMENT DISORDER

CHEMBL_IND_23945
type: DrugIndication
chembl id: CHEMBL_IND_23945
has molecule: CHEMBL117785
highest development phase: 4
has mesh: D006816
has mesh heading: HUNTINGTON DISEASE
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: HUNTINGTON DISEASE

CHEMBL_IND_42524
type: DrugIndication
chembl id: CHEMBL_IND_42524
has molecule: CHEMBL136737
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_40572
type: DrugIndication
chembl id: CHEMBL_IND_40572
has molecule: CHEMBL1220
highest development phase: 1
has mesh: D014245
has mesh heading: TRICHOMONAS INFECTIONS
has EFO: DOID:1947
has EFO name: TRICHOMONIASIS

CHEMBL_IND_52401
type: DrugIndication
chembl id: CHEMBL_IND_52401
has molecule: CHEMBL1220
highest development phase: 2
has mesh: D016780
has mesh heading: MALARIA, VIVAX
has EFO: EFO_0007445
has EFO name: PLASMODIUM VIVAX MALARIA

CHEMBL_IND_40084
type: DrugIndication
chembl id: CHEMBL_IND_40084
has molecule: CHEMBL1220
highest development phase: 0
has mesh: D016585
has mesh heading: VAGINOSIS, BACTERIAL
has EFO: EFO_0003932
has EFO name: BACTERIAL VAGINOSIS

CHEMBL_IND_27843
type: DrugIndication
chembl id: CHEMBL_IND_27843
has molecule: CHEMBL1162
highest development phase: 3
has mesh: D008593
has mesh heading: MENOPAUSE
has EFO: EFO_0003922
has EFO name: MENOPAUSE

CHEMBL_IND_45574
type: DrugIndication
chembl id: CHEMBL_IND_45574
has molecule: CHEMBL1232
highest development phase: 3
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_45006
type: DrugIndication
chembl id: CHEMBL_IND_45006
has molecule: CHEMBL1232
highest development phase: 3
has mesh: D014552
has mesh heading: URINARY TRACT INFECTIONS
has EFO: EFO_0003103
has EFO name: URINARY TRACT INFECTION

CHEMBL_IND_42564
type: DrugIndication
chembl id: CHEMBL_IND_42564
has molecule: CHEMBL1177
highest development phase: 4
has mesh: D001289
has mesh heading: ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY
has EFO: EFO_0003888
has EFO name: ATTENTION DEFICIT HYPERACTIVITY DISORDER

CHEMBL_IND_50201
type: DrugIndication
chembl id: CHEMBL_IND_50201
has molecule: CHEMBL126224
highest development phase: 4
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_43644
type: DrugIndication
chembl id: CHEMBL_IND_43644
has molecule: CHEMBL118218
highest development phase: 2
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_43235
type: DrugIndication
chembl id: CHEMBL_IND_43235
has molecule: CHEMBL118218
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_44949
type: DrugIndication
chembl id: CHEMBL_IND_44949
has molecule: CHEMBL118218
highest development phase: 3
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_47287
type: DrugIndication
chembl id: CHEMBL_IND_47287
has molecule: CHEMBL118218
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_47181
type: DrugIndication
chembl id: CHEMBL_IND_47181
has molecule: CHEMBL118218
highest development phase: 2
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_40701
type: DrugIndication
chembl id: CHEMBL_IND_40701
has molecule: CHEMBL1166
highest development phase: 2
has mesh: D000789
has mesh heading: ANGINA, UNSTABLE
has EFO: EFO_1000985
has EFO name: INTERMEDIATE CORONARY SYNDROME

CHEMBL_IND_41936
type: DrugIndication
chembl id: CHEMBL_IND_41936
has molecule: CHEMBL1166
highest development phase: 4
has mesh: D013921
has mesh heading: THROMBOCYTOPENIA
has EFO: HP_0011874
has EFO name: HEPARIN-INDUCED THROMBOCYTOPENIA

CHEMBL_IND_28544
type: DrugIndication
chembl id: CHEMBL_IND_28544
has molecule: CHEMBL1166
highest development phase: 4
has mesh: D013927
has mesh heading: THROMBOSIS
has EFO: HP_0004419
has EFO name: RECURRENT THROMBOPHLEBITIS

CHEMBL_IND_52973
type: DrugIndication
chembl id: CHEMBL_IND_52973
has molecule: CHEMBL1163
highest development phase: 4
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_54044
type: DrugIndication
chembl id: CHEMBL_IND_54044
has molecule: CHEMBL1163
highest development phase: 1
has mesh: D003922
has mesh heading: DIABETES MELLITUS, TYPE 1
has EFO: EFO_0001359
has EFO name: TYPE I DIABETES MELLITUS

CHEMBL_IND_52842
type: DrugIndication
chembl id: CHEMBL_IND_52842
has molecule: CHEMBL1163
highest development phase: 4
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000180
has EFO name: HIV-1 INFECTION

CHEMBL_IND_46468
type: DrugIndication
chembl id: CHEMBL_IND_46468
has molecule: CHEMBL1076263
highest development phase: 2
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_49991
type: DrugIndication
chembl id: CHEMBL_IND_49991
has molecule: CHEMBL144673
highest development phase: 4
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_49257
type: DrugIndication
chembl id: CHEMBL_IND_49257
has molecule: CHEMBL142635
highest development phase: 3
has mesh: D006965
has mesh heading: HYPERPLASIA
has EFO: EFO_0000536
has EFO name: HYPERPLASIA

CHEMBL_IND_54030
type: DrugIndication
chembl id: CHEMBL_IND_54030
has molecule: CHEMBL1229
highest development phase: 2
has mesh: D014777
has mesh heading: VIRUS DISEASES
has EFO: EFO_0000763
has EFO name: VIRAL DISEASE

CHEMBL_IND_43770
type: DrugIndication
chembl id: CHEMBL_IND_43770
has molecule: CHEMBL1229
highest development phase: 3
has mesh: D007251
has mesh heading: INFLUENZA, HUMAN
has EFO: EFO_0001669
has EFO name: INFLUENZA INFECTION

CHEMBL_IND_45100
type: DrugIndication
chembl id: CHEMBL_IND_45100
has molecule: CHEMBL1229
highest development phase: 1
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_46466
type: DrugIndication
chembl id: CHEMBL_IND_46466
has molecule: CHEMBL1229
highest development phase: 2
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_43239
type: DrugIndication
chembl id: CHEMBL_IND_43239
has molecule: CHEMBL134702
highest development phase: 0
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_47450
type: DrugIndication
chembl id: CHEMBL_IND_47450
has molecule: CHEMBL1308
highest development phase: 1
has mesh: D008268
has mesh heading: MACULAR DEGENERATION
has EFO: EFO_0001365
has EFO name: AGE-RELATED MACULAR DEGENERATION

CHEMBL_IND_50822
type: DrugIndication
chembl id: CHEMBL_IND_50822
has molecule: CHEMBL148674
highest development phase: 2
has mesh: D000755
has mesh heading: ANEMIA, SICKLE CELL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SICKLE CELL ANEMIA

CHEMBL_IND_50496
type: DrugIndication
chembl id: CHEMBL_IND_50496
has molecule: CHEMBL148674
highest development phase: 2
has mesh: D003324
has mesh heading: CORONARY ARTERY DISEASE
has EFO: EFO_0000378
has EFO name: CORONARY ARTERY DISEASE

CHEMBL_IND_54116
type: DrugIndication
chembl id: CHEMBL_IND_54116
has molecule: CHEMBL142438
highest development phase: 2
has mesh: D014008
has mesh heading: TINEA PEDIS
has EFO: EFO_0007512
has EFO name: TINEA PEDIS

CHEMBL_IND_46413
type: DrugIndication
chembl id: CHEMBL_IND_46413
has molecule: CHEMBL142438
highest development phase: 3
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_49702
type: DrugIndication
chembl id: CHEMBL_IND_49702
has molecule: CHEMBL142438
highest development phase: 1
has mesh: D003550
has mesh heading: CYSTIC FIBROSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CYSTIC FIBROSIS

CHEMBL_IND_44923
type: DrugIndication
chembl id: CHEMBL_IND_44923
has molecule: CHEMBL142438
highest development phase: 3
has mesh: D055623
has mesh heading: KERATOSIS, ACTINIC
has EFO: EFO_0002496
has EFO name: ACTINIC KERATOSIS

CHEMBL_IND_47195
type: DrugIndication
chembl id: CHEMBL_IND_47195
has molecule: CHEMBL142438
highest development phase: 2
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0000373
has EFO name: CONGESTIVE HEART FAILURE

CHEMBL_IND_52776
type: DrugIndication
chembl id: CHEMBL_IND_52776
has molecule: CHEMBL1305
highest development phase: 4
has mesh: D006967
has mesh heading: HYPERSENSITIVITY
has EFO: EFO_0003785
has EFO name: ALLERGY

CHEMBL_IND_52802
type: DrugIndication
chembl id: CHEMBL_IND_52802
has molecule: CHEMBL1305
highest development phase: 4
has mesh: D015508
has mesh heading: NASAL OBSTRUCTION
has EFO: HP_0001742
has EFO name: NASAL OBSTRUCTION

CHEMBL_IND_41791
type: DrugIndication
chembl id: CHEMBL_IND_41791
has molecule: CHEMBL152408
highest development phase: 4
has mesh: D006967
has mesh heading: HYPERSENSITIVITY
has EFO: EFO_0003785
has EFO name: ALLERGY

CHEMBL_IND_53007
type: DrugIndication
chembl id: CHEMBL_IND_53007
has molecule: CHEMBL153479
highest development phase: 2
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_44294
type: DrugIndication
chembl id: CHEMBL_IND_44294
has molecule: CHEMBL153479
highest development phase: 1
has mesh: D005776
has mesh heading: GAUCHER DISEASE
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: GAUCHER DISEASE

CHEMBL_IND_27252
type: DrugIndication
chembl id: CHEMBL_IND_27252
has molecule: CHEMBL1311
highest development phase: 1
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_42497
type: DrugIndication
chembl id: CHEMBL_IND_42497
has molecule: CHEMBL1311
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_48853
type: DrugIndication
chembl id: CHEMBL_IND_48853
has molecule: CHEMBL1311
highest development phase: 2
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0003144
has EFO name: HEART FAILURE

CHEMBL_IND_49075
type: DrugIndication
chembl id: CHEMBL_IND_49075
has molecule: CHEMBL1311
highest development phase: 1
has mesh: D005401
has mesh heading: FISSURE IN ANO
has EFO: HP_0012390
has EFO name: ANAL FISSURE

CHEMBL_IND_44248
type: DrugIndication
chembl id: CHEMBL_IND_44248
has molecule: CHEMBL1231
highest development phase: 3
has mesh: D053206
has mesh heading: NOCTURNAL ENURESIS
has EFO: HP_0010677
has EFO name: ENURESIS NOCTURNA

CHEMBL_IND_52146
type: DrugIndication
chembl id: CHEMBL_IND_52146
has molecule: CHEMBL1231
highest development phase: 2
has mesh: D006255
has mesh heading: RHINITIS, ALLERGIC, SEASONAL
has EFO: EFO_0003956
has EFO name: SEASONAL ALLERGIC RHINITIS

CHEMBL_IND_25528
type: DrugIndication
chembl id: CHEMBL_IND_25528
has molecule: CHEMBL1231
highest development phase: 3
has mesh: D006945
has mesh heading: HYPERHIDROSIS
has EFO: HP_0000975
has EFO name: HYPERHIDROSIS

CHEMBL_IND_27360
type: DrugIndication
chembl id: CHEMBL_IND_27360
has molecule: CHEMBL1231
highest development phase: 3
has mesh: D014549
has mesh heading: URINARY INCONTINENCE
has EFO: HP_0000020
has EFO name: URINARY INCONTINENCE

CHEMBL_IND_51741
type: DrugIndication
chembl id: CHEMBL_IND_51741
has molecule: CHEMBL1231
highest development phase: 4
has mesh: D053201
has mesh heading: URINARY BLADDER, OVERACTIVE
has EFO: EFO_1000781
has EFO name: OVERACTIVE BLADDER

CHEMBL_IND_24735
type: DrugIndication
chembl id: CHEMBL_IND_24735
has molecule: CHEMBL1231
highest development phase: 3
has mesh: D001750
has mesh heading: URINARY BLADDER, NEUROGENIC
has EFO: HP_0000011
has EFO name: NEUROGENIC BLADDER

CHEMBL_IND_22635
type: DrugIndication
chembl id: CHEMBL_IND_22635
has molecule: CHEMBL1265
highest development phase: 4
has mesh: D000152
has mesh heading: ACNE VULGARIS
has EFO: EFO_0003894
has EFO name: ACNE

CHEMBL_IND_25035
type: DrugIndication
chembl id: CHEMBL_IND_25035
has molecule: CHEMBL1265
highest development phase: 1
has mesh: D012871
has mesh heading: SKIN DISEASES
has EFO: EFO_0000701
has EFO name: SKIN DISEASE

CHEMBL_IND_49998
type: DrugIndication
chembl id: CHEMBL_IND_49998
has molecule: CHEMBL1279
highest development phase: 4
has mesh: D008881
has mesh heading: MIGRAINE DISORDERS
has EFO: EFO_0003821
has EFO name: MIGRAINE DISORDER

CHEMBL_IND_55198
type: DrugIndication
chembl id: CHEMBL_IND_55198
has molecule: CHEMBL1279
highest development phase: 2
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_45699
type: DrugIndication
chembl id: CHEMBL_IND_45699
has molecule: CHEMBL1314
highest development phase: 2
has mesh: D013345
has mesh heading: SUBARACHNOID HEMORRHAGE
has EFO: EFO_0000713
has EFO name: SUBARACHNOID HEMORRHAGE

CHEMBL_IND_52023
type: DrugIndication
chembl id: CHEMBL_IND_52023
has molecule: CHEMBL1292
highest development phase: 2
has mesh: D014397
has mesh heading: TUBERCULOSIS, PULMONARY
has EFO: EFO_1000049
has EFO name: PULMONARY TUBERCULOSIS

CHEMBL_IND_42410
type: DrugIndication
chembl id: CHEMBL_IND_42410
has molecule: CHEMBL159659
highest development phase: 4
has mesh: D019966
has mesh heading: SUBSTANCE-RELATED DISORDERS
has EFO: EFO_0003890
has EFO name: DRUG DEPENDENCE

CHEMBL_IND_42999
type: DrugIndication
chembl id: CHEMBL_IND_42999
has molecule: CHEMBL1278
highest development phase: 4
has mesh: D008881
has mesh heading: MIGRAINE DISORDERS
has EFO: EFO_0003821
has EFO name: MIGRAINE DISORDER

CHEMBL_IND_48738
type: DrugIndication
chembl id: CHEMBL_IND_48738
has molecule: CHEMBL170
highest development phase: 4
has mesh: D008288
has mesh heading: MALARIA
has EFO: EFO_0001068
has EFO name: MALARIA

CHEMBL_IND_53901
type: DrugIndication
chembl id: CHEMBL_IND_53901
has molecule: CHEMBL170
highest development phase: 3
has mesh: D016778
has mesh heading: MALARIA, FALCIPARUM
has EFO: EFO_0007444
has EFO name: PLASMODIUM FALCIPARUM MALARIA

CHEMBL_IND_25499
type: DrugIndication
chembl id: CHEMBL_IND_25499
has molecule: CHEMBL1337
highest development phase: 3
has mesh: D000474
has mesh heading: ALKAPTONURIA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: ALKAPTONURIA

CHEMBL_IND_41989
type: DrugIndication
chembl id: CHEMBL_IND_41989
has molecule: CHEMBL153983
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_53586
type: DrugIndication
chembl id: CHEMBL_IND_53586
has molecule: CHEMBL160038
highest development phase: 1
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_42656
type: DrugIndication
chembl id: CHEMBL_IND_42656
has molecule: CHEMBL159226
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_52747
type: DrugIndication
chembl id: CHEMBL_IND_52747
has molecule: CHEMBL1350
highest development phase: 4
has mesh: D001847
has mesh heading: BONE DISEASES
has EFO: EFO_0004260
has EFO name: BONE DISEASE

CHEMBL_IND_52215
type: DrugIndication
chembl id: CHEMBL_IND_52215
has molecule: CHEMBL1326
highest development phase: 2
has mesh: D001281
has mesh heading: ATRIAL FIBRILLATION
has EFO: EFO_0000275
has EFO name: ATRIAL FIBRILLATION

CHEMBL_IND_41768
type: DrugIndication
chembl id: CHEMBL_IND_41768
has molecule: CHEMBL1326
highest development phase: 4
has mesh: D008288
has mesh heading: MALARIA
has EFO: EFO_0001068
has EFO name: MALARIA

CHEMBL_IND_47392
type: DrugIndication
chembl id: CHEMBL_IND_47392
has molecule: CHEMBL1326
highest development phase: 2
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_25457
type: DrugIndication
chembl id: CHEMBL_IND_25457
has molecule: CHEMBL1341
highest development phase: 4
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_43269
type: DrugIndication
chembl id: CHEMBL_IND_43269
has molecule: CHEMBL1341
highest development phase: 3
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_24626
type: DrugIndication
chembl id: CHEMBL_IND_24626
has molecule: CHEMBL1341
highest development phase: 4
has mesh: D005334
has mesh heading: FEVER
has EFO: HP_0001945
has EFO name: FEVER

CHEMBL_IND_52977
type: DrugIndication
chembl id: CHEMBL_IND_52977
has molecule: CHEMBL1349
highest development phase: 2
has mesh: D003586
has mesh heading: CYTOMEGALOVIRUS INFECTIONS
has EFO: EFO_0001062
has EFO name: CYTOMEGALOVIRUS INFECTION

CHEMBL_IND_54263
type: DrugIndication
chembl id: CHEMBL_IND_54263
has molecule: CHEMBL1349
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_54211
type: DrugIndication
chembl id: CHEMBL_IND_54211
has molecule: CHEMBL1349
highest development phase: 4
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_53491
type: DrugIndication
chembl id: CHEMBL_IND_53491
has molecule: CHEMBL1349
highest development phase: 2
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_52839
type: DrugIndication
chembl id: CHEMBL_IND_52839
has molecule: CHEMBL1349
highest development phase: 2
has mesh: D015451
has mesh heading: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
has EFO: EFO_0000095
has EFO name: CHRONIC LYMPHOCYTIC LEUKEMIA

CHEMBL_IND_53893
type: DrugIndication
chembl id: CHEMBL_IND_53893
has molecule: CHEMBL1349
highest development phase: 4
has mesh: D006562
has mesh heading: HERPES ZOSTER
has EFO: EFO_0006510
has EFO name: HERPES ZOSTER

CHEMBL_IND_52786
type: DrugIndication
chembl id: CHEMBL_IND_52786
has molecule: CHEMBL1349
highest development phase: 4
has mesh: D014777
has mesh heading: VIRUS DISEASES
has EFO: EFO_0000763
has EFO name: VIRAL DISEASE

CHEMBL_IND_53093
type: DrugIndication
chembl id: CHEMBL_IND_53093
has molecule: CHEMBL1349
highest development phase: 4
has mesh: D006558
has mesh heading: HERPES GENITALIS
has EFO: EFO_0007282
has EFO name: GENITAL HERPES

CHEMBL_IND_53064
type: DrugIndication
chembl id: CHEMBL_IND_53064
has molecule: CHEMBL1349
highest development phase: 2
has mesh: D019698
has mesh heading: HEPATITIS C, CHRONIC
has EFO: EFO_0004220
has EFO name: CHRONIC HEPATITIS C INFECTION

CHEMBL_IND_54424
type: DrugIndication
chembl id: CHEMBL_IND_54424
has molecule: CHEMBL1349
highest development phase: 1
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_26737
type: DrugIndication
chembl id: CHEMBL_IND_26737
has molecule: CHEMBL1373
highest development phase: 1
has mesh: D014012
has mesh heading: TINNITUS
has EFO: HP_0000360
has EFO name: TINNITUS

CHEMBL_IND_48750
type: DrugIndication
chembl id: CHEMBL_IND_48750
has molecule: CHEMBL1373
highest development phase: 2
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: EFO_0001075
has EFO name: OVARIAN CARCINOMA

CHEMBL_IND_44754
type: DrugIndication
chembl id: CHEMBL_IND_44754
has molecule: CHEMBL1373
highest development phase: 3
has mesh: D020521
has mesh heading: STROKE
has EFO: EFO_0000712
has EFO name: STROKE

CHEMBL_IND_45409
type: DrugIndication
chembl id: CHEMBL_IND_45409
has molecule: CHEMBL1373
highest development phase: 3
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_26153
type: DrugIndication
chembl id: CHEMBL_IND_26153
has molecule: CHEMBL1373
highest development phase: 0
has mesh: D007024
has mesh heading: HYPOTENSION, ORTHOSTATIC
has EFO: EFO_0005252
has EFO name: ORTHOSTATIC HYPOTENSION

CHEMBL_IND_26152
type: DrugIndication
chembl id: CHEMBL_IND_26152
has molecule: CHEMBL1373
highest development phase: 3
has mesh: D009290
has mesh heading: NARCOLEPSY
has EFO: EFO_0000614
has EFO name: NARCOLEPSY WITH CATAPLEXY

CHEMBL_IND_26151
type: DrugIndication
chembl id: CHEMBL_IND_26151
has molecule: CHEMBL1373
highest development phase: 2
has mesh: D005221
has mesh heading: FATIGUE
has EFO: HP_0012378
has EFO name: FATIGUE

CHEMBL_IND_26150
type: DrugIndication
chembl id: CHEMBL_IND_26150
has molecule: CHEMBL1373
highest development phase: 3
has mesh: D001932
has mesh heading: BRAIN NEOPLASMS
has EFO: EFO_0003833
has EFO name: BRAIN NEOPLASM

CHEMBL_IND_44343
type: DrugIndication
chembl id: CHEMBL_IND_44343
has molecule: CHEMBL1373
highest development phase: 2
has mesh: D012512
has mesh heading: SARCOMA, EWING
has EFO: EFO_0000174
has EFO name: EWING SARCOMA

CHEMBL_IND_27321
type: DrugIndication
chembl id: CHEMBL_IND_27321
has molecule: CHEMBL1373
highest development phase: 1
has mesh: D012891
has mesh heading: SLEEP APNEA SYNDROMES
has EFO: EFO_0003877
has EFO name: SLEEP APNEA

CHEMBL_IND_27320
type: DrugIndication
chembl id: CHEMBL_IND_27320
has molecule: CHEMBL1373
highest development phase: 2
has mesh: D013313
has mesh heading: STRESS DISORDERS, POST-TRAUMATIC
has EFO: EFO_0001358
has EFO name: POST-TRAUMATIC STRESS DISORDER

CHEMBL_IND_24663
type: DrugIndication
chembl id: CHEMBL_IND_24663
has molecule: CHEMBL1373
highest development phase: 2
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_23522
type: DrugIndication
chembl id: CHEMBL_IND_23522
has molecule: CHEMBL1373
highest development phase: 2
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_23521
type: DrugIndication
chembl id: CHEMBL_IND_23521
has molecule: CHEMBL1373
highest development phase: 2
has mesh: D019969
has mesh heading: AMPHETAMINE-RELATED DISORDERS
has EFO: EFO_0004701
has EFO name: METAMPHETAMINE DEPENDENCE

CHEMBL_IND_23520
type: DrugIndication
chembl id: CHEMBL_IND_23520
has molecule: CHEMBL1373
highest development phase: 2
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_23519
type: DrugIndication
chembl id: CHEMBL_IND_23519
has molecule: CHEMBL1373
highest development phase: 4
has mesh: D001289
has mesh heading: ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY
has EFO: EFO_0003888
has EFO name: ATTENTION DEFICIT HYPERACTIVITY DISORDER

CHEMBL_IND_47070
type: DrugIndication
chembl id: CHEMBL_IND_47070
has molecule: CHEMBL189963
highest development phase: 2
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_41219
type: DrugIndication
chembl id: CHEMBL_IND_41219
has molecule: CHEMBL189963
highest development phase: 4
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0003869
has EFO name: BREAST NEOPLASM

CHEMBL_IND_52462
type: DrugIndication
chembl id: CHEMBL_IND_52462
has molecule: CHEMBL189963
highest development phase: 2
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_25541
type: DrugIndication
chembl id: CHEMBL_IND_25541
has molecule: CHEMBL189963
highest development phase: 4
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_51966
type: DrugIndication
chembl id: CHEMBL_IND_51966
has molecule: CHEMBL189963
highest development phase: 2
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000708
has EFO name: SQUAMOUS CELL LUNG CARCINOMA

CHEMBL_IND_52113
type: DrugIndication
chembl id: CHEMBL_IND_52113
has molecule: CHEMBL189963
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_44174
type: DrugIndication
chembl id: CHEMBL_IND_44174
has molecule: CHEMBL189963
highest development phase: 1
has mesh: D008228
has mesh heading: LYMPHOMA, NON-HODGKIN
has EFO: EFO_0005952
has EFO name: NON-HODGKINS LYMPHOMA

CHEMBL_IND_47278
type: DrugIndication
chembl id: CHEMBL_IND_47278
has molecule: CHEMBL189963
highest development phase: 2
has mesh: D008080
has mesh heading: LIPOSARCOMA
has EFO: EFO_0000569
has EFO name: LIPOSARCOMA

CHEMBL_IND_40517
type: DrugIndication
chembl id: CHEMBL_IND_40517
has molecule: CHEMBL189963
highest development phase: 1
has mesh: D020522
has mesh heading: LYMPHOMA, MANTLE-CELL
has EFO: EFO_1001469
has EFO name: MANTLE CELL LYMPHOMA

CHEMBL_IND_42695
type: DrugIndication
chembl id: CHEMBL_IND_42695
has molecule: CHEMBL189963
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_43209
type: DrugIndication
chembl id: CHEMBL_IND_43209
has molecule: CHEMBL184412
highest development phase: 4
has mesh: D001281
has mesh heading: ATRIAL FIBRILLATION
has EFO: EFO_0000275
has EFO name: ATRIAL FIBRILLATION

CHEMBL_IND_43012
type: DrugIndication
chembl id: CHEMBL_IND_43012
has molecule: CHEMBL184412
highest development phase: 4
has mesh: D001145
has mesh heading: ARRHYTHMIAS, CARDIAC
has EFO: EFO_0004269
has EFO name: CARDIAC ARRHYTHMIA

CHEMBL_IND_44527
type: DrugIndication
chembl id: CHEMBL_IND_44527
has molecule: CHEMBL184412
highest development phase: 3
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0000373
has EFO name: CONGESTIVE HEART FAILURE

CHEMBL_IND_42031
type: DrugIndication
chembl id: CHEMBL_IND_42031
has molecule: CHEMBL1366
highest development phase: 4
has mesh: D001172
has mesh heading: ARTHRITIS, RHEUMATOID
has EFO: EFO_0000685
has EFO name: RHEUMATOID ARTHRITIS

CHEMBL_IND_49367
type: DrugIndication
chembl id: CHEMBL_IND_49367
has molecule: CHEMBL1366
highest development phase: 1
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_52559
type: DrugIndication
chembl id: CHEMBL_IND_52559
has molecule: CHEMBL1366
highest development phase: 2
has mesh: D014376
has mesh heading: TUBERCULOSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: TUBERCULOSIS

CHEMBL_IND_46259
type: DrugIndication
chembl id: CHEMBL_IND_46259
has molecule: CHEMBL1366
highest development phase: 2
has mesh: D015451
has mesh heading: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
has EFO: EFO_0000095
has EFO name: CHRONIC LYMPHOCYTIC LEUKEMIA

CHEMBL_IND_40994
type: DrugIndication
chembl id: CHEMBL_IND_40994
has molecule: CHEMBL1366
highest development phase: 2
has mesh: D005873
has mesh heading: GIARDIASIS
has EFO: DOID:10718
has EFO name: GIARDIASIS

CHEMBL_IND_46686
type: DrugIndication
chembl id: CHEMBL_IND_46686
has molecule: CHEMBL178459
highest development phase: 2
has mesh: D008103
has mesh heading: LIVER CIRRHOSIS
has EFO: EFO_0001422
has EFO name: CIRRHOSIS OF LIVER

CHEMBL_IND_45899
type: DrugIndication
chembl id: CHEMBL_IND_45899
has molecule: CHEMBL178459
highest development phase: 3
has mesh: D065626
has mesh heading: NON-ALCOHOLIC FATTY LIVER DISEASE
has EFO: EFO_0003095
has EFO name: NON-ALCOHOLIC FATTY LIVER DISEASE

CHEMBL_IND_54104
type: DrugIndication
chembl id: CHEMBL_IND_54104
has molecule: CHEMBL182066
highest development phase: 2
has mesh: D009437
has mesh heading: NEURALGIA
has EFO: EFO_0005762
has EFO name: NEUROPATHIC PAIN

CHEMBL_IND_52975
type: DrugIndication
chembl id: CHEMBL_IND_52975
has molecule: CHEMBL1380
highest development phase: 2
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_54551
type: DrugIndication
chembl id: CHEMBL_IND_54551
has molecule: CHEMBL1380
highest development phase: 2
has mesh: D008060
has mesh heading: LIPODYSTROPHY
has EFO: EFO_1000727
has EFO name: LIPODYSTROPHY

CHEMBL_IND_54473
type: DrugIndication
chembl id: CHEMBL_IND_54473
has molecule: CHEMBL1380
highest development phase: 3
has mesh: D000163
has mesh heading: ACQUIRED IMMUNODEFICIENCY SYNDROME
has EFO: EFO_0000765
has EFO name: AIDS

CHEMBL_IND_49254
type: DrugIndication
chembl id: CHEMBL_IND_49254
has molecule: CHEMBL1351
highest development phase: 1
has mesh: D005909
has mesh heading: GLIOBLASTOMA
has EFO: EFO_0000519
has EFO name: GLIOBLASTOMA MULTIFORME

CHEMBL_IND_48050
type: DrugIndication
chembl id: CHEMBL_IND_48050
has molecule: CHEMBL1351
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_47928
type: DrugIndication
chembl id: CHEMBL_IND_47928
has molecule: CHEMBL1351
highest development phase: 1
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_47892
type: DrugIndication
chembl id: CHEMBL_IND_47892
has molecule: CHEMBL1351
highest development phase: 1
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000292
has EFO name: BLADDER CARCINOMA

CHEMBL_IND_45739
type: DrugIndication
chembl id: CHEMBL_IND_45739
has molecule: CHEMBL1351
highest development phase: 3
has mesh: D002583
has mesh heading: UTERINE CERVICAL NEOPLASMS
has EFO: EFO_0001061
has EFO name: CERVICAL CARCINOMA

CHEMBL_IND_40661
type: DrugIndication
chembl id: CHEMBL_IND_40661
has molecule: CHEMBL1351
highest development phase: 2
has mesh: D004806
has mesh heading: EPENDYMOMA
has EFO: EFO_1000028
has EFO name: EPENDYMOMA

CHEMBL_IND_45621
type: DrugIndication
chembl id: CHEMBL_IND_45621
has molecule: CHEMBL1351
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_29239
type: DrugIndication
chembl id: CHEMBL_IND_29239
has molecule: CHEMBL1351
highest development phase: 4
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: EFO_0001075
has EFO name: OVARIAN CARCINOMA

CHEMBL_IND_48942
type: DrugIndication
chembl id: CHEMBL_IND_48942
has molecule: CHEMBL1351
highest development phase: 3
has mesh: D012878
has mesh heading: SKIN NEOPLASMS
has EFO: EFO_0004198
has EFO name: SKIN NEOPLASM

CHEMBL_IND_43264
type: DrugIndication
chembl id: CHEMBL_IND_43264
has molecule: CHEMBL1351
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_43233
type: DrugIndication
chembl id: CHEMBL_IND_43233
has molecule: CHEMBL1351
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_44970
type: DrugIndication
chembl id: CHEMBL_IND_44970
has molecule: CHEMBL1351
highest development phase: 3
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_51669
type: DrugIndication
chembl id: CHEMBL_IND_51669
has molecule: CHEMBL1351
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_51793
type: DrugIndication
chembl id: CHEMBL_IND_51793
has molecule: CHEMBL1351
highest development phase: 3
has mesh: D012175
has mesh heading: RETINOBLASTOMA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: RETINOBLASTOMA

CHEMBL_IND_43868
type: DrugIndication
chembl id: CHEMBL_IND_43868
has molecule: CHEMBL1353
highest development phase: 2
has mesh: D007674
has mesh heading: KIDNEY DISEASES
has EFO: EFO_0003086
has EFO name: KIDNEY DISEASE

CHEMBL_IND_45292
type: DrugIndication
chembl id: CHEMBL_IND_45292
has molecule: CHEMBL1353
highest development phase: 3
has mesh: D058186
has mesh heading: ACUTE KIDNEY INJURY
has EFO: HP_0001919
has EFO name: ACUTE KIDNEY INJURY

CHEMBL_IND_45187
type: DrugIndication
chembl id: CHEMBL_IND_45187
has molecule: CHEMBL1353
highest development phase: 2
has mesh: D016757
has mesh heading: DEATH, SUDDEN, CARDIAC
has EFO: EFO_0004278
has EFO name: SUDDEN CARDIAC ARREST

CHEMBL_IND_45102
type: DrugIndication
chembl id: CHEMBL_IND_45102
has molecule: CHEMBL1353
highest development phase: 3
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_46476
type: DrugIndication
chembl id: CHEMBL_IND_46476
has molecule: CHEMBL1353
highest development phase: 3
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_45476
type: DrugIndication
chembl id: CHEMBL_IND_45476
has molecule: CHEMBL1353
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_44313
type: DrugIndication
chembl id: CHEMBL_IND_44313
has molecule: CHEMBL1353
highest development phase: 1
has mesh: D003550
has mesh heading: CYSTIC FIBROSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CYSTIC FIBROSIS

CHEMBL_IND_43546
type: DrugIndication
chembl id: CHEMBL_IND_43546
has molecule: CHEMBL178803
highest development phase: 3
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_46072
type: DrugIndication
chembl id: CHEMBL_IND_46072
has molecule: CHEMBL189676
highest development phase: 2
has mesh: D016540
has mesh heading: SMOKING CESSATION
has EFO: EFO_0004319
has EFO name: SMOKING CESSATION

CHEMBL_IND_26868
type: DrugIndication
chembl id: CHEMBL_IND_26868
has molecule: CHEMBL193240
highest development phase: 2
has mesh: D003704
has mesh heading: DEMENTIA
has EFO: EFO_0003862
has EFO name: DEMENTIA

CHEMBL_IND_52571
type: DrugIndication
chembl id: CHEMBL_IND_52571
has molecule: CHEMBL193240
highest development phase: 2
has mesh: D003876
has mesh heading: DERMATITIS, ATOPIC
has EFO: EFO_0000274
has EFO name: ATOPIC ECZEMA

CHEMBL_IND_25623
type: DrugIndication
chembl id: CHEMBL_IND_25623
has molecule: CHEMBL193240
highest development phase: 4
has mesh: D008173
has mesh heading: LUNG DISEASES, OBSTRUCTIVE
has EFO: HP_0006536
has EFO name: OBSTRUCTIVE LUNG DISEASE

CHEMBL_IND_26268
type: DrugIndication
chembl id: CHEMBL_IND_26268
has molecule: CHEMBL193240
highest development phase: 2
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_26267
type: DrugIndication
chembl id: CHEMBL_IND_26267
has molecule: CHEMBL193240
highest development phase: 1
has mesh: D009765
has mesh heading: OBESITY
has EFO: EFO_0001073
has EFO name: OBESITY

CHEMBL_IND_23825
type: DrugIndication
chembl id: CHEMBL_IND_23825
has molecule: CHEMBL193240
highest development phase: 2
has mesh: D065626
has mesh heading: NON-ALCOHOLIC FATTY LIVER DISEASE
has EFO: EFO_0003095
has EFO name: NON-ALCOHOLIC FATTY LIVER DISEASE

CHEMBL_IND_23824
type: DrugIndication
chembl id: CHEMBL_IND_23824
has molecule: CHEMBL193240
highest development phase: 4
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_23823
type: DrugIndication
chembl id: CHEMBL_IND_23823
has molecule: CHEMBL193240
highest development phase: 2
has mesh: D001987
has mesh heading: BRONCHIECTASIS
has EFO: HP_0002110
has EFO name: BRONCHIECTASIS

CHEMBL_IND_23822
type: DrugIndication
chembl id: CHEMBL_IND_23822
has molecule: CHEMBL193240
highest development phase: 2
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_27426
type: DrugIndication
chembl id: CHEMBL_IND_27426
has molecule: CHEMBL193240
highest development phase: 1
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_27425
type: DrugIndication
chembl id: CHEMBL_IND_27425
has molecule: CHEMBL193240
highest development phase: 2
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_27424
type: DrugIndication
chembl id: CHEMBL_IND_27424
has molecule: CHEMBL193240
highest development phase: 2
has mesh: D004485
has mesh heading: ECZEMA
has EFO: HP_0000964
has EFO name: ECZEMA

CHEMBL_IND_47039
type: DrugIndication
chembl id: CHEMBL_IND_47039
has molecule: CHEMBL198362
highest development phase: 2
has mesh: D000755
has mesh heading: ANEMIA, SICKLE CELL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SICKLE CELL ANEMIA

CHEMBL_IND_26864
type: DrugIndication
chembl id: CHEMBL_IND_26864
has molecule: CHEMBL198362
highest development phase: 2
has mesh: D054058
has mesh heading: ACUTE CORONARY SYNDROME
has EFO: EFO_0005672
has EFO name: ACUTE CORONARY SYNDROME

CHEMBL_IND_43737
type: DrugIndication
chembl id: CHEMBL_IND_43737
has molecule: CHEMBL198362
highest development phase: 3
has mesh: D008103
has mesh heading: LIVER CIRRHOSIS
has EFO: EFO_0001422
has EFO name: CIRRHOSIS OF LIVER

CHEMBL_IND_48019
type: DrugIndication
chembl id: CHEMBL_IND_48019
has molecule: CHEMBL198362
highest development phase: 3
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_25620
type: DrugIndication
chembl id: CHEMBL_IND_25620
has molecule: CHEMBL198362
highest development phase: 3
has mesh: D054556
has mesh heading: VENOUS THROMBOEMBOLISM
has EFO: EFO_0004286
has EFO name: VENOUS THROMBOEMBOLISM

CHEMBL_IND_28368
type: DrugIndication
chembl id: CHEMBL_IND_28368
has molecule: CHEMBL198362
highest development phase: 1
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_28538
type: DrugIndication
chembl id: CHEMBL_IND_28538
has molecule: CHEMBL198362
highest development phase: 4
has mesh: D013927
has mesh heading: THROMBOSIS
has EFO: HP_0004419
has EFO name: RECURRENT THROMBOPHLEBITIS

CHEMBL_IND_23817
type: DrugIndication
chembl id: CHEMBL_IND_23817
has molecule: CHEMBL198362
highest development phase: 4
has mesh: D020246
has mesh heading: VENOUS THROMBOSIS
has EFO: HP_0004936
has EFO name: VENOUS THROMBOSIS

CHEMBL_IND_23816
type: DrugIndication
chembl id: CHEMBL_IND_23816
has molecule: CHEMBL198362
highest development phase: 3
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_23815
type: DrugIndication
chembl id: CHEMBL_IND_23815
has molecule: CHEMBL198362
highest development phase: 4
has mesh: D001281
has mesh heading: ATRIAL FIBRILLATION
has EFO: EFO_0000275
has EFO name: ATRIAL FIBRILLATION

CHEMBL_IND_27917
type: DrugIndication
chembl id: CHEMBL_IND_27917
has molecule: CHEMBL198362
highest development phase: 4
has mesh: D011655
has mesh heading: PULMONARY EMBOLISM
has EFO: EFO_0003827
has EFO name: PULMONARY EMBOLISM

CHEMBL_IND_24860
type: DrugIndication
chembl id: CHEMBL_IND_24860
has molecule: CHEMBL198362
highest development phase: 3
has mesh: D016736
has mesh heading: ANTIPHOSPHOLIPID SYNDROME
has EFO: EFO_0002689
has EFO name: PRIMARY ANTIPHOSPHOLIPID SYNDROME

CHEMBL_IND_24859
type: DrugIndication
chembl id: CHEMBL_IND_24859
has molecule: CHEMBL198362
highest development phase: 3
has mesh: D013921
has mesh heading: THROMBOCYTOPENIA
has EFO: HP_0011874
has EFO name: HEPARIN-INDUCED THROMBOCYTOPENIA

CHEMBL_IND_24858
type: DrugIndication
chembl id: CHEMBL_IND_24858
has molecule: CHEMBL198362
highest development phase: 4
has mesh: D020246
has mesh heading: VENOUS THROMBOSIS
has EFO: EFO_0003907
has EFO name: DEEP VEIN THROMBOSIS

CHEMBL_IND_44199
type: DrugIndication
chembl id: CHEMBL_IND_44199
has molecule: CHEMBL1370
highest development phase: 3
has mesh: D000532
has mesh heading: ALTITUDE SICKNESS
has EFO: EFO_1000782
has EFO name: ALTITUDE SICKNESS

CHEMBL_IND_27064
type: DrugIndication
chembl id: CHEMBL_IND_27064
has molecule: CHEMBL1370
highest development phase: 2
has mesh: D011349
has mesh heading: PROCTITIS
has EFO: EFO_0005628
has EFO name: PROCTITIS

CHEMBL_IND_27063
type: DrugIndication
chembl id: CHEMBL_IND_27063
has molecule: CHEMBL1370
highest development phase: 3
has mesh: D009298
has mesh heading: NASAL POLYPS
has EFO: EFO_1000391
has EFO name: NASAL CAVITY POLYP

CHEMBL_IND_27062
type: DrugIndication
chembl id: CHEMBL_IND_27062
has molecule: CHEMBL1370
highest development phase: 2
has mesh: D005922
has mesh heading: GLOMERULONEPHRITIS, IGA
has EFO: EFO_0004194
has EFO name: IGA GLOMERULONEPHRITIS

CHEMBL_IND_25833
type: DrugIndication
chembl id: CHEMBL_IND_25833
has molecule: CHEMBL1370
highest development phase: 4
has mesh: D008173
has mesh heading: LUNG DISEASES, OBSTRUCTIVE
has EFO: HP_0006536
has EFO name: OBSTRUCTIVE LUNG DISEASE

CHEMBL_IND_51990
type: DrugIndication
chembl id: CHEMBL_IND_51990
has molecule: CHEMBL1370
highest development phase: 1
has mesh: D006967
has mesh heading: HYPERSENSITIVITY
has EFO: EFO_0003785
has EFO name: ALLERGY

CHEMBL_IND_27588
type: DrugIndication
chembl id: CHEMBL_IND_27588
has molecule: CHEMBL1370
highest development phase: 2
has mesh: D004066
has mesh heading: DIGESTIVE SYSTEM DISEASES
has EFO: EFO_0000405
has EFO name: DIGESTIVE SYSTEM DISEASE

CHEMBL_IND_40132
type: DrugIndication
chembl id: CHEMBL_IND_40132
has molecule: CHEMBL1370
highest development phase: 3
has mesh: D012852
has mesh heading: SINUSITIS
has EFO: EFO_0007486
has EFO name: SINUSITIS

CHEMBL_IND_22801
type: DrugIndication
chembl id: CHEMBL_IND_22801
has molecule: CHEMBL1370
highest development phase: 4
has mesh: D003093
has mesh heading: COLITIS, ULCERATIVE
has EFO: EFO_0000729
has EFO name: ULCERATIVE COLITIS

CHEMBL_IND_22800
type: DrugIndication
chembl id: CHEMBL_IND_22800
has molecule: CHEMBL1370
highest development phase: 2
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_22799
type: DrugIndication
chembl id: CHEMBL_IND_22799
has molecule: CHEMBL1370
highest development phase: 4
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_22798
type: DrugIndication
chembl id: CHEMBL_IND_22798
has molecule: CHEMBL1370
highest development phase: 4
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_22797
type: DrugIndication
chembl id: CHEMBL_IND_22797
has molecule: CHEMBL1370
highest development phase: 4
has mesh: D006255
has mesh heading: RHINITIS, ALLERGIC, SEASONAL
has EFO: EFO_0005854
has EFO name: ALLERGIC RHINITIS

CHEMBL_IND_25126
type: DrugIndication
chembl id: CHEMBL_IND_25126
has molecule: CHEMBL1370
highest development phase: 3
has mesh: D001997
has mesh heading: BRONCHOPULMONARY DYSPLASIA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: BRONCHOPULMONARY DYSPLASIA

CHEMBL_IND_25125
type: DrugIndication
chembl id: CHEMBL_IND_25125
has molecule: CHEMBL1370
highest development phase: 3
has mesh: D006086
has mesh heading: GRAFT VS HOST DISEASE
has EFO: EFO_0004599
has EFO name: ACUTE GRAFT VS. HOST DISEASE

CHEMBL_IND_24222
type: DrugIndication
chembl id: CHEMBL_IND_24222
has molecule: CHEMBL1370
highest development phase: 4
has mesh: D006255
has mesh heading: RHINITIS, ALLERGIC, SEASONAL
has EFO: EFO_0003956
has EFO name: SEASONAL ALLERGIC RHINITIS

CHEMBL_IND_24221
type: DrugIndication
chembl id: CHEMBL_IND_24221
has molecule: CHEMBL1370
highest development phase: 4
has mesh: D015508
has mesh heading: NASAL OBSTRUCTION
has EFO: HP_0001742
has EFO name: NASAL OBSTRUCTION

CHEMBL_IND_24220
type: DrugIndication
chembl id: CHEMBL_IND_24220
has molecule: CHEMBL1370
highest development phase: 3
has mesh: D057765
has mesh heading: EOSINOPHILIC ESOPHAGITIS
has EFO: EFO_0004232
has EFO name: EOSINOPHILIC ESOPHAGITIS

CHEMBL_IND_24219
type: DrugIndication
chembl id: CHEMBL_IND_24219
has molecule: CHEMBL1370
highest development phase: 4
has mesh: D003424
has mesh heading: CROHN DISEASE
has EFO: EFO_0000384
has EFO name: CROHN'S DISEASE

CHEMBL_IND_50100
type: DrugIndication
chembl id: CHEMBL_IND_50100
has molecule: CHEMBL203266
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_50265
type: DrugIndication
chembl id: CHEMBL_IND_50265
has molecule: CHEMBL203266
highest development phase: 2
has mesh: D002312
has mesh heading: CARDIOMYOPATHY, HYPERTROPHIC
has EFO: EFO_0000538
has EFO name: HYPERTROPHIC CARDIOMYOPATHY

CHEMBL_IND_54979
type: DrugIndication
chembl id: CHEMBL_IND_54979
has molecule: CHEMBL203266
highest development phase: 2
has mesh: D006976
has mesh heading: HYPERTENSION, PULMONARY
has EFO: EFO_0001361
has EFO name: PULMONARY HYPERTENSION

CHEMBL_IND_47098
type: DrugIndication
chembl id: CHEMBL_IND_47098
has molecule: CHEMBL188462
highest development phase: 2
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_48909
type: DrugIndication
chembl id: CHEMBL_IND_48909
has molecule: CHEMBL188462
highest development phase: 2
has mesh: D001289
has mesh heading: ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY
has EFO: EFO_0003888
has EFO name: ATTENTION DEFICIT HYPERACTIVITY DISORDER

CHEMBL_IND_47347
type: DrugIndication
chembl id: CHEMBL_IND_47347
has molecule: CHEMBL188462
highest development phase: 2
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_48135
type: DrugIndication
chembl id: CHEMBL_IND_48135
has molecule: CHEMBL191886
highest development phase: 2
has mesh: D006976
has mesh heading: HYPERTENSION, PULMONARY
has EFO: EFO_0001361
has EFO name: PULMONARY HYPERTENSION

CHEMBL_IND_54258
type: DrugIndication
chembl id: CHEMBL_IND_54258
has molecule: CHEMBL189475
highest development phase: 2
has mesh: D003922
has mesh heading: DIABETES MELLITUS, TYPE 1
has EFO: EFO_0001359
has EFO name: TYPE I DIABETES MELLITUS

CHEMBL_IND_54543
type: DrugIndication
chembl id: CHEMBL_IND_54543
has molecule: CHEMBL189475
highest development phase: 2
has mesh: D010391
has mesh heading: PEMPHIGOID, BULLOUS
has EFO: EFO_0007187
has EFO name: BULLOUS PEMPHIGOID

CHEMBL_IND_42635
type: DrugIndication
chembl id: CHEMBL_IND_42635
has molecule: CHEMBL207413
highest development phase: 4
has mesh: D010437
has mesh heading: PEPTIC ULCER
has EFO: HP_0004398
has EFO name: PEPTIC ULCER

CHEMBL_IND_42061
type: DrugIndication
chembl id: CHEMBL_IND_42061
has molecule: CHEMBL207413
highest development phase: 4
has mesh: D005764
has mesh heading: GASTROESOPHAGEAL REFLUX
has EFO: EFO_0003948
has EFO name: GASTROESOPHAGEAL REFLUX DISEASE

CHEMBL_IND_47107
type: DrugIndication
chembl id: CHEMBL_IND_47107
has molecule: CHEMBL207433
highest development phase: 1
has mesh: D003876
has mesh heading: DERMATITIS, ATOPIC
has EFO: EFO_0000274
has EFO name: ATOPIC ECZEMA

CHEMBL_IND_44261
type: DrugIndication
chembl id: CHEMBL_IND_44261
has molecule: CHEMBL207433
highest development phase: 2
has mesh: D003371
has mesh heading: COUGH
has EFO: HP_0012735
has EFO name: COUGH

CHEMBL_IND_46208
type: DrugIndication
chembl id: CHEMBL_IND_46208
has molecule: CHEMBL207433
highest development phase: 2
has mesh: D012220
has mesh heading: RHINITIS
has EFO: HP_0012384
has EFO name: RHINITIS

CHEMBL_IND_44842
type: DrugIndication
chembl id: CHEMBL_IND_44842
has molecule: CHEMBL1411
highest development phase: 1
has mesh: D003922
has mesh heading: DIABETES MELLITUS, TYPE 1
has EFO: EFO_0001359
has EFO name: TYPE I DIABETES MELLITUS

CHEMBL_IND_51983
type: DrugIndication
chembl id: CHEMBL_IND_51983
has molecule: CHEMBL1410
highest development phase: 3
has mesh: D011247
has mesh heading: PREGNANCY
has EFO: EFO_0002950
has EFO name: PREGNANCY

CHEMBL_IND_47387
type: DrugIndication
chembl id: CHEMBL_IND_47387
has molecule: CHEMBL1410
highest development phase: 0
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_42038
type: DrugIndication
chembl id: CHEMBL_IND_42038
has molecule: CHEMBL204656
highest development phase: 4
has mesh: D014777
has mesh heading: VIRUS DISEASES
has EFO: EFO_0000763
has EFO name: VIRAL DISEASE

CHEMBL_IND_48733
type: DrugIndication
chembl id: CHEMBL_IND_48733
has molecule: CHEMBL204656
highest development phase: 4
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_28637
type: DrugIndication
chembl id: CHEMBL_IND_28637
has molecule: CHEMBL204656
highest development phase: 4
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000180
has EFO name: HIV-1 INFECTION

CHEMBL_IND_45831
type: DrugIndication
chembl id: CHEMBL_IND_45831
has molecule: CHEMBL206834
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_44334
type: DrugIndication
chembl id: CHEMBL_IND_44334
has molecule: CHEMBL206834
highest development phase: 2
has mesh: D015451
has mesh heading: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
has EFO: EFO_0000095
has EFO name: CHRONIC LYMPHOCYTIC LEUKEMIA

CHEMBL_IND_26854
type: DrugIndication
chembl id: CHEMBL_IND_26854
has molecule: CHEMBL1404
highest development phase: 2
has mesh: D043183
has mesh heading: IRRITABLE BOWEL SYNDROME
has EFO: EFO_0000555
has EFO name: IRRITABLE BOWEL SYNDROME

CHEMBL_IND_26853
type: DrugIndication
chembl id: CHEMBL_IND_26853
has molecule: CHEMBL1404
highest development phase: 2
has mesh: D054058
has mesh heading: ACUTE CORONARY SYNDROME
has EFO: EFO_0005672
has EFO name: ACUTE CORONARY SYNDROME

CHEMBL_IND_42951
type: DrugIndication
chembl id: CHEMBL_IND_42951
has molecule: CHEMBL1404
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_25607
type: DrugIndication
chembl id: CHEMBL_IND_25607
has molecule: CHEMBL1404
highest development phase: 3
has mesh: D001281
has mesh heading: ATRIAL FIBRILLATION
has EFO: EFO_0000275
has EFO name: ATRIAL FIBRILLATION

CHEMBL_IND_28357
type: DrugIndication
chembl id: CHEMBL_IND_28357
has molecule: CHEMBL1404
highest development phase: 1
has mesh: D006976
has mesh heading: HYPERTENSION, PULMONARY
has EFO: EFO_0001361
has EFO name: PULMONARY HYPERTENSION

CHEMBL_IND_46054
type: DrugIndication
chembl id: CHEMBL_IND_46054
has molecule: CHEMBL1404
highest development phase: 2
has mesh: D014652
has mesh heading: VASCULAR DISEASES
has EFO: EFO_0004264
has EFO name: VASCULAR DISEASE

CHEMBL_IND_23781
type: DrugIndication
chembl id: CHEMBL_IND_23781
has molecule: CHEMBL1404
highest development phase: 3
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_23780
type: DrugIndication
chembl id: CHEMBL_IND_23780
has molecule: CHEMBL1404
highest development phase: 2
has mesh: D002311
has mesh heading: CARDIOMYOPATHY, DILATED
has EFO: EFO_0000407
has EFO name: DILATED CARDIOMYOPATHY

CHEMBL_IND_23779
type: DrugIndication
chembl id: CHEMBL_IND_23779
has molecule: CHEMBL1404
highest development phase: 3
has mesh: D003324
has mesh heading: CORONARY ARTERY DISEASE
has EFO: EFO_0000378
has EFO name: CORONARY ARTERY DISEASE

CHEMBL_IND_27909
type: DrugIndication
chembl id: CHEMBL_IND_27909
has molecule: CHEMBL1404
highest development phase: 2
has mesh: D008133
has mesh heading: LONG QT SYNDROME
has EFO: HP_0001657
has EFO name: PROLONGED QT INTERVAL

CHEMBL_IND_51894
type: DrugIndication
chembl id: CHEMBL_IND_51894
has molecule: CHEMBL1404
highest development phase: 2
has mesh: D054144
has mesh heading: HEART FAILURE, DIASTOLIC
has EFO: EFO_1000899
has EFO name: DIASTOLIC HEART FAILURE

CHEMBL_IND_51755
type: DrugIndication
chembl id: CHEMBL_IND_51755
has molecule: CHEMBL1404
highest development phase: 3
has mesh: D017202
has mesh heading: MYOCARDIAL ISCHEMIA
has EFO: EFO_1001375
has EFO name: MYOCARDIAL ISCHEMIA

CHEMBL_IND_51637
type: DrugIndication
chembl id: CHEMBL_IND_51637
has molecule: CHEMBL1404
highest development phase: 4
has mesh: D060050
has mesh heading: ANGINA, STABLE
has EFO: EFO_0003913
has EFO name: ANGINA PECTORIS

CHEMBL_IND_51614
type: DrugIndication
chembl id: CHEMBL_IND_51614
has molecule: CHEMBL206253
highest development phase: 4
has mesh: D020250
has mesh heading: POSTOPERATIVE NAUSEA AND VOMITING
has EFO: EFO_0006911
has EFO name: CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING

CHEMBL_IND_50579
type: DrugIndication
chembl id: CHEMBL_IND_50579
has molecule: CHEMBL221959
highest development phase: 3
has mesh: D015535
has mesh heading: ARTHRITIS, PSORIATIC
has EFO: EFO_0003778
has EFO name: PSORIATIC ARTHRITIS

CHEMBL_IND_50758
type: DrugIndication
chembl id: CHEMBL_IND_50758
has molecule: CHEMBL221959
highest development phase: 1
has mesh: D008180
has mesh heading: LUPUS ERYTHEMATOSUS, SYSTEMIC
has EFO: EFO_0002690
has EFO name: SYSTEMIC LUPUS ERYTHEMATOSUS

CHEMBL_IND_50940
type: DrugIndication
chembl id: CHEMBL_IND_50940
has molecule: CHEMBL221959
highest development phase: 2
has mesh: D000506
has mesh heading: ALOPECIA AREATA
has EFO: EFO_0004192
has EFO name: ALOPECIA AREATA

CHEMBL_IND_50889
type: DrugIndication
chembl id: CHEMBL_IND_50889
has molecule: CHEMBL221959
highest development phase: 3
has mesh: D003093
has mesh heading: COLITIS, ULCERATIVE
has EFO: EFO_0000729
has EFO name: ULCERATIVE COLITIS

CHEMBL_IND_55320
type: DrugIndication
chembl id: CHEMBL_IND_55320
has molecule: CHEMBL221959
highest development phase: 2
has mesh: D013921
has mesh heading: THROMBOCYTOPENIA
has EFO: HP_0001873
has EFO name: THROMBOCYTOPENIA

CHEMBL_IND_53320
type: DrugIndication
chembl id: CHEMBL_IND_53320
has molecule: CHEMBL221959
highest development phase: 3
has mesh: D001171
has mesh heading: ARTHRITIS, JUVENILE
has EFO: EFO_0002609
has EFO name: CHRONIC CHILDHOOD ARTHRITIS

CHEMBL_IND_50180
type: DrugIndication
chembl id: CHEMBL_IND_50180
has molecule: CHEMBL221959
highest development phase: 4
has mesh: D007154
has mesh heading: IMMUNE SYSTEM DISEASES
has EFO: EFO_0000540
has EFO name: IMMUNE SYSTEM DISEASE

CHEMBL_IND_50288
type: DrugIndication
chembl id: CHEMBL_IND_50288
has molecule: CHEMBL221959
highest development phase: 4
has mesh: D001172
has mesh heading: ARTHRITIS, RHEUMATOID
has EFO: EFO_0000685
has EFO name: RHEUMATOID ARTHRITIS

CHEMBL_IND_55012
type: DrugIndication
chembl id: CHEMBL_IND_55012
has molecule: CHEMBL221959
highest development phase: 2
has mesh: D013167
has mesh heading: SPONDYLITIS, ANKYLOSING
has EFO: EFO_0003898
has EFO name: ANKYLOSING SPONDYLITIS

CHEMBL_IND_54960
type: DrugIndication
chembl id: CHEMBL_IND_54960
has molecule: CHEMBL221959
highest development phase: 1
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_50975
type: DrugIndication
chembl id: CHEMBL_IND_50975
has molecule: CHEMBL221959
highest development phase: 2
has mesh: D003876
has mesh heading: DERMATITIS, ATOPIC
has EFO: EFO_0000274
has EFO name: ATOPIC ECZEMA

CHEMBL_IND_26894
type: DrugIndication
chembl id: CHEMBL_IND_26894
has molecule: CHEMBL413
highest development phase: 3
has mesh: D018192
has mesh heading: LYMPHANGIOLEIOMYOMATOSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: LYMPHANGIOLEIOMYOMATOSIS

CHEMBL_IND_26893
type: DrugIndication
chembl id: CHEMBL_IND_26893
has molecule: CHEMBL413
highest development phase: 1
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_42844
type: DrugIndication
chembl id: CHEMBL_IND_42844
has molecule: CHEMBL413
highest development phase: 4
has mesh: D007154
has mesh heading: IMMUNE SYSTEM DISEASES
has EFO: EFO_0000540
has EFO name: IMMUNE SYSTEM DISEASE

CHEMBL_IND_26896
type: DrugIndication
chembl id: CHEMBL_IND_26896
has molecule: CHEMBL413
highest development phase: 2
has mesh: D008180
has mesh heading: LUPUS ERYTHEMATOSUS, SYSTEMIC
has EFO: EFO_0002690
has EFO name: SYSTEMIC LUPUS ERYTHEMATOSUS

CHEMBL_IND_46821
type: DrugIndication
chembl id: CHEMBL_IND_46821
has molecule: CHEMBL413
highest development phase: 2
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_45154
type: DrugIndication
chembl id: CHEMBL_IND_45154
has molecule: CHEMBL413
highest development phase: 3
has mesh: D012878
has mesh heading: SKIN NEOPLASMS
has EFO: EFO_0004198
has EFO name: SKIN NEOPLASM

CHEMBL_IND_40694
type: DrugIndication
chembl id: CHEMBL_IND_40694
has molecule: CHEMBL413
highest development phase: 2
has mesh: D015352
has mesh heading: DRY EYE SYNDROMES
has EFO: EFO_1000906
has EFO name: DRY EYE SYNDROME

CHEMBL_IND_25649
type: DrugIndication
chembl id: CHEMBL_IND_25649
has molecule: CHEMBL413
highest development phase: 1
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_25648
type: DrugIndication
chembl id: CHEMBL_IND_25648
has molecule: CHEMBL413
highest development phase: 2
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_25647
type: DrugIndication
chembl id: CHEMBL_IND_25647
has molecule: CHEMBL413
highest development phase: 3
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_48587
type: DrugIndication
chembl id: CHEMBL_IND_48587
has molecule: CHEMBL413
highest development phase: 2
has mesh: D003424
has mesh heading: CROHN DISEASE
has EFO: EFO_0000384
has EFO name: CROHN'S DISEASE

CHEMBL_IND_48543
type: DrugIndication
chembl id: CHEMBL_IND_48543
has molecule: CHEMBL413
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_45700
type: DrugIndication
chembl id: CHEMBL_IND_45700
has molecule: CHEMBL413
highest development phase: 1
has mesh: D012595
has mesh heading: SCLERODERMA, SYSTEMIC
has EFO: EFO_0000717
has EFO name: SYSTEMIC SCLERODERMA

CHEMBL_IND_52408
type: DrugIndication
chembl id: CHEMBL_IND_52408
has molecule: CHEMBL413
highest development phase: 1
has mesh: D012004
has mesh heading: RECTAL NEOPLASMS
has EFO: EFO_1000657
has EFO name: RECTUM CANCER

CHEMBL_IND_52367
type: DrugIndication
chembl id: CHEMBL_IND_52367
has molecule: CHEMBL413
highest development phase: 2
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_52304
type: DrugIndication
chembl id: CHEMBL_IND_52304
has molecule: CHEMBL413
highest development phase: 3
has mesh: D014605
has mesh heading: UVEITIS
has EFO: EFO_1001231
has EFO name: UVEITIS

CHEMBL_IND_28383
type: DrugIndication
chembl id: CHEMBL_IND_28383
has molecule: CHEMBL413
highest development phase: 1
has mesh: D053549
has mesh heading: PACHYONYCHIA CONGENITA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: PACHYONYCHIA CONGENITA

CHEMBL_IND_52271
type: DrugIndication
chembl id: CHEMBL_IND_52271
has molecule: CHEMBL413
highest development phase: 1
has mesh: D020529
has mesh heading: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
has EFO: EFO_0003929
has EFO name: RELAPSING-REMITTING MULTIPLE SCLEROSIS

CHEMBL_IND_43115
type: DrugIndication
chembl id: CHEMBL_IND_43115
has molecule: CHEMBL413
highest development phase: 1
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000180
has EFO name: HIV-1 INFECTION

CHEMBL_IND_26289
type: DrugIndication
chembl id: CHEMBL_IND_26289
has molecule: CHEMBL413
highest development phase: 0
has mesh: D010392
has mesh heading: PEMPHIGUS
has EFO: EFO_0004719
has EFO name: PEMPHIGUS VULGARIS

CHEMBL_IND_26288
type: DrugIndication
chembl id: CHEMBL_IND_26288
has molecule: CHEMBL413
highest development phase: 2
has mesh: D008268
has mesh heading: MACULAR DEGENERATION
has EFO: EFO_0001365
has EFO name: AGE-RELATED MACULAR DEGENERATION

CHEMBL_IND_23877
type: DrugIndication
chembl id: CHEMBL_IND_23877
has molecule: CHEMBL413
highest development phase: 3
has mesh: D003922
has mesh heading: DIABETES MELLITUS, TYPE 1
has EFO: EFO_0001359
has EFO name: TYPE I DIABETES MELLITUS

CHEMBL_IND_23876
type: DrugIndication
chembl id: CHEMBL_IND_23876
has molecule: CHEMBL413
highest development phase: 2
has mesh: D007674
has mesh heading: KIDNEY DISEASES
has EFO: EFO_0003086
has EFO name: KIDNEY DISEASE

CHEMBL_IND_23875
type: DrugIndication
chembl id: CHEMBL_IND_23875
has molecule: CHEMBL413
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_23874
type: DrugIndication
chembl id: CHEMBL_IND_23874
has molecule: CHEMBL413
highest development phase: 2
has mesh: D054198
has mesh heading: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
has EFO: EFO_0000220
has EFO name: ACUTE LYMPHOBLASTIC LEUKEMIA

CHEMBL_IND_27936
type: DrugIndication
chembl id: CHEMBL_IND_27936
has molecule: CHEMBL413
highest development phase: 0
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000292
has EFO name: BLADDER CARCINOMA

CHEMBL_IND_27445
type: DrugIndication
chembl id: CHEMBL_IND_27445
has molecule: CHEMBL413
highest development phase: 1
has mesh: D015423
has mesh heading: SCLERITIS
has EFO: HP_0100532
has EFO name: SCLERITIS

CHEMBL_IND_27444
type: DrugIndication
chembl id: CHEMBL_IND_27444
has molecule: CHEMBL413
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_27443
type: DrugIndication
chembl id: CHEMBL_IND_27443
has molecule: CHEMBL413
highest development phase: 1
has mesh: D005350
has mesh heading: FIBROMA
has EFO: EFO_0002424
has EFO name: FIBROMA

CHEMBL_IND_27442
type: DrugIndication
chembl id: CHEMBL_IND_27442
has molecule: CHEMBL413
highest development phase: 2
has mesh: D016410
has mesh heading: LYMPHOMA, T-CELL, CUTANEOUS
has EFO: EFO_0002913
has EFO name: CUTANEOUS T-CELL LYMPHOMA

CHEMBL_IND_51883
type: DrugIndication
chembl id: CHEMBL_IND_51883
has molecule: CHEMBL413
highest development phase: 3
has mesh: D008010
has mesh heading: LICHEN PLANUS
has EFO: EFO_1000726
has EFO name: LICHEN PLANUS

CHEMBL_IND_24905
type: DrugIndication
chembl id: CHEMBL_IND_24905
has molecule: CHEMBL413
highest development phase: 1
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_24904
type: DrugIndication
chembl id: CHEMBL_IND_24904
has molecule: CHEMBL413
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_24903
type: DrugIndication
chembl id: CHEMBL_IND_24903
has molecule: CHEMBL413
highest development phase: 2
has mesh: D003930
has mesh heading: DIABETIC RETINOPATHY
has EFO: EFO_0003770
has EFO name: DIABETIC RETINOPATHY

CHEMBL_IND_24902
type: DrugIndication
chembl id: CHEMBL_IND_24902
has molecule: CHEMBL413
highest development phase: 2
has mesh: D002277
has mesh heading: CARCINOMA
has EFO: EFO_0000313
has EFO name: CARCINOMA

CHEMBL_IND_24901
type: DrugIndication
chembl id: CHEMBL_IND_24901
has molecule: CHEMBL413
highest development phase: 2
has mesh: D006086
has mesh heading: GRAFT VS HOST DISEASE
has EFO: EFO_0004599
has EFO name: ACUTE GRAFT VS. HOST DISEASE

CHEMBL_IND_24900
type: DrugIndication
chembl id: CHEMBL_IND_24900
has molecule: CHEMBL413
highest development phase: 3
has mesh: D018376
has mesh heading: CARDIOVASCULAR ABNORMALITIES
has EFO: HP_0001626
has EFO name: ABNORMALITY OF THE CARDIOVASCULAR SYSTEM

CHEMBL_IND_51772
type: DrugIndication
chembl id: CHEMBL_IND_51772
has molecule: CHEMBL413
highest development phase: 2
has mesh: D000375
has mesh heading: AGING
has EFO: GO:0007568
has EFO name: AGING

CHEMBL_IND_51946
type: DrugIndication
chembl id: CHEMBL_IND_51946
has molecule: CHEMBL413
highest development phase: 2
has mesh: D033461
has mesh heading: HYPERURICEMIA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: DISORDER OF PURINE METABOLISM

CHEMBL_IND_42998
type: DrugIndication
chembl id: CHEMBL_IND_42998
has molecule: CHEMBL1439
highest development phase: 4
has mesh: D014552
has mesh heading: URINARY TRACT INFECTIONS
has EFO: EFO_0003103
has EFO name: URINARY TRACT INFECTION

CHEMBL_IND_41634
type: DrugIndication
chembl id: CHEMBL_IND_41634
has molecule: CHEMBL1439
highest development phase: 4
has mesh: D059413
has mesh heading: INTRAABDOMINAL INFECTIONS

CHEMBL_IND_48723
type: DrugIndication
chembl id: CHEMBL_IND_48723
has molecule: CHEMBL856
highest development phase: 2
has mesh: D020521
has mesh heading: STROKE
has EFO: EFO_0000712
has EFO name: STROKE

CHEMBL_IND_27399
type: DrugIndication
chembl id: CHEMBL_IND_27399
has molecule: CHEMBL856
highest development phase: 4
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_44204
type: DrugIndication
chembl id: CHEMBL_IND_44204
has molecule: CHEMBL184
highest development phase: 3
has mesh: D006560
has mesh heading: HERPES LABIALIS
has EFO: EFO_1001347
has EFO name: HERPES LABIALIS

CHEMBL_IND_42387
type: DrugIndication
chembl id: CHEMBL_IND_42387
has molecule: CHEMBL184
highest development phase: 4
has mesh: D014777
has mesh heading: VIRUS DISEASES
has EFO: EFO_0000763
has EFO name: VIRAL DISEASE

CHEMBL_IND_41583
type: DrugIndication
chembl id: CHEMBL_IND_41583
has molecule: CHEMBL184
highest development phase: 4
has mesh: D006561
has mesh heading: HERPES SIMPLEX

CHEMBL_IND_41866
type: DrugIndication
chembl id: CHEMBL_IND_41866
has molecule: CHEMBL184
highest development phase: 4
has mesh: D006558
has mesh heading: HERPES GENITALIS
has EFO: EFO_0007282
has EFO name: GENITAL HERPES

CHEMBL_IND_41863
type: DrugIndication
chembl id: CHEMBL_IND_41863
has molecule: CHEMBL184
highest development phase: 4
has mesh: D002644
has mesh heading: CHICKENPOX
has EFO: EFO_0007204
has EFO name: CHICKENPOX

CHEMBL_IND_41857
type: DrugIndication
chembl id: CHEMBL_IND_41857
has molecule: CHEMBL184
highest development phase: 4
has mesh: D006562
has mesh heading: HERPES ZOSTER
has EFO: EFO_0006510
has EFO name: HERPES ZOSTER

CHEMBL_IND_51540
type: DrugIndication
chembl id: CHEMBL_IND_51540
has molecule: CHEMBL184
highest development phase: 4
has mesh: D006561
has mesh heading: HERPES SIMPLEX
has EFO: EFO_0007204
has EFO name: CHICKENPOX

CHEMBL_IND_51510
type: DrugIndication
chembl id: CHEMBL_IND_51510
has molecule: CHEMBL184
highest development phase: 4
has mesh: D006561
has mesh heading: HERPES SIMPLEX
has EFO: EFO_0006510
has EFO name: HERPES ZOSTER

CHEMBL_IND_51469
type: DrugIndication
chembl id: CHEMBL_IND_51469
has molecule: CHEMBL184
highest development phase: 4
has mesh: D006561
has mesh heading: HERPES SIMPLEX
has EFO: EFO_0007282
has EFO name: GENITAL HERPES

CHEMBL_IND_45337
type: DrugIndication
chembl id: CHEMBL_IND_45337
has molecule: CHEMBL219586
highest development phase: 2
has mesh: D052439
has mesh heading: LIPID METABOLISM DISORDERS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: DISORDER OF LIPID METABOLISM

CHEMBL_IND_52836
type: DrugIndication
chembl id: CHEMBL_IND_52836
has molecule: CHEMBL637
highest development phase: 4
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_42531
type: DrugIndication
chembl id: CHEMBL_IND_42531
has molecule: CHEMBL216913
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_43614
type: DrugIndication
chembl id: CHEMBL_IND_43614
has molecule: CHEMBL223228
highest development phase: 4
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_46970
type: DrugIndication
chembl id: CHEMBL_IND_46970
has molecule: CHEMBL223228
highest development phase: 1
has mesh: D008228
has mesh heading: LYMPHOMA, NON-HODGKIN
has EFO: EFO_0005952
has EFO name: NON-HODGKINS LYMPHOMA

CHEMBL_IND_49485
type: DrugIndication
chembl id: CHEMBL_IND_49485
has molecule: CHEMBL223228
highest development phase: 1
has mesh: D006526
has mesh heading: HEPATITIS C
has EFO: EFO_0003047
has EFO name: HEPATITIS C INFECTION

CHEMBL_IND_44795
type: DrugIndication
chembl id: CHEMBL_IND_44795
has molecule: CHEMBL223228
highest development phase: 3
has mesh: D000163
has mesh heading: ACQUIRED IMMUNODEFICIENCY SYNDROME
has EFO: EFO_0000765
has EFO name: AIDS

CHEMBL_IND_43417
type: DrugIndication
chembl id: CHEMBL_IND_43417
has molecule: CHEMBL223228
highest development phase: 3
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_43112
type: DrugIndication
chembl id: CHEMBL_IND_43112
has molecule: CHEMBL223228
highest development phase: 4
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000180
has EFO name: HIV-1 INFECTION

CHEMBL_IND_54814
type: DrugIndication
chembl id: CHEMBL_IND_54814
has molecule: CHEMBL146
highest development phase: 1
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_25741
type: DrugIndication
chembl id: CHEMBL_IND_25741
has molecule: CHEMBL750
highest development phase: 2
has mesh: D020329
has mesh heading: ESSENTIAL TREMOR
has EFO: EFO_0003108
has EFO name: ESSENTIAL TREMOR

CHEMBL_IND_26356
type: DrugIndication
chembl id: CHEMBL_IND_26356
has molecule: CHEMBL750
highest development phase: 3
has mesh: D012640
has mesh heading: SEIZURES
has EFO: HP_0001250
has EFO name: SEIZURES

CHEMBL_IND_27514
type: DrugIndication
chembl id: CHEMBL_IND_27514
has molecule: CHEMBL750
highest development phase: 1
has mesh: D014029
has mesh heading: TOBACCO USE DISORDER
has EFO: EFO_0003768
has EFO name: NICOTINE DEPENDENCE

CHEMBL_IND_25025
type: DrugIndication
chembl id: CHEMBL_IND_25025
has molecule: CHEMBL750
highest development phase: 3
has mesh: D001068
has mesh heading: EATING DISORDERS
has EFO: EFO_0005203
has EFO name: EATING DISORDER

CHEMBL_IND_24090
type: DrugIndication
chembl id: CHEMBL_IND_24090
has molecule: CHEMBL750
highest development phase: 2
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_24089
type: DrugIndication
chembl id: CHEMBL_IND_24089
has molecule: CHEMBL750
highest development phase: 4
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_24088
type: DrugIndication
chembl id: CHEMBL_IND_24088
has molecule: CHEMBL750
highest development phase: 3
has mesh: D000437
has mesh heading: ALCOHOLISM
has EFO: EFO_0003829
has EFO name: ALCOHOL DEPENDENCE

CHEMBL_IND_26598
type: DrugIndication
chembl id: CHEMBL_IND_26598
has molecule: CHEMBL185
highest development phase: 3
has mesh: D009303
has mesh heading: NASOPHARYNGEAL NEOPLASMS
has EFO: EFO_0004252
has EFO name: NASOPHARYNGEAL NEOPLASM

CHEMBL_IND_26597
type: DrugIndication
chembl id: CHEMBL_IND_26597
has molecule: CHEMBL185
highest development phase: 2
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_52502
type: DrugIndication
chembl id: CHEMBL_IND_52502
has molecule: CHEMBL185
highest development phase: 3
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0003860
has EFO name: PANCREATIC NEOPLASM

CHEMBL_IND_40877
type: DrugIndication
chembl id: CHEMBL_IND_40877
has molecule: CHEMBL185
highest development phase: 1
has mesh: D004806
has mesh heading: EPENDYMOMA
has EFO: EFO_1000028
has EFO name: EPENDYMOMA

CHEMBL_IND_48943
type: DrugIndication
chembl id: CHEMBL_IND_48943
has molecule: CHEMBL185
highest development phase: 0
has mesh: D012878
has mesh heading: SKIN NEOPLASMS
has EFO: EFO_0004198
has EFO name: SKIN NEOPLASM

CHEMBL_IND_51977
type: DrugIndication
chembl id: CHEMBL_IND_51977
has molecule: CHEMBL185
highest development phase: 2
has mesh: D004938
has mesh heading: ESOPHAGEAL NEOPLASMS
has EFO: EFO_0002916
has EFO name: ESOPHAGEAL CARCINOMA

CHEMBL_IND_51736
type: DrugIndication
chembl id: CHEMBL_IND_51736
has molecule: CHEMBL185
highest development phase: 3
has mesh: D012004
has mesh heading: RECTAL NEOPLASMS
has EFO: EFO_1000657
has EFO name: RECTUM CANCER

CHEMBL_IND_23200
type: DrugIndication
chembl id: CHEMBL_IND_23200
has molecule: CHEMBL185
highest development phase: 3
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_25331
type: DrugIndication
chembl id: CHEMBL_IND_25331
has molecule: CHEMBL185
highest development phase: 3
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_25330
type: DrugIndication
chembl id: CHEMBL_IND_25330
has molecule: CHEMBL185
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_25329
type: DrugIndication
chembl id: CHEMBL_IND_25329
has molecule: CHEMBL185
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_24454
type: DrugIndication
chembl id: CHEMBL_IND_24454
has molecule: CHEMBL185
highest development phase: 3
has mesh: D055623
has mesh heading: KERATOSIS, ACTINIC
has EFO: EFO_0002496
has EFO name: ACTINIC KERATOSIS

CHEMBL_IND_42105
type: DrugIndication
chembl id: CHEMBL_IND_42105
has molecule: CHEMBL220491
highest development phase: 4
has mesh: D009798
has mesh heading: OCULAR HYPERTENSION
has EFO: EFO_1001069
has EFO name: OCULAR HYPERTENSION

CHEMBL_IND_42677
type: DrugIndication
chembl id: CHEMBL_IND_42677
has molecule: CHEMBL220491
highest development phase: 4
has mesh: D005901
has mesh heading: GLAUCOMA
has EFO: EFO_0000516
has EFO name: GLAUCOMA

CHEMBL_IND_24217
type: DrugIndication
chembl id: CHEMBL_IND_24217
has molecule: CHEMBL220491
highest development phase: 4
has mesh: D005902
has mesh heading: GLAUCOMA, OPEN-ANGLE
has EFO: EFO_0004190
has EFO name: OPEN-ANGLE GLAUCOMA

CHEMBL_IND_49664
type: DrugIndication
chembl id: CHEMBL_IND_49664
has molecule: CHEMBL160
highest development phase: 2
has mesh: D058186
has mesh heading: ACUTE KIDNEY INJURY
has EFO: HP_0001919
has EFO name: ACUTE KIDNEY INJURY

CHEMBL_IND_44183
type: DrugIndication
chembl id: CHEMBL_IND_44183
has molecule: CHEMBL160
highest development phase: 3
has mesh: D003233
has mesh heading: CONJUNCTIVITIS, ALLERGIC
has EFO: EFO_0007141
has EFO name: ALLERGIC CONJUNCTIVITIS

CHEMBL_IND_27115
type: DrugIndication
chembl id: CHEMBL_IND_27115
has molecule: CHEMBL160
highest development phase: 2
has mesh: D015433
has mesh heading: GLOMERULONEPHRITIS, MEMBRANOUS
has EFO: EFO_0004254
has EFO name: MEMBRANOUS GLOMERULONEPHRITIS

CHEMBL_IND_27114
type: DrugIndication
chembl id: CHEMBL_IND_27114
has molecule: CHEMBL160
highest development phase: 3
has mesh: D005923
has mesh heading: GLOMERULOSCLEROSIS, FOCAL SEGMENTAL
has EFO: EFO_0004236
has EFO name: FOCAL SEGMENTAL GLOMERULOSCLEROSIS

CHEMBL_IND_45159
type: DrugIndication
chembl id: CHEMBL_IND_45159
has molecule: CHEMBL160
highest development phase: 3
has mesh: D019698
has mesh heading: HEPATITIS C, CHRONIC
has EFO: EFO_0004220
has EFO name: CHRONIC HEPATITIS C INFECTION

CHEMBL_IND_28074
type: DrugIndication
chembl id: CHEMBL_IND_28074
has molecule: CHEMBL160
highest development phase: 2
has mesh: D005901
has mesh heading: GLAUCOMA
has EFO: EFO_0000516
has EFO name: GLAUCOMA

CHEMBL_IND_28073
type: DrugIndication
chembl id: CHEMBL_IND_28073
has molecule: CHEMBL160
highest development phase: 2
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_52297
type: DrugIndication
chembl id: CHEMBL_IND_52297
has molecule: CHEMBL160
highest development phase: 2
has mesh: D018856
has mesh heading: CYSTITIS, INTERSTITIAL
has EFO: EFO_1000869
has EFO name: CHRONIC INTERSTITIAL CYSTITIS

CHEMBL_IND_44692
type: DrugIndication
chembl id: CHEMBL_IND_44692
has molecule: CHEMBL160
highest development phase: 2
has mesh: D010518
has mesh heading: PERIODONTITIS
has EFO: EFO_0000649
has EFO name: PERIODONTITIS

CHEMBL_IND_25886
type: DrugIndication
chembl id: CHEMBL_IND_25886
has molecule: CHEMBL160
highest development phase: 3
has mesh: D009203
has mesh heading: MYOCARDIAL INFARCTION
has EFO: EFO_0000612
has EFO name: MYOCARDIAL INFARCTION

CHEMBL_IND_49019
type: DrugIndication
chembl id: CHEMBL_IND_49019
has molecule: CHEMBL160
highest development phase: 3
has mesh: D016553
has mesh heading: PURPURA, THROMBOCYTOPENIC, IDIOPATHIC
has EFO: EFO_0007160
has EFO name: AUTOIMMUNE THROMBOCYTOPENIC PURPURA

CHEMBL_IND_26478
type: DrugIndication
chembl id: CHEMBL_IND_26478
has molecule: CHEMBL160
highest development phase: 2
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0002890
has EFO name: RENAL CARCINOMA

CHEMBL_IND_26477
type: DrugIndication
chembl id: CHEMBL_IND_26477
has molecule: CHEMBL160
highest development phase: 2
has mesh: D029242
has mesh heading: OPTIC ATROPHY, HEREDITARY, LEBER
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: LEBER HEREDITARY OPTIC NEUROPATHY

CHEMBL_IND_26475
type: DrugIndication
chembl id: CHEMBL_IND_26475
has molecule: CHEMBL160
highest development phase: 1
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_27116
type: DrugIndication
chembl id: CHEMBL_IND_27116
has molecule: CHEMBL160
highest development phase: 3
has mesh: D016757
has mesh heading: DEATH, SUDDEN, CARDIAC
has EFO: EFO_0004278
has EFO name: SUDDEN CARDIAC ARREST

CHEMBL_IND_46302
type: DrugIndication
chembl id: CHEMBL_IND_46302
has molecule: CHEMBL160
highest development phase: 3
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_51958
type: DrugIndication
chembl id: CHEMBL_IND_51958
has molecule: CHEMBL160
highest development phase: 1
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_46031
type: DrugIndication
chembl id: CHEMBL_IND_46031
has molecule: CHEMBL160
highest development phase: 2
has mesh: D017544
has mesh heading: AORTIC ANEURYSM, ABDOMINAL
has EFO: EFO_0004214
has EFO name: ABDOMINAL AORTIC ANEURYSM

CHEMBL_IND_41729
type: DrugIndication
chembl id: CHEMBL_IND_41729
has molecule: CHEMBL160
highest development phase: 4
has mesh: D007154
has mesh heading: IMMUNE SYSTEM DISEASES
has EFO: EFO_0000540
has EFO name: IMMUNE SYSTEM DISEASE

CHEMBL_IND_22959
type: DrugIndication
chembl id: CHEMBL_IND_22959
has molecule: CHEMBL160
highest development phase: 2
has mesh: D011625
has mesh heading: PTERYGIUM
has EFO: EFO_0000678
has EFO name: PTERYGIUM

CHEMBL_IND_22958
type: DrugIndication
chembl id: CHEMBL_IND_22958
has molecule: CHEMBL160
highest development phase: 2
has mesh: D000741
has mesh heading: ANEMIA, APLASTIC
has EFO: HP_0001915
has EFO name: APLASTIC ANEMIA

CHEMBL_IND_22957
type: DrugIndication
chembl id: CHEMBL_IND_22957
has molecule: CHEMBL160
highest development phase: 2
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_22954
type: DrugIndication
chembl id: CHEMBL_IND_22954
has molecule: CHEMBL160
highest development phase: 3
has mesh: D003876
has mesh heading: DERMATITIS, ATOPIC
has EFO: EFO_0000274
has EFO name: ATOPIC ECZEMA

CHEMBL_IND_51746
type: DrugIndication
chembl id: CHEMBL_IND_51746
has molecule: CHEMBL160
highest development phase: 3
has mesh: D007638
has mesh heading: KERATOCONJUNCTIVITIS SICCA
has EFO: EFO_1001001
has EFO name: KERATOCONJUNCTIVITIS SICCA

CHEMBL_IND_39904
type: DrugIndication
chembl id: CHEMBL_IND_39904
has molecule: CHEMBL160
highest development phase: 3
has mesh: D015352
has mesh heading: DRY EYE SYNDROMES
has EFO: EFO_1000906
has EFO name: DRY EYE SYNDROME

CHEMBL_IND_51718
type: DrugIndication
chembl id: CHEMBL_IND_51718
has molecule: CHEMBL160
highest development phase: 3
has mesh: D001989
has mesh heading: BRONCHIOLITIS OBLITERANS
has EFO: EFO_0007183
has EFO name: BRONCHIOLITIS OBLITERANS

CHEMBL_IND_25201
type: DrugIndication
chembl id: CHEMBL_IND_25201
has molecule: CHEMBL160
highest development phase: 2
has mesh: D007918
has mesh heading: LEPROSY
has EFO: EFO_0001054
has EFO name: LEPROSY

CHEMBL_IND_25199
type: DrugIndication
chembl id: CHEMBL_IND_25199
has molecule: CHEMBL160
highest development phase: 3
has mesh: D006086
has mesh heading: GRAFT VS HOST DISEASE
has EFO: EFO_0004599
has EFO name: ACUTE GRAFT VS. HOST DISEASE

CHEMBL_IND_39804
type: DrugIndication
chembl id: CHEMBL_IND_39804
has molecule: CHEMBL160
highest development phase: 2
has mesh: D007945
has mesh heading: LEUKEMIA, LYMPHOID
has EFO: EFO_0004289
has EFO name: LYMPHOID LEUKEMIA

CHEMBL_IND_24293
type: DrugIndication
chembl id: CHEMBL_IND_24293
has molecule: CHEMBL160
highest development phase: 3
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_24292
type: DrugIndication
chembl id: CHEMBL_IND_24292
has molecule: CHEMBL160
highest development phase: 2
has mesh: D009190
has mesh heading: MYELODYSPLASTIC SYNDROMES
has EFO: EFO_0000198
has EFO name: MYELODYSPLASTIC SYNDROME

CHEMBL_IND_52360
type: DrugIndication
chembl id: CHEMBL_IND_52360
has molecule: CHEMBL1428
highest development phase: 3
has mesh: D013345
has mesh heading: SUBARACHNOID HEMORRHAGE
has EFO: EFO_0000713
has EFO name: SUBARACHNOID HEMORRHAGE

CHEMBL_IND_41406
type: DrugIndication
chembl id: CHEMBL_IND_41406
has molecule: CHEMBL1428
highest development phase: 1
has mesh: D002532
has mesh heading: INTRACRANIAL ANEURYSM
has EFO: EFO_0003870
has EFO name: BRAIN ANEURYSM

CHEMBL_IND_44755
type: DrugIndication
chembl id: CHEMBL_IND_44755
has molecule: CHEMBL1428
highest development phase: 2
has mesh: D020521
has mesh heading: STROKE
has EFO: EFO_0000712
has EFO name: STROKE

CHEMBL_IND_28295
type: DrugIndication
chembl id: CHEMBL_IND_28295
has molecule: CHEMBL1428
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_23576
type: DrugIndication
chembl id: CHEMBL_IND_23576
has molecule: CHEMBL1428
highest development phase: 2
has mesh: D007246
has mesh heading: INFERTILITY
has EFO: EFO_0000545
has EFO name: INFERTILITY

CHEMBL_IND_54800
type: DrugIndication
chembl id: CHEMBL_IND_54800
has molecule: CHEMBL220808
highest development phase: 2
has mesh: D015518
has mesh heading: RETT SYNDROME
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: RETT SYNDROME

CHEMBL_IND_51555
type: DrugIndication
chembl id: CHEMBL_IND_51555
has molecule: CHEMBL211471
highest development phase: 4
has mesh: D009157
has mesh heading: MYASTHENIA GRAVIS
has EFO: EFO_0004991
has EFO name: MYASTHENIA GRAVIS

CHEMBL_IND_25621
type: DrugIndication
chembl id: CHEMBL_IND_25621
has molecule: CHEMBL215645
highest development phase: 4
has mesh: D003704
has mesh heading: DEMENTIA
has EFO: EFO_0003862
has EFO name: DEMENTIA

CHEMBL_IND_23820
type: DrugIndication
chembl id: CHEMBL_IND_23820
has molecule: CHEMBL215645
highest development phase: 4
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_26820
type: DrugIndication
chembl id: CHEMBL_IND_26820
has molecule: CHEMBL1423
highest development phase: 4
has mesh: D011618
has mesh heading: PSYCHOTIC DISORDERS
has EFO: EFO_0005407
has EFO name: PSYCHOSIS

CHEMBL_IND_27883
type: DrugIndication
chembl id: CHEMBL_IND_27883
has molecule: CHEMBL1423
highest development phase: 2
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_51644
type: DrugIndication
chembl id: CHEMBL_IND_51644
has molecule: CHEMBL1423
highest development phase: 2
has mesh: D000690
has mesh heading: AMYOTROPHIC LATERAL SCLEROSIS
has EFO: EFO_0000253
has EFO name: AMYOTROPHIC LATERAL SCLEROSIS

CHEMBL_IND_50788
type: DrugIndication
chembl id: CHEMBL_IND_50788
has molecule: CHEMBL219916
highest development phase: 2
has mesh: D020529
has mesh heading: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
has EFO: EFO_0003929
has EFO name: RELAPSING-REMITTING MULTIPLE SCLEROSIS

CHEMBL_IND_50934
type: DrugIndication
chembl id: CHEMBL_IND_50934
has molecule: CHEMBL219916
highest development phase: 2
has mesh: D020528
has mesh heading: MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE
has EFO: EFO_0003840
has EFO name: CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS

CHEMBL_IND_50074
type: DrugIndication
chembl id: CHEMBL_IND_50074
has molecule: CHEMBL219916
highest development phase: 4
has mesh: D004066
has mesh heading: DIGESTIVE SYSTEM DISEASES
has EFO: EFO_0000405
has EFO name: DIGESTIVE SYSTEM DISEASE

CHEMBL_IND_54568
type: DrugIndication
chembl id: CHEMBL_IND_54568
has molecule: CHEMBL219916
highest development phase: 3
has mesh: D005759
has mesh heading: GASTROENTERITIS
has EFO: EFO_1001463
has EFO name: GASTROENTERITIS

CHEMBL_IND_53117
type: DrugIndication
chembl id: CHEMBL_IND_53117
has molecule: CHEMBL219916
highest development phase: 3
has mesh: D018589
has mesh heading: GASTROPARESIS
has EFO: EFO_1000948
has EFO name: GASTROPARESIS

CHEMBL_IND_41938
type: DrugIndication
chembl id: CHEMBL_IND_41938
has molecule: CHEMBL1413
highest development phase: 4
has mesh: D014009
has mesh heading: ONYCHOMYCOSIS
has EFO: HP_0012203
has EFO name: ONYCHOMYCOSIS

CHEMBL_IND_42265
type: DrugIndication
chembl id: CHEMBL_IND_42265
has molecule: CHEMBL1413
highest development phase: 4
has mesh: D012628
has mesh heading: DERMATITIS, SEBORRHEIC
has EFO: EFO_1000764
has EFO name: SEBORRHEIC DERMATITIS

CHEMBL_IND_51875
type: DrugIndication
chembl id: CHEMBL_IND_51875
has molecule: CHEMBL1413
highest development phase: 3
has mesh: D014008
has mesh heading: TINEA PEDIS
has EFO: EFO_0007512
has EFO name: TINEA PEDIS

CHEMBL_IND_41693
type: DrugIndication
chembl id: CHEMBL_IND_41693
has molecule: CHEMBL232201
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_41871
type: DrugIndication
chembl id: CHEMBL_IND_41871
has molecule: CHEMBL1450
highest development phase: 4
has mesh: D011020
has mesh heading: PNEUMONIA, PNEUMOCYSTIS
has EFO: EFO_0007448
has EFO name: PNEUMOCYSTOSIS

CHEMBL_IND_44814
type: DrugIndication
chembl id: CHEMBL_IND_44814
has molecule: CHEMBL1450
highest development phase: 2
has mesh: D008288
has mesh heading: MALARIA
has EFO: EFO_0001068
has EFO name: MALARIA

CHEMBL_IND_47548
type: DrugIndication
chembl id: CHEMBL_IND_47548
has molecule: CHEMBL1450
highest development phase: 0
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_51873
type: DrugIndication
chembl id: CHEMBL_IND_51873
has molecule: CHEMBL1450
highest development phase: 1
has mesh: D016778
has mesh heading: MALARIA, FALCIPARUM
has EFO: EFO_0007444
has EFO name: PLASMODIUM FALCIPARUM MALARIA

CHEMBL_IND_28568
type: DrugIndication
chembl id: CHEMBL_IND_28568
has molecule: CHEMBL1466
highest development phase: 4
has mesh: D013927
has mesh heading: THROMBOSIS
has EFO: HP_0004419
has EFO name: RECURRENT THROMBOPHLEBITIS

CHEMBL_IND_49364
type: DrugIndication
chembl id: CHEMBL_IND_49364
has molecule: CHEMBL231813
highest development phase: 3
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_46171
type: DrugIndication
chembl id: CHEMBL_IND_46171
has molecule: CHEMBL231813
highest development phase: 1
has mesh: D013921
has mesh heading: THROMBOCYTOPENIA
has EFO: HP_0001873
has EFO name: THROMBOCYTOPENIA

CHEMBL_IND_46035
type: DrugIndication
chembl id: CHEMBL_IND_46035
has molecule: CHEMBL231813
highest development phase: 3
has mesh: D019698
has mesh heading: HEPATITIS C, CHRONIC
has EFO: EFO_0004220
has EFO name: CHRONIC HEPATITIS C INFECTION

CHEMBL_IND_44963
type: DrugIndication
chembl id: CHEMBL_IND_44963
has molecule: CHEMBL231813
highest development phase: 2
has mesh: D006526
has mesh heading: HEPATITIS C
has EFO: EFO_0003047
has EFO name: HEPATITIS C INFECTION

CHEMBL_IND_44891
type: DrugIndication
chembl id: CHEMBL_IND_44891
has molecule: CHEMBL231813
highest development phase: 1
has mesh: D008107
has mesh heading: LIVER DISEASES
has EFO: EFO_0001421
has EFO name: LIVER DISEASE

CHEMBL_IND_50184
type: DrugIndication
chembl id: CHEMBL_IND_50184
has molecule: CHEMBL225071
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_55263
type: DrugIndication
chembl id: CHEMBL_IND_55263
has molecule: CHEMBL231884
highest development phase: 2
has mesh: D007246
has mesh heading: INFERTILITY
has EFO: EFO_0000545
has EFO name: INFERTILITY

CHEMBL_IND_55111
type: DrugIndication
chembl id: CHEMBL_IND_55111
has molecule: CHEMBL231884
highest development phase: 1
has mesh: D008595
has mesh heading: MENORRHAGIA
has EFO: EFO_0003945
has EFO name: MENORRHAGIA

CHEMBL_IND_53089
type: DrugIndication
chembl id: CHEMBL_IND_53089
has molecule: CHEMBL186
highest development phase: 3
has mesh: D012772
has mesh heading: SHOCK, SEPTIC
has EFO: EFO_0006834
has EFO name: SEPTIC SHOCK

CHEMBL_IND_47561
type: DrugIndication
chembl id: CHEMBL_IND_47561
has molecule: CHEMBL186
highest development phase: 3
has mesh: D014552
has mesh heading: URINARY TRACT INFECTIONS
has EFO: EFO_0003103
has EFO name: URINARY TRACT INFECTION

CHEMBL_IND_48286
type: DrugIndication
chembl id: CHEMBL_IND_48286
has molecule: CHEMBL190
highest development phase: 2
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_26311
type: DrugIndication
chembl id: CHEMBL_IND_26311
has molecule: CHEMBL190
highest development phase: 4
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_27952
type: DrugIndication
chembl id: CHEMBL_IND_27952
has molecule: CHEMBL190
highest development phase: 2
has mesh: D047928
has mesh heading: PREMATURE BIRTH
has EFO: EFO_0003917
has EFO name: PREMATURE BIRTH

CHEMBL_IND_23951
type: DrugIndication
chembl id: CHEMBL_IND_23951
has molecule: CHEMBL190
highest development phase: 4
has mesh: D008173
has mesh heading: LUNG DISEASES, OBSTRUCTIVE
has EFO: HP_0006536
has EFO name: OBSTRUCTIVE LUNG DISEASE

CHEMBL_IND_23949
type: DrugIndication
chembl id: CHEMBL_IND_23949
has molecule: CHEMBL190
highest development phase: 3
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_44863
type: DrugIndication
chembl id: CHEMBL_IND_44863
has molecule: CHEMBL238804
highest development phase: 3
has mesh: D006976
has mesh heading: HYPERTENSION, PULMONARY
has EFO: EFO_0001361
has EFO name: PULMONARY HYPERTENSION

CHEMBL_IND_42807
type: DrugIndication
chembl id: CHEMBL_IND_42807
has molecule: CHEMBL238804
highest development phase: 4
has mesh: D065627
has mesh heading: FAMILIAL PRIMARY PULMONARY HYPERTENSION
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: IDIOPATHIC AND/OR FAMILIAL PULMONARY ARTERIAL HYPERTENSION

CHEMBL_IND_39707
type: DrugIndication
chembl id: CHEMBL_IND_39707
has molecule: CHEMBL238804
highest development phase: 4
has mesh: D013927
has mesh heading: THROMBOSIS
has EFO: HP_0004419
has EFO name: RECURRENT THROMBOPHLEBITIS

CHEMBL_IND_39678
type: DrugIndication
chembl id: CHEMBL_IND_39678
has molecule: CHEMBL238804
highest development phase: 4
has mesh: D065627
has mesh heading: FAMILIAL PRIMARY PULMONARY HYPERTENSION
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION

CHEMBL_IND_52756
type: DrugIndication
chembl id: CHEMBL_IND_52756
has molecule: CHEMBL1477
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_44139
type: DrugIndication
chembl id: CHEMBL_IND_44139
has molecule: CHEMBL239129
highest development phase: 3
has mesh: D016773
has mesh heading: LEISHMANIASIS, CUTANEOUS
has EFO: EFO_0005046
has EFO name: CUTANEOUS LEISHMANIASIS

CHEMBL_IND_27014
type: DrugIndication
chembl id: CHEMBL_IND_27014
has molecule: CHEMBL1471
highest development phase: 4
has mesh: D009325
has mesh heading: NAUSEA
has EFO: EFO_0006911
has EFO name: CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING

CHEMBL_IND_25784
type: DrugIndication
chembl id: CHEMBL_IND_25784
has molecule: CHEMBL1471
highest development phase: 3
has mesh: D014839
has mesh heading: VOMITING
has EFO: HP_0002013
has EFO name: VOMITING

CHEMBL_IND_45168
type: DrugIndication
chembl id: CHEMBL_IND_45168
has molecule: CHEMBL1471
highest development phase: 1
has mesh: D006556
has mesh heading: HEROIN DEPENDENCE
has EFO: EFO_0004240
has EFO name: HEROIN DEPENDENCE

CHEMBL_IND_52414
type: DrugIndication
chembl id: CHEMBL_IND_52414
has molecule: CHEMBL1471
highest development phase: 3
has mesh: D018589
has mesh heading: GASTROPARESIS
has EFO: EFO_1000948
has EFO name: GASTROPARESIS

CHEMBL_IND_49045
type: DrugIndication
chembl id: CHEMBL_IND_49045
has molecule: CHEMBL1471
highest development phase: 2
has mesh: D011537
has mesh heading: PRURITUS
has EFO: HP_0000989
has EFO name: PRURITUS

CHEMBL_IND_43248
type: DrugIndication
chembl id: CHEMBL_IND_43248
has molecule: CHEMBL1471
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_27544
type: DrugIndication
chembl id: CHEMBL_IND_27544
has molecule: CHEMBL1471
highest development phase: 4
has mesh: D009325
has mesh heading: NAUSEA
has EFO: HP_0002018
has EFO name: NAUSEA

CHEMBL_IND_27543
type: DrugIndication
chembl id: CHEMBL_IND_27543
has molecule: CHEMBL1471
highest development phase: 2
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_28016
type: DrugIndication
chembl id: CHEMBL_IND_28016
has molecule: CHEMBL1471
highest development phase: 3
has mesh: D009373
has mesh heading: NEOPLASMS, GERM CELL AND EMBRYONAL
has EFO: EFO_0000514
has EFO name: GERM CELL TUMOR

CHEMBL_IND_22697
type: DrugIndication
chembl id: CHEMBL_IND_22697
has molecule: CHEMBL1471
highest development phase: 4
has mesh: D020250
has mesh heading: POSTOPERATIVE NAUSEA AND VOMITING
has EFO: EFO_0004888
has EFO name: POST OPERATIVE NAUSEA AND VOMITING

CHEMBL_IND_22696
type: DrugIndication
chembl id: CHEMBL_IND_22696
has molecule: CHEMBL1471
highest development phase: 3
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_22695
type: DrugIndication
chembl id: CHEMBL_IND_22695
has molecule: CHEMBL1471
highest development phase: 3
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_22694
type: DrugIndication
chembl id: CHEMBL_IND_22694
has molecule: CHEMBL1471
highest development phase: 2
has mesh: D002189
has mesh heading: MARIJUANA ABUSE
has EFO: EFO_0004218
has EFO name: MARIJUANA DEPENDENCE

CHEMBL_IND_25067
type: DrugIndication
chembl id: CHEMBL_IND_25067
has molecule: CHEMBL1471
highest development phase: 1
has mesh: D009293
has mesh heading: OPIOID-RELATED DISORDERS
has EFO: EFO_0005611
has EFO name: OPIOID DEPENDENCE

CHEMBL_IND_24153
type: DrugIndication
chembl id: CHEMBL_IND_24153
has molecule: CHEMBL1471
highest development phase: 1
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_22887
type: DrugIndication
chembl id: CHEMBL_IND_22887
has molecule: CHEMBL240597
highest development phase: 2
has mesh: D043183
has mesh heading: IRRITABLE BOWEL SYNDROME
has EFO: EFO_0000555
has EFO name: IRRITABLE BOWEL SYNDROME

CHEMBL_IND_52976
type: DrugIndication
chembl id: CHEMBL_IND_52976
has molecule: CHEMBL192
highest development phase: 2
has mesh: D054990
has mesh heading: IDIOPATHIC PULMONARY FIBROSIS
has EFO: EFO_0000768
has EFO name: IDIOPATHIC PULMONARY FIBROSIS

CHEMBL_IND_53037
type: DrugIndication
chembl id: CHEMBL_IND_53037
has molecule: CHEMBL192
highest development phase: 1
has mesh: D006331
has mesh heading: HEART DISEASES
has EFO: EFO_0003777
has EFO name: HEART DISEASE

CHEMBL_IND_53034
type: DrugIndication
chembl id: CHEMBL_IND_53034
has molecule: CHEMBL192
highest development phase: 3
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0003144
has EFO name: HEART FAILURE

CHEMBL_IND_52993
type: DrugIndication
chembl id: CHEMBL_IND_52993
has molecule: CHEMBL192
highest development phase: 4
has mesh: D006976
has mesh heading: HYPERTENSION, PULMONARY
has EFO: EFO_0001361
has EFO name: PULMONARY HYPERTENSION

CHEMBL_IND_53951
type: DrugIndication
chembl id: CHEMBL_IND_53951
has molecule: CHEMBL192
highest development phase: 2
has mesh: D020388
has mesh heading: MUSCULAR DYSTROPHY, DUCHENNE
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: BECKER MUSCULAR DYSTROPHY

CHEMBL_IND_54150
type: DrugIndication
chembl id: CHEMBL_IND_54150
has molecule: CHEMBL192
highest development phase: 1
has mesh: D058186
has mesh heading: ACUTE KIDNEY INJURY
has EFO: HP_0001919
has EFO name: ACUTE KIDNEY INJURY

CHEMBL_IND_53450
type: DrugIndication
chembl id: CHEMBL_IND_53450
has molecule: CHEMBL192
highest development phase: 3
has mesh: D001157
has mesh heading: ARTERIAL OCCLUSIVE DISEASES
has EFO: HP_0005315
has EFO name: OCCLUSIVE ARTERIAL DISEASE

CHEMBL_IND_54277
type: DrugIndication
chembl id: CHEMBL_IND_54277
has molecule: CHEMBL192
highest development phase: 3
has mesh: D008171
has mesh heading: LUNG DISEASES
has EFO: EFO_0003818
has EFO name: LUNG DISEASE

CHEMBL_IND_54797
type: DrugIndication
chembl id: CHEMBL_IND_54797
has molecule: CHEMBL192
highest development phase: 2
has mesh: D000755
has mesh heading: ANEMIA, SICKLE CELL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SICKLE CELL ANEMIA

CHEMBL_IND_54669
type: DrugIndication
chembl id: CHEMBL_IND_54669
has molecule: CHEMBL192
highest development phase: 3
has mesh: D012595
has mesh heading: SCLERODERMA, SYSTEMIC
has EFO: EFO_0000717
has EFO name: SYSTEMIC SCLERODERMA

CHEMBL_IND_53634
type: DrugIndication
chembl id: CHEMBL_IND_53634
has molecule: CHEMBL192
highest development phase: 2
has mesh: D058729
has mesh heading: PERIPHERAL ARTERIAL DISEASE
has EFO: EFO_0004265
has EFO name: PERIPHERAL ARTERIAL DISEASE

CHEMBL_IND_53623
type: DrugIndication
chembl id: CHEMBL_IND_53623
has molecule: CHEMBL192
highest development phase: 2
has mesh: D047928
has mesh heading: PREMATURE BIRTH
has EFO: EFO_0003917
has EFO name: PREMATURE BIRTH

CHEMBL_IND_52921
type: DrugIndication
chembl id: CHEMBL_IND_52921
has molecule: CHEMBL192
highest development phase: 2
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_53885
type: DrugIndication
chembl id: CHEMBL_IND_53885
has molecule: CHEMBL192
highest development phase: 0
has mesh: D020325
has mesh heading: MIGRAINE WITH AURA
has EFO: EFO_0005295
has EFO name: MIGRAINE WITH AURA

CHEMBL_IND_53829
type: DrugIndication
chembl id: CHEMBL_IND_53829
has molecule: CHEMBL192
highest development phase: 2
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_53699
type: DrugIndication
chembl id: CHEMBL_IND_53699
has molecule: CHEMBL192
highest development phase: 1
has mesh: D006501
has mesh heading: HEPATIC ENCEPHALOPATHY
has EFO: HP_0002480
has EFO name: HEPATIC ENCEPHALOPATHY

CHEMBL_IND_53077
type: DrugIndication
chembl id: CHEMBL_IND_53077
has molecule: CHEMBL192
highest development phase: 2
has mesh: D012735
has mesh heading: SEXUAL DYSFUNCTION, PHYSIOLOGICAL
has EFO: EFO_0004714
has EFO name: SEXUAL DYSFUNCTION

CHEMBL_IND_53065
type: DrugIndication
chembl id: CHEMBL_IND_53065
has molecule: CHEMBL192
highest development phase: 4
has mesh: D007172
has mesh heading: ERECTILE DYSFUNCTION
has EFO: EFO_0004234
has EFO name: ERECTILE DYSFUNCTION

CHEMBL_IND_53207
type: DrugIndication
chembl id: CHEMBL_IND_53207
has molecule: CHEMBL192
highest development phase: 2
has mesh: D011470
has mesh heading: PROSTATIC HYPERPLASIA
has EFO: EFO_0000284
has EFO name: BENIGN PROSTATIC HYPERPLASIA

CHEMBL_IND_54560
type: DrugIndication
chembl id: CHEMBL_IND_54560
has molecule: CHEMBL192
highest development phase: 2
has mesh: D011928
has mesh heading: RAYNAUD DISEASE
has EFO: EFO_1001145
has EFO name: RAYNAUD DISEASE

CHEMBL_IND_53181
type: DrugIndication
chembl id: CHEMBL_IND_53181
has molecule: CHEMBL192
highest development phase: 2
has mesh: D003550
has mesh heading: CYSTIC FIBROSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CYSTIC FIBROSIS

CHEMBL_IND_54488
type: DrugIndication
chembl id: CHEMBL_IND_54488
has molecule: CHEMBL192
highest development phase: 1
has mesh: D008103
has mesh heading: LIVER CIRRHOSIS
has EFO: EFO_0001422
has EFO name: CIRRHOSIS OF LIVER

CHEMBL_IND_54435
type: DrugIndication
chembl id: CHEMBL_IND_54435
has molecule: CHEMBL192
highest development phase: 2
has mesh: D007246
has mesh heading: INFERTILITY
has EFO: EFO_0000545
has EFO name: INFERTILITY

CHEMBL_IND_53525
type: DrugIndication
chembl id: CHEMBL_IND_53525
has molecule: CHEMBL192
highest development phase: 3
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_53521
type: DrugIndication
chembl id: CHEMBL_IND_53521
has molecule: CHEMBL192
highest development phase: 2
has mesh: D005317
has mesh heading: FETAL GROWTH RETARDATION
has EFO: EFO_0000495
has EFO name: FETAL GROWTH RESTRICTION

CHEMBL_IND_50500
type: DrugIndication
chembl id: CHEMBL_IND_50500
has molecule: CHEMBL239243
highest development phase: 3
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_50477
type: DrugIndication
chembl id: CHEMBL_IND_50477
has molecule: CHEMBL239243
highest development phase: 2
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_55074
type: DrugIndication
chembl id: CHEMBL_IND_55074
has molecule: CHEMBL239243
highest development phase: 2
has mesh: D001523
has mesh heading: MENTAL DISORDERS
has EFO: EFO_0000677
has EFO name: MENTAL OR BEHAVIOURAL DISORDER

CHEMBL_IND_48283
type: DrugIndication
chembl id: CHEMBL_IND_48283
has molecule: CHEMBL226267
highest development phase: 2
has mesh: D010024
has mesh heading: OSTEOPOROSIS
has EFO: EFO_0003882
has EFO name: OSTEOPOROSIS

CHEMBL_IND_43231
type: DrugIndication
chembl id: CHEMBL_IND_43231
has molecule: CHEMBL226267
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_45079
type: DrugIndication
chembl id: CHEMBL_IND_45079
has molecule: CHEMBL226267
highest development phase: 3
has mesh: D015663
has mesh heading: OSTEOPOROSIS, POSTMENOPAUSAL
has EFO: EFO_0003854
has EFO name: POSTMENOPAUSAL OSTEOPOROSIS

CHEMBL_IND_45828
type: DrugIndication
chembl id: CHEMBL_IND_45828
has molecule: CHEMBL226335
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_41757
type: DrugIndication
chembl id: CHEMBL_IND_41757
has molecule: CHEMBL1455
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_26675
type: DrugIndication
chembl id: CHEMBL_IND_26675
has molecule: CHEMBL237500
highest development phase: 4
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_26082
type: DrugIndication
chembl id: CHEMBL_IND_26082
has molecule: CHEMBL237500
highest development phase: 1
has mesh: D051437
has mesh heading: RENAL INSUFFICIENCY
has EFO: HP_0000083
has EFO name: RENAL INSUFFICIENCY

CHEMBL_IND_23420
type: DrugIndication
chembl id: CHEMBL_IND_23420
has molecule: CHEMBL237500
highest development phase: 4
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_24592
type: DrugIndication
chembl id: CHEMBL_IND_24592
has molecule: CHEMBL237500
highest development phase: 1
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_54678
type: DrugIndication
chembl id: CHEMBL_IND_54678
has molecule: CHEMBL244243
highest development phase: 2
has mesh: D013313
has mesh heading: STRESS DISORDERS, POST-TRAUMATIC
has EFO: EFO_0001358
has EFO name: POST-TRAUMATIC STRESS DISORDER

CHEMBL_IND_54318
type: DrugIndication
chembl id: CHEMBL_IND_54318
has molecule: CHEMBL244243
highest development phase: 1
has mesh: D001007
has mesh heading: ANXIETY
has EFO: EFO_0005230
has EFO name: ANXIETY

CHEMBL_IND_43532
type: DrugIndication
chembl id: CHEMBL_IND_43532
has molecule: CHEMBL245019
highest development phase: 2
has mesh: D001172
has mesh heading: ARTHRITIS, RHEUMATOID
has EFO: EFO_0000685
has EFO name: RHEUMATOID ARTHRITIS

CHEMBL_IND_49591
type: DrugIndication
chembl id: CHEMBL_IND_49591
has molecule: CHEMBL245019
highest development phase: 3
has mesh: D009404
has mesh heading: NEPHROTIC SYNDROME
has EFO: EFO_0004255
has EFO name: NEPHROTIC SYNDROME

CHEMBL_IND_23153
type: DrugIndication
chembl id: CHEMBL_IND_23153
has molecule: CHEMBL1531
highest development phase: 2
has mesh: D011470
has mesh heading: PROSTATIC HYPERPLASIA
has EFO: EFO_0000284
has EFO name: BENIGN PROSTATIC HYPERPLASIA

CHEMBL_IND_50088
type: DrugIndication
chembl id: CHEMBL_IND_50088
has molecule: CHEMBL1510
highest development phase: 4
has mesh: D008881
has mesh heading: MIGRAINE DISORDERS
has EFO: EFO_0003821
has EFO name: MIGRAINE DISORDER

CHEMBL_IND_26783
type: DrugIndication
chembl id: CHEMBL_IND_26783
has molecule: CHEMBL1503
highest development phase: 2
has mesh: D054990
has mesh heading: IDIOPATHIC PULMONARY FIBROSIS
has EFO: EFO_0000768
has EFO name: IDIOPATHIC PULMONARY FIBROSIS

CHEMBL_IND_26782
type: DrugIndication
chembl id: CHEMBL_IND_26782
has molecule: CHEMBL1503
highest development phase: 3
has mesh: D004381
has mesh heading: DUODENAL ULCER
has EFO: EFO_0004607
has EFO name: DUODENAL ULCER

CHEMBL_IND_47948
type: DrugIndication
chembl id: CHEMBL_IND_47948
has molecule: CHEMBL1503
highest development phase: 2
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_48540
type: DrugIndication
chembl id: CHEMBL_IND_48540
has molecule: CHEMBL1503
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_28451
type: DrugIndication
chembl id: CHEMBL_IND_28451
has molecule: CHEMBL1503
highest development phase: 3
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_46403
type: DrugIndication
chembl id: CHEMBL_IND_46403
has molecule: CHEMBL1503
highest development phase: 3
has mesh: D050500
has mesh heading: PANCREATITIS, CHRONIC
has EFO: EFO_0000342
has EFO name: CHRONIC PANCREATITIS

CHEMBL_IND_26192
type: DrugIndication
chembl id: CHEMBL_IND_26192
has molecule: CHEMBL1503
highest development phase: 3
has mesh: D006470
has mesh heading: HEMORRHAGE
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: HEMORRHAGE

CHEMBL_IND_23615
type: DrugIndication
chembl id: CHEMBL_IND_23615
has molecule: CHEMBL1503
highest development phase: 4
has mesh: D005764
has mesh heading: GASTROESOPHAGEAL REFLUX
has EFO: EFO_0003948
has EFO name: GASTROESOPHAGEAL REFLUX DISEASE

CHEMBL_IND_51819
type: DrugIndication
chembl id: CHEMBL_IND_51819
has molecule: CHEMBL1503
highest development phase: 3
has mesh: D003922
has mesh heading: DIABETES MELLITUS, TYPE 1
has EFO: EFO_0001359
has EFO name: TYPE I DIABETES MELLITUS

CHEMBL_IND_23613
type: DrugIndication
chembl id: CHEMBL_IND_23613
has molecule: CHEMBL1503
highest development phase: 1
has mesh: D007172
has mesh heading: ERECTILE DYSFUNCTION
has EFO: EFO_0004234
has EFO name: ERECTILE DYSFUNCTION

CHEMBL_IND_27855
type: DrugIndication
chembl id: CHEMBL_IND_27855
has molecule: CHEMBL1503
highest development phase: 1
has mesh: D005901
has mesh heading: GLAUCOMA
has EFO: EFO_0000516
has EFO name: GLAUCOMA

CHEMBL_IND_27853
type: DrugIndication
chembl id: CHEMBL_IND_27853
has molecule: CHEMBL1503
highest development phase: 3
has mesh: D001471
has mesh heading: BARRETT ESOPHAGUS
has EFO: EFO_0000280
has EFO name: BARRETT'S ESOPHAGUS

CHEMBL_IND_27352
type: DrugIndication
chembl id: CHEMBL_IND_27352
has molecule: CHEMBL1503
highest development phase: 4
has mesh: D010437
has mesh heading: PEPTIC ULCER
has EFO: HP_0004398
has EFO name: PEPTIC ULCER

CHEMBL_IND_47248
type: DrugIndication
chembl id: CHEMBL_IND_47248
has molecule: CHEMBL1503
highest development phase: 1
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_51901
type: DrugIndication
chembl id: CHEMBL_IND_51901
has molecule: CHEMBL1503
highest development phase: 3
has mesh: D004942
has mesh heading: ESOPHAGITIS, PEPTIC
has EFO: EFO_1001095
has EFO name: PEPTIC ESOPHAGITIS

CHEMBL_IND_25240
type: DrugIndication
chembl id: CHEMBL_IND_25240
has molecule: CHEMBL254219
highest development phase: 2
has mesh: D003550
has mesh heading: CYSTIC FIBROSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CYSTIC FIBROSIS

CHEMBL_IND_25239
type: DrugIndication
chembl id: CHEMBL_IND_25239
has molecule: CHEMBL254219
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_48011
type: DrugIndication
chembl id: CHEMBL_IND_48011
has molecule: CHEMBL1534
highest development phase: 2
has mesh: D009203
has mesh heading: MYOCARDIAL INFARCTION
has EFO: EFO_0000612
has EFO name: MYOCARDIAL INFARCTION

CHEMBL_IND_44715
type: DrugIndication
chembl id: CHEMBL_IND_44715
has molecule: CHEMBL1534
highest development phase: 2
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_51611
type: DrugIndication
chembl id: CHEMBL_IND_51611
has molecule: CHEMBL1534
highest development phase: 4
has mesh: D000740
has mesh heading: ANEMIA
has EFO: EFO_0004272
has EFO name: ANEMIA

CHEMBL_IND_51480
type: DrugIndication
chembl id: CHEMBL_IND_51480
has molecule: CHEMBL1534
highest development phase: 4
has mesh: D018798
has mesh heading: ANEMIA, IRON-DEFICIENCY
has EFO: HP_0001891
has EFO name: IRON DEFICIENCY ANEMIA

CHEMBL_IND_51939
type: DrugIndication
chembl id: CHEMBL_IND_51939
has molecule: CHEMBL1534
highest development phase: 3
has mesh: D007640
has mesh heading: KERATOCONUS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: KERATOCONUS

CHEMBL_IND_53942
type: DrugIndication
chembl id: CHEMBL_IND_53942
has molecule: CHEMBL1487
highest development phase: 4
has mesh: D006937
has mesh heading: HYPERCHOLESTEROLEMIA
has EFO: HP_0003124
has EFO name: HYPERCHOLESTEROLEMIA

CHEMBL_IND_54649
type: DrugIndication
chembl id: CHEMBL_IND_54649
has molecule: CHEMBL1487
highest development phase: 2
has mesh: D010518
has mesh heading: PERIODONTITIS
has EFO: EFO_0000649
has EFO name: PERIODONTITIS

CHEMBL_IND_52721
type: DrugIndication
chembl id: CHEMBL_IND_52721
has molecule: CHEMBL1487
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_50725
type: DrugIndication
chembl id: CHEMBL_IND_50725
has molecule: CHEMBL254316
highest development phase: 3
has mesh: D000163
has mesh heading: ACQUIRED IMMUNODEFICIENCY SYNDROME
has EFO: EFO_0000765
has EFO name: AIDS

CHEMBL_IND_50697
type: DrugIndication
chembl id: CHEMBL_IND_50697
has molecule: CHEMBL254316
highest development phase: 1
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_55204
type: DrugIndication
chembl id: CHEMBL_IND_55204
has molecule: CHEMBL254316
highest development phase: 2
has mesh: D020529
has mesh heading: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
has EFO: EFO_0003929
has EFO name: RELAPSING-REMITTING MULTIPLE SCLEROSIS

CHEMBL_IND_50455
type: DrugIndication
chembl id: CHEMBL_IND_50455
has molecule: CHEMBL254316
highest development phase: 4
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000180
has EFO name: HIV-1 INFECTION

CHEMBL_IND_50303
type: DrugIndication
chembl id: CHEMBL_IND_50303
has molecule: CHEMBL254316
highest development phase: 4
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_50025
type: DrugIndication
chembl id: CHEMBL_IND_50025
has molecule: CHEMBL254316
highest development phase: 4
has mesh: D014777
has mesh heading: VIRUS DISEASES
has EFO: EFO_0000763
has EFO name: VIRAL DISEASE

CHEMBL_IND_55099
type: DrugIndication
chembl id: CHEMBL_IND_55099
has molecule: CHEMBL254316
highest development phase: 1
has mesh: D006526
has mesh heading: HEPATITIS C
has EFO: EFO_0003047
has EFO name: HEPATITIS C INFECTION

CHEMBL_IND_50553
type: DrugIndication
chembl id: CHEMBL_IND_50553
has molecule: CHEMBL254328
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_50106
type: DrugIndication
chembl id: CHEMBL_IND_50106
has molecule: CHEMBL254328
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_55073
type: DrugIndication
chembl id: CHEMBL_IND_55073
has molecule: CHEMBL254328
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_42364
type: DrugIndication
chembl id: CHEMBL_IND_42364
has molecule: CHEMBL1489
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_25808
type: DrugIndication
chembl id: CHEMBL_IND_25808
has molecule: CHEMBL1489
highest development phase: 2
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_52477
type: DrugIndication
chembl id: CHEMBL_IND_52477
has molecule: CHEMBL1489
highest development phase: 1
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: EFO_0001075
has EFO name: OVARIAN CARCINOMA

CHEMBL_IND_48412
type: DrugIndication
chembl id: CHEMBL_IND_48412
has molecule: CHEMBL1489
highest development phase: 3
has mesh: D013921
has mesh heading: THROMBOCYTOPENIA
has EFO: HP_0001873
has EFO name: THROMBOCYTOPENIA

CHEMBL_IND_45369
type: DrugIndication
chembl id: CHEMBL_IND_45369
has molecule: CHEMBL1489
highest development phase: 2
has mesh: D015451
has mesh heading: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
has EFO: EFO_0000095
has EFO name: CHRONIC LYMPHOCYTIC LEUKEMIA

CHEMBL_IND_27561
type: DrugIndication
chembl id: CHEMBL_IND_27561
has molecule: CHEMBL1489
highest development phase: 1
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_25092
type: DrugIndication
chembl id: CHEMBL_IND_25092
has molecule: CHEMBL1489
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_24176
type: DrugIndication
chembl id: CHEMBL_IND_24176
has molecule: CHEMBL1489
highest development phase: 4
has mesh: D000754
has mesh heading: ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS
has EFO: EFO_0003811
has EFO name: REFRACTORY ANEMIA WITH EXCESS BLASTS

CHEMBL_IND_24175
type: DrugIndication
chembl id: CHEMBL_IND_24175
has molecule: CHEMBL1489
highest development phase: 2
has mesh: D055728
has mesh heading: PRIMARY MYELOFIBROSIS
has EFO: EFO_0002430
has EFO name: PRIMARY MYELOFIBROSIS

CHEMBL_IND_24174
type: DrugIndication
chembl id: CHEMBL_IND_24174
has molecule: CHEMBL1489
highest development phase: 2
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_51516
type: DrugIndication
chembl id: CHEMBL_IND_51516
has molecule: CHEMBL1489
highest development phase: 4
has mesh: D015477
has mesh heading: LEUKEMIA, MYELOMONOCYTIC, CHRONIC
has EFO: EFO_1001779
has EFO name: CHRONIC MYELOMONOCYTIC LEUKEMIA

CHEMBL_IND_22743
type: DrugIndication
chembl id: CHEMBL_IND_22743
has molecule: CHEMBL1489
highest development phase: 4
has mesh: D009190
has mesh heading: MYELODYSPLASTIC SYNDROMES
has EFO: EFO_0000198
has EFO name: MYELODYSPLASTIC SYNDROME

CHEMBL_IND_22741
type: DrugIndication
chembl id: CHEMBL_IND_22741
has molecule: CHEMBL1489
highest development phase: 3
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_54605
type: DrugIndication
chembl id: CHEMBL_IND_54605
has molecule: CHEMBL254760
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_53599
type: DrugIndication
chembl id: CHEMBL_IND_53599
has molecule: CHEMBL254760
highest development phase: 2
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_45639
type: DrugIndication
chembl id: CHEMBL_IND_45639
has molecule: CHEMBL1528
highest development phase: 3
has mesh: D010518
has mesh heading: PERIODONTITIS
has EFO: EFO_0000649
has EFO name: PERIODONTITIS

CHEMBL_IND_49039
type: DrugIndication
chembl id: CHEMBL_IND_49039
has molecule: CHEMBL1528
highest development phase: 3
has mesh: D005891
has mesh heading: GINGIVITIS
has EFO: HP_0000230
has EFO name: GINGIVITIS

CHEMBL_IND_48864
type: DrugIndication
chembl id: CHEMBL_IND_48864
has molecule: CHEMBL1528
highest development phase: 4
has mesh: D006967
has mesh heading: HYPERSENSITIVITY
has EFO: EFO_0003785
has EFO name: ALLERGY

CHEMBL_IND_52115
type: DrugIndication
chembl id: CHEMBL_IND_52115
has molecule: CHEMBL1528
highest development phase: 3
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_51687
type: DrugIndication
chembl id: CHEMBL_IND_51687
has molecule: CHEMBL1528
highest development phase: 4
has mesh: D003731
has mesh heading: DENTAL CARIES
has EFO: EFO_0003819
has EFO name: DENTAL CARIES

CHEMBL_IND_42151
type: DrugIndication
chembl id: CHEMBL_IND_42151
has molecule: CHEMBL254832
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_43123
type: DrugIndication
chembl id: CHEMBL_IND_43123
has molecule: CHEMBL259223
highest development phase: 2
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_50601
type: DrugIndication
chembl id: CHEMBL_IND_50601
has molecule: CHEMBL1520
highest development phase: 4
has mesh: D007172
has mesh heading: ERECTILE DYSFUNCTION
has EFO: EFO_0004234
has EFO name: ERECTILE DYSFUNCTION

CHEMBL_IND_50757
type: DrugIndication
chembl id: CHEMBL_IND_50757
has molecule: CHEMBL1520
highest development phase: 1
has mesh: D015427
has mesh heading: REPERFUSION INJURY
has EFO: EFO_0002687
has EFO name: ISCHEMIA REPERFUSION INJURY

CHEMBL_IND_55234
type: DrugIndication
chembl id: CHEMBL_IND_55234
has molecule: CHEMBL1520
highest development phase: 2
has mesh: D003550
has mesh heading: CYSTIC FIBROSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CYSTIC FIBROSIS

CHEMBL_IND_50324
type: DrugIndication
chembl id: CHEMBL_IND_50324
has molecule: CHEMBL1520
highest development phase: 3
has mesh: D006976
has mesh heading: HYPERTENSION, PULMONARY
has EFO: EFO_0001361
has EFO name: PULMONARY HYPERTENSION

CHEMBL_IND_53677
type: DrugIndication
chembl id: CHEMBL_IND_53677
has molecule: CHEMBL1520
highest development phase: 2
has mesh: D011928
has mesh heading: RAYNAUD DISEASE
has EFO: EFO_1001145
has EFO name: RAYNAUD DISEASE

CHEMBL_IND_27187
type: DrugIndication
chembl id: CHEMBL_IND_27187
has molecule: CHEMBL1480
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_27065
type: DrugIndication
chembl id: CHEMBL_IND_27065
has molecule: CHEMBL1098
highest development phase: 3
has mesh: D050723
has mesh heading: FRACTURES, BONE
has EFO: EFO_0003931
has EFO name: BONE FRACTURE

CHEMBL_IND_25836
type: DrugIndication
chembl id: CHEMBL_IND_25836
has molecule: CHEMBL1098
highest development phase: 2
has mesh: D010003
has mesh heading: OSTEOARTHRITIS
has EFO: EFO_0002506
has EFO name: OSTEOARTHRITIS

CHEMBL_IND_25835
type: DrugIndication
chembl id: CHEMBL_IND_25835
has molecule: CHEMBL1098
highest development phase: 3
has mesh: D006552
has mesh heading: HERNIA, INGUINAL
has EFO: HP_0000023
has EFO name: INGUINAL HERNIA

CHEMBL_IND_45827
type: DrugIndication
chembl id: CHEMBL_IND_45827
has molecule: CHEMBL1098
highest development phase: 1
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_48411
type: DrugIndication
chembl id: CHEMBL_IND_48411
has molecule: CHEMBL1098
highest development phase: 3
has mesh: D006215
has mesh heading: HALLUX VALGUS
has EFO: HP_0001822
has EFO name: HALLUX VALGUS

CHEMBL_IND_28443
type: DrugIndication
chembl id: CHEMBL_IND_28443
has molecule: CHEMBL1098
highest development phase: 3
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_51998
type: DrugIndication
chembl id: CHEMBL_IND_51998
has molecule: CHEMBL1098
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0003869
has EFO name: BREAST NEOPLASM

CHEMBL_IND_27589
type: DrugIndication
chembl id: CHEMBL_IND_27589
has molecule: CHEMBL1098
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_52091
type: DrugIndication
chembl id: CHEMBL_IND_52091
has molecule: CHEMBL1098
highest development phase: 3
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_51865
type: DrugIndication
chembl id: CHEMBL_IND_51865
has molecule: CHEMBL1098
highest development phase: 3
has mesh: D020250
has mesh heading: POSTOPERATIVE NAUSEA AND VOMITING
has EFO: EFO_0004888
has EFO name: POST OPERATIVE NAUSEA AND VOMITING

CHEMBL_IND_51891
type: DrugIndication
chembl id: CHEMBL_IND_51891
has molecule: CHEMBL1098
highest development phase: 2
has mesh: D015207
has mesh heading: OSTEOARTHRITIS, HIP
has EFO: EFO_1000786
has EFO name: OSTEOARTHRITIS, HIP

CHEMBL_IND_22811
type: DrugIndication
chembl id: CHEMBL_IND_22811
has molecule: CHEMBL1098
highest development phase: 4
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_22806
type: DrugIndication
chembl id: CHEMBL_IND_22806
has molecule: CHEMBL1098
highest development phase: 2
has mesh: D007022
has mesh heading: HYPOTENSION
has EFO: EFO_0005251
has EFO name: HYPOTENSION

CHEMBL_IND_39725
type: DrugIndication
chembl id: CHEMBL_IND_39725
has molecule: CHEMBL255066
highest development phase: 4
has mesh: D013927
has mesh heading: THROMBOSIS
has EFO: HP_0004419
has EFO name: RECURRENT THROMBOPHLEBITIS

CHEMBL_IND_50411
type: DrugIndication
chembl id: CHEMBL_IND_50411
has molecule: CHEMBL257704
highest development phase: 3
has mesh: D007319
has mesh heading: SLEEP INITIATION AND MAINTENANCE DISORDERS
has EFO: EFO_0004698
has EFO name: INSOMNIA

CHEMBL_IND_51813
type: DrugIndication
chembl id: CHEMBL_IND_51813
has molecule: CHEMBL1525
highest development phase: 3
has mesh: D008288
has mesh heading: MALARIA
has EFO: EFO_0001068
has EFO name: MALARIA

CHEMBL_IND_46842
type: DrugIndication
chembl id: CHEMBL_IND_46842
has molecule: CHEMBL253144
highest development phase: 2
has mesh: D000152
has mesh heading: ACNE VULGARIS
has EFO: EFO_0003894
has EFO name: ACNE

CHEMBL_IND_49553
type: DrugIndication
chembl id: CHEMBL_IND_49553
has molecule: CHEMBL238465
highest development phase: 2
has mesh: D001289
has mesh heading: ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY
has EFO: EFO_0003888
has EFO name: ATTENTION DEFICIT HYPERACTIVITY DISORDER

CHEMBL_IND_46963
type: DrugIndication
chembl id: CHEMBL_IND_46963
has molecule: CHEMBL238465
highest development phase: 2
has mesh: D009437
has mesh heading: NEURALGIA
has EFO: EFO_0005762
has EFO name: NEUROPATHIC PAIN

CHEMBL_IND_27107
type: DrugIndication
chembl id: CHEMBL_IND_27107
has molecule: CHEMBL452
highest development phase: 4
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_52275
type: DrugIndication
chembl id: CHEMBL_IND_52275
has molecule: CHEMBL452
highest development phase: 2
has mesh: D002189
has mesh heading: MARIJUANA ABUSE
has EFO: EFO_0004218
has EFO name: MARIJUANA DEPENDENCE

CHEMBL_IND_24275
type: DrugIndication
chembl id: CHEMBL_IND_24275
has molecule: CHEMBL452
highest development phase: 1
has mesh: D009437
has mesh heading: NEURALGIA
has EFO: EFO_0005762
has EFO name: NEUROPATHIC PAIN

CHEMBL_IND_42441
type: DrugIndication
chembl id: CHEMBL_IND_42441
has molecule: CHEMBL267345
highest development phase: 4
has mesh: D003453
has mesh heading: CRYPTOCOCCOSIS
has EFO: EFO_0007229
has EFO name: CRYPTOCOCCOSIS

CHEMBL_IND_42438
type: DrugIndication
chembl id: CHEMBL_IND_42438
has molecule: CHEMBL267345
highest development phase: 4
has mesh: D001228
has mesh heading: ASPERGILLOSIS
has EFO: EFO_0007157
has EFO name: ASPERGILLOSIS

CHEMBL_IND_41869
type: DrugIndication
chembl id: CHEMBL_IND_41869
has molecule: CHEMBL267345
highest development phase: 4
has mesh: D006660
has mesh heading: HISTOPLASMOSIS
has EFO: EFO_0007310
has EFO name: HISTOPLASMOSIS

CHEMBL_IND_42094
type: DrugIndication
chembl id: CHEMBL_IND_42094
has molecule: CHEMBL267345
highest development phase: 4
has mesh: D013174
has mesh heading: SPOROTRICHOSIS
has EFO: EFO_0007494
has EFO name: SPOROTRICHOSIS

CHEMBL_IND_42092
type: DrugIndication
chembl id: CHEMBL_IND_42092
has molecule: CHEMBL267345
highest development phase: 4
has mesh: D009091
has mesh heading: MUCORMYCOSIS
has EFO: EFO_0007380
has EFO name: MUCORMYCOSIS

CHEMBL_IND_48988
type: DrugIndication
chembl id: CHEMBL_IND_48988
has molecule: CHEMBL267345
highest development phase: 1
has mesh: D016773
has mesh heading: LEISHMANIASIS, CUTANEOUS
has EFO: EFO_0005046
has EFO name: CUTANEOUS LEISHMANIASIS

CHEMBL_IND_41638
type: DrugIndication
chembl id: CHEMBL_IND_41638
has molecule: CHEMBL267345
highest development phase: 4
has mesh: D009181
has mesh heading: MYCOSES

CHEMBL_IND_41627
type: DrugIndication
chembl id: CHEMBL_IND_41627
has molecule: CHEMBL267345
highest development phase: 4
has mesh: D002177
has mesh heading: CANDIDIASIS

CHEMBL_IND_51753
type: DrugIndication
chembl id: CHEMBL_IND_51753
has molecule: CHEMBL267345
highest development phase: 2
has mesh: D058365
has mesh heading: CANDIDIASIS, INVASIVE
has EFO: EFO_1001283
has EFO name: CANDIDIASIS, INVASIVE

CHEMBL_IND_41864
type: DrugIndication
chembl id: CHEMBL_IND_41864
has molecule: CHEMBL267345
highest development phase: 4
has mesh: D016919
has mesh heading: MENINGITIS, CRYPTOCOCCAL
has EFO: EFO_0007228
has EFO name: CRYPTOCOCCAL MENINGITIS

CHEMBL_IND_42738
type: DrugIndication
chembl id: CHEMBL_IND_42738
has molecule: CHEMBL267345
highest development phase: 4
has mesh: D007898
has mesh heading: LEISHMANIASIS, VISCERAL
has EFO: EFO_0005045
has EFO name: VISCERAL LEISHMANIASIS

CHEMBL_IND_42687
type: DrugIndication
chembl id: CHEMBL_IND_42687
has molecule: CHEMBL267345
highest development phase: 4
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_39813
type: DrugIndication
chembl id: CHEMBL_IND_39813
has molecule: CHEMBL267345
highest development phase: 3
has mesh: D007896
has mesh heading: LEISHMANIASIS
has EFO: EFO_0005044
has EFO name: LEISHMANIASIS

CHEMBL_IND_26498
type: DrugIndication
chembl id: CHEMBL_IND_26498
has molecule: CHEMBL1533
highest development phase: 2
has mesh: D020182
has mesh heading: SLEEP APNEA, CENTRAL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: ONDINE SYNDROME

CHEMBL_IND_24311
type: DrugIndication
chembl id: CHEMBL_IND_24311
has molecule: CHEMBL1533
highest development phase: 3
has mesh: D006470
has mesh heading: HEMORRHAGE
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: HEMORRHAGE

CHEMBL_IND_50091
type: DrugIndication
chembl id: CHEMBL_IND_50091
has molecule: CHEMBL251940
highest development phase: 4
has mesh: D011618
has mesh heading: PSYCHOTIC DISORDERS
has EFO: EFO_0005407
has EFO name: PSYCHOSIS

CHEMBL_IND_52337
type: DrugIndication
chembl id: CHEMBL_IND_52337
has molecule: CHEMBL266481
highest development phase: 2
has mesh: D044903
has mesh heading: CONGENITAL HYPERINSULINISM
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CONGENITAL ISOLATED HYPERINSULINISM

CHEMBL_IND_44296
type: DrugIndication
chembl id: CHEMBL_IND_44296
has molecule: CHEMBL266481
highest development phase: 1
has mesh: D012778
has mesh heading: SHORT BOWEL SYNDROME
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: PRIMARY SHORT BOWEL SYNDROME

CHEMBL_IND_51817
type: DrugIndication
chembl id: CHEMBL_IND_51817
has molecule: CHEMBL266481
highest development phase: 1
has mesh: D009765
has mesh heading: OBESITY
has EFO: EFO_0001073
has EFO name: OBESITY

CHEMBL_IND_44552
type: DrugIndication
chembl id: CHEMBL_IND_44552
has molecule: CHEMBL266481
highest development phase: 1
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_27725
type: DrugIndication
chembl id: CHEMBL_IND_27725
has molecule: CHEMBL266481
highest development phase: 1
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_23236
type: DrugIndication
chembl id: CHEMBL_IND_23236
has molecule: CHEMBL266481
highest development phase: 2
has mesh: D003922
has mesh heading: DIABETES MELLITUS, TYPE 1
has EFO: EFO_0001359
has EFO name: TYPE I DIABETES MELLITUS

CHEMBL_IND_23235
type: DrugIndication
chembl id: CHEMBL_IND_23235
has molecule: CHEMBL266481
highest development phase: 1
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0003144
has EFO name: HEART FAILURE

CHEMBL_IND_25351
type: DrugIndication
chembl id: CHEMBL_IND_25351
has molecule: CHEMBL266481
highest development phase: 2
has mesh: D007003
has mesh heading: HYPOGLYCEMIA
has EFO: HP_0001943
has EFO name: HYPOGLYCEMIA

CHEMBL_IND_54142
type: DrugIndication
chembl id: CHEMBL_IND_54142
has molecule: CHEMBL51
highest development phase: 1
has mesh: D017719
has mesh heading: DIABETIC FOOT
has EFO: EFO_1001459
has EFO name: DIABETIC FOOT

CHEMBL_IND_54368
type: DrugIndication
chembl id: CHEMBL_IND_54368
has molecule: CHEMBL51
highest development phase: 3
has mesh: D058186
has mesh heading: ACUTE KIDNEY INJURY
has EFO: HP_0001919
has EFO name: ACUTE KIDNEY INJURY

CHEMBL_IND_25922
type: DrugIndication
chembl id: CHEMBL_IND_25922
has molecule: CHEMBL17
highest development phase: 4
has mesh: D005901
has mesh heading: GLAUCOMA
has EFO: EFO_0000516
has EFO name: GLAUCOMA

CHEMBL_IND_46858
type: DrugIndication
chembl id: CHEMBL_IND_46858
has molecule: CHEMBL267431
highest development phase: 2
has mesh: D008593
has mesh heading: MENOPAUSE
has EFO: EFO_0003922
has EFO name: MENOPAUSE

CHEMBL_IND_45742
type: DrugIndication
chembl id: CHEMBL_IND_45742
has molecule: CHEMBL267431
highest development phase: 2
has mesh: D004715
has mesh heading: ENDOMETRIOSIS
has EFO: EFO_0001065
has EFO name: ENDOMETRIOSIS

CHEMBL_IND_44763
type: DrugIndication
chembl id: CHEMBL_IND_44763
has molecule: CHEMBL267431
highest development phase: 2
has mesh: D007889
has mesh heading: LEIOMYOMA
has EFO: EFO_0000731
has EFO name: UTERINE FIBROID

CHEMBL_IND_47670
type: DrugIndication
chembl id: CHEMBL_IND_47670
has molecule: CHEMBL267431
highest development phase: 2
has mesh: D008595
has mesh heading: MENORRHAGIA
has EFO: EFO_0003945
has EFO name: MENORRHAGIA

CHEMBL_IND_52142
type: DrugIndication
chembl id: CHEMBL_IND_52142
has molecule: CHEMBL448
highest development phase: 1
has mesh: D019966
has mesh heading: SUBSTANCE-RELATED DISORDERS
has EFO: EFO_0003890
has EFO name: DRUG DEPENDENCE

CHEMBL_IND_28478
type: DrugIndication
chembl id: CHEMBL_IND_28478
has molecule: CHEMBL448
highest development phase: 3
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_27874
type: DrugIndication
chembl id: CHEMBL_IND_27874
has molecule: CHEMBL448
highest development phase: 1
has mesh: D006331
has mesh heading: HEART DISEASES
has EFO: EFO_0003777
has EFO name: HEART DISEASE

CHEMBL_IND_46439
type: DrugIndication
chembl id: CHEMBL_IND_46439
has molecule: CHEMBL270190
highest development phase: 3
has mesh: D004066
has mesh heading: DIGESTIVE SYSTEM DISEASES
has EFO: EFO_0000405
has EFO name: DIGESTIVE SYSTEM DISEASE

CHEMBL_IND_45479
type: DrugIndication
chembl id: CHEMBL_IND_45479
has molecule: CHEMBL270190
highest development phase: 2
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_27531
type: DrugIndication
chembl id: CHEMBL_IND_27531
has molecule: CHEMBL270190
highest development phase: 3
has mesh: D003248
has mesh heading: CONSTIPATION
has EFO: HP_0002019
has EFO name: CONSTIPATION

CHEMBL_IND_48465
type: DrugIndication
chembl id: CHEMBL_IND_48465
has molecule: CHEMBL63
highest development phase: 1
has mesh: D006816
has mesh heading: HUNTINGTON DISEASE
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: HUNTINGTON DISEASE

CHEMBL_IND_41946
type: DrugIndication
chembl id: CHEMBL_IND_41946
has molecule: CHEMBL64
highest development phase: 4
has mesh: D014376
has mesh heading: TUBERCULOSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: TUBERCULOSIS

CHEMBL_IND_42261
type: DrugIndication
chembl id: CHEMBL_IND_42261
has molecule: CHEMBL64
highest development phase: 4
has mesh: D014397
has mesh heading: TUBERCULOSIS, PULMONARY
has EFO: EFO_1000049
has EFO name: PULMONARY TUBERCULOSIS

CHEMBL_IND_51761
type: DrugIndication
chembl id: CHEMBL_IND_51761
has molecule: CHEMBL64
highest development phase: 2
has mesh: D017719
has mesh heading: DIABETIC FOOT
has EFO: EFO_1001459
has EFO name: DIABETIC FOOT

CHEMBL_IND_54006
type: DrugIndication
chembl id: CHEMBL_IND_54006
has molecule: CHEMBL445
highest development phase: 2
has mesh: D043183
has mesh heading: IRRITABLE BOWEL SYNDROME
has EFO: EFO_0000555
has EFO name: IRRITABLE BOWEL SYNDROME

CHEMBL_IND_54736
type: DrugIndication
chembl id: CHEMBL_IND_54736
has molecule: CHEMBL445
highest development phase: 3
has mesh: D005764
has mesh heading: GASTROESOPHAGEAL REFLUX
has EFO: EFO_0003948
has EFO name: GASTROESOPHAGEAL REFLUX DISEASE

CHEMBL_IND_54652
type: DrugIndication
chembl id: CHEMBL_IND_54652
has molecule: CHEMBL445
highest development phase: 2
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_52835
type: DrugIndication
chembl id: CHEMBL_IND_52835
has molecule: CHEMBL445
highest development phase: 4
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_54504
type: DrugIndication
chembl id: CHEMBL_IND_54504
has molecule: CHEMBL445
highest development phase: 2
has mesh: D014029
has mesh heading: TOBACCO USE DISORDER
has EFO: EFO_0003768
has EFO name: NICOTINE DEPENDENCE

CHEMBL_IND_46959
type: DrugIndication
chembl id: CHEMBL_IND_46959
has molecule: CHEMBL490
highest development phase: 1
has mesh: D005356
has mesh heading: FIBROMYALGIA
has EFO: EFO_0005687
has EFO name: FIBROMYALGIA

CHEMBL_IND_45759
type: DrugIndication
chembl id: CHEMBL_IND_45759
has molecule: CHEMBL490
highest development phase: 4
has mesh: D013313
has mesh heading: STRESS DISORDERS, POST-TRAUMATIC
has EFO: EFO_0001358
has EFO name: POST-TRAUMATIC STRESS DISORDER

CHEMBL_IND_48440
type: DrugIndication
chembl id: CHEMBL_IND_48440
has molecule: CHEMBL490
highest development phase: 3
has mesh: D061686
has mesh heading: PREMATURE EJACULATION
has EFO: HP_0012876
has EFO name: PREMATURE EJACULATION

CHEMBL_IND_43089
type: DrugIndication
chembl id: CHEMBL_IND_43089
has molecule: CHEMBL490
highest development phase: 4
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_44145
type: DrugIndication
chembl id: CHEMBL_IND_44145
has molecule: CHEMBL490
highest development phase: 3
has mesh: D001007
has mesh heading: ANXIETY
has EFO: EFO_0005230
has EFO name: ANXIETY

CHEMBL_IND_22892
type: DrugIndication
chembl id: CHEMBL_IND_22892
has molecule: CHEMBL498
highest development phase: 4
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_42086
type: DrugIndication
chembl id: CHEMBL_IND_42086
has molecule: CHEMBL268501
highest development phase: 4
has mesh: D012216
has mesh heading: RHEUMATIC DISEASES
has EFO: EFO_0005755
has EFO name: RHEUMATIC DISEASE

CHEMBL_IND_49988
type: DrugIndication
chembl id: CHEMBL_IND_49988
has molecule: CHEMBL40
highest development phase: 4
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_50631
type: DrugIndication
chembl id: CHEMBL_IND_50631
has molecule: CHEMBL40
highest development phase: 1
has mesh: D012640
has mesh heading: SEIZURES
has EFO: HP_0001250
has EFO name: SEIZURES

CHEMBL_IND_53889
type: DrugIndication
chembl id: CHEMBL_IND_53889
has molecule: CHEMBL40
highest development phase: 3
has mesh: D009357
has mesh heading: NEONATAL ABSTINENCE SYNDROME
has EFO: EFO_0005799
has EFO name: NEONATAL ABSTINENCE SYNDROME

CHEMBL_IND_39708
type: DrugIndication
chembl id: CHEMBL_IND_39708
has molecule: CHEMBL266349
highest development phase: 4
has mesh: D013927
has mesh heading: THROMBOSIS
has EFO: HP_0004419
has EFO name: RECURRENT THROMBOPHLEBITIS

CHEMBL_IND_26985
type: DrugIndication
chembl id: CHEMBL_IND_26985
has molecule: CHEMBL271227
highest development phase: 4
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_27997
type: DrugIndication
chembl id: CHEMBL_IND_27997
has molecule: CHEMBL271227
highest development phase: 1
has mesh: D000312
has mesh heading: ADRENAL HYPERPLASIA, CONGENITAL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY

CHEMBL_IND_41758
type: DrugIndication
chembl id: CHEMBL_IND_41758
has molecule: CHEMBL271227
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_22610
type: DrugIndication
chembl id: CHEMBL_IND_22610
has molecule: CHEMBL271227
highest development phase: 4
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_24096
type: DrugIndication
chembl id: CHEMBL_IND_24096
has molecule: CHEMBL271227
highest development phase: 1
has mesh: D051437
has mesh heading: RENAL INSUFFICIENCY
has EFO: HP_0000083
has EFO name: RENAL INSUFFICIENCY

CHEMBL_IND_24095
type: DrugIndication
chembl id: CHEMBL_IND_24095
has molecule: CHEMBL271227
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_43409
type: DrugIndication
chembl id: CHEMBL_IND_43409
has molecule: CHEMBL264241
highest development phase: 1
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_45486
type: DrugIndication
chembl id: CHEMBL_IND_45486
has molecule: CHEMBL264241
highest development phase: 2
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_41666
type: DrugIndication
chembl id: CHEMBL_IND_41666
has molecule: CHEMBL264241
highest development phase: 4
has mesh: D010538
has mesh heading: PERITONITIS

CHEMBL_IND_42774
type: DrugIndication
chembl id: CHEMBL_IND_42774
has molecule: CHEMBL264241
highest development phase: 4
has mesh: D058387
has mesh heading: CANDIDEMIA
has EFO: EFO_1001282
has EFO name: CANDIDEMIA

CHEMBL_IND_42547
type: DrugIndication
chembl id: CHEMBL_IND_42547
has molecule: CHEMBL435
highest development phase: 4
has mesh: D008103
has mesh heading: LIVER CIRRHOSIS
has EFO: EFO_0001422
has EFO name: CIRRHOSIS OF LIVER

CHEMBL_IND_42163
type: DrugIndication
chembl id: CHEMBL_IND_42163
has molecule: CHEMBL435
highest development phase: 4
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0000373
has EFO name: CONGESTIVE HEART FAILURE

CHEMBL_IND_42569
type: DrugIndication
chembl id: CHEMBL_IND_42569
has molecule: CHEMBL435
highest development phase: 4
has mesh: D009404
has mesh heading: NEPHROTIC SYNDROME
has EFO: EFO_0004255
has EFO name: NEPHROTIC SYNDROME

CHEMBL_IND_41803
type: DrugIndication
chembl id: CHEMBL_IND_41803
has molecule: CHEMBL435
highest development phase: 4
has mesh: D007676
has mesh heading: KIDNEY FAILURE, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_41689
type: DrugIndication
chembl id: CHEMBL_IND_41689
has molecule: CHEMBL435
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_41650
type: DrugIndication
chembl id: CHEMBL_IND_41650
has molecule: CHEMBL435
highest development phase: 4
has mesh: D004487
has mesh heading: EDEMA

CHEMBL_IND_41644
type: DrugIndication
chembl id: CHEMBL_IND_41644
has molecule: CHEMBL435
highest development phase: 4
has mesh: D005921
has mesh heading: GLOMERULONEPHRITIS

CHEMBL_IND_23265
type: DrugIndication
chembl id: CHEMBL_IND_23265
has molecule: CHEMBL435
highest development phase: 4
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_24486
type: DrugIndication
chembl id: CHEMBL_IND_24486
has molecule: CHEMBL435
highest development phase: 2
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_23273
type: DrugIndication
chembl id: CHEMBL_IND_23273
has molecule: CHEMBL1549
highest development phase: 4
has mesh: D005128
has mesh heading: EYE DISEASES
has EFO: EFO_0005752
has EFO name: EYE INFLAMMATION

CHEMBL_IND_50564
type: DrugIndication
chembl id: CHEMBL_IND_50564
has molecule: CHEMBL260046
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0002617
has EFO name: METASTATIC MELANOMA

CHEMBL_IND_50511
type: DrugIndication
chembl id: CHEMBL_IND_50511
has molecule: CHEMBL260046
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_50859
type: DrugIndication
chembl id: CHEMBL_IND_50859
has molecule: CHEMBL260046
highest development phase: 2
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_55186
type: DrugIndication
chembl id: CHEMBL_IND_55186
has molecule: CHEMBL260046
highest development phase: 1
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_54965
type: DrugIndication
chembl id: CHEMBL_IND_54965
has molecule: CHEMBL260046
highest development phase: 1
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_52729
type: DrugIndication
chembl id: CHEMBL_IND_52729
has molecule: CHEMBL422
highest development phase: 4
has mesh: D011618
has mesh heading: PSYCHOTIC DISORDERS
has EFO: EFO_0005407
has EFO name: PSYCHOSIS

CHEMBL_IND_45609
type: DrugIndication
chembl id: CHEMBL_IND_45609
has molecule: CHEMBL416
highest development phase: 3
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_52639
type: DrugIndication
chembl id: CHEMBL_IND_52639
has molecule: CHEMBL416
highest development phase: 2
has mesh: D006086
has mesh heading: GRAFT VS HOST DISEASE
has EFO: EFO_0004599
has EFO name: ACUTE GRAFT VS. HOST DISEASE

CHEMBL_IND_46150
type: DrugIndication
chembl id: CHEMBL_IND_46150
has molecule: CHEMBL416
highest development phase: 3
has mesh: D009182
has mesh heading: MYCOSIS FUNGOIDES
has EFO: EFO_1001051
has EFO name: MYCOSIS FUNGOIDES

CHEMBL_IND_45484
type: DrugIndication
chembl id: CHEMBL_IND_45484
has molecule: CHEMBL416
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_42534
type: DrugIndication
chembl id: CHEMBL_IND_42534
has molecule: CHEMBL514
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_48501
type: DrugIndication
chembl id: CHEMBL_IND_48501
has molecule: CHEMBL514
highest development phase: 3
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_43298
type: DrugIndication
chembl id: CHEMBL_IND_43298
has molecule: CHEMBL514
highest development phase: 1
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_44574
type: DrugIndication
chembl id: CHEMBL_IND_44574
has molecule: CHEMBL514
highest development phase: 3
has mesh: D005909
has mesh heading: GLIOBLASTOMA
has EFO: EFO_0000519
has EFO name: GLIOBLASTOMA MULTIFORME

CHEMBL_IND_51671
type: DrugIndication
chembl id: CHEMBL_IND_51671
has molecule: CHEMBL514
highest development phase: 3
has mesh: D001254
has mesh heading: ASTROCYTOMA
has EFO: EFO_0002499
has EFO name: ANAPLASTIC ASTROCYTOMA

CHEMBL_IND_45415
type: DrugIndication
chembl id: CHEMBL_IND_45415
has molecule: CHEMBL249420
highest development phase: 3
has mesh: D000690
has mesh heading: AMYOTROPHIC LATERAL SCLEROSIS
has EFO: EFO_0000253
has EFO name: AMYOTROPHIC LATERAL SCLEROSIS

CHEMBL_IND_54571
type: DrugIndication
chembl id: CHEMBL_IND_54571
has molecule: CHEMBL249420
highest development phase: 2
has mesh: D017681
has mesh heading: HYPEREOSINOPHILIC SYNDROME
has EFO: EFO_1001467
has EFO name: HYPEREOSINOPHILIC SYNDROME

CHEMBL_IND_27248
type: DrugIndication
chembl id: CHEMBL_IND_27248
has molecule: CHEMBL1513
highest development phase: 2
has mesh: D008382
has mesh heading: MARFAN SYNDROME
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: MARFAN SYNDROME

CHEMBL_IND_27247
type: DrugIndication
chembl id: CHEMBL_IND_27247
has molecule: CHEMBL1513
highest development phase: 2
has mesh: D005923
has mesh heading: GLOMERULOSCLEROSIS, FOCAL SEGMENTAL
has EFO: EFO_0004236
has EFO name: FOCAL SEGMENTAL GLOMERULOSCLEROSIS

CHEMBL_IND_27246
type: DrugIndication
chembl id: CHEMBL_IND_27246
has molecule: CHEMBL1513
highest development phase: 3
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0000373
has EFO name: CONGESTIVE HEART FAILURE

CHEMBL_IND_26646
type: DrugIndication
chembl id: CHEMBL_IND_26646
has molecule: CHEMBL1513
highest development phase: 3
has mesh: D019698
has mesh heading: HEPATITIS C, CHRONIC
has EFO: EFO_0004220
has EFO name: CHRONIC HEPATITIS C INFECTION

CHEMBL_IND_23364
type: DrugIndication
chembl id: CHEMBL_IND_23364
has molecule: CHEMBL1513
highest development phase: 4
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_23362
type: DrugIndication
chembl id: CHEMBL_IND_23362
has molecule: CHEMBL1513
highest development phase: 3
has mesh: D001281
has mesh heading: ATRIAL FIBRILLATION
has EFO: EFO_0000275
has EFO name: ATRIAL FIBRILLATION

CHEMBL_IND_42823
type: DrugIndication
chembl id: CHEMBL_IND_42823
has molecule: CHEMBL1513
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_24555
type: DrugIndication
chembl id: CHEMBL_IND_24555
has molecule: CHEMBL1513
highest development phase: 3
has mesh: D018805
has mesh heading: SEPSIS
has EFO: EFO_0001420
has EFO name: SEPSIS

CHEMBL_IND_24553
type: DrugIndication
chembl id: CHEMBL_IND_24553
has molecule: CHEMBL1513
highest development phase: 3
has mesh: D006937
has mesh heading: HYPERCHOLESTEROLEMIA
has EFO: HP_0003124
has EFO name: HYPERCHOLESTEROLEMIA

CHEMBL_IND_44893
type: DrugIndication
chembl id: CHEMBL_IND_44893
has molecule: CHEMBL984
highest development phase: 2
has mesh: D008107
has mesh heading: LIVER DISEASES
has EFO: EFO_0001421
has EFO name: LIVER DISEASE

CHEMBL_IND_50000
type: DrugIndication
chembl id: CHEMBL_IND_50000
has molecule: CHEMBL517
highest development phase: 4
has mesh: D001145
has mesh heading: ARRHYTHMIAS, CARDIAC
has EFO: EFO_0004269
has EFO name: CARDIAC ARRHYTHMIA

CHEMBL_IND_44785
type: DrugIndication
chembl id: CHEMBL_IND_44785
has molecule: CHEMBL638
highest development phase: 1
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_43403
type: DrugIndication
chembl id: CHEMBL_IND_43403
has molecule: CHEMBL638
highest development phase: 3
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_44113
type: DrugIndication
chembl id: CHEMBL_IND_44113
has molecule: CHEMBL638
highest development phase: 1
has mesh: D006086
has mesh heading: GRAFT VS HOST DISEASE
has EFO: EFO_0004599
has EFO name: ACUTE GRAFT VS. HOST DISEASE

CHEMBL_IND_39827
type: DrugIndication
chembl id: CHEMBL_IND_39827
has molecule: CHEMBL638
highest development phase: 3
has mesh: D001228
has mesh heading: ASPERGILLOSIS
has EFO: EFO_0007157
has EFO name: ASPERGILLOSIS

CHEMBL_IND_43573
type: DrugIndication
chembl id: CHEMBL_IND_43573
has molecule: CHEMBL549
highest development phase: 2
has mesh: D020521
has mesh heading: STROKE
has EFO: EFO_0000712
has EFO name: STROKE

CHEMBL_IND_49509
type: DrugIndication
chembl id: CHEMBL_IND_49509
has molecule: CHEMBL549
highest development phase: 1
has mesh: D002659
has mesh heading: CHILD DEVELOPMENT DISORDERS, PERVASIVE
has EFO: EFO_0003756
has EFO name: AUTISM SPECTRUM DISORDER

CHEMBL_IND_48874
type: DrugIndication
chembl id: CHEMBL_IND_48874
has molecule: CHEMBL549
highest development phase: 1
has mesh: D000437
has mesh heading: ALCOHOLISM
has EFO: EFO_0003829
has EFO name: ALCOHOL DEPENDENCE

CHEMBL_IND_43086
type: DrugIndication
chembl id: CHEMBL_IND_43086
has molecule: CHEMBL549
highest development phase: 4
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_47507
type: DrugIndication
chembl id: CHEMBL_IND_47507
has molecule: CHEMBL549
highest development phase: 2
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_44160
type: DrugIndication
chembl id: CHEMBL_IND_44160
has molecule: CHEMBL549
highest development phase: 1
has mesh: D054058
has mesh heading: ACUTE CORONARY SYNDROME
has EFO: EFO_0005672
has EFO name: ACUTE CORONARY SYNDROME

CHEMBL_IND_41956
type: DrugIndication
chembl id: CHEMBL_IND_41956
has molecule: CHEMBL645
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_45361
type: DrugIndication
chembl id: CHEMBL_IND_45361
has molecule: CHEMBL645
highest development phase: 1
has mesh: D007863
has mesh heading: LECITHIN ACYLTRANSFERASE DEFICIENCY
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: FISH-EYE DISEASE

CHEMBL_IND_47676
type: DrugIndication
chembl id: CHEMBL_IND_47676
has molecule: CHEMBL645
highest development phase: 0
has mesh: D017544
has mesh heading: AORTIC ANEURYSM, ABDOMINAL
has EFO: EFO_0004214
has EFO name: ABDOMINAL AORTIC ANEURYSM

CHEMBL_IND_46230
type: DrugIndication
chembl id: CHEMBL_IND_46230
has molecule: CHEMBL645
highest development phase: 1
has mesh: D065627
has mesh heading: FAMILIAL PRIMARY PULMONARY HYPERTENSION
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION

CHEMBL_IND_44440
type: DrugIndication
chembl id: CHEMBL_IND_44440
has molecule: CHEMBL645
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_44536
type: DrugIndication
chembl id: CHEMBL_IND_44536
has molecule: CHEMBL645
highest development phase: 0
has mesh: D003324
has mesh heading: CORONARY ARTERY DISEASE
has EFO: EFO_0000378
has EFO name: CORONARY ARTERY DISEASE

CHEMBL_IND_27087
type: DrugIndication
chembl id: CHEMBL_IND_27087
has molecule: CHEMBL513
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_27086
type: DrugIndication
chembl id: CHEMBL_IND_27086
has molecule: CHEMBL513
highest development phase: 4
has mesh: D006689
has mesh heading: HODGKIN DISEASE
has EFO: EFO_0000183
has EFO name: HODGKINS LYMPHOMA

CHEMBL_IND_28052
type: DrugIndication
chembl id: CHEMBL_IND_28052
has molecule: CHEMBL513
highest development phase: 2
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_22861
type: DrugIndication
chembl id: CHEMBL_IND_22861
has molecule: CHEMBL513
highest development phase: 2
has mesh: D001932
has mesh heading: BRAIN NEOPLASMS
has EFO: EFO_0003833
has EFO name: BRAIN NEOPLASM

CHEMBL_IND_22860
type: DrugIndication
chembl id: CHEMBL_IND_22860
has molecule: CHEMBL513
highest development phase: 4
has mesh: D001254
has mesh heading: ASTROCYTOMA
has EFO: EFO_0000272
has EFO name: ASTROCYTOMA

CHEMBL_IND_24247
type: DrugIndication
chembl id: CHEMBL_IND_24247
has molecule: CHEMBL513
highest development phase: 4
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_24246
type: DrugIndication
chembl id: CHEMBL_IND_24246
has molecule: CHEMBL513
highest development phase: 4
has mesh: D008527
has mesh heading: MEDULLOBLASTOMA
has EFO: EFO_0002939
has EFO name: MEDULLOBLASTOMA

CHEMBL_IND_24245
type: DrugIndication
chembl id: CHEMBL_IND_24245
has molecule: CHEMBL513
highest development phase: 4
has mesh: D005909
has mesh heading: GLIOBLASTOMA
has EFO: EFO_0000519
has EFO name: GLIOBLASTOMA MULTIFORME

CHEMBL_IND_50001
type: DrugIndication
chembl id: CHEMBL_IND_50001
has molecule: CHEMBL277062
highest development phase: 4
has mesh: D001007
has mesh heading: ANXIETY
has EFO: EFO_0005230
has EFO name: ANXIETY

CHEMBL_IND_42355
type: DrugIndication
chembl id: CHEMBL_IND_42355
has molecule: CHEMBL279229
highest development phase: 4
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_47311
type: DrugIndication
chembl id: CHEMBL_IND_47311
has molecule: CHEMBL279229
highest development phase: 3
has mesh: D011225
has mesh heading: PRE-ECLAMPSIA
has EFO: EFO_0000668
has EFO name: PREECLAMPSIA

CHEMBL_IND_44146
type: DrugIndication
chembl id: CHEMBL_IND_44146
has molecule: CHEMBL263881
highest development phase: 2
has mesh: D001007
has mesh heading: ANXIETY
has EFO: EFO_0005230
has EFO name: ANXIETY

CHEMBL_IND_27126
type: DrugIndication
chembl id: CHEMBL_IND_27126
has molecule: CHEMBL612
highest development phase: 2
has mesh: D019969
has mesh heading: AMPHETAMINE-RELATED DISORDERS
has EFO: EFO_0004701
has EFO name: METAMPHETAMINE DEPENDENCE

CHEMBL_IND_28101
type: DrugIndication
chembl id: CHEMBL_IND_28101
has molecule: CHEMBL612
highest development phase: 2
has mesh: D020521
has mesh heading: STROKE
has EFO: EFO_0000712
has EFO name: STROKE

CHEMBL_IND_52577
type: DrugIndication
chembl id: CHEMBL_IND_52577
has molecule: CHEMBL612
highest development phase: 3
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_48290
type: DrugIndication
chembl id: CHEMBL_IND_48290
has molecule: CHEMBL612
highest development phase: 2
has mesh: D009103
has mesh heading: MULTIPLE SCLEROSIS
has EFO: EFO_0003885
has EFO name: MULTIPLE SCLEROSIS

CHEMBL_IND_27125
type: DrugIndication
chembl id: CHEMBL_IND_27125
has molecule: CHEMBL612
highest development phase: 2
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_47343
type: DrugIndication
chembl id: CHEMBL_IND_47343
has molecule: CHEMBL612
highest development phase: 2
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_24325
type: DrugIndication
chembl id: CHEMBL_IND_24325
has molecule: CHEMBL612
highest development phase: 4
has mesh: D001289
has mesh heading: ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY
has EFO: EFO_0003888
has EFO name: ATTENTION DEFICIT HYPERACTIVITY DISORDER

CHEMBL_IND_43705
type: DrugIndication
chembl id: CHEMBL_IND_43705
has molecule: CHEMBL282724
highest development phase: 3
has mesh: D006976
has mesh heading: HYPERTENSION, PULMONARY
has EFO: EFO_0001361
has EFO name: PULMONARY HYPERTENSION

CHEMBL_IND_54774
type: DrugIndication
chembl id: CHEMBL_IND_54774
has molecule: CHEMBL282724
highest development phase: 2
has mesh: D054144
has mesh heading: HEART FAILURE, DIASTOLIC
has EFO: EFO_1000899
has EFO name: DIASTOLIC HEART FAILURE

CHEMBL_IND_48513
type: DrugIndication
chembl id: CHEMBL_IND_48513
has molecule: CHEMBL282724
highest development phase: 2
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_26504
type: DrugIndication
chembl id: CHEMBL_IND_26504
has molecule: CHEMBL904
highest development phase: 4
has mesh: D001289
has mesh heading: ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY
has EFO: EFO_0003888
has EFO name: ATTENTION DEFICIT HYPERACTIVITY DISORDER

CHEMBL_IND_27165
type: DrugIndication
chembl id: CHEMBL_IND_27165
has molecule: CHEMBL679
highest development phase: 4
has mesh: D006470
has mesh heading: HEMORRHAGE
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: HEMORRHAGE

CHEMBL_IND_25958
type: DrugIndication
chembl id: CHEMBL_IND_25958
has molecule: CHEMBL679
highest development phase: 3
has mesh: D016757
has mesh heading: DEATH, SUDDEN, CARDIAC
has EFO: EFO_0004278
has EFO name: SUDDEN CARDIAC ARREST

CHEMBL_IND_26557
type: DrugIndication
chembl id: CHEMBL_IND_26557
has molecule: CHEMBL679
highest development phase: 4
has mesh: D008173
has mesh heading: LUNG DISEASES, OBSTRUCTIVE
has EFO: HP_0006536
has EFO name: OBSTRUCTIVE LUNG DISEASE

CHEMBL_IND_26555
type: DrugIndication
chembl id: CHEMBL_IND_26555
has molecule: CHEMBL679
highest development phase: 4
has mesh: D005901
has mesh heading: GLAUCOMA
has EFO: EFO_0000516
has EFO name: GLAUCOMA

CHEMBL_IND_26554
type: DrugIndication
chembl id: CHEMBL_IND_26554
has molecule: CHEMBL679
highest development phase: 3
has mesh: D001988
has mesh heading: BRONCHIOLITIS
has EFO: HP_0011950
has EFO name: BRONCHIOLITIS

CHEMBL_IND_25289
type: DrugIndication
chembl id: CHEMBL_IND_25289
has molecule: CHEMBL679
highest development phase: 4
has mesh: D015508
has mesh heading: NASAL OBSTRUCTION
has EFO: HP_0001742
has EFO name: NASAL OBSTRUCTION

CHEMBL_IND_51437
type: DrugIndication
chembl id: CHEMBL_IND_51437
has molecule: CHEMBL679
highest development phase: 4
has mesh: D001986
has mesh heading: BRONCHIAL SPASM

CHEMBL_IND_51425
type: DrugIndication
chembl id: CHEMBL_IND_51425
has molecule: CHEMBL679
highest development phase: 4
has mesh: D012713
has mesh heading: SERUM SICKNESS

CHEMBL_IND_23092
type: DrugIndication
chembl id: CHEMBL_IND_23092
has molecule: CHEMBL679
highest development phase: 3
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_42661
type: DrugIndication
chembl id: CHEMBL_IND_42661
has molecule: CHEMBL679
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_51597
type: DrugIndication
chembl id: CHEMBL_IND_51597
has molecule: CHEMBL679
highest development phase: 4
has mesh: D012852
has mesh heading: SINUSITIS
has EFO: EFO_0007486
has EFO name: SINUSITIS

CHEMBL_IND_51556
type: DrugIndication
chembl id: CHEMBL_IND_51556
has molecule: CHEMBL679
highest development phase: 4
has mesh: D000799
has mesh heading: ANGIOEDEMA
has EFO: EFO_0005532
has EFO name: ANGIOEDEMA

CHEMBL_IND_51554
type: DrugIndication
chembl id: CHEMBL_IND_51554
has molecule: CHEMBL679
highest development phase: 4
has mesh: D006323
has mesh heading: HEART ARREST
has EFO: EFO_0004278
has EFO name: SUDDEN CARDIAC ARREST

CHEMBL_IND_51508
type: DrugIndication
chembl id: CHEMBL_IND_51508
has molecule: CHEMBL679
highest development phase: 4
has mesh: D014581
has mesh heading: URTICARIA
has EFO: EFO_0005531
has EFO name: URTICARIA

CHEMBL_IND_51464
type: DrugIndication
chembl id: CHEMBL_IND_51464
has molecule: CHEMBL679
highest development phase: 4
has mesh: D012220
has mesh heading: RHINITIS
has EFO: EFO_0005854
has EFO name: ALLERGIC RHINITIS

CHEMBL_IND_51460
type: DrugIndication
chembl id: CHEMBL_IND_51460
has molecule: CHEMBL679
highest development phase: 4
has mesh: D006255
has mesh heading: RHINITIS, ALLERGIC, SEASONAL
has EFO: EFO_0003956
has EFO name: SEASONAL ALLERGIC RHINITIS

CHEMBL_IND_49418
type: DrugIndication
chembl id: CHEMBL_IND_49418
has molecule: CHEMBL1536
highest development phase: 3
has mesh: D003922
has mesh heading: DIABETES MELLITUS, TYPE 1
has EFO: EFO_0001359
has EFO name: TYPE I DIABETES MELLITUS

CHEMBL_IND_41218
type: DrugIndication
chembl id: CHEMBL_IND_41218
has molecule: CHEMBL1536
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0003869
has EFO name: BREAST NEOPLASM

CHEMBL_IND_52563
type: DrugIndication
chembl id: CHEMBL_IND_52563
has molecule: CHEMBL1536
highest development phase: 2
has mesh: D003550
has mesh heading: CYSTIC FIBROSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CYSTIC FIBROSIS

CHEMBL_IND_52521
type: DrugIndication
chembl id: CHEMBL_IND_52521
has molecule: CHEMBL1536
highest development phase: 2
has mesh: D009902
has mesh heading: OPTIC NEURITIS
has EFO: EFO_0007405
has EFO name: OPTIC NEURITIS

CHEMBL_IND_52506
type: DrugIndication
chembl id: CHEMBL_IND_52506
has molecule: CHEMBL1536
highest development phase: 2
has mesh: D012148
has mesh heading: RESTLESS LEGS SYNDROME
has EFO: EFO_0004270
has EFO name: RESTLESS LEGS SYNDROME

CHEMBL_IND_52492
type: DrugIndication
chembl id: CHEMBL_IND_52492
has molecule: CHEMBL1536
highest development phase: 3
has mesh: D011247
has mesh heading: PREGNANCY
has EFO: EFO_0002950
has EFO name: PREGNANCY

CHEMBL_IND_52465
type: DrugIndication
chembl id: CHEMBL_IND_52465
has molecule: CHEMBL1536
highest development phase: 1
has mesh: D011085
has mesh heading: POLYCYSTIC OVARY SYNDROME
has EFO: EFO_0000660
has EFO name: POLYCYSTIC OVARY SYNDROME

CHEMBL_IND_52450
type: DrugIndication
chembl id: CHEMBL_IND_52450
has molecule: CHEMBL1536
highest development phase: 3
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_52439
type: DrugIndication
chembl id: CHEMBL_IND_52439
has molecule: CHEMBL1536
highest development phase: 3
has mesh: D014376
has mesh heading: TUBERCULOSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: TUBERCULOSIS

CHEMBL_IND_48530
type: DrugIndication
chembl id: CHEMBL_IND_48530
has molecule: CHEMBL1536
highest development phase: 3
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000292
has EFO name: BLADDER CARCINOMA

CHEMBL_IND_52407
type: DrugIndication
chembl id: CHEMBL_IND_52407
has molecule: CHEMBL1536
highest development phase: 1
has mesh: D055948
has mesh heading: SARCOPENIA
has EFO: EFO_1000653
has EFO name: SARCOPENIA

CHEMBL_IND_52361
type: DrugIndication
chembl id: CHEMBL_IND_52361
has molecule: CHEMBL1536
highest development phase: 1
has mesh: D003093
has mesh heading: COLITIS, ULCERATIVE
has EFO: EFO_0000729
has EFO name: ULCERATIVE COLITIS

CHEMBL_IND_52332
type: DrugIndication
chembl id: CHEMBL_IND_52332
has molecule: CHEMBL1536
highest development phase: 2
has mesh: D000755
has mesh heading: ANEMIA, SICKLE CELL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SICKLE CELL ANEMIA

CHEMBL_IND_48232
type: DrugIndication
chembl id: CHEMBL_IND_48232
has molecule: CHEMBL1536
highest development phase: 3
has mesh: D014808
has mesh heading: VITAMIN D DEFICIENCY
has EFO: EFO_0003762
has EFO name: VITAMIN D DEFICIENCY

CHEMBL_IND_52242
type: DrugIndication
chembl id: CHEMBL_IND_52242
has molecule: CHEMBL1536
highest development phase: 3
has mesh: D010003
has mesh heading: OSTEOARTHRITIS
has EFO: EFO_0002506
has EFO name: OSTEOARTHRITIS

CHEMBL_IND_46013
type: DrugIndication
chembl id: CHEMBL_IND_46013
has molecule: CHEMBL1536
highest development phase: 3
has mesh: D013281
has mesh heading: STOMATITIS, APHTHOUS
has EFO: EFO_0003938
has EFO name: APHTHOUS ULCER

CHEMBL_IND_52694
type: DrugIndication
chembl id: CHEMBL_IND_52694
has molecule: CHEMBL1536
highest development phase: 2
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_52620
type: DrugIndication
chembl id: CHEMBL_IND_52620
has molecule: CHEMBL1536
highest development phase: 2
has mesh: D008178
has mesh heading: LUPUS ERYTHEMATOSUS, CUTANEOUS
has EFO: EFO_0003834
has EFO name: CUTANEOUS LUPUS ERYTHEMATOSUS

CHEMBL_IND_52612
type: DrugIndication
chembl id: CHEMBL_IND_52612
has molecule: CHEMBL1536
highest development phase: 2
has mesh: D007333
has mesh heading: INSULIN RESISTANCE
has EFO: EFO_0002614
has EFO name: INSULIN RESISTANCE

CHEMBL_IND_52004
type: DrugIndication
chembl id: CHEMBL_IND_52004
has molecule: CHEMBL1536
highest development phase: 3
has mesh: D019698
has mesh heading: HEPATITIS C, CHRONIC
has EFO: EFO_0004220
has EFO name: CHRONIC HEPATITIS C INFECTION

CHEMBL_IND_51970
type: DrugIndication
chembl id: CHEMBL_IND_51970
has molecule: CHEMBL1536
highest development phase: 3
has mesh: D009765
has mesh heading: OBESITY
has EFO: EFO_0001073
has EFO name: OBESITY

CHEMBL_IND_51963
type: DrugIndication
chembl id: CHEMBL_IND_51963
has molecule: CHEMBL1536
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_52094
type: DrugIndication
chembl id: CHEMBL_IND_52094
has molecule: CHEMBL1536
highest development phase: 3
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000389
has EFO name: CUTANEOUS MELANOMA

CHEMBL_IND_51814
type: DrugIndication
chembl id: CHEMBL_IND_51814
has molecule: CHEMBL1536
highest development phase: 1
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_52132
type: DrugIndication
chembl id: CHEMBL_IND_52132
has molecule: CHEMBL1536
highest development phase: 2
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0003144
has EFO name: HEART FAILURE

CHEMBL_IND_52129
type: DrugIndication
chembl id: CHEMBL_IND_52129
has molecule: CHEMBL1536
highest development phase: 3
has mesh: D065626
has mesh heading: NON-ALCOHOLIC FATTY LIVER DISEASE
has EFO: EFO_0003095
has EFO name: NON-ALCOHOLIC FATTY LIVER DISEASE

CHEMBL_IND_52108
type: DrugIndication
chembl id: CHEMBL_IND_52108
has molecule: CHEMBL1536
highest development phase: 2
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_44505
type: DrugIndication
chembl id: CHEMBL_IND_44505
has molecule: CHEMBL1536
highest development phase: 2
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_27679
type: DrugIndication
chembl id: CHEMBL_IND_27679
has molecule: CHEMBL1536
highest development phase: 3
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_51925
type: DrugIndication
chembl id: CHEMBL_IND_51925
has molecule: CHEMBL1536
highest development phase: 0
has mesh: D001851
has mesh heading: BONE DISEASES, METABOLIC
has EFO: HP_0000938
has EFO name: OSTEOPENIA

CHEMBL_IND_51692
type: DrugIndication
chembl id: CHEMBL_IND_51692
has molecule: CHEMBL1536
highest development phase: 3
has mesh: D009103
has mesh heading: MULTIPLE SCLEROSIS
has EFO: EFO_0003885
has EFO name: MULTIPLE SCLEROSIS

CHEMBL_IND_51682
type: DrugIndication
chembl id: CHEMBL_IND_51682
has molecule: CHEMBL1536
highest development phase: 1
has mesh: D015212
has mesh heading: INFLAMMATORY BOWEL DISEASES
has EFO: EFO_0003767
has EFO name: INFLAMMATORY BOWEL DISEASE

CHEMBL_IND_51665
type: DrugIndication
chembl id: CHEMBL_IND_51665
has molecule: CHEMBL1536
highest development phase: 1
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_51650
type: DrugIndication
chembl id: CHEMBL_IND_51650
has molecule: CHEMBL1536
highest development phase: 1
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_51646
type: DrugIndication
chembl id: CHEMBL_IND_51646
has molecule: CHEMBL1536
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_51776
type: DrugIndication
chembl id: CHEMBL_IND_51776
has molecule: CHEMBL1536
highest development phase: 1
has mesh: D006961
has mesh heading: HYPERPARATHYROIDISM
has EFO: HP_0000843
has EFO name: HYPERPARATHYROIDISM

CHEMBL_IND_54018
type: DrugIndication
chembl id: CHEMBL_IND_54018
has molecule: CHEMBL121
highest development phase: 3
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_54758
type: DrugIndication
chembl id: CHEMBL_IND_54758
has molecule: CHEMBL121
highest development phase: 1
has mesh: D016778
has mesh heading: MALARIA, FALCIPARUM
has EFO: EFO_0007444
has EFO name: PLASMODIUM FALCIPARUM MALARIA

CHEMBL_IND_53297
type: DrugIndication
chembl id: CHEMBL_IND_53297
has molecule: CHEMBL121
highest development phase: 3
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_54673
type: DrugIndication
chembl id: CHEMBL_IND_54673
has molecule: CHEMBL121
highest development phase: 2
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_52860
type: DrugIndication
chembl id: CHEMBL_IND_52860
has molecule: CHEMBL121
highest development phase: 3
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_53562
type: DrugIndication
chembl id: CHEMBL_IND_53562
has molecule: CHEMBL121
highest development phase: 2
has mesh: D003093
has mesh heading: COLITIS, ULCERATIVE
has EFO: EFO_0000729
has EFO name: ULCERATIVE COLITIS

CHEMBL_IND_52736
type: DrugIndication
chembl id: CHEMBL_IND_52736
has molecule: CHEMBL121
highest development phase: 4
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_53067
type: DrugIndication
chembl id: CHEMBL_IND_53067
has molecule: CHEMBL121
highest development phase: 1
has mesh: D005923
has mesh heading: GLOMERULOSCLEROSIS, FOCAL SEGMENTAL
has EFO: EFO_0004236
has EFO name: FOCAL SEGMENTAL GLOMERULOSCLEROSIS

CHEMBL_IND_53066
type: DrugIndication
chembl id: CHEMBL_IND_53066
has molecule: CHEMBL121
highest development phase: 1
has mesh: D007172
has mesh heading: ERECTILE DYSFUNCTION
has EFO: EFO_0004234
has EFO name: ERECTILE DYSFUNCTION

CHEMBL_IND_54583
type: DrugIndication
chembl id: CHEMBL_IND_54583
has molecule: CHEMBL121
highest development phase: 3
has mesh: D052439
has mesh heading: LIPID METABOLISM DISORDERS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: DISORDER OF LIPID METABOLISM

CHEMBL_IND_54553
type: DrugIndication
chembl id: CHEMBL_IND_54553
has molecule: CHEMBL121
highest development phase: 3
has mesh: D003929
has mesh heading: DIABETIC NEUROPATHIES
has EFO: EFO_1000783
has EFO name: DIABETIC NEUROPATHY

CHEMBL_IND_53168
type: DrugIndication
chembl id: CHEMBL_IND_53168
has molecule: CHEMBL121
highest development phase: 2
has mesh: D060825
has mesh heading: MILD COGNITIVE IMPAIRMENT
has EFO: HP_0100543
has EFO name: COGNITIVE IMPAIRMENT

CHEMBL_IND_54808
type: DrugIndication
chembl id: CHEMBL_IND_54808
has molecule: CHEMBL121
highest development phase: 2
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_54115
type: DrugIndication
chembl id: CHEMBL_IND_54115
has molecule: CHEMBL277535
highest development phase: 2
has mesh: D014008
has mesh heading: TINEA PEDIS
has EFO: EFO_0007512
has EFO name: TINEA PEDIS

CHEMBL_IND_55125
type: DrugIndication
chembl id: CHEMBL_IND_55125
has molecule: CHEMBL277535
highest development phase: 3
has mesh: D014009
has mesh heading: ONYCHOMYCOSIS
has EFO: HP_0012203
has EFO name: ONYCHOMYCOSIS

CHEMBL_IND_26866
type: DrugIndication
chembl id: CHEMBL_IND_26866
has molecule: CHEMBL122
highest development phase: 2
has mesh: D011125
has mesh heading: ADENOMATOUS POLYPOSIS COLI
has EFO: EFO_0000662
has EFO name: POLYP

CHEMBL_IND_26865
type: DrugIndication
chembl id: CHEMBL_IND_26865
has molecule: CHEMBL122
highest development phase: 3
has mesh: D020370
has mesh heading: OSTEOARTHRITIS, KNEE
has EFO: EFO_0004616
has EFO name: OSTEOARTHRITIS, KNEE

CHEMBL_IND_42432
type: DrugIndication
chembl id: CHEMBL_IND_42432
has molecule: CHEMBL122
highest development phase: 4
has mesh: D012216
has mesh heading: RHEUMATIC DISEASES
has EFO: EFO_0005755
has EFO name: RHEUMATIC DISEASE

CHEMBL_IND_27423
type: DrugIndication
chembl id: CHEMBL_IND_27423
has molecule: CHEMBL122
highest development phase: 3
has mesh: D010003
has mesh heading: OSTEOARTHRITIS
has EFO: EFO_0002506
has EFO name: OSTEOARTHRITIS

CHEMBL_IND_49656
type: DrugIndication
chembl id: CHEMBL_IND_49656
has molecule: CHEMBL113
highest development phase: 1
has mesh: D000550
has mesh heading: AMBLYOPIA
has EFO: HP_0000646
has EFO name: AMBLYOPIA

CHEMBL_IND_25848
type: DrugIndication
chembl id: CHEMBL_IND_25848
has molecule: CHEMBL113
highest development phase: 3
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_28046
type: DrugIndication
chembl id: CHEMBL_IND_28046
has molecule: CHEMBL113
highest development phase: 4
has mesh: D001289
has mesh heading: ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY
has EFO: EFO_0003888
has EFO name: ATTENTION DEFICIT HYPERACTIVITY DISORDER

CHEMBL_IND_52621
type: DrugIndication
chembl id: CHEMBL_IND_52621
has molecule: CHEMBL113
highest development phase: 1
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_26438
type: DrugIndication
chembl id: CHEMBL_IND_26438
has molecule: CHEMBL113
highest development phase: 2
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_26437
type: DrugIndication
chembl id: CHEMBL_IND_26437
has molecule: CHEMBL113
highest development phase: 3
has mesh: D001281
has mesh heading: ATRIAL FIBRILLATION
has EFO: EFO_0000275
has EFO name: ATRIAL FIBRILLATION

CHEMBL_IND_24236
type: DrugIndication
chembl id: CHEMBL_IND_24236
has molecule: CHEMBL113
highest development phase: 3
has mesh: D008881
has mesh heading: MIGRAINE DISORDERS
has EFO: EFO_0003821
has EFO name: MIGRAINE DISORDER

CHEMBL_IND_24235
type: DrugIndication
chembl id: CHEMBL_IND_24235
has molecule: CHEMBL113
highest development phase: 2
has mesh: D004417
has mesh heading: DYSPNEA
has EFO: HP_0002094
has EFO name: DYSPNEA

CHEMBL_IND_24234
type: DrugIndication
chembl id: CHEMBL_IND_24234
has molecule: CHEMBL113
highest development phase: 3
has mesh: D003324
has mesh heading: CORONARY ARTERY DISEASE
has EFO: EFO_0000378
has EFO name: CORONARY ARTERY DISEASE

CHEMBL_IND_42993
type: DrugIndication
chembl id: CHEMBL_IND_42993
has molecule: CHEMBL585
highest development phase: 4
has mesh: D008103
has mesh heading: LIVER CIRRHOSIS
has EFO: EFO_0001422
has EFO name: CIRRHOSIS OF LIVER

CHEMBL_IND_42834
type: DrugIndication
chembl id: CHEMBL_IND_42834
has molecule: CHEMBL585
highest development phase: 4
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0000373
has EFO name: CONGESTIVE HEART FAILURE

CHEMBL_IND_26949
type: DrugIndication
chembl id: CHEMBL_IND_26949
has molecule: CHEMBL585
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_42229
type: DrugIndication
chembl id: CHEMBL_IND_42229
has molecule: CHEMBL585
highest development phase: 4
has mesh: D009404
has mesh heading: NEPHROTIC SYNDROME
has EFO: EFO_0004255
has EFO name: NEPHROTIC SYNDROME

CHEMBL_IND_41653
type: DrugIndication
chembl id: CHEMBL_IND_41653
has molecule: CHEMBL585
highest development phase: 4
has mesh: D004487
has mesh heading: EDEMA

CHEMBL_IND_41632
type: DrugIndication
chembl id: CHEMBL_IND_41632
has molecule: CHEMBL585
highest development phase: 4
has mesh: D006929
has mesh heading: HYPERALDOSTERONISM

CHEMBL_IND_51839
type: DrugIndication
chembl id: CHEMBL_IND_51839
has molecule: CHEMBL548
highest development phase: 3
has mesh: D011247
has mesh heading: PREGNANCY
has EFO: EFO_0002950
has EFO name: PREGNANCY

CHEMBL_IND_27652
type: DrugIndication
chembl id: CHEMBL_IND_27652
has molecule: CHEMBL548
highest development phase: 3
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_50463
type: DrugIndication
chembl id: CHEMBL_IND_50463
has molecule: CHEMBL272980
highest development phase: 2
has mesh: D006689
has mesh heading: HODGKIN DISEASE
has EFO: EFO_0000183
has EFO name: HODGKINS LYMPHOMA

CHEMBL_IND_50706
type: DrugIndication
chembl id: CHEMBL_IND_50706
has molecule: CHEMBL272980
highest development phase: 2
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_55349
type: DrugIndication
chembl id: CHEMBL_IND_55349
has molecule: CHEMBL272980
highest development phase: 2
has mesh: D002277
has mesh heading: CARCINOMA
has EFO: EFO_0000313
has EFO name: CARCINOMA

CHEMBL_IND_50966
type: DrugIndication
chembl id: CHEMBL_IND_50966
has molecule: CHEMBL272980
highest development phase: 2
has mesh: D015451
has mesh heading: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
has EFO: EFO_0000095
has EFO name: CHRONIC LYMPHOCYTIC LEUKEMIA

CHEMBL_IND_42375
type: DrugIndication
chembl id: CHEMBL_IND_42375
has molecule: CHEMBL118
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_27091
type: DrugIndication
chembl id: CHEMBL_IND_27091
has molecule: CHEMBL118
highest development phase: 1
has mesh: D009062
has mesh heading: MOUTH NEOPLASMS
has EFO: EFO_0003868
has EFO name: MOUTH NEOPLASM

CHEMBL_IND_25860
type: DrugIndication
chembl id: CHEMBL_IND_25860
has molecule: CHEMBL118
highest development phase: 2
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_26452
type: DrugIndication
chembl id: CHEMBL_IND_26452
has molecule: CHEMBL118
highest development phase: 3
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_45174
type: DrugIndication
chembl id: CHEMBL_IND_45174
has molecule: CHEMBL118
highest development phase: 3
has mesh: D009303
has mesh heading: NASOPHARYNGEAL NEOPLASMS
has EFO: EFO_0004252
has EFO name: NASOPHARYNGEAL NEOPLASM

CHEMBL_IND_28055
type: DrugIndication
chembl id: CHEMBL_IND_28055
has molecule: CHEMBL118
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_28054
type: DrugIndication
chembl id: CHEMBL_IND_28054
has molecule: CHEMBL118
highest development phase: 2
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000292
has EFO name: BLADDER CARCINOMA

CHEMBL_IND_48372
type: DrugIndication
chembl id: CHEMBL_IND_48372
has molecule: CHEMBL118
highest development phase: 3
has mesh: D000236
has mesh heading: ADENOMA
has EFO: EFO_0005406
has EFO name: COLORECTAL ADENOMA

CHEMBL_IND_45567
type: DrugIndication
chembl id: CHEMBL_IND_45567
has molecule: CHEMBL118
highest development phase: 3
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_52596
type: DrugIndication
chembl id: CHEMBL_IND_52596
has molecule: CHEMBL118
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_46244
type: DrugIndication
chembl id: CHEMBL_IND_46244
has molecule: CHEMBL118
highest development phase: 2
has mesh: D018192
has mesh heading: LYMPHANGIOLEIOMYOMATOSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: LYMPHANGIOLEIOMYOMATOSIS

CHEMBL_IND_43067
type: DrugIndication
chembl id: CHEMBL_IND_43067
has molecule: CHEMBL118
highest development phase: 4
has mesh: D004412
has mesh heading: DYSMENORRHEA
has EFO: HP_0100607
has EFO name: DYSMENORRHEA

CHEMBL_IND_43023
type: DrugIndication
chembl id: CHEMBL_IND_43023
has molecule: CHEMBL118
highest development phase: 4
has mesh: D012216
has mesh heading: RHEUMATIC DISEASES
has EFO: EFO_0005755
has EFO name: RHEUMATIC DISEASE

CHEMBL_IND_49718
type: DrugIndication
chembl id: CHEMBL_IND_49718
has molecule: CHEMBL118
highest development phase: 0
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_27606
type: DrugIndication
chembl id: CHEMBL_IND_27606
has molecule: CHEMBL118
highest development phase: 0
has mesh: D009765
has mesh heading: OBESITY
has EFO: EFO_0001073
has EFO name: OBESITY

CHEMBL_IND_44879
type: DrugIndication
chembl id: CHEMBL_IND_44879
has molecule: CHEMBL118
highest development phase: 1
has mesh: D002583
has mesh heading: UTERINE CERVICAL NEOPLASMS
has EFO: EFO_0001416
has EFO name: CERVICAL ADENOCARCINOMA

CHEMBL_IND_22874
type: DrugIndication
chembl id: CHEMBL_IND_22874
has molecule: CHEMBL118
highest development phase: 2
has mesh: D014069
has mesh heading: TONSILLITIS
has EFO: HP_0011110
has EFO name: TONSILLITIS

CHEMBL_IND_22873
type: DrugIndication
chembl id: CHEMBL_IND_22873
has molecule: CHEMBL118
highest development phase: 4
has mesh: D001172
has mesh heading: ARTHRITIS, RHEUMATOID
has EFO: EFO_0000685
has EFO name: RHEUMATOID ARTHRITIS

CHEMBL_IND_22872
type: DrugIndication
chembl id: CHEMBL_IND_22872
has molecule: CHEMBL118
highest development phase: 4
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_22871
type: DrugIndication
chembl id: CHEMBL_IND_22871
has molecule: CHEMBL118
highest development phase: 3
has mesh: D020370
has mesh heading: OSTEOARTHRITIS, KNEE
has EFO: EFO_0004616
has EFO name: OSTEOARTHRITIS, KNEE

CHEMBL_IND_22870
type: DrugIndication
chembl id: CHEMBL_IND_22870
has molecule: CHEMBL118
highest development phase: 4
has mesh: D010003
has mesh heading: OSTEOARTHRITIS
has EFO: EFO_0002506
has EFO name: OSTEOARTHRITIS

CHEMBL_IND_22869
type: DrugIndication
chembl id: CHEMBL_IND_22869
has molecule: CHEMBL118
highest development phase: 2
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_22868
type: DrugIndication
chembl id: CHEMBL_IND_22868
has molecule: CHEMBL118
highest development phase: 4
has mesh: D001171
has mesh heading: ARTHRITIS, JUVENILE
has EFO: EFO_0002609
has EFO name: CHRONIC CHILDHOOD ARTHRITIS

CHEMBL_IND_22867
type: DrugIndication
chembl id: CHEMBL_IND_22867
has molecule: CHEMBL118
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_22866
type: DrugIndication
chembl id: CHEMBL_IND_22866
has molecule: CHEMBL118
highest development phase: 4
has mesh: D013167
has mesh heading: SPONDYLITIS, ANKYLOSING
has EFO: EFO_0003898
has EFO name: ANKYLOSING SPONDYLITIS

CHEMBL_IND_51684
type: DrugIndication
chembl id: CHEMBL_IND_51684
has molecule: CHEMBL118
highest development phase: 3
has mesh: D014029
has mesh heading: TOBACCO USE DISORDER
has EFO: EFO_0003768
has EFO name: NICOTINE DEPENDENCE

CHEMBL_IND_25162
type: DrugIndication
chembl id: CHEMBL_IND_25162
has molecule: CHEMBL118
highest development phase: 3
has mesh: D006073
has mesh heading: GOUT
has EFO: EFO_0004274
has EFO name: GOUT

CHEMBL_IND_25161
type: DrugIndication
chembl id: CHEMBL_IND_25161
has molecule: CHEMBL118
highest development phase: 3
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_24252
type: DrugIndication
chembl id: CHEMBL_IND_24252
has molecule: CHEMBL118
highest development phase: 2
has mesh: D011225
has mesh heading: PRE-ECLAMPSIA
has EFO: EFO_0000668
has EFO name: PREECLAMPSIA

CHEMBL_IND_24251
type: DrugIndication
chembl id: CHEMBL_IND_24251
has molecule: CHEMBL118
highest development phase: 4
has mesh: D011125
has mesh heading: ADENOMATOUS POLYPOSIS COLI
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: FAMILIAL ADENOMATOUS POLYPOSIS

CHEMBL_IND_24250
type: DrugIndication
chembl id: CHEMBL_IND_24250
has molecule: CHEMBL118
highest development phase: 2
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_51788
type: DrugIndication
chembl id: CHEMBL_IND_51788
has molecule: CHEMBL118
highest development phase: 1
has mesh: D007249
has mesh heading: INFLAMMATION
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: INFLAMMATION

CHEMBL_IND_50077
type: DrugIndication
chembl id: CHEMBL_IND_50077
has molecule: CHEMBL279516
highest development phase: 4
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_49621
type: DrugIndication
chembl id: CHEMBL_IND_49621
has molecule: CHEMBL573
highest development phase: 2
has mesh: D009293
has mesh heading: OPIOID-RELATED DISORDERS
has EFO: EFO_0005611
has EFO name: OPIOID DEPENDENCE

CHEMBL_IND_43607
type: DrugIndication
chembl id: CHEMBL_IND_43607
has molecule: CHEMBL573
highest development phase: 2
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_49404
type: DrugIndication
chembl id: CHEMBL_IND_49404
has molecule: CHEMBL573
highest development phase: 2
has mesh: D009765
has mesh heading: OBESITY
has EFO: EFO_0001073
has EFO name: OBESITY

CHEMBL_IND_52222
type: DrugIndication
chembl id: CHEMBL_IND_52222
has molecule: CHEMBL573
highest development phase: 2
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_47874
type: DrugIndication
chembl id: CHEMBL_IND_47874
has molecule: CHEMBL573
highest development phase: 0
has mesh: D001024
has mesh heading: AORTIC VALVE STENOSIS
has EFO: EFO_0000266
has EFO name: AORTIC STENOSIS

CHEMBL_IND_45229
type: DrugIndication
chembl id: CHEMBL_IND_45229
has molecule: CHEMBL573
highest development phase: 3
has mesh: D011618
has mesh heading: PSYCHOTIC DISORDERS
has EFO: EFO_0005407
has EFO name: PSYCHOSIS

CHEMBL_IND_52420
type: DrugIndication
chembl id: CHEMBL_IND_52420
has molecule: CHEMBL573
highest development phase: 2
has mesh: D012170
has mesh heading: RETINAL VEIN OCCLUSION
has EFO: EFO_1001157
has EFO name: RETINAL VEIN OCCLUSION

CHEMBL_IND_45332
type: DrugIndication
chembl id: CHEMBL_IND_45332
has molecule: CHEMBL573
highest development phase: 3
has mesh: D052439
has mesh heading: LIPID METABOLISM DISORDERS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: DISORDER OF LIPID METABOLISM

CHEMBL_IND_47784
type: DrugIndication
chembl id: CHEMBL_IND_47784
has molecule: CHEMBL573
highest development phase: 3
has mesh: D006937
has mesh heading: HYPERCHOLESTEROLEMIA
has EFO: HP_0003124
has EFO name: HYPERCHOLESTEROLEMIA

CHEMBL_IND_49002
type: DrugIndication
chembl id: CHEMBL_IND_49002
has molecule: CHEMBL573
highest development phase: 3
has mesh: D054058
has mesh heading: ACUTE CORONARY SYNDROME
has EFO: EFO_0005672
has EFO name: ACUTE CORONARY SYNDROME

CHEMBL_IND_48921
type: DrugIndication
chembl id: CHEMBL_IND_48921
has molecule: CHEMBL573
highest development phase: 3
has mesh: D050197
has mesh heading: ATHEROSCLEROSIS
has EFO: EFO_0003914
has EFO name: ATHEROSCLEROSIS

CHEMBL_IND_52103
type: DrugIndication
chembl id: CHEMBL_IND_52103
has molecule: CHEMBL573
highest development phase: 2
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_47437
type: DrugIndication
chembl id: CHEMBL_IND_47437
has molecule: CHEMBL573
highest development phase: 3
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_51595
type: DrugIndication
chembl id: CHEMBL_IND_51595
has molecule: CHEMBL573
highest development phase: 4
has mesh: D000740
has mesh heading: ANEMIA
has EFO: EFO_0004272
has EFO name: ANEMIA

CHEMBL_IND_53382
type: DrugIndication
chembl id: CHEMBL_IND_53382
has molecule: CHEMBL70
highest development phase: 2
has mesh: D011183
has mesh heading: POSTOPERATIVE COMPLICATIONS
has EFO: EFO_0005323
has EFO name: POST-OPERATIVE SIGN OR SYMPTOM

CHEMBL_IND_54053
type: DrugIndication
chembl id: CHEMBL_IND_54053
has molecule: CHEMBL70
highest development phase: 3
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_53425
type: DrugIndication
chembl id: CHEMBL_IND_53425
has molecule: CHEMBL70
highest development phase: 3
has mesh: D056844
has mesh heading: RENAL COLIC
has EFO: EFO_1001412
has EFO name: RENAL COLIC

CHEMBL_IND_54290
type: DrugIndication
chembl id: CHEMBL_IND_54290
has molecule: CHEMBL70
highest development phase: 2
has mesh: D047928
has mesh heading: PREMATURE BIRTH
has EFO: EFO_0003917
has EFO name: PREMATURE BIRTH

CHEMBL_IND_54802
type: DrugIndication
chembl id: CHEMBL_IND_54802
has molecule: CHEMBL70
highest development phase: 1
has mesh: D005234
has mesh heading: FATTY LIVER
has EFO: HP_0001397
has EFO name: HEPATIC STEATOSIS

CHEMBL_IND_54791
type: DrugIndication
chembl id: CHEMBL_IND_54791
has molecule: CHEMBL70
highest development phase: 1
has mesh: D003248
has mesh heading: CONSTIPATION
has EFO: HP_0002019
has EFO name: CONSTIPATION

CHEMBL_IND_54768
type: DrugIndication
chembl id: CHEMBL_IND_54768
has molecule: CHEMBL70
highest development phase: 2
has mesh: D003929
has mesh heading: DIABETIC NEUROPATHIES
has EFO: EFO_1000783
has EFO name: DIABETIC NEUROPATHY

CHEMBL_IND_52893
type: DrugIndication
chembl id: CHEMBL_IND_52893
has molecule: CHEMBL70
highest development phase: 3
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_52881
type: DrugIndication
chembl id: CHEMBL_IND_52881
has molecule: CHEMBL70
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_53369
type: DrugIndication
chembl id: CHEMBL_IND_53369
has molecule: CHEMBL70
highest development phase: 1
has mesh: D012148
has mesh heading: RESTLESS LEGS SYNDROME
has EFO: EFO_0004270
has EFO name: RESTLESS LEGS SYNDROME

CHEMBL_IND_52935
type: DrugIndication
chembl id: CHEMBL_IND_52935
has molecule: CHEMBL70
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_52929
type: DrugIndication
chembl id: CHEMBL_IND_52929
has molecule: CHEMBL70
highest development phase: 4
has mesh: D009203
has mesh heading: MYOCARDIAL INFARCTION
has EFO: EFO_0000612
has EFO name: MYOCARDIAL INFARCTION

CHEMBL_IND_52919
type: DrugIndication
chembl id: CHEMBL_IND_52919
has molecule: CHEMBL70
highest development phase: 3
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_53867
type: DrugIndication
chembl id: CHEMBL_IND_53867
has molecule: CHEMBL70
highest development phase: 3
has mesh: D020181
has mesh heading: SLEEP APNEA, OBSTRUCTIVE
has EFO: EFO_0003918
has EFO name: OBSTRUCTIVE SLEEP APNEA

CHEMBL_IND_53852
type: DrugIndication
chembl id: CHEMBL_IND_53852
has molecule: CHEMBL70
highest development phase: 3
has mesh: D007669
has mesh heading: KIDNEY CALCULI
has EFO: EFO_0003845
has EFO name: KIDNEY STONE

CHEMBL_IND_53742
type: DrugIndication
chembl id: CHEMBL_IND_53742
has molecule: CHEMBL70
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_52727
type: DrugIndication
chembl id: CHEMBL_IND_52727
has molecule: CHEMBL70
highest development phase: 4
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_53084
type: DrugIndication
chembl id: CHEMBL_IND_53084
has molecule: CHEMBL70
highest development phase: 3
has mesh: D009357
has mesh heading: NEONATAL ABSTINENCE SYNDROME
has EFO: EFO_0005799
has EFO name: NEONATAL ABSTINENCE SYNDROME

CHEMBL_IND_53083
type: DrugIndication
chembl id: CHEMBL_IND_53083
has molecule: CHEMBL70
highest development phase: 2
has mesh: D009437
has mesh heading: NEURALGIA
has EFO: EFO_0005762
has EFO name: NEUROPATHIC PAIN

CHEMBL_IND_53057
type: DrugIndication
chembl id: CHEMBL_IND_53057
has molecule: CHEMBL70
highest development phase: 3
has mesh: D050723
has mesh heading: FRACTURES, BONE
has EFO: EFO_0003931
has EFO name: BONE FRACTURE

CHEMBL_IND_54529
type: DrugIndication
chembl id: CHEMBL_IND_54529
has molecule: CHEMBL70
highest development phase: 3
has mesh: D012600
has mesh heading: SCOLIOSIS
has EFO: EFO_0004273
has EFO name: SCOLIOSIS

CHEMBL_IND_53157
type: DrugIndication
chembl id: CHEMBL_IND_53157
has molecule: CHEMBL70
highest development phase: 3
has mesh: D011537
has mesh heading: PRURITUS
has EFO: HP_0000989
has EFO name: PRURITUS

CHEMBL_IND_50948
type: DrugIndication
chembl id: CHEMBL_IND_50948
has molecule: CHEMBL278172
highest development phase: 3
has mesh: D010033
has mesh heading: OTITIS MEDIA
has EFO: EFO_0004992
has EFO name: OTITIS MEDIA

CHEMBL_IND_55105
type: DrugIndication
chembl id: CHEMBL_IND_55105
has molecule: CHEMBL278172
highest development phase: 1
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_50038
type: DrugIndication
chembl id: CHEMBL_IND_50038
has molecule: CHEMBL278172
highest development phase: 4
has mesh: D011537
has mesh heading: PRURITUS
has EFO: HP_0000989
has EFO name: PRURITUS

CHEMBL_IND_52250
type: DrugIndication
chembl id: CHEMBL_IND_52250
has molecule: CHEMBL530
highest development phase: 1
has mesh: D011247
has mesh heading: PREGNANCY
has EFO: EFO_0002950
has EFO name: PREGNANCY

CHEMBL_IND_49729
type: DrugIndication
chembl id: CHEMBL_IND_49729
has molecule: CHEMBL500
highest development phase: 2
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_24784
type: DrugIndication
chembl id: CHEMBL_IND_24784
has molecule: CHEMBL500
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_52385
type: DrugIndication
chembl id: CHEMBL_IND_52385
has molecule: CHEMBL713
highest development phase: 2
has mesh: D013274
has mesh heading: STOMACH NEOPLASMS
has EFO: EFO_0003897
has EFO name: STOMACH NEOPLASM

CHEMBL_IND_44363
type: DrugIndication
chembl id: CHEMBL_IND_44363
has molecule: CHEMBL713
highest development phase: 2
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_44065
type: DrugIndication
chembl id: CHEMBL_IND_44065
has molecule: CHEMBL713
highest development phase: 3
has mesh: D019694
has mesh heading: HEPATITIS B, CHRONIC
has EFO: EFO_0004239
has EFO name: CHRONIC HEPATITIS B INFECTION

CHEMBL_IND_44036
type: DrugIndication
chembl id: CHEMBL_IND_44036
has molecule: CHEMBL713
highest development phase: 3
has mesh: D019694
has mesh heading: HEPATITIS B, CHRONIC
has EFO: EFO_0004197
has EFO name: HEPATITIS B INFECTION

CHEMBL_IND_51777
type: DrugIndication
chembl id: CHEMBL_IND_51777
has molecule: CHEMBL713
highest development phase: 2
has mesh: D017093
has mesh heading: LIVER FAILURE
has EFO: HP_0001399
has EFO name: LIVER FAILURE

CHEMBL_IND_41578
type: DrugIndication
chembl id: CHEMBL_IND_41578
has molecule: CHEMBL688
highest development phase: 4
has mesh: D059390
has mesh heading: BREAKTHROUGH PAIN

CHEMBL_IND_23187
type: DrugIndication
chembl id: CHEMBL_IND_23187
has molecule: CHEMBL688
highest development phase: 4
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_24442
type: DrugIndication
chembl id: CHEMBL_IND_24442
has molecule: CHEMBL688
highest development phase: 0
has mesh: D004417
has mesh heading: DYSPNEA
has EFO: HP_0002094
has EFO name: DYSPNEA

CHEMBL_IND_24441
type: DrugIndication
chembl id: CHEMBL_IND_24441
has molecule: CHEMBL688
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_43648
type: DrugIndication
chembl id: CHEMBL_IND_43648
has molecule: CHEMBL279785
highest development phase: 3
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_49578
type: DrugIndication
chembl id: CHEMBL_IND_49578
has molecule: CHEMBL1551
highest development phase: 3
has mesh: D019698
has mesh heading: HEPATITIS C, CHRONIC
has EFO: EFO_0004220
has EFO name: CHRONIC HEPATITIS C INFECTION

CHEMBL_IND_26953
type: DrugIndication
chembl id: CHEMBL_IND_26953
has molecule: CHEMBL1551
highest development phase: 3
has mesh: D008107
has mesh heading: LIVER DISEASES
has EFO: EFO_0001421
has EFO name: LIVER DISEASE

CHEMBL_IND_25701
type: DrugIndication
chembl id: CHEMBL_IND_25701
has molecule: CHEMBL1551
highest development phase: 2
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_25700
type: DrugIndication
chembl id: CHEMBL_IND_25700
has molecule: CHEMBL1551
highest development phase: 1
has mesh: D006816
has mesh heading: HUNTINGTON DISEASE
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: HUNTINGTON DISEASE

CHEMBL_IND_25699
type: DrugIndication
chembl id: CHEMBL_IND_25699
has molecule: CHEMBL1551
highest development phase: 2
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_45357
type: DrugIndication
chembl id: CHEMBL_IND_45357
has molecule: CHEMBL1551
highest development phase: 2
has mesh: D011125
has mesh heading: ADENOMATOUS POLYPOSIS COLI
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: FAMILIAL ADENOMATOUS POLYPOSIS

CHEMBL_IND_52610
type: DrugIndication
chembl id: CHEMBL_IND_52610
has molecule: CHEMBL1551
highest development phase: 1
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_47693
type: DrugIndication
chembl id: CHEMBL_IND_47693
has molecule: CHEMBL1551
highest development phase: 1
has mesh: D015209
has mesh heading: CHOLANGITIS, SCLEROSING
has EFO: EFO_0004268
has EFO name: SCLEROSING CHOLANGITIS

CHEMBL_IND_51836
type: DrugIndication
chembl id: CHEMBL_IND_51836
has molecule: CHEMBL1551
highest development phase: 3
has mesh: D011247
has mesh heading: PREGNANCY
has EFO: EFO_0002950
has EFO name: PREGNANCY

CHEMBL_IND_27907
type: DrugIndication
chembl id: CHEMBL_IND_27907
has molecule: CHEMBL1532
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_49853
type: DrugIndication
chembl id: CHEMBL_IND_49853
has molecule: CHEMBL529
highest development phase: 2
has mesh: D010518
has mesh heading: PERIODONTITIS
has EFO: EFO_0000649
has EFO name: PERIODONTITIS

CHEMBL_IND_49848
type: DrugIndication
chembl id: CHEMBL_IND_49848
has molecule: CHEMBL529
highest development phase: 3
has mesh: D001997
has mesh heading: BRONCHOPULMONARY DYSPLASIA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: BRONCHOPULMONARY DYSPLASIA

CHEMBL_IND_49847
type: DrugIndication
chembl id: CHEMBL_IND_49847
has molecule: CHEMBL529
highest development phase: 3
has mesh: D003371
has mesh heading: COUGH
has EFO: HP_0012735
has EFO name: COUGH

CHEMBL_IND_49846
type: DrugIndication
chembl id: CHEMBL_IND_49846
has molecule: CHEMBL529
highest development phase: 2
has mesh: D001988
has mesh heading: BRONCHIOLITIS
has EFO: HP_0011950
has EFO name: BRONCHIOLITIS

CHEMBL_IND_49845
type: DrugIndication
chembl id: CHEMBL_IND_49845
has molecule: CHEMBL529
highest development phase: 2
has mesh: D009771
has mesh heading: OBSESSIVE-COMPULSIVE DISORDER
has EFO: EFO_0004242
has EFO name: OBSESSIVE-COMPULSIVE DISORDER

CHEMBL_IND_49835
type: DrugIndication
chembl id: CHEMBL_IND_49835
has molecule: CHEMBL529
highest development phase: 1
has mesh: D018805
has mesh heading: SEPSIS
has EFO: EFO_0001420
has EFO name: SEPSIS

CHEMBL_IND_49832
type: DrugIndication
chembl id: CHEMBL_IND_49832
has molecule: CHEMBL529
highest development phase: 3
has mesh: D005128
has mesh heading: EYE DISEASES
has EFO: EFO_0003966
has EFO name: EYE DISEASE

CHEMBL_IND_49831
type: DrugIndication
chembl id: CHEMBL_IND_49831
has molecule: CHEMBL529
highest development phase: 3
has mesh: D011014
has mesh heading: PNEUMONIA
has EFO: EFO_0003106
has EFO name: PNEUMONIA

CHEMBL_IND_49822
type: DrugIndication
chembl id: CHEMBL_IND_49822
has molecule: CHEMBL529
highest development phase: 3
has mesh: D001762
has mesh heading: BLEPHARITIS
has EFO: HP_0000498
has EFO name: BLEPHARITIS

CHEMBL_IND_49819
type: DrugIndication
chembl id: CHEMBL_IND_49819
has molecule: CHEMBL529
highest development phase: 3
has mesh: D000152
has mesh heading: ACNE VULGARIS
has EFO: EFO_0003894
has EFO name: ACNE

CHEMBL_IND_49809
type: DrugIndication
chembl id: CHEMBL_IND_49809
has molecule: CHEMBL529
highest development phase: 3
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_49808
type: DrugIndication
chembl id: CHEMBL_IND_49808
has molecule: CHEMBL529
highest development phase: 4
has mesh: D003550
has mesh heading: CYSTIC FIBROSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CYSTIC FIBROSIS

CHEMBL_IND_49806
type: DrugIndication
chembl id: CHEMBL_IND_49806
has molecule: CHEMBL529
highest development phase: 3
has mesh: D010033
has mesh heading: OTITIS MEDIA
has EFO: EFO_0004992
has EFO name: OTITIS MEDIA

CHEMBL_IND_49796
type: DrugIndication
chembl id: CHEMBL_IND_49796
has molecule: CHEMBL529
highest development phase: 2
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_49794
type: DrugIndication
chembl id: CHEMBL_IND_49794
has molecule: CHEMBL529
highest development phase: 3
has mesh: D004066
has mesh heading: DIGESTIVE SYSTEM DISEASES
has EFO: EFO_0000405
has EFO name: DIGESTIVE SYSTEM DISEASE

CHEMBL_IND_49791
type: DrugIndication
chembl id: CHEMBL_IND_49791
has molecule: CHEMBL529
highest development phase: 3
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_49783
type: DrugIndication
chembl id: CHEMBL_IND_49783
has molecule: CHEMBL529
highest development phase: 4
has mesh: D014069
has mesh heading: TONSILLITIS
has EFO: HP_0011110
has EFO name: TONSILLITIS

CHEMBL_IND_49782
type: DrugIndication
chembl id: CHEMBL_IND_49782
has molecule: CHEMBL529
highest development phase: 4
has mesh: D014526
has mesh heading: URETHRITIS
has EFO: EFO_0003878
has EFO name: URETHRITIS

CHEMBL_IND_49905
type: DrugIndication
chembl id: CHEMBL_IND_49905
has molecule: CHEMBL529
highest development phase: 4
has mesh: D010612
has mesh heading: PHARYNGITIS

CHEMBL_IND_49884
type: DrugIndication
chembl id: CHEMBL_IND_49884
has molecule: CHEMBL529
highest development phase: 3
has mesh: D003234
has mesh heading: CONJUNCTIVITIS, BACTERIAL
has EFO: EFO_1000829
has EFO name: BACTERIAL CONJUNCTIVITIS

CHEMBL_IND_49865
type: DrugIndication
chembl id: CHEMBL_IND_49865
has molecule: CHEMBL529
highest development phase: 3
has mesh: D029481
has mesh heading: BRONCHITIS, CHRONIC
has EFO: EFO_0006505
has EFO name: CHRONIC BRONCHITIS

CHEMBL_IND_49862
type: DrugIndication
chembl id: CHEMBL_IND_49862
has molecule: CHEMBL529
highest development phase: 1
has mesh: D007154
has mesh heading: IMMUNE SYSTEM DISEASES
has EFO: EFO_0000540
has EFO name: IMMUNE SYSTEM DISEASE

CHEMBL_IND_49861
type: DrugIndication
chembl id: CHEMBL_IND_49861
has molecule: CHEMBL529
highest development phase: 2
has mesh: D047928
has mesh heading: PREMATURE BIRTH
has EFO: EFO_0003917
has EFO name: PREMATURE BIRTH

CHEMBL_IND_49858
type: DrugIndication
chembl id: CHEMBL_IND_49858
has molecule: CHEMBL529
highest development phase: 2
has mesh: D016773
has mesh heading: LEISHMANIASIS, CUTANEOUS
has EFO: EFO_0005046
has EFO name: CUTANEOUS LEISHMANIASIS

CHEMBL_IND_54895
type: DrugIndication
chembl id: CHEMBL_IND_54895
has molecule: CHEMBL529
highest development phase: 1
has mesh: D049970
has mesh heading: GRAVES OPHTHALMOPATHY
has EFO: EFO_1001466
has EFO name: GRAVES OPHTHALMOPATHY

CHEMBL_IND_54894
type: DrugIndication
chembl id: CHEMBL_IND_54894
has molecule: CHEMBL529
highest development phase: 0
has mesh: D018357
has mesh heading: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
has EFO: EFO_1001413
has EFO name: RESPIRATORY SYNCYTIAL VIRUS INFECTION

CHEMBL_IND_54889
type: DrugIndication
chembl id: CHEMBL_IND_54889
has molecule: CHEMBL529
highest development phase: 2
has mesh: D018589
has mesh heading: GASTROPARESIS
has EFO: EFO_1000948
has EFO name: GASTROPARESIS

CHEMBL_IND_54886
type: DrugIndication
chembl id: CHEMBL_IND_54886
has molecule: CHEMBL529
highest development phase: 3
has mesh: D001989
has mesh heading: BRONCHIOLITIS OBLITERANS
has EFO: EFO_0007183
has EFO name: BRONCHIOLITIS OBLITERANS

CHEMBL_IND_54882
type: DrugIndication
chembl id: CHEMBL_IND_54882
has molecule: CHEMBL529
highest development phase: 1
has mesh: D000755
has mesh heading: ANEMIA, SICKLE CELL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SICKLE CELL ANEMIA

CHEMBL_IND_54871
type: DrugIndication
chembl id: CHEMBL_IND_54871
has molecule: CHEMBL529
highest development phase: 1
has mesh: D016778
has mesh heading: MALARIA, FALCIPARUM
has EFO: EFO_0007444
has EFO name: PLASMODIUM FALCIPARUM MALARIA

CHEMBL_IND_49801
type: DrugIndication
chembl id: CHEMBL_IND_49801
has molecule: CHEMBL572
highest development phase: 4
has mesh: D014552
has mesh heading: URINARY TRACT INFECTIONS
has EFO: EFO_0003103
has EFO name: URINARY TRACT INFECTION

CHEMBL_IND_52683
type: DrugIndication
chembl id: CHEMBL_IND_52683
has molecule: CHEMBL714
highest development phase: 1
has mesh: D007249
has mesh heading: INFLAMMATION
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: INFLAMMATION

CHEMBL_IND_47805
type: DrugIndication
chembl id: CHEMBL_IND_47805
has molecule: CHEMBL714
highest development phase: 3
has mesh: D004402
has mesh heading: DYSAUTONOMIA, FAMILIAL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: FAMILIAL DYSAUTONOMIA

CHEMBL_IND_26366
type: DrugIndication
chembl id: CHEMBL_IND_26366
has molecule: CHEMBL714
highest development phase: 1
has mesh: D020294
has mesh heading: MYASTHENIC SYNDROMES, CONGENITAL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CONGENITAL MYASTHENIC SYNDROME

CHEMBL_IND_27525
type: DrugIndication
chembl id: CHEMBL_IND_27525
has molecule: CHEMBL714
highest development phase: 2
has mesh: D008569
has mesh heading: MEMORY DISORDERS
has EFO: EFO_0001072
has EFO name: MEMORY IMPAIRMENT

CHEMBL_IND_27524
type: DrugIndication
chembl id: CHEMBL_IND_27524
has molecule: CHEMBL714
highest development phase: 2
has mesh: D065627
has mesh heading: FAMILIAL PRIMARY PULMONARY HYPERTENSION
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION

CHEMBL_IND_51435
type: DrugIndication
chembl id: CHEMBL_IND_51435
has molecule: CHEMBL714
highest development phase: 4
has mesh: D001986
has mesh heading: BRONCHIAL SPASM

CHEMBL_IND_51430
type: DrugIndication
chembl id: CHEMBL_IND_51430
has molecule: CHEMBL714
highest development phase: 4
has mesh: D004194
has mesh heading: DISEASE

CHEMBL_IND_28004
type: DrugIndication
chembl id: CHEMBL_IND_28004
has molecule: CHEMBL714
highest development phase: 4
has mesh: D008173
has mesh heading: LUNG DISEASES, OBSTRUCTIVE
has EFO: HP_0006536
has EFO name: OBSTRUCTIVE LUNG DISEASE

CHEMBL_IND_28003
type: DrugIndication
chembl id: CHEMBL_IND_28003
has molecule: CHEMBL714
highest development phase: 1
has mesh: D054990
has mesh heading: IDIOPATHIC PULMONARY FIBROSIS
has EFO: EFO_0000768
has EFO name: IDIOPATHIC PULMONARY FIBROSIS

CHEMBL_IND_51931
type: DrugIndication
chembl id: CHEMBL_IND_51931
has molecule: CHEMBL714
highest development phase: 2
has mesh: D012131
has mesh heading: RESPIRATORY INSUFFICIENCY
has EFO: HP_0002878
has EFO name: RESPIRATORY FAILURE

CHEMBL_IND_22644
type: DrugIndication
chembl id: CHEMBL_IND_22644
has molecule: CHEMBL714
highest development phase: 4
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_22643
type: DrugIndication
chembl id: CHEMBL_IND_22643
has molecule: CHEMBL714
highest development phase: 4
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_25040
type: DrugIndication
chembl id: CHEMBL_IND_25040
has molecule: CHEMBL714
highest development phase: 1
has mesh: D006009
has mesh heading: GLYCOGEN STORAGE DISEASE TYPE II
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY

CHEMBL_IND_25039
type: DrugIndication
chembl id: CHEMBL_IND_25039
has molecule: CHEMBL714
highest development phase: 3
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0000373
has EFO name: CONGESTIVE HEART FAILURE

CHEMBL_IND_51526
type: DrugIndication
chembl id: CHEMBL_IND_51526
has molecule: CHEMBL714
highest development phase: 4
has mesh: D001250
has mesh heading: ASTHMA, EXERCISE-INDUCED
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_52156
type: DrugIndication
chembl id: CHEMBL_IND_52156
has molecule: CHEMBL582
highest development phase: 3
has mesh: D003141
has mesh heading: COMMUNICABLE DISEASES
has EFO: EFO_0005741
has EFO name: INFECTIOUS DISEASE

CHEMBL_IND_52584
type: DrugIndication
chembl id: CHEMBL_IND_52584
has molecule: CHEMBL582
highest development phase: 3
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_51519
type: DrugIndication
chembl id: CHEMBL_IND_51519
has molecule: CHEMBL582
highest development phase: 4
has mesh: D003248
has mesh heading: CONSTIPATION
has EFO: HP_0002019
has EFO name: CONSTIPATION

CHEMBL_IND_43090
type: DrugIndication
chembl id: CHEMBL_IND_43090
has molecule: CHEMBL278819
highest development phase: 4
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_25487
type: DrugIndication
chembl id: CHEMBL_IND_25487
has molecule: CHEMBL649
highest development phase: 2
has mesh: D016540
has mesh heading: SMOKING CESSATION
has EFO: EFO_0004319
has EFO name: SMOKING CESSATION

CHEMBL_IND_25486
type: DrugIndication
chembl id: CHEMBL_IND_25486
has molecule: CHEMBL649
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_28488
type: DrugIndication
chembl id: CHEMBL_IND_28488
has molecule: CHEMBL649
highest development phase: 3
has mesh: D006391
has mesh heading: HEMANGIOMA
has EFO: EFO_1000635
has EFO name: HEMANGIOMA

CHEMBL_IND_23539
type: DrugIndication
chembl id: CHEMBL_IND_23539
has molecule: CHEMBL649
highest development phase: 2
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_42042
type: DrugIndication
chembl id: CHEMBL_IND_42042
has molecule: CHEMBL276443
highest development phase: 4
has mesh: D009765
has mesh heading: OBESITY
has EFO: EFO_0001073
has EFO name: OBESITY

CHEMBL_IND_53170
type: DrugIndication
chembl id: CHEMBL_IND_53170
has molecule: CHEMBL273453
highest development phase: 1
has mesh: D007249
has mesh heading: INFLAMMATION
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: INFLAMMATION

CHEMBL_IND_27101
type: DrugIndication
chembl id: CHEMBL_IND_27101
has molecule: CHEMBL799
highest development phase: 3
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_48441
type: DrugIndication
chembl id: CHEMBL_IND_48441
has molecule: CHEMBL799
highest development phase: 2
has mesh: D060825
has mesh heading: MILD COGNITIVE IMPAIRMENT
has EFO: HP_0100543
has EFO name: COGNITIVE IMPAIRMENT

CHEMBL_IND_28528
type: DrugIndication
chembl id: CHEMBL_IND_28528
has molecule: CHEMBL799
highest development phase: 4
has mesh: D013927
has mesh heading: THROMBOSIS
has EFO: HP_0004419
has EFO name: RECURRENT THROMBOPHLEBITIS

CHEMBL_IND_22906
type: DrugIndication
chembl id: CHEMBL_IND_22906
has molecule: CHEMBL799
highest development phase: 2
has mesh: D007383
has mesh heading: INTERMITTENT CLAUDICATION
has EFO: EFO_0003876
has EFO name: INTERMITTENT VASCULAR CLAUDICATION

CHEMBL_IND_25176
type: DrugIndication
chembl id: CHEMBL_IND_25176
has molecule: CHEMBL799
highest development phase: 3
has mesh: D003324
has mesh heading: CORONARY ARTERY DISEASE
has EFO: EFO_0000378
has EFO name: CORONARY ARTERY DISEASE

CHEMBL_IND_25175
type: DrugIndication
chembl id: CHEMBL_IND_25175
has molecule: CHEMBL799
highest development phase: 3
has mesh: D020520
has mesh heading: BRAIN INFARCTION
has EFO: EFO_0004277
has EFO name: BRAIN INFARCTION

CHEMBL_IND_26123
type: DrugIndication
chembl id: CHEMBL_IND_26123
has molecule: CHEMBL697
highest development phase: 4
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_42083
type: DrugIndication
chembl id: CHEMBL_IND_42083
has molecule: CHEMBL292707
highest development phase: 4
has mesh: D012216
has mesh heading: RHEUMATIC DISEASES
has EFO: EFO_0005755
has EFO name: RHEUMATIC DISEASE

CHEMBL_IND_49307
type: DrugIndication
chembl id: CHEMBL_IND_49307
has molecule: CHEMBL295698
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_46600
type: DrugIndication
chembl id: CHEMBL_IND_46600
has molecule: CHEMBL295698
highest development phase: 1
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_46992
type: DrugIndication
chembl id: CHEMBL_IND_46992
has molecule: CHEMBL295698
highest development phase: 3
has mesh: D012628
has mesh heading: DERMATITIS, SEBORRHEIC
has EFO: EFO_1000764
has EFO name: SEBORRHEIC DERMATITIS

CHEMBL_IND_52162
type: DrugIndication
chembl id: CHEMBL_IND_52162
has molecule: CHEMBL295698
highest development phase: 3
has mesh: D014008
has mesh heading: TINEA PEDIS
has EFO: EFO_0007512
has EFO name: TINEA PEDIS

CHEMBL_IND_48800
type: DrugIndication
chembl id: CHEMBL_IND_48800
has molecule: CHEMBL295698
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_48643
type: DrugIndication
chembl id: CHEMBL_IND_48643
has molecule: CHEMBL295698
highest development phase: 1
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_48625
type: DrugIndication
chembl id: CHEMBL_IND_48625
has molecule: CHEMBL295698
highest development phase: 1
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_45818
type: DrugIndication
chembl id: CHEMBL_IND_45818
has molecule: CHEMBL295698
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_48546
type: DrugIndication
chembl id: CHEMBL_IND_48546
has molecule: CHEMBL295698
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_48514
type: DrugIndication
chembl id: CHEMBL_IND_48514
has molecule: CHEMBL295698
highest development phase: 1
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_45705
type: DrugIndication
chembl id: CHEMBL_IND_45705
has molecule: CHEMBL295698
highest development phase: 1
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_45633
type: DrugIndication
chembl id: CHEMBL_IND_45633
has molecule: CHEMBL295698
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_45579
type: DrugIndication
chembl id: CHEMBL_IND_45579
has molecule: CHEMBL295698
highest development phase: 1
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_49146
type: DrugIndication
chembl id: CHEMBL_IND_49146
has molecule: CHEMBL295698
highest development phase: 1
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_46500
type: DrugIndication
chembl id: CHEMBL_IND_46500
has molecule: CHEMBL295698
highest development phase: 1
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_43254
type: DrugIndication
chembl id: CHEMBL_IND_43254
has molecule: CHEMBL295698
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_46147
type: DrugIndication
chembl id: CHEMBL_IND_46147
has molecule: CHEMBL295698
highest development phase: 4
has mesh: D012628
has mesh heading: DERMATITIS, SEBORRHEIC
has EFO: EFO_1000764
has EFO name: SEBORRHEIC DERMATITIS

CHEMBL_IND_53098
type: DrugIndication
chembl id: CHEMBL_IND_53098
has molecule: CHEMBL295698
highest development phase: 3
has mesh: D014008
has mesh heading: TINEA PEDIS
has EFO: EFO_0007512
has EFO name: TINEA PEDIS

CHEMBL_IND_45057
type: DrugIndication
chembl id: CHEMBL_IND_45057
has molecule: CHEMBL295698
highest development phase: 2
has mesh: D012164
has mesh heading: RETINAL DISEASES
has EFO: EFO_0003839
has EFO name: RETINOPATHY

CHEMBL_IND_45056
type: DrugIndication
chembl id: CHEMBL_IND_45056
has molecule: CHEMBL295698
highest development phase: 2
has mesh: D012164
has mesh heading: RETINAL DISEASES
has EFO: EFO_0003839
has EFO name: RETINOPATHY

CHEMBL_IND_26697
type: DrugIndication
chembl id: CHEMBL_IND_26697
has molecule: CHEMBL979
highest development phase: 4
has mesh: D001007
has mesh heading: ANXIETY
has EFO: EFO_0005230
has EFO name: ANXIETY

CHEMBL_IND_46935
type: DrugIndication
chembl id: CHEMBL_IND_46935
has molecule: CHEMBL957
highest development phase: 2
has mesh: D065630
has mesh heading: HERNIAS, DIAPHRAGMATIC, CONGENITAL
has EFO: EFO_0005207
has EFO name: CONGENITAL HEART DISEASE

CHEMBL_IND_28036
type: DrugIndication
chembl id: CHEMBL_IND_28036
has molecule: CHEMBL957
highest development phase: 3
has mesh: D012595
has mesh heading: SCLERODERMA, SYSTEMIC
has EFO: EFO_0000717
has EFO name: SYSTEMIC SCLERODERMA

CHEMBL_IND_41947
type: DrugIndication
chembl id: CHEMBL_IND_41947
has molecule: CHEMBL957
highest development phase: 4
has mesh: D065627
has mesh heading: FAMILIAL PRIMARY PULMONARY HYPERTENSION
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: IDIOPATHIC AND/OR FAMILIAL PULMONARY ARTERIAL HYPERTENSION

CHEMBL_IND_52032
type: DrugIndication
chembl id: CHEMBL_IND_52032
has molecule: CHEMBL957
highest development phase: 3
has mesh: D018917
has mesh heading: OPTIC NEUROPATHY, ISCHEMIC
has EFO: EFO_1000809
has EFO name: ANTERIOR ISCHEMIC OPTIC NEUROPATHY

CHEMBL_IND_27583
type: DrugIndication
chembl id: CHEMBL_IND_27583
has molecule: CHEMBL957
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_27582
type: DrugIndication
chembl id: CHEMBL_IND_27582
has molecule: CHEMBL957
highest development phase: 2
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_22785
type: DrugIndication
chembl id: CHEMBL_IND_22785
has molecule: CHEMBL957
highest development phase: 3
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_22784
type: DrugIndication
chembl id: CHEMBL_IND_22784
has molecule: CHEMBL957
highest development phase: 3
has mesh: D006976
has mesh heading: HYPERTENSION, PULMONARY
has EFO: EFO_0001361
has EFO name: PULMONARY HYPERTENSION

CHEMBL_IND_24215
type: DrugIndication
chembl id: CHEMBL_IND_24215
has molecule: CHEMBL957
highest development phase: 3
has mesh: D054990
has mesh heading: IDIOPATHIC PULMONARY FIBROSIS
has EFO: EFO_0000768
has EFO name: IDIOPATHIC PULMONARY FIBROSIS

CHEMBL_IND_24214
type: DrugIndication
chembl id: CHEMBL_IND_24214
has molecule: CHEMBL957
highest development phase: 2
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_42586
type: DrugIndication
chembl id: CHEMBL_IND_42586
has molecule: CHEMBL295829
highest development phase: 4
has mesh: D012216
has mesh heading: RHEUMATIC DISEASES
has EFO: EFO_0005755
has EFO name: RHEUMATIC DISEASE

CHEMBL_IND_53481
type: DrugIndication
chembl id: CHEMBL_IND_53481
has molecule: CHEMBL289228
highest development phase: 2
has mesh: D009190
has mesh heading: MYELODYSPLASTIC SYNDROMES
has EFO: EFO_0000198
has EFO name: MYELODYSPLASTIC SYNDROME

CHEMBL_IND_50491
type: DrugIndication
chembl id: CHEMBL_IND_50491
has molecule: CHEMBL289228
highest development phase: 1
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_50756
type: DrugIndication
chembl id: CHEMBL_IND_50756
has molecule: CHEMBL289228
highest development phase: 2
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_50723
type: DrugIndication
chembl id: CHEMBL_IND_50723
has molecule: CHEMBL289228
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_50710
type: DrugIndication
chembl id: CHEMBL_IND_50710
has molecule: CHEMBL289228
highest development phase: 2
has mesh: D018318
has mesh heading: NEUROFIBROMA, PLEXIFORM
has EFO: EFO_0000658
has EFO name: PLEXIFORM NEUROFIBROMA

CHEMBL_IND_50916
type: DrugIndication
chembl id: CHEMBL_IND_50916
has molecule: CHEMBL289228
highest development phase: 2
has mesh: D013964
has mesh heading: THYROID NEOPLASMS
has EFO: EFO_0002892
has EFO name: THYROID CARCINOMA

CHEMBL_IND_55353
type: DrugIndication
chembl id: CHEMBL_IND_55353
has molecule: CHEMBL289228
highest development phase: 2
has mesh: D002277
has mesh heading: CARCINOMA
has EFO: EFO_0000313
has EFO name: CARCINOMA

CHEMBL_IND_55242
type: DrugIndication
chembl id: CHEMBL_IND_55242
has molecule: CHEMBL289228
highest development phase: 3
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_50248
type: DrugIndication
chembl id: CHEMBL_IND_50248
has molecule: CHEMBL289228
highest development phase: 2
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_50452
type: DrugIndication
chembl id: CHEMBL_IND_50452
has molecule: CHEMBL289228
highest development phase: 2
has mesh: D015451
has mesh heading: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
has EFO: EFO_0000095
has EFO name: CHRONIC LYMPHOCYTIC LEUKEMIA

CHEMBL_IND_54360
type: DrugIndication
chembl id: CHEMBL_IND_54360
has molecule: CHEMBL289228
highest development phase: 2
has mesh: D015477
has mesh heading: LEUKEMIA, MYELOMONOCYTIC, CHRONIC
has EFO: EFO_1001779
has EFO name: CHRONIC MYELOMONOCYTIC LEUKEMIA

CHEMBL_IND_55120
type: DrugIndication
chembl id: CHEMBL_IND_55120
has molecule: CHEMBL289228
highest development phase: 2
has mesh: D020522
has mesh heading: LYMPHOMA, MANTLE-CELL
has EFO: EFO_1001469
has EFO name: MANTLE CELL LYMPHOMA

CHEMBL_IND_53144
type: DrugIndication
chembl id: CHEMBL_IND_53144
has molecule: CHEMBL289228
highest development phase: 2
has mesh: D018316
has mesh heading: GLIOSARCOMA
has EFO: EFO_1001465
has EFO name: GLIOSARCOMA

CHEMBL_IND_26755
type: DrugIndication
chembl id: CHEMBL_IND_26755
has molecule: CHEMBL154
highest development phase: 2
has mesh: D020370
has mesh heading: OSTEOARTHRITIS, KNEE
has EFO: EFO_0004616
has EFO name: OSTEOARTHRITIS, KNEE

CHEMBL_IND_26754
type: DrugIndication
chembl id: CHEMBL_IND_26754
has molecule: CHEMBL154
highest development phase: 4
has mesh: D063806
has mesh heading: MYALGIA
has EFO: HP_0003326
has EFO name: MYALGIA

CHEMBL_IND_26752
type: DrugIndication
chembl id: CHEMBL_IND_26752
has molecule: CHEMBL154
highest development phase: 4
has mesh: D013167
has mesh heading: SPONDYLITIS, ANKYLOSING
has EFO: EFO_0003898
has EFO name: ANKYLOSING SPONDYLITIS

CHEMBL_IND_52172
type: DrugIndication
chembl id: CHEMBL_IND_52172
has molecule: CHEMBL154
highest development phase: 3
has mesh: D015207
has mesh heading: OSTEOARTHRITIS, HIP
has EFO: EFO_1000786
has EFO name: OSTEOARTHRITIS, HIP

CHEMBL_IND_25492
type: DrugIndication
chembl id: CHEMBL_IND_25492
has molecule: CHEMBL154
highest development phase: 1
has mesh: D049310
has mesh heading: DISTAL MYOPATHIES
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: TIBIAL MUSCULAR DYSTROPHY

CHEMBL_IND_49139
type: DrugIndication
chembl id: CHEMBL_IND_49139
has molecule: CHEMBL154
highest development phase: 2
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_49060
type: DrugIndication
chembl id: CHEMBL_IND_49060
has molecule: CHEMBL154
highest development phase: 2
has mesh: D010996
has mesh heading: PLEURAL EFFUSION
has EFO: HP_0002202
has EFO name: PLEURAL EFFUSION

CHEMBL_IND_26172
type: DrugIndication
chembl id: CHEMBL_IND_26172
has molecule: CHEMBL154
highest development phase: 4
has mesh: D014627
has mesh heading: VAGINITIS
has EFO: EFO_0005757
has EFO name: VAGINAL INFLAMMATION

CHEMBL_IND_26171
type: DrugIndication
chembl id: CHEMBL_IND_26171
has molecule: CHEMBL154
highest development phase: 1
has mesh: D003123
has mesh heading: COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: LYNCH SYNDROME

CHEMBL_IND_46080
type: DrugIndication
chembl id: CHEMBL_IND_46080
has molecule: CHEMBL154
highest development phase: 2
has mesh: D004381
has mesh heading: DUODENAL ULCER
has EFO: EFO_0004607
has EFO name: DUODENAL ULCER

CHEMBL_IND_41849
type: DrugIndication
chembl id: CHEMBL_IND_41849
has molecule: CHEMBL154
highest development phase: 4
has mesh: D012216
has mesh heading: RHEUMATIC DISEASES
has EFO: EFO_0005755
has EFO name: RHEUMATIC DISEASE

CHEMBL_IND_27835
type: DrugIndication
chembl id: CHEMBL_IND_27835
has molecule: CHEMBL154
highest development phase: 3
has mesh: D010437
has mesh heading: PEPTIC ULCER
has EFO: HP_0004398
has EFO name: PEPTIC ULCER

CHEMBL_IND_27334
type: DrugIndication
chembl id: CHEMBL_IND_27334
has molecule: CHEMBL154
highest development phase: 3
has mesh: D001171
has mesh heading: ARTHRITIS, JUVENILE
has EFO: EFO_0002609
has EFO name: CHRONIC CHILDHOOD ARTHRITIS

CHEMBL_IND_24697
type: DrugIndication
chembl id: CHEMBL_IND_24697
has molecule: CHEMBL154
highest development phase: 4
has mesh: D001172
has mesh heading: ARTHRITIS, RHEUMATOID
has EFO: EFO_0000685
has EFO name: RHEUMATOID ARTHRITIS

CHEMBL_IND_24692
type: DrugIndication
chembl id: CHEMBL_IND_24692
has molecule: CHEMBL154
highest development phase: 4
has mesh: D018771
has mesh heading: ARTHRALGIA
has EFO: HP_0002829
has EFO name: ARTHRALGIA

CHEMBL_IND_51546
type: DrugIndication
chembl id: CHEMBL_IND_51546
has molecule: CHEMBL154
highest development phase: 4
has mesh: D013276
has mesh heading: STOMACH ULCER
has EFO: HP_0002592
has EFO name: GASTRIC ULCER

CHEMBL_IND_23554
type: DrugIndication
chembl id: CHEMBL_IND_23554
has molecule: CHEMBL154
highest development phase: 3
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_23553
type: DrugIndication
chembl id: CHEMBL_IND_23553
has molecule: CHEMBL154
highest development phase: 4
has mesh: D010003
has mesh heading: OSTEOARTHRITIS
has EFO: EFO_0002506
has EFO name: OSTEOARTHRITIS

CHEMBL_IND_41722
type: DrugIndication
chembl id: CHEMBL_IND_41722
has molecule: CHEMBL289480
highest development phase: 4
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_29118
type: DrugIndication
chembl id: CHEMBL_IND_29118
has molecule: CHEMBL942
highest development phase: 4
has mesh: D003248
has mesh heading: CONSTIPATION
has EFO: HP_0002019
has EFO name: CONSTIPATION

CHEMBL_IND_49617
type: DrugIndication
chembl id: CHEMBL_IND_49617
has molecule: CHEMBL807
highest development phase: 3
has mesh: D001007
has mesh heading: ANXIETY
has EFO: EFO_0005230
has EFO name: ANXIETY

CHEMBL_IND_43994
type: DrugIndication
chembl id: CHEMBL_IND_43994
has molecule: CHEMBL807
highest development phase: 3
has mesh: D019966
has mesh heading: SUBSTANCE-RELATED DISORDERS
has EFO: EFO_0003890
has EFO name: DRUG DEPENDENCE

CHEMBL_IND_43895
type: DrugIndication
chembl id: CHEMBL_IND_43895
has molecule: CHEMBL807
highest development phase: 3
has mesh: D002659
has mesh heading: CHILD DEVELOPMENT DISORDERS, PERVASIVE
has EFO: EFO_0003756
has EFO name: AUTISM SPECTRUM DISORDER

CHEMBL_IND_48607
type: DrugIndication
chembl id: CHEMBL_IND_48607
has molecule: CHEMBL807
highest development phase: 2
has mesh: D005909
has mesh heading: GLIOBLASTOMA
has EFO: EFO_0000519
has EFO name: GLIOBLASTOMA MULTIFORME

CHEMBL_IND_48464
type: DrugIndication
chembl id: CHEMBL_IND_48464
has molecule: CHEMBL807
highest development phase: 2
has mesh: D006816
has mesh heading: HUNTINGTON DISEASE
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: HUNTINGTON DISEASE

CHEMBL_IND_48384
type: DrugIndication
chembl id: CHEMBL_IND_48384
has molecule: CHEMBL807
highest development phase: 2
has mesh: D009437
has mesh heading: NEURALGIA
has EFO: EFO_0005762
has EFO name: NEUROPATHIC PAIN

CHEMBL_IND_48380
type: DrugIndication
chembl id: CHEMBL_IND_48380
has molecule: CHEMBL807
highest development phase: 3
has mesh: D005356
has mesh heading: FIBROMYALGIA
has EFO: EFO_0005687
has EFO name: FIBROMYALGIA

CHEMBL_IND_48375
type: DrugIndication
chembl id: CHEMBL_IND_48375
has molecule: CHEMBL807
highest development phase: 2
has mesh: D009293
has mesh heading: OPIOID-RELATED DISORDERS
has EFO: EFO_0005611
has EFO name: OPIOID DEPENDENCE

CHEMBL_IND_48350
type: DrugIndication
chembl id: CHEMBL_IND_48350
has molecule: CHEMBL807
highest development phase: 2
has mesh: D000428
has mesh heading: ALCOHOL DRINKING
has EFO: EFO_0004329
has EFO name: ALCOHOL DRINKING

CHEMBL_IND_48179
type: DrugIndication
chembl id: CHEMBL_IND_48179
has molecule: CHEMBL807
highest development phase: 2
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_44743
type: DrugIndication
chembl id: CHEMBL_IND_44743
has molecule: CHEMBL807
highest development phase: 3
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_45919
type: DrugIndication
chembl id: CHEMBL_IND_45919
has molecule: CHEMBL807
highest development phase: 2
has mesh: D001321
has mesh heading: AUTISTIC DISORDER
has EFO: EFO_0003758
has EFO name: AUTISM

CHEMBL_IND_47800
type: DrugIndication
chembl id: CHEMBL_IND_47800
has molecule: CHEMBL807
highest development phase: 2
has mesh: D060825
has mesh heading: MILD COGNITIVE IMPAIRMENT
has EFO: HP_0100543
has EFO name: COGNITIVE IMPAIRMENT

CHEMBL_IND_48955
type: DrugIndication
chembl id: CHEMBL_IND_48955
has molecule: CHEMBL807
highest development phase: 2
has mesh: D009771
has mesh heading: OBSESSIVE-COMPULSIVE DISORDER
has EFO: EFO_0004242
has EFO name: OBSESSIVE-COMPULSIVE DISORDER

CHEMBL_IND_43186
type: DrugIndication
chembl id: CHEMBL_IND_43186
has molecule: CHEMBL807
highest development phase: 2
has mesh: D000690
has mesh heading: AMYOTROPHIC LATERAL SCLEROSIS
has EFO: EFO_0000253
has EFO name: AMYOTROPHIC LATERAL SCLEROSIS

CHEMBL_IND_43178
type: DrugIndication
chembl id: CHEMBL_IND_43178
has molecule: CHEMBL807
highest development phase: 3
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_44429
type: DrugIndication
chembl id: CHEMBL_IND_44429
has molecule: CHEMBL807
highest development phase: 2
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_45033
type: DrugIndication
chembl id: CHEMBL_IND_45033
has molecule: CHEMBL807
highest development phase: 1
has mesh: D014029
has mesh heading: TOBACCO USE DISORDER
has EFO: EFO_0003768
has EFO name: NICOTINE DEPENDENCE

CHEMBL_IND_47638
type: DrugIndication
chembl id: CHEMBL_IND_47638
has molecule: CHEMBL807
highest development phase: 3
has mesh: D009103
has mesh heading: MULTIPLE SCLEROSIS
has EFO: EFO_0003885
has EFO name: MULTIPLE SCLEROSIS

CHEMBL_IND_41802
type: DrugIndication
chembl id: CHEMBL_IND_41802
has molecule: CHEMBL807
highest development phase: 4
has mesh: D003704
has mesh heading: DEMENTIA
has EFO: EFO_0003862
has EFO name: DEMENTIA

CHEMBL_IND_44787
type: DrugIndication
chembl id: CHEMBL_IND_44787
has molecule: CHEMBL114
highest development phase: 4
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_49400
type: DrugIndication
chembl id: CHEMBL_IND_49400
has molecule: CHEMBL779
highest development phase: 2
has mesh: D009765
has mesh heading: OBESITY
has EFO: EFO_0001073
has EFO name: OBESITY

CHEMBL_IND_45777
type: DrugIndication
chembl id: CHEMBL_IND_45777
has molecule: CHEMBL779
highest development phase: 2
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_52537
type: DrugIndication
chembl id: CHEMBL_IND_52537
has molecule: CHEMBL779
highest development phase: 3
has mesh: D011928
has mesh heading: RAYNAUD DISEASE
has EFO: EFO_1001145
has EFO name: RAYNAUD DISEASE

CHEMBL_IND_52531
type: DrugIndication
chembl id: CHEMBL_IND_52531
has molecule: CHEMBL779
highest development phase: 2
has mesh: D018589
has mesh heading: GASTROPARESIS
has EFO: EFO_1000948
has EFO name: GASTROPARESIS

CHEMBL_IND_25670
type: DrugIndication
chembl id: CHEMBL_IND_25670
has molecule: CHEMBL779
highest development phase: 3
has mesh: D017563
has mesh heading: LUNG DISEASES, INTERSTITIAL
has EFO: EFO_0004244
has EFO name: INTERSTITIAL LUNG DISEASE

CHEMBL_IND_52686
type: DrugIndication
chembl id: CHEMBL_IND_52686
has molecule: CHEMBL779
highest development phase: 2
has mesh: D000755
has mesh heading: ANEMIA, SICKLE CELL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SICKLE CELL ANEMIA

CHEMBL_IND_26299
type: DrugIndication
chembl id: CHEMBL_IND_26299
has molecule: CHEMBL779
highest development phase: 2
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000181
has EFO name: HEAD AND NECK SQUAMOUS CELL CARCINOMA

CHEMBL_IND_27461
type: DrugIndication
chembl id: CHEMBL_IND_27461
has molecule: CHEMBL779
highest development phase: 2
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_27460
type: DrugIndication
chembl id: CHEMBL_IND_27460
has molecule: CHEMBL779
highest development phase: 3
has mesh: D020388
has mesh heading: MUSCULAR DYSTROPHY, DUCHENNE
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: DUCHENNE MUSCULAR DYSTROPHY

CHEMBL_IND_23920
type: DrugIndication
chembl id: CHEMBL_IND_23920
has molecule: CHEMBL779
highest development phase: 4
has mesh: D007172
has mesh heading: ERECTILE DYSFUNCTION
has EFO: EFO_0004234
has EFO name: ERECTILE DYSFUNCTION

CHEMBL_IND_23919
type: DrugIndication
chembl id: CHEMBL_IND_23919
has molecule: CHEMBL779
highest development phase: 4
has mesh: D011470
has mesh heading: PROSTATIC HYPERPLASIA
has EFO: EFO_0000284
has EFO name: BENIGN PROSTATIC HYPERPLASIA

CHEMBL_IND_24924
type: DrugIndication
chembl id: CHEMBL_IND_24924
has molecule: CHEMBL779
highest development phase: 2
has mesh: D012595
has mesh heading: SCLERODERMA, SYSTEMIC
has EFO: EFO_0000717
has EFO name: SYSTEMIC SCLERODERMA

CHEMBL_IND_24923
type: DrugIndication
chembl id: CHEMBL_IND_24923
has molecule: CHEMBL779
highest development phase: 3
has mesh: D006976
has mesh heading: HYPERTENSION, PULMONARY
has EFO: EFO_0001361
has EFO name: PULMONARY HYPERTENSION

CHEMBL_IND_50798
type: DrugIndication
chembl id: CHEMBL_IND_50798
has molecule: CHEMBL982
highest development phase: 1
has mesh: D000428
has mesh heading: ALCOHOL DRINKING
has EFO: EFO_0004329
has EFO name: ALCOHOL DRINKING

CHEMBL_IND_50797
type: DrugIndication
chembl id: CHEMBL_IND_50797
has molecule: CHEMBL982
highest development phase: 2
has mesh: D016540
has mesh heading: SMOKING CESSATION
has EFO: EFO_0004319
has EFO name: SMOKING CESSATION

CHEMBL_IND_50612
type: DrugIndication
chembl id: CHEMBL_IND_50612
has molecule: CHEMBL982
highest development phase: 2
has mesh: D005715
has mesh heading: GAMBLING
has EFO: EFO_0004699
has EFO name: GAMBLING BEHAVIOUR

CHEMBL_IND_50089
type: DrugIndication
chembl id: CHEMBL_IND_50089
has molecule: CHEMBL982
highest development phase: 4
has mesh: D000437
has mesh heading: ALCOHOLISM
has EFO: EFO_0003829
has EFO name: ALCOHOL DEPENDENCE

CHEMBL_IND_54496
type: DrugIndication
chembl id: CHEMBL_IND_54496
has molecule: CHEMBL982
highest development phase: 2
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_54059
type: DrugIndication
chembl id: CHEMBL_IND_54059
has molecule: CHEMBL742
highest development phase: 2
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_54036
type: DrugIndication
chembl id: CHEMBL_IND_54036
has molecule: CHEMBL742
highest development phase: 2
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_53458
type: DrugIndication
chembl id: CHEMBL_IND_53458
has molecule: CHEMBL742
highest development phase: 2
has mesh: D006345
has mesh heading: HEART SEPTAL DEFECTS, VENTRICULAR
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: VENTRICULAR SEPTAL DEFECT

CHEMBL_IND_53946
type: DrugIndication
chembl id: CHEMBL_IND_53946
has molecule: CHEMBL742
highest development phase: 3
has mesh: D000755
has mesh heading: ANEMIA, SICKLE CELL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SICKLE CELL ANEMIA

CHEMBL_IND_54237
type: DrugIndication
chembl id: CHEMBL_IND_54237
has molecule: CHEMBL742
highest development phase: 1
has mesh: D001523
has mesh heading: MENTAL DISORDERS
has EFO: EFO_0000677
has EFO name: MENTAL OR BEHAVIOURAL DISORDER

CHEMBL_IND_54178
type: DrugIndication
chembl id: CHEMBL_IND_54178
has molecule: CHEMBL742
highest development phase: 2
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_53497
type: DrugIndication
chembl id: CHEMBL_IND_53497
has molecule: CHEMBL742
highest development phase: 3
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_54088
type: DrugIndication
chembl id: CHEMBL_IND_54088
has molecule: CHEMBL742
highest development phase: 3
has mesh: D050723
has mesh heading: FRACTURES, BONE
has EFO: EFO_0003931
has EFO name: BONE FRACTURE

CHEMBL_IND_53384
type: DrugIndication
chembl id: CHEMBL_IND_53384
has molecule: CHEMBL742
highest development phase: 3
has mesh: D011183
has mesh heading: POSTOPERATIVE COMPLICATIONS
has EFO: EFO_0005323
has EFO name: POST-OPERATIVE SIGN OR SYMPTOM

CHEMBL_IND_54762
type: DrugIndication
chembl id: CHEMBL_IND_54762
has molecule: CHEMBL742
highest development phase: 3
has mesh: D012128
has mesh heading: RESPIRATORY DISTRESS SYNDROME, ADULT
has EFO: EFO_1000637
has EFO name: ACUTE RESPIRATORY DISTRESS SYNDROME

CHEMBL_IND_53295
type: DrugIndication
chembl id: CHEMBL_IND_53295
has molecule: CHEMBL742
highest development phase: 2
has mesh: D013313
has mesh heading: STRESS DISORDERS, POST-TRAUMATIC
has EFO: EFO_0001358
has EFO name: POST-TRAUMATIC STRESS DISORDER

CHEMBL_IND_53278
type: DrugIndication
chembl id: CHEMBL_IND_53278
has molecule: CHEMBL742
highest development phase: 1
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_54715
type: DrugIndication
chembl id: CHEMBL_IND_54715
has molecule: CHEMBL742
highest development phase: 1
has mesh: D002659
has mesh heading: CHILD DEVELOPMENT DISORDERS, PERVASIVE
has EFO: EFO_0003756
has EFO name: AUTISM SPECTRUM DISORDER

CHEMBL_IND_54668
type: DrugIndication
chembl id: CHEMBL_IND_54668
has molecule: CHEMBL742
highest development phase: 2
has mesh: D013345
has mesh heading: SUBARACHNOID HEMORRHAGE
has EFO: EFO_0000713
has EFO name: SUBARACHNOID HEMORRHAGE

CHEMBL_IND_53305
type: DrugIndication
chembl id: CHEMBL_IND_53305
has molecule: CHEMBL742
highest development phase: 1
has mesh: D018805
has mesh heading: SEPSIS
has EFO: EFO_0001420
has EFO name: SEPSIS

CHEMBL_IND_53646
type: DrugIndication
chembl id: CHEMBL_IND_53646
has molecule: CHEMBL742
highest development phase: 1
has mesh: D009293
has mesh heading: OPIOID-RELATED DISORDERS
has EFO: EFO_0005611
has EFO name: OPIOID DEPENDENCE

CHEMBL_IND_53628
type: DrugIndication
chembl id: CHEMBL_IND_53628
has molecule: CHEMBL742
highest development phase: 2
has mesh: D009771
has mesh heading: OBSESSIVE-COMPULSIVE DISORDER
has EFO: EFO_0004242
has EFO name: OBSESSIVE-COMPULSIVE DISORDER

CHEMBL_IND_52920
type: DrugIndication
chembl id: CHEMBL_IND_52920
has molecule: CHEMBL742
highest development phase: 2
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_53567
type: DrugIndication
chembl id: CHEMBL_IND_53567
has molecule: CHEMBL742
highest development phase: 3
has mesh: D009767
has mesh heading: OBESITY, MORBID
has EFO: EFO_0001074
has EFO name: MORBID OBESITY

CHEMBL_IND_53879
type: DrugIndication
chembl id: CHEMBL_IND_53879
has molecule: CHEMBL742
highest development phase: 3
has mesh: D059020
has mesh heading: SUICIDAL IDEATION
has EFO: EFO_0004320
has EFO name: SUICIDAL IDEATION

CHEMBL_IND_53863
type: DrugIndication
chembl id: CHEMBL_IND_53863
has molecule: CHEMBL742
highest development phase: 1
has mesh: D019966
has mesh heading: SUBSTANCE-RELATED DISORDERS
has EFO: EFO_0003890
has EFO name: DRUG DEPENDENCE

CHEMBL_IND_53807
type: DrugIndication
chembl id: CHEMBL_IND_53807
has molecule: CHEMBL742
highest development phase: 1
has mesh: D020521
has mesh heading: STROKE
has EFO: EFO_0000712
has EFO name: STROKE

CHEMBL_IND_53045
type: DrugIndication
chembl id: CHEMBL_IND_53045
has molecule: CHEMBL742
highest development phase: 3
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_54542
type: DrugIndication
chembl id: CHEMBL_IND_54542
has molecule: CHEMBL742
highest development phase: 2
has mesh: D009437
has mesh heading: NEURALGIA
has EFO: EFO_0005762
has EFO name: NEUROPATHIC PAIN

CHEMBL_IND_53520
type: DrugIndication
chembl id: CHEMBL_IND_53520
has molecule: CHEMBL742
highest development phase: 3
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_53121
type: DrugIndication
chembl id: CHEMBL_IND_53121
has molecule: CHEMBL742
highest development phase: 2
has mesh: D012019
has mesh heading: REFLEX SYMPATHETIC DYSTROPHY
has EFO: EFO_1001147
has EFO name: REFLEX SYMPATHETIC DYSTROPHY

CHEMBL_IND_54821
type: DrugIndication
chembl id: CHEMBL_IND_54821
has molecule: CHEMBL742
highest development phase: 3
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_42505
type: DrugIndication
chembl id: CHEMBL_IND_42505
has molecule: CHEMBL290194
highest development phase: 4
has mesh: D004066
has mesh heading: DIGESTIVE SYSTEM DISEASES
has EFO: EFO_0000405
has EFO name: DIGESTIVE SYSTEM DISEASE

CHEMBL_IND_53009
type: DrugIndication
chembl id: CHEMBL_IND_53009
has molecule: CHEMBL290352
highest development phase: 2
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_53590
type: DrugIndication
chembl id: CHEMBL_IND_53590
has molecule: CHEMBL862
highest development phase: 2
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_52824
type: DrugIndication
chembl id: CHEMBL_IND_52824
has molecule: CHEMBL862
highest development phase: 4
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_53862
type: DrugIndication
chembl id: CHEMBL_IND_53862
has molecule: CHEMBL862
highest development phase: 4
has mesh: D001289
has mesh heading: ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY
has EFO: EFO_0003888
has EFO name: ATTENTION DEFICIT HYPERACTIVITY DISORDER

CHEMBL_IND_53803
type: DrugIndication
chembl id: CHEMBL_IND_53803
has molecule: CHEMBL862
highest development phase: 2
has mesh: D020521
has mesh heading: STROKE
has EFO: EFO_0000712
has EFO name: STROKE

CHEMBL_IND_54308
type: DrugIndication
chembl id: CHEMBL_IND_54308
has molecule: CHEMBL862
highest development phase: 2
has mesh: D016540
has mesh heading: SMOKING CESSATION
has EFO: EFO_0004319
has EFO name: SMOKING CESSATION

CHEMBL_IND_54298
type: DrugIndication
chembl id: CHEMBL_IND_54298
has molecule: CHEMBL862
highest development phase: 1
has mesh: D002189
has mesh heading: MARIJUANA ABUSE
has EFO: EFO_0004218
has EFO name: MARIJUANA DEPENDENCE

CHEMBL_IND_54533
type: DrugIndication
chembl id: CHEMBL_IND_54533
has molecule: CHEMBL862
highest development phase: 2
has mesh: D000428
has mesh heading: ALCOHOL DRINKING
has EFO: EFO_0004329
has EFO name: ALCOHOL DRINKING

CHEMBL_IND_54505
type: DrugIndication
chembl id: CHEMBL_IND_54505
has molecule: CHEMBL862
highest development phase: 2
has mesh: D014029
has mesh heading: TOBACCO USE DISORDER
has EFO: EFO_0003768
has EFO name: NICOTINE DEPENDENCE

CHEMBL_IND_42932
type: DrugIndication
chembl id: CHEMBL_IND_42932
has molecule: CHEMBL509
highest development phase: 4
has mesh: D063806
has mesh heading: MYALGIA
has EFO: HP_0003326
has EFO name: MYALGIA

CHEMBL_IND_42930
type: DrugIndication
chembl id: CHEMBL_IND_42930
has molecule: CHEMBL509
highest development phase: 4
has mesh: D018771
has mesh heading: ARTHRALGIA
has EFO: HP_0002829
has EFO name: ARTHRALGIA

CHEMBL_IND_41846
type: DrugIndication
chembl id: CHEMBL_IND_41846
has molecule: CHEMBL509
highest development phase: 4
has mesh: D012216
has mesh heading: RHEUMATIC DISEASES
has EFO: EFO_0005755
has EFO name: RHEUMATIC DISEASE

CHEMBL_IND_43185
type: DrugIndication
chembl id: CHEMBL_IND_43185
has molecule: CHEMBL290916
highest development phase: 3
has mesh: D000690
has mesh heading: AMYOTROPHIC LATERAL SCLEROSIS
has EFO: EFO_0000253
has EFO name: AMYOTROPHIC LATERAL SCLEROSIS

CHEMBL_IND_42137
type: DrugIndication
chembl id: CHEMBL_IND_42137
has molecule: CHEMBL299175
highest development phase: 4
has mesh: D008173
has mesh heading: LUNG DISEASES, OBSTRUCTIVE
has EFO: HP_0006536
has EFO name: OBSTRUCTIVE LUNG DISEASE

CHEMBL_IND_46880
type: DrugIndication
chembl id: CHEMBL_IND_46880
has molecule: CHEMBL877
highest development phase: 3
has mesh: D017544
has mesh heading: AORTIC ANEURYSM, ABDOMINAL
has EFO: EFO_0004214
has EFO name: ABDOMINAL AORTIC ANEURYSM

CHEMBL_IND_26940
type: DrugIndication
chembl id: CHEMBL_IND_26940
has molecule: CHEMBL877
highest development phase: 3
has mesh: D012600
has mesh heading: SCOLIOSIS
has EFO: EFO_0004273
has EFO name: SCOLIOSIS

CHEMBL_IND_49348
type: DrugIndication
chembl id: CHEMBL_IND_49348
has molecule: CHEMBL877
highest development phase: 2
has mesh: D013345
has mesh heading: SUBARACHNOID HEMORRHAGE
has EFO: EFO_0000713
has EFO name: SUBARACHNOID HEMORRHAGE

CHEMBL_IND_52483
type: DrugIndication
chembl id: CHEMBL_IND_52483
has molecule: CHEMBL877
highest development phase: 3
has mesh: D019337
has mesh heading: HEMATOLOGIC NEOPLASMS
has EFO: EFO_0001642
has EFO name: LYMPHOID NEOPLASM

CHEMBL_IND_44764
type: DrugIndication
chembl id: CHEMBL_IND_44764
has molecule: CHEMBL877
highest development phase: 1
has mesh: D007889
has mesh heading: LEIOMYOMA
has EFO: EFO_0000731
has EFO name: UTERINE FIBROID

CHEMBL_IND_28411
type: DrugIndication
chembl id: CHEMBL_IND_28411
has molecule: CHEMBL877
highest development phase: 3
has mesh: D054179
has mesh heading: ANGIOEDEMAS, HEREDITARY
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: HEREDITARY ANGIOEDEMA

CHEMBL_IND_28410
type: DrugIndication
chembl id: CHEMBL_IND_28410
has molecule: CHEMBL877
highest development phase: 2
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000292
has EFO name: BLADDER CARCINOMA

CHEMBL_IND_26322
type: DrugIndication
chembl id: CHEMBL_IND_26322
has molecule: CHEMBL877
highest development phase: 3
has mesh: D006471
has mesh heading: GASTROINTESTINAL HEMORRHAGE
has EFO: HP_0002239
has EFO name: GASTROINTESTINAL HEMORRHAGE

CHEMBL_IND_46173
type: DrugIndication
chembl id: CHEMBL_IND_46173
has molecule: CHEMBL877
highest development phase: 3
has mesh: D013921
has mesh heading: THROMBOCYTOPENIA
has EFO: HP_0001873
has EFO name: THROMBOCYTOPENIA

CHEMBL_IND_28464
type: DrugIndication
chembl id: CHEMBL_IND_28464
has molecule: CHEMBL877
highest development phase: 3
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_44476
type: DrugIndication
chembl id: CHEMBL_IND_44476
has molecule: CHEMBL877
highest development phase: 3
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_27478
type: DrugIndication
chembl id: CHEMBL_IND_27478
has molecule: CHEMBL877
highest development phase: 3
has mesh: D008595
has mesh heading: MENORRHAGIA
has EFO: EFO_0003945
has EFO name: MENORRHAGIA

CHEMBL_IND_51715
type: DrugIndication
chembl id: CHEMBL_IND_51715
has molecule: CHEMBL877
highest development phase: 2
has mesh: D002543
has mesh heading: CEREBRAL HEMORRHAGE
has EFO: EFO_0005669
has EFO name: INTRACEREBRAL HEMORRHAGE

CHEMBL_IND_24965
type: DrugIndication
chembl id: CHEMBL_IND_24965
has molecule: CHEMBL877
highest development phase: 3
has mesh: D010003
has mesh heading: OSTEOARTHRITIS
has EFO: EFO_0002506
has EFO name: OSTEOARTHRITIS

CHEMBL_IND_23990
type: DrugIndication
chembl id: CHEMBL_IND_23990
has molecule: CHEMBL877
highest development phase: 3
has mesh: D006620
has mesh heading: HIP FRACTURES
has EFO: EFO_0003964
has EFO name: HIP FRACTURE

CHEMBL_IND_23989
type: DrugIndication
chembl id: CHEMBL_IND_23989
has molecule: CHEMBL877
highest development phase: 4
has mesh: D006470
has mesh heading: HEMORRHAGE
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: HEMORRHAGE

CHEMBL_IND_23988
type: DrugIndication
chembl id: CHEMBL_IND_23988
has molecule: CHEMBL877
highest development phase: 3
has mesh: D003324
has mesh heading: CORONARY ARTERY DISEASE
has EFO: EFO_0000378
has EFO name: CORONARY ARTERY DISEASE

CHEMBL_IND_23987
type: DrugIndication
chembl id: CHEMBL_IND_23987
has molecule: CHEMBL877
highest development phase: 3
has mesh: D012600
has mesh heading: SCOLIOSIS
has EFO: EFO_0005423
has EFO name: ADOLESCENT IDIOPATHIC SCOLIOSIS

CHEMBL_IND_42168
type: DrugIndication
chembl id: CHEMBL_IND_42168
has molecule: CHEMBL287631
highest development phase: 4
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_52743
type: DrugIndication
chembl id: CHEMBL_IND_52743
has molecule: CHEMBL905
highest development phase: 4
has mesh: D008881
has mesh heading: MIGRAINE DISORDERS
has EFO: EFO_0003821
has EFO name: MIGRAINE DISORDER

CHEMBL_IND_26843
type: DrugIndication
chembl id: CHEMBL_IND_26843
has molecule: CHEMBL897
highest development phase: 4
has mesh: D006073
has mesh heading: GOUT
has EFO: EFO_0004274
has EFO name: GOUT

CHEMBL_IND_50775
type: DrugIndication
chembl id: CHEMBL_IND_50775
has molecule: CHEMBL302795
highest development phase: 2
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_50117
type: DrugIndication
chembl id: CHEMBL_IND_50117
has molecule: CHEMBL302795
highest development phase: 4
has mesh: D012216
has mesh heading: RHEUMATIC DISEASES
has EFO: EFO_0005755
has EFO name: RHEUMATIC DISEASE

CHEMBL_IND_53426
type: DrugIndication
chembl id: CHEMBL_IND_53426
has molecule: CHEMBL787
highest development phase: 3
has mesh: D012221
has mesh heading: RHINITIS, ALLERGIC, PERENNIAL
has EFO: EFO_1001417
has EFO name: RHINITIS, ALLERGIC, PERENNIAL

CHEMBL_IND_53465
type: DrugIndication
chembl id: CHEMBL_IND_53465
has molecule: CHEMBL787
highest development phase: 1
has mesh: D001997
has mesh heading: BRONCHOPULMONARY DYSPLASIA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: BRONCHOPULMONARY DYSPLASIA

CHEMBL_IND_54294
type: DrugIndication
chembl id: CHEMBL_IND_54294
has molecule: CHEMBL787
highest development phase: 4
has mesh: D006255
has mesh heading: RHINITIS, ALLERGIC, SEASONAL
has EFO: EFO_0003956
has EFO name: SEASONAL ALLERGIC RHINITIS

CHEMBL_IND_54283
type: DrugIndication
chembl id: CHEMBL_IND_54283
has molecule: CHEMBL787
highest development phase: 3
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_53550
type: DrugIndication
chembl id: CHEMBL_IND_53550
has molecule: CHEMBL787
highest development phase: 1
has mesh: D012140
has mesh heading: RESPIRATORY TRACT DISEASES
has EFO: EFO_0000684
has EFO name: RESPIRATORY SYSTEM DISEASE

CHEMBL_IND_53651
type: DrugIndication
chembl id: CHEMBL_IND_53651
has molecule: CHEMBL787
highest development phase: 4
has mesh: D006255
has mesh heading: RHINITIS, ALLERGIC, SEASONAL
has EFO: EFO_0005854
has EFO name: ALLERGIC RHINITIS

CHEMBL_IND_52732
type: DrugIndication
chembl id: CHEMBL_IND_52732
has molecule: CHEMBL787
highest development phase: 4
has mesh: D008173
has mesh heading: LUNG DISEASES, OBSTRUCTIVE
has EFO: HP_0006536
has EFO name: OBSTRUCTIVE LUNG DISEASE

CHEMBL_IND_53167
type: DrugIndication
chembl id: CHEMBL_IND_53167
has molecule: CHEMBL787
highest development phase: 2
has mesh: D003371
has mesh heading: COUGH
has EFO: HP_0012735
has EFO name: COUGH

CHEMBL_IND_54514
type: DrugIndication
chembl id: CHEMBL_IND_54514
has molecule: CHEMBL787
highest development phase: 2
has mesh: D047928
has mesh heading: PREMATURE BIRTH
has EFO: EFO_0003917
has EFO name: PREMATURE BIRTH

CHEMBL_IND_54510
type: DrugIndication
chembl id: CHEMBL_IND_54510
has molecule: CHEMBL787
highest development phase: 2
has mesh: D012891
has mesh heading: SLEEP APNEA SYNDROMES
has EFO: EFO_0003877
has EFO name: SLEEP APNEA

CHEMBL_IND_54809
type: DrugIndication
chembl id: CHEMBL_IND_54809
has molecule: CHEMBL787
highest development phase: 4
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_50481
type: DrugIndication
chembl id: CHEMBL_IND_50481
has molecule: CHEMBL286738
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_50403
type: DrugIndication
chembl id: CHEMBL_IND_50403
has molecule: CHEMBL286738
highest development phase: 2
has mesh: D016889
has mesh heading: ENDOMETRIAL NEOPLASMS
has EFO: EFO_0004230
has EFO name: ENDOMETRIAL NEOPLASM

CHEMBL_IND_50380
type: DrugIndication
chembl id: CHEMBL_IND_50380
has molecule: CHEMBL286738
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0003869
has EFO name: BREAST NEOPLASM

CHEMBL_IND_41764
type: DrugIndication
chembl id: CHEMBL_IND_41764
has molecule: CHEMBL788
highest development phase: 4
has mesh: D014777
has mesh heading: VIRUS DISEASES
has EFO: EFO_0000763
has EFO name: VIRAL DISEASE

CHEMBL_IND_50115
type: DrugIndication
chembl id: CHEMBL_IND_50115
has molecule: CHEMBL304902
highest development phase: 4
has mesh: D011618
has mesh heading: PSYCHOTIC DISORDERS
has EFO: EFO_0005407
has EFO name: PSYCHOSIS

CHEMBL_IND_46606
type: DrugIndication
chembl id: CHEMBL_IND_46606
has molecule: CHEMBL964
highest development phase: 1
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_26522
type: DrugIndication
chembl id: CHEMBL_IND_26522
has molecule: CHEMBL964
highest development phase: 4
has mesh: D000437
has mesh heading: ALCOHOLISM
has EFO: EFO_0003829
has EFO name: ALCOHOL DEPENDENCE

CHEMBL_IND_48361
type: DrugIndication
chembl id: CHEMBL_IND_48361
has molecule: CHEMBL964
highest development phase: 1
has mesh: D019969
has mesh heading: AMPHETAMINE-RELATED DISORDERS
has EFO: EFO_0004701
has EFO name: METAMPHETAMINE DEPENDENCE

CHEMBL_IND_25940
type: DrugIndication
chembl id: CHEMBL_IND_25940
has molecule: CHEMBL964
highest development phase: 4
has mesh: D004478
has mesh heading: ECTOPARASITIC INFESTATIONS
has EFO: EFO_0001067
has EFO name: PARASITIC INFECTION

CHEMBL_IND_25247
type: DrugIndication
chembl id: CHEMBL_IND_25247
has molecule: CHEMBL964
highest development phase: 1
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_24359
type: DrugIndication
chembl id: CHEMBL_IND_24359
has molecule: CHEMBL964
highest development phase: 2
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_50795
type: DrugIndication
chembl id: CHEMBL_IND_50795
has molecule: CHEMBL301265
highest development phase: 4
has mesh: D012148
has mesh heading: RESTLESS LEGS SYNDROME
has EFO: EFO_0004270
has EFO name: RESTLESS LEGS SYNDROME

CHEMBL_IND_49996
type: DrugIndication
chembl id: CHEMBL_IND_49996
has molecule: CHEMBL301265
highest development phase: 4
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_50560
type: DrugIndication
chembl id: CHEMBL_IND_50560
has molecule: CHEMBL301265
highest development phase: 1
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_50661
type: DrugIndication
chembl id: CHEMBL_IND_50661
has molecule: CHEMBL301265
highest development phase: 2
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_50928
type: DrugIndication
chembl id: CHEMBL_IND_50928
has molecule: CHEMBL301265
highest development phase: 3
has mesh: D020329
has mesh heading: ESSENTIAL TREMOR
has EFO: EFO_0003108
has EFO name: ESSENTIAL TREMOR

CHEMBL_IND_55336
type: DrugIndication
chembl id: CHEMBL_IND_55336
has molecule: CHEMBL301265
highest development phase: 2
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_50414
type: DrugIndication
chembl id: CHEMBL_IND_50414
has molecule: CHEMBL301265
highest development phase: 3
has mesh: D005879
has mesh heading: TOURETTE SYNDROME
has EFO: EFO_0004895
has EFO name: TOURETTE SYNDROME

CHEMBL_IND_55118
type: DrugIndication
chembl id: CHEMBL_IND_55118
has molecule: CHEMBL301265
highest development phase: 2
has mesh: D005356
has mesh heading: FIBROMYALGIA
has EFO: EFO_0005687
has EFO name: FIBROMYALGIA

CHEMBL_IND_55025
type: DrugIndication
chembl id: CHEMBL_IND_55025
has molecule: CHEMBL301265
highest development phase: 3
has mesh: D001068
has mesh heading: EATING DISORDERS
has EFO: EFO_0005203
has EFO name: EATING DISORDER

CHEMBL_IND_50833
type: DrugIndication
chembl id: CHEMBL_IND_50833
has molecule: CHEMBL306823
highest development phase: 2
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000181
has EFO name: HEAD AND NECK SQUAMOUS CELL CARCINOMA

CHEMBL_IND_55185
type: DrugIndication
chembl id: CHEMBL_IND_55185
has molecule: CHEMBL306823
highest development phase: 1
has mesh: D006976
has mesh heading: HYPERTENSION, PULMONARY
has EFO: EFO_0001361
has EFO name: PULMONARY HYPERTENSION

CHEMBL_IND_53714
type: DrugIndication
chembl id: CHEMBL_IND_53714
has molecule: CHEMBL301523
highest development phase: 3
has mesh: D010661
has mesh heading: PHENYLKETONURIAS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: PHENYLKETONURIA

CHEMBL_IND_46655
type: DrugIndication
chembl id: CHEMBL_IND_46655
has molecule: CHEMBL294199
highest development phase: 2
has mesh: D006976
has mesh heading: HYPERTENSION, PULMONARY
has EFO: EFO_0001361
has EFO name: PULMONARY HYPERTENSION

CHEMBL_IND_27081
type: DrugIndication
chembl id: CHEMBL_IND_27081
has molecule: CHEMBL294199
highest development phase: 4
has mesh: D063806
has mesh heading: MYALGIA
has EFO: HP_0003326
has EFO name: MYALGIA

CHEMBL_IND_27079
type: DrugIndication
chembl id: CHEMBL_IND_27079
has molecule: CHEMBL294199
highest development phase: 4
has mesh: D018771
has mesh heading: ARTHRALGIA
has EFO: HP_0002829
has EFO name: ARTHRALGIA

CHEMBL_IND_52207
type: DrugIndication
chembl id: CHEMBL_IND_52207
has molecule: CHEMBL294199
highest development phase: 2
has mesh: D052439
has mesh heading: LIPID METABOLISM DISORDERS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: DISORDER OF LIPID METABOLISM

CHEMBL_IND_52170
type: DrugIndication
chembl id: CHEMBL_IND_52170
has molecule: CHEMBL294199
highest development phase: 3
has mesh: D003929
has mesh heading: DIABETIC NEUROPATHIES
has EFO: EFO_1000783
has EFO name: DIABETIC NEUROPATHY

CHEMBL_IND_52430
type: DrugIndication
chembl id: CHEMBL_IND_52430
has molecule: CHEMBL294199
highest development phase: 1
has mesh: D011537
has mesh heading: PRURITUS
has EFO: HP_0000989
has EFO name: PRURITUS

CHEMBL_IND_52706
type: DrugIndication
chembl id: CHEMBL_IND_52706
has molecule: CHEMBL294199
highest development phase: 3
has mesh: D060050
has mesh heading: ANGINA, STABLE
has EFO: EFO_0003913
has EFO name: ANGINA PECTORIS

CHEMBL_IND_52589
type: DrugIndication
chembl id: CHEMBL_IND_52589
has molecule: CHEMBL294199
highest development phase: 0
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_43183
type: DrugIndication
chembl id: CHEMBL_IND_43183
has molecule: CHEMBL294199
highest development phase: 0
has mesh: D000690
has mesh heading: AMYOTROPHIC LATERAL SCLEROSIS
has EFO: EFO_0000253
has EFO name: AMYOTROPHIC LATERAL SCLEROSIS

CHEMBL_IND_46210
type: DrugIndication
chembl id: CHEMBL_IND_46210
has molecule: CHEMBL294199
highest development phase: 1
has mesh: D003371
has mesh heading: COUGH
has EFO: HP_0012735
has EFO name: COUGH

CHEMBL_IND_51442
type: DrugIndication
chembl id: CHEMBL_IND_51442
has molecule: CHEMBL294199
highest development phase: 4
has mesh: D009120
has mesh heading: MUSCLE CRAMP

CHEMBL_IND_51844
type: DrugIndication
chembl id: CHEMBL_IND_51844
has molecule: CHEMBL294199
highest development phase: 0
has mesh: D008881
has mesh heading: MIGRAINE DISORDERS
has EFO: EFO_0003821
has EFO name: MIGRAINE DISORDER

CHEMBL_IND_44926
type: DrugIndication
chembl id: CHEMBL_IND_44926
has molecule: CHEMBL294199
highest development phase: 3
has mesh: D010003
has mesh heading: OSTEOARTHRITIS
has EFO: EFO_0002506
has EFO name: OSTEOARTHRITIS

CHEMBL_IND_52114
type: DrugIndication
chembl id: CHEMBL_IND_52114
has molecule: CHEMBL294199
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_25156
type: DrugIndication
chembl id: CHEMBL_IND_25156
has molecule: CHEMBL294199
highest development phase: 3
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_51673
type: DrugIndication
chembl id: CHEMBL_IND_51673
has molecule: CHEMBL294199
highest development phase: 1
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_51634
type: DrugIndication
chembl id: CHEMBL_IND_51634
has molecule: CHEMBL294199
highest development phase: 4
has mesh: D052256
has mesh heading: TENDINOPATHY
has EFO: EFO_1001434
has EFO name: TENDINOPATHY

CHEMBL_IND_51631
type: DrugIndication
chembl id: CHEMBL_IND_51631
has molecule: CHEMBL294199
highest development phase: 4
has mesh: D002062
has mesh heading: BURSITIS
has EFO: EFO_1000941
has EFO name: FROZEN SHOULDER

CHEMBL_IND_51500
type: DrugIndication
chembl id: CHEMBL_IND_51500
has molecule: CHEMBL294199
highest development phase: 4
has mesh: D001416
has mesh heading: BACK PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_51467
type: DrugIndication
chembl id: CHEMBL_IND_51467
has molecule: CHEMBL294199
highest development phase: 4
has mesh: D001168
has mesh heading: ARTHRITIS
has EFO: EFO_0005856
has EFO name: ARTHRITIS

CHEMBL_IND_51940
type: DrugIndication
chembl id: CHEMBL_IND_51940
has molecule: CHEMBL294199
highest development phase: 0
has mesh: D003554
has mesh heading: CYSTINOSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CYSTINOSIS

CHEMBL_IND_50730
type: DrugIndication
chembl id: CHEMBL_IND_50730
has molecule: CHEMBL305187
highest development phase: 1
has mesh: D013313
has mesh heading: STRESS DISORDERS, POST-TRAUMATIC
has EFO: EFO_0001358
has EFO name: POST-TRAUMATIC STRESS DISORDER

CHEMBL_IND_50067
type: DrugIndication
chembl id: CHEMBL_IND_50067
has molecule: CHEMBL305187
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_50911
type: DrugIndication
chembl id: CHEMBL_IND_50911
has molecule: CHEMBL296913
highest development phase: 3
has mesh: D010003
has mesh heading: OSTEOARTHRITIS
has EFO: EFO_0002506
has EFO name: OSTEOARTHRITIS

CHEMBL_IND_41576
type: DrugIndication
chembl id: CHEMBL_IND_41576
has molecule: CHEMBL927
highest development phase: 4
has mesh: D010612
has mesh heading: PHARYNGITIS

CHEMBL_IND_29027
type: DrugIndication
chembl id: CHEMBL_IND_29027
has molecule: CHEMBL927
highest development phase: 4
has mesh: D010033
has mesh heading: OTITIS MEDIA
has EFO: EFO_0004992
has EFO name: OTITIS MEDIA

CHEMBL_IND_41934
type: DrugIndication
chembl id: CHEMBL_IND_41934
has molecule: CHEMBL927
highest development phase: 4
has mesh: D014069
has mesh heading: TONSILLITIS
has EFO: HP_0011110
has EFO name: TONSILLITIS

CHEMBL_IND_51557
type: DrugIndication
chembl id: CHEMBL_IND_51557
has molecule: CHEMBL927
highest development phase: 4
has mesh: D029481
has mesh heading: BRONCHITIS, CHRONIC
has EFO: EFO_0006505
has EFO name: CHRONIC BRONCHITIS

CHEMBL_IND_48898
type: DrugIndication
chembl id: CHEMBL_IND_48898
has molecule: CHEMBL319144
highest development phase: 2
has mesh: D010024
has mesh heading: OSTEOPOROSIS
has EFO: EFO_0003882
has EFO name: OSTEOPOROSIS

CHEMBL_IND_42032
type: DrugIndication
chembl id: CHEMBL_IND_42032
has molecule: CHEMBL1200467
highest development phase: 4
has mesh: D012871
has mesh heading: SKIN DISEASES
has EFO: EFO_0000701
has EFO name: SKIN DISEASE

CHEMBL_IND_42117
type: DrugIndication
chembl id: CHEMBL_IND_42117
has molecule: CHEMBL1200467
highest development phase: 4
has mesh: D011537
has mesh heading: PRURITUS
has EFO: HP_0000989
has EFO name: PRURITUS

CHEMBL_IND_42068
type: DrugIndication
chembl id: CHEMBL_IND_42068
has molecule: CHEMBL1200467
highest development phase: 4
has mesh: D009497
has mesh heading: NEUROTIC DISORDERS
has EFO: EFO_0004257
has EFO name: NEUROTIC DISORDER

CHEMBL_IND_41838
type: DrugIndication
chembl id: CHEMBL_IND_41838
has molecule: CHEMBL1200467
highest development phase: 4
has mesh: D014581
has mesh heading: URTICARIA
has EFO: EFO_0005531
has EFO name: URTICARIA

CHEMBL_IND_26892
type: DrugIndication
chembl id: CHEMBL_IND_26892
has molecule: CHEMBL1064
highest development phase: 1
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_26891
type: DrugIndication
chembl id: CHEMBL_IND_26891
has molecule: CHEMBL1064
highest development phase: 2
has mesh: D012772
has mesh heading: SHOCK, SEPTIC
has EFO: EFO_0006834
has EFO name: SEPTIC SHOCK

CHEMBL_IND_26890
type: DrugIndication
chembl id: CHEMBL_IND_26890
has molecule: CHEMBL1064
highest development phase: 0
has mesh: D058729
has mesh heading: PERIPHERAL ARTERIAL DISEASE
has EFO: EFO_0004265
has EFO name: PERIPHERAL ARTERIAL DISEASE

CHEMBL_IND_26888
type: DrugIndication
chembl id: CHEMBL_IND_26888
has molecule: CHEMBL1064
highest development phase: 1
has mesh: D002446
has mesh heading: CELIAC DISEASE
has EFO: EFO_0001060
has EFO name: CELIAC DISEASE

CHEMBL_IND_26887
type: DrugIndication
chembl id: CHEMBL_IND_26887
has molecule: CHEMBL1064
highest development phase: 3
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_49607
type: DrugIndication
chembl id: CHEMBL_IND_49607
has molecule: CHEMBL1064
highest development phase: 2
has mesh: D016540
has mesh heading: SMOKING CESSATION
has EFO: EFO_0004319
has EFO name: SMOKING CESSATION

CHEMBL_IND_46872
type: DrugIndication
chembl id: CHEMBL_IND_46872
has molecule: CHEMBL1064
highest development phase: 1
has mesh: D000506
has mesh heading: ALOPECIA AREATA
has EFO: EFO_0004192
has EFO name: ALOPECIA AREATA

CHEMBL_IND_49467
type: DrugIndication
chembl id: CHEMBL_IND_49467
has molecule: CHEMBL1064
highest development phase: 2
has mesh: D008258
has mesh heading: WALDENSTROM MACROGLOBULINEMIA
has EFO: EFO_0002616
has EFO name: MACROGLOBULINEMIA

CHEMBL_IND_52487
type: DrugIndication
chembl id: CHEMBL_IND_52487
has molecule: CHEMBL1064
highest development phase: 2
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_25646
type: DrugIndication
chembl id: CHEMBL_IND_25646
has molecule: CHEMBL1064
highest development phase: 3
has mesh: D013345
has mesh heading: SUBARACHNOID HEMORRHAGE
has EFO: EFO_0000713
has EFO name: SUBARACHNOID HEMORRHAGE

CHEMBL_IND_25645
type: DrugIndication
chembl id: CHEMBL_IND_25645
has molecule: CHEMBL1064
highest development phase: 2
has mesh: D019082
has mesh heading: SMITH-LEMLI-OPITZ SYNDROME
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SMITH-LEMLI-OPITZ SYNDROME

CHEMBL_IND_25644
type: DrugIndication
chembl id: CHEMBL_IND_25644
has molecule: CHEMBL1064
highest development phase: 3
has mesh: D020529
has mesh heading: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
has EFO: EFO_0003929
has EFO name: RELAPSING-REMITTING MULTIPLE SCLEROSIS

CHEMBL_IND_25643
type: DrugIndication
chembl id: CHEMBL_IND_25643
has molecule: CHEMBL1064
highest development phase: 3
has mesh: D011014
has mesh heading: PNEUMONIA
has EFO: EFO_0003106
has EFO name: PNEUMONIA

CHEMBL_IND_25641
type: DrugIndication
chembl id: CHEMBL_IND_25641
has molecule: CHEMBL1064
highest development phase: 1
has mesh: D019694
has mesh heading: HEPATITIS B, CHRONIC
has EFO: EFO_0004197
has EFO name: HEPATITIS B INFECTION

CHEMBL_IND_25640
type: DrugIndication
chembl id: CHEMBL_IND_25640
has molecule: CHEMBL1064
highest development phase: 2
has mesh: D020528
has mesh heading: MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE
has EFO: EFO_0003840
has EFO name: CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS

CHEMBL_IND_25639
type: DrugIndication
chembl id: CHEMBL_IND_25639
has molecule: CHEMBL1064
highest development phase: 1
has mesh: D015794
has mesh heading: CHOROIDEREMIA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CHOROIDEREMIA

CHEMBL_IND_25638
type: DrugIndication
chembl id: CHEMBL_IND_25638
has molecule: CHEMBL1064
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_28382
type: DrugIndication
chembl id: CHEMBL_IND_28382
has molecule: CHEMBL1064
highest development phase: 2
has mesh: D014820
has mesh heading: VITILIGO
has EFO: EFO_0004208
has EFO name: VITILIGO

CHEMBL_IND_28381
type: DrugIndication
chembl id: CHEMBL_IND_28381
has molecule: CHEMBL1064
highest development phase: 2
has mesh: D018805
has mesh heading: SEPSIS
has EFO: EFO_0001420
has EFO name: SEPSIS

CHEMBL_IND_28380
type: DrugIndication
chembl id: CHEMBL_IND_28380
has molecule: CHEMBL1064
highest development phase: 3
has mesh: D013274
has mesh heading: STOMACH NEOPLASMS
has EFO: EFO_0000178
has EFO name: GASTRIC CARCINOMA

CHEMBL_IND_28379
type: DrugIndication
chembl id: CHEMBL_IND_28379
has molecule: CHEMBL1064
highest development phase: 1
has mesh: D015451
has mesh heading: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
has EFO: EFO_0000095
has EFO name: CHRONIC LYMPHOCYTIC LEUKEMIA

CHEMBL_IND_28378
type: DrugIndication
chembl id: CHEMBL_IND_28378
has molecule: CHEMBL1064
highest development phase: 2
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_52238
type: DrugIndication
chembl id: CHEMBL_IND_52238
has molecule: CHEMBL1064
highest development phase: 2
has mesh: D008103
has mesh heading: LIVER CIRRHOSIS
has EFO: EFO_0001422
has EFO name: CIRRHOSIS OF LIVER

CHEMBL_IND_52230
type: DrugIndication
chembl id: CHEMBL_IND_52230
has molecule: CHEMBL1064
highest development phase: 2
has mesh: D010518
has mesh heading: PERIODONTITIS
has EFO: EFO_0000649
has EFO name: PERIODONTITIS

CHEMBL_IND_52670
type: DrugIndication
chembl id: CHEMBL_IND_52670
has molecule: CHEMBL1064
highest development phase: 2
has mesh: D014605
has mesh heading: UVEITIS
has EFO: EFO_1001231
has EFO name: UVEITIS

CHEMBL_IND_52652
type: DrugIndication
chembl id: CHEMBL_IND_52652
has molecule: CHEMBL1064
highest development phase: 2
has mesh: D012004
has mesh heading: RECTAL NEOPLASMS
has EFO: EFO_1000657
has EFO name: RECTUM CANCER

CHEMBL_IND_40868
type: DrugIndication
chembl id: CHEMBL_IND_40868
has molecule: CHEMBL1064
highest development phase: 2
has mesh: D012852
has mesh heading: SINUSITIS
has EFO: EFO_0007486
has EFO name: SINUSITIS

CHEMBL_IND_43469
type: DrugIndication
chembl id: CHEMBL_IND_43469
has molecule: CHEMBL1064
highest development phase: 4
has mesh: D009203
has mesh heading: MYOCARDIAL INFARCTION
has EFO: EFO_0000612
has EFO name: MYOCARDIAL INFARCTION

CHEMBL_IND_26287
type: DrugIndication
chembl id: CHEMBL_IND_26287
has molecule: CHEMBL1064
highest development phase: 2
has mesh: D000755
has mesh heading: ANEMIA, SICKLE CELL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SICKLE CELL ANEMIA

CHEMBL_IND_26286
type: DrugIndication
chembl id: CHEMBL_IND_26286
has molecule: CHEMBL1064
highest development phase: 1
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_26285
type: DrugIndication
chembl id: CHEMBL_IND_26285
has molecule: CHEMBL1064
highest development phase: 1
has mesh: D007319
has mesh heading: SLEEP INITIATION AND MAINTENANCE DISORDERS
has EFO: EFO_0004698
has EFO name: INSOMNIA

CHEMBL_IND_43014
type: DrugIndication
chembl id: CHEMBL_IND_43014
has molecule: CHEMBL1064
highest development phase: 4
has mesh: D006938
has mesh heading: HYPERLIPOPROTEINEMIA TYPE II
has EFO: EFO_0004911
has EFO name: FAMILIAL HYPERCHOLESTEROLEMIA

CHEMBL_IND_23873
type: DrugIndication
chembl id: CHEMBL_IND_23873
has molecule: CHEMBL1064
highest development phase: 4
has mesh: D006937
has mesh heading: HYPERCHOLESTEROLEMIA
has EFO: HP_0003124
has EFO name: HYPERCHOLESTEROLEMIA

CHEMBL_IND_23872
type: DrugIndication
chembl id: CHEMBL_IND_23872
has molecule: CHEMBL1064
highest development phase: 3
has mesh: D052439
has mesh heading: LIPID METABOLISM DISORDERS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: DISORDER OF LIPID METABOLISM

CHEMBL_IND_23871
type: DrugIndication
chembl id: CHEMBL_IND_23871
has molecule: CHEMBL1064
highest development phase: 3
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_23870
type: DrugIndication
chembl id: CHEMBL_IND_23870
has molecule: CHEMBL1064
highest development phase: 2
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_45036
type: DrugIndication
chembl id: CHEMBL_IND_45036
has molecule: CHEMBL1064
highest development phase: 3
has mesh: D003930
has mesh heading: DIABETIC RETINOPATHY
has EFO: EFO_0003770
has EFO name: DIABETIC RETINOPATHY

CHEMBL_IND_27935
type: DrugIndication
chembl id: CHEMBL_IND_27935
has molecule: CHEMBL1064
highest development phase: 3
has mesh: D011085
has mesh heading: POLYCYSTIC OVARY SYNDROME
has EFO: EFO_0000660
has EFO name: POLYCYSTIC OVARY SYNDROME

CHEMBL_IND_27933
type: DrugIndication
chembl id: CHEMBL_IND_27933
has molecule: CHEMBL1064
highest development phase: 1
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_27932
type: DrugIndication
chembl id: CHEMBL_IND_27932
has molecule: CHEMBL1064
highest development phase: 3
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_47573
type: DrugIndication
chembl id: CHEMBL_IND_47573
has molecule: CHEMBL1064
highest development phase: 0
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0003144
has EFO name: HEART FAILURE

CHEMBL_IND_27441
type: DrugIndication
chembl id: CHEMBL_IND_27441
has molecule: CHEMBL1064
highest development phase: 2
has mesh: D006976
has mesh heading: HYPERTENSION, PULMONARY
has EFO: EFO_0001361
has EFO name: PULMONARY HYPERTENSION

CHEMBL_IND_51935
type: DrugIndication
chembl id: CHEMBL_IND_51935
has molecule: CHEMBL1064
highest development phase: 3
has mesh: D007249
has mesh heading: INFLAMMATION
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: INFLAMMATION

CHEMBL_IND_24897
type: DrugIndication
chembl id: CHEMBL_IND_24897
has molecule: CHEMBL1064
highest development phase: 2
has mesh: D002543
has mesh heading: CEREBRAL HEMORRHAGE
has EFO: EFO_0005669
has EFO name: INTRACEREBRAL HEMORRHAGE

CHEMBL_IND_24896
type: DrugIndication
chembl id: CHEMBL_IND_24896
has molecule: CHEMBL1064
highest development phase: 3
has mesh: D015228
has mesh heading: HYPERTRIGLYCERIDEMIA
has EFO: EFO_0004211
has EFO name: HYPERTRIGLYCERIDEMIA

CHEMBL_IND_24895
type: DrugIndication
chembl id: CHEMBL_IND_24895
has molecule: CHEMBL1064
highest development phase: 4
has mesh: D006949
has mesh heading: HYPERLIPIDEMIAS
has EFO: EFO_0003774
has EFO name: HYPERLIPIDEMIA

CHEMBL_IND_24894
type: DrugIndication
chembl id: CHEMBL_IND_24894
has molecule: CHEMBL1064
highest development phase: 3
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_24893
type: DrugIndication
chembl id: CHEMBL_IND_24893
has molecule: CHEMBL1064
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_24892
type: DrugIndication
chembl id: CHEMBL_IND_24892
has molecule: CHEMBL1064
highest development phase: 2
has mesh: D001281
has mesh heading: ATRIAL FIBRILLATION
has EFO: EFO_0000275
has EFO name: ATRIAL FIBRILLATION

CHEMBL_IND_42789
type: DrugIndication
chembl id: CHEMBL_IND_42789
has molecule: CHEMBL1064
highest development phase: 4
has mesh: D050171
has mesh heading: DYSLIPIDEMIAS
has EFO: HP_0003119
has EFO name: ABNORMALITY OF LIPID METABOLISM

CHEMBL_IND_43618
type: DrugIndication
chembl id: CHEMBL_IND_43618
has molecule: CHEMBL308954
highest development phase: 4
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_49269
type: DrugIndication
chembl id: CHEMBL_IND_49269
has molecule: CHEMBL308954
highest development phase: 1
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_43111
type: DrugIndication
chembl id: CHEMBL_IND_43111
has molecule: CHEMBL308954
highest development phase: 4
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000180
has EFO name: HIV-1 INFECTION

CHEMBL_IND_51570
type: DrugIndication
chembl id: CHEMBL_IND_51570
has molecule: CHEMBL308954
highest development phase: 4
has mesh: D006678
has mesh heading: HIV
has EFO: EFO_0000180
has EFO name: HIV-1 INFECTION

CHEMBL_IND_43640
type: DrugIndication
chembl id: CHEMBL_IND_43640
has molecule: CHEMBL298470
highest development phase: 2
has mesh: D008288
has mesh heading: MALARIA
has EFO: EFO_0001068
has EFO name: MALARIA

CHEMBL_IND_53393
type: DrugIndication
chembl id: CHEMBL_IND_53393
has molecule: CHEMBL298470
highest development phase: 1
has mesh: D016780
has mesh heading: MALARIA, VIVAX
has EFO: EFO_0007445
has EFO name: PLASMODIUM VIVAX MALARIA

CHEMBL_IND_48509
type: DrugIndication
chembl id: CHEMBL_IND_48509
has molecule: CHEMBL887
highest development phase: 2
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_48341
type: DrugIndication
chembl id: CHEMBL_IND_48341
has molecule: CHEMBL887
highest development phase: 2
has mesh: D012148
has mesh heading: RESTLESS LEGS SYNDROME
has EFO: EFO_0004270
has EFO name: RESTLESS LEGS SYNDROME

CHEMBL_IND_45413
type: DrugIndication
chembl id: CHEMBL_IND_45413
has molecule: CHEMBL887
highest development phase: 2
has mesh: D000690
has mesh heading: AMYOTROPHIC LATERAL SCLEROSIS
has EFO: EFO_0000253
has EFO name: AMYOTROPHIC LATERAL SCLEROSIS

CHEMBL_IND_46250
type: DrugIndication
chembl id: CHEMBL_IND_46250
has molecule: CHEMBL887
highest development phase: 3
has mesh: D013494
has mesh heading: SUPRANUCLEAR PALSY, PROGRESSIVE
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: PROGRESSIVE SUPRANUCLEAR PALSY

CHEMBL_IND_41775
type: DrugIndication
chembl id: CHEMBL_IND_41775
has molecule: CHEMBL887
highest development phase: 4
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_25834
type: DrugIndication
chembl id: CHEMBL_IND_25834
has molecule: CHEMBL1072
highest development phase: 1
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_51988
type: DrugIndication
chembl id: CHEMBL_IND_51988
has molecule: CHEMBL1072
highest development phase: 2
has mesh: D001321
has mesh heading: AUTISTIC DISORDER
has EFO: EFO_0003758
has EFO name: AUTISM

CHEMBL_IND_22804
type: DrugIndication
chembl id: CHEMBL_IND_22804
has molecule: CHEMBL1072
highest development phase: 4
has mesh: D009404
has mesh heading: NEPHROTIC SYNDROME
has EFO: EFO_0004255
has EFO name: NEPHROTIC SYNDROME

CHEMBL_IND_22803
type: DrugIndication
chembl id: CHEMBL_IND_22803
has molecule: CHEMBL1072
highest development phase: 4
has mesh: D007674
has mesh heading: KIDNEY DISEASES
has EFO: EFO_0003086
has EFO name: KIDNEY DISEASE

CHEMBL_IND_22802
type: DrugIndication
chembl id: CHEMBL_IND_22802
has molecule: CHEMBL1072
highest development phase: 4
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0000373
has EFO name: CONGESTIVE HEART FAILURE

CHEMBL_IND_42821
type: DrugIndication
chembl id: CHEMBL_IND_42821
has molecule: CHEMBL1072
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_25127
type: DrugIndication
chembl id: CHEMBL_IND_25127
has molecule: CHEMBL1072
highest development phase: 1
has mesh: D012640
has mesh heading: SEIZURES
has EFO: HP_0001250
has EFO name: SEIZURES

CHEMBL_IND_24224
type: DrugIndication
chembl id: CHEMBL_IND_24224
has molecule: CHEMBL1072
highest development phase: 4
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0003144
has EFO name: HEART FAILURE

CHEMBL_IND_27023
type: DrugIndication
chembl id: CHEMBL_IND_27023
has molecule: CHEMBL296419
highest development phase: 4
has mesh: D006967
has mesh heading: HYPERSENSITIVITY
has EFO: EFO_0003785
has EFO name: ALLERGY

CHEMBL_IND_25864
type: DrugIndication
chembl id: CHEMBL_IND_25864
has molecule: CHEMBL842
highest development phase: 4
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0000373
has EFO name: CONGESTIVE HEART FAILURE

CHEMBL_IND_42153
type: DrugIndication
chembl id: CHEMBL_IND_42153
has molecule: CHEMBL842
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_22890
type: DrugIndication
chembl id: CHEMBL_IND_22890
has molecule: CHEMBL842
highest development phase: 4
has mesh: D009404
has mesh heading: NEPHROTIC SYNDROME
has EFO: EFO_0004255
has EFO name: NEPHROTIC SYNDROME

CHEMBL_IND_22889
type: DrugIndication
chembl id: CHEMBL_IND_22889
has molecule: CHEMBL842
highest development phase: 4
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_42445
type: DrugIndication
chembl id: CHEMBL_IND_42445
has molecule: CHEMBL1003
highest development phase: 4
has mesh: D012852
has mesh heading: SINUSITIS
has EFO: EFO_0007486
has EFO name: SINUSITIS

CHEMBL_IND_42940
type: DrugIndication
chembl id: CHEMBL_IND_42940
has molecule: CHEMBL1003
highest development phase: 4
has mesh: D012141
has mesh heading: RESPIRATORY TRACT INFECTIONS
has EFO: HP_0011947
has EFO name: RESPIRATORY TRACT INFECTION

CHEMBL_IND_41652
type: DrugIndication
chembl id: CHEMBL_IND_41652
has molecule: CHEMBL1003
highest development phase: 4
has mesh: D018461
has mesh heading: SOFT TISSUE INFECTIONS

CHEMBL_IND_42736
type: DrugIndication
chembl id: CHEMBL_IND_42736
has molecule: CHEMBL1003
highest development phase: 4
has mesh: D010033
has mesh heading: OTITIS MEDIA
has EFO: EFO_0004992
has EFO name: OTITIS MEDIA

CHEMBL_IND_42716
type: DrugIndication
chembl id: CHEMBL_IND_42716
has molecule: CHEMBL1003
highest development phase: 4
has mesh: D014552
has mesh heading: URINARY TRACT INFECTIONS
has EFO: EFO_0003103
has EFO name: URINARY TRACT INFECTION

CHEMBL_IND_42688
type: DrugIndication
chembl id: CHEMBL_IND_42688
has molecule: CHEMBL1003
highest development phase: 4
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_26842
type: DrugIndication
chembl id: CHEMBL_IND_26842
has molecule: CHEMBL1059
highest development phase: 2
has mesh: D050500
has mesh heading: PANCREATITIS, CHRONIC
has EFO: EFO_0000342
has EFO name: CHRONIC PANCREATITIS

CHEMBL_IND_48078
type: DrugIndication
chembl id: CHEMBL_IND_48078
has molecule: CHEMBL1059
highest development phase: 1
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000707
has EFO name: SQUAMOUS CELL CARCINOMA

CHEMBL_IND_48794
type: DrugIndication
chembl id: CHEMBL_IND_48794
has molecule: CHEMBL1059
highest development phase: 3
has mesh: D008103
has mesh heading: LIVER CIRRHOSIS
has EFO: EFO_0001422
has EFO name: CIRRHOSIS OF LIVER

CHEMBL_IND_41486
type: DrugIndication
chembl id: CHEMBL_IND_41486
has molecule: CHEMBL1059
highest development phase: 2
has mesh: D015352
has mesh heading: DRY EYE SYNDROMES
has EFO: EFO_1000906
has EFO name: DRY EYE SYNDROME

CHEMBL_IND_52390
type: DrugIndication
chembl id: CHEMBL_IND_52390
has molecule: CHEMBL1059
highest development phase: 0
has mesh: D002189
has mesh heading: MARIJUANA ABUSE
has EFO: EFO_0004218
has EFO name: MARIJUANA DEPENDENCE

CHEMBL_IND_52373
type: DrugIndication
chembl id: CHEMBL_IND_52373
has molecule: CHEMBL1059
highest development phase: 1
has mesh: D011247
has mesh heading: PREGNANCY
has EFO: EFO_0002950
has EFO name: PREGNANCY

CHEMBL_IND_52293
type: DrugIndication
chembl id: CHEMBL_IND_52293
has molecule: CHEMBL1059
highest development phase: 2
has mesh: D053201
has mesh heading: URINARY BLADDER, OVERACTIVE
has EFO: EFO_1000781
has EFO name: OVERACTIVE BLADDER

CHEMBL_IND_28350
type: DrugIndication
chembl id: CHEMBL_IND_28350
has molecule: CHEMBL1059
highest development phase: 3
has mesh: D050723
has mesh heading: FRACTURES, BONE
has EFO: EFO_0003931
has EFO name: BONE FRACTURE

CHEMBL_IND_52667
type: DrugIndication
chembl id: CHEMBL_IND_52667
has molecule: CHEMBL1059
highest development phase: 2
has mesh: D012019
has mesh heading: REFLEX SYMPATHETIC DYSTROPHY
has EFO: EFO_1001147
has EFO name: REFLEX SYMPATHETIC DYSTROPHY

CHEMBL_IND_49077
type: DrugIndication
chembl id: CHEMBL_IND_49077
has molecule: CHEMBL1059
highest development phase: 1
has mesh: D003371
has mesh heading: COUGH
has EFO: HP_0012735
has EFO name: COUGH

CHEMBL_IND_26236
type: DrugIndication
chembl id: CHEMBL_IND_26236
has molecule: CHEMBL1059
highest development phase: 3
has mesh: D007405
has mesh heading: INTERVERTEBRAL DISC DISPLACEMENT
has EFO: EFO_0004994
has EFO name: LUMBAR DISC DEGENERATION

CHEMBL_IND_23738
type: DrugIndication
chembl id: CHEMBL_IND_23738
has molecule: CHEMBL1059
highest development phase: 4
has mesh: D012640
has mesh heading: SEIZURES
has EFO: HP_0001250
has EFO name: SEIZURES

CHEMBL_IND_23737
type: DrugIndication
chembl id: CHEMBL_IND_23737
has molecule: CHEMBL1059
highest development phase: 3
has mesh: D012148
has mesh heading: RESTLESS LEGS SYNDROME
has EFO: EFO_0004270
has EFO name: RESTLESS LEGS SYNDROME

CHEMBL_IND_23736
type: DrugIndication
chembl id: CHEMBL_IND_23736
has molecule: CHEMBL1059
highest development phase: 3
has mesh: D004828
has mesh heading: EPILEPSIES, PARTIAL
has EFO: EFO_0004263
has EFO name: PARTIAL EPILEPSY

CHEMBL_IND_23735
type: DrugIndication
chembl id: CHEMBL_IND_23735
has molecule: CHEMBL1059
highest development phase: 3
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_23734
type: DrugIndication
chembl id: CHEMBL_IND_23734
has molecule: CHEMBL1059
highest development phase: 3
has mesh: D010523
has mesh heading: PERIPHERAL NERVOUS SYSTEM DISEASES
has EFO: EFO_0004149
has EFO name: NEUROPATHY

CHEMBL_IND_23733
type: DrugIndication
chembl id: CHEMBL_IND_23733
has molecule: CHEMBL1059
highest development phase: 4
has mesh: D005356
has mesh heading: FIBROMYALGIA
has EFO: EFO_0005687
has EFO name: FIBROMYALGIA

CHEMBL_IND_27894
type: DrugIndication
chembl id: CHEMBL_IND_27894
has molecule: CHEMBL1059
highest development phase: 0
has mesh: D014029
has mesh heading: TOBACCO USE DISORDER
has EFO: EFO_0003768
has EFO name: NICOTINE DEPENDENCE

CHEMBL_IND_51888
type: DrugIndication
chembl id: CHEMBL_IND_51888
has molecule: CHEMBL1059
highest development phase: 3
has mesh: D003929
has mesh heading: DIABETIC NEUROPATHIES
has EFO: EFO_1000783
has EFO name: DIABETIC NEUROPATHY

CHEMBL_IND_51721
type: DrugIndication
chembl id: CHEMBL_IND_51721
has molecule: CHEMBL1059
highest development phase: 3
has mesh: D016697
has mesh heading: HERPES ZOSTER OTICUS
has EFO: EFO_0007281
has EFO name: GENICULATE HERPES ZOSTER

CHEMBL_IND_24815
type: DrugIndication
chembl id: CHEMBL_IND_24815
has molecule: CHEMBL1059
highest development phase: 4
has mesh: D009437
has mesh heading: NEURALGIA
has EFO: EFO_0005762
has EFO name: NEUROPATHIC PAIN

CHEMBL_IND_24814
type: DrugIndication
chembl id: CHEMBL_IND_24814
has molecule: CHEMBL1059
highest development phase: 2
has mesh: D043183
has mesh heading: IRRITABLE BOWEL SYNDROME
has EFO: EFO_0000555
has EFO name: IRRITABLE BOWEL SYNDROME

CHEMBL_IND_24813
type: DrugIndication
chembl id: CHEMBL_IND_24813
has molecule: CHEMBL1059
highest development phase: 3
has mesh: D004830
has mesh heading: EPILEPSY, TONIC-CLONIC
has EFO: HP_0002069
has EFO name: GENERALIZED TONIC-CLONIC SEIZURES

CHEMBL_IND_24812
type: DrugIndication
chembl id: CHEMBL_IND_24812
has molecule: CHEMBL1059
highest development phase: 4
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_24810
type: DrugIndication
chembl id: CHEMBL_IND_24810
has molecule: CHEMBL1059
highest development phase: 2
has mesh: D000437
has mesh heading: ALCOHOLISM
has EFO: EFO_0003829
has EFO name: ALCOHOL DEPENDENCE

CHEMBL_IND_24809
type: DrugIndication
chembl id: CHEMBL_IND_24809
has molecule: CHEMBL1059
highest development phase: 1
has mesh: D012030
has mesh heading: REFRACTIVE ERRORS
has EFO: HP_0000539
has EFO name: ABNORMALITY OF REFRACTION

CHEMBL_IND_50685
type: DrugIndication
chembl id: CHEMBL_IND_50685
has molecule: CHEMBL298734
highest development phase: 1
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_55282
type: DrugIndication
chembl id: CHEMBL_IND_55282
has molecule: CHEMBL298734
highest development phase: 2
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: EFO_0001075
has EFO name: OVARIAN CARCINOMA

CHEMBL_IND_53899
type: DrugIndication
chembl id: CHEMBL_IND_53899
has molecule: CHEMBL298734
highest development phase: 2
has mesh: D003699
has mesh heading: HEPATITIS D
has EFO: EFO_0007304
has EFO name: HEPATITIS D

CHEMBL_IND_55049
type: DrugIndication
chembl id: CHEMBL_IND_55049
has molecule: CHEMBL298734
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_50744
type: DrugIndication
chembl id: CHEMBL_IND_50744
has molecule: CHEMBL313006
highest development phase: 3
has mesh: D003327
has mesh heading: CORONARY DISEASE
has EFO: EFO_0001645
has EFO name: CORONARY HEART DISEASE

CHEMBL_IND_50680
type: DrugIndication
chembl id: CHEMBL_IND_50680
has molecule: CHEMBL313006
highest development phase: 3
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_50953
type: DrugIndication
chembl id: CHEMBL_IND_50953
has molecule: CHEMBL313006
highest development phase: 3
has mesh: D054058
has mesh heading: ACUTE CORONARY SYNDROME
has EFO: EFO_0005672
has EFO name: ACUTE CORONARY SYNDROME

CHEMBL_IND_45312
type: DrugIndication
chembl id: CHEMBL_IND_45312
has molecule: CHEMBL298817
highest development phase: 2
has mesh: D014009
has mesh heading: ONYCHOMYCOSIS
has EFO: HP_0012203
has EFO name: ONYCHOMYCOSIS

CHEMBL_IND_49984
type: DrugIndication
chembl id: CHEMBL_IND_49984
has molecule: CHEMBL317094
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_50866
type: DrugIndication
chembl id: CHEMBL_IND_50866
has molecule: CHEMBL317094
highest development phase: 3
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_49994
type: DrugIndication
chembl id: CHEMBL_IND_49994
has molecule: CHEMBL888
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_50615
type: DrugIndication
chembl id: CHEMBL_IND_50615
has molecule: CHEMBL888
highest development phase: 2
has mesh: D018281
has mesh heading: CHOLANGIOCARCINOMA
has EFO: EFO_0005221
has EFO name: CHOLANGIOCARCINOMA

CHEMBL_IND_50508
type: DrugIndication
chembl id: CHEMBL_IND_50508
has molecule: CHEMBL888
highest development phase: 1
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_50485
type: DrugIndication
chembl id: CHEMBL_IND_50485
has molecule: CHEMBL888
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_50740
type: DrugIndication
chembl id: CHEMBL_IND_50740
has molecule: CHEMBL888
highest development phase: 3
has mesh: D002583
has mesh heading: UTERINE CERVICAL NEOPLASMS
has EFO: EFO_0001416
has EFO name: CERVICAL ADENOCARCINOMA

CHEMBL_IND_50715
type: DrugIndication
chembl id: CHEMBL_IND_50715
has molecule: CHEMBL888
highest development phase: 2
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_50669
type: DrugIndication
chembl id: CHEMBL_IND_50669
has molecule: CHEMBL888
highest development phase: 3
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000292
has EFO name: BLADDER CARCINOMA

CHEMBL_IND_50618
type: DrugIndication
chembl id: CHEMBL_IND_50618
has molecule: CHEMBL888
highest development phase: 1
has mesh: D001650
has mesh heading: BILE DUCT NEOPLASMS
has EFO: EFO_0005540
has EFO name: BILE DUCT CARCINOMA

CHEMBL_IND_50898
type: DrugIndication
chembl id: CHEMBL_IND_50898
has molecule: CHEMBL888
highest development phase: 2
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: EFO_0001075
has EFO name: OVARIAN CARCINOMA

CHEMBL_IND_50856
type: DrugIndication
chembl id: CHEMBL_IND_50856
has molecule: CHEMBL888
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_55334
type: DrugIndication
chembl id: CHEMBL_IND_55334
has molecule: CHEMBL888
highest development phase: 2
has mesh: D002277
has mesh heading: CARCINOMA
has EFO: EFO_0000313
has EFO name: CARCINOMA

CHEMBL_IND_55280
type: DrugIndication
chembl id: CHEMBL_IND_55280
has molecule: CHEMBL888
highest development phase: 3
has mesh: D002583
has mesh heading: UTERINE CERVICAL NEOPLASMS
has EFO: EFO_0001061
has EFO name: CERVICAL CARCINOMA

CHEMBL_IND_54730
type: DrugIndication
chembl id: CHEMBL_IND_54730
has molecule: CHEMBL888
highest development phase: 2
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: EFO_0003893
has EFO name: OVARIAN NEOPLASM

CHEMBL_IND_53830
type: DrugIndication
chembl id: CHEMBL_IND_53830
has molecule: CHEMBL888
highest development phase: 3
has mesh: D021441
has mesh heading: CARCINOMA, PANCREATIC DUCTAL
has EFO: EFO_0002517
has EFO name: PANCREATIC DUCTAL ADENOCARCINOMA

CHEMBL_IND_50393
type: DrugIndication
chembl id: CHEMBL_IND_50393
has molecule: CHEMBL888
highest development phase: 2
has mesh: D001661
has mesh heading: BILIARY TRACT NEOPLASMS
has EFO: EFO_0003891
has EFO name: BILIARY TRACT NEOPLASM

CHEMBL_IND_50376
type: DrugIndication
chembl id: CHEMBL_IND_50376
has molecule: CHEMBL888
highest development phase: 3
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0003860
has EFO name: PANCREATIC NEOPLASM

CHEMBL_IND_50355
type: DrugIndication
chembl id: CHEMBL_IND_50355
has molecule: CHEMBL888
highest development phase: 3
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_50345
type: DrugIndication
chembl id: CHEMBL_IND_50345
has molecule: CHEMBL888
highest development phase: 3
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_54322
type: DrugIndication
chembl id: CHEMBL_IND_54322
has molecule: CHEMBL888
highest development phase: 2
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0005842
has EFO name: COLORECTAL CANCER

CHEMBL_IND_55141
type: DrugIndication
chembl id: CHEMBL_IND_55141
has molecule: CHEMBL888
highest development phase: 2
has mesh: D000230
has mesh heading: ADENOCARCINOMA
has EFO: EFO_0000228
has EFO name: ADENOCARCINOMA

CHEMBL_IND_54500
type: DrugIndication
chembl id: CHEMBL_IND_54500
has molecule: CHEMBL888
highest development phase: 2
has mesh: D013964
has mesh heading: THYROID NEOPLASMS
has EFO: EFO_0002892
has EFO name: THYROID CARCINOMA

CHEMBL_IND_54968
type: DrugIndication
chembl id: CHEMBL_IND_54968
has molecule: CHEMBL888
highest development phase: 2
has mesh: D055752
has mesh heading: SMALL CELL LUNG CARCINOMA
has EFO: EFO_0000702
has EFO name: SMALL CELL LUNG CARCINOMA

CHEMBL_IND_50980
type: DrugIndication
chembl id: CHEMBL_IND_50980
has molecule: CHEMBL888
highest development phase: 3
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000294
has EFO name: BLADDER TUMOR

CHEMBL_IND_50075
type: DrugIndication
chembl id: CHEMBL_IND_50075
has molecule: CHEMBL325109
highest development phase: 4
has mesh: D004066
has mesh heading: DIGESTIVE SYSTEM DISEASES
has EFO: EFO_0000405
has EFO name: DIGESTIVE SYSTEM DISEASE

CHEMBL_IND_46100
type: DrugIndication
chembl id: CHEMBL_IND_46100
has molecule: CHEMBL318191
highest development phase: 2
has mesh: D020325
has mesh heading: MIGRAINE WITH AURA
has EFO: EFO_0005295
has EFO name: MIGRAINE WITH AURA

CHEMBL_IND_50472
type: DrugIndication
chembl id: CHEMBL_IND_50472
has molecule: CHEMBL325424
highest development phase: 1
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_42132
type: DrugIndication
chembl id: CHEMBL_IND_42132
has molecule: CHEMBL316561
highest development phase: 4
has mesh: D010437
has mesh heading: PEPTIC ULCER
has EFO: HP_0004398
has EFO name: PEPTIC ULCER

CHEMBL_IND_42729
type: DrugIndication
chembl id: CHEMBL_IND_42729
has molecule: CHEMBL316561
highest development phase: 4
has mesh: D005764
has mesh heading: GASTROESOPHAGEAL REFLUX
has EFO: EFO_0003948
has EFO name: GASTROESOPHAGEAL REFLUX DISEASE

CHEMBL_IND_46943
type: DrugIndication
chembl id: CHEMBL_IND_46943
has molecule: CHEMBL308148
highest development phase: 3
has mesh: D001007
has mesh heading: ANXIETY
has EFO: EFO_0005230
has EFO name: ANXIETY

CHEMBL_IND_49772
type: DrugIndication
chembl id: CHEMBL_IND_49772
has molecule: CHEMBL308148
highest development phase: 3
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_26739
type: DrugIndication
chembl id: CHEMBL_IND_26739
has molecule: CHEMBL1161
highest development phase: 2
has mesh: D000755
has mesh heading: ANEMIA, SICKLE CELL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SICKLE CELL ANEMIA

CHEMBL_IND_26738
type: DrugIndication
chembl id: CHEMBL_IND_26738
has molecule: CHEMBL1161
highest development phase: 2
has mesh: D057765
has mesh heading: EOSINOPHILIC ESOPHAGITIS
has EFO: EFO_0004232
has EFO name: EOSINOPHILIC ESOPHAGITIS

CHEMBL_IND_28280
type: DrugIndication
chembl id: CHEMBL_IND_28280
has molecule: CHEMBL1161
highest development phase: 3
has mesh: D020181
has mesh heading: SLEEP APNEA, OBSTRUCTIVE
has EFO: EFO_0003918
has EFO name: OBSTRUCTIVE SLEEP APNEA

CHEMBL_IND_49827
type: DrugIndication
chembl id: CHEMBL_IND_49827
has molecule: CHEMBL1161
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_49784
type: DrugIndication
chembl id: CHEMBL_IND_49784
has molecule: CHEMBL1161
highest development phase: 4
has mesh: D012871
has mesh heading: SKIN DISEASES
has EFO: EFO_0000701
has EFO name: SKIN DISEASE

CHEMBL_IND_27825
type: DrugIndication
chembl id: CHEMBL_IND_27825
has molecule: CHEMBL1161
highest development phase: 3
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_49877
type: DrugIndication
chembl id: CHEMBL_IND_49877
has molecule: CHEMBL1161
highest development phase: 3
has mesh: D012852
has mesh heading: SINUSITIS
has EFO: EFO_0007486
has EFO name: SINUSITIS

CHEMBL_IND_24668
type: DrugIndication
chembl id: CHEMBL_IND_24668
has molecule: CHEMBL1161
highest development phase: 2
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_24667
type: DrugIndication
chembl id: CHEMBL_IND_24667
has molecule: CHEMBL1161
highest development phase: 4
has mesh: D015508
has mesh heading: NASAL OBSTRUCTION
has EFO: HP_0001742
has EFO name: NASAL OBSTRUCTION

CHEMBL_IND_24666
type: DrugIndication
chembl id: CHEMBL_IND_24666
has molecule: CHEMBL1161
highest development phase: 4
has mesh: D009298
has mesh heading: NASAL POLYPS
has EFO: EFO_1000391
has EFO name: NASAL CAVITY POLYP

CHEMBL_IND_24665
type: DrugIndication
chembl id: CHEMBL_IND_24665
has molecule: CHEMBL1161
highest development phase: 2
has mesh: D003876
has mesh heading: DERMATITIS, ATOPIC
has EFO: EFO_0000274
has EFO name: ATOPIC ECZEMA

CHEMBL_IND_54873
type: DrugIndication
chembl id: CHEMBL_IND_54873
has molecule: CHEMBL1161
highest development phase: 3
has mesh: D012221
has mesh heading: RHINITIS, ALLERGIC, PERENNIAL
has EFO: EFO_1001417
has EFO name: RHINITIS, ALLERGIC, PERENNIAL

CHEMBL_IND_54868
type: DrugIndication
chembl id: CHEMBL_IND_54868
has molecule: CHEMBL1161
highest development phase: 1
has mesh: D006967
has mesh heading: HYPERSENSITIVITY
has EFO: EFO_0003785
has EFO name: ALLERGY

CHEMBL_IND_23528
type: DrugIndication
chembl id: CHEMBL_IND_23528
has molecule: CHEMBL1161
highest development phase: 4
has mesh: D006255
has mesh heading: RHINITIS, ALLERGIC, SEASONAL
has EFO: EFO_0003956
has EFO name: SEASONAL ALLERGIC RHINITIS

CHEMBL_IND_23527
type: DrugIndication
chembl id: CHEMBL_IND_23527
has molecule: CHEMBL1161
highest development phase: 4
has mesh: D008173
has mesh heading: LUNG DISEASES, OBSTRUCTIVE
has EFO: HP_0006536
has EFO name: OBSTRUCTIVE LUNG DISEASE

CHEMBL_IND_23526
type: DrugIndication
chembl id: CHEMBL_IND_23526
has molecule: CHEMBL1161
highest development phase: 3
has mesh: D006984
has mesh heading: HYPERTROPHY
has EFO: EFO_0002460
has EFO name: HYPERTROPHY

CHEMBL_IND_23525
type: DrugIndication
chembl id: CHEMBL_IND_23525
has molecule: CHEMBL1161
highest development phase: 4
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_23524
type: DrugIndication
chembl id: CHEMBL_IND_23524
has molecule: CHEMBL1161
highest development phase: 4
has mesh: D006255
has mesh heading: RHINITIS, ALLERGIC, SEASONAL
has EFO: EFO_0005854
has EFO name: ALLERGIC RHINITIS

CHEMBL_IND_52705
type: DrugIndication
chembl id: CHEMBL_IND_52705
has molecule: CHEMBL1091
highest development phase: 0
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_24489
type: DrugIndication
chembl id: CHEMBL_IND_24489
has molecule: CHEMBL1091
highest development phase: 4
has mesh: D005128
has mesh heading: EYE DISEASES
has EFO: EFO_0005752
has EFO name: EYE INFLAMMATION

CHEMBL_IND_27005
type: DrugIndication
chembl id: CHEMBL_IND_27005
has molecule: CHEMBL1169
highest development phase: 2
has mesh: D003424
has mesh heading: CROHN DISEASE
has EFO: EFO_0000384
has EFO name: CROHN'S DISEASE

CHEMBL_IND_25770
type: DrugIndication
chembl id: CHEMBL_IND_25770
has molecule: CHEMBL1169
highest development phase: 4
has mesh: D014376
has mesh heading: TUBERCULOSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: TUBERCULOSIS

CHEMBL_IND_25056
type: DrugIndication
chembl id: CHEMBL_IND_25056
has molecule: CHEMBL1169
highest development phase: 3
has mesh: D003093
has mesh heading: COLITIS, ULCERATIVE
has EFO: EFO_0000729
has EFO name: ULCERATIVE COLITIS

CHEMBL_IND_42971
type: DrugIndication
chembl id: CHEMBL_IND_42971
has molecule: CHEMBL310555
highest development phase: 4
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_42340
type: DrugIndication
chembl id: CHEMBL_IND_42340
has molecule: CHEMBL1129
highest development phase: 4
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_42201
type: DrugIndication
chembl id: CHEMBL_IND_42201
has molecule: CHEMBL1129
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_29287
type: DrugIndication
chembl id: CHEMBL_IND_29287
has molecule: CHEMBL1129
highest development phase: 4
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0005842
has EFO name: COLORECTAL CANCER

CHEMBL_IND_41903
type: DrugIndication
chembl id: CHEMBL_IND_41903
has molecule: CHEMBL1112
highest development phase: 4
has mesh: D011595
has mesh heading: PSYCHOMOTOR AGITATION
has EFO: HP_0000713
has EFO name: AGITATION

CHEMBL_IND_26392
type: DrugIndication
chembl id: CHEMBL_IND_26392
has molecule: CHEMBL1112
highest development phase: 2
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_27545
type: DrugIndication
chembl id: CHEMBL_IND_27545
has molecule: CHEMBL1112
highest development phase: 2
has mesh: D013313
has mesh heading: STRESS DISORDERS, POST-TRAUMATIC
has EFO: EFO_0001358
has EFO name: POST-TRAUMATIC STRESS DISORDER

CHEMBL_IND_28017
type: DrugIndication
chembl id: CHEMBL_IND_28017
has molecule: CHEMBL1112
highest development phase: 3
has mesh: D000856
has mesh heading: ANOREXIA NERVOSA
has EFO: EFO_0004215
has EFO name: ANOREXIA NERVOSA

CHEMBL_IND_52122
type: DrugIndication
chembl id: CHEMBL_IND_52122
has molecule: CHEMBL1112
highest development phase: 1
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_47575
type: DrugIndication
chembl id: CHEMBL_IND_47575
has molecule: CHEMBL1112
highest development phase: 2
has mesh: D002659
has mesh heading: CHILD DEVELOPMENT DISORDERS, PERVASIVE
has EFO: EFO_0003756
has EFO name: AUTISM SPECTRUM DISORDER

CHEMBL_IND_41789
type: DrugIndication
chembl id: CHEMBL_IND_41789
has molecule: CHEMBL1112
highest development phase: 4
has mesh: D003865
has mesh heading: DEPRESSIVE DISORDER, MAJOR
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_41780
type: DrugIndication
chembl id: CHEMBL_IND_41780
has molecule: CHEMBL1112
highest development phase: 4
has mesh: D000374
has mesh heading: AGGRESSION
has EFO: EFO_0003015
has EFO name: AGGRESSIVE BEHAVIOR

CHEMBL_IND_22705
type: DrugIndication
chembl id: CHEMBL_IND_22705
has molecule: CHEMBL1112
highest development phase: 4
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_22704
type: DrugIndication
chembl id: CHEMBL_IND_22704
has molecule: CHEMBL1112
highest development phase: 4
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_22703
type: DrugIndication
chembl id: CHEMBL_IND_22703
has molecule: CHEMBL1112
highest development phase: 4
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_22702
type: DrugIndication
chembl id: CHEMBL_IND_22702
has molecule: CHEMBL1112
highest development phase: 4
has mesh: D001321
has mesh heading: AUTISTIC DISORDER
has EFO: EFO_0003758
has EFO name: AUTISM

CHEMBL_IND_22701
type: DrugIndication
chembl id: CHEMBL_IND_22701
has molecule: CHEMBL1112
highest development phase: 2
has mesh: D001289
has mesh heading: ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY
has EFO: EFO_0003888
has EFO name: ATTENTION DEFICIT HYPERACTIVITY DISORDER

CHEMBL_IND_22700
type: DrugIndication
chembl id: CHEMBL_IND_22700
has molecule: CHEMBL1112
highest development phase: 3
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_22699
type: DrugIndication
chembl id: CHEMBL_IND_22699
has molecule: CHEMBL1112
highest development phase: 3
has mesh: D000437
has mesh heading: ALCOHOLISM
has EFO: EFO_0003829
has EFO name: ALCOHOL DEPENDENCE

CHEMBL_IND_51724
type: DrugIndication
chembl id: CHEMBL_IND_51724
has molecule: CHEMBL1112
highest development phase: 3
has mesh: D019052
has mesh heading: DEPRESSION, POSTPARTUM
has EFO: EFO_0007453
has EFO name: POSTPARTUM DEPRESSION

CHEMBL_IND_25071
type: DrugIndication
chembl id: CHEMBL_IND_25071
has molecule: CHEMBL1112
highest development phase: 3
has mesh: D005879
has mesh heading: TOURETTE SYNDROME
has EFO: EFO_0004895
has EFO name: TOURETTE SYNDROME

CHEMBL_IND_25070
type: DrugIndication
chembl id: CHEMBL_IND_25070
has molecule: CHEMBL1112
highest development phase: 4
has mesh: D011618
has mesh heading: PSYCHOTIC DISORDERS
has EFO: EFO_0005407
has EFO name: PSYCHOSIS

CHEMBL_IND_25069
type: DrugIndication
chembl id: CHEMBL_IND_25069
has molecule: CHEMBL1112
highest development phase: 3
has mesh: D001523
has mesh heading: MENTAL DISORDERS
has EFO: EFO_0000677
has EFO name: MENTAL OR BEHAVIOURAL DISORDER

CHEMBL_IND_42143
type: DrugIndication
chembl id: CHEMBL_IND_42143
has molecule: CHEMBL328875
highest development phase: 4
has mesh: D006470
has mesh heading: HEMORRHAGE
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: HEMORRHAGE

CHEMBL_IND_42859
type: DrugIndication
chembl id: CHEMBL_IND_42859
has molecule: CHEMBL1023
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_27047
type: DrugIndication
chembl id: CHEMBL_IND_27047
has molecule: CHEMBL1023
highest development phase: 1
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_25824
type: DrugIndication
chembl id: CHEMBL_IND_25824
has molecule: CHEMBL1023
highest development phase: 0
has mesh: D013964
has mesh heading: THYROID NEOPLASMS
has EFO: EFO_0002892
has EFO name: THYROID CARCINOMA

CHEMBL_IND_22773
type: DrugIndication
chembl id: CHEMBL_IND_22773
has molecule: CHEMBL1023
highest development phase: 1
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_42714
type: DrugIndication
chembl id: CHEMBL_IND_42714
has molecule: CHEMBL1023
highest development phase: 4
has mesh: D016410
has mesh heading: LYMPHOMA, T-CELL, CUTANEOUS
has EFO: EFO_0002913
has EFO name: CUTANEOUS T-CELL LYMPHOMA

CHEMBL_IND_25110
type: DrugIndication
chembl id: CHEMBL_IND_25110
has molecule: CHEMBL1023
highest development phase: 2
has mesh: D000506
has mesh heading: ALOPECIA AREATA
has EFO: EFO_0004192
has EFO name: ALOPECIA AREATA

CHEMBL_IND_25109
type: DrugIndication
chembl id: CHEMBL_IND_25109
has molecule: CHEMBL1023
highest development phase: 2
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_24204
type: DrugIndication
chembl id: CHEMBL_IND_24204
has molecule: CHEMBL1023
highest development phase: 3
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_24203
type: DrugIndication
chembl id: CHEMBL_IND_24203
has molecule: CHEMBL1023
highest development phase: 2
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_49495
type: DrugIndication
chembl id: CHEMBL_IND_49495
has molecule: CHEMBL325041
highest development phase: 2
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_27055
type: DrugIndication
chembl id: CHEMBL_IND_27055
has molecule: CHEMBL325041
highest development phase: 2
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0002890
has EFO name: RENAL CARCINOMA

CHEMBL_IND_27054
type: DrugIndication
chembl id: CHEMBL_IND_27054
has molecule: CHEMBL325041
highest development phase: 1
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_52519
type: DrugIndication
chembl id: CHEMBL_IND_52519
has molecule: CHEMBL325041
highest development phase: 2
has mesh: D001989
has mesh heading: BRONCHIOLITIS OBLITERANS
has EFO: EFO_0007183
has EFO name: BRONCHIOLITIS OBLITERANS

CHEMBL_IND_45549
type: DrugIndication
chembl id: CHEMBL_IND_45549
has molecule: CHEMBL325041
highest development phase: 3
has mesh: D016403
has mesh heading: LYMPHOMA, LARGE B-CELL, DIFFUSE
has EFO: EFO_0000403
has EFO name: DIFFUSE LARGE B-CELL LYMPHOMA

CHEMBL_IND_42109
type: DrugIndication
chembl id: CHEMBL_IND_42109
has molecule: CHEMBL325041
highest development phase: 4
has mesh: D020522
has mesh heading: LYMPHOMA, MANTLE-CELL
has EFO: EFO_1001469
has EFO name: MANTLE CELL LYMPHOMA

CHEMBL_IND_49175
type: DrugIndication
chembl id: CHEMBL_IND_49175
has molecule: CHEMBL325041
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_52007
type: DrugIndication
chembl id: CHEMBL_IND_52007
has molecule: CHEMBL325041
highest development phase: 2
has mesh: D009471
has mesh heading: NEUROMYELITIS OPTICA
has EFO: EFO_0004256
has EFO name: NEUROMYELITIS OPTICA

CHEMBL_IND_46276
type: DrugIndication
chembl id: CHEMBL_IND_46276
has molecule: CHEMBL325041
highest development phase: 2
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_27580
type: DrugIndication
chembl id: CHEMBL_IND_27580
has molecule: CHEMBL325041
highest development phase: 1
has mesh: D009136
has mesh heading: MUSCULAR DYSTROPHIES
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: QUALITATIVE OR QUANTITATIVE DEFECTS OF DYSFERLIN

CHEMBL_IND_27579
type: DrugIndication
chembl id: CHEMBL_IND_27579
has molecule: CHEMBL325041
highest development phase: 2
has mesh: D008654
has mesh heading: MESOTHELIOMA
has EFO: EFO_0000588
has EFO name: MESOTHELIOMA

CHEMBL_IND_22783
type: DrugIndication
chembl id: CHEMBL_IND_22783
has molecule: CHEMBL325041
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_22782
type: DrugIndication
chembl id: CHEMBL_IND_22782
has molecule: CHEMBL325041
highest development phase: 4
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_22781
type: DrugIndication
chembl id: CHEMBL_IND_22781
has molecule: CHEMBL325041
highest development phase: 2
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_22780
type: DrugIndication
chembl id: CHEMBL_IND_22780
has molecule: CHEMBL325041
highest development phase: 2
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_22779
type: DrugIndication
chembl id: CHEMBL_IND_22779
has molecule: CHEMBL325041
highest development phase: 1
has mesh: D028226
has mesh heading: AMYLOIDOSIS, FAMILIAL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: AL AMYLOIDOSIS

CHEMBL_IND_25117
type: DrugIndication
chembl id: CHEMBL_IND_25117
has molecule: CHEMBL325041
highest development phase: 2
has mesh: D008258
has mesh heading: WALDENSTROM MACROGLOBULINEMIA
has EFO: EFO_0002616
has EFO name: MACROGLOBULINEMIA

CHEMBL_IND_25116
type: DrugIndication
chembl id: CHEMBL_IND_25116
has molecule: CHEMBL325041
highest development phase: 2
has mesh: D015473
has mesh heading: LEUKEMIA, PROMYELOCYTIC, ACUTE
has EFO: EFO_0000224
has EFO name: ACUTE PROMYELOCYTIC LEUKEMIA

CHEMBL_IND_25119
type: DrugIndication
chembl id: CHEMBL_IND_25119
has molecule: CHEMBL325041
highest development phase: 2
has mesh: D008224
has mesh heading: LYMPHOMA, FOLLICULAR
has EFO: EFO_0000096
has EFO name: NEOPLASM OF MATURE B-CELLS

CHEMBL_IND_25118
type: DrugIndication
chembl id: CHEMBL_IND_25118
has molecule: CHEMBL325041
highest development phase: 2
has mesh: D009190
has mesh heading: MYELODYSPLASTIC SYNDROMES
has EFO: EFO_0000198
has EFO name: MYELODYSPLASTIC SYNDROME

CHEMBL_IND_24213
type: DrugIndication
chembl id: CHEMBL_IND_24213
has molecule: CHEMBL325041
highest development phase: 1
has mesh: D009447
has mesh heading: NEUROBLASTOMA
has EFO: EFO_0000621
has EFO name: NEUROBLASTOMA

CHEMBL_IND_24212
type: DrugIndication
chembl id: CHEMBL_IND_24212
has molecule: CHEMBL325041
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_24211
type: DrugIndication
chembl id: CHEMBL_IND_24211
has molecule: CHEMBL325041
highest development phase: 2
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_24210
type: DrugIndication
chembl id: CHEMBL_IND_24210
has molecule: CHEMBL325041
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_24209
type: DrugIndication
chembl id: CHEMBL_IND_24209
has molecule: CHEMBL325041
highest development phase: 2
has mesh: D006086
has mesh heading: GRAFT VS HOST DISEASE
has EFO: EFO_0004599
has EFO name: ACUTE GRAFT VS. HOST DISEASE

CHEMBL_IND_42593
type: DrugIndication
chembl id: CHEMBL_IND_42593
has molecule: CHEMBL340978
highest development phase: 4
has mesh: D012216
has mesh heading: RHEUMATIC DISEASES
has EFO: EFO_0005755
has EFO name: RHEUMATIC DISEASE

CHEMBL_IND_49374
type: DrugIndication
chembl id: CHEMBL_IND_49374
has molecule: CHEMBL337612
highest development phase: 2
has mesh: D000163
has mesh heading: ACQUIRED IMMUNODEFICIENCY SYNDROME
has EFO: EFO_0000765
has EFO name: AIDS

CHEMBL_IND_50586
type: DrugIndication
chembl id: CHEMBL_IND_50586
has molecule: CHEMBL535
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0003869
has EFO name: BREAST NEOPLASM

CHEMBL_IND_50562
type: DrugIndication
chembl id: CHEMBL_IND_50562
has molecule: CHEMBL535
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0002617
has EFO name: METASTATIC MELANOMA

CHEMBL_IND_50526
type: DrugIndication
chembl id: CHEMBL_IND_50526
has molecule: CHEMBL535
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_50468
type: DrugIndication
chembl id: CHEMBL_IND_50468
has molecule: CHEMBL535
highest development phase: 2
has mesh: D000230
has mesh heading: ADENOCARCINOMA
has EFO: EFO_0000228
has EFO name: ADENOCARCINOMA

CHEMBL_IND_50464
type: DrugIndication
chembl id: CHEMBL_IND_50464
has molecule: CHEMBL535
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000196
has EFO name: METASTATIC PROSTATE CANCER

CHEMBL_IND_50458
type: DrugIndication
chembl id: CHEMBL_IND_50458
has molecule: CHEMBL535
highest development phase: 2
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_50755
type: DrugIndication
chembl id: CHEMBL_IND_50755
has molecule: CHEMBL535
highest development phase: 2
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_50747
type: DrugIndication
chembl id: CHEMBL_IND_50747
has molecule: CHEMBL535
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_50675
type: DrugIndication
chembl id: CHEMBL_IND_50675
has molecule: CHEMBL535
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_50670
type: DrugIndication
chembl id: CHEMBL_IND_50670
has molecule: CHEMBL535
highest development phase: 2
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000292
has EFO name: BLADDER CARCINOMA

CHEMBL_IND_50627
type: DrugIndication
chembl id: CHEMBL_IND_50627
has molecule: CHEMBL535
highest development phase: 2
has mesh: D013945
has mesh heading: THYMOMA
has EFO: EFO_1000581
has EFO name: THYMOMA

CHEMBL_IND_50938
type: DrugIndication
chembl id: CHEMBL_IND_50938
has molecule: CHEMBL535
highest development phase: 2
has mesh: D013274
has mesh heading: STOMACH NEOPLASMS
has EFO: EFO_0003897
has EFO name: STOMACH NEOPLASM

CHEMBL_IND_50897
type: DrugIndication
chembl id: CHEMBL_IND_50897
has molecule: CHEMBL535
highest development phase: 2
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: EFO_0001075
has EFO name: OVARIAN CARCINOMA

CHEMBL_IND_50886
type: DrugIndication
chembl id: CHEMBL_IND_50886
has molecule: CHEMBL535
highest development phase: 2
has mesh: D055752
has mesh heading: SMALL CELL LUNG CARCINOMA
has EFO: EFO_0000702
has EFO name: SMALL CELL LUNG CARCINOMA

CHEMBL_IND_50864
type: DrugIndication
chembl id: CHEMBL_IND_50864
has molecule: CHEMBL535
highest development phase: 2
has mesh: D005909
has mesh heading: GLIOBLASTOMA
has EFO: EFO_0000519
has EFO name: GLIOBLASTOMA MULTIFORME

CHEMBL_IND_55333
type: DrugIndication
chembl id: CHEMBL_IND_55333
has molecule: CHEMBL535
highest development phase: 2
has mesh: D002277
has mesh heading: CARCINOMA
has EFO: EFO_0000313
has EFO name: CARCINOMA

CHEMBL_IND_55216
type: DrugIndication
chembl id: CHEMBL_IND_55216
has molecule: CHEMBL535
highest development phase: 2
has mesh: D018281
has mesh heading: CHOLANGIOCARCINOMA
has EFO: EFO_0005221
has EFO name: CHOLANGIOCARCINOMA

CHEMBL_IND_50082
type: DrugIndication
chembl id: CHEMBL_IND_50082
has molecule: CHEMBL535
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_50283
type: DrugIndication
chembl id: CHEMBL_IND_50283
has molecule: CHEMBL535
highest development phase: 4
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0000681
has EFO name: RENAL CELL CARCINOMA

CHEMBL_IND_50223
type: DrugIndication
chembl id: CHEMBL_IND_50223
has molecule: CHEMBL535
highest development phase: 2
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000294
has EFO name: BLADDER TUMOR

CHEMBL_IND_50456
type: DrugIndication
chembl id: CHEMBL_IND_50456
has molecule: CHEMBL535
highest development phase: 2
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000181
has EFO name: HEAD AND NECK SQUAMOUS CELL CARCINOMA

CHEMBL_IND_50446
type: DrugIndication
chembl id: CHEMBL_IND_50446
has molecule: CHEMBL535
highest development phase: 3
has mesh: D046152
has mesh heading: GASTROINTESTINAL STROMAL TUMORS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: GASTROINTESTINAL STROMAL TUMOR

CHEMBL_IND_50357
type: DrugIndication
chembl id: CHEMBL_IND_50357
has molecule: CHEMBL535
highest development phase: 2
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_50310
type: DrugIndication
chembl id: CHEMBL_IND_50310
has molecule: CHEMBL535
highest development phase: 2
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_55152
type: DrugIndication
chembl id: CHEMBL_IND_55152
has molecule: CHEMBL535
highest development phase: 4
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0000349
has EFO name: CLEAR CELL RENAL CARCINOMA

CHEMBL_IND_55075
type: DrugIndication
chembl id: CHEMBL_IND_55075
has molecule: CHEMBL535
highest development phase: 2
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_55071
type: DrugIndication
chembl id: CHEMBL_IND_55071
has molecule: CHEMBL535
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_55032
type: DrugIndication
chembl id: CHEMBL_IND_55032
has molecule: CHEMBL535
highest development phase: 2
has mesh: D001201
has mesh heading: ASCITES
has EFO: HP_0001541
has EFO name: ASCITES

CHEMBL_IND_54999
type: DrugIndication
chembl id: CHEMBL_IND_54999
has molecule: CHEMBL535
highest development phase: 2
has mesh: D013964
has mesh heading: THYROID NEOPLASMS
has EFO: EFO_0002892
has EFO name: THYROID CARCINOMA

CHEMBL_IND_54996
type: DrugIndication
chembl id: CHEMBL_IND_54996
has molecule: CHEMBL535
highest development phase: 4
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0002890
has EFO name: RENAL CARCINOMA

CHEMBL_IND_53120
type: DrugIndication
chembl id: CHEMBL_IND_53120
has molecule: CHEMBL535
highest development phase: 2
has mesh: D010534
has mesh heading: PERITONEAL NEOPLASMS
has EFO: EFO_1001100
has EFO name: PERITONEAL NEOPLASM

CHEMBL_IND_24944
type: DrugIndication
chembl id: CHEMBL_IND_24944
has molecule: CHEMBL1201
highest development phase: 4
has mesh: D011618
has mesh heading: PSYCHOTIC DISORDERS
has EFO: EFO_0005407
has EFO name: PSYCHOSIS

CHEMBL_IND_26835
type: DrugIndication
chembl id: CHEMBL_IND_26835
has molecule: CHEMBL1152
highest development phase: 3
has mesh: D012585
has mesh heading: SCIATICA
has EFO: HP_0011868
has EFO name: SCIATICA

CHEMBL_IND_49528
type: DrugIndication
chembl id: CHEMBL_IND_49528
has molecule: CHEMBL1152
highest development phase: 3
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_25587
type: DrugIndication
chembl id: CHEMBL_IND_25587
has molecule: CHEMBL1152
highest development phase: 4
has mesh: D015508
has mesh heading: NASAL OBSTRUCTION
has EFO: HP_0001742
has EFO name: NASAL OBSTRUCTION

CHEMBL_IND_48399
type: DrugIndication
chembl id: CHEMBL_IND_48399
has molecule: CHEMBL1152
highest development phase: 2
has mesh: D007500
has mesh heading: IRITIS
has EFO: EFO_1000997
has EFO name: IRITIS

CHEMBL_IND_47745
type: DrugIndication
chembl id: CHEMBL_IND_47745
has molecule: CHEMBL1152
highest development phase: 4
has mesh: D003233
has mesh heading: CONJUNCTIVITIS, ALLERGIC
has EFO: EFO_0007141
has EFO name: ALLERGIC CONJUNCTIVITIS

CHEMBL_IND_23725
type: DrugIndication
chembl id: CHEMBL_IND_23725
has molecule: CHEMBL1152
highest development phase: 3
has mesh: D002386
has mesh heading: CATARACT
has EFO: EFO_0001059
has EFO name: CATARACT

CHEMBL_IND_27398
type: DrugIndication
chembl id: CHEMBL_IND_27398
has molecule: CHEMBL1152
highest development phase: 4
has mesh: D005128
has mesh heading: EYE DISEASES
has EFO: EFO_0005752
has EFO name: EYE INFLAMMATION

CHEMBL_IND_47625
type: DrugIndication
chembl id: CHEMBL_IND_47625
has molecule: CHEMBL328190
highest development phase: 3
has mesh: D010024
has mesh heading: OSTEOPOROSIS
has EFO: EFO_0003882
has EFO name: OSTEOPOROSIS

CHEMBL_IND_43004
type: DrugIndication
chembl id: CHEMBL_IND_43004
has molecule: CHEMBL1233
highest development phase: 4
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_41588
type: DrugIndication
chembl id: CHEMBL_IND_41588
has molecule: CHEMBL1233
highest development phase: 4
has mesh: D013035
has mesh heading: SPASM

CHEMBL_IND_42328
type: DrugIndication
chembl id: CHEMBL_IND_42328
has molecule: CHEMBL344159
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_26319
type: DrugIndication
chembl id: CHEMBL_IND_26319
has molecule: CHEMBL344159
highest development phase: 2
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_24955
type: DrugIndication
chembl id: CHEMBL_IND_24955
has molecule: CHEMBL344159
highest development phase: 4
has mesh: D007010
has mesh heading: HYPONATREMIA
has EFO: HP_0002902
has EFO name: HYPONATREMIA

CHEMBL_IND_24954
type: DrugIndication
chembl id: CHEMBL_IND_24954
has molecule: CHEMBL344159
highest development phase: 4
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0003144
has EFO name: HEART FAILURE

CHEMBL_IND_24953
type: DrugIndication
chembl id: CHEMBL_IND_24953
has molecule: CHEMBL344159
highest development phase: 3
has mesh: D008103
has mesh heading: LIVER CIRRHOSIS
has EFO: EFO_0001422
has EFO name: CIRRHOSIS OF LIVER

CHEMBL_IND_24956
type: DrugIndication
chembl id: CHEMBL_IND_24956
has molecule: CHEMBL344159
highest development phase: 2
has mesh: D007674
has mesh heading: KIDNEY DISEASES
has EFO: EFO_0003086
has EFO name: KIDNEY DISEASE

CHEMBL_IND_23977
type: DrugIndication
chembl id: CHEMBL_IND_23977
has molecule: CHEMBL344159
highest development phase: 2
has mesh: D002277
has mesh heading: CARCINOMA
has EFO: EFO_0000313
has EFO name: CARCINOMA

CHEMBL_IND_44506
type: DrugIndication
chembl id: CHEMBL_IND_44506
has molecule: CHEMBL332750
highest development phase: 2
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_40484
type: DrugIndication
chembl id: CHEMBL_IND_40484
has molecule: CHEMBL333950
highest development phase: 3
has mesh: D006962
has mesh heading: HYPERPARATHYROIDISM, SECONDARY
has EFO: EFO_1001173
has EFO name: SECONDARY HYPERPARATHYROIDISM

CHEMBL_IND_43332
type: DrugIndication
chembl id: CHEMBL_IND_43332
has molecule: CHEMBL355200
highest development phase: 2
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_23766
type: DrugIndication
chembl id: CHEMBL_IND_23766
has molecule: CHEMBL1218
highest development phase: 4
has mesh: D007319
has mesh heading: SLEEP INITIATION AND MAINTENANCE DISORDERS
has EFO: EFO_0004698
has EFO name: INSOMNIA

CHEMBL_IND_47578
type: DrugIndication
chembl id: CHEMBL_IND_47578
has molecule: CHEMBL1218
highest development phase: 2
has mesh: D014029
has mesh heading: TOBACCO USE DISORDER
has EFO: EFO_0003768
has EFO name: NICOTINE DEPENDENCE

CHEMBL_IND_24837
type: DrugIndication
chembl id: CHEMBL_IND_24837
has molecule: CHEMBL1218
highest development phase: 3
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_50200
type: DrugIndication
chembl id: CHEMBL_IND_50200
has molecule: CHEMBL350221
highest development phase: 4
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_43568
type: DrugIndication
chembl id: CHEMBL_IND_43568
has molecule: CHEMBL345237
highest development phase: 2
has mesh: D020521
has mesh heading: STROKE
has EFO: EFO_0000712
has EFO name: STROKE

CHEMBL_IND_44935
type: DrugIndication
chembl id: CHEMBL_IND_44935
has molecule: CHEMBL345237
highest development phase: 2
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_54929
type: DrugIndication
chembl id: CHEMBL_IND_54929
has molecule: CHEMBL348475
highest development phase: 2
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_54215
type: DrugIndication
chembl id: CHEMBL_IND_54215
has molecule: CHEMBL362558
highest development phase: 2
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_50776
type: DrugIndication
chembl id: CHEMBL_IND_50776
has molecule: CHEMBL359713
highest development phase: 3
has mesh: D015663
has mesh heading: OSTEOPOROSIS, POSTMENOPAUSAL
has EFO: EFO_0003854
has EFO name: POSTMENOPAUSAL OSTEOPOROSIS

CHEMBL_IND_50384
type: DrugIndication
chembl id: CHEMBL_IND_50384
has molecule: CHEMBL359713
highest development phase: 3
has mesh: D010024
has mesh heading: OSTEOPOROSIS
has EFO: EFO_0003882
has EFO name: OSTEOPOROSIS

CHEMBL_IND_46109
type: DrugIndication
chembl id: CHEMBL_IND_46109
has molecule: CHEMBL1234
highest development phase: 2
has mesh: D002543
has mesh heading: CEREBRAL HEMORRHAGE
has EFO: EFO_0005669
has EFO name: INTRACEREBRAL HEMORRHAGE

CHEMBL_IND_52766
type: DrugIndication
chembl id: CHEMBL_IND_52766
has molecule: CHEMBL346977
highest development phase: 4
has mesh: D008881
has mesh heading: MIGRAINE DISORDERS
has EFO: EFO_0003821
has EFO name: MIGRAINE DISORDER

CHEMBL_IND_49749
type: DrugIndication
chembl id: CHEMBL_IND_49749
has molecule: CHEMBL367149
highest development phase: 2
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_50946
type: DrugIndication
chembl id: CHEMBL_IND_50946
has molecule: CHEMBL354541
highest development phase: 3
has mesh: D006938
has mesh heading: HYPERLIPOPROTEINEMIA TYPE II
has EFO: EFO_0004911
has EFO name: FAMILIAL HYPERCHOLESTEROLEMIA

CHEMBL_IND_50072
type: DrugIndication
chembl id: CHEMBL_IND_50072
has molecule: CHEMBL354541
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_55130
type: DrugIndication
chembl id: CHEMBL_IND_55130
has molecule: CHEMBL354541
highest development phase: 3
has mesh: D006938
has mesh heading: HYPERLIPOPROTEINEMIA TYPE II
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

CHEMBL_IND_25632
type: DrugIndication
chembl id: CHEMBL_IND_25632
has molecule: CHEMBL1303
highest development phase: 4
has mesh: D012148
has mesh heading: RESTLESS LEGS SYNDROME
has EFO: EFO_0004270
has EFO name: RESTLESS LEGS SYNDROME

CHEMBL_IND_23842
type: DrugIndication
chembl id: CHEMBL_IND_23842
has molecule: CHEMBL1303
highest development phase: 4
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_23841
type: DrugIndication
chembl id: CHEMBL_IND_23841
has molecule: CHEMBL1303
highest development phase: 2
has mesh: D005356
has mesh heading: FIBROMYALGIA
has EFO: EFO_0005687
has EFO name: FIBROMYALGIA

CHEMBL_IND_47028
type: DrugIndication
chembl id: CHEMBL_IND_47028
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D060825
has mesh heading: MILD COGNITIVE IMPAIRMENT
has EFO: HP_0100543
has EFO name: COGNITIVE IMPAIRMENT

CHEMBL_IND_54206
type: DrugIndication
chembl id: CHEMBL_IND_54206
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D016403
has mesh heading: LYMPHOMA, LARGE B-CELL, DIFFUSE
has EFO: EFO_0000403
has EFO name: DIFFUSE LARGE B-CELL LYMPHOMA

CHEMBL_IND_54143
type: DrugIndication
chembl id: CHEMBL_IND_54143
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D017719
has mesh heading: DIABETIC FOOT
has EFO: EFO_1001459
has EFO name: DIABETIC FOOT

CHEMBL_IND_54134
type: DrugIndication
chembl id: CHEMBL_IND_54134
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D010534
has mesh heading: PERITONEAL NEOPLASMS
has EFO: EFO_1001100
has EFO name: PERITONEAL NEOPLASM

CHEMBL_IND_46581
type: DrugIndication
chembl id: CHEMBL_IND_46581
has molecule: CHEMBL1431
highest development phase: 1
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000707
has EFO name: SQUAMOUS CELL CARCINOMA

CHEMBL_IND_49469
type: DrugIndication
chembl id: CHEMBL_IND_49469
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0002617
has EFO name: METASTATIC MELANOMA

CHEMBL_IND_43494
type: DrugIndication
chembl id: CHEMBL_IND_43494
has molecule: CHEMBL1431
highest development phase: 3
has mesh: D011085
has mesh heading: POLYCYSTIC OVARY SYNDROME
has EFO: EFO_0000660
has EFO name: POLYCYSTIC OVARY SYNDROME

CHEMBL_IND_54077
type: DrugIndication
chembl id: CHEMBL_IND_54077
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_49427
type: DrugIndication
chembl id: CHEMBL_IND_49427
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D006976
has mesh heading: HYPERTENSION, PULMONARY
has EFO: EFO_0001361
has EFO name: PULMONARY HYPERTENSION

CHEMBL_IND_46757
type: DrugIndication
chembl id: CHEMBL_IND_46757
has molecule: CHEMBL1431
highest development phase: 1
has mesh: D065626
has mesh heading: NON-ALCOHOLIC FATTY LIVER DISEASE
has EFO: EFO_0003095
has EFO name: NON-ALCOHOLIC FATTY LIVER DISEASE

CHEMBL_IND_43684
type: DrugIndication
chembl id: CHEMBL_IND_43684
has molecule: CHEMBL1431
highest development phase: 3
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_43679
type: DrugIndication
chembl id: CHEMBL_IND_43679
has molecule: CHEMBL1431
highest development phase: 3
has mesh: D003922
has mesh heading: DIABETES MELLITUS, TYPE 1
has EFO: EFO_0001359
has EFO name: TYPE I DIABETES MELLITUS

CHEMBL_IND_43660
type: DrugIndication
chembl id: CHEMBL_IND_43660
has molecule: CHEMBL1431
highest development phase: 3
has mesh: D009765
has mesh heading: OBESITY
has EFO: EFO_0001073
has EFO name: OBESITY

CHEMBL_IND_48094
type: DrugIndication
chembl id: CHEMBL_IND_48094
has molecule: CHEMBL1431
highest development phase: 1
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_48611
type: DrugIndication
chembl id: CHEMBL_IND_48611
has molecule: CHEMBL1431
highest development phase: 0
has mesh: D006965
has mesh heading: HYPERPLASIA
has EFO: EFO_0000536
has EFO name: HYPERPLASIA

CHEMBL_IND_40561
type: DrugIndication
chembl id: CHEMBL_IND_40561
has molecule: CHEMBL1431
highest development phase: 1
has mesh: D016864
has mesh heading: LI-FRAUMENI SYNDROME
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: LI-FRAUMENI SYNDROME

CHEMBL_IND_48259
type: DrugIndication
chembl id: CHEMBL_IND_48259
has molecule: CHEMBL1431
highest development phase: 3
has mesh: D001932
has mesh heading: BRAIN NEOPLASMS
has EFO: EFO_0003833
has EFO name: BRAIN NEOPLASM

CHEMBL_IND_48250
type: DrugIndication
chembl id: CHEMBL_IND_48250
has molecule: CHEMBL1431
highest development phase: 3
has mesh: D008881
has mesh heading: MIGRAINE DISORDERS
has EFO: EFO_0003821
has EFO name: MIGRAINE DISORDER

CHEMBL_IND_48238
type: DrugIndication
chembl id: CHEMBL_IND_48238
has molecule: CHEMBL1431
highest development phase: 0
has mesh: D003930
has mesh heading: DIABETIC RETINOPATHY
has EFO: EFO_0003770
has EFO name: DIABETIC RETINOPATHY

CHEMBL_IND_44698
type: DrugIndication
chembl id: CHEMBL_IND_44698
has molecule: CHEMBL1431
highest development phase: 3
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_53619
type: DrugIndication
chembl id: CHEMBL_IND_53619
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0003869
has EFO name: BREAST NEOPLASM

CHEMBL_IND_45445
type: DrugIndication
chembl id: CHEMBL_IND_45445
has molecule: CHEMBL1431
highest development phase: 3
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_49136
type: DrugIndication
chembl id: CHEMBL_IND_49136
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D000230
has mesh heading: ADENOCARCINOMA
has EFO: EFO_0000228
has EFO name: ADENOCARCINOMA

CHEMBL_IND_46414
type: DrugIndication
chembl id: CHEMBL_IND_46414
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_46370
type: DrugIndication
chembl id: CHEMBL_IND_46370
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_46252
type: DrugIndication
chembl id: CHEMBL_IND_46252
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D011125
has mesh heading: ADENOMATOUS POLYPOSIS COLI
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: FAMILIAL ADENOMATOUS POLYPOSIS

CHEMBL_IND_43250
type: DrugIndication
chembl id: CHEMBL_IND_43250
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_43140
type: DrugIndication
chembl id: CHEMBL_IND_43140
has molecule: CHEMBL1431
highest development phase: 3
has mesh: D024821
has mesh heading: METABOLIC SYNDROME X
has EFO: EFO_0000195
has EFO name: METABOLIC SYNDROME

CHEMBL_IND_43106
type: DrugIndication
chembl id: CHEMBL_IND_43106
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D015451
has mesh heading: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
has EFO: EFO_0000095
has EFO name: CHRONIC LYMPHOCYTIC LEUKEMIA

CHEMBL_IND_53720
type: DrugIndication
chembl id: CHEMBL_IND_53720
has molecule: CHEMBL1431
highest development phase: 1
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000181
has EFO name: HEAD AND NECK SQUAMOUS CELL CARCINOMA

CHEMBL_IND_44371
type: DrugIndication
chembl id: CHEMBL_IND_44371
has molecule: CHEMBL1431
highest development phase: 3
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000196
has EFO name: METASTATIC PROSTATE CANCER

CHEMBL_IND_40093
type: DrugIndication
chembl id: CHEMBL_IND_40093
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D015430
has mesh heading: WEIGHT GAIN
has EFO: EFO_0004566
has EFO name: BODY WEIGHT GAIN

CHEMBL_IND_44973
type: DrugIndication
chembl id: CHEMBL_IND_44973
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_47452
type: DrugIndication
chembl id: CHEMBL_IND_47452
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D008268
has mesh heading: MACULAR DEGENERATION
has EFO: EFO_0001365
has EFO name: AGE-RELATED MACULAR DEGENERATION

CHEMBL_IND_44904
type: DrugIndication
chembl id: CHEMBL_IND_44904
has molecule: CHEMBL1431
highest development phase: 3
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_44054
type: DrugIndication
chembl id: CHEMBL_IND_44054
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D016889
has mesh heading: ENDOMETRIAL NEOPLASMS
has EFO: EFO_0004230
has EFO name: ENDOMETRIAL NEOPLASM

CHEMBL_IND_41711
type: DrugIndication
chembl id: CHEMBL_IND_41711
has molecule: CHEMBL1431
highest development phase: 4
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_47408
type: DrugIndication
chembl id: CHEMBL_IND_47408
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_47307
type: DrugIndication
chembl id: CHEMBL_IND_47307
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D010518
has mesh heading: PERIODONTITIS
has EFO: EFO_0000649
has EFO name: PERIODONTITIS

CHEMBL_IND_44663
type: DrugIndication
chembl id: CHEMBL_IND_44663
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_53102
type: DrugIndication
chembl id: CHEMBL_IND_53102
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D012004
has mesh heading: RECTAL NEOPLASMS
has EFO: EFO_1000657
has EFO name: RECTUM CANCER

CHEMBL_IND_54431
type: DrugIndication
chembl id: CHEMBL_IND_54431
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D005909
has mesh heading: GLIOBLASTOMA
has EFO: EFO_0000519
has EFO name: GLIOBLASTOMA MULTIFORME

CHEMBL_IND_54403
type: DrugIndication
chembl id: CHEMBL_IND_54403
has molecule: CHEMBL1431
highest development phase: 2
has mesh: D001281
has mesh heading: ATRIAL FIBRILLATION
has EFO: EFO_0000275
has EFO name: ATRIAL FIBRILLATION

CHEMBL_IND_39806
type: DrugIndication
chembl id: CHEMBL_IND_39806
has molecule: CHEMBL1431
highest development phase: 3
has mesh: D016640
has mesh heading: DIABETES, GESTATIONAL
has EFO: EFO_0004593
has EFO name: GESTATIONAL DIABETES

CHEMBL_IND_54807
type: DrugIndication
chembl id: CHEMBL_IND_54807
has molecule: CHEMBL1431
highest development phase: 3
has mesh: D005234
has mesh heading: FATTY LIVER
has EFO: HP_0001397
has EFO name: HEPATIC STEATOSIS

CHEMBL_IND_41842
type: DrugIndication
chembl id: CHEMBL_IND_41842
has molecule: CHEMBL367463
highest development phase: 4
has mesh: D005128
has mesh heading: EYE DISEASES
has EFO: EFO_0005752
has EFO name: EYE INFLAMMATION

CHEMBL_IND_49494
type: DrugIndication
chembl id: CHEMBL_IND_49494
has molecule: CHEMBL372764
highest development phase: 1
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_48813
type: DrugIndication
chembl id: CHEMBL_IND_48813
has molecule: CHEMBL372764
highest development phase: 2
has mesh: D008258
has mesh heading: WALDENSTROM MACROGLOBULINEMIA
has EFO: EFO_0002616
has EFO name: MACROGLOBULINEMIA

CHEMBL_IND_48060
type: DrugIndication
chembl id: CHEMBL_IND_48060
has molecule: CHEMBL372764
highest development phase: 2
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0000681
has EFO name: RENAL CELL CARCINOMA

CHEMBL_IND_45618
type: DrugIndication
chembl id: CHEMBL_IND_45618
has molecule: CHEMBL372764
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_45601
type: DrugIndication
chembl id: CHEMBL_IND_45601
has molecule: CHEMBL372764
highest development phase: 2
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_48191
type: DrugIndication
chembl id: CHEMBL_IND_48191
has molecule: CHEMBL372764
highest development phase: 2
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0002890
has EFO name: RENAL CARCINOMA

CHEMBL_IND_44738
type: DrugIndication
chembl id: CHEMBL_IND_44738
has molecule: CHEMBL372764
highest development phase: 2
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_43453
type: DrugIndication
chembl id: CHEMBL_IND_43453
has molecule: CHEMBL372764
highest development phase: 2
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_43104
type: DrugIndication
chembl id: CHEMBL_IND_43104
has molecule: CHEMBL372764
highest development phase: 2
has mesh: D015451
has mesh heading: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
has EFO: EFO_0000095
has EFO name: CHRONIC LYMPHOCYTIC LEUKEMIA

CHEMBL_IND_44471
type: DrugIndication
chembl id: CHEMBL_IND_44471
has molecule: CHEMBL372764
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_47321
type: DrugIndication
chembl id: CHEMBL_IND_47321
has molecule: CHEMBL372764
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_42362
type: DrugIndication
chembl id: CHEMBL_IND_42362
has molecule: CHEMBL1274
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_24707
type: DrugIndication
chembl id: CHEMBL_IND_24707
has molecule: CHEMBL1274
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_45710
type: DrugIndication
chembl id: CHEMBL_IND_45710
has molecule: CHEMBL374731
highest development phase: 2
has mesh: D014777
has mesh heading: VIRUS DISEASES
has EFO: EFO_0000763
has EFO name: VIRAL DISEASE

CHEMBL_IND_44063
type: DrugIndication
chembl id: CHEMBL_IND_44063
has molecule: CHEMBL374731
highest development phase: 4
has mesh: D019694
has mesh heading: HEPATITIS B, CHRONIC
has EFO: EFO_0004239
has EFO name: CHRONIC HEPATITIS B INFECTION

CHEMBL_IND_44037
type: DrugIndication
chembl id: CHEMBL_IND_44037
has molecule: CHEMBL374731
highest development phase: 4
has mesh: D019694
has mesh heading: HEPATITIS B, CHRONIC
has EFO: EFO_0004197
has EFO name: HEPATITIS B INFECTION

CHEMBL_IND_42333
type: DrugIndication
chembl id: CHEMBL_IND_42333
has molecule: CHEMBL357995
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_50343
type: DrugIndication
chembl id: CHEMBL_IND_50343
has molecule: CHEMBL370805
highest development phase: 2
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_41967
type: DrugIndication
chembl id: CHEMBL_IND_41967
has molecule: CHEMBL358040
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_43881
type: DrugIndication
chembl id: CHEMBL_IND_43881
has molecule: CHEMBL365528
highest development phase: 3
has mesh: D011014
has mesh heading: PNEUMONIA
has EFO: EFO_0003106
has EFO name: PNEUMONIA

CHEMBL_IND_50563
type: DrugIndication
chembl id: CHEMBL_IND_50563
has molecule: CHEMBL377559
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0002617
has EFO name: METASTATIC MELANOMA

CHEMBL_IND_50727
type: DrugIndication
chembl id: CHEMBL_IND_50727
has molecule: CHEMBL377559
highest development phase: 2
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_50925
type: DrugIndication
chembl id: CHEMBL_IND_50925
has molecule: CHEMBL377559
highest development phase: 2
has mesh: D008080
has mesh heading: LIPOSARCOMA
has EFO: EFO_0003085
has EFO name: DEDIFFERENTIATED LIPOSARCOMA

CHEMBL_IND_55248
type: DrugIndication
chembl id: CHEMBL_IND_55248
has molecule: CHEMBL377559
highest development phase: 1
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_55232
type: DrugIndication
chembl id: CHEMBL_IND_55232
has molecule: CHEMBL377559
highest development phase: 3
has mesh: D046152
has mesh heading: GASTROINTESTINAL STROMAL TUMORS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: GASTROINTESTINAL STROMAL TUMOR

CHEMBL_IND_55167
type: DrugIndication
chembl id: CHEMBL_IND_55167
has molecule: CHEMBL377559
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_42863
type: DrugIndication
chembl id: CHEMBL_IND_42863
has molecule: CHEMBL1252
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_26980
type: DrugIndication
chembl id: CHEMBL_IND_26980
has molecule: CHEMBL1252
highest development phase: 3
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_46521
type: DrugIndication
chembl id: CHEMBL_IND_46521
has molecule: CHEMBL1397
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_49074
type: DrugIndication
chembl id: CHEMBL_IND_49074
has molecule: CHEMBL1397
highest development phase: 2
has mesh: D014009
has mesh heading: ONYCHOMYCOSIS
has EFO: HP_0012203
has EFO name: ONYCHOMYCOSIS

CHEMBL_IND_43411
type: DrugIndication
chembl id: CHEMBL_IND_43411
has molecule: CHEMBL1397
highest development phase: 3
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_51927
type: DrugIndication
chembl id: CHEMBL_IND_51927
has molecule: CHEMBL1397
highest development phase: 1
has mesh: D009503
has mesh heading: NEUTROPENIA
has EFO: HP_0001875
has EFO name: NEUTROPENIA

CHEMBL_IND_40382
type: DrugIndication
chembl id: CHEMBL_IND_40382
has molecule: CHEMBL1397
highest development phase: 3
has mesh: D001228
has mesh heading: ASPERGILLOSIS
has EFO: EFO_0007157
has EFO name: ASPERGILLOSIS

CHEMBL_IND_49679
type: DrugIndication
chembl id: CHEMBL_IND_49679
has molecule: CHEMBL1401
highest development phase: 2
has mesh: D001988
has mesh heading: BRONCHIOLITIS
has EFO: HP_0011950
has EFO name: BRONCHIOLITIS

CHEMBL_IND_49666
type: DrugIndication
chembl id: CHEMBL_IND_49666
has molecule: CHEMBL1401
highest development phase: 3
has mesh: D003967
has mesh heading: DIARRHEA
has EFO: HP_0002014
has EFO name: DIARRHEA

CHEMBL_IND_45882
type: DrugIndication
chembl id: CHEMBL_IND_45882
has molecule: CHEMBL1401
highest development phase: 2
has mesh: D006526
has mesh heading: HEPATITIS C
has EFO: EFO_0003047
has EFO name: HEPATITIS C INFECTION

CHEMBL_IND_40588
type: DrugIndication
chembl id: CHEMBL_IND_40588
has molecule: CHEMBL1401
highest development phase: 2
has mesh: D012400
has mesh heading: ROTAVIRUS INFECTIONS
has EFO: EFO_0002622
has EFO name: ROTAVIRUS INFECTION

CHEMBL_IND_48169
type: DrugIndication
chembl id: CHEMBL_IND_48169
has molecule: CHEMBL1401
highest development phase: 3
has mesh: D007251
has mesh heading: INFLUENZA, HUMAN
has EFO: EFO_0001669
has EFO name: INFLUENZA INFECTION

CHEMBL_IND_44290
type: DrugIndication
chembl id: CHEMBL_IND_44290
has molecule: CHEMBL1401
highest development phase: 2
has mesh: D014376
has mesh heading: TUBERCULOSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: TUBERCULOSIS

CHEMBL_IND_44540
type: DrugIndication
chembl id: CHEMBL_IND_44540
has molecule: CHEMBL1401
highest development phase: 2
has mesh: D003424
has mesh heading: CROHN DISEASE
has EFO: EFO_0000384
has EFO name: CROHN'S DISEASE

CHEMBL_IND_51918
type: DrugIndication
chembl id: CHEMBL_IND_51918
has molecule: CHEMBL1401
highest development phase: 2
has mesh: D005759
has mesh heading: GASTROENTERITIS
has EFO: EFO_1001463
has EFO name: GASTROENTERITIS

CHEMBL_IND_53247
type: DrugIndication
chembl id: CHEMBL_IND_53247
has molecule: CHEMBL178
highest development phase: 2
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_52760
type: DrugIndication
chembl id: CHEMBL_IND_52760
has molecule: CHEMBL178
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_53199
type: DrugIndication
chembl id: CHEMBL_IND_53199
has molecule: CHEMBL178
highest development phase: 3
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_50270
type: DrugIndication
chembl id: CHEMBL_IND_50270
has molecule: CHEMBL382301
highest development phase: 2
has mesh: D007246
has mesh heading: INFERTILITY
has EFO: EFO_0000545
has EFO name: INFERTILITY

CHEMBL_IND_50395
type: DrugIndication
chembl id: CHEMBL_IND_50395
has molecule: CHEMBL382301
highest development phase: 3
has mesh: D047928
has mesh heading: PREMATURE BIRTH
has EFO: EFO_0003917
has EFO name: PREMATURE BIRTH

CHEMBL_IND_42972
type: DrugIndication
chembl id: CHEMBL_IND_42972
has molecule: CHEMBL1440
highest development phase: 4
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_44688
type: DrugIndication
chembl id: CHEMBL_IND_44688
has molecule: CHEMBL1440
highest development phase: 3
has mesh: D010518
has mesh heading: PERIODONTITIS
has EFO: EFO_0000649
has EFO name: PERIODONTITIS

CHEMBL_IND_43605
type: DrugIndication
chembl id: CHEMBL_IND_43605
has molecule: CHEMBL383322
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_53004
type: DrugIndication
chembl id: CHEMBL_IND_53004
has molecule: CHEMBL383322
highest development phase: 2
has mesh: D055623
has mesh heading: KERATOSIS, ACTINIC
has EFO: EFO_0002496
has EFO name: ACTINIC KERATOSIS

CHEMBL_IND_46874
type: DrugIndication
chembl id: CHEMBL_IND_46874
has molecule: CHEMBL383322
highest development phase: 1
has mesh: D002280
has mesh heading: CARCINOMA, BASAL CELL
has EFO: EFO_0004193
has EFO name: BASAL CELL CARCINOMA

CHEMBL_IND_48825
type: DrugIndication
chembl id: CHEMBL_IND_48825
has molecule: CHEMBL383322
highest development phase: 1
has mesh: D016410
has mesh heading: LYMPHOMA, T-CELL, CUTANEOUS
has EFO: EFO_0002913
has EFO name: CUTANEOUS T-CELL LYMPHOMA

CHEMBL_IND_45857
type: DrugIndication
chembl id: CHEMBL_IND_45857
has molecule: CHEMBL383322
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0002617
has EFO name: METASTATIC MELANOMA

CHEMBL_IND_43355
type: DrugIndication
chembl id: CHEMBL_IND_43355
has molecule: CHEMBL383322
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000389
has EFO name: CUTANEOUS MELANOMA

CHEMBL_IND_44919
type: DrugIndication
chembl id: CHEMBL_IND_44919
has molecule: CHEMBL383322
highest development phase: 1
has mesh: D007251
has mesh heading: INFLUENZA, HUMAN
has EFO: EFO_0001669
has EFO name: INFLUENZA INFECTION

CHEMBL_IND_42479
type: DrugIndication
chembl id: CHEMBL_IND_42479
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D003876
has mesh heading: DERMATITIS, ATOPIC
has EFO: EFO_0000274
has EFO name: ATOPIC ECZEMA

CHEMBL_IND_42453
type: DrugIndication
chembl id: CHEMBL_IND_42453
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D015866
has mesh heading: UVEITIS, POSTERIOR
has EFO: EFO_1001119
has EFO name: POSTERIOR UVEITIS

CHEMBL_IND_42451
type: DrugIndication
chembl id: CHEMBL_IND_42451
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D007500
has mesh heading: IRITIS
has EFO: EFO_1000997
has EFO name: IRITIS

CHEMBL_IND_42442
type: DrugIndication
chembl id: CHEMBL_IND_42442
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D011657
has mesh heading: PULMONARY EOSINOPHILIA
has EFO: EFO_0007257
has EFO name: EOSINOPHILIC PNEUMONIA

CHEMBL_IND_42439
type: DrugIndication
chembl id: CHEMBL_IND_42439
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D016553
has mesh heading: PURPURA, THROMBOCYTOPENIC, IDIOPATHIC
has EFO: EFO_0007160
has EFO name: AUTOIMMUNE THROMBOCYTOPENIC PURPURA

CHEMBL_IND_42425
type: DrugIndication
chembl id: CHEMBL_IND_42425
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D000743
has mesh heading: ANEMIA, HEMOLYTIC
has EFO: EFO_0005558
has EFO name: HEMOLYTIC ANEMIA

CHEMBL_IND_42616
type: DrugIndication
chembl id: CHEMBL_IND_42616
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D000741
has mesh heading: ANEMIA, APLASTIC
has EFO: HP_0001915
has EFO name: APLASTIC ANEMIA

CHEMBL_IND_42570
type: DrugIndication
chembl id: CHEMBL_IND_42570
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D009404
has mesh heading: NEPHROTIC SYNDROME
has EFO: EFO_0004255
has EFO name: NEPHROTIC SYNDROME

CHEMBL_IND_42920
type: DrugIndication
chembl id: CHEMBL_IND_42920
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D013968
has mesh heading: THYROIDITIS, SUBACUTE
has EFO: EFO_1001194
has EFO name: SUBACUTE THYROIDITIS

CHEMBL_IND_42892
type: DrugIndication
chembl id: CHEMBL_IND_42892
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D010392
has mesh heading: PEMPHIGUS
has EFO: EFO_0004719
has EFO name: PEMPHIGUS VULGARIS

CHEMBL_IND_42877
type: DrugIndication
chembl id: CHEMBL_IND_42877
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D015535
has mesh heading: ARTHRITIS, PSORIATIC
has EFO: EFO_0003778
has EFO name: PSORIATIC ARTHRITIS

CHEMBL_IND_42874
type: DrugIndication
chembl id: CHEMBL_IND_42874
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D011014
has mesh heading: PNEUMONIA
has EFO: EFO_0003106
has EFO name: PNEUMONIA

CHEMBL_IND_42393
type: DrugIndication
chembl id: CHEMBL_IND_42393
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D010003
has mesh heading: OSTEOARTHRITIS
has EFO: EFO_0002506
has EFO name: OSTEOARTHRITIS

CHEMBL_IND_42314
type: DrugIndication
chembl id: CHEMBL_IND_42314
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D000312
has mesh heading: ADRENAL HYPERPLASIA, CONGENITAL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY

CHEMBL_IND_42537
type: DrugIndication
chembl id: CHEMBL_IND_42537
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D001172
has mesh heading: ARTHRITIS, RHEUMATOID
has EFO: EFO_0000685
has EFO name: RHEUMATOID ARTHRITIS

CHEMBL_IND_42052
type: DrugIndication
chembl id: CHEMBL_IND_42052
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D008180
has mesh heading: LUPUS ERYTHEMATOSUS, SYSTEMIC
has EFO: EFO_0002690
has EFO name: SYSTEMIC LUPUS ERYTHEMATOSUS

CHEMBL_IND_42051
type: DrugIndication
chembl id: CHEMBL_IND_42051
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D001171
has mesh heading: ARTHRITIS, JUVENILE
has EFO: EFO_0002609
has EFO name: CHRONIC CHILDHOOD ARTHRITIS

CHEMBL_IND_46764
type: DrugIndication
chembl id: CHEMBL_IND_46764
has molecule: CHEMBL384467
highest development phase: 3
has mesh: D014552
has mesh heading: URINARY TRACT INFECTIONS
has EFO: EFO_0003103
has EFO name: URINARY TRACT INFECTION

CHEMBL_IND_45216
type: DrugIndication
chembl id: CHEMBL_IND_45216
has molecule: CHEMBL384467
highest development phase: 3
has mesh: D065630
has mesh heading: HERNIAS, DIAPHRAGMATIC, CONGENITAL
has EFO: EFO_0005207
has EFO name: CONGENITAL HEART DISEASE

CHEMBL_IND_52208
type: DrugIndication
chembl id: CHEMBL_IND_52208
has molecule: CHEMBL384467
highest development phase: 2
has mesh: D016471
has mesh heading: OVARIAN HYPERSTIMULATION SYNDROME
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: OVARIAN HYPERSTIMULATION SYNDROME

CHEMBL_IND_28094
type: DrugIndication
chembl id: CHEMBL_IND_28094
has molecule: CHEMBL384467
highest development phase: 2
has mesh: D057135
has mesh heading: WET MACULAR DEGENERATION
has EFO: EFO_0004683
has EFO name: WET MACULAR DEGENERATION

CHEMBL_IND_28092
type: DrugIndication
chembl id: CHEMBL_IND_28092
has molecule: CHEMBL384467
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_52510
type: DrugIndication
chembl id: CHEMBL_IND_52510
has molecule: CHEMBL384467
highest development phase: 3
has mesh: D056887
has mesh heading: PELVIC ORGAN PROLAPSE
has EFO: EFO_0004710
has EFO name: PELVIC ORGAN PROLAPSE

CHEMBL_IND_41586
type: DrugIndication
chembl id: CHEMBL_IND_41586
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D002825
has mesh heading: CHORIORETINITIS

CHEMBL_IND_52409
type: DrugIndication
chembl id: CHEMBL_IND_52409
has molecule: CHEMBL384467
highest development phase: 3
has mesh: D008010
has mesh heading: LICHEN PLANUS
has EFO: EFO_1000726
has EFO name: LICHEN PLANUS

CHEMBL_IND_41930
type: DrugIndication
chembl id: CHEMBL_IND_41930
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D000224
has mesh heading: ADDISON DISEASE
has EFO: HP_0008207
has EFO name: PRIMARY ADRENAL INSUFFICIENCY

CHEMBL_IND_41881
type: DrugIndication
chembl id: CHEMBL_IND_41881
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D004892
has mesh heading: ERYTHEMA MULTIFORME
has EFO: EFO_1000694
has EFO name: ERYTHEMA MULTIFORME

CHEMBL_IND_41873
type: DrugIndication
chembl id: CHEMBL_IND_41873
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D014390
has mesh heading: TUBERCULOSIS, MENINGEAL
has EFO: EFO_1000039
has EFO name: MENINGEAL TUBERCULOSIS

CHEMBL_IND_52259
type: DrugIndication
chembl id: CHEMBL_IND_52259
has molecule: CHEMBL384467
highest development phase: 3
has mesh: D006967
has mesh heading: HYPERSENSITIVITY
has EFO: EFO_0003785
has EFO name: ALLERGY

CHEMBL_IND_42133
type: DrugIndication
chembl id: CHEMBL_IND_42133
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D010437
has mesh heading: PEPTIC ULCER
has EFO: HP_0004398
has EFO name: PEPTIC ULCER

CHEMBL_IND_42104
type: DrugIndication
chembl id: CHEMBL_IND_42104
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D009182
has mesh heading: MYCOSIS FUNGOIDES
has EFO: EFO_1001051
has EFO name: MYCOSIS FUNGOIDES

CHEMBL_IND_25913
type: DrugIndication
chembl id: CHEMBL_IND_25913
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D012507
has mesh heading: SARCOIDOSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SARCOIDOSIS

CHEMBL_IND_40854
type: DrugIndication
chembl id: CHEMBL_IND_40854
has molecule: CHEMBL384467
highest development phase: 3
has mesh: D017359
has mesh heading: HELLP SYNDROME
has EFO: EFO_0007297
has EFO name: HELLP SYNDROME

CHEMBL_IND_52593
type: DrugIndication
chembl id: CHEMBL_IND_52593
has molecule: CHEMBL384467
highest development phase: 2
has mesh: D009422
has mesh heading: NERVOUS SYSTEM DISEASES
has EFO: EFO_0000618
has EFO name: NERVOUS SYSTEM DISEASE

CHEMBL_IND_52588
type: DrugIndication
chembl id: CHEMBL_IND_52588
has molecule: CHEMBL384467
highest development phase: 1
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_25912
type: DrugIndication
chembl id: CHEMBL_IND_25912
has molecule: CHEMBL384467
highest development phase: 2
has mesh: D054990
has mesh heading: IDIOPATHIC PULMONARY FIBROSIS
has EFO: EFO_0000768
has EFO name: IDIOPATHIC PULMONARY FIBROSIS

CHEMBL_IND_25911
type: DrugIndication
chembl id: CHEMBL_IND_25911
has molecule: CHEMBL384467
highest development phase: 3
has mesh: D008103
has mesh heading: LIVER CIRRHOSIS
has EFO: EFO_0001422
has EFO name: CIRRHOSIS OF LIVER

CHEMBL_IND_25910
type: DrugIndication
chembl id: CHEMBL_IND_25910
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_49042
type: DrugIndication
chembl id: CHEMBL_IND_49042
has molecule: CHEMBL384467
highest development phase: 1
has mesh: D000309
has mesh heading: ADRENAL INSUFFICIENCY
has EFO: HP_0000846
has EFO name: ADRENAL INSUFFICIENCY

CHEMBL_IND_26501
type: DrugIndication
chembl id: CHEMBL_IND_26501
has molecule: CHEMBL384467
highest development phase: 2
has mesh: D047928
has mesh heading: PREMATURE BIRTH
has EFO: EFO_0003917
has EFO name: PREMATURE BIRTH

CHEMBL_IND_26500
type: DrugIndication
chembl id: CHEMBL_IND_26500
has molecule: CHEMBL384467
highest development phase: 2
has mesh: D006470
has mesh heading: HEMORRHAGE
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: HEMORRHAGE

CHEMBL_IND_42277
type: DrugIndication
chembl id: CHEMBL_IND_42277
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D013717
has mesh heading: TENOSYNOVITIS
has EFO: EFO_1001435
has EFO name: TENOSYNOVITIS

CHEMBL_IND_42274
type: DrugIndication
chembl id: CHEMBL_IND_42274
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D009879
has mesh heading: OPHTHALMIA, SYMPATHETIC
has EFO: EFO_1001205
has EFO name: SYMPATHETIC OPHTHALMIA

CHEMBL_IND_42267
type: DrugIndication
chembl id: CHEMBL_IND_42267
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D012628
has mesh heading: DERMATITIS, SEBORRHEIC
has EFO: EFO_1000764
has EFO name: SEBORRHEIC DERMATITIS

CHEMBL_IND_42263
type: DrugIndication
chembl id: CHEMBL_IND_42263
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D003874
has mesh heading: DERMATITIS HERPETIFORMIS
has EFO: EFO_1000684
has EFO name: DERMATITIS HERPETIFORMIS

CHEMBL_IND_42257
type: DrugIndication
chembl id: CHEMBL_IND_42257
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D014235
has mesh heading: TRICHINELLOSIS
has EFO: EFO_0007520
has EFO name: TRICHINOSIS

CHEMBL_IND_42251
type: DrugIndication
chembl id: CHEMBL_IND_42251
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D006255
has mesh heading: RHINITIS, ALLERGIC, SEASONAL
has EFO: EFO_0005854
has EFO name: ALLERGIC RHINITIS

CHEMBL_IND_42225
type: DrugIndication
chembl id: CHEMBL_IND_42225
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D013167
has mesh heading: SPONDYLITIS, ANKYLOSING
has EFO: EFO_0003898
has EFO name: ANKYLOSING SPONDYLITIS

CHEMBL_IND_42188
type: DrugIndication
chembl id: CHEMBL_IND_42188
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_46236
type: DrugIndication
chembl id: CHEMBL_IND_46236
has molecule: CHEMBL384467
highest development phase: 2
has mesh: D014376
has mesh heading: TUBERCULOSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: TUBERCULOSIS

CHEMBL_IND_43069
type: DrugIndication
chembl id: CHEMBL_IND_43069
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D007249
has mesh heading: INFLAMMATION
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: INFLAMMATION

CHEMBL_IND_43066
type: DrugIndication
chembl id: CHEMBL_IND_43066
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D009205
has mesh heading: MYOCARDITIS
has EFO: HP_0012819
has EFO name: MYOCARDITIS

CHEMBL_IND_43031
type: DrugIndication
chembl id: CHEMBL_IND_43031
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D002062
has mesh heading: BURSITIS
has EFO: EFO_1000941
has EFO name: FROZEN SHOULDER

CHEMBL_IND_43027
type: DrugIndication
chembl id: CHEMBL_IND_43027
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D006563
has mesh heading: HERPES ZOSTER OPHTHALMICUS
has EFO: EFO_0007403
has EFO name: OPHTHALMIC HERPES ZOSTER

CHEMBL_IND_52107
type: DrugIndication
chembl id: CHEMBL_IND_52107
has molecule: CHEMBL384467
highest development phase: 1
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_44996
type: DrugIndication
chembl id: CHEMBL_IND_44996
has molecule: CHEMBL384467
highest development phase: 2
has mesh: D004653
has mesh heading: EMPYEMA
has EFO: EFO_0003097
has EFO name: EMPYEMA

CHEMBL_IND_41834
type: DrugIndication
chembl id: CHEMBL_IND_41834
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D003877
has mesh heading: DERMATITIS, CONTACT
has EFO: EFO_0005319
has EFO name: CONTACT DERMATITIS

CHEMBL_IND_41825
type: DrugIndication
chembl id: CHEMBL_IND_41825
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D013262
has mesh heading: STEVENS-JOHNSON SYNDROME
has EFO: EFO_0004276
has EFO name: STEVENS-JOHNSON SYNDROME

CHEMBL_IND_41824
type: DrugIndication
chembl id: CHEMBL_IND_41824
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D015210
has mesh heading: ARTHRITIS, GOUTY
has EFO: EFO_0004274
has EFO name: GOUT

CHEMBL_IND_47590
type: DrugIndication
chembl id: CHEMBL_IND_47590
has molecule: CHEMBL384467
highest development phase: 3
has mesh: D008881
has mesh heading: MIGRAINE DISORDERS
has EFO: EFO_0003821
has EFO name: MIGRAINE DISORDER

CHEMBL_IND_44131
type: DrugIndication
chembl id: CHEMBL_IND_44131
has molecule: CHEMBL384467
highest development phase: 3
has mesh: D020250
has mesh heading: POSTOPERATIVE NAUSEA AND VOMITING
has EFO: EFO_0004888
has EFO name: POST OPERATIVE NAUSEA AND VOMITING

CHEMBL_IND_41762
type: DrugIndication
chembl id: CHEMBL_IND_41762
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D003093
has mesh heading: COLITIS, ULCERATIVE
has EFO: EFO_0000729
has EFO name: ULCERATIVE COLITIS

CHEMBL_IND_41759
type: DrugIndication
chembl id: CHEMBL_IND_41759
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_41671
type: DrugIndication
chembl id: CHEMBL_IND_41671
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D015863
has mesh heading: IRIDOCYCLITIS

CHEMBL_IND_41667
type: DrugIndication
chembl id: CHEMBL_IND_41667
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D013716
has mesh heading: TENNIS ELBOW

CHEMBL_IND_41658
type: DrugIndication
chembl id: CHEMBL_IND_41658
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D013585
has mesh heading: SYNOVITIS

CHEMBL_IND_41655
type: DrugIndication
chembl id: CHEMBL_IND_41655
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D002833
has mesh heading: CHOROIDITIS

CHEMBL_IND_41651
type: DrugIndication
chembl id: CHEMBL_IND_41651
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D003873
has mesh heading: DERMATITIS, EXFOLIATIVE

CHEMBL_IND_41647
type: DrugIndication
chembl id: CHEMBL_IND_41647
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D012713
has mesh heading: SERUM SICKNESS

CHEMBL_IND_41623
type: DrugIndication
chembl id: CHEMBL_IND_41623
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D007634
has mesh heading: KERATITIS

CHEMBL_IND_27637
type: DrugIndication
chembl id: CHEMBL_IND_27637
has molecule: CHEMBL384467
highest development phase: 1
has mesh: D006111
has mesh heading: GRAVES DISEASE
has EFO: EFO_0004237
has EFO name: GRAVES DISEASE

CHEMBL_IND_27636
type: DrugIndication
chembl id: CHEMBL_IND_27636
has molecule: CHEMBL384467
highest development phase: 2
has mesh: D006073
has mesh heading: GOUT
has EFO: EFO_0004274
has EFO name: GOUT

CHEMBL_IND_27635
type: DrugIndication
chembl id: CHEMBL_IND_27635
has molecule: CHEMBL384467
highest development phase: 3
has mesh: D001762
has mesh heading: BLEPHARITIS
has EFO: HP_0000498
has EFO name: BLEPHARITIS

CHEMBL_IND_27634
type: DrugIndication
chembl id: CHEMBL_IND_27634
has molecule: CHEMBL384467
highest development phase: 3
has mesh: D006086
has mesh heading: GRAFT VS HOST DISEASE
has EFO: EFO_0004599
has EFO name: ACUTE GRAFT VS. HOST DISEASE

CHEMBL_IND_51905
type: DrugIndication
chembl id: CHEMBL_IND_51905
has molecule: CHEMBL384467
highest development phase: 2
has mesh: D012170
has mesh heading: RETINAL VEIN OCCLUSION
has EFO: EFO_1001157
has EFO name: RETINAL VEIN OCCLUSION

CHEMBL_IND_23012
type: DrugIndication
chembl id: CHEMBL_IND_23012
has molecule: CHEMBL384467
highest development phase: 3
has mesh: D014839
has mesh heading: VOMITING
has EFO: HP_0002013
has EFO name: VOMITING

CHEMBL_IND_23011
type: DrugIndication
chembl id: CHEMBL_IND_23011
has molecule: CHEMBL384467
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_23010
type: DrugIndication
chembl id: CHEMBL_IND_23010
has molecule: CHEMBL384467
highest development phase: 3
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_23009
type: DrugIndication
chembl id: CHEMBL_IND_23009
has molecule: CHEMBL384467
highest development phase: 3
has mesh: D009437
has mesh heading: NEURALGIA
has EFO: EFO_0005762
has EFO name: NEUROPATHIC PAIN

CHEMBL_IND_23008
type: DrugIndication
chembl id: CHEMBL_IND_23008
has molecule: CHEMBL384467
highest development phase: 3
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_23007
type: DrugIndication
chembl id: CHEMBL_IND_23007
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D005128
has mesh heading: EYE DISEASES
has EFO: EFO_0005752
has EFO name: EYE INFLAMMATION

CHEMBL_IND_42780
type: DrugIndication
chembl id: CHEMBL_IND_42780
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D013921
has mesh heading: THROMBOCYTOPENIA
has EFO: HP_0001873
has EFO name: THROMBOCYTOPENIA

CHEMBL_IND_42765
type: DrugIndication
chembl id: CHEMBL_IND_42765
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D014397
has mesh heading: TUBERCULOSIS, PULMONARY
has EFO: EFO_1000049
has EFO name: PULMONARY TUBERCULOSIS

CHEMBL_IND_42759
type: DrugIndication
chembl id: CHEMBL_IND_42759
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D009902
has mesh heading: OPTIC NEURITIS
has EFO: EFO_0007405
has EFO name: OPTIC NEURITIS

CHEMBL_IND_42757
type: DrugIndication
chembl id: CHEMBL_IND_42757
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D003233
has mesh heading: CONJUNCTIVITIS, ALLERGIC
has EFO: EFO_0007141
has EFO name: ALLERGIC CONJUNCTIVITIS

CHEMBL_IND_25217
type: DrugIndication
chembl id: CHEMBL_IND_25217
has molecule: CHEMBL384467
highest development phase: 1
has mesh: D015423
has mesh heading: SCLERITIS
has EFO: HP_0100532
has EFO name: SCLERITIS

CHEMBL_IND_25216
type: DrugIndication
chembl id: CHEMBL_IND_25216
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D015508
has mesh heading: NASAL OBSTRUCTION
has EFO: HP_0001742
has EFO name: NASAL OBSTRUCTION

CHEMBL_IND_25215
type: DrugIndication
chembl id: CHEMBL_IND_25215
has molecule: CHEMBL384467
highest development phase: 3
has mesh: D008269
has mesh heading: MACULAR EDEMA
has EFO: HP_0040049
has EFO name: MACULAR EDEMA

CHEMBL_IND_25214
type: DrugIndication
chembl id: CHEMBL_IND_25214
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D005128
has mesh heading: EYE DISEASES
has EFO: EFO_0003966
has EFO name: EYE DISEASE

CHEMBL_IND_25213
type: DrugIndication
chembl id: CHEMBL_IND_25213
has molecule: CHEMBL384467
highest development phase: 3
has mesh: D003930
has mesh heading: DIABETIC RETINOPATHY
has EFO: EFO_0003770
has EFO name: DIABETIC RETINOPATHY

CHEMBL_IND_25212
type: DrugIndication
chembl id: CHEMBL_IND_25212
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D003424
has mesh heading: CROHN DISEASE
has EFO: EFO_0000384
has EFO name: CROHN'S DISEASE

CHEMBL_IND_25211
type: DrugIndication
chembl id: CHEMBL_IND_25211
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D000152
has mesh heading: ACNE VULGARIS
has EFO: EFO_0003894
has EFO name: ACNE

CHEMBL_IND_42689
type: DrugIndication
chembl id: CHEMBL_IND_42689
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_51580
type: DrugIndication
chembl id: CHEMBL_IND_51580
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D006255
has mesh heading: RHINITIS, ALLERGIC, SEASONAL
has EFO: EFO_0003956
has EFO name: SEASONAL ALLERGIC RHINITIS

CHEMBL_IND_24320
type: DrugIndication
chembl id: CHEMBL_IND_24320
has molecule: CHEMBL384467
highest development phase: 3
has mesh: D000755
has mesh heading: ANEMIA, SICKLE CELL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SICKLE CELL ANEMIA

CHEMBL_IND_24319
type: DrugIndication
chembl id: CHEMBL_IND_24319
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_24317
type: DrugIndication
chembl id: CHEMBL_IND_24317
has molecule: CHEMBL384467
highest development phase: 3
has mesh: D002386
has mesh heading: CATARACT
has EFO: EFO_0001059
has EFO name: CATARACT

CHEMBL_IND_24316
type: DrugIndication
chembl id: CHEMBL_IND_24316
has molecule: CHEMBL384467
highest development phase: 1
has mesh: D001988
has mesh heading: BRONCHIOLITIS
has EFO: HP_0011950
has EFO name: BRONCHIOLITIS

CHEMBL_IND_24314
type: DrugIndication
chembl id: CHEMBL_IND_24314
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_51541
type: DrugIndication
chembl id: CHEMBL_IND_51541
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D000308
has mesh heading: ADRENOCORTICAL HYPERFUNCTION
has EFO: EFO_1000797
has EFO name: ADRENAL GLAND HYPERFUNCTION

CHEMBL_IND_51521
type: DrugIndication
chembl id: CHEMBL_IND_51521
has molecule: CHEMBL384467
highest development phase: 4
has mesh: D006934
has mesh heading: HYPERCALCEMIA
has EFO: HP_0003072
has EFO name: HYPERCALCEMIA

CHEMBL_IND_50131
type: DrugIndication
chembl id: CHEMBL_IND_50131
has molecule: CHEMBL397420
highest development phase: 4
has mesh: D013927
has mesh heading: THROMBOSIS
has EFO: HP_0004419
has EFO name: RECURRENT THROMBOPHLEBITIS

CHEMBL_IND_25687
type: DrugIndication
chembl id: CHEMBL_IND_25687
has molecule: CHEMBL398435
highest development phase: 3
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_25686
type: DrugIndication
chembl id: CHEMBL_IND_25686
has molecule: CHEMBL398435
highest development phase: 3
has mesh: D058729
has mesh heading: PERIPHERAL ARTERIAL DISEASE
has EFO: EFO_0004265
has EFO name: PERIPHERAL ARTERIAL DISEASE

CHEMBL_IND_25685
type: DrugIndication
chembl id: CHEMBL_IND_25685
has molecule: CHEMBL398435
highest development phase: 1
has mesh: D007511
has mesh heading: ISCHEMIA
has EFO: EFO_0000556
has EFO name: ISCHEMIA

CHEMBL_IND_25684
type: DrugIndication
chembl id: CHEMBL_IND_25684
has molecule: CHEMBL398435
highest development phase: 3
has mesh: D003327
has mesh heading: CORONARY DISEASE
has EFO: EFO_0001645
has EFO name: CORONARY HEART DISEASE

CHEMBL_IND_28398
type: DrugIndication
chembl id: CHEMBL_IND_28398
has molecule: CHEMBL398435
highest development phase: 3
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_49143
type: DrugIndication
chembl id: CHEMBL_IND_49143
has molecule: CHEMBL398435
highest development phase: 3
has mesh: D001024
has mesh heading: AORTIC VALVE STENOSIS
has EFO: EFO_0000266
has EFO name: AORTIC STENOSIS

CHEMBL_IND_49089
type: DrugIndication
chembl id: CHEMBL_IND_49089
has molecule: CHEMBL398435
highest development phase: 2
has mesh: D000755
has mesh heading: ANEMIA, SICKLE CELL
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SICKLE CELL ANEMIA

CHEMBL_IND_28512
type: DrugIndication
chembl id: CHEMBL_IND_28512
has molecule: CHEMBL398435
highest development phase: 4
has mesh: D013927
has mesh heading: THROMBOSIS
has EFO: HP_0004419
has EFO name: RECURRENT THROMBOPHLEBITIS

CHEMBL_IND_47162
type: DrugIndication
chembl id: CHEMBL_IND_47162
has molecule: CHEMBL398435
highest development phase: 2
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_27469
type: DrugIndication
chembl id: CHEMBL_IND_27469
has molecule: CHEMBL398435
highest development phase: 2
has mesh: D011014
has mesh heading: PNEUMONIA
has EFO: EFO_0003106
has EFO name: PNEUMONIA

CHEMBL_IND_27956
type: DrugIndication
chembl id: CHEMBL_IND_27956
has molecule: CHEMBL398435
highest development phase: 2
has mesh: D017544
has mesh heading: AORTIC ANEURYSM, ABDOMINAL
has EFO: EFO_0004214
has EFO name: ABDOMINAL AORTIC ANEURYSM

CHEMBL_IND_47359
type: DrugIndication
chembl id: CHEMBL_IND_47359
has molecule: CHEMBL398435
highest development phase: 3
has mesh: D020521
has mesh heading: STROKE
has EFO: EFO_0000712
has EFO name: STROKE

CHEMBL_IND_23960
type: DrugIndication
chembl id: CHEMBL_IND_23960
has molecule: CHEMBL398435
highest development phase: 4
has mesh: D009203
has mesh heading: MYOCARDIAL INFARCTION
has EFO: EFO_0000612
has EFO name: MYOCARDIAL INFARCTION

CHEMBL_IND_23959
type: DrugIndication
chembl id: CHEMBL_IND_23959
has molecule: CHEMBL398435
highest development phase: 3
has mesh: D003324
has mesh heading: CORONARY ARTERY DISEASE
has EFO: EFO_0000378
has EFO name: CORONARY ARTERY DISEASE

CHEMBL_IND_23958
type: DrugIndication
chembl id: CHEMBL_IND_23958
has molecule: CHEMBL398435
highest development phase: 4
has mesh: D054058
has mesh heading: ACUTE CORONARY SYNDROME
has EFO: EFO_0005672
has EFO name: ACUTE CORONARY SYNDROME

CHEMBL_IND_50763
type: DrugIndication
chembl id: CHEMBL_IND_50763
has molecule: CHEMBL383675
highest development phase: 1
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_50457
type: DrugIndication
chembl id: CHEMBL_IND_50457
has molecule: CHEMBL383675
highest development phase: 2
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000181
has EFO name: HEAD AND NECK SQUAMOUS CELL CARCINOMA

CHEMBL_IND_50942
type: DrugIndication
chembl id: CHEMBL_IND_50942
has molecule: CHEMBL383675
highest development phase: 2
has mesh: D009303
has mesh heading: NASOPHARYNGEAL NEOPLASMS
has EFO: EFO_0004252
has EFO name: NASOPHARYNGEAL NEOPLASM

CHEMBL_IND_54320
type: DrugIndication
chembl id: CHEMBL_IND_54320
has molecule: CHEMBL383675
highest development phase: 2
has mesh: D001650
has mesh heading: BILE DUCT NEOPLASMS
has EFO: EFO_0005540
has EFO name: BILE DUCT CARCINOMA

CHEMBL_IND_26510
type: DrugIndication
chembl id: CHEMBL_IND_26510
has molecule: CHEMBL181
highest development phase: 4
has mesh: D007003
has mesh heading: HYPOGLYCEMIA
has EFO: HP_0001943
has EFO name: HYPOGLYCEMIA

CHEMBL_IND_48130
type: DrugIndication
chembl id: CHEMBL_IND_48130
has molecule: CHEMBL181
highest development phase: 2
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_24335
type: DrugIndication
chembl id: CHEMBL_IND_24335
has molecule: CHEMBL181
highest development phase: 1
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_24334
type: DrugIndication
chembl id: CHEMBL_IND_24334
has molecule: CHEMBL181
highest development phase: 2
has mesh: D009765
has mesh heading: OBESITY
has EFO: EFO_0001073
has EFO name: OBESITY

CHEMBL_IND_24333
type: DrugIndication
chembl id: CHEMBL_IND_24333
has molecule: CHEMBL181
highest development phase: 4
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_52057
type: DrugIndication
chembl id: CHEMBL_IND_52057
has molecule: CHEMBL387675
highest development phase: 3
has mesh: D017719
has mesh heading: DIABETIC FOOT
has EFO: EFO_1001459
has EFO name: DIABETIC FOOT

CHEMBL_IND_46822
type: DrugIndication
chembl id: CHEMBL_IND_46822
has molecule: CHEMBL387675
highest development phase: 1
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_48712
type: DrugIndication
chembl id: CHEMBL_IND_48712
has molecule: CHEMBL387675
highest development phase: 3
has mesh: D012871
has mesh heading: SKIN DISEASES
has EFO: EFO_0000701
has EFO name: SKIN DISEASE

CHEMBL_IND_40806
type: DrugIndication
chembl id: CHEMBL_IND_40806
has molecule: CHEMBL387675
highest development phase: 3
has mesh: D010019
has mesh heading: OSTEOMYELITIS
has EFO: EFO_0003102
has EFO name: OSTEOMYELITIS

CHEMBL_IND_46441
type: DrugIndication
chembl id: CHEMBL_IND_46441
has molecule: CHEMBL387675
highest development phase: 2
has mesh: D004696
has mesh heading: ENDOCARDITIS
has EFO: EFO_0000465
has EFO name: ENDOCARDITIS

CHEMBL_IND_43404
type: DrugIndication
chembl id: CHEMBL_IND_43404
has molecule: CHEMBL387675
highest development phase: 3
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_44880
type: DrugIndication
chembl id: CHEMBL_IND_44880
has molecule: CHEMBL387675
highest development phase: 1
has mesh: D018805
has mesh heading: SEPSIS
has EFO: EFO_0001420
has EFO name: SEPSIS

CHEMBL_IND_44647
type: DrugIndication
chembl id: CHEMBL_IND_44647
has molecule: CHEMBL387675
highest development phase: 1
has mesh: D008581
has mesh heading: MENINGITIS
has EFO: EFO_0000584
has EFO name: INFECTIOUS MENINGITIS

CHEMBL_IND_46540
type: DrugIndication
chembl id: CHEMBL_IND_46540
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_46937
type: DrugIndication
chembl id: CHEMBL_IND_46937
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D018281
has mesh heading: CHOLANGIOCARCINOMA
has EFO: EFO_0005221
has EFO name: CHOLANGIOCARCINOMA

CHEMBL_IND_41217
type: DrugIndication
chembl id: CHEMBL_IND_41217
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0003869
has EFO name: BREAST NEOPLASM

CHEMBL_IND_28082
type: DrugIndication
chembl id: CHEMBL_IND_28082
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D011087
has mesh heading: POLYCYTHEMIA VERA
has EFO: EFO_0002429
has EFO name: POLYCYTHEMIA VERA

CHEMBL_IND_28081
type: DrugIndication
chembl id: CHEMBL_IND_28081
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D008654
has mesh heading: MESOTHELIOMA
has EFO: EFO_0000588
has EFO name: MESOTHELIOMA

CHEMBL_IND_28080
type: DrugIndication
chembl id: CHEMBL_IND_28080
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_44752
type: DrugIndication
chembl id: CHEMBL_IND_44752
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D055752
has mesh heading: SMALL CELL LUNG CARCINOMA
has EFO: EFO_0000702
has EFO name: SMALL CELL LUNG CARCINOMA

CHEMBL_IND_52266
type: DrugIndication
chembl id: CHEMBL_IND_52266
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_52674
type: DrugIndication
chembl id: CHEMBL_IND_52674
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D018316
has mesh heading: GLIOSARCOMA
has EFO: EFO_1001465
has EFO name: GLIOSARCOMA

CHEMBL_IND_25900
type: DrugIndication
chembl id: CHEMBL_IND_25900
has molecule: CHEMBL1421
highest development phase: 1
has mesh: D012595
has mesh heading: SCLERODERMA, SYSTEMIC
has EFO: EFO_0000717
has EFO name: SYSTEMIC SCLERODERMA

CHEMBL_IND_25899
type: DrugIndication
chembl id: CHEMBL_IND_25899
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0002617
has EFO name: METASTATIC MELANOMA

CHEMBL_IND_25898
type: DrugIndication
chembl id: CHEMBL_IND_25898
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_25897
type: DrugIndication
chembl id: CHEMBL_IND_25897
has molecule: CHEMBL1421
highest development phase: 1
has mesh: D005909
has mesh heading: GLIOBLASTOMA
has EFO: EFO_0000519
has EFO name: GLIOBLASTOMA MULTIFORME

CHEMBL_IND_25896
type: DrugIndication
chembl id: CHEMBL_IND_25896
has molecule: CHEMBL1421
highest development phase: 4
has mesh: D054198
has mesh heading: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
has EFO: EFO_0000220
has EFO name: ACUTE LYMPHOBLASTIC LEUKEMIA

CHEMBL_IND_26488
type: DrugIndication
chembl id: CHEMBL_IND_26488
has molecule: CHEMBL1421
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_26487
type: DrugIndication
chembl id: CHEMBL_IND_26487
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D008654
has mesh heading: MESOTHELIOMA
has EFO: EFO_0000770
has EFO name: MALIGNANT PLEURAL MESOTHELIOMA

CHEMBL_IND_26486
type: DrugIndication
chembl id: CHEMBL_IND_26486
has molecule: CHEMBL1421
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_26485
type: DrugIndication
chembl id: CHEMBL_IND_26485
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_27118
type: DrugIndication
chembl id: CHEMBL_IND_27118
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D016403
has mesh heading: LYMPHOMA, LARGE B-CELL, DIFFUSE
has EFO: EFO_0000403
has EFO name: DIFFUSE LARGE B-CELL LYMPHOMA

CHEMBL_IND_44357
type: DrugIndication
chembl id: CHEMBL_IND_44357
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_44636
type: DrugIndication
chembl id: CHEMBL_IND_44636
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_22986
type: DrugIndication
chembl id: CHEMBL_IND_22986
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000708
has EFO name: SQUAMOUS CELL LUNG CARCINOMA

CHEMBL_IND_22985
type: DrugIndication
chembl id: CHEMBL_IND_22985
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_22984
type: DrugIndication
chembl id: CHEMBL_IND_22984
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_22983
type: DrugIndication
chembl id: CHEMBL_IND_22983
has molecule: CHEMBL1421
highest development phase: 1
has mesh: D008228
has mesh heading: LYMPHOMA, NON-HODGKIN
has EFO: EFO_0005952
has EFO name: NON-HODGKINS LYMPHOMA

CHEMBL_IND_22982
type: DrugIndication
chembl id: CHEMBL_IND_22982
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_22981
type: DrugIndication
chembl id: CHEMBL_IND_22981
has molecule: CHEMBL1421
highest development phase: 3
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_22980
type: DrugIndication
chembl id: CHEMBL_IND_22980
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D015451
has mesh heading: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
has EFO: EFO_0000095
has EFO name: CHRONIC LYMPHOCYTIC LEUKEMIA

CHEMBL_IND_22979
type: DrugIndication
chembl id: CHEMBL_IND_22979
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D008415
has mesh heading: MASTOCYTOSIS
has EFO: HP_0001871
has EFO name: ABNORMALITY OF BLOOD AND BLOOD-FORMING TISSUES

CHEMBL_IND_24305
type: DrugIndication
chembl id: CHEMBL_IND_24305
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_24304
type: DrugIndication
chembl id: CHEMBL_IND_24304
has molecule: CHEMBL1421
highest development phase: 3
has mesh: D015464
has mesh heading: LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE
has EFO: EFO_0000339
has EFO name: CHRONIC MYELOGENOUS LEUKEMIA

CHEMBL_IND_24303
type: DrugIndication
chembl id: CHEMBL_IND_24303
has molecule: CHEMBL1421
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_54381
type: DrugIndication
chembl id: CHEMBL_IND_54381
has molecule: CHEMBL388590
highest development phase: 2
has mesh: D065627
has mesh heading: FAMILIAL PRIMARY PULMONARY HYPERTENSION
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION

CHEMBL_IND_50032
type: DrugIndication
chembl id: CHEMBL_IND_50032
has molecule: CHEMBL388590
highest development phase: 4
has mesh: D006073
has mesh heading: GOUT
has EFO: EFO_0004274
has EFO name: GOUT

CHEMBL_IND_42964
type: DrugIndication
chembl id: CHEMBL_IND_42964
has molecule: CHEMBL400599
highest development phase: 4
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_48131
type: DrugIndication
chembl id: CHEMBL_IND_48131
has molecule: CHEMBL400599
highest development phase: 2
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_55345
type: DrugIndication
chembl id: CHEMBL_IND_55345
has molecule: CHEMBL395091
highest development phase: 3
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_55293
type: DrugIndication
chembl id: CHEMBL_IND_55293
has molecule: CHEMBL395091
highest development phase: 1
has mesh: D008107
has mesh heading: LIVER DISEASES
has EFO: EFO_0001421
has EFO name: LIVER DISEASE

CHEMBL_IND_42741
type: DrugIndication
chembl id: CHEMBL_IND_42741
has molecule: CHEMBL404216
highest development phase: 4
has mesh: D001007
has mesh heading: ANXIETY
has EFO: EFO_0005230
has EFO name: ANXIETY

CHEMBL_IND_26003
type: DrugIndication
chembl id: CHEMBL_IND_26003
has molecule: CHEMBL1512
highest development phase: 4
has mesh: D015508
has mesh heading: NASAL OBSTRUCTION
has EFO: HP_0001742
has EFO name: NASAL OBSTRUCTION

CHEMBL_IND_25326
type: DrugIndication
chembl id: CHEMBL_IND_25326
has molecule: CHEMBL1512
highest development phase: 4
has mesh: D008173
has mesh heading: LUNG DISEASES, OBSTRUCTIVE
has EFO: HP_0006536
has EFO name: OBSTRUCTIVE LUNG DISEASE

CHEMBL_IND_24452
type: DrugIndication
chembl id: CHEMBL_IND_24452
has molecule: CHEMBL1512
highest development phase: 4
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_47876
type: DrugIndication
chembl id: CHEMBL_IND_47876
has molecule: CHEMBL405821
highest development phase: 2
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_47479
type: DrugIndication
chembl id: CHEMBL_IND_47479
has molecule: CHEMBL402548
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_47455
type: DrugIndication
chembl id: CHEMBL_IND_47455
has molecule: CHEMBL402548
highest development phase: 2
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_46895
type: DrugIndication
chembl id: CHEMBL_IND_46895
has molecule: CHEMBL395429
highest development phase: 2
has mesh: D009771
has mesh heading: OBSESSIVE-COMPULSIVE DISORDER
has EFO: EFO_0004242
has EFO name: OBSESSIVE-COMPULSIVE DISORDER

CHEMBL_IND_52391
type: DrugIndication
chembl id: CHEMBL_IND_52391
has molecule: CHEMBL395429
highest development phase: 2
has mesh: D019964
has mesh heading: MOOD DISORDERS
has EFO: EFO_0004247
has EFO name: MOOD DISORDER

CHEMBL_IND_25535
type: DrugIndication
chembl id: CHEMBL_IND_25535
has molecule: CHEMBL395429
highest development phase: 2
has mesh: D057180
has mesh heading: FRONTOTEMPORAL DEMENTIA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: FRONTOTEMPORAL DEMENTIA

CHEMBL_IND_28322
type: DrugIndication
chembl id: CHEMBL_IND_28322
has molecule: CHEMBL395429
highest development phase: 1
has mesh: D009293
has mesh heading: OPIOID-RELATED DISORDERS
has EFO: EFO_0005611
has EFO name: OPIOID DEPENDENCE

CHEMBL_IND_52035
type: DrugIndication
chembl id: CHEMBL_IND_52035
has molecule: CHEMBL395429
highest development phase: 0
has mesh: D018589
has mesh heading: GASTROPARESIS
has EFO: EFO_1000948
has EFO name: GASTROPARESIS

CHEMBL_IND_51996
type: DrugIndication
chembl id: CHEMBL_IND_51996
has molecule: CHEMBL395429
highest development phase: 2
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_26201
type: DrugIndication
chembl id: CHEMBL_IND_26201
has molecule: CHEMBL395429
highest development phase: 2
has mesh: D012735
has mesh heading: SEXUAL DYSFUNCTION, PHYSIOLOGICAL
has EFO: EFO_0004714
has EFO name: SEXUAL DYSFUNCTION

CHEMBL_IND_26200
type: DrugIndication
chembl id: CHEMBL_IND_26200
has molecule: CHEMBL395429
highest development phase: 0
has mesh: D009765
has mesh heading: OBESITY
has EFO: EFO_0001073
has EFO name: OBESITY

CHEMBL_IND_49758
type: DrugIndication
chembl id: CHEMBL_IND_49758
has molecule: CHEMBL395429
highest development phase: 2
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_23639
type: DrugIndication
chembl id: CHEMBL_IND_23639
has molecule: CHEMBL395429
highest development phase: 3
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_23638
type: DrugIndication
chembl id: CHEMBL_IND_23638
has molecule: CHEMBL395429
highest development phase: 0
has mesh: D011225
has mesh heading: PRE-ECLAMPSIA
has EFO: EFO_0000668
has EFO name: PREECLAMPSIA

CHEMBL_IND_23637
type: DrugIndication
chembl id: CHEMBL_IND_23637
has molecule: CHEMBL395429
highest development phase: 2
has mesh: D011218
has mesh heading: PRADER-WILLI SYNDROME
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: PRADER-WILLI SYNDROME

CHEMBL_IND_23636
type: DrugIndication
chembl id: CHEMBL_IND_23636
has molecule: CHEMBL395429
highest development phase: 4
has mesh: D006470
has mesh heading: HEMORRHAGE
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: HEMORRHAGE

CHEMBL_IND_23635
type: DrugIndication
chembl id: CHEMBL_IND_23635
has molecule: CHEMBL395429
highest development phase: 2
has mesh: D002659
has mesh heading: CHILD DEVELOPMENT DISORDERS, PERVASIVE
has EFO: EFO_0003756
has EFO name: AUTISM SPECTRUM DISORDER

CHEMBL_IND_27363
type: DrugIndication
chembl id: CHEMBL_IND_27363
has molecule: CHEMBL395429
highest development phase: 2
has mesh: D005600
has mesh heading: FRAGILE X SYNDROME
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: FRAGILE X SYNDROME

CHEMBL_IND_27362
type: DrugIndication
chembl id: CHEMBL_IND_27362
has molecule: CHEMBL395429
highest development phase: 3
has mesh: D000437
has mesh heading: ALCOHOLISM
has EFO: EFO_0003829
has EFO name: ALCOHOL DEPENDENCE

CHEMBL_IND_51937
type: DrugIndication
chembl id: CHEMBL_IND_51937
has molecule: CHEMBL395429
highest development phase: 2
has mesh: D007249
has mesh heading: INFLAMMATION
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: INFLAMMATION

CHEMBL_IND_24746
type: DrugIndication
chembl id: CHEMBL_IND_24746
has molecule: CHEMBL395429
highest development phase: 2
has mesh: D013313
has mesh heading: STRESS DISORDERS, POST-TRAUMATIC
has EFO: EFO_0001358
has EFO name: POST-TRAUMATIC STRESS DISORDER

CHEMBL_IND_24745
type: DrugIndication
chembl id: CHEMBL_IND_24745
has molecule: CHEMBL395429
highest development phase: 2
has mesh: D009437
has mesh heading: NEURALGIA
has EFO: EFO_0005762
has EFO name: NEUROPATHIC PAIN

CHEMBL_IND_24744
type: DrugIndication
chembl id: CHEMBL_IND_24744
has molecule: CHEMBL395429
highest development phase: 2
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_24743
type: DrugIndication
chembl id: CHEMBL_IND_24743
has molecule: CHEMBL395429
highest development phase: 0
has mesh: D001145
has mesh heading: ARRHYTHMIAS, CARDIAC
has EFO: EFO_0004269
has EFO name: CARDIAC ARRHYTHMIA

CHEMBL_IND_24742
type: DrugIndication
chembl id: CHEMBL_IND_24742
has molecule: CHEMBL395429
highest development phase: 2
has mesh: D001321
has mesh heading: AUTISTIC DISORDER
has EFO: EFO_0003758
has EFO name: AUTISM

CHEMBL_IND_24741
type: DrugIndication
chembl id: CHEMBL_IND_24741
has molecule: CHEMBL395429
highest development phase: 1
has mesh: D013375
has mesh heading: SUBSTANCE WITHDRAWAL SYNDROME
has EFO: EFO_0004777
has EFO name: ALCOHOL WITHDRAWAL

CHEMBL_IND_51677
type: DrugIndication
chembl id: CHEMBL_IND_51677
has molecule: CHEMBL395429
highest development phase: 1
has mesh: D011247
has mesh heading: PREGNANCY
has EFO: EFO_0002950
has EFO name: PREGNANCY

CHEMBL_IND_42565
type: DrugIndication
chembl id: CHEMBL_IND_42565
has molecule: CHEMBL1514
highest development phase: 4
has mesh: D019966
has mesh heading: SUBSTANCE-RELATED DISORDERS
has EFO: EFO_0003890
has EFO name: DRUG DEPENDENCE

CHEMBL_IND_23140
type: DrugIndication
chembl id: CHEMBL_IND_23140
has molecule: CHEMBL1511
highest development phase: 3
has mesh: D007246
has mesh heading: INFERTILITY
has EFO: EFO_0000545
has EFO name: INFERTILITY

CHEMBL_IND_51617
type: DrugIndication
chembl id: CHEMBL_IND_51617
has molecule: CHEMBL1511
highest development phase: 4
has mesh: D016649
has mesh heading: PRIMARY OVARIAN INSUFFICIENCY
has EFO: HP_0001587
has EFO name: PRIMARY OVARIAN FAILURE

CHEMBL_IND_51542
type: DrugIndication
chembl id: CHEMBL_IND_51542
has molecule: CHEMBL1511
highest development phase: 4
has mesh: D007006
has mesh heading: HYPOGONADISM
has EFO: HP_0000135
has EFO name: HYPOGONADISM

CHEMBL_IND_51503
type: DrugIndication
chembl id: CHEMBL_IND_51503
has molecule: CHEMBL1511
highest development phase: 4
has mesh: D008595
has mesh heading: MENORRHAGIA
has EFO: EFO_0003945
has EFO name: MENORRHAGIA

CHEMBL_IND_27027
type: DrugIndication
chembl id: CHEMBL_IND_27027
has molecule: CHEMBL393220
highest development phase: 3
has mesh: D008180
has mesh heading: LUPUS ERYTHEMATOSUS, SYSTEMIC
has EFO: EFO_0002690
has EFO name: SYSTEMIC LUPUS ERYTHEMATOSUS

CHEMBL_IND_27026
type: DrugIndication
chembl id: CHEMBL_IND_27026
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D007251
has mesh heading: INFLUENZA, HUMAN
has EFO: EFO_0001669
has EFO name: INFLUENZA INFECTION

CHEMBL_IND_27025
type: DrugIndication
chembl id: CHEMBL_IND_27025
has molecule: CHEMBL393220
highest development phase: 3
has mesh: D002312
has mesh heading: CARDIOMYOPATHY, HYPERTROPHIC
has EFO: EFO_0000538
has EFO name: HYPERTROPHIC CARDIOMYOPATHY

CHEMBL_IND_27024
type: DrugIndication
chembl id: CHEMBL_IND_27024
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_25799
type: DrugIndication
chembl id: CHEMBL_IND_25799
has molecule: CHEMBL393220
highest development phase: 3
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_25798
type: DrugIndication
chembl id: CHEMBL_IND_25798
has molecule: CHEMBL393220
highest development phase: 3
has mesh: D015228
has mesh heading: HYPERTRIGLYCERIDEMIA
has EFO: EFO_0004211
has EFO name: HYPERTRIGLYCERIDEMIA

CHEMBL_IND_25797
type: DrugIndication
chembl id: CHEMBL_IND_25797
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_25796
type: DrugIndication
chembl id: CHEMBL_IND_25796
has molecule: CHEMBL393220
highest development phase: 4
has mesh: D003327
has mesh heading: CORONARY DISEASE
has EFO: EFO_0001645
has EFO name: CORONARY HEART DISEASE

CHEMBL_IND_25795
type: DrugIndication
chembl id: CHEMBL_IND_25795
has molecule: CHEMBL393220
highest development phase: 1
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_25794
type: DrugIndication
chembl id: CHEMBL_IND_25794
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_49353
type: DrugIndication
chembl id: CHEMBL_IND_49353
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D012595
has mesh heading: SCLERODERMA, SYSTEMIC
has EFO: EFO_0000717
has EFO name: SYSTEMIC SCLERODERMA

CHEMBL_IND_47983
type: DrugIndication
chembl id: CHEMBL_IND_47983
has molecule: CHEMBL393220
highest development phase: 4
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_45273
type: DrugIndication
chembl id: CHEMBL_IND_45273
has molecule: CHEMBL393220
highest development phase: 3
has mesh: D051437
has mesh heading: RENAL INSUFFICIENCY
has EFO: HP_0000083
has EFO name: RENAL INSUFFICIENCY

CHEMBL_IND_52149
type: DrugIndication
chembl id: CHEMBL_IND_52149
has molecule: CHEMBL393220
highest development phase: 0
has mesh: D016889
has mesh heading: ENDOMETRIAL NEOPLASMS
has EFO: EFO_0004230
has EFO name: ENDOMETRIAL NEOPLASM

CHEMBL_IND_41916
type: DrugIndication
chembl id: CHEMBL_IND_41916
has molecule: CHEMBL393220
highest development phase: 4
has mesh: D050171
has mesh heading: DYSLIPIDEMIAS
has EFO: HP_0003119
has EFO name: ABNORMALITY OF LIPID METABOLISM

CHEMBL_IND_48333
type: DrugIndication
chembl id: CHEMBL_IND_48333
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D009303
has mesh heading: NASOPHARYNGEAL NEOPLASMS
has EFO: EFO_0004252
has EFO name: NASOPHARYNGEAL NEOPLASM

CHEMBL_IND_48220
type: DrugIndication
chembl id: CHEMBL_IND_48220
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D065626
has mesh heading: NON-ALCOHOLIC FATTY LIVER DISEASE
has EFO: EFO_0003095
has EFO name: NON-ALCOHOLIC FATTY LIVER DISEASE

CHEMBL_IND_52676
type: DrugIndication
chembl id: CHEMBL_IND_52676
has molecule: CHEMBL393220
highest development phase: 3
has mesh: D016923
has mesh heading: CELL DEATH
has EFO: GO:0008219
has EFO name: CELL DEATH

CHEMBL_IND_43462
type: DrugIndication
chembl id: CHEMBL_IND_43462
has molecule: CHEMBL393220
highest development phase: 4
has mesh: D009203
has mesh heading: MYOCARDIAL INFARCTION
has EFO: EFO_0000612
has EFO name: MYOCARDIAL INFARCTION

CHEMBL_IND_26402
type: DrugIndication
chembl id: CHEMBL_IND_26402
has molecule: CHEMBL393220
highest development phase: 3
has mesh: D024821
has mesh heading: METABOLIC SYNDROME X
has EFO: EFO_0000195
has EFO name: METABOLIC SYNDROME

CHEMBL_IND_26401
type: DrugIndication
chembl id: CHEMBL_IND_26401
has molecule: CHEMBL393220
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_26400
type: DrugIndication
chembl id: CHEMBL_IND_26400
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D006086
has mesh heading: GRAFT VS HOST DISEASE
has EFO: EFO_0004599
has EFO name: ACUTE GRAFT VS. HOST DISEASE

CHEMBL_IND_26399
type: DrugIndication
chembl id: CHEMBL_IND_26399
has molecule: CHEMBL393220
highest development phase: 3
has mesh: D054058
has mesh heading: ACUTE CORONARY SYNDROME
has EFO: EFO_0005672
has EFO name: ACUTE CORONARY SYNDROME

CHEMBL_IND_46030
type: DrugIndication
chembl id: CHEMBL_IND_46030
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D014820
has mesh heading: VITILIGO
has EFO: EFO_0004208
has EFO name: VITILIGO

CHEMBL_IND_27555
type: DrugIndication
chembl id: CHEMBL_IND_27555
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D010518
has mesh heading: PERIODONTITIS
has EFO: EFO_0000649
has EFO name: PERIODONTITIS

CHEMBL_IND_27554
type: DrugIndication
chembl id: CHEMBL_IND_27554
has molecule: CHEMBL393220
highest development phase: 1
has mesh: D009080
has mesh heading: MUCOCUTANEOUS LYMPH NODE SYNDROME
has EFO: EFO_0004246
has EFO name: MUCOCUTANEOUS LYMPH NODE SYNDROME

CHEMBL_IND_27553
type: DrugIndication
chembl id: CHEMBL_IND_27553
has molecule: CHEMBL393220
highest development phase: 1
has mesh: D007319
has mesh heading: SLEEP INITIATION AND MAINTENANCE DISORDERS
has EFO: EFO_0004698
has EFO name: INSOMNIA

CHEMBL_IND_27551
type: DrugIndication
chembl id: CHEMBL_IND_27551
has molecule: CHEMBL393220
highest development phase: 4
has mesh: D006938
has mesh heading: HYPERLIPOPROTEINEMIA TYPE II
has EFO: EFO_0004911
has EFO name: FAMILIAL HYPERCHOLESTEROLEMIA

CHEMBL_IND_52090
type: DrugIndication
chembl id: CHEMBL_IND_52090
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_40076
type: DrugIndication
chembl id: CHEMBL_IND_40076
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0003869
has EFO name: BREAST NEOPLASM

CHEMBL_IND_28023
type: DrugIndication
chembl id: CHEMBL_IND_28023
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D003922
has mesh heading: DIABETES MELLITUS, TYPE 1
has EFO: EFO_0001359
has EFO name: TYPE I DIABETES MELLITUS

CHEMBL_IND_47572
type: DrugIndication
chembl id: CHEMBL_IND_47572
has molecule: CHEMBL393220
highest development phase: 4
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0003144
has EFO name: HEART FAILURE

CHEMBL_IND_22729
type: DrugIndication
chembl id: CHEMBL_IND_22729
has molecule: CHEMBL393220
highest development phase: 3
has mesh: D052439
has mesh heading: LIPID METABOLISM DISORDERS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: DISORDER OF LIPID METABOLISM

CHEMBL_IND_22728
type: DrugIndication
chembl id: CHEMBL_IND_22728
has molecule: CHEMBL393220
highest development phase: 3
has mesh: D006950
has mesh heading: HYPERLIPIDEMIA, FAMILIAL COMBINED
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: COMBINED HYPERLIPIDEMIA

CHEMBL_IND_22727
type: DrugIndication
chembl id: CHEMBL_IND_22727
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_22726
type: DrugIndication
chembl id: CHEMBL_IND_22726
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_25086
type: DrugIndication
chembl id: CHEMBL_IND_25086
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D012507
has mesh heading: SARCOIDOSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SARCOIDOSIS

CHEMBL_IND_25084
type: DrugIndication
chembl id: CHEMBL_IND_25084
has molecule: CHEMBL393220
highest development phase: 3
has mesh: D007674
has mesh heading: KIDNEY DISEASES
has EFO: EFO_0003086
has EFO name: KIDNEY DISEASE

CHEMBL_IND_25083
type: DrugIndication
chembl id: CHEMBL_IND_25083
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000180
has EFO name: HIV-1 INFECTION

CHEMBL_IND_24169
type: DrugIndication
chembl id: CHEMBL_IND_24169
has molecule: CHEMBL393220
highest development phase: 1
has mesh: D003251
has mesh heading: CONSTRICTION, PATHOLOGIC
has EFO: EFO_0006818
has EFO name: STRICTURE

CHEMBL_IND_24168
type: DrugIndication
chembl id: CHEMBL_IND_24168
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D018805
has mesh heading: SEPSIS
has EFO: EFO_0001420
has EFO name: SEPSIS

CHEMBL_IND_24167
type: DrugIndication
chembl id: CHEMBL_IND_24167
has molecule: CHEMBL393220
highest development phase: 3
has mesh: D011225
has mesh heading: PRE-ECLAMPSIA
has EFO: EFO_0000668
has EFO name: PREECLAMPSIA

CHEMBL_IND_24166
type: DrugIndication
chembl id: CHEMBL_IND_24166
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_24165
type: DrugIndication
chembl id: CHEMBL_IND_24165
has molecule: CHEMBL393220
highest development phase: 4
has mesh: D003324
has mesh heading: CORONARY ARTERY DISEASE
has EFO: EFO_0000378
has EFO name: CORONARY ARTERY DISEASE

CHEMBL_IND_24164
type: DrugIndication
chembl id: CHEMBL_IND_24164
has molecule: CHEMBL393220
highest development phase: 3
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_22736
type: DrugIndication
chembl id: CHEMBL_IND_22736
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D014652
has mesh heading: VASCULAR DISEASES
has EFO: EFO_0004264
has EFO name: VASCULAR DISEASE

CHEMBL_IND_22735
type: DrugIndication
chembl id: CHEMBL_IND_22735
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D006976
has mesh heading: HYPERTENSION, PULMONARY
has EFO: EFO_0001361
has EFO name: PULMONARY HYPERTENSION

CHEMBL_IND_22734
type: DrugIndication
chembl id: CHEMBL_IND_22734
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_22733
type: DrugIndication
chembl id: CHEMBL_IND_22733
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D011085
has mesh heading: POLYCYSTIC OVARY SYNDROME
has EFO: EFO_0000660
has EFO name: POLYCYSTIC OVARY SYNDROME

CHEMBL_IND_22732
type: DrugIndication
chembl id: CHEMBL_IND_22732
has molecule: CHEMBL393220
highest development phase: 2
has mesh: D009103
has mesh heading: MULTIPLE SCLEROSIS
has EFO: EFO_0003885
has EFO name: MULTIPLE SCLEROSIS

CHEMBL_IND_22731
type: DrugIndication
chembl id: CHEMBL_IND_22731
has molecule: CHEMBL393220
highest development phase: 4
has mesh: D006949
has mesh heading: HYPERLIPIDEMIAS
has EFO: EFO_0003774
has EFO name: HYPERLIPIDEMIA

CHEMBL_IND_22730
type: DrugIndication
chembl id: CHEMBL_IND_22730
has molecule: CHEMBL393220
highest development phase: 4
has mesh: D006937
has mesh heading: HYPERCHOLESTEROLEMIA
has EFO: HP_0003124
has EFO name: HYPERCHOLESTEROLEMIA

CHEMBL_IND_26764
type: DrugIndication
chembl id: CHEMBL_IND_26764
has molecule: CHEMBL193
highest development phase: 3
has mesh: D007669
has mesh heading: KIDNEY CALCULI
has EFO: EFO_0003845
has EFO name: KIDNEY STONE

CHEMBL_IND_42953
type: DrugIndication
chembl id: CHEMBL_IND_42953
has molecule: CHEMBL193
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_23573
type: DrugIndication
chembl id: CHEMBL_IND_23573
has molecule: CHEMBL193
highest development phase: 3
has mesh: D047928
has mesh heading: PREMATURE BIRTH
has EFO: EFO_0003917
has EFO name: PREMATURE BIRTH

CHEMBL_IND_23572
type: DrugIndication
chembl id: CHEMBL_IND_23572
has molecule: CHEMBL193
highest development phase: 2
has mesh: D005401
has mesh heading: FISSURE IN ANO
has EFO: HP_0012390
has EFO name: ANAL FISSURE

CHEMBL_IND_44600
type: DrugIndication
chembl id: CHEMBL_IND_44600
has molecule: CHEMBL409542
highest development phase: 2
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_51474
type: DrugIndication
chembl id: CHEMBL_IND_51474
has molecule: CHEMBL409542
highest development phase: 4
has mesh: D007169
has mesh heading: IMPETIGO
has EFO: EFO_1000714
has EFO name: IMPETIGO

CHEMBL_IND_43049
type: DrugIndication
chembl id: CHEMBL_IND_43049
has molecule: CHEMBL398615
highest development phase: 4
has mesh: D009325
has mesh heading: NAUSEA
has EFO: HP_0002018
has EFO name: NAUSEA

CHEMBL_IND_50262
type: DrugIndication
chembl id: CHEMBL_IND_50262
has molecule: CHEMBL1516
highest development phase: 3
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_50976
type: DrugIndication
chembl id: CHEMBL_IND_50976
has molecule: CHEMBL1516
highest development phase: 3
has mesh: D001281
has mesh heading: ATRIAL FIBRILLATION
has EFO: EFO_0000275
has EFO name: ATRIAL FIBRILLATION

CHEMBL_IND_50029
type: DrugIndication
chembl id: CHEMBL_IND_50029
has molecule: CHEMBL1505
highest development phase: 4
has mesh: D008881
has mesh heading: MIGRAINE DISORDERS
has EFO: EFO_0003821
has EFO name: MIGRAINE DISORDER

CHEMBL_IND_49288
type: DrugIndication
chembl id: CHEMBL_IND_49288
has molecule: CHEMBL415049
highest development phase: 1
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_47853
type: DrugIndication
chembl id: CHEMBL_IND_47853
has molecule: CHEMBL415049
highest development phase: 2
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_49637
type: DrugIndication
chembl id: CHEMBL_IND_49637
has molecule: CHEMBL408403
highest development phase: 1
has mesh: D012772
has mesh heading: SHOCK, SEPTIC
has EFO: EFO_0006834
has EFO name: SEPTIC SHOCK

CHEMBL_IND_44729
type: DrugIndication
chembl id: CHEMBL_IND_44729
has molecule: CHEMBL415324
highest development phase: 2
has mesh: D001172
has mesh heading: ARTHRITIS, RHEUMATOID
has EFO: EFO_0000685
has EFO name: RHEUMATOID ARTHRITIS

CHEMBL_IND_28065
type: DrugIndication
chembl id: CHEMBL_IND_28065
has molecule: CHEMBL134
highest development phase: 1
has mesh: D009293
has mesh heading: OPIOID-RELATED DISORDERS
has EFO: EFO_0005611
has EFO name: OPIOID DEPENDENCE

CHEMBL_IND_52410
type: DrugIndication
chembl id: CHEMBL_IND_52410
has molecule: CHEMBL134
highest development phase: 2
has mesh: D003929
has mesh heading: DIABETIC NEUROPATHIES
has EFO: EFO_1000783
has EFO name: DIABETIC NEUROPATHY

CHEMBL_IND_52323
type: DrugIndication
chembl id: CHEMBL_IND_52323
has molecule: CHEMBL134
highest development phase: 1
has mesh: D002545
has mesh heading: BRAIN ISCHEMIA
has EFO: HP_0002637
has EFO name: CEREBRAL ISCHEMIA

CHEMBL_IND_48325
type: DrugIndication
chembl id: CHEMBL_IND_48325
has molecule: CHEMBL134
highest development phase: 2
has mesh: D002189
has mesh heading: MARIJUANA ABUSE
has EFO: EFO_0004218
has EFO name: MARIJUANA DEPENDENCE

CHEMBL_IND_25877
type: DrugIndication
chembl id: CHEMBL_IND_25877
has molecule: CHEMBL134
highest development phase: 2
has mesh: D012772
has mesh heading: SHOCK, SEPTIC
has EFO: EFO_0006834
has EFO name: SEPTIC SHOCK

CHEMBL_IND_25876
type: DrugIndication
chembl id: CHEMBL_IND_25876
has molecule: CHEMBL134
highest development phase: 2
has mesh: D009357
has mesh heading: NEONATAL ABSTINENCE SYNDROME
has EFO: EFO_0005799
has EFO name: NEONATAL ABSTINENCE SYNDROME

CHEMBL_IND_51987
type: DrugIndication
chembl id: CHEMBL_IND_51987
has molecule: CHEMBL134
highest development phase: 2
has mesh: D002659
has mesh heading: CHILD DEVELOPMENT DISORDERS, PERVASIVE
has EFO: EFO_0003756
has EFO name: AUTISM SPECTRUM DISORDER

CHEMBL_IND_27617
type: DrugIndication
chembl id: CHEMBL_IND_27617
has molecule: CHEMBL134
highest development phase: 2
has mesh: D001007
has mesh heading: ANXIETY
has EFO: EFO_0005230
has EFO name: ANXIETY

CHEMBL_IND_22926
type: DrugIndication
chembl id: CHEMBL_IND_22926
has molecule: CHEMBL134
highest development phase: 2
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_22924
type: DrugIndication
chembl id: CHEMBL_IND_22924
has molecule: CHEMBL134
highest development phase: 4
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_22923
type: DrugIndication
chembl id: CHEMBL_IND_22923
has molecule: CHEMBL134
highest development phase: 4
has mesh: D005901
has mesh heading: GLAUCOMA
has EFO: EFO_0000516
has EFO name: GLAUCOMA

CHEMBL_IND_22920
type: DrugIndication
chembl id: CHEMBL_IND_22920
has molecule: CHEMBL134
highest development phase: 3
has mesh: D001289
has mesh heading: ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY
has EFO: EFO_0003888
has EFO name: ATTENTION DEFICIT HYPERACTIVITY DISORDER

CHEMBL_IND_25185
type: DrugIndication
chembl id: CHEMBL_IND_25185
has molecule: CHEMBL134
highest development phase: 4
has mesh: D008881
has mesh heading: MIGRAINE DISORDERS
has EFO: EFO_0003821
has EFO name: MIGRAINE DISORDER

CHEMBL_IND_25183
type: DrugIndication
chembl id: CHEMBL_IND_25183
has molecule: CHEMBL134
highest development phase: 3
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_42021
type: DrugIndication
chembl id: CHEMBL_IND_42021
has molecule: CHEMBL408513
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_28028
type: DrugIndication
chembl id: CHEMBL_IND_28028
has molecule: CHEMBL408513
highest development phase: 4
has mesh: D016411
has mesh heading: LYMPHOMA, T-CELL, PERIPHERAL
has EFO: EFO_0000211
has EFO name: UNSPECIFIED PERIPHERAL T-CELL LYMPHOMA

CHEMBL_IND_49120
type: DrugIndication
chembl id: CHEMBL_IND_49120
has molecule: CHEMBL408513
highest development phase: 1
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_43461
type: DrugIndication
chembl id: CHEMBL_IND_43461
has molecule: CHEMBL408513
highest development phase: 2
has mesh: D008654
has mesh heading: MESOTHELIOMA
has EFO: EFO_0000588
has EFO name: MESOTHELIOMA

CHEMBL_IND_26409
type: DrugIndication
chembl id: CHEMBL_IND_26409
has molecule: CHEMBL408513
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_46286
type: DrugIndication
chembl id: CHEMBL_IND_46286
has molecule: CHEMBL408513
highest development phase: 2
has mesh: D009190
has mesh heading: MYELODYSPLASTIC SYNDROMES
has EFO: EFO_0000198
has EFO name: MYELODYSPLASTIC SYNDROME

CHEMBL_IND_43157
type: DrugIndication
chembl id: CHEMBL_IND_43157
has molecule: CHEMBL408513
highest development phase: 2
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_44645
type: DrugIndication
chembl id: CHEMBL_IND_44645
has molecule: CHEMBL408513
highest development phase: 1
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_54511
type: DrugIndication
chembl id: CHEMBL_IND_54511
has molecule: CHEMBL858
highest development phase: 1
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_51450
type: DrugIndication
chembl id: CHEMBL_IND_51450
has molecule: CHEMBL422330
highest development phase: 4
has mesh: D008288
has mesh heading: MALARIA
has EFO: EFO_0001068
has EFO name: MALARIA

CHEMBL_IND_51874
type: DrugIndication
chembl id: CHEMBL_IND_51874
has molecule: CHEMBL422330
highest development phase: 2
has mesh: D016780
has mesh heading: MALARIA, VIVAX
has EFO: EFO_0007445
has EFO name: PLASMODIUM VIVAX MALARIA

CHEMBL_IND_25484
type: DrugIndication
chembl id: CHEMBL_IND_25484
has molecule: CHEMBL866
highest development phase: 3
has mesh: D006086
has mesh heading: GRAFT VS HOST DISEASE
has EFO: EFO_0004599
has EFO name: ACUTE GRAFT VS. HOST DISEASE

CHEMBL_IND_47632
type: DrugIndication
chembl id: CHEMBL_IND_47632
has molecule: CHEMBL866
highest development phase: 1
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_41730
type: DrugIndication
chembl id: CHEMBL_IND_41730
has molecule: CHEMBL866
highest development phase: 4
has mesh: D007154
has mesh heading: IMMUNE SYSTEM DISEASES
has EFO: EFO_0000540
has EFO name: IMMUNE SYSTEM DISEASE

CHEMBL_IND_53429
type: DrugIndication
chembl id: CHEMBL_IND_53429
has molecule: CHEMBL422648
highest development phase: 3
has mesh: D005759
has mesh heading: GASTROENTERITIS
has EFO: EFO_1001463
has EFO name: GASTROENTERITIS

CHEMBL_IND_47564
type: DrugIndication
chembl id: CHEMBL_IND_47564
has molecule: CHEMBL422648
highest development phase: 2
has mesh: D014552
has mesh heading: URINARY TRACT INFECTIONS
has EFO: EFO_0003103
has EFO name: URINARY TRACT INFECTION

CHEMBL_IND_40376
type: DrugIndication
chembl id: CHEMBL_IND_40376
has molecule: CHEMBL422648
highest development phase: 3
has mesh: D029481
has mesh heading: BRONCHITIS, CHRONIC
has EFO: EFO_0006505
has EFO name: CHRONIC BRONCHITIS

CHEMBL_IND_47721
type: DrugIndication
chembl id: CHEMBL_IND_47721
has molecule: CHEMBL426084
highest development phase: 2
has mesh: D001068
has mesh heading: EATING DISORDERS
has EFO: EFO_0005203
has EFO name: EATING DISORDER

CHEMBL_IND_47504
type: DrugIndication
chembl id: CHEMBL_IND_47504
has molecule: CHEMBL426084
highest development phase: 1
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_24424
type: DrugIndication
chembl id: CHEMBL_IND_24424
has molecule: CHEMBL464
highest development phase: 4
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_28502
type: DrugIndication
chembl id: CHEMBL_IND_28502
has molecule: CHEMBL932
highest development phase: 4
has mesh: D013927
has mesh heading: THROMBOSIS
has EFO: HP_0004419
has EFO name: RECURRENT THROMBOPHLEBITIS

CHEMBL_IND_23044
type: DrugIndication
chembl id: CHEMBL_IND_23044
has molecule: CHEMBL932
highest development phase: 2
has mesh: D001172
has mesh heading: ARTHRITIS, RHEUMATOID
has EFO: EFO_0000685
has EFO name: RHEUMATOID ARTHRITIS

CHEMBL_IND_24357
type: DrugIndication
chembl id: CHEMBL_IND_24357
has molecule: CHEMBL932
highest development phase: 1
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_26024
type: DrugIndication
chembl id: CHEMBL_IND_26024
has molecule: CHEMBL970
highest development phase: 4
has mesh: D001007
has mesh heading: ANXIETY
has EFO: EFO_0005230
has EFO name: ANXIETY

CHEMBL_IND_49983
type: DrugIndication
chembl id: CHEMBL_IND_49983
has molecule: CHEMBL434200
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_27519
type: DrugIndication
chembl id: CHEMBL_IND_27519
has molecule: CHEMBL1224
highest development phase: 4
has mesh: D006967
has mesh heading: HYPERSENSITIVITY
has EFO: EFO_0003785
has EFO name: ALLERGY

CHEMBL_IND_52963
type: DrugIndication
chembl id: CHEMBL_IND_52963
has molecule: CHEMBL1027
highest development phase: 3
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_54291
type: DrugIndication
chembl id: CHEMBL_IND_54291
has molecule: CHEMBL1027
highest development phase: 2
has mesh: D020181
has mesh heading: SLEEP APNEA, OBSTRUCTIVE
has EFO: EFO_0003918
has EFO name: OBSTRUCTIVE SLEEP APNEA

CHEMBL_IND_53344
type: DrugIndication
chembl id: CHEMBL_IND_53344
has molecule: CHEMBL1027
highest development phase: 1
has mesh: D000437
has mesh heading: ALCOHOLISM
has EFO: EFO_0003829
has EFO name: ALCOHOL DEPENDENCE

CHEMBL_IND_52794
type: DrugIndication
chembl id: CHEMBL_IND_52794
has molecule: CHEMBL1027
highest development phase: 4
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_50827
type: DrugIndication
chembl id: CHEMBL_IND_50827
has molecule: CHEMBL434394
highest development phase: 3
has mesh: D008382
has mesh heading: MARFAN SYNDROME
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: MARFAN SYNDROME

CHEMBL_IND_50104
type: DrugIndication
chembl id: CHEMBL_IND_50104
has molecule: CHEMBL434394
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_50263
type: DrugIndication
chembl id: CHEMBL_IND_50263
has molecule: CHEMBL434394
highest development phase: 4
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_44864
type: DrugIndication
chembl id: CHEMBL_IND_44864
has molecule: CHEMBL435883
highest development phase: 3
has mesh: D006976
has mesh heading: HYPERTENSION, PULMONARY
has EFO: EFO_0001361
has EFO name: PULMONARY HYPERTENSION

CHEMBL_IND_50207
type: DrugIndication
chembl id: CHEMBL_IND_50207
has molecule: CHEMBL435966
highest development phase: 3
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000181
has EFO name: HEAD AND NECK SQUAMOUS CELL CARCINOMA

CHEMBL_IND_52354
type: DrugIndication
chembl id: CHEMBL_IND_52354
has molecule: CHEMBL1251
highest development phase: 0
has mesh: D011085
has mesh heading: POLYCYSTIC OVARY SYNDROME
has EFO: EFO_0000660
has EFO name: POLYCYSTIC OVARY SYNDROME

CHEMBL_IND_25343
type: DrugIndication
chembl id: CHEMBL_IND_25343
has molecule: CHEMBL1251
highest development phase: 3
has mesh: D007246
has mesh heading: INFERTILITY
has EFO: EFO_0000545
has EFO name: INFERTILITY

CHEMBL_IND_49754
type: DrugIndication
chembl id: CHEMBL_IND_49754
has molecule: CHEMBL435381
highest development phase: 2
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_50545
type: DrugIndication
chembl id: CHEMBL_IND_50545
has molecule: CHEMBL1502
highest development phase: 2
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_50689
type: DrugIndication
chembl id: CHEMBL_IND_50689
has molecule: CHEMBL1502
highest development phase: 3
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_50097
type: DrugIndication
chembl id: CHEMBL_IND_50097
has molecule: CHEMBL1502
highest development phase: 4
has mesh: D010437
has mesh heading: PEPTIC ULCER
has EFO: HP_0004398
has EFO name: PEPTIC ULCER

CHEMBL_IND_50436
type: DrugIndication
chembl id: CHEMBL_IND_50436
has molecule: CHEMBL1502
highest development phase: 3
has mesh: D006471
has mesh heading: GASTROINTESTINAL HEMORRHAGE
has EFO: HP_0002239
has EFO name: GASTROINTESTINAL HEMORRHAGE

CHEMBL_IND_55055
type: DrugIndication
chembl id: CHEMBL_IND_55055
has molecule: CHEMBL1502
highest development phase: 3
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0000373
has EFO name: CONGESTIVE HEART FAILURE

CHEMBL_IND_50031
type: DrugIndication
chembl id: CHEMBL_IND_50031
has molecule: CHEMBL1502
highest development phase: 4
has mesh: D005764
has mesh heading: GASTROESOPHAGEAL REFLUX
has EFO: EFO_0003948
has EFO name: GASTROESOPHAGEAL REFLUX DISEASE

CHEMBL_IND_55027
type: DrugIndication
chembl id: CHEMBL_IND_55027
has molecule: CHEMBL1502
highest development phase: 1
has mesh: D054058
has mesh heading: ACUTE CORONARY SYNDROME
has EFO: EFO_0005672
has EFO name: ACUTE CORONARY SYNDROME

CHEMBL_IND_54983
type: DrugIndication
chembl id: CHEMBL_IND_54983
has molecule: CHEMBL1502
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_54026
type: DrugIndication
chembl id: CHEMBL_IND_54026
has molecule: CHEMBL429317
highest development phase: 1
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_49582
type: DrugIndication
chembl id: CHEMBL_IND_49582
has molecule: CHEMBL428647
highest development phase: 2
has mesh: D016889
has mesh heading: ENDOMETRIAL NEOPLASMS
has EFO: EFO_0004230
has EFO name: ENDOMETRIAL NEOPLASM

CHEMBL_IND_26792
type: DrugIndication
chembl id: CHEMBL_IND_26792
has molecule: CHEMBL428647
highest development phase: 2
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_26791
type: DrugIndication
chembl id: CHEMBL_IND_26791
has molecule: CHEMBL428647
highest development phase: 2
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_26790
type: DrugIndication
chembl id: CHEMBL_IND_26790
has molecule: CHEMBL428647
highest development phase: 3
has mesh: D012514
has mesh heading: SARCOMA, KAPOSI
has EFO: EFO_0000558
has EFO name: KAPOSI'S SARCOMA

CHEMBL_IND_52044
type: DrugIndication
chembl id: CHEMBL_IND_52044
has molecule: CHEMBL428647
highest development phase: 1
has mesh: D010534
has mesh heading: PERITONEAL NEOPLASMS
has EFO: EFO_1001100
has EFO name: PERITONEAL NEOPLASM

CHEMBL_IND_52151
type: DrugIndication
chembl id: CHEMBL_IND_52151
has molecule: CHEMBL428647
highest development phase: 3
has mesh: D058729
has mesh heading: PERIPHERAL ARTERIAL DISEASE
has EFO: EFO_0004265
has EFO name: PERIPHERAL ARTERIAL DISEASE

CHEMBL_IND_48589
type: DrugIndication
chembl id: CHEMBL_IND_48589
has molecule: CHEMBL428647
highest development phase: 3
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000389
has EFO name: CUTANEOUS MELANOMA

CHEMBL_IND_48389
type: DrugIndication
chembl id: CHEMBL_IND_48389
has molecule: CHEMBL428647
highest development phase: 1
has mesh: D018567
has mesh heading: BREAST NEOPLASMS, MALE
has EFO: EFO_0006861
has EFO name: MALE BREAST CARCINOMA

CHEMBL_IND_25540
type: DrugIndication
chembl id: CHEMBL_IND_25540
has molecule: CHEMBL428647
highest development phase: 3
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000708
has EFO name: SQUAMOUS CELL LUNG CARCINOMA

CHEMBL_IND_25539
type: DrugIndication
chembl id: CHEMBL_IND_25539
has molecule: CHEMBL428647
highest development phase: 2
has mesh: D055752
has mesh heading: SMALL CELL LUNG CARCINOMA
has EFO: EFO_0000702
has EFO name: SMALL CELL LUNG CARCINOMA

CHEMBL_IND_25538
type: DrugIndication
chembl id: CHEMBL_IND_25538
has molecule: CHEMBL428647
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_25537
type: DrugIndication
chembl id: CHEMBL_IND_25537
has molecule: CHEMBL428647
highest development phase: 1
has mesh: D023903
has mesh heading: CORONARY RESTENOSIS
has EFO: EFO_0004224
has EFO name: CORONARY RESTENOSIS

CHEMBL_IND_28324
type: DrugIndication
chembl id: CHEMBL_IND_28324
has molecule: CHEMBL428647
highest development phase: 1
has mesh: D014594
has mesh heading: UTERINE NEOPLASMS
has EFO: EFO_0003859
has EFO name: UTERINE NEOPLASM

CHEMBL_IND_28323
type: DrugIndication
chembl id: CHEMBL_IND_28323
has molecule: CHEMBL428647
highest development phase: 1
has mesh: D013964
has mesh heading: THYROID NEOPLASMS
has EFO: EFO_0002892
has EFO name: THYROID CARCINOMA

CHEMBL_IND_45389
type: DrugIndication
chembl id: CHEMBL_IND_45389
has molecule: CHEMBL428647
highest development phase: 1
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_52714
type: DrugIndication
chembl id: CHEMBL_IND_52714
has molecule: CHEMBL428647
highest development phase: 2
has mesh: D002277
has mesh heading: CARCINOMA
has EFO: EFO_0000313
has EFO name: CARCINOMA

CHEMBL_IND_52623
type: DrugIndication
chembl id: CHEMBL_IND_52623
has molecule: CHEMBL428647
highest development phase: 2
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0003860
has EFO name: PANCREATIC NEOPLASM

CHEMBL_IND_49165
type: DrugIndication
chembl id: CHEMBL_IND_49165
has molecule: CHEMBL428647
highest development phase: 2
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000292
has EFO name: BLADDER CARCINOMA

CHEMBL_IND_43382
type: DrugIndication
chembl id: CHEMBL_IND_43382
has molecule: CHEMBL428647
highest development phase: 1
has mesh: D005909
has mesh heading: GLIOBLASTOMA
has EFO: EFO_0000519
has EFO name: GLIOBLASTOMA MULTIFORME

CHEMBL_IND_26202
type: DrugIndication
chembl id: CHEMBL_IND_26202
has molecule: CHEMBL428647
highest development phase: 3
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000707
has EFO name: SQUAMOUS CELL CARCINOMA

CHEMBL_IND_49699
type: DrugIndication
chembl id: CHEMBL_IND_49699
has molecule: CHEMBL428647
highest development phase: 2
has mesh: D046152
has mesh heading: GASTROINTESTINAL STROMAL TUMORS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: GASTROINTESTINAL STROMAL TUMOR

CHEMBL_IND_44352
type: DrugIndication
chembl id: CHEMBL_IND_44352
has molecule: CHEMBL428647
highest development phase: 3
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000181
has EFO name: HEAD AND NECK SQUAMOUS CELL CARCINOMA

CHEMBL_IND_52102
type: DrugIndication
chembl id: CHEMBL_IND_52102
has molecule: CHEMBL428647
highest development phase: 2
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_40069
type: DrugIndication
chembl id: CHEMBL_IND_40069
has molecule: CHEMBL428647
highest development phase: 4
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0003869
has EFO name: BREAST NEOPLASM

CHEMBL_IND_23645
type: DrugIndication
chembl id: CHEMBL_IND_23645
has molecule: CHEMBL428647
highest development phase: 3
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_23644
type: DrugIndication
chembl id: CHEMBL_IND_23644
has molecule: CHEMBL428647
highest development phase: 3
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0002617
has EFO name: METASTATIC MELANOMA

CHEMBL_IND_23643
type: DrugIndication
chembl id: CHEMBL_IND_23643
has molecule: CHEMBL428647
highest development phase: 3
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_23642
type: DrugIndication
chembl id: CHEMBL_IND_23642
has molecule: CHEMBL428647
highest development phase: 3
has mesh: D013274
has mesh heading: STOMACH NEOPLASMS
has EFO: EFO_0000178
has EFO name: GASTRIC CARCINOMA

CHEMBL_IND_23641
type: DrugIndication
chembl id: CHEMBL_IND_23641
has molecule: CHEMBL428647
highest development phase: 3
has mesh: D013274
has mesh heading: STOMACH NEOPLASMS
has EFO: EFO_0000503
has EFO name: GASTRIC ADENOCARCINOMA

CHEMBL_IND_23640
type: DrugIndication
chembl id: CHEMBL_IND_23640
has molecule: CHEMBL428647
highest development phase: 4
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_27863
type: DrugIndication
chembl id: CHEMBL_IND_27863
has molecule: CHEMBL428647
highest development phase: 2
has mesh: D016491
has mesh heading: PERIPHERAL VASCULAR DISEASES
has EFO: EFO_0003875
has EFO name: PERIPHERAL VASCULAR DISEASE

CHEMBL_IND_27364
type: DrugIndication
chembl id: CHEMBL_IND_27364
has molecule: CHEMBL428647
highest development phase: 2
has mesh: D004938
has mesh heading: ESOPHAGEAL NEOPLASMS
has EFO: EFO_0002916
has EFO name: ESOPHAGEAL CARCINOMA

CHEMBL_IND_47182
type: DrugIndication
chembl id: CHEMBL_IND_47182
has molecule: CHEMBL428647
highest development phase: 2
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_24751
type: DrugIndication
chembl id: CHEMBL_IND_24751
has molecule: CHEMBL428647
highest development phase: 2
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: EFO_0001075
has EFO name: OVARIAN CARCINOMA

CHEMBL_IND_24750
type: DrugIndication
chembl id: CHEMBL_IND_24750
has molecule: CHEMBL428647
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_24749
type: DrugIndication
chembl id: CHEMBL_IND_24749
has molecule: CHEMBL428647
highest development phase: 3
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_24748
type: DrugIndication
chembl id: CHEMBL_IND_24748
has molecule: CHEMBL428647
highest development phase: 3
has mesh: D002583
has mesh heading: UTERINE CERVICAL NEOPLASMS
has EFO: EFO_0001061
has EFO name: CERVICAL CARCINOMA

CHEMBL_IND_24747
type: DrugIndication
chembl id: CHEMBL_IND_24747
has molecule: CHEMBL428647
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_51769
type: DrugIndication
chembl id: CHEMBL_IND_51769
has molecule: CHEMBL428647
highest development phase: 2
has mesh: D015266
has mesh heading: CARCINOMA, MERKEL CELL
has EFO: EFO_1001471
has EFO name: MERKEL CELL SKIN CANCER

CHEMBL_IND_43759
type: DrugIndication
chembl id: CHEMBL_IND_43759
has molecule: CHEMBL428690
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_45787
type: DrugIndication
chembl id: CHEMBL_IND_45787
has molecule: CHEMBL428690
highest development phase: 2
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_43445
type: DrugIndication
chembl id: CHEMBL_IND_43445
has molecule: CHEMBL428690
highest development phase: 2
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_46260
type: DrugIndication
chembl id: CHEMBL_IND_46260
has molecule: CHEMBL428690
highest development phase: 2
has mesh: D015451
has mesh heading: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
has EFO: EFO_0000095
has EFO name: CHRONIC LYMPHOCYTIC LEUKEMIA

CHEMBL_IND_44898
type: DrugIndication
chembl id: CHEMBL_IND_44898
has molecule: CHEMBL428690
highest development phase: 1
has mesh: D019337
has mesh heading: HEMATOLOGIC NEOPLASMS
has EFO: EFO_0001642
has EFO name: LYMPHOID NEOPLASM

CHEMBL_IND_44664
type: DrugIndication
chembl id: CHEMBL_IND_44664
has molecule: CHEMBL428690
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_27039
type: DrugIndication
chembl id: CHEMBL_IND_27039
has molecule: CHEMBL1497
highest development phase: 3
has mesh: D003876
has mesh heading: DERMATITIS, ATOPIC
has EFO: EFO_0000274
has EFO name: ATOPIC ECZEMA

CHEMBL_IND_25820
type: DrugIndication
chembl id: CHEMBL_IND_25820
has molecule: CHEMBL1497
highest development phase: 4
has mesh: D008173
has mesh heading: LUNG DISEASES, OBSTRUCTIVE
has EFO: HP_0006536
has EFO name: OBSTRUCTIVE LUNG DISEASE

CHEMBL_IND_25819
type: DrugIndication
chembl id: CHEMBL_IND_25819
has molecule: CHEMBL1497
highest development phase: 4
has mesh: D005128
has mesh heading: EYE DISEASES
has EFO: EFO_0005752
has EFO name: EYE INFLAMMATION

CHEMBL_IND_52598
type: DrugIndication
chembl id: CHEMBL_IND_52598
has molecule: CHEMBL1497
highest development phase: 1
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_24196
type: DrugIndication
chembl id: CHEMBL_IND_24196
has molecule: CHEMBL1497
highest development phase: 4
has mesh: D015508
has mesh heading: NASAL OBSTRUCTION
has EFO: HP_0001742
has EFO name: NASAL OBSTRUCTION

CHEMBL_IND_43953
type: DrugIndication
chembl id: CHEMBL_IND_43953
has molecule: CHEMBL1550
highest development phase: 2
has mesh: D015663
has mesh heading: OSTEOPOROSIS, POSTMENOPAUSAL
has EFO: EFO_0003854
has EFO name: POSTMENOPAUSAL OSTEOPOROSIS

CHEMBL_IND_52451
type: DrugIndication
chembl id: CHEMBL_IND_52451
has molecule: CHEMBL1550
highest development phase: 3
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_52254
type: DrugIndication
chembl id: CHEMBL_IND_52254
has molecule: CHEMBL1550
highest development phase: 2
has mesh: D007674
has mesh heading: KIDNEY DISEASES
has EFO: EFO_0003086
has EFO name: KIDNEY DISEASE

CHEMBL_IND_41817
type: DrugIndication
chembl id: CHEMBL_IND_41817
has molecule: CHEMBL922
highest development phase: 4
has mesh: D019694
has mesh heading: HEPATITIS B, CHRONIC
has EFO: EFO_0004239
has EFO name: CHRONIC HEPATITIS B INFECTION

CHEMBL_IND_41815
type: DrugIndication
chembl id: CHEMBL_IND_41815
has molecule: CHEMBL922
highest development phase: 4
has mesh: D019694
has mesh heading: HEPATITIS B, CHRONIC
has EFO: EFO_0004197
has EFO name: HEPATITIS B INFECTION

CHEMBL_IND_53996
type: DrugIndication
chembl id: CHEMBL_IND_53996
has molecule: CHEMBL429876
highest development phase: 2
has mesh: D005909
has mesh heading: GLIOBLASTOMA
has EFO: EFO_0000519
has EFO name: GLIOBLASTOMA MULTIFORME

CHEMBL_IND_54144
type: DrugIndication
chembl id: CHEMBL_IND_54144
has molecule: CHEMBL429876
highest development phase: 2
has mesh: D018316
has mesh heading: GLIOSARCOMA
has EFO: EFO_1001465
has EFO name: GLIOSARCOMA

CHEMBL_IND_50515
type: DrugIndication
chembl id: CHEMBL_IND_50515
has molecule: CHEMBL429876
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_50749
type: DrugIndication
chembl id: CHEMBL_IND_50749
has molecule: CHEMBL429876
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_50714
type: DrugIndication
chembl id: CHEMBL_IND_50714
has molecule: CHEMBL429876
highest development phase: 1
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_54972
type: DrugIndication
chembl id: CHEMBL_IND_54972
has molecule: CHEMBL429876
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_24847
type: DrugIndication
chembl id: CHEMBL_IND_24847
has molecule: CHEMBL1668
highest development phase: 4
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_49534
type: DrugIndication
chembl id: CHEMBL_IND_49534
has molecule: CHEMBL449317
highest development phase: 3
has mesh: D010024
has mesh heading: OSTEOPOROSIS
has EFO: EFO_0003882
has EFO name: OSTEOPOROSIS

CHEMBL_IND_53059
type: DrugIndication
chembl id: CHEMBL_IND_53059
has molecule: CHEMBL448343
highest development phase: 2
has mesh: D005764
has mesh heading: GASTROESOPHAGEAL REFLUX
has EFO: EFO_0003948
has EFO name: GASTROESOPHAGEAL REFLUX DISEASE

CHEMBL_IND_40540
type: DrugIndication
chembl id: CHEMBL_IND_40540
has molecule: CHEMBL1200335
highest development phase: 1
has mesh: D002100
has mesh heading: CACHEXIA
has EFO: HP_0004326
has EFO name: CACHEXIA

CHEMBL_IND_27950
type: DrugIndication
chembl id: CHEMBL_IND_27950
has molecule: CHEMBL1200335
highest development phase: 3
has mesh: D007006
has mesh heading: HYPOGONADISM
has EFO: HP_0000135
has EFO name: HYPOGONADISM

CHEMBL_IND_25760
type: DrugIndication
chembl id: CHEMBL_IND_25760
has molecule: CHEMBL705
highest development phase: 2
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_25759
type: DrugIndication
chembl id: CHEMBL_IND_25759
has molecule: CHEMBL705
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_27528
type: DrugIndication
chembl id: CHEMBL_IND_27528
has molecule: CHEMBL705
highest development phase: 4
has mesh: D004485
has mesh heading: ECZEMA
has EFO: HP_0000964
has EFO name: ECZEMA

CHEMBL_IND_28007
type: DrugIndication
chembl id: CHEMBL_IND_28007
has molecule: CHEMBL705
highest development phase: 2
has mesh: D008178
has mesh heading: LUPUS ERYTHEMATOSUS, CUTANEOUS
has EFO: EFO_0003834
has EFO name: CUTANEOUS LUPUS ERYTHEMATOSUS

CHEMBL_IND_53588
type: DrugIndication
chembl id: CHEMBL_IND_53588
has molecule: CHEMBL447664
highest development phase: 2
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_55274
type: DrugIndication
chembl id: CHEMBL_IND_55274
has molecule: CHEMBL443684
highest development phase: 1
has mesh: D055752
has mesh heading: SMALL CELL LUNG CARCINOMA
has EFO: EFO_0000702
has EFO name: SMALL CELL LUNG CARCINOMA

CHEMBL_IND_50277
type: DrugIndication
chembl id: CHEMBL_IND_50277
has molecule: CHEMBL443684
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_55050
type: DrugIndication
chembl id: CHEMBL_IND_55050
has molecule: CHEMBL443684
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_55041
type: DrugIndication
chembl id: CHEMBL_IND_55041
has molecule: CHEMBL443684
highest development phase: 2
has mesh: D015451
has mesh heading: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
has EFO: EFO_0000095
has EFO name: CHRONIC LYMPHOCYTIC LEUKEMIA

CHEMBL_IND_26494
type: DrugIndication
chembl id: CHEMBL_IND_26494
has molecule: CHEMBL1614
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_46164
type: DrugIndication
chembl id: CHEMBL_IND_46164
has molecule: CHEMBL447955
highest development phase: 2
has mesh: D011537
has mesh heading: PRURITUS
has EFO: HP_0000989
has EFO name: PRURITUS

CHEMBL_IND_45719
type: DrugIndication
chembl id: CHEMBL_IND_45719
has molecule: CHEMBL444633
highest development phase: 1
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_54409
type: DrugIndication
chembl id: CHEMBL_IND_54409
has molecule: CHEMBL449062
highest development phase: 1
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_26720
type: DrugIndication
chembl id: CHEMBL_IND_26720
has molecule: CHEMBL1200337
highest development phase: 4
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0000373
has EFO name: CONGESTIVE HEART FAILURE

CHEMBL_IND_48563
type: DrugIndication
chembl id: CHEMBL_IND_48563
has molecule: CHEMBL1200337
highest development phase: 3
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_25466
type: DrugIndication
chembl id: CHEMBL_IND_25466
has molecule: CHEMBL1200337
highest development phase: 4
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0003144
has EFO name: HEART FAILURE

CHEMBL_IND_42226
type: DrugIndication
chembl id: CHEMBL_IND_42226
has molecule: CHEMBL1200337
highest development phase: 4
has mesh: D000787
has mesh heading: ANGINA PECTORIS
has EFO: EFO_0003913
has EFO name: ANGINA PECTORIS

CHEMBL_IND_27310
type: DrugIndication
chembl id: CHEMBL_IND_27310
has molecule: CHEMBL1200337
highest development phase: 1
has mesh: D007863
has mesh heading: LECITHIN ACYLTRANSFERASE DEFICIENCY
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: FISH-EYE DISEASE

CHEMBL_IND_24641
type: DrugIndication
chembl id: CHEMBL_IND_24641
has molecule: CHEMBL1200337
highest development phase: 2
has mesh: D001024
has mesh heading: AORTIC VALVE STENOSIS
has EFO: EFO_0000266
has EFO name: AORTIC STENOSIS

CHEMBL_IND_23505
type: DrugIndication
chembl id: CHEMBL_IND_23505
has molecule: CHEMBL1200337
highest development phase: 4
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_41574
type: DrugIndication
chembl id: CHEMBL_IND_41574
has molecule: CHEMBL1560
highest development phase: 4
has mesh: D018487
has mesh heading: VENTRICULAR DYSFUNCTION, LEFT

CHEMBL_IND_27602
type: DrugIndication
chembl id: CHEMBL_IND_27602
has molecule: CHEMBL1560
highest development phase: 1
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_47410
type: DrugIndication
chembl id: CHEMBL_IND_47410
has molecule: CHEMBL1560
highest development phase: 2
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_41684
type: DrugIndication
chembl id: CHEMBL_IND_41684
has molecule: CHEMBL1560
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_22853
type: DrugIndication
chembl id: CHEMBL_IND_22853
has molecule: CHEMBL1560
highest development phase: 4
has mesh: D009203
has mesh heading: MYOCARDIAL INFARCTION
has EFO: EFO_0000612
has EFO name: MYOCARDIAL INFARCTION

CHEMBL_IND_22852
type: DrugIndication
chembl id: CHEMBL_IND_22852
has molecule: CHEMBL1560
highest development phase: 4
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_22851
type: DrugIndication
chembl id: CHEMBL_IND_22851
has molecule: CHEMBL1560
highest development phase: 2
has mesh: D006331
has mesh heading: HEART DISEASES
has EFO: EFO_0003777
has EFO name: HEART DISEASE

CHEMBL_IND_22850
type: DrugIndication
chembl id: CHEMBL_IND_22850
has molecule: CHEMBL1560
highest development phase: 4
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0000373
has EFO name: CONGESTIVE HEART FAILURE

CHEMBL_IND_42718
type: DrugIndication
chembl id: CHEMBL_IND_42718
has molecule: CHEMBL1560
highest development phase: 4
has mesh: D003930
has mesh heading: DIABETIC RETINOPATHY
has EFO: EFO_0003770
has EFO name: DIABETIC RETINOPATHY

CHEMBL_IND_24243
type: DrugIndication
chembl id: CHEMBL_IND_24243
has molecule: CHEMBL1560
highest development phase: 4
has mesh: D003928
has mesh heading: DIABETIC NEPHROPATHIES
has EFO: EFO_0000401
has EFO name: DIABETIC NEPHROPATHY

CHEMBL_IND_27085
type: DrugIndication
chembl id: CHEMBL_IND_27085
has molecule: CHEMBL451887
highest development phase: 2
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_25855
type: DrugIndication
chembl id: CHEMBL_IND_25855
has molecule: CHEMBL451887
highest development phase: 1
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_47709
type: DrugIndication
chembl id: CHEMBL_IND_47709
has molecule: CHEMBL451887
highest development phase: 2
has mesh: D006086
has mesh heading: GRAFT VS HOST DISEASE
has EFO: EFO_0004599
has EFO name: ACUTE GRAFT VS. HOST DISEASE

CHEMBL_IND_42202
type: DrugIndication
chembl id: CHEMBL_IND_42202
has molecule: CHEMBL451887
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_22858
type: DrugIndication
chembl id: CHEMBL_IND_22858
has molecule: CHEMBL451887
highest development phase: 2
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0002890
has EFO name: RENAL CARCINOMA

CHEMBL_IND_22857
type: DrugIndication
chembl id: CHEMBL_IND_22857
has molecule: CHEMBL451887
highest development phase: 4
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_22856
type: DrugIndication
chembl id: CHEMBL_IND_22856
has molecule: CHEMBL451887
highest development phase: 1
has mesh: D054198
has mesh heading: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
has EFO: EFO_0000220
has EFO name: ACUTE LYMPHOBLASTIC LEUKEMIA

CHEMBL_IND_25157
type: DrugIndication
chembl id: CHEMBL_IND_25157
has molecule: CHEMBL451887
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_52064
type: DrugIndication
chembl id: CHEMBL_IND_52064
has molecule: CHEMBL1566
highest development phase: 2
has mesh: D000375
has mesh heading: AGING
has EFO: GO:0007568
has EFO name: AGING

CHEMBL_IND_22615
type: DrugIndication
chembl id: CHEMBL_IND_22615
has molecule: CHEMBL1566
highest development phase: 4
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_22614
type: DrugIndication
chembl id: CHEMBL_IND_22614
has molecule: CHEMBL1566
highest development phase: 2
has mesh: D065626
has mesh heading: NON-ALCOHOLIC FATTY LIVER DISEASE
has EFO: EFO_0003095
has EFO name: NON-ALCOHOLIC FATTY LIVER DISEASE

CHEMBL_IND_22613
type: DrugIndication
chembl id: CHEMBL_IND_22613
has molecule: CHEMBL1566
highest development phase: 3
has mesh: D024821
has mesh heading: METABOLIC SYNDROME X
has EFO: EFO_0000195
has EFO name: METABOLIC SYNDROME

CHEMBL_IND_22612
type: DrugIndication
chembl id: CHEMBL_IND_22612
has molecule: CHEMBL1566
highest development phase: 4
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_43763
type: DrugIndication
chembl id: CHEMBL_IND_43763
has molecule: CHEMBL451930
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_45839
type: DrugIndication
chembl id: CHEMBL_IND_45839
has molecule: CHEMBL451930
highest development phase: 2
has mesh: D055728
has mesh heading: PRIMARY MYELOFIBROSIS
has EFO: EFO_0002430
has EFO name: PRIMARY MYELOFIBROSIS

CHEMBL_IND_47550
type: DrugIndication
chembl id: CHEMBL_IND_47550
has molecule: CHEMBL451930
highest development phase: 2
has mesh: D008080
has mesh heading: LIPOSARCOMA
has EFO: EFO_0003085
has EFO name: DEDIFFERENTIATED LIPOSARCOMA

CHEMBL_IND_42705
type: DrugIndication
chembl id: CHEMBL_IND_42705
has molecule: CHEMBL460499
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_47710
type: DrugIndication
chembl id: CHEMBL_IND_47710
has molecule: CHEMBL1580
highest development phase: 2
has mesh: D006086
has mesh heading: GRAFT VS HOST DISEASE
has EFO: EFO_0004599
has EFO name: ACUTE GRAFT VS. HOST DISEASE

CHEMBL_IND_26211
type: DrugIndication
chembl id: CHEMBL_IND_26211
has molecule: CHEMBL1580
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_41755
type: DrugIndication
chembl id: CHEMBL_IND_41755
has molecule: CHEMBL1580
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_53448
type: DrugIndication
chembl id: CHEMBL_IND_53448
has molecule: CHEMBL457748
highest development phase: 2
has mesh: D006937
has mesh heading: HYPERCHOLESTEROLEMIA
has EFO: HP_0003124
has EFO name: HYPERCHOLESTEROLEMIA

CHEMBL_IND_26937
type: DrugIndication
chembl id: CHEMBL_IND_26937
has molecule: CHEMBL1607
highest development phase: 2
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_45737
type: DrugIndication
chembl id: CHEMBL_IND_45737
has molecule: CHEMBL1607
highest development phase: 2
has mesh: D002583
has mesh heading: UTERINE CERVICAL NEOPLASMS
has EFO: EFO_0001061
has EFO name: CERVICAL CARCINOMA

CHEMBL_IND_26321
type: DrugIndication
chembl id: CHEMBL_IND_26321
has molecule: CHEMBL1607
highest development phase: 3
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_47170
type: DrugIndication
chembl id: CHEMBL_IND_47170
has molecule: CHEMBL1607
highest development phase: 0
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_51879
type: DrugIndication
chembl id: CHEMBL_IND_51879
has molecule: CHEMBL1607
highest development phase: 1
has mesh: D012004
has mesh heading: RECTAL NEOPLASMS
has EFO: EFO_1000657
has EFO name: RECTUM CANCER

CHEMBL_IND_24962
type: DrugIndication
chembl id: CHEMBL_IND_24962
has molecule: CHEMBL1607
highest development phase: 3
has mesh: D055752
has mesh heading: SMALL CELL LUNG CARCINOMA
has EFO: EFO_0000702
has EFO name: SMALL CELL LUNG CARCINOMA

CHEMBL_IND_24961
type: DrugIndication
chembl id: CHEMBL_IND_24961
has molecule: CHEMBL1607
highest development phase: 3
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: EFO_0001075
has EFO name: OVARIAN CARCINOMA

CHEMBL_IND_24960
type: DrugIndication
chembl id: CHEMBL_IND_24960
has molecule: CHEMBL1607
highest development phase: 1
has mesh: D001932
has mesh heading: BRAIN NEOPLASMS
has EFO: EFO_0003833
has EFO name: BRAIN NEOPLASM

CHEMBL_IND_23980
type: DrugIndication
chembl id: CHEMBL_IND_23980
has molecule: CHEMBL1607
highest development phase: 2
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_45904
type: DrugIndication
chembl id: CHEMBL_IND_45904
has molecule: CHEMBL454446
highest development phase: 3
has mesh: D014552
has mesh heading: URINARY TRACT INFECTIONS
has EFO: EFO_0003103
has EFO name: URINARY TRACT INFECTION

CHEMBL_IND_41933
type: DrugIndication
chembl id: CHEMBL_IND_41933
has molecule: CHEMBL454446
highest development phase: 4
has mesh: D014069
has mesh heading: TONSILLITIS
has EFO: HP_0011110
has EFO name: TONSILLITIS

CHEMBL_IND_41611
type: DrugIndication
chembl id: CHEMBL_IND_41611
has molecule: CHEMBL454446
highest development phase: 4
has mesh: D010612
has mesh heading: PHARYNGITIS

CHEMBL_IND_41856
type: DrugIndication
chembl id: CHEMBL_IND_41856
has molecule: CHEMBL454446
highest development phase: 4
has mesh: D029481
has mesh heading: BRONCHITIS, CHRONIC
has EFO: EFO_0006505
has EFO name: CHRONIC BRONCHITIS

CHEMBL_IND_50501
type: DrugIndication
chembl id: CHEMBL_IND_50501
has molecule: CHEMBL460291
highest development phase: 3
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_50013
type: DrugIndication
chembl id: CHEMBL_IND_50013
has molecule: CHEMBL460291
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_42312
type: DrugIndication
chembl id: CHEMBL_IND_42312
has molecule: CHEMBL453087
highest development phase: 4
has mesh: D014376
has mesh heading: TUBERCULOSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: TUBERCULOSIS

CHEMBL_IND_41900
type: DrugIndication
chembl id: CHEMBL_IND_41900
has molecule: CHEMBL453087
highest development phase: 4
has mesh: D014406
has mesh heading: TULAREMIA
has EFO: EFO_1001444
has EFO name: TULAREMIA

CHEMBL_IND_41868
type: DrugIndication
chembl id: CHEMBL_IND_41868
has molecule: CHEMBL453087
highest development phase: 4
has mesh: D006100
has mesh heading: GRANULOMA INGUINALE
has EFO: EFO_0007291
has EFO name: GRANULOMA INGUINALE

CHEMBL_IND_42210
type: DrugIndication
chembl id: CHEMBL_IND_42210
has molecule: CHEMBL453087
highest development phase: 4
has mesh: D014552
has mesh heading: URINARY TRACT INFECTIONS
has EFO: EFO_0003103
has EFO name: URINARY TRACT INFECTION

CHEMBL_IND_41646
type: DrugIndication
chembl id: CHEMBL_IND_41646
has molecule: CHEMBL453087
highest development phase: 4
has mesh: D002602
has mesh heading: CHANCROID

CHEMBL_IND_42760
type: DrugIndication
chembl id: CHEMBL_IND_42760
has molecule: CHEMBL453087
highest development phase: 4
has mesh: D010930
has mesh heading: PLAGUE
has EFO: EFO_0007481
has EFO name: SEPTICEMIC PLAGUE

CHEMBL_IND_42717
type: DrugIndication
chembl id: CHEMBL_IND_42717
has molecule: CHEMBL453087
highest development phase: 4
has mesh: D011014
has mesh heading: PNEUMONIA
has EFO: EFO_0003106
has EFO name: PNEUMONIA

CHEMBL_IND_46991
type: DrugIndication
chembl id: CHEMBL_IND_46991
has molecule: CHEMBL1617
highest development phase: 2
has mesh: D012393
has mesh heading: ROSACEA
has EFO: EFO_1000760
has EFO name: ROSACEA

CHEMBL_IND_43735
type: DrugIndication
chembl id: CHEMBL_IND_43735
has molecule: CHEMBL1617
highest development phase: 3
has mesh: D008103
has mesh heading: LIVER CIRRHOSIS
has EFO: EFO_0001422
has EFO name: CIRRHOSIS OF LIVER

CHEMBL_IND_46739
type: DrugIndication
chembl id: CHEMBL_IND_46739
has molecule: CHEMBL1617
highest development phase: 2
has mesh: D006526
has mesh heading: HEPATITIS C
has EFO: EFO_0003047
has EFO name: HEPATITIS C INFECTION

CHEMBL_IND_46704
type: DrugIndication
chembl id: CHEMBL_IND_46704
has molecule: CHEMBL1617
highest development phase: 3
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_45296
type: DrugIndication
chembl id: CHEMBL_IND_45296
has molecule: CHEMBL1617
highest development phase: 4
has mesh: D003967
has mesh heading: DIARRHEA
has EFO: HP_0002014
has EFO name: DIARRHEA

CHEMBL_IND_52165
type: DrugIndication
chembl id: CHEMBL_IND_52165
has molecule: CHEMBL1617
highest development phase: 3
has mesh: D012004
has mesh heading: RECTAL NEOPLASMS
has EFO: EFO_1000657
has EFO name: RECTUM CANCER

CHEMBL_IND_52145
type: DrugIndication
chembl id: CHEMBL_IND_52145
has molecule: CHEMBL1617
highest development phase: 2
has mesh: D016585
has mesh heading: VAGINOSIS, BACTERIAL
has EFO: EFO_0003932
has EFO name: BACTERIAL VAGINOSIS

CHEMBL_IND_47694
type: DrugIndication
chembl id: CHEMBL_IND_47694
has molecule: CHEMBL1617
highest development phase: 1
has mesh: D015209
has mesh heading: CHOLANGITIS, SCLEROSING
has EFO: EFO_0004268
has EFO name: SCLEROSING CHOLANGITIS

CHEMBL_IND_49181
type: DrugIndication
chembl id: CHEMBL_IND_49181
has molecule: CHEMBL1617
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_46424
type: DrugIndication
chembl id: CHEMBL_IND_46424
has molecule: CHEMBL1617
highest development phase: 3
has mesh: D003424
has mesh heading: CROHN DISEASE
has EFO: EFO_0000384
has EFO name: CROHN'S DISEASE

CHEMBL_IND_43438
type: DrugIndication
chembl id: CHEMBL_IND_43438
has molecule: CHEMBL1617
highest development phase: 3
has mesh: D043183
has mesh heading: IRRITABLE BOWEL SYNDROME
has EFO: EFO_0000555
has EFO name: IRRITABLE BOWEL SYNDROME

CHEMBL_IND_43114
type: DrugIndication
chembl id: CHEMBL_IND_43114
has molecule: CHEMBL1617
highest development phase: 2
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000180
has EFO name: HIV-1 INFECTION

CHEMBL_IND_45090
type: DrugIndication
chembl id: CHEMBL_IND_45090
has molecule: CHEMBL1617
highest development phase: 0
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_40000
type: DrugIndication
chembl id: CHEMBL_IND_40000
has molecule: CHEMBL1617
highest development phase: 4
has mesh: D006501
has mesh heading: HEPATIC ENCEPHALOPATHY
has EFO: HP_0002480
has EFO name: HEPATIC ENCEPHALOPATHY

CHEMBL_IND_49717
type: DrugIndication
chembl id: CHEMBL_IND_49717
has molecule: CHEMBL440294
highest development phase: 3
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_42743
type: DrugIndication
chembl id: CHEMBL_IND_42743
has molecule: CHEMBL440294
highest development phase: 4
has mesh: D011618
has mesh heading: PSYCHOTIC DISORDERS
has EFO: EFO_0005407
has EFO name: PSYCHOSIS

CHEMBL_IND_53008
type: DrugIndication
chembl id: CHEMBL_IND_53008
has molecule: CHEMBL454801
highest development phase: 2
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_53244
type: DrugIndication
chembl id: CHEMBL_IND_53244
has molecule: CHEMBL454801
highest development phase: 0
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_54742
type: DrugIndication
chembl id: CHEMBL_IND_54742
has molecule: CHEMBL454801
highest development phase: 1
has mesh: D016757
has mesh heading: DEATH, SUDDEN, CARDIAC
has EFO: EFO_0004278
has EFO name: SUDDEN CARDIAC ARREST

CHEMBL_IND_52871
type: DrugIndication
chembl id: CHEMBL_IND_52871
has molecule: CHEMBL454801
highest development phase: 1
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_52905
type: DrugIndication
chembl id: CHEMBL_IND_52905
has molecule: CHEMBL454801
highest development phase: 2
has mesh: D003324
has mesh heading: CORONARY ARTERY DISEASE
has EFO: EFO_0000378
has EFO name: CORONARY ARTERY DISEASE

CHEMBL_IND_53792
type: DrugIndication
chembl id: CHEMBL_IND_53792
has molecule: CHEMBL454801
highest development phase: 3
has mesh: D011225
has mesh heading: PRE-ECLAMPSIA
has EFO: EFO_0000668
has EFO name: PREECLAMPSIA

CHEMBL_IND_43182
type: DrugIndication
chembl id: CHEMBL_IND_43182
has molecule: CHEMBL454801
highest development phase: 2
has mesh: D000690
has mesh heading: AMYOTROPHIC LATERAL SCLEROSIS
has EFO: EFO_0000253
has EFO name: AMYOTROPHIC LATERAL SCLEROSIS

CHEMBL_IND_46240
type: DrugIndication
chembl id: CHEMBL_IND_46240
has molecule: CHEMBL454801
highest development phase: 3
has mesh: D006816
has mesh heading: HUNTINGTON DISEASE
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: HUNTINGTON DISEASE

CHEMBL_IND_54588
type: DrugIndication
chembl id: CHEMBL_IND_54588
has molecule: CHEMBL454801
highest development phase: 3
has mesh: D020388
has mesh heading: MUSCULAR DYSTROPHY, DUCHENNE
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: DUCHENNE MUSCULAR DYSTROPHY

CHEMBL_IND_54390
type: DrugIndication
chembl id: CHEMBL_IND_54390
has molecule: CHEMBL454801
highest development phase: 2
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_42830
type: DrugIndication
chembl id: CHEMBL_IND_42830
has molecule: CHEMBL454801
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_43606
type: DrugIndication
chembl id: CHEMBL_IND_43606
has molecule: CHEMBL1200340
highest development phase: 2
has mesh: D014777
has mesh heading: VIRUS DISEASES
has EFO: EFO_0000763
has EFO name: VIRAL DISEASE

CHEMBL_IND_43769
type: DrugIndication
chembl id: CHEMBL_IND_43769
has molecule: CHEMBL1200340
highest development phase: 3
has mesh: D007251
has mesh heading: INFLUENZA, HUMAN
has EFO: EFO_0001669
has EFO name: INFLUENZA INFECTION

CHEMBL_IND_48731
type: DrugIndication
chembl id: CHEMBL_IND_48731
has molecule: CHEMBL458876
highest development phase: 2
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_48029
type: DrugIndication
chembl id: CHEMBL_IND_48029
has molecule: CHEMBL460702
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_23693
type: DrugIndication
chembl id: CHEMBL_IND_23693
has molecule: CHEMBL1574
highest development phase: 4
has mesh: D009765
has mesh heading: OBESITY
has EFO: EFO_0001073
has EFO name: OBESITY

CHEMBL_IND_51693
type: DrugIndication
chembl id: CHEMBL_IND_51693
has molecule: CHEMBL1574
highest development phase: 1
has mesh: D019966
has mesh heading: SUBSTANCE-RELATED DISORDERS
has EFO: EFO_0003890
has EFO name: DRUG DEPENDENCE

CHEMBL_IND_25096
type: DrugIndication
chembl id: CHEMBL_IND_25096
has molecule: CHEMBL1684
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_50628
type: DrugIndication
chembl id: CHEMBL_IND_50628
has molecule: CHEMBL457547
highest development phase: 4
has mesh: D058387
has mesh heading: CANDIDEMIA
has EFO: EFO_1001282
has EFO name: CANDIDEMIA

CHEMBL_IND_50268
type: DrugIndication
chembl id: CHEMBL_IND_50268
has molecule: CHEMBL457547
highest development phase: 3
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_50429
type: DrugIndication
chembl id: CHEMBL_IND_50429
has molecule: CHEMBL457547
highest development phase: 2
has mesh: D009503
has mesh heading: NEUTROPENIA
has EFO: HP_0001875
has EFO name: NEUTROPENIA

CHEMBL_IND_50424
type: DrugIndication
chembl id: CHEMBL_IND_50424
has molecule: CHEMBL457547
highest development phase: 2
has mesh: D001228
has mesh heading: ASPERGILLOSIS
has EFO: EFO_0007157
has EFO name: ASPERGILLOSIS

CHEMBL_IND_55143
type: DrugIndication
chembl id: CHEMBL_IND_55143
has molecule: CHEMBL457547
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_54948
type: DrugIndication
chembl id: CHEMBL_IND_54948
has molecule: CHEMBL457547
highest development phase: 2
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_53135
type: DrugIndication
chembl id: CHEMBL_IND_53135
has molecule: CHEMBL457547
highest development phase: 3
has mesh: D058365
has mesh heading: CANDIDIASIS, INVASIVE
has EFO: EFO_1001283
has EFO name: CANDIDIASIS, INVASIVE

CHEMBL_IND_49504
type: DrugIndication
chembl id: CHEMBL_IND_49504
has molecule: CHEMBL1628
highest development phase: 2
has mesh: D011014
has mesh heading: PNEUMONIA
has EFO: EFO_0003106
has EFO name: PNEUMONIA

CHEMBL_IND_52049
type: DrugIndication
chembl id: CHEMBL_IND_52049
has molecule: CHEMBL1628
highest development phase: 3
has mesh: D004716
has mesh heading: ENDOMETRITIS
has EFO: EFO_1001312
has EFO name: ENDOMETRITIS

CHEMBL_IND_43491
type: DrugIndication
chembl id: CHEMBL_IND_43491
has molecule: CHEMBL1628
highest development phase: 3
has mesh: D010518
has mesh heading: PERIODONTITIS
has EFO: EFO_0000649
has EFO name: PERIODONTITIS

CHEMBL_IND_43730
type: DrugIndication
chembl id: CHEMBL_IND_43730
has molecule: CHEMBL1628
highest development phase: 2
has mesh: D018805
has mesh heading: SEPSIS
has EFO: EFO_0001420
has EFO name: SEPSIS

CHEMBL_IND_45576
type: DrugIndication
chembl id: CHEMBL_IND_45576
has molecule: CHEMBL1628
highest development phase: 3
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_52378
type: DrugIndication
chembl id: CHEMBL_IND_52378
has molecule: CHEMBL1628
highest development phase: 1
has mesh: D003731
has mesh heading: DENTAL CARIES
has EFO: EFO_0003819
has EFO name: DENTAL CARIES

CHEMBL_IND_41902
type: DrugIndication
chembl id: CHEMBL_IND_41902
has molecule: CHEMBL1628
highest development phase: 4
has mesh: D005891
has mesh heading: GINGIVITIS
has EFO: HP_0000230
has EFO name: GINGIVITIS

CHEMBL_IND_51756
type: DrugIndication
chembl id: CHEMBL_IND_51756
has molecule: CHEMBL1628
highest development phase: 3
has mesh: D057873
has mesh heading: PERI-IMPLANTITIS
has EFO: EFO_1001390
has EFO name: PERI-IMPLANTITIS

CHEMBL_IND_47568
type: DrugIndication
chembl id: CHEMBL_IND_47568
has molecule: CHEMBL455461
highest development phase: 2
has mesh: D011014
has mesh heading: PNEUMONIA
has EFO: EFO_0003106
has EFO name: PNEUMONIA

CHEMBL_IND_45259
type: DrugIndication
chembl id: CHEMBL_IND_45259
has molecule: CHEMBL1633
highest development phase: 3
has mesh: D003233
has mesh heading: CONJUNCTIVITIS, ALLERGIC
has EFO: EFO_0007141
has EFO name: ALLERGIC CONJUNCTIVITIS

CHEMBL_IND_48409
type: DrugIndication
chembl id: CHEMBL_IND_48409
has molecule: CHEMBL1633
highest development phase: 3
has mesh: D004485
has mesh heading: ECZEMA
has EFO: HP_0000964
has EFO name: ECZEMA

CHEMBL_IND_52310
type: DrugIndication
chembl id: CHEMBL_IND_52310
has molecule: CHEMBL1633
highest development phase: 3
has mesh: D012221
has mesh heading: RHINITIS, ALLERGIC, PERENNIAL
has EFO: EFO_1001417
has EFO name: RHINITIS, ALLERGIC, PERENNIAL

CHEMBL_IND_27760
type: DrugIndication
chembl id: CHEMBL_IND_27760
has molecule: CHEMBL1633
highest development phase: 3
has mesh: D003876
has mesh heading: DERMATITIS, ATOPIC
has EFO: EFO_0000274
has EFO name: ATOPIC ECZEMA

CHEMBL_IND_50596
type: DrugIndication
chembl id: CHEMBL_IND_50596
has molecule: CHEMBL1639
highest development phase: 3
has mesh: D005922
has mesh heading: GLOMERULONEPHRITIS, IGA
has EFO: EFO_0004194
has EFO name: IGA GLOMERULONEPHRITIS

CHEMBL_IND_50780
type: DrugIndication
chembl id: CHEMBL_IND_50780
has molecule: CHEMBL1639
highest development phase: 1
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_50766
type: DrugIndication
chembl id: CHEMBL_IND_50766
has molecule: CHEMBL1639
highest development phase: 4
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0003144
has EFO name: HEART FAILURE

CHEMBL_IND_50686
type: DrugIndication
chembl id: CHEMBL_IND_50686
has molecule: CHEMBL1639
highest development phase: 4
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0000373
has EFO name: CONGESTIVE HEART FAILURE

CHEMBL_IND_50930
type: DrugIndication
chembl id: CHEMBL_IND_50930
has molecule: CHEMBL1639
highest development phase: 2
has mesh: D003930
has mesh heading: DIABETIC RETINOPATHY
has EFO: EFO_0003770
has EFO name: DIABETIC RETINOPATHY

CHEMBL_IND_50873
type: DrugIndication
chembl id: CHEMBL_IND_50873
has molecule: CHEMBL1639
highest development phase: 3
has mesh: D009203
has mesh heading: MYOCARDIAL INFARCTION
has EFO: EFO_0000612
has EFO name: MYOCARDIAL INFARCTION

CHEMBL_IND_55202
type: DrugIndication
chembl id: CHEMBL_IND_55202
has molecule: CHEMBL1639
highest development phase: 2
has mesh: D050197
has mesh heading: ATHEROSCLEROSIS
has EFO: EFO_0003914
has EFO name: ATHEROSCLEROSIS

CHEMBL_IND_50071
type: DrugIndication
chembl id: CHEMBL_IND_50071
has molecule: CHEMBL1639
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_50260
type: DrugIndication
chembl id: CHEMBL_IND_50260
has molecule: CHEMBL1639
highest development phase: 4
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_55154
type: DrugIndication
chembl id: CHEMBL_IND_55154
has molecule: CHEMBL1639
highest development phase: 3
has mesh: D003324
has mesh heading: CORONARY ARTERY DISEASE
has EFO: EFO_0000378
has EFO name: CORONARY ARTERY DISEASE

CHEMBL_IND_54599
type: DrugIndication
chembl id: CHEMBL_IND_54599
has molecule: CHEMBL1639
highest development phase: 3
has mesh: D001281
has mesh heading: ATRIAL FIBRILLATION
has EFO: EFO_0000275
has EFO name: ATRIAL FIBRILLATION

CHEMBL_IND_54978
type: DrugIndication
chembl id: CHEMBL_IND_54978
has molecule: CHEMBL1639
highest development phase: 1
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_28095
type: DrugIndication
chembl id: CHEMBL_IND_28095
has molecule: CHEMBL1651
highest development phase: 2
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_25914
type: DrugIndication
chembl id: CHEMBL_IND_25914
has molecule: CHEMBL1651
highest development phase: 4
has mesh: D005128
has mesh heading: EYE DISEASES
has EFO: EFO_0005752
has EFO name: EYE INFLAMMATION

CHEMBL_IND_27123
type: DrugIndication
chembl id: CHEMBL_IND_27123
has molecule: CHEMBL1651
highest development phase: 4
has mesh: D015508
has mesh heading: NASAL OBSTRUCTION
has EFO: HP_0001742
has EFO name: NASAL OBSTRUCTION

CHEMBL_IND_25218
type: DrugIndication
chembl id: CHEMBL_IND_25218
has molecule: CHEMBL1651
highest development phase: 4
has mesh: D000152
has mesh heading: ACNE VULGARIS
has EFO: EFO_0003894
has EFO name: ACNE

CHEMBL_IND_48711
type: DrugIndication
chembl id: CHEMBL_IND_48711
has molecule: CHEMBL1657
highest development phase: 2
has mesh: D012871
has mesh heading: SKIN DISEASES
has EFO: EFO_0000701
has EFO name: SKIN DISEASE

CHEMBL_IND_46387
type: DrugIndication
chembl id: CHEMBL_IND_46387
has molecule: CHEMBL1657
highest development phase: 2
has mesh: D002277
has mesh heading: CARCINOMA
has EFO: EFO_0000313
has EFO name: CARCINOMA

CHEMBL_IND_23927
type: DrugIndication
chembl id: CHEMBL_IND_23927
has molecule: CHEMBL1657
highest development phase: 4
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_23926
type: DrugIndication
chembl id: CHEMBL_IND_23926
has molecule: CHEMBL1657
highest development phase: 4
has mesh: D000152
has mesh heading: ACNE VULGARIS
has EFO: EFO_0003894
has EFO name: ACNE

CHEMBL_IND_46709
type: DrugIndication
chembl id: CHEMBL_IND_46709
has molecule: CHEMBL462605
highest development phase: 3
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_48014
type: DrugIndication
chembl id: CHEMBL_IND_48014
has molecule: CHEMBL462605
highest development phase: 3
has mesh: D009290
has mesh heading: NARCOLEPSY
has EFO: EFO_0000614
has EFO name: NARCOLEPSY WITH CATAPLEXY

CHEMBL_IND_45261
type: DrugIndication
chembl id: CHEMBL_IND_45261
has molecule: CHEMBL461806
highest development phase: 4
has mesh: D016553
has mesh heading: PURPURA, THROMBOCYTOPENIC, IDIOPATHIC
has EFO: EFO_0007160
has EFO name: AUTOIMMUNE THROMBOCYTOPENIC PURPURA

CHEMBL_IND_28140
type: DrugIndication
chembl id: CHEMBL_IND_28140
has molecule: CHEMBL461806
highest development phase: 1
has mesh: D009190
has mesh heading: MYELODYSPLASTIC SYNDROMES
has EFO: EFO_0000198
has EFO name: MYELODYSPLASTIC SYNDROME

CHEMBL_IND_25281
type: DrugIndication
chembl id: CHEMBL_IND_25281
has molecule: CHEMBL461806
highest development phase: 2
has mesh: D019698
has mesh heading: HEPATITIS C, CHRONIC
has EFO: EFO_0004220
has EFO name: CHRONIC HEPATITIS C INFECTION

CHEMBL_IND_24395
type: DrugIndication
chembl id: CHEMBL_IND_24395
has molecule: CHEMBL461806
highest development phase: 2
has mesh: D013921
has mesh heading: THROMBOCYTOPENIA
has EFO: HP_0001873
has EFO name: THROMBOCYTOPENIA

CHEMBL_IND_51511
type: DrugIndication
chembl id: CHEMBL_IND_51511
has molecule: CHEMBL461806
highest development phase: 4
has mesh: D000741
has mesh heading: ANEMIA, APLASTIC
has EFO: EFO_0006927
has EFO name: SEVERE APLASTIC ANEMIA

CHEMBL_IND_49330
type: DrugIndication
chembl id: CHEMBL_IND_49330
has molecule: CHEMBL462019
highest development phase: 2
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_26734
type: DrugIndication
chembl id: CHEMBL_IND_26734
has molecule: CHEMBL1670
highest development phase: 3
has mesh: D018268
has mesh heading: ADRENOCORTICAL CARCINOMA
has EFO: EFO_0003093
has EFO name: ADRENOCORTICAL CARCINOMA

CHEMBL_IND_42860
type: DrugIndication
chembl id: CHEMBL_IND_42860
has molecule: CHEMBL1670
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_26148
type: DrugIndication
chembl id: CHEMBL_IND_26148
has molecule: CHEMBL1670
highest development phase: 1
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_50843
type: DrugIndication
chembl id: CHEMBL_IND_50843
has molecule: CHEMBL463981
highest development phase: 1
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_55169
type: DrugIndication
chembl id: CHEMBL_IND_55169
has molecule: CHEMBL464982
highest development phase: 3
has mesh: D001172
has mesh heading: ARTHRITIS, RHEUMATOID
has EFO: EFO_0000685
has EFO name: RHEUMATOID ARTHRITIS

CHEMBL_IND_44850
type: DrugIndication
chembl id: CHEMBL_IND_44850
has molecule: CHEMBL471498
highest development phase: 3
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_41709
type: DrugIndication
chembl id: CHEMBL_IND_41709
has molecule: CHEMBL471498
highest development phase: 4
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_42679
type: DrugIndication
chembl id: CHEMBL_IND_42679
has molecule: CHEMBL461343
highest development phase: 4
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_48031
type: DrugIndication
chembl id: CHEMBL_IND_48031
has molecule: CHEMBL1663
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_45658
type: DrugIndication
chembl id: CHEMBL_IND_45658
has molecule: CHEMBL1663
highest development phase: 2
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0000681
has EFO name: RENAL CELL CARCINOMA

CHEMBL_IND_52625
type: DrugIndication
chembl id: CHEMBL_IND_52625
has molecule: CHEMBL1663
highest development phase: 2
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_51658
type: DrugIndication
chembl id: CHEMBL_IND_51658
has molecule: CHEMBL1663
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_48659
type: DrugIndication
chembl id: CHEMBL_IND_48659
has molecule: CHEMBL482767
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_48588
type: DrugIndication
chembl id: CHEMBL_IND_48588
has molecule: CHEMBL1671
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000389
has EFO name: CUTANEOUS MELANOMA

CHEMBL_IND_27901
type: DrugIndication
chembl id: CHEMBL_IND_27901
has molecule: CHEMBL1671
highest development phase: 1
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_41726
type: DrugIndication
chembl id: CHEMBL_IND_41726
has molecule: CHEMBL1671
highest development phase: 4
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_43908
type: DrugIndication
chembl id: CHEMBL_IND_43908
has molecule: CHEMBL1620
highest development phase: 1
has mesh: D006967
has mesh heading: HYPERSENSITIVITY
has EFO: EFO_0003785
has EFO name: ALLERGY

CHEMBL_IND_52158
type: DrugIndication
chembl id: CHEMBL_IND_52158
has molecule: CHEMBL1620
highest development phase: 1
has mesh: D006255
has mesh heading: RHINITIS, ALLERGIC, SEASONAL
has EFO: EFO_0005854
has EFO name: ALLERGIC RHINITIS

CHEMBL_IND_53964
type: DrugIndication
chembl id: CHEMBL_IND_53964
has molecule: CHEMBL476323
highest development phase: 2
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_53355
type: DrugIndication
chembl id: CHEMBL_IND_53355
has molecule: CHEMBL476323
highest development phase: 2
has mesh: D001289
has mesh heading: ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY
has EFO: EFO_0003888
has EFO name: ATTENTION DEFICIT HYPERACTIVITY DISORDER

CHEMBL_IND_53558
type: DrugIndication
chembl id: CHEMBL_IND_53558
has molecule: CHEMBL476323
highest development phase: 2
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_47139
type: DrugIndication
chembl id: CHEMBL_IND_47139
has molecule: CHEMBL487253
highest development phase: 1
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_46641
type: DrugIndication
chembl id: CHEMBL_IND_46641
has molecule: CHEMBL487253
highest development phase: 2
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: EFO_0001075
has EFO name: OVARIAN CARCINOMA

CHEMBL_IND_43723
type: DrugIndication
chembl id: CHEMBL_IND_43723
has molecule: CHEMBL487253
highest development phase: 2
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_49111
type: DrugIndication
chembl id: CHEMBL_IND_49111
has molecule: CHEMBL487253
highest development phase: 3
has mesh: D008224
has mesh heading: LYMPHOMA, FOLLICULAR
has EFO: EFO_0000096
has EFO name: NEOPLASM OF MATURE B-CELLS

CHEMBL_IND_46278
type: DrugIndication
chembl id: CHEMBL_IND_46278
has molecule: CHEMBL487253
highest development phase: 2
has mesh: D006689
has mesh heading: HODGKIN DISEASE
has EFO: EFO_0000183
has EFO name: HODGKINS LYMPHOMA

CHEMBL_IND_43102
type: DrugIndication
chembl id: CHEMBL_IND_43102
has molecule: CHEMBL487253
highest development phase: 2
has mesh: D015451
has mesh heading: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
has EFO: EFO_0000095
has EFO name: CHRONIC LYMPHOCYTIC LEUKEMIA

CHEMBL_IND_53761
type: DrugIndication
chembl id: CHEMBL_IND_53761
has molecule: CHEMBL487253
highest development phase: 2
has mesh: D016403
has mesh heading: LYMPHOMA, LARGE B-CELL, DIFFUSE
has EFO: EFO_0000403
has EFO name: DIFFUSE LARGE B-CELL LYMPHOMA

CHEMBL_IND_46123
type: DrugIndication
chembl id: CHEMBL_IND_46123
has molecule: CHEMBL487253
highest development phase: 3
has mesh: D008228
has mesh heading: LYMPHOMA, NON-HODGKIN
has EFO: EFO_0005952
has EFO name: NON-HODGKINS LYMPHOMA

CHEMBL_IND_45472
type: DrugIndication
chembl id: CHEMBL_IND_45472
has molecule: CHEMBL487253
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_47279
type: DrugIndication
chembl id: CHEMBL_IND_47279
has molecule: CHEMBL487253
highest development phase: 2
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_47277
type: DrugIndication
chembl id: CHEMBL_IND_47277
has molecule: CHEMBL487253
highest development phase: 1
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_48270
type: DrugIndication
chembl id: CHEMBL_IND_48270
has molecule: CHEMBL487894
highest development phase: 2
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_54353
type: DrugIndication
chembl id: CHEMBL_IND_54353
has molecule: CHEMBL487894
highest development phase: 3
has mesh: D005759
has mesh heading: GASTROENTERITIS
has EFO: EFO_1001463
has EFO name: GASTROENTERITIS

CHEMBL_IND_55189
type: DrugIndication
chembl id: CHEMBL_IND_55189
has molecule: CHEMBL490665
highest development phase: 2
has mesh: D008107
has mesh heading: LIVER DISEASES
has EFO: EFO_0001421
has EFO name: LIVER DISEASE

CHEMBL_IND_55007
type: DrugIndication
chembl id: CHEMBL_IND_55007
has molecule: CHEMBL490665
highest development phase: 1
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_49581
type: DrugIndication
chembl id: CHEMBL_IND_49581
has molecule: CHEMBL490672
highest development phase: 1
has mesh: D019698
has mesh heading: HEPATITIS C, CHRONIC
has EFO: EFO_0004220
has EFO name: CHRONIC HEPATITIS C INFECTION

CHEMBL_IND_43834
type: DrugIndication
chembl id: CHEMBL_IND_43834
has molecule: CHEMBL490672
highest development phase: 2
has mesh: D006526
has mesh heading: HEPATITIS C
has EFO: EFO_0003047
has EFO name: HEPATITIS C INFECTION

CHEMBL_IND_50068
type: DrugIndication
chembl id: CHEMBL_IND_50068
has molecule: CHEMBL475534
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_54940
type: DrugIndication
chembl id: CHEMBL_IND_54940
has molecule: CHEMBL475534
highest development phase: 2
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_41982
type: DrugIndication
chembl id: CHEMBL_IND_41982
has molecule: CHEMBL488280
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_46779
type: DrugIndication
chembl id: CHEMBL_IND_46779
has molecule: CHEMBL1621
highest development phase: 3
has mesh: D001321
has mesh heading: AUTISTIC DISORDER
has EFO: EFO_0003758
has EFO name: AUTISM

CHEMBL_IND_23648
type: DrugIndication
chembl id: CHEMBL_IND_23648
has molecule: CHEMBL1621
highest development phase: 4
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_23647
type: DrugIndication
chembl id: CHEMBL_IND_23647
has molecule: CHEMBL1621
highest development phase: 3
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_27867
type: DrugIndication
chembl id: CHEMBL_IND_27867
has molecule: CHEMBL1621
highest development phase: 4
has mesh: D011618
has mesh heading: PSYCHOTIC DISORDERS
has EFO: EFO_0005407
has EFO name: PSYCHOSIS

CHEMBL_IND_27866
type: DrugIndication
chembl id: CHEMBL_IND_27866
has molecule: CHEMBL1621
highest development phase: 2
has mesh: D009771
has mesh heading: OBSESSIVE-COMPULSIVE DISORDER
has EFO: EFO_0004242
has EFO name: OBSESSIVE-COMPULSIVE DISORDER

CHEMBL_IND_24753
type: DrugIndication
chembl id: CHEMBL_IND_24753
has molecule: CHEMBL1621
highest development phase: 4
has mesh: D011618
has mesh heading: PSYCHOTIC DISORDERS
has EFO: EFO_0005411
has EFO name: SCHIZOAFFECTIVE DISORDER

CHEMBL_IND_44026
type: DrugIndication
chembl id: CHEMBL_IND_44026
has molecule: CHEMBL1676
highest development phase: 3
has mesh: D006255
has mesh heading: RHINITIS, ALLERGIC, SEASONAL
has EFO: EFO_0003956
has EFO name: SEASONAL ALLERGIC RHINITIS

CHEMBL_IND_51912
type: DrugIndication
chembl id: CHEMBL_IND_51912
has molecule: CHEMBL1676
highest development phase: 3
has mesh: D012221
has mesh heading: RHINITIS, ALLERGIC, PERENNIAL
has EFO: EFO_1001417
has EFO name: RHINITIS, ALLERGIC, PERENNIAL

CHEMBL_IND_23206
type: DrugIndication
chembl id: CHEMBL_IND_23206
has molecule: CHEMBL1676
highest development phase: 4
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_25337
type: DrugIndication
chembl id: CHEMBL_IND_25337
has molecule: CHEMBL1676
highest development phase: 3
has mesh: D012220
has mesh heading: RHINITIS
has EFO: HP_0012384
has EFO name: RHINITIS

CHEMBL_IND_25336
type: DrugIndication
chembl id: CHEMBL_IND_25336
has molecule: CHEMBL1676
highest development phase: 4
has mesh: D015508
has mesh heading: NASAL OBSTRUCTION
has EFO: HP_0001742
has EFO name: NASAL OBSTRUCTION

CHEMBL_IND_24456
type: DrugIndication
chembl id: CHEMBL_IND_24456
has molecule: CHEMBL1676
highest development phase: 4
has mesh: D008173
has mesh heading: LUNG DISEASES, OBSTRUCTIVE
has EFO: HP_0006536
has EFO name: OBSTRUCTIVE LUNG DISEASE

CHEMBL_IND_24455
type: DrugIndication
chembl id: CHEMBL_IND_24455
has molecule: CHEMBL1676
highest development phase: 4
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_43645
type: DrugIndication
chembl id: CHEMBL_IND_43645
has molecule: CHEMBL491473
highest development phase: 1
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_42532
type: DrugIndication
chembl id: CHEMBL_IND_42532
has molecule: CHEMBL491473
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_43669
type: DrugIndication
chembl id: CHEMBL_IND_43669
has molecule: CHEMBL491473
highest development phase: 3
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: EFO_0001075
has EFO name: OVARIAN CARCINOMA

CHEMBL_IND_45660
type: DrugIndication
chembl id: CHEMBL_IND_45660
has molecule: CHEMBL491473
highest development phase: 2
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0000681
has EFO name: RENAL CELL CARCINOMA

CHEMBL_IND_46452
type: DrugIndication
chembl id: CHEMBL_IND_46452
has molecule: CHEMBL491473
highest development phase: 3
has mesh: D005909
has mesh heading: GLIOBLASTOMA
has EFO: EFO_0000519
has EFO name: GLIOBLASTOMA MULTIFORME

CHEMBL_IND_53664
type: DrugIndication
chembl id: CHEMBL_IND_53664
has molecule: CHEMBL491473
highest development phase: 1
has mesh: D012004
has mesh heading: RECTAL NEOPLASMS
has EFO: EFO_1000657
has EFO name: RECTUM CANCER

CHEMBL_IND_44481
type: DrugIndication
chembl id: CHEMBL_IND_44481
has molecule: CHEMBL491473
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_50281
type: DrugIndication
chembl id: CHEMBL_IND_50281
has molecule: CHEMBL484785
highest development phase: 2
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_50065
type: DrugIndication
chembl id: CHEMBL_IND_50065
has molecule: CHEMBL484785
highest development phase: 4
has mesh: D003876
has mesh heading: DERMATITIS, ATOPIC
has EFO: EFO_0000274
has EFO name: ATOPIC ECZEMA

CHEMBL_IND_42399
type: DrugIndication
chembl id: CHEMBL_IND_42399
has molecule: CHEMBL491571
highest development phase: 4
has mesh: D014552
has mesh heading: URINARY TRACT INFECTIONS
has EFO: EFO_0003103
has EFO name: URINARY TRACT INFECTION

CHEMBL_IND_45612
type: DrugIndication
chembl id: CHEMBL_IND_45612
has molecule: CHEMBL491571
highest development phase: 1
has mesh: D008581
has mesh heading: MENINGITIS
has EFO: EFO_0000584
has EFO name: INFECTIOUS MENINGITIS

CHEMBL_IND_41663
type: DrugIndication
chembl id: CHEMBL_IND_41663
has molecule: CHEMBL491571
highest development phase: 4
has mesh: D059413
has mesh heading: INTRAABDOMINAL INFECTIONS

CHEMBL_IND_51632
type: DrugIndication
chembl id: CHEMBL_IND_51632
has molecule: CHEMBL491571
highest development phase: 4
has mesh: D011704
has mesh heading: PYELONEPHRITIS
has EFO: EFO_1001141
has EFO name: PYELONEPHRITIS

CHEMBL_IND_54939
type: DrugIndication
chembl id: CHEMBL_IND_54939
has molecule: CHEMBL492399
highest development phase: 2
has mesh: D005909
has mesh heading: GLIOBLASTOMA
has EFO: EFO_0000519
has EFO name: GLIOBLASTOMA MULTIFORME

CHEMBL_IND_47038
type: DrugIndication
chembl id: CHEMBL_IND_47038
has molecule: CHEMBL1622
highest development phase: 3
has mesh: D006470
has mesh heading: HEMORRHAGE
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: HEMORRHAGE

CHEMBL_IND_42457
type: DrugIndication
chembl id: CHEMBL_IND_42457
has molecule: CHEMBL1622
highest development phase: 4
has mesh: D018798
has mesh heading: ANEMIA, IRON-DEFICIENCY
has EFO: HP_0001891
has EFO name: IRON DEFICIENCY ANEMIA

CHEMBL_IND_49326
type: DrugIndication
chembl id: CHEMBL_IND_49326
has molecule: CHEMBL1622
highest development phase: 2
has mesh: D001172
has mesh heading: ARTHRITIS, RHEUMATOID
has EFO: EFO_0000685
has EFO name: RHEUMATOID ARTHRITIS

CHEMBL_IND_42870
type: DrugIndication
chembl id: CHEMBL_IND_42870
has molecule: CHEMBL1622
highest development phase: 4
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_48854
type: DrugIndication
chembl id: CHEMBL_IND_48854
has molecule: CHEMBL1622
highest development phase: 2
has mesh: D001321
has mesh heading: AUTISTIC DISORDER
has EFO: EFO_0003758
has EFO name: AUTISM

CHEMBL_IND_49414
type: DrugIndication
chembl id: CHEMBL_IND_49414
has molecule: CHEMBL1622
highest development phase: 3
has mesh: D003922
has mesh heading: DIABETES MELLITUS, TYPE 1
has EFO: EFO_0001359
has EFO name: TYPE I DIABETES MELLITUS

CHEMBL_IND_47946
type: DrugIndication
chembl id: CHEMBL_IND_47946
has molecule: CHEMBL1622
highest development phase: 2
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_52572
type: DrugIndication
chembl id: CHEMBL_IND_52572
has molecule: CHEMBL1622
highest development phase: 2
has mesh: D053713
has mesh heading: AZOOSPERMIA
has EFO: EFO_0000279
has EFO name: AZOOSPERMIA

CHEMBL_IND_48343
type: DrugIndication
chembl id: CHEMBL_IND_48343
has molecule: CHEMBL1622
highest development phase: 4
has mesh: D000740
has mesh heading: ANEMIA
has EFO: EFO_0004272
has EFO name: ANEMIA

CHEMBL_IND_48241
type: DrugIndication
chembl id: CHEMBL_IND_48241
has molecule: CHEMBL1622
highest development phase: 3
has mesh: D006331
has mesh heading: HEART DISEASES
has EFO: EFO_0003777
has EFO name: HEART DISEASE

CHEMBL_IND_44806
type: DrugIndication
chembl id: CHEMBL_IND_44806
has molecule: CHEMBL1622
highest development phase: 2
has mesh: D002583
has mesh heading: UTERINE CERVICAL NEOPLASMS
has EFO: EFO_0001061
has EFO name: CERVICAL CARCINOMA

CHEMBL_IND_44783
type: DrugIndication
chembl id: CHEMBL_IND_44783
has molecule: CHEMBL1622
highest development phase: 2
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_46442
type: DrugIndication
chembl id: CHEMBL_IND_46442
has molecule: CHEMBL1622
highest development phase: 3
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_49775
type: DrugIndication
chembl id: CHEMBL_IND_49775
has molecule: CHEMBL1622
highest development phase: 2
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_51854
type: DrugIndication
chembl id: CHEMBL_IND_51854
has molecule: CHEMBL1622
highest development phase: 3
has mesh: D047928
has mesh heading: PREMATURE BIRTH
has EFO: EFO_0003917
has EFO name: PREMATURE BIRTH

CHEMBL_IND_47637
type: DrugIndication
chembl id: CHEMBL_IND_47637
has molecule: CHEMBL1622
highest development phase: 2
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_51744
type: DrugIndication
chembl id: CHEMBL_IND_51744
has molecule: CHEMBL1622
highest development phase: 2
has mesh: D000026
has mesh heading: ABORTION, HABITUAL
has EFO: EFO_1000954
has EFO name: HABITUAL ABORTION

CHEMBL_IND_53413
type: DrugIndication
chembl id: CHEMBL_IND_53413
has molecule: CHEMBL489095
highest development phase: 2
has mesh: D018589
has mesh heading: GASTROPARESIS
has EFO: EFO_1000948
has EFO name: GASTROPARESIS

CHEMBL_IND_27253
type: DrugIndication
chembl id: CHEMBL_IND_27253
has molecule: CHEMBL1648
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_28225
type: DrugIndication
chembl id: CHEMBL_IND_28225
has molecule: CHEMBL1648
highest development phase: 1
has mesh: D009293
has mesh heading: OPIOID-RELATED DISORDERS
has EFO: EFO_0005611
has EFO name: OPIOID DEPENDENCE

CHEMBL_IND_25405
type: DrugIndication
chembl id: CHEMBL_IND_25405
has molecule: CHEMBL1648
highest development phase: 2
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_23372
type: DrugIndication
chembl id: CHEMBL_IND_23372
has molecule: CHEMBL1648
highest development phase: 3
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_50460
type: DrugIndication
chembl id: CHEMBL_IND_50460
has molecule: CHEMBL502835
highest development phase: 2
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_50739
type: DrugIndication
chembl id: CHEMBL_IND_50739
has molecule: CHEMBL502835
highest development phase: 2
has mesh: D002583
has mesh heading: UTERINE CERVICAL NEOPLASMS
has EFO: EFO_0001416
has EFO name: CERVICAL ADENOCARCINOMA

CHEMBL_IND_50736
type: DrugIndication
chembl id: CHEMBL_IND_50736
has molecule: CHEMBL502835
highest development phase: 1
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_50721
type: DrugIndication
chembl id: CHEMBL_IND_50721
has molecule: CHEMBL502835
highest development phase: 2
has mesh: D055752
has mesh heading: SMALL CELL LUNG CARCINOMA
has EFO: EFO_0000702
has EFO name: SMALL CELL LUNG CARCINOMA

CHEMBL_IND_50660
type: DrugIndication
chembl id: CHEMBL_IND_50660
has molecule: CHEMBL502835
highest development phase: 1
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_50872
type: DrugIndication
chembl id: CHEMBL_IND_50872
has molecule: CHEMBL502835
highest development phase: 2
has mesh: D008654
has mesh heading: MESOTHELIOMA
has EFO: EFO_0000588
has EFO name: MESOTHELIOMA

CHEMBL_IND_55259
type: DrugIndication
chembl id: CHEMBL_IND_55259
has molecule: CHEMBL502835
highest development phase: 1
has mesh: D005909
has mesh heading: GLIOBLASTOMA
has EFO: EFO_0000519
has EFO name: GLIOBLASTOMA MULTIFORME

CHEMBL_IND_55244
type: DrugIndication
chembl id: CHEMBL_IND_55244
has molecule: CHEMBL502835
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_54675
type: DrugIndication
chembl id: CHEMBL_IND_54675
has molecule: CHEMBL502835
highest development phase: 2
has mesh: D008654
has mesh heading: MESOTHELIOMA
has EFO: EFO_0000770
has EFO name: MALIGNANT PLEURAL MESOTHELIOMA

CHEMBL_IND_54659
type: DrugIndication
chembl id: CHEMBL_IND_54659
has molecule: CHEMBL502835
highest development phase: 2
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_50080
type: DrugIndication
chembl id: CHEMBL_IND_50080
has molecule: CHEMBL502835
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_50285
type: DrugIndication
chembl id: CHEMBL_IND_50285
has molecule: CHEMBL502835
highest development phase: 2
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0000681
has EFO name: RENAL CELL CARCINOMA

CHEMBL_IND_50354
type: DrugIndication
chembl id: CHEMBL_IND_50354
has molecule: CHEMBL502835
highest development phase: 3
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_50305
type: DrugIndication
chembl id: CHEMBL_IND_50305
has molecule: CHEMBL502835
highest development phase: 3
has mesh: D054990
has mesh heading: IDIOPATHIC PULMONARY FIBROSIS
has EFO: EFO_0000768
has EFO name: IDIOPATHIC PULMONARY FIBROSIS

CHEMBL_IND_50297
type: DrugIndication
chembl id: CHEMBL_IND_50297
has molecule: CHEMBL502835
highest development phase: 3
has mesh: D012595
has mesh heading: SCLERODERMA, SYSTEMIC
has EFO: EFO_0000717
has EFO name: SYSTEMIC SCLERODERMA

CHEMBL_IND_54498
type: DrugIndication
chembl id: CHEMBL_IND_54498
has molecule: CHEMBL502835
highest development phase: 1
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_54997
type: DrugIndication
chembl id: CHEMBL_IND_54997
has molecule: CHEMBL502835
highest development phase: 2
has mesh: D013964
has mesh heading: THYROID NEOPLASMS
has EFO: EFO_0002892
has EFO name: THYROID CARCINOMA

CHEMBL_IND_54955
type: DrugIndication
chembl id: CHEMBL_IND_54955
has molecule: CHEMBL502835
highest development phase: 1
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_54938
type: DrugIndication
chembl id: CHEMBL_IND_54938
has molecule: CHEMBL502835
highest development phase: 2
has mesh: D013274
has mesh heading: STOMACH NEOPLASMS
has EFO: EFO_0000503
has EFO name: GASTRIC ADENOCARCINOMA

CHEMBL_IND_54622
type: DrugIndication
chembl id: CHEMBL_IND_54622
has molecule: CHEMBL500826
highest development phase: 2
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_43714
type: DrugIndication
chembl id: CHEMBL_IND_43714
has molecule: CHEMBL482968
highest development phase: 1
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_47900
type: DrugIndication
chembl id: CHEMBL_IND_47900
has molecule: CHEMBL482968
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_48700
type: DrugIndication
chembl id: CHEMBL_IND_48700
has molecule: CHEMBL482968
highest development phase: 2
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_48488
type: DrugIndication
chembl id: CHEMBL_IND_48488
has molecule: CHEMBL482968
highest development phase: 2
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_40997
type: DrugIndication
chembl id: CHEMBL_IND_40997
has molecule: CHEMBL482968
highest development phase: 2
has mesh: D018262
has mesh heading: ADENOCARCINOMA, CLEAR CELL
has EFO: EFO_0000348
has EFO name: CLEAR CELL ADENOCARCINOMA

CHEMBL_IND_47158
type: DrugIndication
chembl id: CHEMBL_IND_47158
has molecule: CHEMBL482968
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_47065
type: DrugIndication
chembl id: CHEMBL_IND_47065
has molecule: CHEMBL1642
highest development phase: 2
has mesh: D013274
has mesh heading: STOMACH NEOPLASMS
has EFO: EFO_0000178
has EFO name: GASTRIC CARCINOMA

CHEMBL_IND_52063
type: DrugIndication
chembl id: CHEMBL_IND_52063
has molecule: CHEMBL1642
highest development phase: 2
has mesh: D015266
has mesh heading: CARCINOMA, MERKEL CELL
has EFO: EFO_1001471
has EFO name: MERKEL CELL SKIN CANCER

CHEMBL_IND_27239
type: DrugIndication
chembl id: CHEMBL_IND_27239
has molecule: CHEMBL1642
highest development phase: 2
has mesh: D009456
has mesh heading: NEUROFIBROMATOSIS 1
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: NEUROFIBROMATOSIS TYPE 1

CHEMBL_IND_27237
type: DrugIndication
chembl id: CHEMBL_IND_27237
has molecule: CHEMBL1642
highest development phase: 1
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_27236
type: DrugIndication
chembl id: CHEMBL_IND_27236
has molecule: CHEMBL1642
highest development phase: 2
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_47917
type: DrugIndication
chembl id: CHEMBL_IND_47917
has molecule: CHEMBL1642
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_48388
type: DrugIndication
chembl id: CHEMBL_IND_48388
has molecule: CHEMBL1642
highest development phase: 2
has mesh: D018567
has mesh heading: BREAST NEOPLASMS, MALE
has EFO: EFO_0006861
has EFO name: MALE BREAST CARCINOMA

CHEMBL_IND_25384
type: DrugIndication
chembl id: CHEMBL_IND_25384
has molecule: CHEMBL1642
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_26042
type: DrugIndication
chembl id: CHEMBL_IND_26042
has molecule: CHEMBL1642
highest development phase: 2
has mesh: D009442
has mesh heading: NEURILEMMOMA
has EFO: EFO_0000760
has EFO name: MALIGNANT PERIPHERAL NERVE SHEATH TUMOR

CHEMBL_IND_43284
type: DrugIndication
chembl id: CHEMBL_IND_43284
has molecule: CHEMBL1642
highest development phase: 2
has mesh: D002277
has mesh heading: CARCINOMA
has EFO: EFO_0000313
has EFO name: CARCINOMA

CHEMBL_IND_51960
type: DrugIndication
chembl id: CHEMBL_IND_51960
has molecule: CHEMBL1642
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_47173
type: DrugIndication
chembl id: CHEMBL_IND_47173
has molecule: CHEMBL1642
highest development phase: 2
has mesh: D002813
has mesh heading: CHONDROSARCOMA
has EFO: EFO_0000333
has EFO name: CHONDROSARCOMA

CHEMBL_IND_52060
type: DrugIndication
chembl id: CHEMBL_IND_52060
has molecule: CHEMBL1642
highest development phase: 2
has mesh: D017681
has mesh heading: HYPEREOSINOPHILIC SYNDROME
has EFO: EFO_1001467
has EFO name: HYPEREOSINOPHILIC SYNDROME

CHEMBL_IND_47433
type: DrugIndication
chembl id: CHEMBL_IND_47433
has molecule: CHEMBL1642
highest development phase: 2
has mesh: D003922
has mesh heading: DIABETES MELLITUS, TYPE 1
has EFO: EFO_0001359
has EFO name: TYPE I DIABETES MELLITUS

CHEMBL_IND_23311
type: DrugIndication
chembl id: CHEMBL_IND_23311
has molecule: CHEMBL1642
highest development phase: 3
has mesh: D006976
has mesh heading: HYPERTENSION, PULMONARY
has EFO: EFO_0001361
has EFO name: PULMONARY HYPERTENSION

CHEMBL_IND_23310
type: DrugIndication
chembl id: CHEMBL_IND_23310
has molecule: CHEMBL1642
highest development phase: 2
has mesh: D011087
has mesh heading: POLYCYTHEMIA VERA
has EFO: EFO_0002429
has EFO name: POLYCYTHEMIA VERA

CHEMBL_IND_23309
type: DrugIndication
chembl id: CHEMBL_IND_23309
has molecule: CHEMBL1642
highest development phase: 2
has mesh: D018318
has mesh heading: NEUROFIBROMA, PLEXIFORM
has EFO: EFO_0000658
has EFO name: PLEXIFORM NEUROFIBROMA

CHEMBL_IND_23308
type: DrugIndication
chembl id: CHEMBL_IND_23308
has molecule: CHEMBL1642
highest development phase: 4
has mesh: D046152
has mesh heading: GASTROINTESTINAL STROMAL TUMORS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: GASTROINTESTINAL STROMAL TUMOR

CHEMBL_IND_23307
type: DrugIndication
chembl id: CHEMBL_IND_23307
has molecule: CHEMBL1642
highest development phase: 3
has mesh: D015464
has mesh heading: LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE
has EFO: EFO_0000339
has EFO name: CHRONIC MYELOGENOUS LEUKEMIA

CHEMBL_IND_24522
type: DrugIndication
chembl id: CHEMBL_IND_24522
has molecule: CHEMBL1642
highest development phase: 2
has mesh: D012595
has mesh heading: SCLERODERMA, SYSTEMIC
has EFO: EFO_0000717
has EFO name: SYSTEMIC SCLERODERMA

CHEMBL_IND_24521
type: DrugIndication
chembl id: CHEMBL_IND_24521
has molecule: CHEMBL1642
highest development phase: 2
has mesh: D055752
has mesh heading: SMALL CELL LUNG CARCINOMA
has EFO: EFO_0000702
has EFO name: SMALL CELL LUNG CARCINOMA

CHEMBL_IND_24520
type: DrugIndication
chembl id: CHEMBL_IND_24520
has molecule: CHEMBL1642
highest development phase: 3
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_24519
type: DrugIndication
chembl id: CHEMBL_IND_24519
has molecule: CHEMBL1642
highest development phase: 2
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: EFO_0001075
has EFO name: OVARIAN CARCINOMA

CHEMBL_IND_24518
type: DrugIndication
chembl id: CHEMBL_IND_24518
has molecule: CHEMBL1642
highest development phase: 2
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_24517
type: DrugIndication
chembl id: CHEMBL_IND_24517
has molecule: CHEMBL1642
highest development phase: 2
has mesh: D054198
has mesh heading: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
has EFO: EFO_0000220
has EFO name: ACUTE LYMPHOBLASTIC LEUKEMIA

CHEMBL_IND_53231
type: DrugIndication
chembl id: CHEMBL_IND_53231
has molecule: CHEMBL511115
highest development phase: 3
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_43617
type: DrugIndication
chembl id: CHEMBL_IND_43617
has molecule: CHEMBL511142
highest development phase: 3
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_25838
type: DrugIndication
chembl id: CHEMBL_IND_25838
has molecule: CHEMBL511142
highest development phase: 3
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_25837
type: DrugIndication
chembl id: CHEMBL_IND_25837
has molecule: CHEMBL511142
highest development phase: 3
has mesh: D010003
has mesh heading: OSTEOARTHRITIS
has EFO: EFO_0002506
has EFO name: OSTEOARTHRITIS

CHEMBL_IND_48602
type: DrugIndication
chembl id: CHEMBL_IND_48602
has molecule: CHEMBL511142
highest development phase: 3
has mesh: D004827
has mesh heading: EPILEPSY
has EFO: EFO_0000474
has EFO name: EPILEPSY

CHEMBL_IND_47776
type: DrugIndication
chembl id: CHEMBL_IND_47776
has molecule: CHEMBL511142
highest development phase: 2
has mesh: D003248
has mesh heading: CONSTIPATION
has EFO: HP_0002019
has EFO name: CONSTIPATION

CHEMBL_IND_47719
type: DrugIndication
chembl id: CHEMBL_IND_47719
has molecule: CHEMBL511142
highest development phase: 3
has mesh: D007405
has mesh heading: INTERVERTEBRAL DISC DISPLACEMENT
has EFO: EFO_0004994
has EFO name: LUMBAR DISC DEGENERATION

CHEMBL_IND_49044
type: DrugIndication
chembl id: CHEMBL_IND_49044
has molecule: CHEMBL511142
highest development phase: 2
has mesh: D011537
has mesh heading: PRURITUS
has EFO: HP_0000989
has EFO name: PRURITUS

CHEMBL_IND_48989
type: DrugIndication
chembl id: CHEMBL_IND_48989
has molecule: CHEMBL511142
highest development phase: 2
has mesh: D001068
has mesh heading: EATING DISORDERS
has EFO: EFO_0005203
has EFO name: EATING DISORDER

CHEMBL_IND_51816
type: DrugIndication
chembl id: CHEMBL_IND_51816
has molecule: CHEMBL511142
highest development phase: 2
has mesh: D009765
has mesh heading: OBESITY
has EFO: EFO_0001073
has EFO name: OBESITY

CHEMBL_IND_44942
type: DrugIndication
chembl id: CHEMBL_IND_44942
has molecule: CHEMBL511142
highest development phase: 1
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_41805
type: DrugIndication
chembl id: CHEMBL_IND_41805
has molecule: CHEMBL511142
highest development phase: 4
has mesh: D019966
has mesh heading: SUBSTANCE-RELATED DISORDERS
has EFO: EFO_0003890
has EFO name: DRUG DEPENDENCE

CHEMBL_IND_22816
type: DrugIndication
chembl id: CHEMBL_IND_22816
has molecule: CHEMBL511142
highest development phase: 4
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_22812
type: DrugIndication
chembl id: CHEMBL_IND_22812
has molecule: CHEMBL511142
highest development phase: 2
has mesh: D006556
has mesh heading: HEROIN DEPENDENCE
has EFO: EFO_0004240
has EFO name: HEROIN DEPENDENCE

CHEMBL_IND_25130
type: DrugIndication
chembl id: CHEMBL_IND_25130
has molecule: CHEMBL511142
highest development phase: 3
has mesh: D009357
has mesh heading: NEONATAL ABSTINENCE SYNDROME
has EFO: EFO_0005799
has EFO name: NEONATAL ABSTINENCE SYNDROME

CHEMBL_IND_24226
type: DrugIndication
chembl id: CHEMBL_IND_24226
has molecule: CHEMBL511142
highest development phase: 4
has mesh: D009293
has mesh heading: OPIOID-RELATED DISORDERS
has EFO: EFO_0005611
has EFO name: OPIOID DEPENDENCE

CHEMBL_IND_51868
type: DrugIndication
chembl id: CHEMBL_IND_51868
has molecule: CHEMBL1659
highest development phase: 2
has mesh: D006255
has mesh heading: RHINITIS, ALLERGIC, SEASONAL
has EFO: EFO_0005854
has EFO name: ALLERGIC RHINITIS

CHEMBL_IND_45947
type: DrugIndication
chembl id: CHEMBL_IND_45947
has molecule: CHEMBL1591
highest development phase: 1
has mesh: D001932
has mesh heading: BRAIN NEOPLASMS
has EFO: EFO_0003833
has EFO name: BRAIN NEOPLASM

CHEMBL_IND_48650
type: DrugIndication
chembl id: CHEMBL_IND_48650
has molecule: CHEMBL1206245
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_24627
type: DrugIndication
chembl id: CHEMBL_IND_24627
has molecule: CHEMBL1577
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_55196
type: DrugIndication
chembl id: CHEMBL_IND_55196
has molecule: CHEMBL503160
highest development phase: 2
has mesh: D008178
has mesh heading: LUPUS ERYTHEMATOSUS, CUTANEOUS
has EFO: EFO_0003834
has EFO name: CUTANEOUS LUPUS ERYTHEMATOSUS

CHEMBL_IND_50023
type: DrugIndication
chembl id: CHEMBL_IND_50023
has molecule: CHEMBL503160
highest development phase: 4
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_44629
type: DrugIndication
chembl id: CHEMBL_IND_44629
has molecule: CHEMBL514270
highest development phase: 2
has mesh: D043183
has mesh heading: IRRITABLE BOWEL SYNDROME
has EFO: EFO_0000555
has EFO name: IRRITABLE BOWEL SYNDROME

CHEMBL_IND_46296
type: DrugIndication
chembl id: CHEMBL_IND_46296
has molecule: CHEMBL501867
highest development phase: 2
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_27505
type: DrugIndication
chembl id: CHEMBL_IND_27505
has molecule: CHEMBL501867
highest development phase: 1
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_24051
type: DrugIndication
chembl id: CHEMBL_IND_24051
has molecule: CHEMBL501867
highest development phase: 3
has mesh: D054198
has mesh heading: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
has EFO: EFO_0000220
has EFO name: ACUTE LYMPHOBLASTIC LEUKEMIA

CHEMBL_IND_44430
type: DrugIndication
chembl id: CHEMBL_IND_44430
has molecule: CHEMBL522302
highest development phase: 1
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_50666
type: DrugIndication
chembl id: CHEMBL_IND_50666
has molecule: CHEMBL512351
highest development phase: 2
has mesh: D001281
has mesh heading: ATRIAL FIBRILLATION
has EFO: EFO_0000275
has EFO name: ATRIAL FIBRILLATION

CHEMBL_IND_55021
type: DrugIndication
chembl id: CHEMBL_IND_55021
has molecule: CHEMBL512351
highest development phase: 3
has mesh: D054556
has mesh heading: VENOUS THROMBOEMBOLISM
has EFO: EFO_0004286
has EFO name: VENOUS THROMBOEMBOLISM

CHEMBL_IND_49362
type: DrugIndication
chembl id: CHEMBL_IND_49362
has molecule: CHEMBL1646
highest development phase: 1
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_48057
type: DrugIndication
chembl id: CHEMBL_IND_48057
has molecule: CHEMBL1646
highest development phase: 1
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0000681
has EFO name: RENAL CELL CARCINOMA

CHEMBL_IND_44824
type: DrugIndication
chembl id: CHEMBL_IND_44824
has molecule: CHEMBL1646
highest development phase: 1
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_44697
type: DrugIndication
chembl id: CHEMBL_IND_44697
has molecule: CHEMBL1646
highest development phase: 3
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_43319
type: DrugIndication
chembl id: CHEMBL_IND_43319
has molecule: CHEMBL1646
highest development phase: 2
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_46378
type: DrugIndication
chembl id: CHEMBL_IND_46378
has molecule: CHEMBL1646
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_43244
type: DrugIndication
chembl id: CHEMBL_IND_43244
has molecule: CHEMBL1646
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_41024
type: DrugIndication
chembl id: CHEMBL_IND_41024
has molecule: CHEMBL1646
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0003869
has EFO name: BREAST NEOPLASM

CHEMBL_IND_44969
type: DrugIndication
chembl id: CHEMBL_IND_44969
has molecule: CHEMBL1646
highest development phase: 1
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_44690
type: DrugIndication
chembl id: CHEMBL_IND_44690
has molecule: CHEMBL1646
highest development phase: 2
has mesh: D010518
has mesh heading: PERIODONTITIS
has EFO: EFO_0000649
has EFO name: PERIODONTITIS

CHEMBL_IND_44683
type: DrugIndication
chembl id: CHEMBL_IND_44683
has molecule: CHEMBL1646
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_51670
type: DrugIndication
chembl id: CHEMBL_IND_51670
has molecule: CHEMBL1646
highest development phase: 3
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_40320
type: DrugIndication
chembl id: CHEMBL_IND_40320
has molecule: CHEMBL1646
highest development phase: 1
has mesh: D008209
has mesh heading: LYMPHEDEMA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: LYMPHEDEMA

CHEMBL_IND_27012
type: DrugIndication
chembl id: CHEMBL_IND_27012
has molecule: CHEMBL1616
highest development phase: 4
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_45770
type: DrugIndication
chembl id: CHEMBL_IND_45770
has molecule: CHEMBL519504
highest development phase: 3
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_47002
type: DrugIndication
chembl id: CHEMBL_IND_47002
has molecule: CHEMBL517712
highest development phase: 3
has mesh: D009216
has mesh heading: MYOPIA
has EFO: HP_0000545
has EFO name: MYOPIA

CHEMBL_IND_27028
type: DrugIndication
chembl id: CHEMBL_IND_27028
has molecule: CHEMBL517712
highest development phase: 4
has mesh: D004066
has mesh heading: DIGESTIVE SYSTEM DISEASES
has EFO: EFO_0000405
has EFO name: DIGESTIVE SYSTEM DISEASE

CHEMBL_IND_25801
type: DrugIndication
chembl id: CHEMBL_IND_25801
has molecule: CHEMBL517712
highest development phase: 3
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_45295
type: DrugIndication
chembl id: CHEMBL_IND_45295
has molecule: CHEMBL517712
highest development phase: 0
has mesh: D007003
has mesh heading: HYPOGLYCEMIA
has EFO: HP_0001943
has EFO name: HYPOGLYCEMIA

CHEMBL_IND_24170
type: DrugIndication
chembl id: CHEMBL_IND_24170
has molecule: CHEMBL517712
highest development phase: 2
has mesh: D006255
has mesh heading: RHINITIS, ALLERGIC, SEASONAL
has EFO: EFO_0003956
has EFO name: SEASONAL ALLERGIC RHINITIS

CHEMBL_IND_22737
type: DrugIndication
chembl id: CHEMBL_IND_22737
has molecule: CHEMBL517712
highest development phase: 3
has mesh: D000550
has mesh heading: AMBLYOPIA
has EFO: HP_0000646
has EFO name: AMBLYOPIA

CHEMBL_IND_42921
type: DrugIndication
chembl id: CHEMBL_IND_42921
has molecule: CHEMBL520400
highest development phase: 4
has mesh: D011537
has mesh heading: PRURITUS
has EFO: HP_0000989
has EFO name: PRURITUS

CHEMBL_IND_42719
type: DrugIndication
chembl id: CHEMBL_IND_42719
has molecule: CHEMBL520400
highest development phase: 4
has mesh: D006967
has mesh heading: HYPERSENSITIVITY
has EFO: EFO_0003785
has EFO name: ALLERGY

CHEMBL_IND_47049
type: DrugIndication
chembl id: CHEMBL_IND_47049
has molecule: CHEMBL507361
highest development phase: 2
has mesh: D009456
has mesh heading: NEUROFIBROMATOSIS 1
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: NEUROFIBROMATOSIS TYPE 1

CHEMBL_IND_53510
type: DrugIndication
chembl id: CHEMBL_IND_53510
has molecule: CHEMBL507361
highest development phase: 1
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_44985
type: DrugIndication
chembl id: CHEMBL_IND_44985
has molecule: CHEMBL507361
highest development phase: 2
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_43880
type: DrugIndication
chembl id: CHEMBL_IND_43880
has molecule: CHEMBL520642
highest development phase: 1
has mesh: D011014
has mesh heading: PNEUMONIA
has EFO: EFO_0003106
has EFO name: PNEUMONIA

CHEMBL_IND_53626
type: DrugIndication
chembl id: CHEMBL_IND_53626
has molecule: CHEMBL508338
highest development phase: 3
has mesh: D019694
has mesh heading: HEPATITIS B, CHRONIC
has EFO: EFO_0004197
has EFO name: HEPATITIS B INFECTION

CHEMBL_IND_39748
type: DrugIndication
chembl id: CHEMBL_IND_39748
has molecule: CHEMBL522038
highest development phase: 4
has mesh: D013927
has mesh heading: THROMBOSIS
has EFO: HP_0004419
has EFO name: RECURRENT THROMBOPHLEBITIS

CHEMBL_IND_44789
type: DrugIndication
chembl id: CHEMBL_IND_44789
has molecule: CHEMBL518520
highest development phase: 4
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_50010
type: DrugIndication
chembl id: CHEMBL_IND_50010
has molecule: CHEMBL506569
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_54062
type: DrugIndication
chembl id: CHEMBL_IND_54062
has molecule: CHEMBL1680
highest development phase: 3
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_45171
type: DrugIndication
chembl id: CHEMBL_IND_45171
has molecule: CHEMBL1680
highest development phase: 3
has mesh: D002276
has mesh heading: CARCINOID TUMOR
has EFO: EFO_0004243
has EFO name: CARCINOID TUMOR

CHEMBL_IND_40689
type: DrugIndication
chembl id: CHEMBL_IND_40689
has molecule: CHEMBL1680
highest development phase: 3
has mesh: D008303
has mesh heading: MALIGNANT CARCINOID SYNDROME
has EFO: EFO_1000852
has EFO name: CARCINOID SYNDROME

CHEMBL_IND_48489
type: DrugIndication
chembl id: CHEMBL_IND_48489
has molecule: CHEMBL1680
highest development phase: 3
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_48418
type: DrugIndication
chembl id: CHEMBL_IND_48418
has molecule: CHEMBL1680
highest development phase: 3
has mesh: D003967
has mesh heading: DIARRHEA
has EFO: HP_0002014
has EFO name: DIARRHEA

CHEMBL_IND_49061
type: DrugIndication
chembl id: CHEMBL_IND_49061
has molecule: CHEMBL1680
highest development phase: 1
has mesh: D006471
has mesh heading: GASTROINTESTINAL HEMORRHAGE
has EFO: HP_0002239
has EFO name: GASTROINTESTINAL HEMORRHAGE

CHEMBL_IND_43421
type: DrugIndication
chembl id: CHEMBL_IND_43421
has molecule: CHEMBL1680
highest development phase: 1
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_41071
type: DrugIndication
chembl id: CHEMBL_IND_41071
has molecule: CHEMBL1680
highest development phase: 2
has mesh: D013945
has mesh heading: THYMOMA
has EFO: EFO_1000581
has EFO name: THYMOMA

CHEMBL_IND_53150
type: DrugIndication
chembl id: CHEMBL_IND_53150
has molecule: CHEMBL1680
highest development phase: 4
has mesh: D000172
has mesh heading: ACROMEGALY
has EFO: EFO_1001485
has EFO name: ACROMEGALY

CHEMBL_IND_47393
type: DrugIndication
chembl id: CHEMBL_IND_47393
has molecule: CHEMBL1680
highest development phase: 1
has mesh: D054990
has mesh heading: IDIOPATHIC PULMONARY FIBROSIS
has EFO: EFO_0000768
has EFO name: IDIOPATHIC PULMONARY FIBROSIS

CHEMBL_IND_49249
type: DrugIndication
chembl id: CHEMBL_IND_49249
has molecule: CHEMBL521686
highest development phase: 2
has mesh: D009373
has mesh heading: NEOPLASMS, GERM CELL AND EMBRYONAL
has EFO: EFO_0000514
has EFO name: GERM CELL TUMOR

CHEMBL_IND_46692
type: DrugIndication
chembl id: CHEMBL_IND_46692
has molecule: CHEMBL521686
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_52561
type: DrugIndication
chembl id: CHEMBL_IND_52561
has molecule: CHEMBL521686
highest development phase: 4
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: MALIGNANT EPITHELIAL TUMOR OF OVARY

CHEMBL_IND_25518
type: DrugIndication
chembl id: CHEMBL_IND_25518
has molecule: CHEMBL521686
highest development phase: 2
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_52268
type: DrugIndication
chembl id: CHEMBL_IND_52268
has molecule: CHEMBL521686
highest development phase: 4
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: EFO_0003893
has EFO name: OVARIAN NEOPLASM

CHEMBL_IND_28308
type: DrugIndication
chembl id: CHEMBL_IND_28308
has molecule: CHEMBL521686
highest development phase: 2
has mesh: D012512
has mesh heading: SARCOMA, EWING
has EFO: EFO_0000174
has EFO name: EWING SARCOMA

CHEMBL_IND_28307
type: DrugIndication
chembl id: CHEMBL_IND_28307
has molecule: CHEMBL521686
highest development phase: 1
has mesh: D002277
has mesh heading: CARCINOMA
has EFO: EFO_0000313
has EFO name: CARCINOMA

CHEMBL_IND_28306
type: DrugIndication
chembl id: CHEMBL_IND_28306
has molecule: CHEMBL521686
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_45384
type: DrugIndication
chembl id: CHEMBL_IND_45384
has molecule: CHEMBL521686
highest development phase: 2
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000181
has EFO name: HEAD AND NECK SQUAMOUS CELL CARCINOMA

CHEMBL_IND_43263
type: DrugIndication
chembl id: CHEMBL_IND_43263
has molecule: CHEMBL521686
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_26189
type: DrugIndication
chembl id: CHEMBL_IND_26189
has molecule: CHEMBL521686
highest development phase: 2
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_51830
type: DrugIndication
chembl id: CHEMBL_IND_51830
has molecule: CHEMBL521686
highest development phase: 2
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_24726
type: DrugIndication
chembl id: CHEMBL_IND_24726
has molecule: CHEMBL521686
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_24725
type: DrugIndication
chembl id: CHEMBL_IND_24725
has molecule: CHEMBL521686
highest development phase: 4
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: EFO_0001075
has EFO name: OVARIAN CARCINOMA

CHEMBL_IND_24724
type: DrugIndication
chembl id: CHEMBL_IND_24724
has molecule: CHEMBL521686
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_51640
type: DrugIndication
chembl id: CHEMBL_IND_51640
has molecule: CHEMBL521686
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000196
has EFO name: METASTATIC PROSTATE CANCER

CHEMBL_IND_40348
type: DrugIndication
chembl id: CHEMBL_IND_40348
has molecule: CHEMBL521686
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0003869
has EFO name: BREAST NEOPLASM

CHEMBL_IND_51809
type: DrugIndication
chembl id: CHEMBL_IND_51809
has molecule: CHEMBL521686
highest development phase: 1
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_42498
type: DrugIndication
chembl id: CHEMBL_IND_42498
has molecule: CHEMBL517427
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_44387
type: DrugIndication
chembl id: CHEMBL_IND_44387
has molecule: CHEMBL517427
highest development phase: 3
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_55095
type: DrugIndication
chembl id: CHEMBL_IND_55095
has molecule: CHEMBL529437
highest development phase: 1
has mesh: D019970
has mesh heading: COCAINE-RELATED DISORDERS
has EFO: EFO_0002610
has EFO name: COCAINE DEPENDENCE

CHEMBL_IND_26859
type: DrugIndication
chembl id: CHEMBL_IND_26859
has molecule: CHEMBL1643
highest development phase: 3
has mesh: D019694
has mesh heading: HEPATITIS B, CHRONIC
has EFO: EFO_0004197
has EFO name: HEPATITIS B INFECTION

CHEMBL_IND_44779
type: DrugIndication
chembl id: CHEMBL_IND_44779
has molecule: CHEMBL1643
highest development phase: 3
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_28361
type: DrugIndication
chembl id: CHEMBL_IND_28361
has molecule: CHEMBL1643
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_23793
type: DrugIndication
chembl id: CHEMBL_IND_23793
has molecule: CHEMBL1643
highest development phase: 3
has mesh: D006526
has mesh heading: HEPATITIS C
has EFO: EFO_0003047
has EFO name: HEPATITIS C INFECTION

CHEMBL_IND_23792
type: DrugIndication
chembl id: CHEMBL_IND_23792
has molecule: CHEMBL1643
highest development phase: 3
has mesh: D019698
has mesh heading: HEPATITIS C, CHRONIC
has EFO: EFO_0004220
has EFO name: CHRONIC HEPATITIS C INFECTION

CHEMBL_IND_23791
type: DrugIndication
chembl id: CHEMBL_IND_23791
has molecule: CHEMBL1643
highest development phase: 1
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_23790
type: DrugIndication
chembl id: CHEMBL_IND_23790
has molecule: CHEMBL1643
highest development phase: 2
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_41765
type: DrugIndication
chembl id: CHEMBL_IND_41765
has molecule: CHEMBL1643
highest development phase: 4
has mesh: D014777
has mesh heading: VIRUS DISEASES
has EFO: EFO_0000763
has EFO name: VIRAL DISEASE

CHEMBL_IND_27413
type: DrugIndication
chembl id: CHEMBL_IND_27413
has molecule: CHEMBL1643
highest development phase: 3
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_23662
type: DrugIndication
chembl id: CHEMBL_IND_23662
has molecule: CHEMBL1708
highest development phase: 1
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_42033
type: DrugIndication
chembl id: CHEMBL_IND_42033
has molecule: CHEMBL515408
highest development phase: 4
has mesh: D014777
has mesh heading: VIRUS DISEASES
has EFO: EFO_0000763
has EFO name: VIRAL DISEASE

CHEMBL_IND_44808
type: DrugIndication
chembl id: CHEMBL_IND_44808
has molecule: CHEMBL515408
highest development phase: 3
has mesh: D003586
has mesh heading: CYTOMEGALOVIRUS INFECTIONS
has EFO: EFO_0001062
has EFO name: CYTOMEGALOVIRUS INFECTION

CHEMBL_IND_50014
type: DrugIndication
chembl id: CHEMBL_IND_50014
has molecule: CHEMBL517199
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_53338
type: DrugIndication
chembl id: CHEMBL_IND_53338
has molecule: CHEMBL1207366
highest development phase: 2
has mesh: D014029
has mesh heading: TOBACCO USE DISORDER
has EFO: EFO_0003768
has EFO name: NICOTINE DEPENDENCE

CHEMBL_IND_42638
type: DrugIndication
chembl id: CHEMBL_IND_42638
has molecule: CHEMBL521589
highest development phase: 4
has mesh: D008173
has mesh heading: LUNG DISEASES, OBSTRUCTIVE
has EFO: HP_0006536
has EFO name: OBSTRUCTIVE LUNG DISEASE

CHEMBL_IND_28176
type: DrugIndication
chembl id: CHEMBL_IND_28176
has molecule: CHEMBL544665
highest development phase: 2
has mesh: D000690
has mesh heading: AMYOTROPHIC LATERAL SCLEROSIS
has EFO: EFO_0000253
has EFO name: AMYOTROPHIC LATERAL SCLEROSIS

CHEMBL_IND_51552
type: DrugIndication
chembl id: CHEMBL_IND_51552
has molecule: CHEMBL544665
highest development phase: 4
has mesh: D009103
has mesh heading: MULTIPLE SCLEROSIS
has EFO: EFO_0003885
has EFO name: MULTIPLE SCLEROSIS

CHEMBL_IND_29225
type: DrugIndication
chembl id: CHEMBL_IND_29225
has molecule: CHEMBL1694
highest development phase: 4
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_43647
type: DrugIndication
chembl id: CHEMBL_IND_43647
has molecule: CHEMBL1698
highest development phase: 3
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_41593
type: DrugIndication
chembl id: CHEMBL_IND_41593
has molecule: CHEMBL1698
highest development phase: 4
has mesh: D016574
has mesh heading: SEASONAL AFFECTIVE DISORDER

CHEMBL_IND_48332
type: DrugIndication
chembl id: CHEMBL_IND_48332
has molecule: CHEMBL1698
highest development phase: 1
has mesh: D019964
has mesh heading: MOOD DISORDERS
has EFO: EFO_0004247
has EFO name: MOOD DISORDER

CHEMBL_IND_22823
type: DrugIndication
chembl id: CHEMBL_IND_22823
has molecule: CHEMBL1698
highest development phase: 4
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_22819
type: DrugIndication
chembl id: CHEMBL_IND_22819
has molecule: CHEMBL1698
highest development phase: 1
has mesh: D014029
has mesh heading: TOBACCO USE DISORDER
has EFO: EFO_0003768
has EFO name: NICOTINE DEPENDENCE

CHEMBL_IND_22817
type: DrugIndication
chembl id: CHEMBL_IND_22817
has molecule: CHEMBL1698
highest development phase: 3
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_51591
type: DrugIndication
chembl id: CHEMBL_IND_51591
has molecule: CHEMBL1698
highest development phase: 4
has mesh: D016574
has mesh heading: SEASONAL AFFECTIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_24279
type: DrugIndication
chembl id: CHEMBL_IND_24279
has molecule: CHEMBL1705
highest development phase: 3
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_26222
type: DrugIndication
chembl id: CHEMBL_IND_26222
has molecule: CHEMBL1715
highest development phase: 2
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_26220
type: DrugIndication
chembl id: CHEMBL_IND_26220
has molecule: CHEMBL1715
highest development phase: 2
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_23707
type: DrugIndication
chembl id: CHEMBL_IND_23707
has molecule: CHEMBL1715
highest development phase: 4
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_23705
type: DrugIndication
chembl id: CHEMBL_IND_23705
has molecule: CHEMBL1715
highest development phase: 1
has mesh: D065626
has mesh heading: NON-ALCOHOLIC FATTY LIVER DISEASE
has EFO: EFO_0003095
has EFO name: NON-ALCOHOLIC FATTY LIVER DISEASE

CHEMBL_IND_27887
type: DrugIndication
chembl id: CHEMBL_IND_27887
has molecule: CHEMBL1715
highest development phase: 2
has mesh: D007972
has mesh heading: LEUKOPLAKIA, ORAL
has EFO: HP_0002745
has EFO name: ORAL LEUKOPLAKIA

CHEMBL_IND_24883
type: DrugIndication
chembl id: CHEMBL_IND_24883
has molecule: CHEMBL1709
highest development phase: 2
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_53707
type: DrugIndication
chembl id: CHEMBL_IND_53707
has molecule: CHEMBL1738
highest development phase: 1
has mesh: D006330
has mesh heading: HEART DEFECTS, CONGENITAL
has EFO: HP_0030680
has EFO name: MALFORMATION OF THE HEART AND GREAT VESSELS

CHEMBL_IND_54928
type: DrugIndication
chembl id: CHEMBL_IND_54928
has molecule: CHEMBL1738
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_52009
type: DrugIndication
chembl id: CHEMBL_IND_52009
has molecule: CHEMBL542257
highest development phase: 2
has mesh: D012148
has mesh heading: RESTLESS LEGS SYNDROME
has EFO: EFO_0004270
has EFO name: RESTLESS LEGS SYNDROME

CHEMBL_IND_23713
type: DrugIndication
chembl id: CHEMBL_IND_23713
has molecule: CHEMBL542257
highest development phase: 4
has mesh: D010300
has mesh heading: PARKINSON DISEASE
has EFO: EFO_0002508
has EFO name: PARKINSON'S DISEASE

CHEMBL_IND_47775
type: DrugIndication
chembl id: CHEMBL_IND_47775
has molecule: CHEMBL1707
highest development phase: 3
has mesh: D003967
has mesh heading: DIARRHEA
has EFO: HP_0002014
has EFO name: DIARRHEA

CHEMBL_IND_43626
type: DrugIndication
chembl id: CHEMBL_IND_43626
has molecule: CHEMBL525076
highest development phase: 3
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_42867
type: DrugIndication
chembl id: CHEMBL_IND_42867
has molecule: CHEMBL525076
highest development phase: 4
has mesh: D014777
has mesh heading: VIRUS DISEASES
has EFO: EFO_0000763
has EFO name: VIRAL DISEASE

CHEMBL_IND_47748
type: DrugIndication
chembl id: CHEMBL_IND_47748
has molecule: CHEMBL1554
highest development phase: 3
has mesh: D006828
has mesh heading: HYDATIDIFORM MOLE
has EFO: EFO_1000298
has EFO name: HYDATIDIFORM MOLE

CHEMBL_IND_26989
type: DrugIndication
chembl id: CHEMBL_IND_26989
has molecule: CHEMBL551466
highest development phase: 4
has mesh: D008173
has mesh heading: LUNG DISEASES, OBSTRUCTIVE
has EFO: HP_0006536
has EFO name: OBSTRUCTIVE LUNG DISEASE

CHEMBL_IND_41997
type: DrugIndication
chembl id: CHEMBL_IND_41997
has molecule: CHEMBL551466
highest development phase: 4
has mesh: D004646
has mesh heading: EMPHYSEMA
has EFO: EFO_0000464
has EFO name: EMPHYSEMA

CHEMBL_IND_41617
type: DrugIndication
chembl id: CHEMBL_IND_41617
has molecule: CHEMBL551466
highest development phase: 4
has mesh: D001986
has mesh heading: BRONCHIAL SPASM

CHEMBL_IND_22630
type: DrugIndication
chembl id: CHEMBL_IND_22630
has molecule: CHEMBL551466
highest development phase: 4
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_51628
type: DrugIndication
chembl id: CHEMBL_IND_51628
has molecule: CHEMBL551466
highest development phase: 4
has mesh: D029481
has mesh heading: BRONCHITIS, CHRONIC
has EFO: EFO_0006505
has EFO name: CHRONIC BRONCHITIS

CHEMBL_IND_45475
type: DrugIndication
chembl id: CHEMBL_IND_45475
has molecule: CHEMBL1699
highest development phase: 3
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_27795
type: DrugIndication
chembl id: CHEMBL_IND_27795
has molecule: CHEMBL1699
highest development phase: 2
has mesh: D005715
has mesh heading: GAMBLING
has EFO: EFO_0004699
has EFO name: GAMBLING BEHAVIOUR

CHEMBL_IND_53935
type: DrugIndication
chembl id: CHEMBL_IND_53935
has molecule: CHEMBL1734
highest development phase: 2
has mesh: D014549
has mesh heading: URINARY INCONTINENCE
has EFO: HP_0000020
has EFO name: URINARY INCONTINENCE

CHEMBL_IND_53109
type: DrugIndication
chembl id: CHEMBL_IND_53109
has molecule: CHEMBL1734
highest development phase: 4
has mesh: D053201
has mesh heading: URINARY BLADDER, OVERACTIVE
has EFO: EFO_1000781
has EFO name: OVERACTIVE BLADDER

CHEMBL_IND_55355
type: DrugIndication
chembl id: CHEMBL_IND_55355
has molecule: CHEMBL537669
highest development phase: 2
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_27562
type: DrugIndication
chembl id: CHEMBL_IND_27562
has molecule: CHEMBL1542
highest development phase: 3
has mesh: D003093
has mesh heading: COLITIS, ULCERATIVE
has EFO: EFO_0000729
has EFO name: ULCERATIVE COLITIS

CHEMBL_IND_41727
type: DrugIndication
chembl id: CHEMBL_IND_41727
has molecule: CHEMBL1542
highest development phase: 4
has mesh: D007154
has mesh heading: IMMUNE SYSTEM DISEASES
has EFO: EFO_0000540
has EFO name: IMMUNE SYSTEM DISEASE

CHEMBL_IND_25093
type: DrugIndication
chembl id: CHEMBL_IND_25093
has molecule: CHEMBL1542
highest development phase: 3
has mesh: D003424
has mesh heading: CROHN DISEASE
has EFO: EFO_0000384
has EFO name: CROHN'S DISEASE

CHEMBL_IND_24178
type: DrugIndication
chembl id: CHEMBL_IND_24178
has molecule: CHEMBL1542
highest development phase: 3
has mesh: D014657
has mesh heading: VASCULITIS
has EFO: EFO_0006803
has EFO name: VASCULITIS

CHEMBL_IND_24177
type: DrugIndication
chembl id: CHEMBL_IND_24177
has molecule: CHEMBL1542
highest development phase: 4
has mesh: D001172
has mesh heading: ARTHRITIS, RHEUMATOID
has EFO: EFO_0000685
has EFO name: RHEUMATOID ARTHRITIS

CHEMBL_IND_22744
type: DrugIndication
chembl id: CHEMBL_IND_22744
has molecule: CHEMBL1542
highest development phase: 3
has mesh: D009157
has mesh heading: MYASTHENIA GRAVIS
has EFO: EFO_0004991
has EFO name: MYASTHENIA GRAVIS

CHEMBL_IND_46903
type: DrugIndication
chembl id: CHEMBL_IND_46903
has molecule: CHEMBL537847
highest development phase: 3
has mesh: D001145
has mesh heading: ARRHYTHMIAS, CARDIAC
has EFO: EFO_0004269
has EFO name: CARDIAC ARRHYTHMIA

CHEMBL_IND_44417
type: DrugIndication
chembl id: CHEMBL_IND_44417
has molecule: CHEMBL537847
highest development phase: 3
has mesh: D001281
has mesh heading: ATRIAL FIBRILLATION
has EFO: EFO_0000275
has EFO name: ATRIAL FIBRILLATION

CHEMBL_IND_27651
type: DrugIndication
chembl id: CHEMBL_IND_27651
has molecule: CHEMBL1697
highest development phase: 1
has mesh: D012871
has mesh heading: SKIN DISEASES
has EFO: EFO_0000701
has EFO name: SKIN DISEASE

CHEMBL_IND_27650
type: DrugIndication
chembl id: CHEMBL_IND_27650
has molecule: CHEMBL1697
highest development phase: 3
has mesh: D005401
has mesh heading: FISSURE IN ANO
has EFO: HP_0012390
has EFO name: ANAL FISSURE

CHEMBL_IND_25244
type: DrugIndication
chembl id: CHEMBL_IND_25244
has molecule: CHEMBL1697
highest development phase: 1
has mesh: D003248
has mesh heading: CONSTIPATION
has EFO: HP_0002019
has EFO name: CONSTIPATION

CHEMBL_IND_51638
type: DrugIndication
chembl id: CHEMBL_IND_51638
has molecule: CHEMBL1697
highest development phase: 4
has mesh: D060050
has mesh heading: ANGINA, STABLE
has EFO: EFO_0003913
has EFO name: ANGINA PECTORIS

CHEMBL_IND_52056
type: DrugIndication
chembl id: CHEMBL_IND_52056
has molecule: CHEMBL1703
highest development phase: 2
has mesh: D017719
has mesh heading: DIABETIC FOOT
has EFO: EFO_1001459
has EFO name: DIABETIC FOOT

CHEMBL_IND_26701
type: DrugIndication
chembl id: CHEMBL_IND_26701
has molecule: CHEMBL1703
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_26700
type: DrugIndication
chembl id: CHEMBL_IND_26700
has molecule: CHEMBL1703
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_25446
type: DrugIndication
chembl id: CHEMBL_IND_25446
has molecule: CHEMBL1703
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_52086
type: DrugIndication
chembl id: CHEMBL_IND_52086
has molecule: CHEMBL1703
highest development phase: 3
has mesh: D024821
has mesh heading: METABOLIC SYNDROME X
has EFO: EFO_0000195
has EFO name: METABOLIC SYNDROME

CHEMBL_IND_27800
type: DrugIndication
chembl id: CHEMBL_IND_27800
has molecule: CHEMBL1703
highest development phase: 1
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_23480
type: DrugIndication
chembl id: CHEMBL_IND_23480
has molecule: CHEMBL1703
highest development phase: 4
has mesh: D003924
has mesh heading: DIABETES MELLITUS, TYPE 2
has EFO: EFO_0001360
has EFO name: TYPE II DIABETES MELLITUS

CHEMBL_IND_23477
type: DrugIndication
chembl id: CHEMBL_IND_23477
has molecule: CHEMBL1703
highest development phase: 2
has mesh: D009765
has mesh heading: OBESITY
has EFO: EFO_0001073
has EFO name: OBESITY

CHEMBL_IND_23475
type: DrugIndication
chembl id: CHEMBL_IND_23475
has molecule: CHEMBL1703
highest development phase: 3
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_53027
type: DrugIndication
chembl id: CHEMBL_IND_53027
has molecule: CHEMBL553025
highest development phase: 3
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_54195
type: DrugIndication
chembl id: CHEMBL_IND_54195
has molecule: CHEMBL553025
highest development phase: 2
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_53251
type: DrugIndication
chembl id: CHEMBL_IND_53251
has molecule: CHEMBL553025
highest development phase: 2
has mesh: D008654
has mesh heading: MESOTHELIOMA
has EFO: EFO_0000588
has EFO name: MESOTHELIOMA

CHEMBL_IND_54618
type: DrugIndication
chembl id: CHEMBL_IND_54618
has molecule: CHEMBL553025
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000389
has EFO name: CUTANEOUS MELANOMA

CHEMBL_IND_52870
type: DrugIndication
chembl id: CHEMBL_IND_52870
has molecule: CHEMBL553025
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_52723
type: DrugIndication
chembl id: CHEMBL_IND_52723
has molecule: CHEMBL553025
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_54509
type: DrugIndication
chembl id: CHEMBL_IND_54509
has molecule: CHEMBL553025
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0003869
has EFO name: BREAST NEOPLASM

CHEMBL_IND_49256
type: DrugIndication
chembl id: CHEMBL_IND_49256
has molecule: CHEMBL549386
highest development phase: 2
has mesh: D005909
has mesh heading: GLIOBLASTOMA
has EFO: EFO_0000519
has EFO name: GLIOBLASTOMA MULTIFORME

CHEMBL_IND_42975
type: DrugIndication
chembl id: CHEMBL_IND_42975
has molecule: CHEMBL549386
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_53367
type: DrugIndication
chembl id: CHEMBL_IND_53367
has molecule: CHEMBL539423
highest development phase: 2
has mesh: D005923
has mesh heading: GLOMERULOSCLEROSIS, FOCAL SEGMENTAL
has EFO: EFO_0004236
has EFO name: FOCAL SEGMENTAL GLOMERULOSCLEROSIS

CHEMBL_IND_44584
type: DrugIndication
chembl id: CHEMBL_IND_44584
has molecule: CHEMBL539423
highest development phase: 2
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_47878
type: DrugIndication
chembl id: CHEMBL_IND_47878
has molecule: CHEMBL6
highest development phase: 2
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_25391
type: DrugIndication
chembl id: CHEMBL_IND_25391
has molecule: CHEMBL6
highest development phase: 2
has mesh: D004374
has mesh heading: DUCTUS ARTERIOSUS, PATENT
has EFO: HP_0001643
has EFO name: PATENT DUCTUS ARTERIOSUS

CHEMBL_IND_25390
type: DrugIndication
chembl id: CHEMBL_IND_25390
has molecule: CHEMBL6
highest development phase: 3
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_25388
type: DrugIndication
chembl id: CHEMBL_IND_25388
has molecule: CHEMBL6
highest development phase: 4
has mesh: D018771
has mesh heading: ARTHRALGIA
has EFO: HP_0002829
has EFO name: ARTHRALGIA

CHEMBL_IND_26046
type: DrugIndication
chembl id: CHEMBL_IND_26046
has molecule: CHEMBL6
highest development phase: 4
has mesh: D063806
has mesh heading: MYALGIA
has EFO: HP_0003326
has EFO name: MYALGIA

CHEMBL_IND_26044
type: DrugIndication
chembl id: CHEMBL_IND_26044
has molecule: CHEMBL6
highest development phase: 1
has mesh: D007863
has mesh heading: LECITHIN ACYLTRANSFERASE DEFICIENCY
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: FISH-EYE DISEASE

CHEMBL_IND_41850
type: DrugIndication
chembl id: CHEMBL_IND_41850
has molecule: CHEMBL6
highest development phase: 4
has mesh: D012216
has mesh heading: RHEUMATIC DISEASES
has EFO: EFO_0005755
has EFO name: RHEUMATIC DISEASE

CHEMBL_IND_27739
type: DrugIndication
chembl id: CHEMBL_IND_27739
has molecule: CHEMBL6
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_51758
type: DrugIndication
chembl id: CHEMBL_IND_51758
has molecule: CHEMBL6
highest development phase: 3
has mesh: D056844
has mesh heading: RENAL COLIC
has EFO: EFO_1001412
has EFO name: RENAL COLIC

CHEMBL_IND_23328
type: DrugIndication
chembl id: CHEMBL_IND_23328
has molecule: CHEMBL6
highest development phase: 3
has mesh: D047928
has mesh heading: PREMATURE BIRTH
has EFO: EFO_0003917
has EFO name: PREMATURE BIRTH

CHEMBL_IND_23327
type: DrugIndication
chembl id: CHEMBL_IND_23327
has molecule: CHEMBL6
highest development phase: 2
has mesh: D010195
has mesh heading: PANCREATITIS
has EFO: EFO_0000278
has EFO name: PANCREATITIS

CHEMBL_IND_23323
type: DrugIndication
chembl id: CHEMBL_IND_23323
has molecule: CHEMBL6
highest development phase: 3
has mesh: D006073
has mesh heading: GOUT
has EFO: EFO_0004274
has EFO name: GOUT

CHEMBL_IND_23322
type: DrugIndication
chembl id: CHEMBL_IND_23322
has molecule: CHEMBL6
highest development phase: 0
has mesh: D004066
has mesh heading: DIGESTIVE SYSTEM DISEASES
has EFO: EFO_0000405
has EFO name: DIGESTIVE SYSTEM DISEASE

CHEMBL_IND_24530
type: DrugIndication
chembl id: CHEMBL_IND_24530
has molecule: CHEMBL6
highest development phase: 4
has mesh: D005128
has mesh heading: EYE DISEASES
has EFO: EFO_0005752
has EFO name: EYE INFLAMMATION

CHEMBL_IND_24528
type: DrugIndication
chembl id: CHEMBL_IND_24528
has molecule: CHEMBL6
highest development phase: 3
has mesh: D013167
has mesh heading: SPONDYLITIS, ANKYLOSING
has EFO: EFO_0003898
has EFO name: ANKYLOSING SPONDYLITIS

CHEMBL_IND_28628
type: DrugIndication
chembl id: CHEMBL_IND_28628
has molecule: CHEMBL2364637
highest development phase: 4
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000180
has EFO name: HIV-1 INFECTION

CHEMBL_IND_26884
type: DrugIndication
chembl id: CHEMBL_IND_26884
has molecule: CHEMBL1737
highest development phase: 1
has mesh: D004412
has mesh heading: DYSMENORRHEA
has EFO: HP_0100607
has EFO name: DYSMENORRHEA

CHEMBL_IND_42477
type: DrugIndication
chembl id: CHEMBL_IND_42477
has molecule: CHEMBL1737
highest development phase: 4
has mesh: D065627
has mesh heading: FAMILIAL PRIMARY PULMONARY HYPERTENSION
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: IDIOPATHIC AND/OR FAMILIAL PULMONARY ARTERIAL HYPERTENSION

CHEMBL_IND_26282
type: DrugIndication
chembl id: CHEMBL_IND_26282
has molecule: CHEMBL1737
highest development phase: 3
has mesh: D005317
has mesh heading: FETAL GROWTH RETARDATION
has EFO: EFO_0000495
has EFO name: FETAL GROWTH RESTRICTION

CHEMBL_IND_23867
type: DrugIndication
chembl id: CHEMBL_IND_23867
has molecule: CHEMBL1737
highest development phase: 1
has mesh: D020521
has mesh heading: STROKE
has EFO: EFO_0000712
has EFO name: STROKE

CHEMBL_IND_23865
type: DrugIndication
chembl id: CHEMBL_IND_23865
has molecule: CHEMBL1737
highest development phase: 4
has mesh: D007172
has mesh heading: ERECTILE DYSFUNCTION
has EFO: EFO_0004234
has EFO name: ERECTILE DYSFUNCTION

CHEMBL_IND_23863
type: DrugIndication
chembl id: CHEMBL_IND_23863
has molecule: CHEMBL1737
highest development phase: 2
has mesh: D008268
has mesh heading: MACULAR DEGENERATION
has EFO: EFO_0001365
has EFO name: AGE-RELATED MACULAR DEGENERATION

CHEMBL_IND_24889
type: DrugIndication
chembl id: CHEMBL_IND_24889
has molecule: CHEMBL1737
highest development phase: 4
has mesh: D006976
has mesh heading: HYPERTENSION, PULMONARY
has EFO: EFO_0001361
has EFO name: PULMONARY HYPERTENSION

CHEMBL_IND_45012
type: DrugIndication
chembl id: CHEMBL_IND_45012
has molecule: CHEMBL556262
highest development phase: 3
has mesh: D011014
has mesh heading: PNEUMONIA
has EFO: EFO_0003106
has EFO name: PNEUMONIA

CHEMBL_IND_42881
type: DrugIndication
chembl id: CHEMBL_IND_42881
has molecule: CHEMBL559288
highest development phase: 4
has mesh: D010146
has mesh heading: PAIN
has EFO: EFO_0003843
has EFO name: PAIN

CHEMBL_IND_48000
type: DrugIndication
chembl id: CHEMBL_IND_48000
has molecule: CHEMBL559362
highest development phase: 2
has mesh: D012514
has mesh heading: SARCOMA, KAPOSI
has EFO: EFO_0000558
has EFO name: KAPOSI'S SARCOMA

CHEMBL_IND_48511
type: DrugIndication
chembl id: CHEMBL_IND_48511
has molecule: CHEMBL1746
highest development phase: 1
has mesh: D000690
has mesh heading: AMYOTROPHIC LATERAL SCLEROSIS
has EFO: EFO_0000253
has EFO name: AMYOTROPHIC LATERAL SCLEROSIS

CHEMBL_IND_41384
type: DrugIndication
chembl id: CHEMBL_IND_41384
has molecule: CHEMBL1746
highest development phase: 2
has mesh: D017827
has mesh heading: MACHADO-JOSEPH DISEASE
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SPINOCEREBELLAR ATAXIA TYPE 3

CHEMBL_IND_46246
type: DrugIndication
chembl id: CHEMBL_IND_46246
has molecule: CHEMBL1746
highest development phase: 1
has mesh: D003550
has mesh heading: CYSTIC FIBROSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CYSTIC FIBROSIS

CHEMBL_IND_44644
type: DrugIndication
chembl id: CHEMBL_IND_44644
has molecule: CHEMBL1746
highest development phase: 1
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_45681
type: DrugIndication
chembl id: CHEMBL_IND_45681
has molecule: CHEMBL567597
highest development phase: 3
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_55359
type: DrugIndication
chembl id: CHEMBL_IND_55359
has molecule: CHEMBL556578
highest development phase: 3
has mesh: D009293
has mesh heading: OPIOID-RELATED DISORDERS
has EFO: EFO_0005611
has EFO name: OPIOID DEPENDENCE

CHEMBL_IND_46684
type: DrugIndication
chembl id: CHEMBL_IND_46684
has molecule: CHEMBL550348
highest development phase: 1
has mesh: D008107
has mesh heading: LIVER DISEASES
has EFO: EFO_0001421
has EFO name: LIVER DISEASE

CHEMBL_IND_48839
type: DrugIndication
chembl id: CHEMBL_IND_48839
has molecule: CHEMBL550348
highest development phase: 1
has mesh: D065626
has mesh heading: NON-ALCOHOLIC FATTY LIVER DISEASE
has EFO: EFO_0003095
has EFO name: NON-ALCOHOLIC FATTY LIVER DISEASE

CHEMBL_IND_41180
type: DrugIndication
chembl id: CHEMBL_IND_41180
has molecule: CHEMBL550348
highest development phase: 3
has mesh: D017086
has mesh heading: BETA-THALASSEMIA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: BETA-THALASSEMIA MAJOR

CHEMBL_IND_40551
type: DrugIndication
chembl id: CHEMBL_IND_40551
has molecule: CHEMBL550348
highest development phase: 3
has mesh: D017119
has mesh heading: PORPHYRIA CUTANEA TARDA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: PORPHYRIA CUTANEA TARDA

CHEMBL_IND_45397
type: DrugIndication
chembl id: CHEMBL_IND_45397
has molecule: CHEMBL550348
highest development phase: 4
has mesh: D009190
has mesh heading: MYELODYSPLASTIC SYNDROMES
has EFO: EFO_0000198
has EFO name: MYELODYSPLASTIC SYNDROME

CHEMBL_IND_46224
type: DrugIndication
chembl id: CHEMBL_IND_46224
has molecule: CHEMBL550348
highest development phase: 3
has mesh: D017086
has mesh heading: BETA-THALASSEMIA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: BETA-THALASSEMIA INTERMEDIA

CHEMBL_IND_40039
type: DrugIndication
chembl id: CHEMBL_IND_40039
has molecule: CHEMBL550348
highest development phase: 3
has mesh: D017086
has mesh heading: BETA-THALASSEMIA
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: BETA-THALASSEMIA

CHEMBL_IND_44091
type: DrugIndication
chembl id: CHEMBL_IND_44091
has molecule: CHEMBL550348
highest development phase: 2
has mesh: D000740
has mesh heading: ANEMIA
has EFO: EFO_0004272
has EFO name: ANEMIA

CHEMBL_IND_48660
type: DrugIndication
chembl id: CHEMBL_IND_48660
has molecule: CHEMBL566534
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_52020
type: DrugIndication
chembl id: CHEMBL_IND_52020
has molecule: CHEMBL566534
highest development phase: 3
has mesh: D016778
has mesh heading: MALARIA, FALCIPARUM
has EFO: EFO_0007444
has EFO name: PLASMODIUM FALCIPARUM MALARIA

CHEMBL_IND_51576
type: DrugIndication
chembl id: CHEMBL_IND_51576
has molecule: CHEMBL566534
highest development phase: 4
has mesh: D008288
has mesh heading: MALARIA
has EFO: EFO_0001068
has EFO name: MALARIA

CHEMBL_IND_53973
type: DrugIndication
chembl id: CHEMBL_IND_53973
has molecule: CHEMBL1753
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_55307
type: DrugIndication
chembl id: CHEMBL_IND_55307
has molecule: CHEMBL1753
highest development phase: 3
has mesh: D016585
has mesh heading: VAGINOSIS, BACTERIAL
has EFO: EFO_0003932
has EFO name: BACTERIAL VAGINOSIS

CHEMBL_IND_55011
type: DrugIndication
chembl id: CHEMBL_IND_55011
has molecule: CHEMBL1753
highest development phase: 3
has mesh: D000152
has mesh heading: ACNE VULGARIS
has EFO: EFO_0003894
has EFO name: ACNE

CHEMBL_IND_48016
type: DrugIndication
chembl id: CHEMBL_IND_48016
has molecule: CHEMBL575448
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_49174
type: DrugIndication
chembl id: CHEMBL_IND_49174
has molecule: CHEMBL575448
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_52547
type: DrugIndication
chembl id: CHEMBL_IND_52547
has molecule: CHEMBL1750
highest development phase: 1
has mesh: D015477
has mesh heading: LEUKEMIA, MYELOMONOCYTIC, CHRONIC
has EFO: EFO_1001779
has EFO name: CHRONIC MYELOMONOCYTIC LEUKEMIA

CHEMBL_IND_48386
type: DrugIndication
chembl id: CHEMBL_IND_48386
has molecule: CHEMBL1750
highest development phase: 2
has mesh: D008228
has mesh heading: LYMPHOMA, NON-HODGKIN
has EFO: EFO_0005952
has EFO name: NON-HODGKINS LYMPHOMA

CHEMBL_IND_45370
type: DrugIndication
chembl id: CHEMBL_IND_45370
has molecule: CHEMBL1750
highest development phase: 1
has mesh: D015451
has mesh heading: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
has EFO: EFO_0000095
has EFO name: CHRONIC LYMPHOCYTIC LEUKEMIA

CHEMBL_IND_25874
type: DrugIndication
chembl id: CHEMBL_IND_25874
has molecule: CHEMBL1750
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_26466
type: DrugIndication
chembl id: CHEMBL_IND_26466
has molecule: CHEMBL1750
highest development phase: 1
has mesh: D008224
has mesh heading: LYMPHOMA, FOLLICULAR
has EFO: EFO_0000096
has EFO name: NEOPLASM OF MATURE B-CELLS

CHEMBL_IND_28484
type: DrugIndication
chembl id: CHEMBL_IND_28484
has molecule: CHEMBL1750
highest development phase: 2
has mesh: D015614
has mesh heading: HISTIOCYTOSIS
has EFO: HP_0100727
has EFO name: HISTIOCYTOSIS

CHEMBL_IND_27615
type: DrugIndication
chembl id: CHEMBL_IND_27615
has molecule: CHEMBL1750
highest development phase: 2
has mesh: D009101
has mesh heading: MULTIPLE MYELOMA
has EFO: EFO_0001378
has EFO name: MULTIPLE MYELOMA

CHEMBL_IND_22917
type: DrugIndication
chembl id: CHEMBL_IND_22917
has molecule: CHEMBL1750
highest development phase: 2
has mesh: D009190
has mesh heading: MYELODYSPLASTIC SYNDROMES
has EFO: EFO_0000198
has EFO name: MYELODYSPLASTIC SYNDROME

CHEMBL_IND_22916
type: DrugIndication
chembl id: CHEMBL_IND_22916
has molecule: CHEMBL1750
highest development phase: 3
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_25181
type: DrugIndication
chembl id: CHEMBL_IND_25181
has molecule: CHEMBL1750
highest development phase: 2
has mesh: D054198
has mesh heading: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
has EFO: EFO_0000220
has EFO name: ACUTE LYMPHOBLASTIC LEUKEMIA

CHEMBL_IND_24272
type: DrugIndication
chembl id: CHEMBL_IND_24272
has molecule: CHEMBL1750
highest development phase: 2
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_26766
type: DrugIndication
chembl id: CHEMBL_IND_26766
has molecule: CHEMBL1726
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_42145
type: DrugIndication
chembl id: CHEMBL_IND_42145
has molecule: CHEMBL1711
highest development phase: 4
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_41821
type: DrugIndication
chembl id: CHEMBL_IND_41821
has molecule: CHEMBL1762
highest development phase: 4
has mesh: D001145
has mesh heading: ARRHYTHMIAS, CARDIAC
has EFO: EFO_0004269
has EFO name: CARDIAC ARRHYTHMIA

CHEMBL_IND_47017
type: DrugIndication
chembl id: CHEMBL_IND_47017
has molecule: CHEMBL1747
highest development phase: 2
has mesh: D001987
has mesh heading: BRONCHIECTASIS
has EFO: HP_0002110
has EFO name: BRONCHIECTASIS

CHEMBL_IND_47988
type: DrugIndication
chembl id: CHEMBL_IND_47988
has molecule: CHEMBL1747
highest development phase: 3
has mesh: D007239
has mesh heading: INFECTION
has EFO: EFO_0000544
has EFO name: INFECTION

CHEMBL_IND_41396
type: DrugIndication
chembl id: CHEMBL_IND_41396
has molecule: CHEMBL1747
highest development phase: 3
has mesh: D011552
has mesh heading: PSEUDOMONAS INFECTION
has EFO: EFO_0001076
has EFO name: PSEUDOMONAS INFECTION

CHEMBL_IND_40905
type: DrugIndication
chembl id: CHEMBL_IND_40905
has molecule: CHEMBL1747
highest development phase: 1
has mesh: D015352
has mesh heading: DRY EYE SYNDROMES
has EFO: EFO_1000906
has EFO name: DRY EYE SYNDROME

CHEMBL_IND_47761
type: DrugIndication
chembl id: CHEMBL_IND_47761
has molecule: CHEMBL1747
highest development phase: 3
has mesh: D001762
has mesh heading: BLEPHARITIS
has EFO: HP_0000498
has EFO name: BLEPHARITIS

CHEMBL_IND_44311
type: DrugIndication
chembl id: CHEMBL_IND_44311
has molecule: CHEMBL1747
highest development phase: 4
has mesh: D003550
has mesh heading: CYSTIC FIBROSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CYSTIC FIBROSIS

CHEMBL_IND_39894
type: DrugIndication
chembl id: CHEMBL_IND_39894
has molecule: CHEMBL1747
highest development phase: 3
has mesh: D003234
has mesh heading: CONJUNCTIVITIS, BACTERIAL
has EFO: EFO_1000829
has EFO name: BACTERIAL CONJUNCTIVITIS

CHEMBL_IND_51786
type: DrugIndication
chembl id: CHEMBL_IND_51786
has molecule: CHEMBL1747
highest development phase: 3
has mesh: D007249
has mesh heading: INFLAMMATION
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: INFLAMMATION

CHEMBL_IND_54817
type: DrugIndication
chembl id: CHEMBL_IND_54817
has molecule: CHEMBL564829
highest development phase: 2
has mesh: D002277
has mesh heading: CARCINOMA
has EFO: EFO_0000313
has EFO name: CARCINOMA

CHEMBL_IND_52052
type: DrugIndication
chembl id: CHEMBL_IND_52052
has molecule: CHEMBL566315
highest development phase: 2
has mesh: D006519
has mesh heading: HEPATITIS, ALCOHOLIC
has EFO: EFO_1001345
has EFO name: HEPATITIS, ALCOHOLIC

CHEMBL_IND_50926
type: DrugIndication
chembl id: CHEMBL_IND_50926
has molecule: CHEMBL566315
highest development phase: 3
has mesh: D065626
has mesh heading: NON-ALCOHOLIC FATTY LIVER DISEASE
has EFO: EFO_0003095
has EFO name: NON-ALCOHOLIC FATTY LIVER DISEASE

CHEMBL_IND_55180
type: DrugIndication
chembl id: CHEMBL_IND_55180
has molecule: CHEMBL566315
highest development phase: 1
has mesh: D009765
has mesh heading: OBESITY
has EFO: EFO_0001073
has EFO name: OBESITY

CHEMBL_IND_50143
type: DrugIndication
chembl id: CHEMBL_IND_50143
has molecule: CHEMBL566315
highest development phase: 4
has mesh: D008105
has mesh heading: LIVER CIRRHOSIS, BILIARY
has EFO: EFO_0004267
has EFO name: BILIARY LIVER CIRRHOSIS

CHEMBL_IND_50330
type: DrugIndication
chembl id: CHEMBL_IND_50330
has molecule: CHEMBL566315
highest development phase: 1
has mesh: D008107
has mesh heading: LIVER DISEASES
has EFO: EFO_0001421
has EFO name: LIVER DISEASE

CHEMBL_IND_50540
type: DrugIndication
chembl id: CHEMBL_IND_50540
has molecule: CHEMBL1757
highest development phase: 1
has mesh: D011552
has mesh heading: PSEUDOMONAS INFECTION
has EFO: EFO_0001076
has EFO name: PSEUDOMONAS INFECTION

CHEMBL_IND_43158
type: DrugIndication
chembl id: CHEMBL_IND_43158
has molecule: CHEMBL576982
highest development phase: 3
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_44661
type: DrugIndication
chembl id: CHEMBL_IND_44661
has molecule: CHEMBL576982
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_54708
type: DrugIndication
chembl id: CHEMBL_IND_54708
has molecule: CHEMBL572878
highest development phase: 2
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_54626
type: DrugIndication
chembl id: CHEMBL_IND_54626
has molecule: CHEMBL572878
highest development phase: 2
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_52874
type: DrugIndication
chembl id: CHEMBL_IND_52874
has molecule: CHEMBL572878
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_23275
type: DrugIndication
chembl id: CHEMBL_IND_23275
has molecule: CHEMBL1763
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_49128
type: DrugIndication
chembl id: CHEMBL_IND_49128
has molecule: CHEMBL571546
highest development phase: 1
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_44915
type: DrugIndication
chembl id: CHEMBL_IND_44915
has molecule: CHEMBL571546
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_54493
type: DrugIndication
chembl id: CHEMBL_IND_54493
has molecule: CHEMBL571546
highest development phase: 2
has mesh: D055623
has mesh heading: KERATOSIS, ACTINIC
has EFO: EFO_0002496
has EFO name: ACTINIC KERATOSIS

CHEMBL_IND_42311
type: DrugIndication
chembl id: CHEMBL_IND_42311
has molecule: CHEMBL590799
highest development phase: 4
has mesh: D006470
has mesh heading: HEMORRHAGE
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: HEMORRHAGE

CHEMBL_IND_47860
type: DrugIndication
chembl id: CHEMBL_IND_47860
has molecule: CHEMBL589390
highest development phase: 3
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_49096
type: DrugIndication
chembl id: CHEMBL_IND_49096
has molecule: CHEMBL589390
highest development phase: 3
has mesh: D006816
has mesh heading: HUNTINGTON DISEASE
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: HUNTINGTON DISEASE

CHEMBL_IND_53159
type: DrugIndication
chembl id: CHEMBL_IND_53159
has molecule: CHEMBL589390
highest development phase: 1
has mesh: D017093
has mesh heading: LIVER FAILURE
has EFO: HP_0001399
has EFO name: LIVER FAILURE

CHEMBL_IND_44071
type: DrugIndication
chembl id: CHEMBL_IND_44071
has molecule: CHEMBL1690
highest development phase: 2
has mesh: D017563
has mesh heading: LUNG DISEASES, INTERSTITIAL
has EFO: EFO_0004244
has EFO name: INTERSTITIAL LUNG DISEASE

CHEMBL_IND_54271
type: DrugIndication
chembl id: CHEMBL_IND_54271
has molecule: CHEMBL1771
highest development phase: 2
has mesh: D011247
has mesh heading: PREGNANCY
has EFO: EFO_0002950
has EFO name: PREGNANCY

CHEMBL_IND_53011
type: DrugIndication
chembl id: CHEMBL_IND_53011
has molecule: CHEMBL1771
highest development phase: 3
has mesh: D016893
has mesh heading: CAROTID STENOSIS
has EFO: EFO_0002615
has EFO name: INTERNAL CAROTID ARTERY STENOSIS

CHEMBL_IND_52998
type: DrugIndication
chembl id: CHEMBL_IND_52998
has molecule: CHEMBL1771
highest development phase: 3
has mesh: D003327
has mesh heading: CORONARY DISEASE
has EFO: EFO_0001645
has EFO name: CORONARY HEART DISEASE

CHEMBL_IND_53456
type: DrugIndication
chembl id: CHEMBL_IND_53456
has molecule: CHEMBL1771
highest development phase: 3
has mesh: D006330
has mesh heading: HEART DEFECTS, CONGENITAL
has EFO: HP_0030680
has EFO name: MALFORMATION OF THE HEART AND GREAT VESSELS

CHEMBL_IND_54154
type: DrugIndication
chembl id: CHEMBL_IND_54154
has molecule: CHEMBL1771
highest development phase: 3
has mesh: D020246
has mesh heading: VENOUS THROMBOSIS
has EFO: HP_0004936
has EFO name: VENOUS THROMBOSIS

CHEMBL_IND_53486
type: DrugIndication
chembl id: CHEMBL_IND_53486
has molecule: CHEMBL1771
highest development phase: 3
has mesh: D001281
has mesh heading: ATRIAL FIBRILLATION
has EFO: EFO_0000275
has EFO name: ATRIAL FIBRILLATION

CHEMBL_IND_53476
type: DrugIndication
chembl id: CHEMBL_IND_53476
has molecule: CHEMBL1771
highest development phase: 2
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000180
has EFO name: HIV-1 INFECTION

CHEMBL_IND_54697
type: DrugIndication
chembl id: CHEMBL_IND_54697
has molecule: CHEMBL1771
highest development phase: 3
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_53341
type: DrugIndication
chembl id: CHEMBL_IND_53341
has molecule: CHEMBL1771
highest development phase: 2
has mesh: D006331
has mesh heading: HEART DISEASES
has EFO: EFO_0003777
has EFO name: HEART DISEASE

CHEMBL_IND_52930
type: DrugIndication
chembl id: CHEMBL_IND_52930
has molecule: CHEMBL1771
highest development phase: 4
has mesh: D009203
has mesh heading: MYOCARDIAL INFARCTION
has EFO: EFO_0000612
has EFO name: MYOCARDIAL INFARCTION

CHEMBL_IND_52903
type: DrugIndication
chembl id: CHEMBL_IND_52903
has molecule: CHEMBL1771
highest development phase: 3
has mesh: D003324
has mesh heading: CORONARY ARTERY DISEASE
has EFO: EFO_0000378
has EFO name: CORONARY ARTERY DISEASE

CHEMBL_IND_53857
type: DrugIndication
chembl id: CHEMBL_IND_53857
has molecule: CHEMBL1771
highest development phase: 3
has mesh: D051436
has mesh heading: RENAL INSUFFICIENCY, CHRONIC
has EFO: EFO_0003884
has EFO name: CHRONIC KIDNEY DISEASE

CHEMBL_IND_53854
type: DrugIndication
chembl id: CHEMBL_IND_53854
has molecule: CHEMBL1771
highest development phase: 2
has mesh: D016491
has mesh heading: PERIPHERAL VASCULAR DISEASES
has EFO: EFO_0003875
has EFO name: PERIPHERAL VASCULAR DISEASE

CHEMBL_IND_53708
type: DrugIndication
chembl id: CHEMBL_IND_53708
has molecule: CHEMBL1771
highest development phase: 3
has mesh: D006470
has mesh heading: HEMORRHAGE
has EFO: http://www.ebi.ac.uk/ontology-lookup/browse.do
has EFO name: HEMORRHAGE

CHEMBL_IND_53081
type: DrugIndication
chembl id: CHEMBL_IND_53081
has molecule: CHEMBL1771
highest development phase: 4
has mesh: D054058
has mesh heading: ACUTE CORONARY SYNDROME
has EFO: EFO_0005672
has EFO name: ACUTE CORONARY SYNDROME

CHEMBL_IND_53071
type: DrugIndication
chembl id: CHEMBL_IND_53071
has molecule: CHEMBL1771
highest development phase: 4
has mesh: D058729
has mesh heading: PERIPHERAL ARTERIAL DISEASE
has EFO: EFO_0004265
has EFO name: PERIPHERAL ARTERIAL DISEASE

CHEMBL_IND_52804
type: DrugIndication
chembl id: CHEMBL_IND_52804
has molecule: CHEMBL1771
highest development phase: 4
has mesh: D013927
has mesh heading: THROMBOSIS
has EFO: HP_0004419
has EFO name: RECURRENT THROMBOPHLEBITIS

CHEMBL_IND_54526
type: DrugIndication
chembl id: CHEMBL_IND_54526
has molecule: CHEMBL1771
highest development phase: 3
has mesh: D014652
has mesh heading: VASCULAR DISEASES
has EFO: EFO_0004264
has EFO name: VASCULAR DISEASE

CHEMBL_IND_54503
type: DrugIndication
chembl id: CHEMBL_IND_54503
has molecule: CHEMBL1771
highest development phase: 3
has mesh: D006333
has mesh heading: HEART FAILURE
has EFO: EFO_0003144
has EFO name: HEART FAILURE

CHEMBL_IND_54846
type: DrugIndication
chembl id: CHEMBL_IND_54846
has molecule: CHEMBL1771
highest development phase: 2
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_54844
type: DrugIndication
chembl id: CHEMBL_IND_54844
has molecule: CHEMBL1771
highest development phase: 1
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_54832
type: DrugIndication
chembl id: CHEMBL_IND_54832
has molecule: CHEMBL1771
highest development phase: 3
has mesh: D060050
has mesh heading: ANGINA, STABLE
has EFO: EFO_0003913
has EFO name: ANGINA PECTORIS

CHEMBL_IND_26499
type: DrugIndication
chembl id: CHEMBL_IND_26499
has molecule: CHEMBL1766
highest development phase: 3
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_41697
type: DrugIndication
chembl id: CHEMBL_IND_41697
has molecule: CHEMBL588119
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_53855
type: DrugIndication
chembl id: CHEMBL_IND_53855
has molecule: CHEMBL605525
highest development phase: 2
has mesh: D010024
has mesh heading: OSTEOPOROSIS
has EFO: EFO_0003882
has EFO name: OSTEOPOROSIS

CHEMBL_IND_53126
type: DrugIndication
chembl id: CHEMBL_IND_53126
has molecule: CHEMBL605525
highest development phase: 2
has mesh: D006962
has mesh heading: HYPERPARATHYROIDISM, SECONDARY
has EFO: EFO_1001173
has EFO name: SECONDARY HYPERPARATHYROIDISM

CHEMBL_IND_51482
type: DrugIndication
chembl id: CHEMBL_IND_51482
has molecule: CHEMBL591665
highest development phase: 4
has mesh: D018798
has mesh heading: ANEMIA, IRON-DEFICIENCY
has EFO: HP_0001891
has EFO name: IRON DEFICIENCY ANEMIA

CHEMBL_IND_51462
type: DrugIndication
chembl id: CHEMBL_IND_51462
has molecule: CHEMBL591665
highest development phase: 4
has mesh: D000740
has mesh heading: ANEMIA
has EFO: EFO_0004272
has EFO name: ANEMIA

CHEMBL_IND_49276
type: DrugIndication
chembl id: CHEMBL_IND_49276
has molecule: CHEMBL606759
highest development phase: 3
has mesh: D043183
has mesh heading: IRRITABLE BOWEL SYNDROME
has EFO: EFO_0000555
has EFO name: IRRITABLE BOWEL SYNDROME

CHEMBL_IND_49458
type: DrugIndication
chembl id: CHEMBL_IND_49458
has molecule: CHEMBL606759
highest development phase: 3
has mesh: D010003
has mesh heading: OSTEOARTHRITIS
has EFO: EFO_0002506
has EFO name: OSTEOARTHRITIS

CHEMBL_IND_45469
type: DrugIndication
chembl id: CHEMBL_IND_45469
has molecule: CHEMBL606759
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_42751
type: DrugIndication
chembl id: CHEMBL_IND_42751
has molecule: CHEMBL606759
highest development phase: 4
has mesh: D012216
has mesh heading: RHEUMATIC DISEASES
has EFO: EFO_0005755
has EFO name: RHEUMATIC DISEASE

CHEMBL_IND_47681
type: DrugIndication
chembl id: CHEMBL_IND_47681
has molecule: CHEMBL592445
highest development phase: 2
has mesh: D016889
has mesh heading: ENDOMETRIAL NEOPLASMS
has EFO: EFO_0004230
has EFO name: ENDOMETRIAL NEOPLASM

CHEMBL_IND_49129
type: DrugIndication
chembl id: CHEMBL_IND_49129
has molecule: CHEMBL592445
highest development phase: 2
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_44124
type: DrugIndication
chembl id: CHEMBL_IND_44124
has molecule: CHEMBL593430
highest development phase: 2
has mesh: D007319
has mesh heading: SLEEP INITIATION AND MAINTENANCE DISORDERS
has EFO: EFO_0004698
has EFO name: INSOMNIA

CHEMBL_IND_28070
type: DrugIndication
chembl id: CHEMBL_IND_28070
has molecule: CHEMBL601719
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_28069
type: DrugIndication
chembl id: CHEMBL_IND_28069
has molecule: CHEMBL601719
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_52463
type: DrugIndication
chembl id: CHEMBL_IND_52463
has molecule: CHEMBL601719
highest development phase: 2
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0000640
has EFO name: PAPILLARY RENAL CELL CARCINOMA

CHEMBL_IND_45608
type: DrugIndication
chembl id: CHEMBL_IND_45608
has molecule: CHEMBL601719
highest development phase: 2
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_22953
type: DrugIndication
chembl id: CHEMBL_IND_22953
has molecule: CHEMBL601719
highest development phase: 4
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_22951
type: DrugIndication
chembl id: CHEMBL_IND_22951
has molecule: CHEMBL601719
highest development phase: 1
has mesh: D005909
has mesh heading: GLIOBLASTOMA
has EFO: EFO_0000519
has EFO name: GLIOBLASTOMA MULTIFORME

CHEMBL_IND_42824
type: DrugIndication
chembl id: CHEMBL_IND_42824
has molecule: CHEMBL601773
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_25957
type: DrugIndication
chembl id: CHEMBL_IND_25957
has molecule: CHEMBL1082407
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_26553
type: DrugIndication
chembl id: CHEMBL_IND_26553
has molecule: CHEMBL1082407
highest development phase: 4
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000196
has EFO name: METASTATIC PROSTATE CANCER

CHEMBL_IND_49441
type: DrugIndication
chembl id: CHEMBL_IND_49441
has molecule: CHEMBL1082407
highest development phase: 1
has mesh: D008107
has mesh heading: LIVER DISEASES
has EFO: EFO_0001421
has EFO name: LIVER DISEASE

CHEMBL_IND_45896
type: DrugIndication
chembl id: CHEMBL_IND_45896
has molecule: CHEMBL1082407
highest development phase: 1
has mesh: D007674
has mesh heading: KIDNEY DISEASES
has EFO: EFO_0003086
has EFO name: KIDNEY DISEASE

CHEMBL_IND_48487
type: DrugIndication
chembl id: CHEMBL_IND_48487
has molecule: CHEMBL1082407
highest development phase: 2
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_52223
type: DrugIndication
chembl id: CHEMBL_IND_52223
has molecule: CHEMBL1082407
highest development phase: 0
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0000349
has EFO name: CLEAR CELL RENAL CARCINOMA

CHEMBL_IND_45452
type: DrugIndication
chembl id: CHEMBL_IND_45452
has molecule: CHEMBL1082407
highest development phase: 2
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000292
has EFO name: BLADDER CARCINOMA

CHEMBL_IND_27676
type: DrugIndication
chembl id: CHEMBL_IND_27676
has molecule: CHEMBL1082407
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_23090
type: DrugIndication
chembl id: CHEMBL_IND_23090
has molecule: CHEMBL1082407
highest development phase: 4
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_42699
type: DrugIndication
chembl id: CHEMBL_IND_42699
has molecule: CHEMBL1082407
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_24398
type: DrugIndication
chembl id: CHEMBL_IND_24398
has molecule: CHEMBL1082407
highest development phase: 4
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_55332
type: DrugIndication
chembl id: CHEMBL_IND_55332
has molecule: CHEMBL605846
highest development phase: 4
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_50244
type: DrugIndication
chembl id: CHEMBL_IND_50244
has molecule: CHEMBL605846
highest development phase: 3
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_50061
type: DrugIndication
chembl id: CHEMBL_IND_50061
has molecule: CHEMBL605846
highest development phase: 4
has mesh: D008173
has mesh heading: LUNG DISEASES, OBSTRUCTIVE
has EFO: HP_0006536
has EFO name: OBSTRUCTIVE LUNG DISEASE

CHEMBL_IND_52999
type: DrugIndication
chembl id: CHEMBL_IND_52999
has molecule: CHEMBL1078983
highest development phase: 1
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_54613
type: DrugIndication
chembl id: CHEMBL_IND_54613
has molecule: CHEMBL1078983
highest development phase: 2
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0000349
has EFO name: CLEAR CELL RENAL CARCINOMA

CHEMBL_IND_53766
type: DrugIndication
chembl id: CHEMBL_IND_53766
has molecule: CHEMBL1078983
highest development phase: 1
has mesh: D005909
has mesh heading: GLIOBLASTOMA
has EFO: EFO_0000519
has EFO name: GLIOBLASTOMA MULTIFORME

CHEMBL_IND_53746
type: DrugIndication
chembl id: CHEMBL_IND_53746
has molecule: CHEMBL1078983
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_41845
type: DrugIndication
chembl id: CHEMBL_IND_41845
has molecule: CHEMBL15870
highest development phase: 4
has mesh: D012216
has mesh heading: RHEUMATIC DISEASES
has EFO: EFO_0005755
has EFO name: RHEUMATIC DISEASE

CHEMBL_IND_54646
type: DrugIndication
chembl id: CHEMBL_IND_54646
has molecule: CHEMBL384304
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_49320
type: DrugIndication
chembl id: CHEMBL_IND_49320
has molecule: CHEMBL603469
highest development phase: 2
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_48636
type: DrugIndication
chembl id: CHEMBL_IND_48636
has molecule: CHEMBL603469
highest development phase: 2
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_48504
type: DrugIndication
chembl id: CHEMBL_IND_48504
has molecule: CHEMBL603469
highest development phase: 2
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_27172
type: DrugIndication
chembl id: CHEMBL_IND_27172
has molecule: CHEMBL1079742
highest development phase: 2
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0002890
has EFO name: RENAL CARCINOMA

CHEMBL_IND_49480
type: DrugIndication
chembl id: CHEMBL_IND_49480
has molecule: CHEMBL1079742
highest development phase: 2
has mesh: D004938
has mesh heading: ESOPHAGEAL NEOPLASMS
has EFO: EFO_0002916
has EFO name: ESOPHAGEAL CARCINOMA

CHEMBL_IND_45659
type: DrugIndication
chembl id: CHEMBL_IND_45659
has molecule: CHEMBL1079742
highest development phase: 2
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0000681
has EFO name: RENAL CELL CARCINOMA

CHEMBL_IND_25970
type: DrugIndication
chembl id: CHEMBL_IND_25970
has molecule: CHEMBL1079742
highest development phase: 1
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_25969
type: DrugIndication
chembl id: CHEMBL_IND_25969
has molecule: CHEMBL1079742
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_25968
type: DrugIndication
chembl id: CHEMBL_IND_25968
has molecule: CHEMBL1079742
highest development phase: 2
has mesh: D001932
has mesh heading: BRAIN NEOPLASMS
has EFO: EFO_0003833
has EFO name: BRAIN NEOPLASM

CHEMBL_IND_43458
type: DrugIndication
chembl id: CHEMBL_IND_43458
has molecule: CHEMBL1079742
highest development phase: 2
has mesh: D008654
has mesh heading: MESOTHELIOMA
has EFO: EFO_0000588
has EFO name: MESOTHELIOMA

CHEMBL_IND_27682
type: DrugIndication
chembl id: CHEMBL_IND_27682
has molecule: CHEMBL1079742
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_27681
type: DrugIndication
chembl id: CHEMBL_IND_27681
has molecule: CHEMBL1079742
highest development phase: 2
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_27680
type: DrugIndication
chembl id: CHEMBL_IND_27680
has molecule: CHEMBL1079742
highest development phase: 2
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000292
has EFO name: BLADDER CARCINOMA

CHEMBL_IND_23116
type: DrugIndication
chembl id: CHEMBL_IND_23116
has molecule: CHEMBL1079742
highest development phase: 3
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_23114
type: DrugIndication
chembl id: CHEMBL_IND_23114
has molecule: CHEMBL1079742
highest development phase: 3
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_23113
type: DrugIndication
chembl id: CHEMBL_IND_23113
has molecule: CHEMBL1079742
highest development phase: 2
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000181
has EFO name: HEAD AND NECK SQUAMOUS CELL CARCINOMA

CHEMBL_IND_23111
type: DrugIndication
chembl id: CHEMBL_IND_23111
has molecule: CHEMBL1079742
highest development phase: 2
has mesh: D002277
has mesh heading: CARCINOMA
has EFO: EFO_0000313
has EFO name: CARCINOMA

CHEMBL_IND_23110
type: DrugIndication
chembl id: CHEMBL_IND_23110
has molecule: CHEMBL1079742
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_24412
type: DrugIndication
chembl id: CHEMBL_IND_24412
has molecule: CHEMBL1079742
highest development phase: 2
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_24410
type: DrugIndication
chembl id: CHEMBL_IND_24410
has molecule: CHEMBL1079742
highest development phase: 2
has mesh: D008654
has mesh heading: MESOTHELIOMA
has EFO: EFO_0005567
has EFO name: MALIGNANT PERITONEAL MESOTHELIOMA

CHEMBL_IND_51810
type: DrugIndication
chembl id: CHEMBL_IND_51810
has molecule: CHEMBL1079742
highest development phase: 2
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000708
has EFO name: SQUAMOUS CELL LUNG CARCINOMA

CHEMBL_IND_51944
type: DrugIndication
chembl id: CHEMBL_IND_51944
has molecule: CHEMBL1079742
highest development phase: 2
has mesh: D011125
has mesh heading: ADENOMATOUS POLYPOSIS COLI
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: FAMILIAL ADENOMATOUS POLYPOSIS

CHEMBL_IND_42725
type: DrugIndication
chembl id: CHEMBL_IND_42725
has molecule: CHEMBL1079905
highest development phase: 4
has mesh: D001289
has mesh heading: ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY
has EFO: EFO_0003888
has EFO name: ATTENTION DEFICIT HYPERACTIVITY DISORDER

CHEMBL_IND_54185
type: DrugIndication
chembl id: CHEMBL_IND_54185
has molecule: CHEMBL1094636
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_50876
type: DrugIndication
chembl id: CHEMBL_IND_50876
has molecule: CHEMBL1094636
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_55267
type: DrugIndication
chembl id: CHEMBL_IND_55267
has molecule: CHEMBL1094636
highest development phase: 2
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_50085
type: DrugIndication
chembl id: CHEMBL_IND_50085
has molecule: CHEMBL1094636
highest development phase: 4
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: EFO_0001075
has EFO name: OVARIAN CARCINOMA

CHEMBL_IND_50191
type: DrugIndication
chembl id: CHEMBL_IND_50191
has molecule: CHEMBL1094636
highest development phase: 4
has mesh: D010534
has mesh heading: PERITONEAL NEOPLASMS
has EFO: EFO_1001100
has EFO name: PERITONEAL NEOPLASM

CHEMBL_IND_50150
type: DrugIndication
chembl id: CHEMBL_IND_50150
has molecule: CHEMBL1094636
highest development phase: 4
has mesh: D005185
has mesh heading: FALLOPIAN TUBE NEOPLASMS
has EFO: EFO_1000251
has EFO name: FALLOPIAN TUBE CARCINOMA

CHEMBL_IND_53793
type: DrugIndication
chembl id: CHEMBL_IND_53793
has molecule: CHEMBL1094636
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_54582
type: DrugIndication
chembl id: CHEMBL_IND_54582
has molecule: CHEMBL1094636
highest development phase: 3
has mesh: D061325
has mesh heading: HEREDITARY BREAST AND OVARIAN CANCER SYNDROME
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: HEREDITARY BREAST AND OVARIAN CANCER SYNDROME

CHEMBL_IND_54407
type: DrugIndication
chembl id: CHEMBL_IND_54407
has molecule: CHEMBL1094636
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_47933
type: DrugIndication
chembl id: CHEMBL_IND_47933
has molecule: CHEMBL1094785
highest development phase: 2
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_53603
type: DrugIndication
chembl id: CHEMBL_IND_53603
has molecule: CHEMBL604608
highest development phase: 1
has mesh: D065626
has mesh heading: NON-ALCOHOLIC FATTY LIVER DISEASE
has EFO: EFO_0003095
has EFO name: NON-ALCOHOLIC FATTY LIVER DISEASE

CHEMBL_IND_42493
type: DrugIndication
chembl id: CHEMBL_IND_42493
has molecule: CHEMBL1089962
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_48006
type: DrugIndication
chembl id: CHEMBL_IND_48006
has molecule: CHEMBL608533
highest development phase: 2
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_48787
type: DrugIndication
chembl id: CHEMBL_IND_48787
has molecule: CHEMBL608533
highest development phase: 1
has mesh: D008107
has mesh heading: LIVER DISEASES
has EFO: EFO_0001421
has EFO name: LIVER DISEASE

CHEMBL_IND_43155
type: DrugIndication
chembl id: CHEMBL_IND_43155
has molecule: CHEMBL608533
highest development phase: 2
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_52763
type: DrugIndication
chembl id: CHEMBL_IND_52763
has molecule: CHEMBL608533
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_54327
type: DrugIndication
chembl id: CHEMBL_IND_54327
has molecule: CHEMBL608533
highest development phase: 1
has mesh: D012004
has mesh heading: RECTAL NEOPLASMS
has EFO: EFO_1000657
has EFO name: RECTUM CANCER

CHEMBL_IND_55091
type: DrugIndication
chembl id: CHEMBL_IND_55091
has molecule: CHEMBL1088977
highest development phase: 3
has mesh: D008107
has mesh heading: LIVER DISEASES
has EFO: EFO_0001421
has EFO name: LIVER DISEASE

CHEMBL_IND_46051
type: DrugIndication
chembl id: CHEMBL_IND_46051
has molecule: CHEMBL1083659
highest development phase: 0
has mesh: D016584
has mesh heading: PANIC DISORDER
has EFO: EFO_0004262
has EFO name: PANIC DISORDER

CHEMBL_IND_23915
type: DrugIndication
chembl id: CHEMBL_IND_23915
has molecule: CHEMBL1083659
highest development phase: 4
has mesh: D007319
has mesh heading: SLEEP INITIATION AND MAINTENANCE DISORDERS
has EFO: EFO_0004698
has EFO name: INSOMNIA

CHEMBL_IND_27944
type: DrugIndication
chembl id: CHEMBL_IND_27944
has molecule: CHEMBL1083659
highest development phase: 1
has mesh: D012891
has mesh heading: SLEEP APNEA SYNDROMES
has EFO: EFO_0003877
has EFO name: SLEEP APNEA

CHEMBL_IND_25722
type: DrugIndication
chembl id: CHEMBL_IND_25722
has molecule: CHEMBL373742
highest development phase: 2
has mesh: D002659
has mesh heading: CHILD DEVELOPMENT DISORDERS, PERVASIVE
has EFO: EFO_0003756
has EFO name: AUTISM SPECTRUM DISORDER

CHEMBL_IND_28473
type: DrugIndication
chembl id: CHEMBL_IND_28473
has molecule: CHEMBL373742
highest development phase: 2
has mesh: D014947
has mesh heading: WOUNDS AND INJURIES
has EFO: EFO_0000546
has EFO name: INJURY

CHEMBL_IND_27500
type: DrugIndication
chembl id: CHEMBL_IND_27500
has molecule: CHEMBL373742
highest development phase: 3
has mesh: D016757
has mesh heading: DEATH, SUDDEN, CARDIAC
has EFO: EFO_0004278
has EFO name: SUDDEN CARDIAC ARREST

CHEMBL_IND_51434
type: DrugIndication
chembl id: CHEMBL_IND_51434
has molecule: CHEMBL373742
highest development phase: 4
has mesh: D003919
has mesh heading: DIABETES INSIPIDUS

CHEMBL_IND_24039
type: DrugIndication
chembl id: CHEMBL_IND_24039
has molecule: CHEMBL373742
highest development phase: 2
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_24038
type: DrugIndication
chembl id: CHEMBL_IND_24038
has molecule: CHEMBL373742
highest development phase: 3
has mesh: D012772
has mesh heading: SHOCK, SEPTIC
has EFO: EFO_0006834
has EFO name: SEPTIC SHOCK

CHEMBL_IND_46859
type: DrugIndication
chembl id: CHEMBL_IND_46859
has molecule: CHEMBL1096146
highest development phase: 2
has mesh: D020529
has mesh heading: MULTIPLE SCLEROSIS, RELAPSING-REMITTING
has EFO: EFO_0003929
has EFO name: RELAPSING-REMITTING MULTIPLE SCLEROSIS

CHEMBL_IND_54081
type: DrugIndication
chembl id: CHEMBL_IND_54081
has molecule: CHEMBL1096146
highest development phase: 2
has mesh: D009103
has mesh heading: MULTIPLE SCLEROSIS
has EFO: EFO_0003885
has EFO name: MULTIPLE SCLEROSIS

CHEMBL_IND_44711
type: DrugIndication
chembl id: CHEMBL_IND_44711
has molecule: CHEMBL1096146
highest development phase: 2
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_42855
type: DrugIndication
chembl id: CHEMBL_IND_42855
has molecule: CHEMBL1096885
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_49163
type: DrugIndication
chembl id: CHEMBL_IND_49163
has molecule: CHEMBL1096885
highest development phase: 3
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000292
has EFO name: BLADDER CARCINOMA

CHEMBL_IND_27499
type: DrugIndication
chembl id: CHEMBL_IND_27499
has molecule: CHEMBL1096885
highest development phase: 1
has mesh: D002277
has mesh heading: CARCINOMA
has EFO: EFO_0000313
has EFO name: CARCINOMA

CHEMBL_IND_46554
type: DrugIndication
chembl id: CHEMBL_IND_46554
has molecule: CHEMBL1097999
highest development phase: 2
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_46527
type: DrugIndication
chembl id: CHEMBL_IND_46527
has molecule: CHEMBL1097999
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_41577
type: DrugIndication
chembl id: CHEMBL_IND_41577
has molecule: CHEMBL1213250
highest development phase: 4
has mesh: D059413
has mesh heading: INTRAABDOMINAL INFECTIONS

CHEMBL_IND_42715
type: DrugIndication
chembl id: CHEMBL_IND_42715
has molecule: CHEMBL1213250
highest development phase: 4
has mesh: D014552
has mesh heading: URINARY TRACT INFECTIONS
has EFO: EFO_0003103
has EFO name: URINARY TRACT INFECTION

CHEMBL_IND_50619
type: DrugIndication
chembl id: CHEMBL_IND_50619
has molecule: CHEMBL1095032
highest development phase: 2
has mesh: D054058
has mesh heading: ACUTE CORONARY SYNDROME
has EFO: EFO_0005672
has EFO name: ACUTE CORONARY SYNDROME

CHEMBL_IND_55214
type: DrugIndication
chembl id: CHEMBL_IND_55214
has molecule: CHEMBL1095032
highest development phase: 2
has mesh: D054556
has mesh heading: VENOUS THROMBOEMBOLISM
has EFO: EFO_0004286
has EFO name: VENOUS THROMBOEMBOLISM

CHEMBL_IND_53250
type: DrugIndication
chembl id: CHEMBL_IND_53250
has molecule: CHEMBL1079593
highest development phase: 1
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_29279
type: DrugIndication
chembl id: CHEMBL_IND_29279
has molecule: CHEMBL1083993
highest development phase: 4
has mesh: D014693
has mesh heading: VENTRICULAR FIBRILLATION
has EFO: EFO_0004287
has EFO name: VENTRICULAR FIBRILLATION

CHEMBL_IND_29278
type: DrugIndication
chembl id: CHEMBL_IND_29278
has molecule: CHEMBL1083993
highest development phase: 4
has mesh: D017180
has mesh heading: TACHYCARDIA, VENTRICULAR
has EFO: EFO_0005306
has EFO name: VENTRICULAR TACHYCARDIA

CHEMBL_IND_42631
type: DrugIndication
chembl id: CHEMBL_IND_42631
has molecule: CHEMBL1076211
highest development phase: 4
has mesh: D063806
has mesh heading: MYALGIA
has EFO: HP_0003326
has EFO name: MYALGIA

CHEMBL_IND_45289
type: DrugIndication
chembl id: CHEMBL_IND_45289
has molecule: CHEMBL1076211
highest development phase: 2
has mesh: D009128
has mesh heading: MUSCLE SPASTICITY
has EFO: HP_0001257
has EFO name: SPASTICITY

CHEMBL_IND_42787
type: DrugIndication
chembl id: CHEMBL_IND_42787
has molecule: CHEMBL1076211
highest development phase: 4
has mesh: D018771
has mesh heading: ARTHRALGIA
has EFO: HP_0002829
has EFO name: ARTHRALGIA

CHEMBL_IND_52889
type: DrugIndication
chembl id: CHEMBL_IND_52889
has molecule: CHEMBL1160819
highest development phase: 0
has mesh: D009202
has mesh heading: CARDIOMYOPATHIES
has EFO: EFO_0000318
has EFO name: CARDIOMYOPATHY

CHEMBL_IND_50790
type: DrugIndication
chembl id: CHEMBL_IND_50790
has molecule: CHEMBL1336
highest development phase: 2
has mesh: D007627
has mesh heading: KELOID
has EFO: EFO_0004212
has EFO name: KELOID

CHEMBL_IND_50574
type: DrugIndication
chembl id: CHEMBL_IND_50574
has molecule: CHEMBL1336
highest development phase: 2
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_50565
type: DrugIndication
chembl id: CHEMBL_IND_50565
has molecule: CHEMBL1336
highest development phase: 2
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_50759
type: DrugIndication
chembl id: CHEMBL_IND_50759
has molecule: CHEMBL1336
highest development phase: 2
has mesh: D013964
has mesh heading: THYROID NEOPLASMS
has EFO: EFO_0002892
has EFO name: THYROID CARCINOMA

CHEMBL_IND_50746
type: DrugIndication
chembl id: CHEMBL_IND_50746
has molecule: CHEMBL1336
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_50712
type: DrugIndication
chembl id: CHEMBL_IND_50712
has molecule: CHEMBL1336
highest development phase: 2
has mesh: D006975
has mesh heading: HYPERTENSION, PORTAL
has EFO: EFO_0000666
has EFO name: PORTAL HYPERTENSION

CHEMBL_IND_50704
type: DrugIndication
chembl id: CHEMBL_IND_50704
has molecule: CHEMBL1336
highest development phase: 1
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_50677
type: DrugIndication
chembl id: CHEMBL_IND_50677
has molecule: CHEMBL1336
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_50895
type: DrugIndication
chembl id: CHEMBL_IND_50895
has molecule: CHEMBL1336
highest development phase: 2
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_50887
type: DrugIndication
chembl id: CHEMBL_IND_50887
has molecule: CHEMBL1336
highest development phase: 1
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000707
has EFO name: SQUAMOUS CELL CARCINOMA

CHEMBL_IND_50846
type: DrugIndication
chembl id: CHEMBL_IND_50846
has molecule: CHEMBL1336
highest development phase: 2
has mesh: D001749
has mesh heading: URINARY BLADDER NEOPLASMS
has EFO: EFO_0000292
has EFO name: BLADDER CARCINOMA

CHEMBL_IND_50826
type: DrugIndication
chembl id: CHEMBL_IND_50826
has molecule: CHEMBL1336
highest development phase: 2
has mesh: D046152
has mesh heading: GASTROINTESTINAL STROMAL TUMORS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: GASTROINTESTINAL STROMAL TUMOR

CHEMBL_IND_55335
type: DrugIndication
chembl id: CHEMBL_IND_55335
has molecule: CHEMBL1336
highest development phase: 3
has mesh: D002277
has mesh heading: CARCINOMA
has EFO: EFO_0000313
has EFO name: CARCINOMA

CHEMBL_IND_55312
type: DrugIndication
chembl id: CHEMBL_IND_55312
has molecule: CHEMBL1336
highest development phase: 2
has mesh: D013736
has mesh heading: TESTICULAR NEOPLASMS
has EFO: EFO_0005088
has EFO name: TESTICULAR CARCINOMA

CHEMBL_IND_55283
type: DrugIndication
chembl id: CHEMBL_IND_55283
has molecule: CHEMBL1336
highest development phase: 2
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: EFO_0001075
has EFO name: OVARIAN CARCINOMA

CHEMBL_IND_55278
type: DrugIndication
chembl id: CHEMBL_IND_55278
has molecule: CHEMBL1336
highest development phase: 1
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_55174
type: DrugIndication
chembl id: CHEMBL_IND_55174
has molecule: CHEMBL1336
highest development phase: 2
has mesh: D055752
has mesh heading: SMALL CELL LUNG CARCINOMA
has EFO: EFO_0000702
has EFO name: SMALL CELL LUNG CARCINOMA

CHEMBL_IND_50284
type: DrugIndication
chembl id: CHEMBL_IND_50284
has molecule: CHEMBL1336
highest development phase: 3
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0000681
has EFO name: RENAL CELL CARCINOMA

CHEMBL_IND_50274
type: DrugIndication
chembl id: CHEMBL_IND_50274
has molecule: CHEMBL1336
highest development phase: 1
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_50213
type: DrugIndication
chembl id: CHEMBL_IND_50213
has molecule: CHEMBL1336
highest development phase: 2
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_50208
type: DrugIndication
chembl id: CHEMBL_IND_50208
has molecule: CHEMBL1336
highest development phase: 4
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_50453
type: DrugIndication
chembl id: CHEMBL_IND_50453
has molecule: CHEMBL1336
highest development phase: 2
has mesh: D015451
has mesh heading: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL
has EFO: EFO_0000095
has EFO name: CHRONIC LYMPHOCYTIC LEUKEMIA

CHEMBL_IND_50377
type: DrugIndication
chembl id: CHEMBL_IND_50377
has molecule: CHEMBL1336
highest development phase: 3
has mesh: D007680
has mesh heading: KIDNEY NEOPLASMS
has EFO: EFO_0003865
has EFO name: KIDNEY NEOPLASM

CHEMBL_IND_50290
type: DrugIndication
chembl id: CHEMBL_IND_50290
has molecule: CHEMBL1336
highest development phase: 2
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_50021
type: DrugIndication
chembl id: CHEMBL_IND_50021
has molecule: CHEMBL1336
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_55165
type: DrugIndication
chembl id: CHEMBL_IND_55165
has molecule: CHEMBL1336
highest development phase: 2
has mesh: D012516
has mesh heading: OSTEOSARCOMA
has EFO: EFO_0000637
has EFO name: OSTEOSARCOMA

CHEMBL_IND_55042
type: DrugIndication
chembl id: CHEMBL_IND_55042
has molecule: CHEMBL1336
highest development phase: 2
has mesh: D013274
has mesh heading: STOMACH NEOPLASMS
has EFO: EFO_0000178
has EFO name: GASTRIC CARCINOMA

CHEMBL_IND_54980
type: DrugIndication
chembl id: CHEMBL_IND_54980
has molecule: CHEMBL1336
highest development phase: 1
has mesh: D006976
has mesh heading: HYPERTENSION, PULMONARY
has EFO: EFO_0001361
has EFO name: PULMONARY HYPERTENSION

CHEMBL_IND_54926
type: DrugIndication
chembl id: CHEMBL_IND_54926
has molecule: CHEMBL1336
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_53401
type: DrugIndication
chembl id: CHEMBL_IND_53401
has molecule: CHEMBL1078261
highest development phase: 3
has mesh: D053201
has mesh heading: URINARY BLADDER, OVERACTIVE
has EFO: EFO_1000781
has EFO name: OVERACTIVE BLADDER

CHEMBL_IND_46977
type: DrugIndication
chembl id: CHEMBL_IND_46977
has molecule: CHEMBL217092
highest development phase: 2
has mesh: D018567
has mesh heading: BREAST NEOPLASMS, MALE
has EFO: EFO_0006861
has EFO name: MALE BREAST CARCINOMA

CHEMBL_IND_46696
type: DrugIndication
chembl id: CHEMBL_IND_46696
has molecule: CHEMBL217092
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_47869
type: DrugIndication
chembl id: CHEMBL_IND_47869
has molecule: CHEMBL217092
highest development phase: 1
has mesh: D000544
has mesh heading: ALZHEIMER DISEASE
has EFO: EFO_0000249
has EFO name: ALZHEIMERS DISEASE

CHEMBL_IND_45889
type: DrugIndication
chembl id: CHEMBL_IND_45889
has molecule: CHEMBL217092
highest development phase: 2
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_48258
type: DrugIndication
chembl id: CHEMBL_IND_48258
has molecule: CHEMBL217092
highest development phase: 1
has mesh: D000437
has mesh heading: ALCOHOLISM
has EFO: EFO_0003829
has EFO name: ALCOHOL DEPENDENCE

CHEMBL_IND_47708
type: DrugIndication
chembl id: CHEMBL_IND_47708
has molecule: CHEMBL217092
highest development phase: 2
has mesh: D000428
has mesh heading: ALCOHOL DRINKING
has EFO: EFO_0004329
has EFO name: ALCOHOL DRINKING

CHEMBL_IND_46384
type: DrugIndication
chembl id: CHEMBL_IND_46384
has molecule: CHEMBL217092
highest development phase: 2
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_44303
type: DrugIndication
chembl id: CHEMBL_IND_44303
has molecule: CHEMBL217092
highest development phase: 2
has mesh: D018192
has mesh heading: LYMPHANGIOLEIOMYOMATOSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: LYMPHANGIOLEIOMYOMATOSIS

CHEMBL_IND_47384
type: DrugIndication
chembl id: CHEMBL_IND_47384
has molecule: CHEMBL217092
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_47286
type: DrugIndication
chembl id: CHEMBL_IND_47286
has molecule: CHEMBL217092
highest development phase: 2
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_44687
type: DrugIndication
chembl id: CHEMBL_IND_44687
has molecule: CHEMBL217092
highest development phase: 2
has mesh: D012516
has mesh heading: OSTEOSARCOMA
has EFO: EFO_0000637
has EFO name: OSTEOSARCOMA

CHEMBL_IND_27180
type: DrugIndication
chembl id: CHEMBL_IND_27180
has molecule: CHEMBL44657
highest development phase: 2
has mesh: D055752
has mesh heading: SMALL CELL LUNG CARCINOMA
has EFO: EFO_0000702
has EFO name: SMALL CELL LUNG CARCINOMA

CHEMBL_IND_27179
type: DrugIndication
chembl id: CHEMBL_IND_27179
has molecule: CHEMBL44657
highest development phase: 2
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_42856
type: DrugIndication
chembl id: CHEMBL_IND_42856
has molecule: CHEMBL44657
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_41068
type: DrugIndication
chembl id: CHEMBL_IND_41068
has molecule: CHEMBL44657
highest development phase: 2
has mesh: D004806
has mesh heading: EPENDYMOMA
has EFO: EFO_1000028
has EFO name: EPENDYMOMA

CHEMBL_IND_44982
type: DrugIndication
chembl id: CHEMBL_IND_44982
has molecule: CHEMBL44657
highest development phase: 2
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_47537
type: DrugIndication
chembl id: CHEMBL_IND_47537
has molecule: CHEMBL44657
highest development phase: 2
has mesh: D008527
has mesh heading: MEDULLOBLASTOMA
has EFO: EFO_0002939
has EFO name: MEDULLOBLASTOMA

CHEMBL_IND_27696
type: DrugIndication
chembl id: CHEMBL_IND_27696
has molecule: CHEMBL44657
highest development phase: 2
has mesh: D009447
has mesh heading: NEUROBLASTOMA
has EFO: EFO_0000621
has EFO name: NEUROBLASTOMA

CHEMBL_IND_23154
type: DrugIndication
chembl id: CHEMBL_IND_23154
has molecule: CHEMBL44657
highest development phase: 3
has mesh: D054198
has mesh heading: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
has EFO: EFO_0000220
has EFO name: ACUTE LYMPHOBLASTIC LEUKEMIA

CHEMBL_IND_24423
type: DrugIndication
chembl id: CHEMBL_IND_24423
has molecule: CHEMBL44657
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_48481
type: DrugIndication
chembl id: CHEMBL_IND_48481
has molecule: CHEMBL229383
highest development phase: 3
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000180
has EFO name: HIV-1 INFECTION

CHEMBL_IND_54229
type: DrugIndication
chembl id: CHEMBL_IND_54229
has molecule: CHEMBL1094408
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_26583
type: DrugIndication
chembl id: CHEMBL_IND_26583
has molecule: CHEMBL1164729
highest development phase: 2
has mesh: D006973
has mesh heading: HYPERTENSION
has EFO: EFO_0000537
has EFO name: HYPERTENSION

CHEMBL_IND_26582
type: DrugIndication
chembl id: CHEMBL_IND_26582
has molecule: CHEMBL1164729
highest development phase: 3
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_52699
type: DrugIndication
chembl id: CHEMBL_IND_52699
has molecule: CHEMBL1164729
highest development phase: 2
has mesh: D060050
has mesh heading: ANGINA, STABLE
has EFO: EFO_0003913
has EFO name: ANGINA PECTORIS

CHEMBL_IND_47613
type: DrugIndication
chembl id: CHEMBL_IND_47613
has molecule: CHEMBL1164729
highest development phase: 2
has mesh: D007669
has mesh heading: KIDNEY CALCULI
has EFO: EFO_0003845
has EFO name: KIDNEY STONE

CHEMBL_IND_23177
type: DrugIndication
chembl id: CHEMBL_IND_23177
has molecule: CHEMBL1164729
highest development phase: 4
has mesh: D006073
has mesh heading: GOUT
has EFO: EFO_0004274
has EFO name: GOUT

CHEMBL_IND_51565
type: DrugIndication
chembl id: CHEMBL_IND_51565
has molecule: CHEMBL1164729
highest development phase: 4
has mesh: D033461
has mesh heading: HYPERURICEMIA
has EFO: HP_0002149
has EFO name: HYPERURICEMIA

CHEMBL_IND_42577
type: DrugIndication
chembl id: CHEMBL_IND_42577
has molecule: CHEMBL1095282
highest development phase: 4
has mesh: D001007
has mesh heading: ANXIETY
has EFO: EFO_0005230
has EFO name: ANXIETY

CHEMBL_IND_46681
type: DrugIndication
chembl id: CHEMBL_IND_46681
has molecule: CHEMBL1213456
highest development phase: 1
has mesh: D008107
has mesh heading: LIVER DISEASES
has EFO: EFO_0001421
has EFO name: LIVER DISEASE

CHEMBL_IND_43877
type: DrugIndication
chembl id: CHEMBL_IND_43877
has molecule: CHEMBL1213456
highest development phase: 3
has mesh: D011014
has mesh heading: PNEUMONIA
has EFO: EFO_0003106
has EFO name: PNEUMONIA

CHEMBL_IND_53333
type: DrugIndication
chembl id: CHEMBL_IND_53333
has molecule: CHEMBL1213456
highest development phase: 1
has mesh: D007674
has mesh heading: KIDNEY DISEASES
has EFO: EFO_0003086
has EFO name: KIDNEY DISEASE

CHEMBL_IND_52971
type: DrugIndication
chembl id: CHEMBL_IND_52971
has molecule: CHEMBL1160160
highest development phase: 3
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_53545
type: DrugIndication
chembl id: CHEMBL_IND_53545
has molecule: CHEMBL1160160
highest development phase: 2
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_47102
type: DrugIndication
chembl id: CHEMBL_IND_47102
has molecule: CHEMBL216981
highest development phase: 2
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_45512
type: DrugIndication
chembl id: CHEMBL_IND_45512
has molecule: CHEMBL216981
highest development phase: 2
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_47326
type: DrugIndication
chembl id: CHEMBL_IND_47326
has molecule: CHEMBL216981
highest development phase: 2
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_27078
type: DrugIndication
chembl id: CHEMBL_IND_27078
has molecule: CHEMBL1773
highest development phase: 2
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0000681
has EFO name: RENAL CELL CARCINOMA

CHEMBL_IND_25853
type: DrugIndication
chembl id: CHEMBL_IND_25853
has molecule: CHEMBL1773
highest development phase: 2
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_28049
type: DrugIndication
chembl id: CHEMBL_IND_28049
has molecule: CHEMBL1773
highest development phase: 2
has mesh: D001661
has mesh heading: BILIARY TRACT NEOPLASMS
has EFO: EFO_0003891
has EFO name: BILIARY TRACT NEOPLASM

CHEMBL_IND_48752
type: DrugIndication
chembl id: CHEMBL_IND_48752
has molecule: CHEMBL1773
highest development phase: 2
has mesh: D010051
has mesh heading: OVARIAN NEOPLASMS
has EFO: EFO_0001075
has EFO name: OVARIAN CARCINOMA

CHEMBL_IND_48368
type: DrugIndication
chembl id: CHEMBL_IND_48368
has molecule: CHEMBL1773
highest development phase: 3
has mesh: D018281
has mesh heading: CHOLANGIOCARCINOMA
has EFO: EFO_0005221
has EFO name: CHOLANGIOCARCINOMA

CHEMBL_IND_52352
type: DrugIndication
chembl id: CHEMBL_IND_52352
has molecule: CHEMBL1773
highest development phase: 2
has mesh: D008654
has mesh heading: MESOTHELIOMA
has EFO: EFO_0000588
has EFO name: MESOTHELIOMA

CHEMBL_IND_26446
type: DrugIndication
chembl id: CHEMBL_IND_26446
has molecule: CHEMBL1773
highest development phase: 3
has mesh: D009303
has mesh heading: NASOPHARYNGEAL NEOPLASMS
has EFO: EFO_0004252
has EFO name: NASOPHARYNGEAL NEOPLASM

CHEMBL_IND_26445
type: DrugIndication
chembl id: CHEMBL_IND_26445
has molecule: CHEMBL1773
highest development phase: 2
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0005543
has EFO name: GLIOMA

CHEMBL_IND_49011
type: DrugIndication
chembl id: CHEMBL_IND_49011
has molecule: CHEMBL1773
highest development phase: 2
has mesh: D018567
has mesh heading: BREAST NEOPLASMS, MALE
has EFO: EFO_0006861
has EFO name: MALE BREAST CARCINOMA

CHEMBL_IND_22849
type: DrugIndication
chembl id: CHEMBL_IND_22849
has molecule: CHEMBL1773
highest development phase: 3
has mesh: D013274
has mesh heading: STOMACH NEOPLASMS
has EFO: EFO_0003897
has EFO name: STOMACH NEOPLASM

CHEMBL_IND_22848
type: DrugIndication
chembl id: CHEMBL_IND_22848
has molecule: CHEMBL1773
highest development phase: 3
has mesh: D002294
has mesh heading: CARCINOMA, SQUAMOUS CELL
has EFO: EFO_0000707
has EFO name: SQUAMOUS CELL CARCINOMA

CHEMBL_IND_22847
type: DrugIndication
chembl id: CHEMBL_IND_22847
has molecule: CHEMBL1773
highest development phase: 3
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_22846
type: DrugIndication
chembl id: CHEMBL_IND_22846
has molecule: CHEMBL1773
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_22845
type: DrugIndication
chembl id: CHEMBL_IND_22845
has molecule: CHEMBL1773
highest development phase: 3
has mesh: D013274
has mesh heading: STOMACH NEOPLASMS
has EFO: EFO_0000178
has EFO name: GASTRIC CARCINOMA

CHEMBL_IND_22844
type: DrugIndication
chembl id: CHEMBL_IND_22844
has molecule: CHEMBL1773
highest development phase: 1
has mesh: D004938
has mesh heading: ESOPHAGEAL NEOPLASMS
has EFO: EFO_0002916
has EFO name: ESOPHAGEAL CARCINOMA

CHEMBL_IND_22843
type: DrugIndication
chembl id: CHEMBL_IND_22843
has molecule: CHEMBL1773
highest development phase: 3
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_22842
type: DrugIndication
chembl id: CHEMBL_IND_22842
has molecule: CHEMBL1773
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_22841
type: DrugIndication
chembl id: CHEMBL_IND_22841
has molecule: CHEMBL1773
highest development phase: 4
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_51738
type: DrugIndication
chembl id: CHEMBL_IND_51738
has molecule: CHEMBL1773
highest development phase: 3
has mesh: D012004
has mesh heading: RECTAL NEOPLASMS
has EFO: EFO_1000657
has EFO name: RECTUM CANCER

CHEMBL_IND_25155
type: DrugIndication
chembl id: CHEMBL_IND_25155
has molecule: CHEMBL1773
highest development phase: 2
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_40345
type: DrugIndication
chembl id: CHEMBL_IND_40345
has molecule: CHEMBL1773
highest development phase: 4
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0003869
has EFO name: BREAST NEOPLASM

CHEMBL_IND_24242
type: DrugIndication
chembl id: CHEMBL_IND_24242
has molecule: CHEMBL1773
highest development phase: 1
has mesh: D021441
has mesh heading: CARCINOMA, PANCREATIC DUCTAL
has EFO: EFO_0002517
has EFO name: PANCREATIC DUCTAL ADENOCARCINOMA

CHEMBL_IND_24241
type: DrugIndication
chembl id: CHEMBL_IND_24241
has molecule: CHEMBL1773
highest development phase: 4
has mesh: D003110
has mesh heading: COLONIC NEOPLASMS
has EFO: EFO_0004288
has EFO name: COLONIC NEOPLASM

CHEMBL_IND_50825
type: DrugIndication
chembl id: CHEMBL_IND_50825
has molecule: CHEMBL1171837
highest development phase: 2
has mesh: D046152
has mesh heading: GASTROINTESTINAL STROMAL TUMORS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: GASTROINTESTINAL STROMAL TUMOR

CHEMBL_IND_50571
type: DrugIndication
chembl id: CHEMBL_IND_50571
has molecule: CHEMBL1171837
highest development phase: 2
has mesh: D002289
has mesh heading: CARCINOMA, NON-SMALL-CELL LUNG
has EFO: EFO_0003060
has EFO name: NON-SMALL CELL LUNG CARCINOMA

CHEMBL_IND_50507
type: DrugIndication
chembl id: CHEMBL_IND_50507
has molecule: CHEMBL1171837
highest development phase: 2
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_50492
type: DrugIndication
chembl id: CHEMBL_IND_50492
has molecule: CHEMBL1171837
highest development phase: 3
has mesh: D015464
has mesh heading: LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE
has EFO: EFO_0000339
has EFO name: CHRONIC MYELOGENOUS LEUKEMIA

CHEMBL_IND_55301
type: DrugIndication
chembl id: CHEMBL_IND_55301
has molecule: CHEMBL1171837
highest development phase: 2
has mesh: D013964
has mesh heading: THYROID NEOPLASMS
has EFO: EFO_0003841
has EFO name: THYROID NEOPLASM

CHEMBL_IND_50211
type: DrugIndication
chembl id: CHEMBL_IND_50211
has molecule: CHEMBL1171837
highest development phase: 2
has mesh: D054198
has mesh heading: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
has EFO: EFO_0000220
has EFO name: ACUTE LYMPHOBLASTIC LEUKEMIA

CHEMBL_IND_55060
type: DrugIndication
chembl id: CHEMBL_IND_55060
has molecule: CHEMBL1171837
highest development phase: 2
has mesh: D005909
has mesh heading: GLIOBLASTOMA
has EFO: EFO_0000519
has EFO name: GLIOBLASTOMA MULTIFORME

CHEMBL_IND_50048
type: DrugIndication
chembl id: CHEMBL_IND_50048
has molecule: CHEMBL1171837
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_50494
type: DrugIndication
chembl id: CHEMBL_IND_50494
has molecule: CHEMBL1215923
highest development phase: 2
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_54958
type: DrugIndication
chembl id: CHEMBL_IND_54958
has molecule: CHEMBL1215923
highest development phase: 2
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_50719
type: DrugIndication
chembl id: CHEMBL_IND_50719
has molecule: CHEMBL1169880
highest development phase: 3
has mesh: D012559
has mesh heading: SCHIZOPHRENIA
has EFO: EFO_0000692
has EFO name: SCHIZOPHRENIA

CHEMBL_IND_55310
type: DrugIndication
chembl id: CHEMBL_IND_55310
has molecule: CHEMBL1169880
highest development phase: 2
has mesh: D009771
has mesh heading: OBSESSIVE-COMPULSIVE DISORDER
has EFO: EFO_0004242
has EFO name: OBSESSIVE-COMPULSIVE DISORDER

CHEMBL_IND_51495
type: DrugIndication
chembl id: CHEMBL_IND_51495
has molecule: CHEMBL1213165
highest development phase: 4
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_26280
type: DrugIndication
chembl id: CHEMBL_IND_26280
has molecule: CHEMBL1187846
highest development phase: 4
has mesh: D009325
has mesh heading: NAUSEA
has EFO: HP_0002018
has EFO name: NAUSEA

CHEMBL_IND_50041
type: DrugIndication
chembl id: CHEMBL_IND_50041
has molecule: CHEMBL1159717
highest development phase: 4
has mesh: D008173
has mesh heading: LUNG DISEASES, OBSTRUCTIVE
has EFO: HP_0006536
has EFO name: OBSTRUCTIVE LUNG DISEASE

CHEMBL_IND_27949
type: DrugIndication
chembl id: CHEMBL_IND_27949
has molecule: CHEMBL1160544
highest development phase: 3
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_24934
type: DrugIndication
chembl id: CHEMBL_IND_24934
has molecule: CHEMBL1160544
highest development phase: 4
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_26794
type: DrugIndication
chembl id: CHEMBL_IND_26794
has molecule: CHEMBL1201821
highest development phase: 1
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_28325
type: DrugIndication
chembl id: CHEMBL_IND_28325
has molecule: CHEMBL1201821
highest development phase: 2
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_27864
type: DrugIndication
chembl id: CHEMBL_IND_27864
has molecule: CHEMBL1201821
highest development phase: 2
has mesh: D015658
has mesh heading: HIV INFECTIONS
has EFO: EFO_0000764
has EFO name: HIV INFECTION

CHEMBL_IND_27365
type: DrugIndication
chembl id: CHEMBL_IND_27365
has molecule: CHEMBL1201821
highest development phase: 2
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_26852
type: DrugIndication
chembl id: CHEMBL_IND_26852
has molecule: CHEMBL1201825
highest development phase: 4
has mesh: D008269
has mesh heading: MACULAR EDEMA
has EFO: HP_0040049
has EFO name: MACULAR EDEMA

CHEMBL_IND_53411
type: DrugIndication
chembl id: CHEMBL_IND_53411
has molecule: CHEMBL1201825
highest development phase: 1
has mesh: D016510
has mesh heading: CORNEAL NEOVASCULARIZATION
has EFO: EFO_1000880
has EFO name: CORNEAL NEOVASCULARIZATION

CHEMBL_IND_25604
type: DrugIndication
chembl id: CHEMBL_IND_25604
has molecule: CHEMBL1201825
highest development phase: 4
has mesh: D015861
has mesh heading: RETINAL NEOVASCULARIZATION
has EFO: EFO_0005753
has EFO name: OCULAR VASCULAR DISORDER

CHEMBL_IND_25603
type: DrugIndication
chembl id: CHEMBL_IND_25603
has molecule: CHEMBL1201825
highest development phase: 1
has mesh: D009216
has mesh heading: MYOPIA
has EFO: HP_0000545
has EFO name: MYOPIA

CHEMBL_IND_26254
type: DrugIndication
chembl id: CHEMBL_IND_26254
has molecule: CHEMBL1201825
highest development phase: 2
has mesh: D005901
has mesh heading: GLAUCOMA
has EFO: EFO_0000516
has EFO name: GLAUCOMA

CHEMBL_IND_26253
type: DrugIndication
chembl id: CHEMBL_IND_26253
has molecule: CHEMBL1201825
highest development phase: 2
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_54334
type: DrugIndication
chembl id: CHEMBL_IND_54334
has molecule: CHEMBL1201825
highest development phase: 1
has mesh: D018917
has mesh heading: OPTIC NEUROPATHY, ISCHEMIC
has EFO: EFO_1000809
has EFO name: ANTERIOR ISCHEMIC OPTIC NEUROPATHY

CHEMBL_IND_40119
type: DrugIndication
chembl id: CHEMBL_IND_40119
has molecule: CHEMBL1201825
highest development phase: 2
has mesh: D006660
has mesh heading: HISTOPLASMOSIS
has EFO: EFO_0007310
has EFO name: HISTOPLASMOSIS

CHEMBL_IND_23776
type: DrugIndication
chembl id: CHEMBL_IND_23776
has molecule: CHEMBL1201825
highest development phase: 2
has mesh: D012164
has mesh heading: RETINAL DISEASES
has EFO: EFO_0003839
has EFO name: RETINOPATHY

CHEMBL_IND_23774
type: DrugIndication
chembl id: CHEMBL_IND_23774
has molecule: CHEMBL1201825
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000756
has EFO name: MELANOMA

CHEMBL_IND_23773
type: DrugIndication
chembl id: CHEMBL_IND_23773
has molecule: CHEMBL1201825
highest development phase: 4
has mesh: D003930
has mesh heading: DIABETIC RETINOPATHY
has EFO: EFO_0003770
has EFO name: DIABETIC RETINOPATHY

CHEMBL_IND_23772
type: DrugIndication
chembl id: CHEMBL_IND_23772
has molecule: CHEMBL1201825
highest development phase: 4
has mesh: D008269
has mesh heading: MACULAR EDEMA
has EFO: HP_0011505
has EFO name: CYSTOID MACULAR EDEMA

CHEMBL_IND_23771
type: DrugIndication
chembl id: CHEMBL_IND_23771
has molecule: CHEMBL1201825
highest development phase: 4
has mesh: D008268
has mesh heading: MACULAR DEGENERATION
has EFO: EFO_0001365
has EFO name: AGE-RELATED MACULAR DEGENERATION

CHEMBL_IND_27411
type: DrugIndication
chembl id: CHEMBL_IND_27411
has molecule: CHEMBL1201825
highest development phase: 4
has mesh: D057135
has mesh heading: WET MACULAR DEGENERATION
has EFO: EFO_0004683
has EFO name: WET MACULAR DEGENERATION

CHEMBL_IND_27410
type: DrugIndication
chembl id: CHEMBL_IND_27410
has molecule: CHEMBL1201825
highest development phase: 2
has mesh: D011625
has mesh heading: PTERYGIUM
has EFO: EFO_0000678
has EFO name: PTERYGIUM

CHEMBL_IND_53124
type: DrugIndication
chembl id: CHEMBL_IND_53124
has molecule: CHEMBL1201825
highest development phase: 3
has mesh: D012178
has mesh heading: RETINOPATHY OF PREMATURITY
has EFO: EFO_1001158
has EFO name: RETINOPATHY OF PREMATURITY

CHEMBL_IND_53122
type: DrugIndication
chembl id: CHEMBL_IND_53122
has molecule: CHEMBL1201825
highest development phase: 4
has mesh: D012170
has mesh heading: RETINAL VEIN OCCLUSION
has EFO: EFO_1001157
has EFO name: RETINAL VEIN OCCLUSION

CHEMBL_IND_52834
type: DrugIndication
chembl id: CHEMBL_IND_52834
has molecule: CHEMBL1201826
highest development phase: 4
has mesh: D016532
has mesh heading: MUCOPOLYSACCHARIDOSIS II
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: MUCOPOLYSACCHARIDOSIS TYPE 2

CHEMBL_IND_26861
type: DrugIndication
chembl id: CHEMBL_IND_26861
has molecule: CHEMBL1201830
highest development phase: 2
has mesh: D010505
has mesh heading: FAMILIAL MEDITERRANEAN FEVER
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: FAMILIAL MEDITERRANEAN FEVER

CHEMBL_IND_26860
type: DrugIndication
chembl id: CHEMBL_IND_26860
has molecule: CHEMBL1201830
highest development phase: 2
has mesh: D001171
has mesh heading: ARTHRITIS, JUVENILE
has EFO: EFO_0002609
has EFO name: CHRONIC CHILDHOOD ARTHRITIS

CHEMBL_IND_42008
type: DrugIndication
chembl id: CHEMBL_IND_42008
has molecule: CHEMBL1201830
highest development phase: 4
has mesh: D007154
has mesh heading: IMMUNE SYSTEM DISEASES
has EFO: EFO_0000540
has EFO name: IMMUNE SYSTEM DISEASE

CHEMBL_IND_52734
type: DrugIndication
chembl id: CHEMBL_IND_52734
has molecule: CHEMBL1201830
highest development phase: 4
has mesh: D056587
has mesh heading: CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME

CHEMBL_IND_52806
type: DrugIndication
chembl id: CHEMBL_IND_52806
has molecule: CHEMBL1201830
highest development phase: 4
has mesh: D056587
has mesh heading: CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: MUCKLE-WELLS SYNDROME

CHEMBL_IND_52805
type: DrugIndication
chembl id: CHEMBL_IND_52805
has molecule: CHEMBL1201830
highest development phase: 4
has mesh: D056587
has mesh heading: CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: FAMILIAL COLD URTICARIA

CHEMBL_IND_23794
type: DrugIndication
chembl id: CHEMBL_IND_23794
has molecule: CHEMBL1201830
highest development phase: 3
has mesh: D006073
has mesh heading: GOUT
has EFO: EFO_0004274
has EFO name: GOUT

CHEMBL_IND_27910
type: DrugIndication
chembl id: CHEMBL_IND_27910
has molecule: CHEMBL1201830
highest development phase: 1
has mesh: D003922
has mesh heading: DIABETES MELLITUS, TYPE 1
has EFO: EFO_0001359
has EFO name: TYPE I DIABETES MELLITUS

CHEMBL_IND_43507
type: DrugIndication
chembl id: CHEMBL_IND_43507
has molecule: CHEMBL1201831
highest development phase: 3
has mesh: D011565
has mesh heading: PSORIASIS
has EFO: EFO_0000676
has EFO name: PSORIASIS

CHEMBL_IND_26455
type: DrugIndication
chembl id: CHEMBL_IND_26455
has molecule: CHEMBL1201831
highest development phase: 4
has mesh: D003424
has mesh heading: CROHN DISEASE
has EFO: EFO_0000384
has EFO name: CROHN'S DISEASE

CHEMBL_IND_26454
type: DrugIndication
chembl id: CHEMBL_IND_26454
has molecule: CHEMBL1201831
highest development phase: 4
has mesh: D013167
has mesh heading: SPONDYLITIS, ANKYLOSING
has EFO: EFO_0003898
has EFO name: ANKYLOSING SPONDYLITIS

CHEMBL_IND_27608
type: DrugIndication
chembl id: CHEMBL_IND_27608
has molecule: CHEMBL1201831
highest development phase: 3
has mesh: D001171
has mesh heading: ARTHRITIS, JUVENILE
has EFO: EFO_0002609
has EFO name: CHRONIC CHILDHOOD ARTHRITIS

CHEMBL_IND_54555
type: DrugIndication
chembl id: CHEMBL_IND_54555
has molecule: CHEMBL1201831
highest development phase: 3
has mesh: D018856
has mesh heading: CYSTITIS, INTERSTITIAL
has EFO: EFO_1000869
has EFO name: CHRONIC INTERSTITIAL CYSTITIS

CHEMBL_IND_22875
type: DrugIndication
chembl id: CHEMBL_IND_22875
has molecule: CHEMBL1201831
highest development phase: 4
has mesh: D001172
has mesh heading: ARTHRITIS, RHEUMATOID
has EFO: EFO_0000685
has EFO name: RHEUMATOID ARTHRITIS

CHEMBL_IND_25163
type: DrugIndication
chembl id: CHEMBL_IND_25163
has molecule: CHEMBL1201831
highest development phase: 2
has mesh: D003093
has mesh heading: COLITIS, ULCERATIVE
has EFO: EFO_0000729
has EFO name: ULCERATIVE COLITIS

CHEMBL_IND_24255
type: DrugIndication
chembl id: CHEMBL_IND_24255
has molecule: CHEMBL1201831
highest development phase: 4
has mesh: D015535
has mesh heading: ARTHRITIS, PSORIATIC
has EFO: EFO_0003778
has EFO name: PSORIATIC ARTHRITIS

CHEMBL_IND_26612
type: DrugIndication
chembl id: CHEMBL_IND_26612
has molecule: CHEMBL1201833
highest development phase: 4
has mesh: D015535
has mesh heading: ARTHRITIS, PSORIATIC
has EFO: EFO_0003778
has EFO name: PSORIATIC ARTHRITIS

CHEMBL_IND_54679
type: DrugIndication
chembl id: CHEMBL_IND_54679
has molecule: CHEMBL1201833
highest development phase: 2
has mesh: D003922
has mesh heading: DIABETES MELLITUS, TYPE 1
has EFO: EFO_0001359
has EFO name: TYPE I DIABETES MELLITUS

CHEMBL_IND_26020
type: DrugIndication
chembl id: CHEMBL_IND_26020
has molecule: CHEMBL1201833
highest development phase: 2
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_27727
type: DrugIndication
chembl id: CHEMBL_IND_27727
has molecule: CHEMBL1201833
highest development phase: 2
has mesh: D012507
has mesh heading: SARCOIDOSIS
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: SARCOIDOSIS

CHEMBL_IND_25352
type: DrugIndication
chembl id: CHEMBL_IND_25352
has molecule: CHEMBL1201833
highest development phase: 4
has mesh: D013167
has mesh heading: SPONDYLITIS, ANKYLOSING
has EFO: EFO_0003898
has EFO name: ANKYLOSING SPONDYLITIS

CHEMBL_IND_24476
type: DrugIndication
chembl id: CHEMBL_IND_24476
has molecule: CHEMBL1201833
highest development phase: 4
has mesh: D003093
has mesh heading: COLITIS, ULCERATIVE
has EFO: EFO_0000729
has EFO name: ULCERATIVE COLITIS

CHEMBL_IND_24475
type: DrugIndication
chembl id: CHEMBL_IND_24475
has molecule: CHEMBL1201833
highest development phase: 3
has mesh: D025242
has mesh heading: SPONDYLARTHROPATHIES
has EFO: EFO_0000706
has EFO name: SPONDYLOARTHROPATHY

CHEMBL_IND_24474
type: DrugIndication
chembl id: CHEMBL_IND_24474
has molecule: CHEMBL1201833
highest development phase: 4
has mesh: D001172
has mesh heading: ARTHRITIS, RHEUMATOID
has EFO: EFO_0000685
has EFO name: RHEUMATOID ARTHRITIS

CHEMBL_IND_49690
type: DrugIndication
chembl id: CHEMBL_IND_49690
has molecule: CHEMBL1201834
highest development phase: 4
has mesh: D056587
has mesh heading: CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CINCA SYNDROME

CHEMBL_IND_53472
type: DrugIndication
chembl id: CHEMBL_IND_53472
has molecule: CHEMBL1201834
highest development phase: 2
has mesh: D017565
has mesh heading: SARCOIDOSIS, PULMONARY
has EFO: DOID:13406
has EFO name: PULMONARY SARCOIDOSIS

CHEMBL_IND_27075
type: DrugIndication
chembl id: CHEMBL_IND_27075
has molecule: CHEMBL1201834
highest development phase: 2
has mesh: D001172
has mesh heading: ARTHRITIS, RHEUMATOID
has EFO: EFO_0000685
has EFO name: RHEUMATOID ARTHRITIS

CHEMBL_IND_27074
type: DrugIndication
chembl id: CHEMBL_IND_27074
has molecule: CHEMBL1201834
highest development phase: 3
has mesh: D050197
has mesh heading: ATHEROSCLEROSIS
has EFO: EFO_0003914
has EFO name: ATHEROSCLEROSIS

CHEMBL_IND_25851
type: DrugIndication
chembl id: CHEMBL_IND_25851
has molecule: CHEMBL1201834
highest development phase: 2
has mesh: D011711
has mesh heading: PYODERMA
has EFO: HP_0000999
has EFO name: PYODERMA

CHEMBL_IND_25850
type: DrugIndication
chembl id: CHEMBL_IND_25850
has molecule: CHEMBL1201834
highest development phase: 4
has mesh: D010505
has mesh heading: FAMILIAL MEDITERRANEAN FEVER
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: FAMILIAL MEDITERRANEAN FEVER

CHEMBL_IND_46700
type: DrugIndication
chembl id: CHEMBL_IND_46700
has molecule: CHEMBL1201834
highest development phase: 2
has mesh: D010003
has mesh heading: OSTEOARTHRITIS
has EFO: EFO_0002506
has EFO name: OSTEOARTHRITIS

CHEMBL_IND_47962
type: DrugIndication
chembl id: CHEMBL_IND_47962
has molecule: CHEMBL1201834
highest development phase: 2
has mesh: D003920
has mesh heading: DIABETES MELLITUS
has EFO: EFO_0000400
has EFO name: DIABETES MELLITUS

CHEMBL_IND_47885
type: DrugIndication
chembl id: CHEMBL_IND_47885
has molecule: CHEMBL1201834
highest development phase: 2
has mesh: D001281
has mesh heading: ATRIAL FIBRILLATION
has EFO: EFO_0000275
has EFO name: ATRIAL FIBRILLATION

CHEMBL_IND_53339
type: DrugIndication
chembl id: CHEMBL_IND_53339
has molecule: CHEMBL1201834
highest development phase: 1
has mesh: D003930
has mesh heading: DIABETIC RETINOPATHY
has EFO: EFO_0003770
has EFO name: DIABETIC RETINOPATHY

CHEMBL_IND_26442
type: DrugIndication
chembl id: CHEMBL_IND_26442
has molecule: CHEMBL1201834
highest development phase: 1
has mesh: D029424
has mesh heading: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE
has EFO: EFO_0000341
has EFO name: CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHEMBL_IND_46055
type: DrugIndication
chembl id: CHEMBL_IND_46055
has molecule: CHEMBL1201834
highest development phase: 2
has mesh: D058729
has mesh heading: PERIPHERAL ARTERIAL DISEASE
has EFO: EFO_0004265
has EFO name: PERIPHERAL ARTERIAL DISEASE

CHEMBL_IND_52733
type: DrugIndication
chembl id: CHEMBL_IND_52733
has molecule: CHEMBL1201834
highest development phase: 4
has mesh: D056587
has mesh heading: CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME

CHEMBL_IND_54559
type: DrugIndication
chembl id: CHEMBL_IND_54559
has molecule: CHEMBL1201834
highest development phase: 2
has mesh: D015352
has mesh heading: DRY EYE SYNDROMES
has EFO: EFO_1000906
has EFO name: DRY EYE SYNDROME

CHEMBL_IND_44045
type: DrugIndication
chembl id: CHEMBL_IND_44045
has molecule: CHEMBL1201834
highest development phase: 2
has mesh: D017544
has mesh heading: AORTIC ANEURYSM, ABDOMINAL
has EFO: EFO_0004214
has EFO name: ABDOMINAL AORTIC ANEURYSM

CHEMBL_IND_41732
type: DrugIndication
chembl id: CHEMBL_IND_41732
has molecule: CHEMBL1201834
highest development phase: 4
has mesh: D007154
has mesh heading: IMMUNE SYSTEM DISEASES
has EFO: EFO_0000540
has EFO name: IMMUNE SYSTEM DISEASE

CHEMBL_IND_54482
type: DrugIndication
chembl id: CHEMBL_IND_54482
has molecule: CHEMBL1201834
highest development phase: 2
has mesh: D003922
has mesh heading: DIABETES MELLITUS, TYPE 1
has EFO: EFO_0001359
has EFO name: TYPE I DIABETES MELLITUS

CHEMBL_IND_22838
type: DrugIndication
chembl id: CHEMBL_IND_22838
has molecule: CHEMBL1201834
highest development phase: 4
has mesh: D054078
has mesh heading: MEVALONATE KINASE DEFICIENCY
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: MEVALONATE KINASE DEFICIENCY

CHEMBL_IND_22837
type: DrugIndication
chembl id: CHEMBL_IND_22837
has molecule: CHEMBL1201834
highest development phase: 4
has mesh: D001171
has mesh heading: ARTHRITIS, JUVENILE
has EFO: EFO_0002609
has EFO name: CHRONIC CHILDHOOD ARTHRITIS

CHEMBL_IND_25150
type: DrugIndication
chembl id: CHEMBL_IND_25150
has molecule: CHEMBL1201834
highest development phase: 2
has mesh: D014581
has mesh heading: URTICARIA
has EFO: EFO_0005531
has EFO name: URTICARIA

CHEMBL_IND_25149
type: DrugIndication
chembl id: CHEMBL_IND_25149
has molecule: CHEMBL1201834
highest development phase: 3
has mesh: D005334
has mesh heading: FEVER
has EFO: HP_0001945
has EFO name: FEVER

CHEMBL_IND_24240
type: DrugIndication
chembl id: CHEMBL_IND_24240
has molecule: CHEMBL1201834
highest development phase: 3
has mesh: D006073
has mesh heading: GOUT
has EFO: EFO_0004274
has EFO name: GOUT

CHEMBL_IND_25276
type: DrugIndication
chembl id: CHEMBL_IND_25276
has molecule: CHEMBL1201837
highest development phase: 4
has mesh: D054179
has mesh heading: ANGIOEDEMAS, HEREDITARY
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: HEREDITARY ANGIOEDEMA

CHEMBL_IND_25275
type: DrugIndication
chembl id: CHEMBL_IND_25275
has molecule: CHEMBL1201837
highest development phase: 2
has mesh: D000799
has mesh heading: ANGIOEDEMA
has EFO: EFO_0005532
has EFO name: ANGIOEDEMA

CHEMBL_IND_28083
type: DrugIndication
chembl id: CHEMBL_IND_28083
has molecule: CHEMBL1200475
highest development phase: 1
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_42950
type: DrugIndication
chembl id: CHEMBL_IND_42950
has molecule: CHEMBL1200477
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_41657
type: DrugIndication
chembl id: CHEMBL_IND_41657
has molecule: CHEMBL1200477
highest development phase: 4
has mesh: D066066
has mesh heading: RESPONSE EVALUATION CRITERIA IN SOLID TUMORS

CHEMBL_IND_22662
type: DrugIndication
chembl id: CHEMBL_IND_22662
has molecule: CHEMBL1200477
highest development phase: 4
has mesh: D008223
has mesh heading: LYMPHOMA
has EFO: EFO_0000574
has EFO name: LYMPHOMA

CHEMBL_IND_22660
type: DrugIndication
chembl id: CHEMBL_IND_22660
has molecule: CHEMBL1200477
highest development phase: 4
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_22658
type: DrugIndication
chembl id: CHEMBL_IND_22658
has molecule: CHEMBL1200477
highest development phase: 4
has mesh: D006073
has mesh heading: GOUT
has EFO: EFO_0004274
has EFO name: GOUT

CHEMBL_IND_52673
type: DrugIndication
chembl id: CHEMBL_IND_52673
has molecule: CHEMBL1200681
highest development phase: 3
has mesh: D012221
has mesh heading: RHINITIS, ALLERGIC, PERENNIAL
has EFO: EFO_1001417
has EFO name: RHINITIS, ALLERGIC, PERENNIAL

CHEMBL_IND_24670
type: DrugIndication
chembl id: CHEMBL_IND_24670
has molecule: CHEMBL1200681
highest development phase: 4
has mesh: D006255
has mesh heading: RHINITIS, ALLERGIC, SEASONAL
has EFO: EFO_0003956
has EFO name: SEASONAL ALLERGIC RHINITIS

CHEMBL_IND_24669
type: DrugIndication
chembl id: CHEMBL_IND_24669
has molecule: CHEMBL1200681
highest development phase: 4
has mesh: D006255
has mesh heading: RHINITIS, ALLERGIC, SEASONAL
has EFO: EFO_0005854
has EFO name: ALLERGIC RHINITIS

CHEMBL_IND_23530
type: DrugIndication
chembl id: CHEMBL_IND_23530
has molecule: CHEMBL1200681
highest development phase: 1
has mesh: D057765
has mesh heading: EOSINOPHILIC ESOPHAGITIS
has EFO: EFO_0004232
has EFO name: EOSINOPHILIC ESOPHAGITIS

CHEMBL_IND_23529
type: DrugIndication
chembl id: CHEMBL_IND_23529
has molecule: CHEMBL1200681
highest development phase: 4
has mesh: D001249
has mesh heading: ASTHMA
has EFO: EFO_0000270
has EFO name: ASTHMA

CHEMBL_IND_23244
type: DrugIndication
chembl id: CHEMBL_IND_23244
has molecule: CHEMBL1200501
highest development phase: 3
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_23243
type: DrugIndication
chembl id: CHEMBL_IND_23243
has molecule: CHEMBL1200501
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_49253
type: DrugIndication
chembl id: CHEMBL_IND_49253
has molecule: CHEMBL1200512
highest development phase: 2
has mesh: D005909
has mesh heading: GLIOBLASTOMA
has EFO: EFO_0000519
has EFO name: GLIOBLASTOMA MULTIFORME

CHEMBL_IND_26058
type: DrugIndication
chembl id: CHEMBL_IND_26058
has molecule: CHEMBL1200512
highest development phase: 2
has mesh: D005910
has mesh heading: GLIOMA
has EFO: EFO_0000326
has EFO name: CENTRAL NERVOUS SYSTEM CANCER

CHEMBL_IND_27750
type: DrugIndication
chembl id: CHEMBL_IND_27750
has molecule: CHEMBL1200512
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_23367
type: DrugIndication
chembl id: CHEMBL_IND_23367
has molecule: CHEMBL1200512
highest development phase: 2
has mesh: D015179
has mesh heading: COLORECTAL NEOPLASMS
has EFO: EFO_0000365
has EFO name: COLORECTAL ADENOCARCINOMA

CHEMBL_IND_23366
type: DrugIndication
chembl id: CHEMBL_IND_23366
has molecule: CHEMBL1200512
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_23365
type: DrugIndication
chembl id: CHEMBL_IND_23365
has molecule: CHEMBL1200512
highest development phase: 2
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_23744
type: DrugIndication
chembl id: CHEMBL_IND_23744
has molecule: CHEMBL1200750
highest development phase: 1
has mesh: D006967
has mesh heading: HYPERSENSITIVITY
has EFO: EFO_0003785
has EFO name: ALLERGY

CHEMBL_IND_42987
type: DrugIndication
chembl id: CHEMBL_IND_42987
has molecule: CHEMBL1200751
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_25445
type: DrugIndication
chembl id: CHEMBL_IND_25445
has molecule: CHEMBL1200751
highest development phase: 3
has mesh: D054198
has mesh heading: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
has EFO: EFO_0000220
has EFO name: ACUTE LYMPHOBLASTIC LEUKEMIA

CHEMBL_IND_45081
type: DrugIndication
chembl id: CHEMBL_IND_45081
has molecule: CHEMBL1200751
highest development phase: 2
has mesh: D003092
has mesh heading: COLITIS
has EFO: EFO_0003872
has EFO name: COLITIS

CHEMBL_IND_23462
type: DrugIndication
chembl id: CHEMBL_IND_23462
has molecule: CHEMBL1200751
highest development phase: 3
has mesh: D003424
has mesh heading: CROHN DISEASE
has EFO: EFO_0000384
has EFO name: CROHN'S DISEASE

CHEMBL_IND_51729
type: DrugIndication
chembl id: CHEMBL_IND_51729
has molecule: CHEMBL1200836
highest development phase: 1
has mesh: D014008
has mesh heading: TINEA PEDIS
has EFO: EFO_0007512
has EFO name: TINEA PEDIS

CHEMBL_IND_26836
type: DrugIndication
chembl id: CHEMBL_IND_26836
has molecule: CHEMBL1200909
highest development phase: 4
has mesh: D015508
has mesh heading: NASAL OBSTRUCTION
has EFO: HP_0001742
has EFO name: NASAL OBSTRUCTION

CHEMBL_IND_26233
type: DrugIndication
chembl id: CHEMBL_IND_26233
has molecule: CHEMBL1200909
highest development phase: 4
has mesh: D005128
has mesh heading: EYE DISEASES
has EFO: EFO_0005752
has EFO name: EYE INFLAMMATION

CHEMBL_IND_42851
type: DrugIndication
chembl id: CHEMBL_IND_42851
has molecule: CHEMBL1200992
highest development phase: 4
has mesh: D009290
has mesh heading: NARCOLEPSY
has EFO: EFO_0000614
has EFO name: NARCOLEPSY

CHEMBL_IND_23017
type: DrugIndication
chembl id: CHEMBL_IND_23017
has molecule: CHEMBL1200992
highest development phase: 4
has mesh: D001289
has mesh heading: ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY
has EFO: EFO_0003888
has EFO name: ATTENTION DEFICIT HYPERACTIVITY DISORDER

CHEMBL_IND_49716
type: DrugIndication
chembl id: CHEMBL_IND_49716
has molecule: CHEMBL1193948
highest development phase: 3
has mesh: D003866
has mesh heading: DEPRESSIVE DISORDER
has EFO: EFO_0003761
has EFO name: UNIPOLAR DEPRESSION

CHEMBL_IND_26808
type: DrugIndication
chembl id: CHEMBL_IND_26808
has molecule: CHEMBL1201733
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_47937
type: DrugIndication
chembl id: CHEMBL_IND_47937
has molecule: CHEMBL1201733
highest development phase: 4
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0000349
has EFO name: CLEAR CELL RENAL CARCINOMA

CHEMBL_IND_45257
type: DrugIndication
chembl id: CHEMBL_IND_45257
has molecule: CHEMBL1201733
highest development phase: 2
has mesh: D018567
has mesh heading: BREAST NEOPLASMS, MALE
has EFO: EFO_0006861
has EFO name: MALE BREAST CARCINOMA

CHEMBL_IND_52186
type: DrugIndication
chembl id: CHEMBL_IND_52186
has molecule: CHEMBL1201733
highest development phase: 2
has mesh: D018316
has mesh heading: GLIOSARCOMA
has EFO: EFO_1001465
has EFO name: GLIOSARCOMA

CHEMBL_IND_45613
type: DrugIndication
chembl id: CHEMBL_IND_45613
has molecule: CHEMBL1201733
highest development phase: 2
has mesh: D008654
has mesh heading: MESOTHELIOMA
has EFO: EFO_0000588
has EFO name: MESOTHELIOMA

CHEMBL_IND_51959
type: DrugIndication
chembl id: CHEMBL_IND_51959
has molecule: CHEMBL1201733
highest development phase: 1
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_23673
type: DrugIndication
chembl id: CHEMBL_IND_23673
has molecule: CHEMBL1201733
highest development phase: 4
has mesh: D012509
has mesh heading: SARCOMA
has EFO: EFO_0000691
has EFO name: SARCOMA

CHEMBL_IND_44547
type: DrugIndication
chembl id: CHEMBL_IND_44547
has molecule: CHEMBL1201733
highest development phase: 2
has mesh: D008545
has mesh heading: MELANOMA
has EFO: EFO_0000389
has EFO name: CUTANEOUS MELANOMA

CHEMBL_IND_24765
type: DrugIndication
chembl id: CHEMBL_IND_24765
has molecule: CHEMBL1201733
highest development phase: 2
has mesh: D008175
has mesh heading: LUNG NEOPLASMS
has EFO: EFO_0001071
has EFO name: LUNG CARCINOMA

CHEMBL_IND_51608
type: DrugIndication
chembl id: CHEMBL_IND_51608
has molecule: CHEMBL1201733
highest development phase: 4
has mesh: D002292
has mesh heading: CARCINOMA, RENAL CELL
has EFO: EFO_0000681
has EFO name: RENAL CELL CARCINOMA

CHEMBL_IND_27200
type: DrugIndication
chembl id: CHEMBL_IND_27200
has molecule: CHEMBL1201064
highest development phase: 4
has mesh: D005128
has mesh heading: EYE DISEASES
has EFO: EFO_0005752
has EFO name: EYE INFLAMMATION

CHEMBL_IND_27199
type: DrugIndication
chembl id: CHEMBL_IND_27199
has molecule: CHEMBL1201064
highest development phase: 4
has mesh: D000152
has mesh heading: ACNE VULGARIS
has EFO: EFO_0003894
has EFO name: ACNE

CHEMBL_IND_47912
type: DrugIndication
chembl id: CHEMBL_IND_47912
has molecule: CHEMBL1200480
highest development phase: 3
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_25510
type: DrugIndication
chembl id: CHEMBL_IND_25510
has molecule: CHEMBL1200480
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0001663
has EFO name: PROSTATE CARCINOMA

CHEMBL_IND_28302
type: DrugIndication
chembl id: CHEMBL_IND_28302
has molecule: CHEMBL1200480
highest development phase: 2
has mesh: D044903
has mesh heading: CONGENITAL HYPERINSULINISM
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: CONGENITAL ISOLATED HYPERINSULINISM

CHEMBL_IND_27845
type: DrugIndication
chembl id: CHEMBL_IND_27845
has molecule: CHEMBL1200480
highest development phase: 3
has mesh: D001943
has mesh heading: BREAST NEOPLASMS
has EFO: EFO_0000305
has EFO name: BREAST CARCINOMA

CHEMBL_IND_23592
type: DrugIndication
chembl id: CHEMBL_IND_23592
has molecule: CHEMBL1200480
highest development phase: 3
has mesh: D003930
has mesh heading: DIABETIC RETINOPATHY
has EFO: EFO_0003770
has EFO name: DIABETIC RETINOPATHY

CHEMBL_IND_23591
type: DrugIndication
chembl id: CHEMBL_IND_23591
has molecule: CHEMBL1200480
highest development phase: 2
has mesh: D002277
has mesh heading: CARCINOMA
has EFO: EFO_0000313
has EFO name: CARCINOMA

CHEMBL_IND_51770
type: DrugIndication
chembl id: CHEMBL_IND_51770
has molecule: CHEMBL1200480
highest development phase: 4
has mesh: D000172
has mesh heading: ACROMEGALY
has EFO: EFO_1001485
has EFO name: ACROMEGALY

CHEMBL_IND_26595
type: DrugIndication
chembl id: CHEMBL_IND_26595
has molecule: CHEMBL1200600
highest development phase: 4
has mesh: D005128
has mesh heading: EYE DISEASES
has EFO: EFO_0005752
has EFO name: EYE INFLAMMATION

CHEMBL_IND_26594
type: DrugIndication
chembl id: CHEMBL_IND_26594
has molecule: CHEMBL1200600
highest development phase: 4
has mesh: D000152
has mesh heading: ACNE VULGARIS
has EFO: EFO_0003894
has EFO name: ACNE

CHEMBL_IND_23199
type: DrugIndication
chembl id: CHEMBL_IND_23199
has molecule: CHEMBL1200600
highest development phase: 2
has mesh: D003318
has mesh heading: CORNEAL OPACITY
has EFO: HP_0007957
has EFO name: CORNEAL OPACITY

CHEMBL_IND_40629
type: DrugIndication
chembl id: CHEMBL_IND_40629
has molecule: CHEMBL1200724
highest development phase: 3
has mesh: D003139
has mesh heading: COMMON COLD
has EFO: EFO_0007214
has EFO name: COMMON COLD

CHEMBL_IND_46542
type: DrugIndication
chembl id: CHEMBL_IND_46542
has molecule: CHEMBL1200895
highest development phase: 2
has mesh: D011471
has mesh heading: PROSTATIC NEOPLASMS
has EFO: EFO_0000673
has EFO name: PROSTATE ADENOCARCINOMA

CHEMBL_IND_42977
type: DrugIndication
chembl id: CHEMBL_IND_42977
has molecule: CHEMBL1200978
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000616
has EFO name: NEOPLASM

CHEMBL_IND_52545
type: DrugIndication
chembl id: CHEMBL_IND_52545
has molecule: CHEMBL1200978
highest development phase: 1
has mesh: D018316
has mesh heading: GLIOSARCOMA
has EFO: EFO_1001465
has EFO name: GLIOSARCOMA

CHEMBL_IND_45694
type: DrugIndication
chembl id: CHEMBL_IND_45694
has molecule: CHEMBL1200978
highest development phase: 2
has mesh: D055752
has mesh heading: SMALL CELL LUNG CARCINOMA
has EFO: EFO_0000702
has EFO name: SMALL CELL LUNG CARCINOMA

CHEMBL_IND_26394
type: DrugIndication
chembl id: CHEMBL_IND_26394
has molecule: CHEMBL1200978
highest development phase: 2
has mesh: D008180
has mesh heading: LUPUS ERYTHEMATOSUS, SYSTEMIC
has EFO: EFO_0002690
has EFO name: SYSTEMIC LUPUS ERYTHEMATOSUS

CHEMBL_IND_51860
type: DrugIndication
chembl id: CHEMBL_IND_51860
has molecule: CHEMBL1200978
highest development phase: 2
has mesh: D006086
has mesh heading: GRAFT VS HOST DISEASE
has EFO: EFO_0004599
has EFO name: ACUTE GRAFT VS. HOST DISEASE

CHEMBL_IND_22710
type: DrugIndication
chembl id: CHEMBL_IND_22710
has molecule: CHEMBL1200978
highest development phase: 2
has mesh: D007938
has mesh heading: LEUKEMIA
has EFO: EFO_0000565
has EFO name: LEUKEMIA

CHEMBL_IND_25789
type: DrugIndication
chembl id: CHEMBL_IND_25789
has molecule: CHEMBL1200978
highest development phase: 2
has mesh: D010190
has mesh heading: PANCREATIC NEOPLASMS
has EFO: EFO_0002618
has EFO name: PANCREATIC CARCINOMA

CHEMBL_IND_25788
type: DrugIndication
chembl id: CHEMBL_IND_25788
has molecule: CHEMBL1200978
highest development phase: 4
has mesh: D015473
has mesh heading: LEUKEMIA, PROMYELOCYTIC, ACUTE
has EFO: EFO_0000224
has EFO name: ACUTE PROMYELOCYTIC LEUKEMIA

CHEMBL_IND_25787
type: DrugIndication
chembl id: CHEMBL_IND_25787
has molecule: CHEMBL1200978
highest development phase: 2
has mesh: D015470
has mesh heading: LEUKEMIA, MYELOID, ACUTE
has EFO: EFO_0000222
has EFO name: ACUTE MYELOID LEUKEMIA

CHEMBL_IND_25076
type: DrugIndication
chembl id: CHEMBL_IND_25076
has molecule: CHEMBL1200978
highest development phase: 4
has mesh: D009369
has mesh heading: NEOPLASMS
has EFO: EFO_0000311
has EFO name: CANCER

CHEMBL_IND_25075
type: DrugIndication
chembl id: CHEMBL_IND_25075
has molecule: CHEMBL1200978
highest development phase: 2
has mesh: D006528
has mesh heading: CARCINOMA, HEPATOCELLULAR
has EFO: EFO_0000182
has EFO name: HEPATOCELLULAR CARCINOMA

CHEMBL_IND_25074
type: DrugIndication
chembl id: CHEMBL_IND_25074
has molecule: CHEMBL1200978
highest development phase: 1
has mesh: D015464
has mesh heading: LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE
has EFO: EFO_0000339
has EFO name: CHRONIC MYELOGENOUS LEUKEMIA

CHEMBL_IND_42350
type: DrugIndication
chembl id: CHEMBL_IND_42350
has molecule: CHEMBL1201262
highest development phase: 4
has mesh: D005901
has mesh heading: GLAUCOMA
has EFO: EFO_0000516
has EFO name: GLAUCOMA

CHEMBL_IND_25050
type: DrugIndication
chembl id: CHEMBL_IND_25050
has molecule: CHEMBL1200521
highest development phase: 4
has mesh: D008881
has mesh heading: MIGRAINE DISORDERS
has EFO: EFO_0003821
has EFO name: MIGRAINE DISORDER

CHEMBL_IND_47122
type: DrugIndication
chembl id: CHEMBL_IND_47122
has molecule: CHEMBL6966
highest development phase: 3
has mesh: D001714
has mesh heading: BIPOLAR DISORDER
has EFO: EFO_0000289
has EFO name: BIPOLAR DISORDER

CHEMBL_IND_48126
type: DrugIndication
chembl id: CHEMBL_IND_48126
has molecule: CHEMBL6966
highest development phase: 2
has mesh: D003922
has mesh heading: DIABETES MELLITUS, TYPE 1
has EFO: EFO_0001359
has EFO name: TYPE I DIABETES MELLITUS

CHEMBL_IND_42149
type: DrugIndication
chembl id: CHEMBL_IND_42149
has molecule: CHEMBL6966
highest development phase: 4
has mesh: D002318
has mesh heading: CARDIOVASCULAR DISEASES
has EFO: EFO_0000319
has EFO name: CARDIOVASCULAR DISEASE

CHEMBL_IND_47808
type: DrugIndication
chembl id: CHEMBL_IND_47808
has molecule: CHEMBL6966
highest development phase: 2
has mesh: D004831
has mesh heading: EPILEPSIES, MYOCLONIC
has EFO: http://www.orpha.net/consor/cgi-bin/OC_Exp.php
has EFO name: DRAVET SYNDROME

CHEMBL_IND_43210
type: DrugIndication
chembl id: CHEMBL_IND_43210
has molecule: CHEMBL6966
highest development phase: 4
has mesh: D001281
has mesh heading: ATRIAL FIBRILLATION
has EFO: EFO_0000275
has EFO name: ATRIAL FIBRILLATION